,protein_name,pubmed_id,title,authors,mesh_terms,paper_url
0,HTR1B,32231051,"HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia.","['Grubor M', 'Zivkovic M', 'Sagud M', 'Nikolac Perkovic M', 'Mihaljevic-Peles A', 'Pivac N', 'Muck-Seler D', 'Svob Strac D']","['Adult', 'Antipsychotic Agents/*adverse effects/therapeutic use', 'Haloperidol/*adverse effects/therapeutic use', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptor, Serotonin, 5-HT2A/genetics', 'Receptor, Serotonin, 5-HT2C/genetics', 'Receptors, Serotonin/*genetics', 'Schizophrenia/*drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/32231051/
1,HTR1B,35853382,HTR1B genotype and psychopathy: Main effect and interaction with paternal maltreatment.,"['Palumbo S', 'Mariotti V', 'Vellucci S', 'Antonelli K', 'Anderson N', 'Harenski C', 'Pietrini P', 'Kiehl KA', 'Pellegrini S']","['Adolescent', 'Adult', 'Alleles', '*Antisocial Personality Disorder/genetics/psychology', '*Emotions', 'Genotype', 'Humans', 'Male', 'Parenting', 'Receptor, Serotonin, 5-HT1B/genetics']",https://pubmed.ncbi.nlm.nih.gov/35853382/
2,HTR1B,34773671,The impact of HTR1A and HTR1B methylation combined with stress/genotype on early antidepressant efficacy.,"['Xu Z', 'Chen Z', 'Shen T', 'Chen L', 'Tan T', 'Gao C', 'Chen B', 'Yuan Y', 'Zhang Z']","['*Antidepressive Agents/pharmacology', 'Case-Control Studies', 'DNA Methylation', '*Depressive Disorder, Major/drug therapy/genetics', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide/genetics', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Stress, Psychological/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/34773671/
3,HTR1B,25993020,Serotonin 1B Receptor Gene (HTR1B) Methylation as a Risk Factor for Callous-Unemotional Traits in Antisocial Boys.,"['Moul C', 'Dobson-Stone C', 'Brennan J', 'Hawes DJ', 'Dadds MR']","['Alleles', 'Antisocial Personality Disorder/diagnosis/*genetics/*psychology', 'CpG Islands', '*DNA Methylation', '*Emotions', '*Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', '*Quantitative Trait, Heritable', 'Receptor, Serotonin, 5-HT1B/*genetics', 'Risk Factors', 'Sex Factors']",https://pubmed.ncbi.nlm.nih.gov/25993020/
4,HTR1B,38760456,"Association of OPRM1 rs1799971, HTR1B rs6296 and COMT rs4680 polymorphisms with clinical phenotype among women with fibromyalgia.","['Fernandez-de-Las-Penas C', 'Ambite-Quesada S', 'Fernandez-Mendez LM', 'Jimenez-Antona C', 'Gomez-Calero C', 'Pocinho R', 'Valera-Calero JA', 'Cigaran-Mendez M', 'Arendt-Nielsen L']","['Adult', 'Female', 'Humans', '*Catechol O-Methyltransferase/genetics', '*Fibromyalgia/genetics', 'Genetic Predisposition to Disease', 'Genotype', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Quality of Life', '*Receptor, Serotonin, 5-HT1B/genetics', '*Receptors, Opioid, mu/genetics']",https://pubmed.ncbi.nlm.nih.gov/38760456/
5,HTR1B,19809810,HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory.,"['Drago A', 'Alboni S', 'Brunello N', 'De Ronchi D', 'Serretti A']","['Genetic Variation', 'Humans', '*Memory', 'Mental Disorders/*genetics', '*Motivation', '*Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT1B/*genetics', 'Risk']",https://pubmed.ncbi.nlm.nih.gov/19809810/
6,HTR1B,35438303,Methylation and expression quantitative trait locus rs6296 in the HTR1B gene is associated with susceptibility to opioid use disorder.,"['Li Y', 'Lu Y', 'Xie Q', 'Zeng X', 'Zhang R', 'Dang W', 'Zhu Y', 'Zhang J']","['DNA Methylation', 'Heroin', 'Humans', '*Opioid-Related Disorders/genetics', 'Polymorphism, Single Nucleotide', '*Quantitative Trait Loci', '*Receptor, Serotonin, 5-HT1B/genetics', 'Receptors, Serotonin']",https://pubmed.ncbi.nlm.nih.gov/35438303/
7,HTR1B,28025020,Epigenetic and genetic variants in the HTR1B gene and clinical improvement in children and adolescents treated with fluoxetine.,"['Gasso P', 'Rodriguez N', 'Blazquez A', 'Monteagudo A', 'Boloc D', 'Plana MT', 'Lafuente A', 'Lazaro L', 'Arnaiz JA', 'Mas S']","['Adolescent', 'Antidepressive Agents, Second-Generation/*therapeutic use', 'Anxiety Disorders/diet therapy/genetics', 'Child', 'DNA Methylation/drug effects/genetics', 'Depressive Disorder, Major/drug therapy/genetics', 'Dose-Response Relationship, Drug', 'Epigenesis, Genetic/*drug effects/genetics', 'Female', 'Fluoxetine/*therapeutic use', 'Gene Frequency', 'Genotype', 'Humans', 'Male', '*Pharmacogenetics', 'Polymorphism, Single Nucleotide/*genetics', 'Psychiatric Status Rating Scales', 'Receptor, Serotonin, 5-HT1B/*genetics', 'Statistics as Topic', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/28025020/
8,HTR1B,32689951,Effects of HTR1B 3' region polymorphisms and functional regions on gene expression regulation.,"['Xia X', 'Ding M', 'Xuan JF', 'Xing JX', 'Pang H', 'Yao J', 'Wu X', 'Wang BJ']","['Alleles', 'Cell Line', '*Gene Expression Regulation', 'Haplotypes', 'Humans', 'MicroRNAs/genetics', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1B/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32689951/
9,HTR1B,33036580,Functional polymorphisms and transcriptional analysis in the 5' region of the human serotonin receptor 1B gene (HTR1B) and their associations with psychiatric disorders.,"['Xia X', 'Ding M', 'Xuan JF', 'Xing JX', 'Yao J', 'Wu X', 'Wang BJ']","['*Genome-Wide Association Study', 'HEK293 Cells', 'Haplotypes', 'Humans', '*Mental Disorders/genetics', 'Polymorphism, Genetic/genetics', 'Polymorphism, Single Nucleotide/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptors, Serotonin/genetics']",https://pubmed.ncbi.nlm.nih.gov/33036580/
10,HTR1B,19626271,Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor gene polymorphisms in Borderline personality disorder.,"['Tadic A', 'Elsasser A', 'Victor A', 'von Cube R', 'Baskaya O', 'Wagner S', 'Lieb K', 'Hoppner W', 'Dahmen N']","['Adult', 'Borderline Personality Disorder/*genetics', 'Brain-Derived Neurotrophic Factor/*genetics', 'Female', 'Gene Frequency', '*Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Logistic Models', 'Male', 'Polymorphism, Single Nucleotide/*genetics', 'Receptor, Serotonin, 5-HT1B/*genetics', 'White People']",https://pubmed.ncbi.nlm.nih.gov/19626271/
11,HTR1B,39183370,Increased mRNA expression for serotonin receptor 1B (HTR1B) is associated with thrombosis in BCR::ABL1-negative myeloproliferative neoplasms.,"['Gurban P', 'Mambet C', 'Botezatu A', 'Necula LG', 'Matei L', 'Neagu AI', 'Pitica IM', 'Dragu LD', 'Nastasie Schulman A', 'Ataman M', 'Nedeianu S', 'Chivu-Economescu M', 'Bleotu C', 'Anton G', 'Diaconu CC']","['Humans', 'Female', 'Male', 'Middle Aged', '*Receptor, Serotonin, 5-HT1B/genetics/metabolism', '*RNA, Messenger/genetics/metabolism', 'Aged', '*Myeloproliferative Disorders/genetics/complications/metabolism', '*Thrombosis/genetics', 'Adult', 'Fusion Proteins, bcr-abl/genetics', 'Leukocytes, Mononuclear/metabolism', 'Aged, 80 and over']",https://pubmed.ncbi.nlm.nih.gov/39183370/
12,HTR1B,16344719,Association analysis of polymorphisms in serotonin 1B receptor (HTR1B) gene with heroin addiction: a comparison of molecular and statistically estimated haplotypes.,"['Proudnikov D', 'LaForge KS', 'Hofflich H', 'Levenstien M', 'Gordon D', 'Barral S', 'Ott J', 'Kreek MJ']","['Black or African American/genetics', 'Asian People/genetics', 'Black People/genetics', 'Case-Control Studies', '*Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Haplotypes/*genetics', 'Heroin Dependence/*genetics', 'Humans', 'Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1B/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16344719/
13,HTR1B,20638825,The HTR1A and HTR1B receptor genes influence stress-related information processing.,"['Mekli K', 'Payton A', 'Miyajima F', 'Platt H', 'Thomas E', 'Downey D', 'Lloyd-Williams K', 'Chase D', 'Toth ZG', 'Elliott R', 'Ollier WE', 'Anderson IM', 'Deakin JF', 'Bagdy G', 'Juhasz G']","['Adult', 'Alleles', 'Anxiety/*genetics/psychology', '*Cognition', 'Cohort Studies', 'DNA/analysis/genetics', 'Depression/*genetics/psychology', 'Emotions', 'Female', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', '*Life Change Events', 'Male', 'Middle Aged', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Psychiatric Status Rating Scales', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Receptor, Serotonin, 5-HT1B/*genetics', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Stress, Psychological/*genetics/psychology', 'Surveys and Questionnaires', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/20638825/
14,HTR1B,28923721,Evidence of sexual dimorphism of HTR1B gene on major adult ADHD comorbidities.,"['Muller D', 'Grevet EH', 'Panzenhagen AC', 'Cupertino RB', 'da Silva BS', 'Kappel DB', 'Mota NR', 'Blaya-Rocha P', 'Teche SP', 'Vitola ES', 'Rohde LA', 'Contini V', 'Rovaris DL', 'Schuch JB', 'Bau CHD']","['Adult', 'Anxiety Disorders/epidemiology/*genetics', 'Attention Deficit Disorder with Hyperactivity/epidemiology/*genetics', 'Comorbidity', 'Female', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT1B/*genetics', '*Sex Characteristics', 'Substance-Related Disorders/*genetics', 'Tobacco Use Disorder/epidemiology/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28923721/
15,ADRB1,38951961,"Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.","['Duarte JD', 'Thomas CD', 'Lee CR', 'Huddart R', 'Agundez JAG', 'Baye JF', 'Gaedigk A', 'Klein TE', 'Lanfear DE', 'Monte AA', 'Nagy M', 'Schwab M', 'Stein CM', 'Uppugunduri CRS', 'van Schaik RHN', 'Donnelly RS', 'Caudle KE', 'Luzum JA']","['Humans', '*Adrenergic beta-Antagonists/pharmacokinetics/therapeutic use', '*Cytochrome P-450 CYP2D6/genetics/metabolism', '*G-Protein-Coupled Receptor Kinase 5/genetics', '*Genotype', 'Metoprolol/pharmacokinetics', '*Pharmacogenetics/methods/standards', 'Pharmacogenomic Variants', 'Receptors, Adrenergic, alpha-2/genetics', '*Receptors, Adrenergic, beta-1/genetics', '*Receptors, Adrenergic, beta-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/38951961/
16,ADRB1,34270905,Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype.,"['Piccini JP', 'Dufton C', 'Carroll IA', 'Healey JS', 'Abraham WT', 'Khaykin Y', 'Aleong R', 'Krueger SK', 'Sauer WH', 'Wilton SB', 'Rienstra M', 'van Veldhuisen DJ', 'Anand IS', 'White M', 'Camm AJ', 'Ziegler PD', 'Marshall D', 'Bristow MR', 'Connolly SJ']","['Adrenergic beta-Antagonists/therapeutic use', 'Aged', 'Atrial Fibrillation/etiology/genetics/*prevention & control', 'Electrocardiography/*drug effects', 'Female', 'Follow-Up Studies', 'Genotype', 'Heart Failure/complications/*genetics/physiopathology', 'Humans', 'Male', 'Propanolamines/*therapeutic use', 'Receptors, Adrenergic, beta-1/drug effects/*genetics/metabolism', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/34270905/
17,ADRB1,37952358,"Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.","['Castano-Amores C', 'Antunez-Rodriguez A', 'Pozo-Agundo A', 'Garcia-Rodriguez S', 'Martinez-Gonzalez LJ', 'Davila-Fajardo CL']","['Humans', 'Cytochrome P-450 CYP2D6/genetics', '*Acute Coronary Syndrome/drug therapy/genetics', 'Bisoprolol/therapeutic use', '*Percutaneous Coronary Intervention', 'Adrenergic beta-Antagonists/therapeutic use', 'Genotype', 'Polymorphism, Single Nucleotide/genetics', '*Hypotension', 'Receptors, Adrenergic, beta-1/genetics', 'Receptors, Adrenergic, beta-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/37952358/
18,ADRB1,38138160,Associations between Selected ADRB1 and CYP2D6 Gene Polymorphisms in Children with Ventricular and Supraventricular Arrhythmias.,"['Moric-Janiszewska E', 'Smolik S', 'Szydlowski L', 'Kapral M']","['Child', 'Female', 'Humans', '*Adrenergic beta-Antagonists/therapeutic use', 'Arrhythmias, Cardiac/genetics', '*Cytochrome P-450 CYP2D6/genetics', 'DNA', 'Polymorphism, Genetic/genetics', 'Receptors, Adrenergic, beta-1/genetics']",https://pubmed.ncbi.nlm.nih.gov/38138160/
19,ADRB1,25823457,Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to beta-blocker therapy in hypertension.,"['Wu D', 'Li G', 'Deng M', 'Song W', 'Huang X', 'Guo X', 'Wu Z', 'Wu S', 'Xu J']","['Adrenergic beta-Antagonists/therapeutic use', 'Adult', 'Aged', 'Antihypertensive Agents/therapeutic use', 'Blood Pressure/drug effects', 'China', 'Cytochrome P-450 CYP2D6/*genetics', 'Essential Hypertension', 'Gene Frequency/genetics', 'Humans', 'Hypertension/*drug therapy/*genetics/physiopathology', 'Metoprolol/*therapeutic use', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, beta-1/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/25823457/
20,ADRB1,19462935,Rapid detection of the R389G polymorphism of ADRB1 by real time PCR using fluorescence resonance energy transfer.,"['Sauer M', 'Tews J', 'Schwarzer M', 'Seeburger J', 'Adams V', 'Falk V', 'Dhein S', 'Mohr FW']","['Adult', 'Female', 'Fluorescence Resonance Energy Transfer/*methods', 'Gene Frequency', 'Genotype', 'Humans', 'Male', 'Polymerase Chain Reaction/*methods', 'Polymorphism, Genetic', 'Polymorphism, Restriction Fragment Length', 'Receptors, Adrenergic, beta-1/*genetics', 'Reproducibility of Results', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/19462935/
21,ADRB1,32586526,Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome.,"['Van Driest SL', 'Sleeper LA', 'Gelb BD', 'Morris SA', 'Dietz HC', 'Forbus GA', 'Goldmuntz E', 'Hoskoppal A', 'James J', 'Lee TM', 'Levine JC', 'Li JS', 'Loeys BL', 'Markham LW', 'Meester JAN', 'Mital S', 'Mosley JD', 'Olson AK', 'Renard M', 'Shaffer CM', 'Sharkey A', 'Young L', 'Lacro RV', 'Roden DM']","['Adolescent', 'Adrenergic beta-1 Receptor Antagonists/therapeutic use', 'Adult', 'Angiotensin II Type 1 Receptor Blockers/therapeutic use', 'Atenolol/*therapeutic use', 'Child', 'Child, Preschool', 'Cytochrome P-450 CYP2C9/biosynthesis/*genetics', 'DNA/genetics', 'Female', 'Follow-Up Studies', '*Gene Expression Regulation', 'Genotype', 'Humans', 'Infant', 'Losartan/*therapeutic use', 'Male', 'Marfan Syndrome/*drug therapy/genetics/metabolism', 'Receptors, Adrenergic, beta-1/biosynthesis/*genetics', 'Retrospective Studies', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32586526/
22,ADRB1,27108086,Multiplex SNaPshot-a new simple and efficient CYP2D6 and ADRB1 genotyping method.,"['Ben S', 'Cooper-DeHoff RM', 'Flaten HK', 'Evero O', 'Ferrara TM', 'Spritz RA', 'Monte AA']","['Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Cytochrome P-450 CYP2D6/*genetics/isolation & purification', 'DNA Copy Number Variations', 'Female', 'Gene Duplication', 'Genotype', 'Genotyping Techniques/*methods', 'Haplotypes/genetics', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Receptors, Adrenergic, beta-1/*genetics/isolation & purification']",https://pubmed.ncbi.nlm.nih.gov/27108086/
23,ADRB1,17635183,Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.,"['Zateyshchikov DA', 'Minushkina LO', 'Brovkin AN', ""Savel'eva EG"", 'Zateyshchikova AA', 'Manchaeva BB', 'Nikitin AG', 'Sidorenko BA', 'Nosikov VV']","['*Adrenergic beta-1 Receptor Antagonists', 'Antihypertensive Agents/*pharmacology/therapeutic use', 'Betaxolol/*pharmacology/therapeutic use', 'Blood Pressure/drug effects', 'Cytochrome P-450 CYP2D6/*genetics', 'Exercise Test', 'Female', 'Gene Frequency', 'Genotype', 'Heart Rate/drug effects', 'Humans', 'Hypertension/drug therapy', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Receptors, Adrenergic, beta-1/*genetics', 'Rest']",https://pubmed.ncbi.nlm.nih.gov/17635183/
24,ADRB1,29768300,The hemodynamic response to constant dobutamine infusion: the effect of ADRB1 389 polymorphism and sex.,"['Yogev D', 'Basheer M', 'Perlman A', 'Blotnick S', 'Caraco Y', 'Muszkat M']","['Adult', 'Blood Pressure', 'Dobutamine/*administration & dosage', 'Female', 'Genotype', 'Healthy Volunteers', 'Heart Rate', 'Hemodynamics', 'Humans', 'Male', '*Pharmacogenomic Variants', 'Receptors, Adrenergic, beta-1/*genetics', 'Renin/*blood', 'Sex Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29768300/
25,ADRB1,29549925,The Association of ADRB1 and CYP2D6 Polymorphisms With Antihypertensive Effects and Analysis of Their Contribution to Hypertension Risk.,"['Chen L', 'Xiao T', 'Chen L', 'Xie S', 'Deng M', 'Wu D']","['Adult', 'Antihypertensive Agents/therapeutic use', 'Blood Glucose/metabolism', 'Case-Control Studies', 'Cytochrome P-450 CYP2D6/*genetics', 'Dyslipidemias/epidemiology', 'Essential Hypertension/drug therapy/*genetics', 'Fasting/metabolism', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Hypertriglyceridemia/epidemiology', 'Logistic Models', 'Male', 'Metoprolol/therapeutic use', 'Middle Aged', 'Multivariate Analysis', 'Polymorphism, Genetic', 'Receptors, Adrenergic, beta-1/*genetics', 'Risk Factors', 'Smoking/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/29549925/
26,ADRB1,25638254,Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure.,"['Kang S', 'Hong X', 'Ruan CW', 'Yu P', 'Yu SS', 'Chen M', 'Zhang DF', 'Fan HM', 'Liu ZM']","['Adrenergic beta-Antagonists/therapeutic use', 'Base Sequence', 'G-Protein-Coupled Receptor Kinase 5/*genetics', 'Heart Failure, Systolic/drug therapy/*genetics', 'Humans', 'Models, Genetic', 'Molecular Sequence Data', 'Multivariate Analysis', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Adrenergic, beta-1/*genetics', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/25638254/
27,ADRB1,26694722,Correlation of ADRB1 rs1801253 Polymorphism with Analgesic Effect of Fentanyl After Cancer Surgeries.,"['Wei W', 'Tian Y', 'Zhao C', 'Sui Z', 'Liu C', 'Wang C', 'Yang R']","['Adult', 'Aged', 'Analgesics, Opioid/*pharmacology', 'Female', 'Fentanyl/*pharmacology', 'Humans', 'Male', 'Middle Aged', 'Neoplasms/*surgery', 'Pain, Postoperative/*drug therapy', '*Polymorphism, Genetic', 'Receptors, Adrenergic, beta-1/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26694722/
28,ADRB1,20384459,Association of ADRB1 gene polymorphism with atrial fibrillation.,"['Nicoulina S', 'Shulman V', 'Shesternya P', 'Chernova A', 'Salmina A', 'Issachenko O', 'Maksimov V', 'Voevoda M']","['Adult', 'Amino Acid Substitution', 'Atrial Fibrillation/etiology/*genetics', 'Base Sequence', 'Case-Control Studies', 'DNA Primers/genetics', 'Female', 'Gene Frequency', 'Genetic Markers', 'Genetic Predisposition to Disease', 'Heterozygote', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, beta-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/20384459/
29,ADRB1,38682747,Assessment of ADRB1 polymorphism in patients with acute coronary syndrome treated with ticagrelor and aspirin.,"['Zhang X', 'Yuan Q', 'Zhang D']","['Humans', '*Acute Coronary Syndrome/genetics/drug therapy', '*Ticagrelor/therapeutic use', 'Male', 'Female', '*Aspirin/therapeutic use', 'Middle Aged', '*Receptors, Adrenergic, beta-1/genetics', 'Aged', '*Platelet Aggregation Inhibitors/therapeutic use', '*Polymorphism, Single Nucleotide/genetics', '*Genotype', 'Prognosis', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/38682747/
30,ADRB1,35987510,Expression of the beta1-adrenergic receptor (ADRB1) gene in the myocardium and beta-adrenergic reactivity of the body in patients with a history of myocardium infraction.,"['Muslimova E', 'Rebrova T', 'Kondratieva D', 'Korepanov V', 'Sonduev E', 'Kozlov B', 'Afanasiev S']","['Adrenergic Agents', 'Adrenergic beta-Antagonists', '*Cardiomyopathies', 'Humans', '*Myocardial Infarction/genetics', 'Myocardium', 'Receptors, Adrenergic, beta-1/genetics', 'Stroke Volume']",https://pubmed.ncbi.nlm.nih.gov/35987510/
31,ADRB1,16315032,"Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study.","['Nieminen T', 'Uusitalo H', 'Maenpaa J', 'Turjanmaa V', 'Rane A', 'Lundgren S', 'Ropo A', 'Rontu R', 'Lehtimaki T', 'Kahonen M']","['Adrenergic beta-Antagonists/blood/pharmacokinetics/*pharmacology', 'Adult', 'Area Under Curve', 'Blood Pressure/drug effects', 'Chromogranins', 'Cross-Over Studies', 'Cytochrome P-450 CYP2D6/*genetics', 'Double-Blind Method', 'Female', 'GTP-Binding Protein alpha Subunits, Gs/*genetics', 'Genotype', 'Half-Life', 'Humans', 'Male', 'Middle Aged', 'Pilot Projects', '*Polymorphism, Genetic', 'Receptors, Adrenergic, beta/*genetics', 'Timolol/blood/pharmacokinetics/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/16315032/
32,FDPS,25842099,All-ceramic or metal-ceramic tooth-supported fixed dental prostheses (FDPs)? A systematic review of the survival and complication rates. Part I: Single crowns (SCs).,"['Sailer I', 'Makarov NA', 'Thoma DS', 'Zwahlen M', 'Pjetursson BE']","['Ceramics/*chemistry', '*Crowns', '*Dental Prosthesis Design', '*Dental Prosthesis, Implant-Supported', '*Dental Restoration Failure', 'Esthetics, Dental', 'Humans', 'Metal Ceramic Alloys/chemistry', 'Metals/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/25842099/
33,FDPS,25935732,All-ceramic or metal-ceramic tooth-supported fixed dental prostheses (FDPs)? A systematic review of the survival and complication rates. Part II: Multiple-unit FDPs.,"['Pjetursson BE', 'Sailer I', 'Makarov NA', 'Zwahlen M', 'Thoma DS']","['Ceramics/*chemistry', '*Dental Prosthesis Design', '*Dental Prosthesis, Implant-Supported', '*Dental Restoration Failure', '*Denture, Partial, Fixed', 'Esthetics, Dental', 'Humans', 'Metal Ceramic Alloys/chemistry', 'Metals/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/25935732/
34,FDPS,17594374,Comparison of survival and complication rates of tooth-supported fixed dental prostheses (FDPs) and implant-supported FDPs and single crowns (SCs).,"['Pjetursson BE', 'Bragger U', 'Lang NP', 'Zwahlen M']","['Crowns/*adverse effects', 'Dental Prosthesis Design', 'Dental Prosthesis, Implant-Supported/*adverse effects', 'Dental Restoration Failure', 'Dental Restoration, Permanent/methods', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/17594374/
35,FDPS,23062125,A systematic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years.,"['Pjetursson BE', 'Thoma D', 'Jung R', 'Zwahlen M', 'Zembic A']","['*Dental Prosthesis, Implant-Supported', '*Dental Restoration Failure', '*Denture, Partial, Fixed', 'Humans', 'Longitudinal Studies', 'Postoperative Complications/*epidemiology', 'Prospective Studies', 'Retrospective Studies', 'Survival Rate']",https://pubmed.ncbi.nlm.nih.gov/23062125/
36,FDPS,19169719,Three-year clinical prospective evaluation of zirconia-based posterior fixed dental prostheses (FDPs).,"['Beuer F', 'Edelhoff D', 'Gernet W', 'Sorensen JA']","['Adult', 'Aged', 'Bicuspid', 'Cementation/methods', 'Ceramics/chemistry', 'Dental Abutments', 'Dental Materials/*chemistry', 'Dental Restoration Failure', 'Dental Veneers', '*Denture Design', 'Denture Retention', '*Denture, Partial, Fixed', 'Female', 'Follow-Up Studies', 'Glass Ionomer Cements/chemistry', 'Humans', 'Longitudinal Studies', 'Male', 'Middle Aged', 'Molar', 'Patient Satisfaction', 'Prospective Studies', 'Surface Properties', 'Survival Analysis', 'Zirconium/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/19169719/
37,FDPS,34388276,Evaluation of the implant disease risk assessment (IDRA) tool: A retrospective study in patients with treated periodontitis and implant-supported fixed dental prostheses (FDPs).,"['De Ry SP', 'Roccuzzo A', 'Lang NP', 'Heitz-Mayfield LJ', 'Ramseier CA', 'Sculean A', 'Salvi GE']","['Aged', '*Dental Implants', 'Female', 'Humans', 'Male', '*Peri-Implantitis/diagnosis/etiology', '*Periodontitis', 'Retrospective Studies', 'Risk Assessment']",https://pubmed.ncbi.nlm.nih.gov/34388276/
38,FDPS,23289599,Accuracy and reliability of methods to measure marginal adaptation of crowns and FDPs: a literature review.,"['Nawafleh NA', 'Mack F', 'Evans J', 'Mackay J', 'Hatamleh MM']","['Crowns/*standards', 'Dental Marginal Adaptation/*standards', 'Dental Prosthesis Design/standards', 'Denture Design/standards', 'Denture, Partial, Fixed/*standards', 'Humans', 'Reproducibility of Results']",https://pubmed.ncbi.nlm.nih.gov/23289599/
39,FDPS,29075041,Deregulated expression and activity of Farnesyl Diphosphate Synthase (FDPS) in Glioblastoma.,"['Abate M', 'Laezza C', 'Pisanti S', 'Torelli G', 'Seneca V', 'Catapano G', 'Montella F', 'Ranieri R', 'Notarnicola M', 'Gazzerro P', 'Bifulco M', 'Ciaglia E']","['Apoptosis', 'Cell Cycle', 'Cell Line, Tumor', '*Gene Expression Regulation, Neoplastic', 'Geranyltranstransferase/*genetics/*metabolism', 'Glioblastoma/*pathology', 'Humans', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/29075041/
40,FDPS,31097285,Zirconia single crowns and multiple-unit FDPs-An up to 8 -year retrospective clinical study.,"['Tanner J', 'Niemi H', 'Ojala E', 'Tolvanen M', 'Narhi T', 'Hjerppe J']","['Aged', '*Crowns', 'Dental Porcelain', 'Dental Restoration Failure', '*Denture, Partial, Fixed', 'Female', 'Finland', 'Follow-Up Studies', 'Humans', 'Male', 'Retrospective Studies', 'Zirconium']",https://pubmed.ncbi.nlm.nih.gov/31097285/
41,FDPS,30879990,Influence of different preparation forms on the loading-bearing capacity of zirconia cantilever FDPs. A laboratory study.,"['Bishti S', 'Jakel C', 'Kern M', 'Wolfart S']","['Computer-Aided Design', '*Dental Abutments', 'Dental Porcelain', 'Dental Restoration Failure', 'Dental Stress Analysis', '*Denture Design', 'Humans', 'Materials Testing', 'Zirconium']",https://pubmed.ncbi.nlm.nih.gov/30879990/
42,FDPS,34751146,Novel missense mutations of MVK and FDPS gene in Chinese patients with disseminated superficial actinic porokeratosis.,"['Li L', 'Zuo N', 'Yang D', 'Zhang D', 'Feng Y', 'Li X']","['China', 'Geranyltranstransferase/*genetics', 'Humans', 'Mutation, Missense', 'Pedigree', '*Phosphotransferases (Alcohol Group Acceptor)/genetics', '*Porokeratosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/34751146/
43,FDPS,26121970,Fit of 4-unit FDPs from CoCr and zirconia after conventional and digital impressions.,"['Ueda K', 'Beuer F', 'Stimmelmayr M', 'Erdelt K', 'Keul C', 'Guth JF']","['Chromium Alloys', 'Computer-Aided Design', '*Dental Impression Technique', '*Dental Marginal Adaptation', '*Denture Design', '*Denture, Partial, Fixed', 'Elastic Modulus', 'Titanium', 'Zirconium']",https://pubmed.ncbi.nlm.nih.gov/26121970/
44,FDPS,31774873,"Polymorphisms of FDPS, LRP5, SOST and VKORC1 genes and their relation with osteoporosis in postmenopausal Romanian women.","['Ciubean AD', 'Ungur RA', 'Irsay L', 'Ciortea VM', 'Borda IM', 'Dogaru GB', 'Trifa AP', 'Vesa SC', 'Buzoianu AD']","['Adaptor Proteins, Signal Transducing/*genetics', 'Aged', 'Biomarkers/analysis', 'Case-Control Studies', 'Female', 'Follow-Up Studies', 'Geranyltranstransferase/*genetics', 'Humans', 'Low Density Lipoprotein Receptor-Related Protein-5/*genetics', 'Middle Aged', 'Osteoporosis, Postmenopausal/epidemiology/*genetics/*pathology', '*Polymorphism, Single Nucleotide', 'Prognosis', 'Prospective Studies', 'Romania/epidemiology', 'Vitamin K Epoxide Reductases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31774873/
45,FDPS,39947581,Three-unit CAD/CAM-manufactured lithium disilicate FDPs after an average observation period of 120 months.,"['Homa M', 'Schneider O', 'Neumann P', 'Endres L', 'Rafai N', 'Reich S', 'Wolfart S', 'Tuna T']","['Humans', '*Computer-Aided Design', '*Dental Porcelain/chemistry', 'Female', 'Male', '*Dental Restoration Failure', 'Middle Aged', 'Adult', 'Follow-Up Studies', 'Aged', 'Denture, Partial, Fixed', 'Bicuspid', 'Dental Prosthesis Design', 'Dental Veneers', 'Esthetics, Dental', 'Denture Design']",https://pubmed.ncbi.nlm.nih.gov/39947581/
46,FDPS,22834726,Comparison of fracture-load values of cantilevered FDPs.,"['Ohlmann B', 'Dittmar A', 'Rues S', 'Rammelsberg P']","['*Dental Stress Analysis', '*Denture, Partial, Fixed', 'Zirconium']",https://pubmed.ncbi.nlm.nih.gov/22834726/
47,FDPS,17594371,Ante's (1926) law revisited: a systematic review on survival rates and complications of fixed dental prostheses (FDPs) on severely reduced periodontal tissue support.,"['Lulic M', 'Bragger U', 'Lang NP', 'Zwahlen M', 'Salvi GE']","['Dental Prosthesis/*adverse effects', '*Dental Restoration Failure', 'Follow-Up Studies', 'Humans', 'Mastication', 'Periodontal Diseases/etiology/*therapy']",https://pubmed.ncbi.nlm.nih.gov/17594371/
48,FDPS,36125866,Zirconia Crowns and FDPs with Feather-Edge Margins on Conical Implant Abutments-Up-To-5-year Clinical Retrospective Study.,"['Canullo L', 'Hjerppe J', 'Menini M', 'Bagnasco F', 'Petazzi GM', 'Pesce P']","['*Biological Products', '*Bone Resorption', 'Crowns', 'Dental Prosthesis, Implant-Supported', 'Dental Restoration Failure', 'Humans', 'Metal Ceramic Alloys', 'Retrospective Studies', 'Titanium', 'Zirconium']",https://pubmed.ncbi.nlm.nih.gov/36125866/
49,KCNH2,36333337,Computational analysis of arrhythmogenesis in KCNH2 T618I mutation-associated short QT syndrome and the pharmacological effects of quinidine and sotalol.,"['Zhang S', 'Lu W', 'Yang F', 'Li Z', 'Wang S', 'Jiang M', 'Wang X', 'Wei Z']","['*Quinidine/pharmacology/therapeutic use', 'ERG1 Potassium Channel/genetics', 'Arrhythmias, Cardiac', 'Humans', '*Sotalol/pharmacology', 'Action Potentials/genetics', 'Mutation/genetics', 'Anti-Arrhythmia Agents/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/36333337/
50,KCNH2,37660555,Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.,"['Goual L', 'Bounasri E', 'Vincenti M', 'Amedro P', 'Desprat R', 'Bernex F', 'Lemaitre JM', 'Pasquie JL', 'Lacampagne A', 'Thireau J', 'Meli AC']","['Humans', '*Induced Pluripotent Stem Cells/metabolism', 'ERG1 Potassium Channel/genetics', '*Long QT Syndrome/metabolism', 'Arrhythmias, Cardiac/metabolism', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/37660555/
51,KCNH2,35526388,Establishment of human embryonic stem cell WAe009-A-88 carrying a long QT syndrome mutation in KCNH2.,"['Wen H', 'Sun L', 'Zhong J', 'Wu F']","['Cell Line', 'ERG1 Potassium Channel/genetics', '*Human Embryonic Stem Cells/metabolism', 'Humans', '*Long QT Syndrome/genetics/metabolism', 'Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/35526388/
52,KCNH2,35806392,Mutation-Specific Differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) Channel Dysfunction and Long QT Syndrome Phenotypes.,"['Kekenes-Huskey PM', 'Burgess DE', 'Sun B', 'Bartos DC', 'Rozmus ER', 'Anderson CL', 'January CT', 'Eckhardt LL', 'Delisle BP']","['ERG1 Potassium Channel/genetics', 'Electrocardiography', 'Humans', '*KCNQ1 Potassium Channel/genetics', 'Mutation', 'Phenotype', '*Romano-Ward Syndrome/genetics']",https://pubmed.ncbi.nlm.nih.gov/35806392/
53,KCNH2,35569348,Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation.,"['Guo F', 'Sun Y', 'Wang H', 'Wang H', 'Zhou J', 'Fan H', 'Su J', 'Gong T', 'Jiang C', 'Liang P']","['Arrhythmias, Cardiac/metabolism', 'ERG1 Potassium Channel/genetics/metabolism', 'Fibroblasts/metabolism', 'Humans', '*Induced Pluripotent Stem Cells/metabolism', '*Long QT Syndrome/metabolism', 'Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/35569348/
54,KCNH2,33941567,A Novel Mutation in the KCNH2 Gene Associatedwith Long QT Syndrome: A Case Report.,"['Zha K', 'Ye Q']","['Adult', 'ERG1 Potassium Channel/*genetics/metabolism', 'Electrocardiography', 'Family', 'Female', 'Genetic Testing', 'Humans', 'Long QT Syndrome/*genetics/metabolism', 'Mutation', 'Pedigree', 'Torsades de Pointes/genetics/metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33941567/
55,KCNH2,33176122,Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias.,"['Brandao KO', 'van den Brink L', 'Miller DC', 'Grandela C', 'van Meer BJ', 'Mol MPH', 'de Korte T', 'Tertoolen LGJ', 'Mummery CL', 'Sala L', 'Verkerk AO', 'Davis RP']","['Arrhythmias, Cardiac/chemically induced', 'Cell Line', 'ERG1 Potassium Channel/genetics/*metabolism', 'Electrophysiology', 'Gene Editing', 'Genetic Predisposition to Disease', 'Humans', 'Induced Pluripotent Stem Cells/drug effects/*physiology', 'Long QT Syndrome/genetics/*metabolism', 'Models, Biological', 'Mutation', 'Myocytes, Cardiac/drug effects/*physiology', 'Patch-Clamp Techniques', 'Piperidines/adverse effects', 'Pyridines/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/33176122/
56,KCNH2,38547667,Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome).,"['Wang B', 'Ren Q', 'Cui X', 'Shan W', 'Guo X', 'Wang X', 'Wang J', 'Li Y', 'An G']","['*Induced Pluripotent Stem Cells/metabolism', 'Humans', '*ERG1 Potassium Channel/genetics/metabolism', '*Long QT Syndrome/genetics/metabolism/pathology', '*Heterozygote', 'Cell Line', 'CRISPR-Cas Systems', 'Gene Knockout Techniques', 'Cell Differentiation', 'Gene Editing', 'Arrhythmias, Cardiac']",https://pubmed.ncbi.nlm.nih.gov/38547667/
57,KCNH2,34438161,Generation of induced pluripotent stem cells (iPSCs) from a Chinese infant (XACHi015-A) with type 2 Long QT syndrome carrying the heterozygous mutation c.1814C>T(p.P605L) in KCNH2.,"['Wang T', 'Zhou Y', 'Zhou R', 'Huang W', 'Wang J', 'Li H', 'Lei M', 'Tan X', 'Zhang Y']","['Cell Differentiation', 'Cellular Reprogramming', 'Child', 'China', 'ERG1 Potassium Channel/genetics', 'Humans', '*Induced Pluripotent Stem Cells', 'Infant', 'Kruppel-Like Factor 4', 'Leukocytes, Mononuclear', '*Long QT Syndrome/genetics', 'Male', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/34438161/
58,KCNH2,32843460,Compound heterozygous mutations in KCNJ2 and KCNH2 in a patient with severe Andersen-Tawil syndrome.,"['Polyak ME', 'Shestak A', 'Podolyak D', 'Zaklyazminskaya E']","['Andersen Syndrome/*genetics', 'ERG1 Potassium Channel/*genetics', 'Female', 'Heterozygote', 'Humans', '*Mutation', 'Pedigree', 'Potassium Channels, Inwardly Rectifying/*genetics', 'Severity of Illness Index', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32843460/
59,KCNH2,33002718,Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.,"['Ge N', 'Liu M', 'Krawczyk J', 'McInerney V', 'Ward D', 'Shen S', ""O'Brien T"", 'Prendiville T']","['Arrhythmias, Cardiac', 'ERG1 Potassium Channel/genetics', 'Humans', '*Induced Pluripotent Stem Cells', '*Long QT Syndrome/genetics', 'Mutation', 'Myocytes, Cardiac']",https://pubmed.ncbi.nlm.nih.gov/33002718/
60,KCNH2,23899126,"Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death.","['Partemi S', 'Cestele S', 'Pezzella M', 'Campuzano O', 'Paravidino R', 'Pascali VL', 'Zara F', 'Tassinari CA', 'Striano S', 'Oliva A', 'Brugada R', 'Mantegazza M', 'Striano P']","['Adolescent', 'Bacterial Proteins/genetics/metabolism', 'Biophysical Phenomena/genetics', 'Cell Line, Transformed', 'DNA Mutational Analysis', '*Death, Sudden', 'ERG1 Potassium Channel', 'Electric Stimulation', 'Electrocardiography', 'Epilepsy/complications/*genetics', 'Ether-A-Go-Go Potassium Channels/*genetics', '*Family Health', 'Female', 'Humans', 'Long QT Syndrome/complications/*genetics', 'Luminescent Proteins/genetics/metabolism', 'Membrane Potentials/drug effects/genetics', 'Patch-Clamp Techniques', 'Point Mutation/genetics', 'Transfection', 'Twins, Dizygotic/genetics']",https://pubmed.ncbi.nlm.nih.gov/23899126/
61,KCNH2,33449212,A novel mutation in KCNH2 yields loss-of-function of hERG potassium channel in long QT syndrome 2.,"['Gu K', 'Qian D', 'Qin H', 'Cui C', 'Fernando WCHA', 'Wang D', 'Wang J', 'Cao K', 'Chen M']","['Action Potentials', 'ERG1 Potassium Channel/*genetics/metabolism', 'Genetic Predisposition to Disease', 'HEK293 Cells', 'Heart Rate', 'Humans', 'Long QT Syndrome/*genetics/metabolism/physiopathology', '*Loss of Function Mutation', 'Models, Cardiovascular', 'Phenotype', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/33449212/
62,KCNH2,35700634,Human induced pluripotent stem cell line ZZUNEUi027-A generated from a long QT syndrome patient with a heterozygous KCNH2 (c. 128 A > G) mutant.,"['Zhao J', 'Wang L', 'Zhu K', 'Chen X', 'Qin F', 'Li X', 'Dong J', 'Tao H']","['Cell Line', 'ERG1 Potassium Channel/genetics/metabolism', 'Female', 'Heterozygote', 'Humans', '*Induced Pluripotent Stem Cells/metabolism', '*Long QT Syndrome/metabolism', 'Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/35700634/
63,KCNH2,36252106,Suppression and Replacement Gene Therapy for KCNH2-Mediated Arrhythmias.,"['Bains S', 'Zhou W', 'Dotzler SM', 'Martinez K', 'Kim CJ', 'Tester DJ', 'Ye D', 'Ackerman MJ']","['Humans', 'ERG1 Potassium Channel/genetics', '*Arrhythmias, Cardiac/genetics/therapy', '*Long QT Syndrome/genetics/therapy', 'Genetic Therapy']",https://pubmed.ncbi.nlm.nih.gov/36252106/
64,KCNH2,29037423,Unique ECG presentations and clinical management of a symptomatic LQT2 female carrying a novel de novo KCNH2 mutation.,"['Yin C', 'Zhang P', 'Yang J', 'Zhang L']","['Adrenergic beta-Antagonists/adverse effects', 'Adult', '*Electrocardiography', 'Female', 'Genotype', 'Heart Rate/drug effects', 'Heterozygote', 'Humans', 'Long QT Syndrome/complications/diagnosis/drug therapy/*genetics', '*Mutation, Missense', 'Postpartum Period', 'Syncope/etiology', 'Torsades de Pointes/etiology', 'Ventricular Fibrillation/etiology']",https://pubmed.ncbi.nlm.nih.gov/29037423/
65,SCN5A,37122208,"SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond.",['Remme CA'],"['Humans', '*Channelopathies/genetics/metabolism', 'Arrhythmias, Cardiac/genetics/metabolism', 'NAV1.5 Voltage-Gated Sodium Channel/genetics/metabolism', 'Mutation', '*Cardiomyopathies/genetics', '*Epilepsy/genetics']",https://pubmed.ncbi.nlm.nih.gov/37122208/
66,SCN5A,30203441,Systematic re-evaluation of SCN5A variants associated with Brugada syndrome.,"['Denham NC', 'Pearman CM', 'Ding WY', 'Waktare J', 'Gupta D', 'Snowdon R', 'Hall M', 'Cooper R', 'Modi S', 'Todd D', 'Mahida S']","['Action Potentials', 'Brugada Syndrome/diagnosis/*genetics/metabolism/physiopathology', 'Genetic Predisposition to Disease', '*Genetic Variation', 'Heart Rate', 'Humans', 'NAV1.5 Voltage-Gated Sodium Channel/*genetics/metabolism', 'Phenotype', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/30203441/
67,SCN5A,29798782,"Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.","['Wilde AAM', 'Amin AS']","['*Brugada Syndrome/genetics/physiopathology/therapy', '*Cardiomyopathies/genetics/physiopathology/therapy', 'Humans', '*Long QT Syndrome/genetics/physiopathology/therapy', 'Mutation/genetics', '*NAV1.5 Voltage-Gated Sodium Channel/genetics/metabolism/physiology']",https://pubmed.ncbi.nlm.nih.gov/29798782/
68,SCN5A,32533946,High-Throughput Reclassification of SCN5A Variants.,"['Glazer AM', 'Wada Y', 'Li B', 'Muhammad A', 'Kalash OR', ""O'Neill MJ"", 'Shields T', 'Hall L', 'Short L', 'Blair MA', 'Kroncke BM', 'Capra JA', 'Roden DM']","['Arrhythmias, Cardiac/genetics', 'Brugada Syndrome/genetics', 'Cell Line', 'Female', 'Genetic Variation', 'Genotype', 'HEK293 Cells', 'High-Throughput Screening Assays/methods', 'Humans', 'Male', 'NAV1.5 Voltage-Gated Sodium Channel/*genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/32533946/
69,SCN5A,19027780,SCN5A channelopathies--an update on mutations and mechanisms.,"['Zimmer T', 'Surber R']","['Arrhythmias, Cardiac/etiology/*genetics/physiopathology', 'Brugada Syndrome/genetics', 'Electrophysiological Phenomena', 'Genotype', 'Humans', 'Long QT Syndrome/classification/genetics', 'Models, Molecular', 'Muscle Proteins/chemistry/*genetics/physiology', '*Mutation', 'NAV1.5 Voltage-Gated Sodium Channel', 'Phenotype', 'Sodium Channels/chemistry/*genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/19027780/
70,SCN5A,20129283,An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.,"['Kapplinger JD', 'Tester DJ', 'Alders M', 'Benito B', 'Berthet M', 'Brugada J', 'Brugada P', 'Fressart V', 'Guerchicoff A', 'Harris-Kerr C', 'Kamakura S', 'Kyndt F', 'Koopmann TT', 'Miyamoto Y', 'Pfeiffer R', 'Pollevick GD', 'Probst V', 'Zumhagen S', 'Vatta M', 'Towbin JA', 'Shimizu W', 'Schulze-Bahr E', 'Antzelevitch C', 'Salisbury BA', 'Guicheney P', 'Wilde AA', 'Brugada R', 'Schott JJ', 'Ackerman MJ']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Brugada Syndrome/epidemiology/*genetics', 'Case-Control Studies', 'Child', 'Child, Preschool', 'Databases, Genetic', 'Death, Sudden, Cardiac/epidemiology', 'Exons/genetics', 'Female', '*Genetic Testing', 'Genotype', '*Global Health', 'Humans', 'Infant', '*Internationality', 'Male', 'Middle Aged', 'Multivariate Analysis', 'Muscle Proteins/*genetics', 'Mutation, Missense', 'NAV1.5 Voltage-Gated Sodium Channel', 'Retrospective Studies', 'Risk Factors', 'Sodium Channels/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/20129283/
71,SCN5A,14753626,The implications of genetic mutations in the sodium channel gene (SCN5A).,"['Moric E', 'Herbert E', 'Trusz-Gluza M', 'Filipecki A', 'Mazurek U', 'Wilczok T']","['Adult', 'Arrhythmias, Cardiac/*genetics', 'Child, Preschool', 'Electrocardiography', 'Heart Conduction System/physiopathology', 'Humans', 'Infant', 'Long QT Syndrome/genetics', '*Mutation', 'Mutation, Missense', 'NAV1.5 Voltage-Gated Sodium Channel', 'Risk Assessment', 'Sodium Channels/*genetics', 'Sudden Infant Death/genetics']",https://pubmed.ncbi.nlm.nih.gov/14753626/
72,SCN5A,10973849,"Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.","['Splawski I', 'Shen J', 'Timothy KW', 'Lehmann MH', 'Priori S', 'Robinson JL', 'Moss AJ', 'Schwartz PJ', 'Towbin JA', 'Vincent GM', 'Keating MT']","['Adolescent', 'Adult', 'Aged', 'Child', 'DNA Mutational Analysis', 'Female', 'Frameshift Mutation', 'Genotype', 'Humans', 'Long QT Syndrome/*genetics', 'Male', 'Middle Aged', 'Mutation, Missense', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/10973849/
73,SCN5A,35351625,SCN5A overlap syndromes: An open-minded approach.,"['Porretta AP', 'Probst V', 'Bhuiyan ZA', 'Davoine E', 'Deliniere A', 'Pascale P', 'Schlaepfer J', 'Superti-Furga A', 'Pruvot E']","['Arrhythmias, Cardiac/genetics', '*Brugada Syndrome/genetics', 'Humans', 'Mutation', '*NAV1.5 Voltage-Gated Sodium Channel/genetics', 'Phenotype', 'Syndrome']",https://pubmed.ncbi.nlm.nih.gov/35351625/
74,SCN5A,37385135,Generation of an induced pluripotent stem cell line from a patient with conduction disease and recurrent ventricular fibrillation with a sodium voltage-gated channel alpha subunit 5 (SCN5A) gene c.392 + 3A > G splice-site variant.,"['Li S', 'Fraser S', 'Ranpura G', 'Lim S', 'Singer ES', 'Parker JDK', 'Crowe J', 'Bagnall RD', 'Laksman Z', 'Semsarian C']","['Humans', '*Ventricular Fibrillation/genetics', '*Induced Pluripotent Stem Cells/metabolism', 'Cardiac Conduction System Disease', 'Arrhythmias, Cardiac', 'NAV1.5 Voltage-Gated Sodium Channel/genetics', 'Sodium/metabolism', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/37385135/
75,SCN5A,35093717,Generation of a heterozygous SCN5A knockout human induced pluripotent stem cell line by CRISPR/Cas9 edition.,"['Gizon M', 'Duboscq-Bidot L', 'El Kassar L', 'Bobin P', 'Ader F', 'Giraud-Triboult K', 'Charron P', 'Villard E', 'Fontaine V', 'Neyroud N']","['CRISPR-Cas Systems/genetics', 'Heterozygote', 'Humans', '*Induced Pluripotent Stem Cells/metabolism', 'Mutation', 'Myocytes, Cardiac/metabolism', 'NAV1.5 Voltage-Gated Sodium Channel/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35093717/
76,SCN5A,35772296,Generation of four induced pluripotent stem cell lines from a family harboring a single nucleotide variant in SCN5A.,"['Martinez-Moreno R', 'Carreras D', 'Aran B', 'Kuebler B', 'Sarquella-Brugada G', 'Brugada R', 'Perez GJ', 'Scornik FS', 'Selga E']","['Cell Line', 'Humans', '*Induced Pluripotent Stem Cells/metabolism', 'Mutation/genetics', 'NAV1.5 Voltage-Gated Sodium Channel/genetics/metabolism', 'Nucleotides/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35772296/
77,SCN5A,38614189,SCN5A gene variants and arrhythmic risk in Brugada syndrome: An updated systematic review and meta-analysis.,"['Doundoulakis I', 'Pannone L', 'Chiotis S', 'Della Rocca DG', 'Sorgente A', 'Tsioufis P', 'Del Monte A', 'Vetta G', 'Piperis C', 'Overeinder I', 'Bala G', 'Almorad A', 'Stroker E', 'Sieira J', 'La Meir M', 'Brugada P', 'Tsiachris D', 'Sarkozy A', 'Chierchia GB', 'de Asmundis C']","['*Brugada Syndrome/genetics/physiopathology/complications', 'Humans', '*NAV1.5 Voltage-Gated Sodium Channel/genetics', 'Electrocardiography', 'Genetic Predisposition to Disease', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/38614189/
78,SCN5A,29806494,Dysfunctional Nav1.5 channels due to SCN5A mutations.,"['Han D', 'Tan H', 'Sun C', 'Li G']","['*Action Potentials', 'Humans', 'Mutant Proteins/*genetics/*metabolism', '*Mutation', 'Myocytes, Cardiac/*physiology', 'NAV1.5 Voltage-Gated Sodium Channel/*genetics/*metabolism', 'Sodium/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29806494/
79,SCN5A,39121653,Generation of an induced pluripotent stem cell line from a Brugada syndrome patient carrying SCN5A/c.3118G>C mutation.,"['Fan H', 'Su J', 'Wang X', 'Wang H', 'Chen X', 'Sun Y', 'Jiang C', 'Liang P']","['Humans', '*Induced Pluripotent Stem Cells/metabolism', '*Brugada Syndrome/genetics/pathology', '*NAV1.5 Voltage-Gated Sodium Channel/genetics/metabolism', 'Male', 'Cell Line', 'Cell Differentiation', 'Mutation', 'Mutation, Missense']",https://pubmed.ncbi.nlm.nih.gov/39121653/
80,SCN5A,37651922,Maturation of iPSC-derived cardiomyocytes in a heart-on-a-chip device enables modeling of dilated cardiomyopathy caused by R222Q-SCN5A mutation.,"['Wauchop M', 'Rafatian N', 'Zhao Y', 'Chen W', 'Gagliardi M', 'Masse S', 'Cox BJ', 'Lai P', 'Liang T', 'Landau S', 'Protze S', 'Gao XD', 'Wang EY', 'Tung KC', 'Laksman Z', 'Lu RXZ', 'Keller G', 'Nanthakumar K', 'Radisic M', 'Backx PH']","['Adult', 'Humans', 'Myocytes, Cardiac', '*Cardiomyopathy, Dilated/genetics', '*Induced Pluripotent Stem Cells', 'Endothelial Cells', 'Lab-On-A-Chip Devices']",https://pubmed.ncbi.nlm.nih.gov/37651922/
81,SCN5A,20025708,Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome.,"['Hu D', 'Barajas-Martinez H', 'Nesterenko VV', 'Pfeiffer R', 'Guerchicoff A', 'Cordeiro JM', 'Curtis AB', 'Pollevick GD', 'Wu Y', 'Burashnikov E', 'Antzelevitch C']","['Adolescent', 'Alleles', 'Analysis of Variance', 'Bradycardia/*genetics/physiopathology', 'Brugada Syndrome/genetics/physiopathology', 'Calcium Channels, L-Type/*genetics', 'Electrophysiologic Techniques, Cardiac', 'Female', 'Heart Block/*genetics/physiopathology', 'Heart Conduction System/*physiopathology', 'Humans', 'Male', 'Microscopy, Confocal', 'Middle Aged', 'Muscle Proteins/*genetics', '*Mutation', 'NAV1.5 Voltage-Gated Sodium Channel', 'Pedigree', 'Phenotype', 'Polymerase Chain Reaction', '*Polymorphism, Single Nucleotide', 'Sodium Channels/*genetics']",https://pubmed.ncbi.nlm.nih.gov/20025708/
82,SCN5A,25871451,An investigation of the association of the H558R polymorphism of the SCN5A gene with idiopathic cardiac conduction disorders.,"['Nikulina SY', 'Chernova AA', 'Shulman VA', 'Maksimov VN', 'Gavrilyuk OA', 'Tretyakova SS', 'Marilovceva OV']","['Adult', 'Arrhythmias, Cardiac/*genetics', 'Brugada Syndrome', 'Bundle-Branch Block/genetics', 'Cardiac Conduction System Disease', 'Case-Control Studies', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Heart Conduction System/*abnormalities', 'Humans', 'Male', 'Middle Aged', 'Models, Genetic', 'NAV1.5 Voltage-Gated Sodium Channel/*genetics', 'Polymorphism, Single Nucleotide', 'Predictive Value of Tests', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25871451/
83,ADCY2,34010241,ADCY2 rs10059539 C>T polymorphism confers a decreased risk of hepatocellular carcinoma in Chinese Han women.,"['Chao X', 'Miao F', 'Feng X', 'Shi H', 'Wang Y', 'Wu J', 'Zhao L', 'Zhang W', 'Jiang C']","['Adenylyl Cyclases/*genetics', '*Carcinoma, Hepatocellular/epidemiology/genetics', 'Case-Control Studies', 'China/epidemiology', 'Female', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', '*Liver Neoplasms/epidemiology/genetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/34010241/
84,ADCY2,37493101,circSLC25A13 acts as a ceRNA to regulate AML progression via miR-616-3p/ADCY2 axis.,"['Wei W', 'Pan J', 'Wang J', 'Mao S', 'Qian Y', 'Lin X', 'Ling Q', 'Ye W', 'Zhou Y', 'Zhao Y', 'Huang J', 'Huang X', 'Ma Z', 'Wang H', 'Li C', 'Sun J', 'Jin J']","['Humans', 'Apoptosis/genetics', 'Cell Line, Tumor', 'Cell Proliferation/genetics', 'Down-Regulation', 'Gene Expression Regulation, Neoplastic', '*Leukemia, Myeloid, Acute/genetics/metabolism', '*MicroRNAs/genetics/metabolism', 'RNA, Circular/genetics']",https://pubmed.ncbi.nlm.nih.gov/37493101/
85,ADCY2,22461431,"CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland.","['Hardin M', 'Zielinski J', 'Wan ES', 'Hersh CP', 'Castaldi PJ', 'Schwinder E', 'Hawrylkiewicz I', 'Sliwinski P', 'Cho MH', 'Silverman EK']","['Adenylyl Cyclases/*genetics', 'Cohort Studies', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study/methods', 'Humans', 'Iron Regulatory Protein 2/*genetics', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', 'Phenotype', 'Poland', 'Polymorphism, Single Nucleotide', 'Pulmonary Disease, Chronic Obstructive/*genetics', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/22461431/
86,ADCY2,32893730,"Investigation of the impact of an ADCY2 polymorphism as a predictive biomarker in bipolar disorder, suicide tendency and response to lithium carbonate therapy: the first report from Iran.","['Aghabozorg Afjeh SS', 'Shams J', 'Hamednia S', 'Boshehri B', 'Olfat A', 'Omrani MD']","['Adenylyl Cyclases/*genetics', 'Alleles', 'Biomarkers/*metabolism', 'Bipolar Disorder/*drug therapy/*genetics/metabolism', 'Case-Control Studies', 'Endothelium/drug effects', 'Female', 'Genotype', 'Humans', 'Iran', 'Lithium Carbonate/*therapeutic use', 'Male', 'Mutation/*genetics', 'Suicidal Ideation', 'Suicide, Attempted']",https://pubmed.ncbi.nlm.nih.gov/32893730/
87,ADCY2,21528083,"SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer.","['Yu SJ', 'Yu JK', 'Ge WT', 'Hu HG', 'Yuan Y', 'Zheng S']","['Adenylyl Cyclases/*metabolism', 'Biomarkers, Tumor/metabolism', 'Cadherins/*metabolism', 'Calcium-Binding Proteins/*metabolism', 'Colorectal Neoplasms/diagnosis/*metabolism/pathology', 'Extracellular Matrix Proteins/*metabolism', 'Humans', 'Kaplan-Meier Estimate', 'Mitogen-Activated Protein Kinases/*metabolism', 'MutS Homolog 2 Protein/*metabolism', 'Neoplasm Staging', 'Prognosis', 'Protein Tyrosine Phosphatase, Non-Receptor Type 11/*metabolism', 'Tumor Suppressor Protein p53/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/21528083/
88,ADCY1,34650124,GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses.,"['Zhang Y', 'Yang J', 'Wang X', 'Li X']","['Adenocarcinoma/*diagnosis/metabolism/mortality', 'Adenylyl Cyclases/*metabolism', 'Adult', 'Biomarkers', 'Computational Biology', 'Female', 'GTP-Binding Protein gamma Subunits/*metabolism', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Kaplan-Meier Estimate', 'Male', 'Middle Aged', 'Oligonucleotide Array Sequence Analysis', 'Pancreatic Neoplasms/*diagnosis/metabolism/mortality', 'Prognosis', 'Protein Interaction Maps', 'Survival Analysis']",https://pubmed.ncbi.nlm.nih.gov/34650124/
89,ADCY1,29331508,Compartmentalized crosstalk of CFTR and TMEM16A (ANO1) through EPAC1 and ADCY1.,"['Lerias J', 'Pinto M', 'Benedetto R', 'Schreiber R', 'Amaral M', 'Aureli M', 'Kunzelmann K']","['Adenylyl Cyclases/*metabolism', 'Alveolar Epithelial Cells/*metabolism', 'Anoctamin-1/*metabolism', 'Cells, Cultured', 'Cystic Fibrosis Transmembrane Conductance Regulator/*metabolism', 'Guanine Nucleotide Exchange Factors/*metabolism', 'Humans', 'Neoplasm Proteins/*metabolism', 'Protein Transport', 'Receptor, Muscarinic M3/metabolism', 'Receptors, Purinergic P2Y2/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/29331508/
90,ADCY1,35076816,Circ-LTBP1 is involved in doxorubicin-induced intracellular toxicity in cardiomyocytes via miR-107/ADCY1 signal.,"['Li C', 'Zhang L', 'Bu X', 'Wang J', 'Li L', 'Yang Z']","['Adenylyl Cyclases/genetics/*metabolism', 'Cell Line', 'Doxorubicin/*adverse effects/pharmacology', 'Humans', 'MicroRNAs/genetics/*metabolism', 'Myocytes, Cardiac/*metabolism', 'RNA, Circular/genetics/*metabolism', 'Signal Transduction/*drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/35076816/
91,ADCY1,36913138,Downregulated INHBB in endometrial tissue of recurrent implantation failure patients impeded decidualization through the ADCY1/cAMP signalling pathway.,"['Zhang H', 'Wang Z', 'Zhou Q', 'Cao Z', 'Jiang Y', 'Xu M', 'Liu J', 'Zhou J', 'Yan G', 'Sun H']","['Female', 'Humans', '*Decidua/metabolism', '*Endometrium/metabolism', 'Epithelium', 'Inhibin-beta Subunits', 'Signal Transduction/genetics', 'Stromal Cells/metabolism', 'Transforming Growth Factor beta']",https://pubmed.ncbi.nlm.nih.gov/36913138/
92,PPP3CB,8978785,"Calcineurin A alpha (PPP3CA), calcineurin A beta (PPP3CB) and calcineurin B (PPP3R1) are located on human chromosomes 4, 10q21-->q22 and 2p16-->p15 respectively.","['Wang MG', 'Yi H', 'Guerini D', 'Klee CB', 'McBride OW']","['Base Sequence', 'Calcineurin', 'Calmodulin-Binding Proteins/*genetics', 'Chromosome Mapping', 'Chromosomes, Human, Pair 10/*genetics', 'Chromosomes, Human, Pair 2/*genetics', 'Chromosomes, Human, Pair 4/*genetics', 'Humans', 'Molecular Sequence Data', 'Phosphoprotein Phosphatases/*genetics', 'Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/8978785/
93,PPP3CB,30457174,PPP3CB contributes to poor prognosis through activating nuclear factor of activated T-cells signaling in neuroblastoma.,"['Shakhova I', 'Li Y', 'Yu F', 'Kaneko Y', 'Nakamura Y', 'Ohira M', 'Izumi H', 'Mae T', 'Varfolomeeva SR', 'Rumyantsev AG', 'Nakagawara A']","['Apoptosis', 'Biomarkers, Tumor/genetics/*metabolism', 'Calcineurin/genetics/*metabolism', 'Cell Proliferation', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Infant', 'Mutation', 'NFATC Transcription Factors/genetics/metabolism', 'Neuroblastoma/genetics/metabolism/*pathology', 'Prognosis', 'Survival Rate', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/30457174/
94,PPP3CB,21531385,"ANXA7, PPP3CB, DNAJC9, and ZMYND17 genes at chromosome 10q22 associated with the subgroup of schizophrenia with deficits in attention and executive function.","['Liu CM', 'Fann CS', 'Chen CY', 'Liu YL', 'Oyang YJ', 'Yang WC', 'Chang CC', 'Wen CC', 'Chen WJ', 'Hwang TJ', 'Hsieh MH', 'Liu CC', 'Faraone SV', 'Tsuang MT', 'Hwu HG']","['Adult', 'Annexin A7/biosynthesis/*genetics', 'Attention Deficit Disorder with Hyperactivity/complications/*genetics', 'Calcineurin/biosynthesis/*genetics', 'Carrier Proteins/biosynthesis/*genetics', 'Cells, Cultured', 'Chromosomes, Human, Pair 10/genetics', 'Executive Function/*physiology', 'Female', 'Gene Expression', 'Genetic Association Studies/methods', 'Genetic Linkage', 'Genotype', 'HSP40 Heat-Shock Proteins/biosynthesis/*genetics', 'Humans', 'Male', 'Neuropsychological Tests', 'Polymorphism, Single Nucleotide', 'Schizophrenia/complications/*genetics/metabolism', '*Schizophrenic Psychology']",https://pubmed.ncbi.nlm.nih.gov/21531385/
95,PPP3CA,33963760,PPP3CA truncating variants clustered in the regulatory domain cause early-onset refractory epilepsy.,"['Panneerselvam S', 'Wang J', 'Zhu W', 'Dai H', 'Pappas JG', 'Rabin R', 'Low KJ', 'Rosenfeld JA', 'Emrick L', 'Xiao R', 'Xia F', 'Yang Y', 'Eng CM', 'Anderson A', 'Chau V', 'Soler-Alfonso C', 'Streff H', 'Lalani SR', 'Mercimek-Andrews S', 'Bi W']","['Adolescent', 'Calcineurin/*genetics/metabolism', 'Child', 'Child, Preschool', 'Drug Resistant Epilepsy/etiology/genetics', 'Epilepsy/etiology/*genetics', 'Female', 'Gene Expression', 'Humans', 'Male', '*Mutation', 'Sequence Analysis, RNA']",https://pubmed.ncbi.nlm.nih.gov/33963760/
96,PPP3CA,8978785,"Calcineurin A alpha (PPP3CA), calcineurin A beta (PPP3CB) and calcineurin B (PPP3R1) are located on human chromosomes 4, 10q21-->q22 and 2p16-->p15 respectively.","['Wang MG', 'Yi H', 'Guerini D', 'Klee CB', 'McBride OW']","['Base Sequence', 'Calcineurin', 'Calmodulin-Binding Proteins/*genetics', 'Chromosome Mapping', 'Chromosomes, Human, Pair 10/*genetics', 'Chromosomes, Human, Pair 2/*genetics', 'Chromosomes, Human, Pair 4/*genetics', 'Humans', 'Molecular Sequence Data', 'Phosphoprotein Phosphatases/*genetics', 'Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/8978785/
97,PPP3CA,30776328,Protein phosphatase PPP3CA (calcineurin A) down-regulates hypoxia-inducible factor transcriptional activity.,"['Karagiota A', 'Mylonis I', 'Simos G', 'Chachami G']","['Calcineurin/genetics/*metabolism', '*Down-Regulation', 'Enzyme Activation', 'Gene Silencing', 'HeLa Cells', 'Humans', 'Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism', 'Ionomycin/pharmacology', '*Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/30776328/
98,PPP3CA,28942967,De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.,"['Myers CT', 'Stong N', 'Mountier EI', 'Helbig KL', 'Freytag S', 'Sullivan JE', 'Ben Zeev B', 'Nissenkorn A', 'Tzadok M', 'Heimer G', 'Shinde DN', 'Rezazadeh A', 'Regan BM', 'Oliver KL', 'Ernst ME', 'Lippa NC', 'Mulhern MS', 'Ren Z', 'Poduri A', 'Andrade DM', 'Bird LM', 'Bahlo M', 'Berkovic SF', 'Lowenstein DH', 'Scheffer IE', 'Sadleir LG', 'Goldstein DB', 'Mefford HC', 'Heinzen EL']","['Adolescent', 'Adult', 'Calcineurin/*genetics/metabolism', 'Child', 'Child, Preschool', 'Cohort Studies', 'Epilepsy/*genetics/pathology', 'Exome/genetics', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Lennox Gastaut Syndrome/pathology', 'Male', '*Mutation', 'Neurodevelopmental Disorders/*genetics/pathology', 'Sequence Analysis, DNA', 'Severity of Illness Index', 'Spasms, Infantile/genetics/pathology', 'Synaptic Transmission/*physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28942967/
99,PPP3CA,39305655,PPP3CA gene-related developmental and epileptic encephalopathy: Expanding the electro-clinical phenotype.,"['Favaro J', 'Iodice A', 'Nosadini M', 'Asta F', 'Toldo I', 'Ancona C', 'Cavaliere E', 'Pelizza MF', 'Casara G', 'Parmeggiani L', 'Sartori S']","['Humans', '*Calcineurin/genetics', '*Developmental Disabilities/diagnosis/genetics/physiopathology', '*Drug Resistant Epilepsy/diagnosis/genetics/physiopathology', '*Electroencephalography', 'Mutation', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/39305655/
100,PPP3CA,39707491,Expanding the clinical spectrum of PPP3CA variants - alternative isoforms matter.,"['Castiglioni S', 'Pezzoli L', 'Pezzani L', 'Lettieri A', 'Di Fede E', 'Cereda A', 'Ancona S', 'Gallina A', 'Colombo EA', 'Parodi C', 'Grazioli P', 'Taci E', 'Milani D', 'Iascone M', 'Massa V', 'Gervasini C']","['Humans', '*Protein Isoforms/genetics/metabolism', '*Calcineurin/metabolism/genetics', 'Male', 'Female', 'Exome Sequencing', 'Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/39707491/
101,PPP3CA,35324524,TRIM72 exerts antitumor effects in breast cancer and modulates lactate production and MCT4 promoter activity by interacting with PPP3CA.,"['Wang Z', 'Li H', 'Wang H', 'Li X', 'Zhang Q', 'Wang H', 'Li K', 'Qiu Y']","['*Breast Neoplasms/drug therapy', 'Calcineurin/pharmacology/therapeutic use', 'Cell Line, Tumor', 'Cell Proliferation', 'Female', 'Humans', 'Hypoxia', 'Lactic Acid/pharmacology/therapeutic use', 'Monocarboxylic Acid Transporters', 'Muscle Proteins', 'Phosphatidylinositol 3-Kinases/genetics/metabolism', 'Proto-Oncogene Proteins c-akt/metabolism', 'TOR Serine-Threonine Kinases/metabolism', 'Tripartite Motif Proteins', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/35324524/
102,PPP3CA,30455226,Early-onset infant epileptic encephalopathy associated with a de novo PPP3CA gene mutation.,"['Qian Y', 'Wu B', 'Lu Y', 'Dong X', 'Qin Q', 'Zhou W', 'Wang H']","['Calcineurin/*genetics/*metabolism', 'Epilepsy/complications', 'Female', 'Frameshift Mutation/genetics', 'Humans', 'Infant', 'Intellectual Disability', 'Mutation', 'Neurodevelopmental Disorders', 'Phenotype', 'Seizures/complications', 'Spasms, Infantile/complications/*genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/30455226/
103,PPP3CA,30254215,"Novel calcineurin A (PPP3CA) variant associated with epilepsy, constitutive enzyme activation and downregulation of protein expression.","['Rydzanicz M', 'Wachowska M', 'Cook EC', 'Lisowski P', 'Kuzniewska B', 'Szymanska K', 'Diecke S', 'Prigione A', 'Szczaluba K', 'Szybinska A', 'Koppolu A', 'Murcia Pienkowski V', 'Kosinska J', 'Wiweger M', 'Kostrzewa G', 'Brzozowska M', 'Domanska-Pakiela D', 'Jurkiewicz E', 'Stawinski P', 'Gromadka A', 'Zielenkiewicz P', 'Demkow U', 'Dziembowska M', 'Kuznicki J', 'Creamer TP', 'Ploski R']","['Calcineurin/*genetics/metabolism', 'Cells, Cultured', 'Child', 'Craniofacial Abnormalities/*genetics/pathology', 'Down-Regulation', 'Epilepsy/*genetics/pathology', 'Humans', 'Male', '*Mutation, Missense', 'Phenotype', 'Syndrome']",https://pubmed.ncbi.nlm.nih.gov/30254215/
104,PPP3CA,29432562,Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders.,"['Mizuguchi T', 'Nakashima M', 'Kato M', 'Okamoto N', 'Kurahashi H', 'Ekhilevitch N', 'Shiina M', 'Nishimura G', 'Shibata T', 'Matsuo M', 'Ikeda T', 'Ogata K', 'Tsuchida N', 'Mitsuhashi S', 'Miyatake S', 'Takata A', 'Miyake N', 'Hata K', 'Kaname T', 'Matsubara Y', 'Saitsu H', 'Matsumoto N']","['Amino Acid Sequence', 'Arthrogryposis/*genetics/metabolism/pathology', 'Base Sequence', 'Calcineurin/chemistry/*genetics/metabolism', 'Child', 'Child, Preschool', 'Craniofacial Abnormalities/*genetics/metabolism/pathology', 'Dwarfism/*genetics/metabolism/pathology', 'Female', '*Gain of Function Mutation', 'Gene Expression Regulation', 'Genetic Association Studies', 'Humans', '*Loss of Function Mutation', 'Male', 'Models, Molecular', 'Pedigree', 'Protein Conformation, alpha-Helical', 'Protein Conformation, beta-Strand', 'Protein Domains', 'Recombinant Proteins/chemistry/genetics/metabolism', 'Saccharomyces cerevisiae/genetics/metabolism', 'Sequence Alignment', 'Sequence Homology, Amino Acid', 'Spasms, Infantile/*genetics/metabolism/pathology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29432562/
105,PPP3CA,20590401,"Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease.","['Chiocco MJ', 'Zhu X', 'Walther D', 'Pletnikova O', 'Troncoso JC', 'Uhl GR', 'Liu QR']","[""*5' Untranslated Regions"", '*Alternative Splicing', 'Alzheimer Disease/*genetics/metabolism', 'Behavior, Addictive/*genetics', 'Brain/metabolism', 'Calcineurin/*genetics', 'Gene Frequency', 'Humans', 'Polymorphism, Single Nucleotide', 'Protein Isoforms/*genetics/metabolism', 'RNA', '*Trinucleotide Repeats']",https://pubmed.ncbi.nlm.nih.gov/20590401/
106,PPP3CA,32593294,Clinical and Genetic Study on a Chinese Patient with Infantile Onset Epileptic Encephalopathy carrying a PPP3CA Null Variant: a case report.,"['Yang S', 'Shen X', 'Kang Q', 'Kuang X', 'Ning Z', 'Liu S', 'Liao H', 'Cao Z', 'Yang L']","['Calcineurin/genetics', 'Child, Preschool', 'China', 'Electroencephalography', '*Epilepsy', 'Humans', 'Mutation', '*Spasms, Infantile/diagnosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/32593294/
107,RAC1,31035701,Coordination between Rac1 and Rab Proteins: Functional Implications in Health and Disease.,"['Margiotta A', 'Bucci C']","['Actin Cytoskeleton/metabolism', 'Actins/metabolism', 'Cell Movement/physiology', 'DNA Repair/physiology', 'Humans', 'Immunity, Innate/physiology', 'Neoplasms/physiopathology', 'Nervous System Diseases/physiopathology', 'Reactive Oxygen Species/metabolism', 'Transcription, Genetic/physiology', 'rab GTP-Binding Proteins/*physiology', 'rac1 GTP-Binding Protein/*physiology']",https://pubmed.ncbi.nlm.nih.gov/31035701/
108,RAC1,39838818,Diverse Clinical Presentation of RAC1-Related Intellectual Developmental Disorder.,"['Upadia J', 'Liu J', 'Bier C', 'Chenevert M', 'Li Y']","['Humans', '*rac1 GTP-Binding Protein/genetics', '*Intellectual Disability/genetics/pathology/diagnosis', 'Female', 'Male', 'Phenotype', 'Mutation', 'Child', 'Child, Preschool']",https://pubmed.ncbi.nlm.nih.gov/39838818/
109,RAC1,38750717,Acetylation of ELMO1 correlates with Rac1 activity and colorectal cancer progress.,"['Li C', 'Yi J', 'Jie H', 'Liu Z', 'Li S', 'Zeng Z', 'Zhou Y']","['Humans', '*Colorectal Neoplasms/metabolism/pathology/genetics', 'Acetylation', '*rac1 GTP-Binding Protein/metabolism', '*Adaptor Proteins, Signal Transducing/metabolism/genetics', 'Cell Line, Tumor', 'Disease Progression', 'Sirtuin 2/metabolism/genetics', 'Cell Movement', 'HCT116 Cells']",https://pubmed.ncbi.nlm.nih.gov/38750717/
110,RAC1,25465943,RAC1 and melanoma.,['Halaban R'],"['Humans', 'Melanoma/drug therapy/*genetics', 'Mutation', 'Protein Kinase Inhibitors/therapeutic use', 'Skin Neoplasms/drug therapy/*genetics', 'rac1 GTP-Binding Protein/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25465943/
111,RAC1,29723737,Compartmentalisation of RAC1 signalling.,"['Payapilly A', 'Malliri A']","['*Cell Compartmentation', 'GTPase-Activating Proteins/metabolism', 'Guanine Nucleotide Exchange Factors/metabolism', 'Humans', '*Signal Transduction', 'rac1 GTP-Binding Protein/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29723737/
112,RAC1,27869202,Suppression of Rac1 Signaling by Influenza A Virus NS1 Facilitates Viral Replication.,"['Jiang W', 'Sheng C', 'Gu X', 'Liu D', 'Yao C', 'Gao S', 'Chen S', 'Huang Y', 'Huang W', 'Fang M']","['A549 Cells', 'Down-Regulation', 'Host-Pathogen Interactions', 'Humans', 'Influenza A virus/*physiology', 'Protein Binding', 'Protein Processing, Post-Translational', 'Signal Transduction', 'Viral Nonstructural Proteins/genetics/*metabolism', 'Virus Replication', 'rac1 GTP-Binding Protein/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/27869202/
113,RAC1,22293830,Rac1 gets fattier.,"['Tsai FD', 'Philips MR']","['Acylation', 'Palmitic Acid/metabolism', 'Protein Processing, Post-Translational', 'rac1 GTP-Binding Protein/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/22293830/
114,RAC1,25669881,Nuclear and cellular plasticity: nuclear RAC1 takes center stage.,"['Disanza A', 'Scita G']","['Actins/*metabolism', 'Cytosol/*metabolism', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/25669881/
115,RAC1,32122794,"Sarcoidosis and the mTOR, Rac1, and Autophagy Triad.","['Pacheco Y', 'Lim CX', 'Weichhart T', 'Valeyre D', 'Bentaher A', 'Calender A']","['*Autophagy/genetics', 'Humans', 'Macrophages/immunology/pathology', '*Sarcoidosis/genetics/immunology', '*TOR Serine-Threonine Kinases/immunology', 'Th1 Cells/immunology/pathology', 'Th17 Cells/immunology', '*rac1 GTP-Binding Protein/immunology']",https://pubmed.ncbi.nlm.nih.gov/32122794/
116,RAC1,33848152,Mechanistic Differences of Activation of Rac1(P29S) and Rac1(A159V).,"['Senyuz S', 'Jang H', 'Nussinov R', 'Keskin O', 'Gursoy A']","['Guanosine Triphosphate', 'Humans', '*Melanoma', 'Molecular Conformation', 'Mutation', '*rac1 GTP-Binding Protein/genetics/metabolism', 'ras Proteins']",https://pubmed.ncbi.nlm.nih.gov/33848152/
117,RAC1,34402856,"Dynamic Rac1 inhibition by CYRI helps cells drink, but stops them from driving.",['King JS'],['*Pinocytosis'],https://pubmed.ncbi.nlm.nih.gov/34402856/
118,RAC1,29198968,Clustering of Rac1: Selective Lipid Sorting Drives Signaling.,"['Maxwell KN', 'Zhou Y', 'Hancock JF']","['Cell Membrane', 'Lipids', 'Membrane Proteins', '*Protein Transport', '*Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/29198968/
119,KLK1,29328364,Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).,"['Devetzi M', 'Goulielmaki M', 'Khoury N', 'Spandidos DA', 'Sotiropoulou G', 'Christodoulou I', 'Zoumpourlis V']","['*Disease', '*Genetic Engineering', 'Humans', '*Molecular Targeted Therapy', '*Stem Cell Transplantation', 'Stem Cells/*metabolism', 'Tissue Kallikreins/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29328364/
120,KLK1,35513865,"Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population.","['Tang L', 'Zhong X', 'Gong H', 'Tuerxun M', 'Ma T', 'Ren J', 'Xie C', 'Zheng A', 'Abudureheman Z', 'Abudukadeer A', 'Aini P', 'Yilamujiang S', 'Li L']","['Anoctamins/genetics', 'Case-Control Studies', 'China/epidemiology', 'Collagen Type IV/genetics', 'Gene Frequency', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Mucins/genetics', 'Polymorphism, Single Nucleotide', '*Pulmonary Disease, Chronic Obstructive/epidemiology/genetics', 'Tissue Kallikreins/genetics']",https://pubmed.ncbi.nlm.nih.gov/35513865/
121,KLK1,36610381,saKLK1-374 is more difficult to induce KLK1 expression in normal prostate cell lines than that in prostate cancer cell lines: Rethinking the universality of RNA activation.,"['Zhang M', 'Lin D', 'Luo C', 'Wei P', 'Cui K', 'Chen K', 'Chen Z']","['Male', 'Humans', '*Prostate/metabolism', 'RNA, Double-Stranded', 'Cyclin-Dependent Kinase Inhibitor p21/genetics/metabolism', '*Prostatic Neoplasms/pathology', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/36610381/
122,KLK1,27329205,"Association of serum levels of AngII, KLK1, and ACE/KLK1 polymorphisms with acute myocardial infarction induced by coronary artery stenosis.","['Dai SH', 'Li JF', 'Feng JB', 'Li RJ', 'Li CB', 'Li Z', 'Zhang Y', 'Li DQ']","['Angiotensin II/*blood', 'Case-Control Studies', 'Chi-Square Distribution', 'Coronary Stenosis/blood/*complications', 'Female', 'Gene Frequency', 'Humans', 'INDEL Mutation/genetics', 'Logistic Models', 'Male', 'Middle Aged', 'Myocardial Infarction/blood/*etiology/*genetics', 'Peptidyl-Dipeptidase A/*genetics', 'Polymerase Chain Reaction', 'Polymorphism, Single Nucleotide/*genetics', 'Tissue Kallikreins/*blood/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27329205/
123,KLK1,23765970,KLK1 A1789G gene polymorphism and the risk of coronary artery stenosis in the Chinese population.,"['Li QD', 'Li FJ', 'Liu XC', 'Jiang H']","['Amino Acid Substitution/*genetics', 'Asian People/*genetics', 'Case-Control Studies', 'China', 'Coronary Stenosis/*genetics', 'Female', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Risk Factors', 'Smoking/adverse effects/genetics', 'Tissue Kallikreins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23765970/
124,KLK1,28000848,Transcriptome reveals the overexpression of a kallikrein gene cluster (KLK1/3/7/8/12) in the Tibetans with high altitude-associated polycythemia.,"['Li K', 'Gesang L', 'Dan Z', 'Gusang L']","['Adult', '*Altitude', 'Case-Control Studies', 'Cholesterol/metabolism', 'Chromosome Mapping', 'Endoscopy, Gastrointestinal', 'Female', 'Gastric Mucosa/metabolism/pathology', '*Gene Expression', 'Gene Expression Profiling', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Kallikreins/*genetics', 'Male', 'Middle Aged', '*Multigene Family', 'Polycythemia/diagnosis/*etiology', 'Tibet', '*Transcriptome', 'Upper Gastrointestinal Tract/pathology']",https://pubmed.ncbi.nlm.nih.gov/28000848/
125,KLK1,27858843,Association of the KLK1 rs5516 G allele and the ACE D allele with aortic aneurysm and atherosclerotic stenosis.,"['Zhang Y', 'Huang H', 'Ma Y', 'Sun Y', 'Wang G', 'Tang L']","['Aged', 'Alleles', 'Aortic Aneurysm/*genetics', 'Aortic Diseases/*genetics', 'Arterial Occlusive Diseases/*genetics', 'Asian People', 'Atherosclerosis/*genetics', 'Case-Control Studies', 'Female', 'Humans', 'Male', 'Middle Aged', 'Peptidyl-Dipeptidase A/*genetics', 'Tissue Kallikreins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27858843/
126,KLK1,29614347,"Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology.","['Adamopoulos PG', 'Kontos CK', 'Scorilas A']","['*Alternative Splicing', 'Cell Line, Tumor', 'Humans', 'Isoenzymes/genetics/metabolism', 'Kallikreins/*genetics/metabolism', 'Neoplasms/*genetics/metabolism', 'RNA, Messenger/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29614347/
127,KLK1,10614994,The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library.,"['Rae F', 'Bulmer B', 'Nicol D', 'Clements J']","['Alleles', 'Amino Acid Sequence', 'Base Sequence', 'Carcinoma, Renal Cell/*enzymology/genetics', 'Female', '*Gene Library', 'Humans', 'Kidney Neoplasms/*enzymology/genetics', 'Molecular Sequence Data', 'Prostate-Specific Antigen/biosynthesis/blood', 'RNA, Messenger/*biosynthesis', 'Tissue Kallikreins/*biosynthesis/blood/*genetics', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/10614994/
128,KLK1,7903227,No effect of TaqI polymorphism at the human renal kallikrein (KLK1) locus on normal blood pressure level or variability.,"['Berge KE', 'Berg K']","['Adult', 'Aged', 'Blood Pressure', 'DNA/isolation & purification', 'Female', 'Genotype', 'Humans', 'Hypertension/etiology/*genetics', 'Kallikreins/*genetics', 'Kidney/*enzymology', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Polymorphism, Restriction Fragment Length', 'Twins, Monozygotic']",https://pubmed.ncbi.nlm.nih.gov/7903227/
129,KLK1,1684954,Human glandular Kallikrein genes: genetic and physical mapping of the KLK1 locus using a highly polymorphic microsatellite PCR marker.,"['Richards RI', 'Holman K', 'Shen Y', 'Kozman H', 'Harley H', 'Brook D', 'Shaw D']","['Alleles', 'Base Composition', 'Base Sequence', '*Chromosomes, Human, Pair 19', 'DNA', 'DNA, Satellite', 'Female', 'Gene Frequency', 'Genetic Markers', 'Humans', 'Kallikreins/*genetics', 'Male', 'Molecular Sequence Data', 'Pedigree', 'Polymerase Chain Reaction', '*Polymorphism, Restriction Fragment Length', '*Repetitive Sequences, Nucleic Acid', 'Restriction Mapping']",https://pubmed.ncbi.nlm.nih.gov/1684954/
130,KCNN2,33242881,Variants in the SK2 channel gene (KCNN2) lead to dominant neurodevelopmental movement disorders.,"['Mochel F', 'Rastetter A', 'Ceulemans B', 'Platzer K', 'Yang S', 'Shinde DN', 'Helbig KL', 'Lopergolo D', 'Mari F', 'Renieri A', 'Benetti E', 'Canitano R', 'Waisfisz Q', 'Plomp AS', 'Huisman SA', 'Wilson GN', 'Cathey SS', 'Louie RJ', 'Gaudio DD', 'Waggoner D', 'Kacker S', 'Nugent KM', 'Roeder ER', 'Bruel AL', 'Thevenon J', 'Ehmke N', 'Horn D', 'Holtgrewe M', 'Kaiser FJ', 'Kamphausen SB', 'Abou Jamra R', 'Weckhuysen S', 'Dalle C', 'Depienne C']","['Adolescent', 'Adult', 'Cerebellar Ataxia/genetics/psychology', 'Child', 'Child, Preschool', 'Electrophysiological Phenomena', 'Exome', 'Frameshift Mutation', 'Genetic Variation', 'Haploinsufficiency', 'Humans', 'Intellectual Disability/genetics/psychology', 'Learning Disabilities/genetics/psychology', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Movement Disorders/*genetics/psychology', 'Mutation, Missense/genetics', 'Neurodevelopmental Disorders/*genetics/psychology', 'Patch-Clamp Techniques', 'Small-Conductance Calcium-Activated Potassium Channels/*genetics', 'White Matter/abnormalities/diagnostic imaging', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33242881/
131,KCNN2,27442679,KCNN2 polymorphisms and cardiac tachyarrhythmias.,"['Yu CC', 'Chia-Ti T', 'Chen PL', 'Wu CK', 'Chiu FC', 'Chiang FT', 'Chen PS', 'Chen CL', 'Lin LY', 'Juang JM', 'Ho LT', 'Lai LP', 'Yang WS', 'Lin JL']","['Adult', 'Aged', 'Defibrillators, Implantable', 'Female', 'Gene Frequency/genetics', 'Genetic Predisposition to Disease/genetics', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Prospective Studies', 'Small-Conductance Calcium-Activated Potassium Channels/*genetics', 'Statistics as Topic', 'Tachycardia/*genetics/therapy']",https://pubmed.ncbi.nlm.nih.gov/27442679/
132,KCNN2,37510285,A Novel KCNN2 Variant in a Family with Essential Tremor Plus: Clinical Characteristics and In Silico Analysis.,"[""d'Apolito M"", 'Ceccarini C', 'Savino R', 'Adipietro I', 'di Bari I', 'Santacroce R', 'Curcetti M', ""D'Andrea G"", 'Croce AI', 'Cesarano C', 'Polito AN', 'Margaglione M']","['Female', 'Humans', '*Essential Tremor/genetics/pathology', 'Tremor/genetics', 'Calcium', 'Mutation, Missense', 'Genetic Testing', 'Small-Conductance Calcium-Activated Potassium Channels/genetics']",https://pubmed.ncbi.nlm.nih.gov/37510285/
133,KCNN2,35106185,KCNN2 Mutation in Pediatric Tremor Myoclonus Dystonia Syndrome with Electrophysiological Evaluation.,"['Lavenstein B', 'McGurrin P', 'Attaripour S', 'Vial F', 'Hallett M']","['Child', '*Dystonia/complications/diagnosis/genetics', 'Dystonic Disorders', 'Humans', 'Male', '*Movement Disorders/complications', 'Mutation/genetics', '*Myoclonus/complications/diagnosis/genetics', 'Small-Conductance Calcium-Activated Potassium Channels/genetics', 'Tremor/diagnosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/35106185/
134,KCNN2,39884404,The role of genetic polymorphisms in KCNN2 in cardiovascular complications in patients with renal failure.,"['Gomaa AA', 'Zeid AM', 'Nagy IM']","['Humans', 'Female', 'Male', '*Small-Conductance Calcium-Activated Potassium Channels/genetics', '*Polymorphism, Single Nucleotide', 'Middle Aged', '*Kidney Failure, Chronic/genetics/complications', '*Cardiovascular Diseases/genetics', 'Aged', '*Genetic Predisposition to Disease', 'Haplotypes', 'Adult', 'Alleles', 'Risk Factors', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/39884404/
135,KCNN2,23677057,Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis.,"['Kim JJ', 'Park YM', 'Yoon D', 'Lee KY', 'Seob Song M', 'Doo Lee H', 'Kim KJ', 'Park IS', 'Nam HK', 'Weon Yun S', 'Ki Han M', 'Mi Hong Y', 'Young Jang G', 'Lee JK']","['Child, Preschool', 'Coronary Aneurysm/*complications/*genetics', 'Exons/genetics', 'Female', 'Genetic Loci/genetics', '*Genetic Predisposition to Disease', '*Genome-Wide Association Study', 'Humans', 'Male', 'Mucocutaneous Lymph Node Syndrome/*complications/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Repetitive Sequences, Nucleic Acid/genetics', 'Reproducibility of Results', 'Risk Factors', 'Sequence Analysis, DNA', 'Small-Conductance Calcium-Activated Potassium Channels/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23677057/
136,CAMK4,32572897,MiR-507 inhibits the growth and invasion of trophoblasts by targeting CAMK4.,"['Li HQ', 'Fan JJ', 'Li XH', 'Bao D']","['Calcium-Calmodulin-Dependent Protein Kinase Type 4/genetics/*metabolism', 'Cell Proliferation', 'Cells, Cultured', 'Female', 'Humans', 'MicroRNAs/genetics/*metabolism', 'Pre-Eclampsia/*metabolism/pathology', 'Pregnancy', 'Trophoblasts/*metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/32572897/
137,CAMK4,34252574,"Complement activation and increased expression of Syk, mucin-1 and CaMK4 in kidneys of patients with COVID-19.","['Jamaly S', 'Tsokos MG', 'Bhargava R', 'Brook OR', 'Hecht JL', 'Abdi R', 'Moulton VR', 'Satyam A', 'Tsokos GC']","['Aged', 'Aged, 80 and over', 'COVID-19/*metabolism/pathology', 'Calcium-Calmodulin-Dependent Protein Kinase Type 4/genetics/metabolism', 'Complement System Proteins/genetics/*metabolism', 'Fatal Outcome', 'Female', 'Gene Expression Regulation', 'Humans', 'Kidney/*metabolism', 'Male', 'Middle Aged', 'Mucin-1/genetics/*metabolism', '*SARS-CoV-2', 'Syk Kinase/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34252574/
138,CAMK4,34780752,Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6/p-CaMK4 signaling.,"['Chen L', 'Tang YL', 'Liu ZH', 'Pan Y', 'Jiao RQ', 'Kong LD']","['Antioxidants/*pharmacology', 'Calcium-Calmodulin-Dependent Protein Kinase Type 4/antagonists & inhibitors/metabolism', 'Cell Line', 'Cell Movement/drug effects', 'Down-Regulation/drug effects', 'Fructose/*adverse effects', 'Furans/*pharmacology', 'Humans', 'Microfilament Proteins/metabolism', 'Oxidative Stress/drug effects', 'Phosphorylation', 'Podocytes/*drug effects/physiology', 'Proteolysis/drug effects', 'Signal Transduction/drug effects', 'Sweetening Agents/*adverse effects', 'TRPC6 Cation Channel/antagonists & inhibitors/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34780752/
139,GUCY2F,16941478,"Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.","['Wood LD', 'Calhoun ES', 'Silliman N', 'Ptak J', 'Szabo S', 'Powell SM', 'Riggins GJ', 'Wang TL', 'Yan H', 'Gazdar A', 'Kern SE', 'Pennacchio L', 'Kinzler KW', 'Vogelstein B', 'Velculescu VE']","['Adenocarcinoma/genetics', 'Base Sequence', 'Breast Neoplasms/genetics', 'Carcinoma, Non-Small-Cell Lung/genetics', 'Carcinoma, Small Cell/genetics', 'Carcinoma, Squamous Cell/genetics', 'DNA Mutational Analysis', 'Female', 'Guanylate Cyclase/*genetics', 'Humans', 'Lung Neoplasms/genetics', 'Mutation/*genetics', 'Neoplasms/*genetics', 'Pancreatic Neoplasms/genetics', 'Polymerase Chain Reaction', 'Receptor Protein-Tyrosine Kinases/*genetics', 'Receptor, EphA3', 'Receptor, trkC/*genetics', 'Receptors, Cell Surface/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16941478/
140,HDAC2,32367603,Histone Deacetylase 2 (HDAC2) Inhibitors Containing Boron.,"['Kavianpour P', 'Gemmell MCM', 'Kahlert JU', 'Rendina LM']","['Boron Compounds/chemical synthesis/chemistry/*pharmacology', 'Histone Deacetylase 2/*antagonists & inhibitors/metabolism', 'Histone Deacetylase Inhibitors/chemical synthesis/chemistry/*pharmacology', 'Humans', 'Molecular Structure']",https://pubmed.ncbi.nlm.nih.gov/32367603/
141,HDAC2,31254352,HDAC2-dependent miRNA signature in acute myeloid leukemia.,"['Conte M', ""Dell'Aversana C"", 'Sgueglia G', 'Carissimo A', 'Altucci L']","['Cell Line, Tumor', 'Gene Regulatory Networks', 'Genes, MHC Class II/genetics', 'Histone Deacetylase 2/*metabolism', 'Humans', 'Leukemia, Myeloid, Acute/genetics/*pathology', 'MicroRNAs/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31254352/
142,HDAC2,28028031,HDAC2 promotes loss of primary cilia in pancreatic ductal adenocarcinoma.,"['Kobayashi T', 'Nakazono K', 'Tokuda M', 'Mashima Y', 'Dynlacht BD', 'Itoh H']","['Aurora Kinase A/metabolism', 'Biomarkers', 'Carcinoma, Pancreatic Ductal/*genetics/*pathology', 'Cell Line, Tumor', 'Cell Proliferation', 'Cell Transformation, Neoplastic/genetics/metabolism', 'Cilia/drug effects/*metabolism/*pathology', 'Genes, ras', 'Histone Deacetylase 2/*genetics/metabolism', 'Histone Deacetylase Inhibitors/pharmacology', 'Humans', 'Pancreatic Neoplasms/*genetics/*pathology', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/28028031/
143,HDAC2,33267897,HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer.,"['Hu XT', 'Xing W', 'Zhao RS', 'Tan Y', 'Wu XF', 'Ao LQ', 'Li Z', 'Yao MW', 'Yuan M', 'Guo W', 'Li SZ', 'Yu J', 'Ao X', 'Xu X']","['Cell Line, Tumor', 'Cell Proliferation/physiology', 'Colorectal Neoplasms/genetics/*metabolism/*pathology', 'Down-Regulation', 'Epithelial-Mesenchymal Transition', 'Histone Deacetylase 2/genetics/*metabolism', 'Humans', 'Neoplasm Metastasis', 'RNA, Long Noncoding/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33267897/
144,HDAC2,38134358,"Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation.","['Qiao X', 'Wu X', 'Chen S', 'Niu MM', 'Hua H', 'Zhang Y']","['Humans', '*Molecular Dynamics Simulation', 'Molecular Docking Simulation', 'Pharmacophore', 'Histone Deacetylase 2/metabolism', 'Histone Deacetylase Inhibitors/pharmacology', 'Early Detection of Cancer', '*Colorectal Neoplasms/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/38134358/
145,HDAC2,35974388,YTHDC1 is downregulated by the YY1/HDAC2 complex and controls the sensitivity of ccRCC to sunitinib by targeting the ANXA1-MAPK pathway.,"['Li W', 'Ye K', 'Li X', 'Liu X', 'Peng M', 'Chen F', 'Xiong W', 'Wang Y', 'Zhu L']","['Annexin A1/genetics/metabolism', '*Carcinoma, Renal Cell/drug therapy/genetics/metabolism', 'Cell Line, Tumor', 'Cell Proliferation/genetics', 'Histone Deacetylase 2/genetics/metabolism', 'Humans', '*Kidney Neoplasms/drug therapy/genetics/metabolism', 'MAP Kinase Signaling System', '*Nerve Tissue Proteins/genetics/metabolism', 'Protein Kinase Inhibitors', '*RNA Splicing Factors/genetics/metabolism', 'Sunitinib/pharmacology', 'YY1 Transcription Factor/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35974388/
146,F8,25406352,The intron-22-inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics.,"['Sauna ZE', 'Lozier JN', 'Kasper CK', 'Yanover C', 'Nichols T', 'Howard TE']","['Chromosome Inversion', 'Factor VIII/genetics/*immunology/therapeutic use', 'Hemophilia A/drug therapy/*genetics/*immunology', 'Humans', 'Introns/genetics', 'Mutation', '*Pharmacogenetics']",https://pubmed.ncbi.nlm.nih.gov/25406352/
147,F8,35924581,Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association.,"['Testa MF', 'Lombardi S', 'Bernardi F', 'Ferrarese M', 'Belvini D', 'Radossi P', 'Castaman G', 'Pinotti M', 'Branchini A']","['Humans', '*Factor VIII', '*Hemophilia A', 'Protein Biosynthesis', 'Codon, Nonsense', 'Mutation, Missense', 'Factor IX/genetics']",https://pubmed.ncbi.nlm.nih.gov/35924581/
148,F8,33715149,Factor VIII levels and bleeding according to factor 8 (F8) mutation in pregnant carriers of haemophilia A: a multicentre retrospective cohort study.,"['Collins AEI', 'Curry N', 'Raza-Burton S', 'Bignell P', 'Davies C', 'Joffe M', 'Shapiro S', 'Desborough MJR']","['Adolescent', 'Adult', 'Factor VIII/analysis/*genetics', 'Female', 'Genotype', 'Hemophilia A/complications/diagnosis/*genetics', 'Heterozygote', 'Humans', 'Incidence', 'Mutation', 'Polymerase Chain Reaction/methods', 'Polymorphism, Single Nucleotide', 'Postpartum Hemorrhage/epidemiology/etiology/*genetics', 'Pregnancy', 'Pregnancy Trimester, Third/*blood', 'Retrospective Studies', 'Severity of Illness Index', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33715149/
149,F8,29313431,Hb Mozhaisk [beta92(F8)His-->Arg; HBB: c.278A>G] as a De Novo Mutation in a Child of Mixed Ethnic Origins.,"['Benzoni E', 'Giannone V', 'Michetti L', 'Seia M', 'Cavalleri L', 'Curcio C']","['Anemia, Hemolytic/*genetics', 'Child, Preschool', '*Codon', 'Hemoglobins, Abnormal/*genetics', 'Humans', 'Male', '*Point Mutation']",https://pubmed.ncbi.nlm.nih.gov/29313431/
150,F8,34962362,Silent variant in F8:c.222G>T (p.Thr74Thr) causes a partial exon skipping in a patient with mild hemophilia A.,"['Letelier A', 'Ljung R', 'Olsson A', 'Andersson NG']","['Exons', 'Factor VIII/genetics', '*Hemophilia A/diagnosis/genetics', 'Humans', 'Male']",https://pubmed.ncbi.nlm.nih.gov/34962362/
151,F8,35590009,Prolonged alpha-thrombin-related activation and delayed active protein C-associated degradation confer mild phenotype in a patient with severe hemophilia A with F8 p.H118R.,"['Miyashita R', 'Shinozawa K', 'Inaba H', 'Amano K', 'Kinai E']","['Humans', 'Chromogenic Compounds', 'Culture Media', 'Factor VIII/metabolism', '*Hemophilia A/genetics', 'Phenotype', 'Protein C/genetics', 'Thrombin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35590009/
152,F8,22282501,F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis.,"['Gouw SC', 'van den Berg HM', 'Oldenburg J', 'Astermark J', 'de Groot PG', 'Margaglione M', 'Thompson AR', 'van Heerde W', 'Boekhorst J', 'Miller CH', 'le Cessie S', 'van der Bom JG']","['Antibodies, Neutralizing/blood/*immunology', 'Factor VIII/*genetics/*immunology/therapeutic use', 'Hemophilia A/drug therapy/*genetics', 'Humans', '*Mutation']",https://pubmed.ncbi.nlm.nih.gov/22282501/
153,F8,24270469,First molecular analysis of F8 gene in algeria: identification of two novel mutations.,"['Abdi M', 'Zemani-Fodil F', 'Fodil M', 'Aberkane MS', 'Touhami H', 'Saidi-Mehtar N', 'Costa C', 'Boudjema A']","['Adolescent', 'Adult', 'Algeria', 'Child', 'Child, Preschool', 'DNA Mutational Analysis', 'Factor VIII/*genetics', 'Female', 'Humans', '*Introns', 'Male', 'Middle Aged', 'Multiplex Polymerase Chain Reaction', '*Mutation']",https://pubmed.ncbi.nlm.nih.gov/24270469/
154,F8,34496342,"Generation of induced pluripotent stem cell, BCHSCTi001-A, derived from a Hemophilia A patient with F8 (p. R391C) mutation.","['Zheng J', 'Li G', 'Qin M']","['Factor VIII/genetics', '*Hemophilia A/genetics', 'Humans', '*Induced Pluripotent Stem Cells', 'Mutation', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/34496342/
155,F8,350847,"Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli: structure of F100, F152, and F8 and mapping of the Escherichia coli chromosomal region fep-supE-gal-attlambda-uvrB.","['Ohtsubo E', 'Hsu MT']","['Chromosome Mapping', '*Chromosomes, Bacterial', 'DNA, Bacterial/analysis/*genetics', 'Escherichia coli/*genetics/ultrastructure', '*F Factor', 'Microscopy, Electron', 'Molecular Weight']",https://pubmed.ncbi.nlm.nih.gov/350847/
156,F8,32715611,"Upconversion process in BaY(2) F(8) :Yb(3+) ,Ho(3+) phosphor for optical thermometry.","['Nair GB', 'Sharma AK', 'Dhoble SJ', 'Swart HC']","['Bays', 'Luminescence', 'Temperature', '*Thermometry', '*Ytterbium']",https://pubmed.ncbi.nlm.nih.gov/32715611/
157,F8,24296544,F8 genetic analysis strategies when standard approaches fail.,"['Pezeshkpoor B', 'Pavlova A', 'Oldenburg J', 'El-Maarri O']","['Factor VIII/*genetics', 'Genetic Markers/genetics', 'Genetic Predisposition to Disease/*genetics', 'Genetic Testing/*methods', 'Hemophilia A/diagnosis/*epidemiology/*genetics', 'Humans', 'Molecular Diagnostic Techniques/*methods', 'Polymorphism, Single Nucleotide/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24296544/
158,F8,9268649,Tension in haemoglobin revealed by Fe-His(F8) bond rupture in the fully liganded T-state.,"['Paoli M', 'Dodson G', 'Liddington RC', 'Wilkinson AJ']","['Binding Sites', 'Heme/chemistry', 'Hemoglobin A/*chemistry', 'Hemoglobins/*chemistry', '*Histidine', 'Humans', '*Iron', 'Macromolecular Substances', 'Models, Molecular', 'Oxyhemoglobins/chemistry', 'Porphyrins', '*Protein Conformation']",https://pubmed.ncbi.nlm.nih.gov/9268649/
159,F8,24824129,Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients.,"['Pinto P', 'Ghosh K', 'Shetty S']","['Adolescent', 'Adult', 'Child', 'Child, Preschool', '*Chromosome Inversion', 'Factor VIII/*genetics/*immunology/therapeutic use', 'Hemophilia A/diagnosis/drug therapy/*genetics/*immunology', 'Humans', 'India', 'Infant', 'Introns', 'Isoantibodies/*immunology', 'Male', 'Middle Aged', 'Risk Factors', 'Severity of Illness Index', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24824129/
160,F8,22057311,Unusual genomic rearrangements in introns 1 and 22 of the F8 gene.,"['Zimmermann MA', 'Oldenburg J', 'Muller CR', 'Rost S']","['Chromosome Inversion/*genetics', 'Factor VIII/*genetics', 'Gene Rearrangement/*genetics', 'Genetic Predisposition to Disease/genetics', 'Genome, Human/*genetics', 'Hemophilia A/*genetics', 'Humans', 'Introns/*genetics', 'Mutation/genetics', 'Polymorphism, Single Nucleotide/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22057311/
161,F8,4639022,Hemoglobin Istanbul: substitution of glutamine for histidine in a proximal histidine (F8(92) ).,"['Aksoy M', 'Erdem S', 'Efremov GD', 'Wilson JB', 'Huisman TH', 'Schroeder WA', 'Shelton JR', 'Shelton JB', 'Ulitin ON', 'Muftuoglu A']","['Adult', 'Amino Acid Sequence', 'Amino Acids/blood', 'Chemical Phenomena', 'Chemistry', 'Chromatography, DEAE-Cellulose', 'Electrophoresis, Starch Gel', 'Glutamine/*blood', 'Hemoglobinopathies/genetics/therapy', 'Hemoglobins, Abnormal/*analysis', 'Histidine/*blood', 'Hot Temperature', 'Humans', 'Hydrogen-Ion Concentration', 'Male', 'Molecular Weight', 'Mutation', 'Peptides/blood', 'Splenectomy', 'Tryptophan/blood']",https://pubmed.ncbi.nlm.nih.gov/4639022/
162,F8,1385361,A second observation of the fetal methemoglobin variant Hb F-M-Fort Ripley or alpha 2G gamma 2(92)(F8)His----Tyr.,"['Molchanova TP', 'Wilson JB', 'Gu LH', 'Hain RD', 'Chang LS', 'Poon AO', 'Huisman TH']","['Base Sequence', 'Canada', 'Cyanosis/congenital/genetics', 'Fetal Blood/*chemistry', 'Fetal Hemoglobin/chemistry/*genetics', 'Hemoglobin M/chemistry/*genetics', 'Humans', 'Infant, Newborn', 'Molecular Sequence Data', 'Spectrophotometry']",https://pubmed.ncbi.nlm.nih.gov/1385361/
163,F8,32073743,The highly prevalent deletions in F8 intron 13 found in French mild hemophilia A patients result from both founder effect and recurrent de novo events.,"['Jourdy Y', 'Fretigny M', 'Lassalle F', 'Lillicrap D', 'Negrier C', 'Vinciguerra C']","['Canada', 'DNA Mutational Analysis', 'Factor VIII/genetics', 'Founder Effect', 'France/epidemiology', '*Hemophilia A/diagnosis/epidemiology/genetics', 'Humans', 'Introns', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/32073743/
164,F5,36878303,The clinical relevance of the adhesion G protein-coupled receptor F5 for human diseases and cancers.,"['Jacenik D', 'Hikisz P', 'Beswick EJ', 'Fichna J']","['Humans', 'Cell Adhesion', '*Clinical Relevance', 'Lung/metabolism', '*Neoplasms/genetics/metabolism', 'Receptors, G-Protein-Coupled/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36878303/
165,F5,35943082,B(C(6) F(5) )(3) -Catalyzed E-Selective Isomerization of Alkenes.,"['Kustiana BA', 'Elsherbeni SA', 'Linford-Wood TG', 'Melen RL', 'Grayson MN', 'Morrill LC']","['*Alkenes', 'Catalysis', 'Isomerism']",https://pubmed.ncbi.nlm.nih.gov/35943082/
166,F5,22172278,Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5.,"['Kalb SR', 'Baudys J', 'Webb RP', 'Wright P', 'Smith TJ', 'Smith LA', 'Fernandez R', 'Raphael BH', 'Maslanka SE', 'Pirkle JL', 'Barr JR']","['Amino Acid Sequence', 'Botulinum Toxins/*chemistry/genetics/*metabolism', 'Catalytic Domain/genetics', 'Cloning, Molecular', 'Molecular Sequence Data', 'Mutagenesis, Site-Directed', 'Peptide Hydrolases/chemistry/genetics/metabolism', '*Protein Interaction Domains and Motifs/genetics', 'Protein Interaction Maps', '*Proteolysis', 'Substrate Specificity/genetics', 'Vesicle-Associated Membrane Protein 2/chemistry/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/22172278/
167,F5,18026232,Induction and preliminary characterization of a novel halophage SNJ1 from lysogenic Natrinema sp. F5.,"['Mei Y', 'Chen J', 'Sun D', 'Chen D', 'Yang Y', 'Shen P', 'Chen X']","['*Archaeal Viruses/classification/physiology/ultrastructure', 'Halobacteriaceae/*virology', 'Lysogeny/*physiology', 'Mitomycin/pharmacology', '*Siphoviridae/classification/physiology/ultrastructure', 'Sodium Chloride/pharmacology', 'Viral Plaque Assay', 'Virus Activation/*physiology']",https://pubmed.ncbi.nlm.nih.gov/18026232/
168,F5,34826880,Coagulation Factor V (F5) is an Estrogen-Responsive Gene in Breast Cancer Cells.,"['Andresen MS', 'Sletten M', 'Sandset PM', 'Iversen N', 'Stavik B', 'Tinholt M']","['*Breast Neoplasms/drug therapy/genetics', 'Cell Line, Tumor', 'Estradiol/pharmacology', '*Estrogen Receptor alpha/genetics/metabolism', 'Estrogens/pharmacology', '*Factor V/genetics', 'Female', 'Gene Expression Regulation, Neoplastic', 'Humans', 'MCF-7 Cells', 'Neoplasm Recurrence, Local/genetics']",https://pubmed.ncbi.nlm.nih.gov/34826880/
169,F5,35678551,"Solvent-free, B(C(6) F(5) )(3) -Catalyzed S-H Insertion of Thiophenols and Thiols with alpha-Diazoesters.","['Wang P', 'Gong Y', 'Wang X', 'Ren Y', 'Wang L', 'Zhai L', 'Li H', 'She X']","['Catalysis', '*Phenols', 'Solvents', '*Sulfhydryl Compounds']",https://pubmed.ncbi.nlm.nih.gov/35678551/
170,F5,38224207,H(2) O ⋅ B(C(6) F(5) )(3) -Catalyzed para-Alkylation of Anilines with Alkenes Applied to Late-Stage Functionalization of Non-Steroidal Anti-Inflammatory Drugs.,"['Winfrey L', 'Yun L', 'Passeri G', 'Suntharalingam K', 'Pulis AP']","['*Alkenes/chemistry', '*Aniline Compounds/chemistry', 'Alkylation', 'Anti-Inflammatory Agents, Non-Steroidal', 'Catalysis']",https://pubmed.ncbi.nlm.nih.gov/38224207/
171,F5,33816626,Genotyping by Sequencing-Based Discovery of SNP Markers and Construction of Linkage Map from F(5) Population of Pepper with Contrasting Powdery Mildew Resistance Trait.,"['Manivannan A', 'Choi S', 'Jun TH', 'Yang EY', 'Kim JH', 'Lee ES', 'Lee HE', 'Kim DS', 'Ahn YK']","['Capsicum/*genetics/microbiology', '*Chromosome Mapping', 'Disease Resistance/*genetics', '*Genotype', 'Plant Diseases/*genetics/microbiology', '*Polymorphism, Single Nucleotide', '*Quantitative Trait, Heritable']",https://pubmed.ncbi.nlm.nih.gov/33816626/
172,F5,32912024,"Hb A(2)-Pistoia [delta89(F5)Ser-->Asn, HBD: c.269G>a]: a Novel Mutation on the delta-Globin Gene in an Italian Child.","['Guastini A', 'Rizzi L', 'Santoni F', 'Mogni M', 'Maffei M', 'Vinci S', 'Barberio G', 'Coviello D', 'Ivaldi G']","['*Alleles', 'Child', 'Electrophoresis, Capillary', 'Family', 'Genotype', 'Hematologic Diseases/blood/diagnosis/genetics', 'Hemoglobin A2/*genetics', 'Hemoglobins, Abnormal/genetics', 'Humans', 'Italy', 'Male', '*Mutation', 'Sequence Analysis, DNA', 'delta-Globins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32912024/
173,F5,31657650,A Kindred with a beta-Globin Base Substitution [beta89(F5)Ser-->Arg (AGT>AGG); HBB: c.270T>G] Resulting in Hemoglobin Vanderbilt.,"['Shomali W', 'Brar R', 'Arekapudi SR', 'Gotlib JR']","['*Amino Acid Substitution', 'Arginine', 'Hemoglobins, Abnormal/*genetics', 'Humans', 'Oxygen/metabolism', 'Polycythemia/congenital/genetics', 'Serine', 'beta-Globins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31657650/
174,F5,31414285,"The O-polysaccharide of Escherichia coli F5, which is structurally related to that of E. coli O28ab, provides cells only weak protection against bacteriophage attack.","['Golomidova AK', 'Naumenko OI', 'Senchenkova SN', 'Knirel YA', 'Letarov AV']","['Bacteriophages/*metabolism', 'Escherichia coli/classification/genetics/*metabolism', 'O Antigens/genetics/*metabolism', '*Virus Attachment']",https://pubmed.ncbi.nlm.nih.gov/31414285/
175,F5,17165695,Stabilizing and destabilizing effects of phenylalanine --> F5-phenylalanine mutations on the folding of a small protein.,"['Woll MG', 'Hadley EB', 'Mecozzi S', 'Gellman SH']","['Amino Acid Sequence', 'Models, Molecular', 'Mutation/*genetics', 'Phenylalanine/genetics/*metabolism', '*Protein Folding', 'Protein Structure, Tertiary', 'Proteins/*chemistry/genetics/*metabolism', 'Sequence Alignment']",https://pubmed.ncbi.nlm.nih.gov/17165695/
176,F5,21797710,"A novel base change leading to Hb Vanderbilt [beta89(F5)Ser-->Arg, AGT>AGA].","['Goodyer MJ', 'Elhassadi EI', 'Percy MJ', 'McMullin MF']","['Adult', 'Binding, Competitive', 'DNA Mutational Analysis', 'Hemoglobins, Abnormal/*genetics/metabolism', 'Humans', 'Male', '*Mutation, Missense', 'Oxygen/metabolism', 'Protein Binding', 'beta-Globins/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/21797710/
177,F5,18646829,Epoxydons and a pyrone from the marine-derived fungus Nigrospora sp. PSU-F5.,"['Trisuwan K', 'Rukachaisirikul V', 'Sukpondma Y', 'Preedanon S', 'Phongpaichit S', 'Rungjindamai N', 'Sakayaroj J']","['Anti-Bacterial Agents/chemistry/isolation & purification', 'Ascomycota/*chemistry', 'Biological Products/chemistry/*isolation & purification', 'Magnetic Resonance Spectroscopy', 'Microbial Sensitivity Tests', 'Pyrones/chemistry/*isolation & purification/pharmacology', 'Spectrometry, Mass, Electrospray Ionization', 'Spectrophotometry, Infrared', 'Spectrophotometry, Ultraviolet']",https://pubmed.ncbi.nlm.nih.gov/18646829/
178,F9,34649996,Inherent hepatocytic heterogeneity determines expression and retention of edited F9 alleles post-AAV/CRISPR infusion.,"['Wang Q', 'Zhang L', 'Zhang GW', 'Mao JH', 'Xi XD', 'Jiang L', 'Lv G', 'Lu J', 'Shen Y', 'Chen Z', 'Zhu J', 'Chen SJ']","['*Alleles', '*Clustered Regularly Interspaced Short Palindromic Repeats', 'Dependovirus/*genetics', 'Enhancer Elements, Genetic', 'Factor IX/*genetics', 'Gene Editing/methods', 'Hemophilia B/genetics', 'Hepatocytes/*metabolism', 'Mutation', 'Promoter Regions, Genetic', 'Transcription Factors/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34649996/
179,F9,28905352,Factor IX Gene (F9) Genotyping Trends and Spectrum of Mutations Identified: A Reference Laboratory Experience.,"['Perez Botero J', 'Coon LM', 'Majerus JA', 'Chen D', 'Pruthi RK']","['Factor IX/*genetics', 'Female', 'Genotyping Techniques/*trends', 'Humans', 'Laboratories', 'Male', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/28905352/
180,F9,24816826,Characterisation of large F9 deletions in seven unrelated patients with severe haemophilia B.,"['Wu X', 'Lu Y', 'Ding Q', 'You G', 'Dai J', 'Xi X', 'Wang H', 'Wang X']","['Adult', 'Alleles', 'Base Sequence', 'Child', 'Child, Preschool', 'Chromosomes, Human, X/*genetics', 'DNA Breaks', 'Disease Progression', 'Factor IX/*genetics', 'Female', 'Hemophilia B/*genetics', 'Humans', 'Long Interspersed Nucleotide Elements/*genetics', 'Male', 'Molecular Sequence Data', 'Recombinational DNA Repair', 'Sequence Deletion/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24816826/
181,F9,4038260,Post-translational assembly and glycosylation of laminin subunits in parietal endoderm-like F9 cells.,"['Morita A', 'Sugimoto E', 'Kitagawa Y']","['Cell Line', 'Electrophoresis, Polyacrylamide Gel', 'Endoderm/metabolism', 'Kinetics', 'Laminin/*biosynthesis/genetics', 'Macromolecular Substances', 'Models, Biological', 'Protein Biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/4038260/
182,F9,10612837,Nine independent F9 mutations in the Mexican hemophilia B population: nonrandom recurrences of point mutation events in the human germline.,"['Jaloma-Cruz AR', 'Scaringe WA', 'Drost JB', 'Roberts S', 'Li X', 'Barros-Nunez P', 'Figuera LE', 'Rivas F', 'Cantu JM', 'Sommer SS']","['Factor IX/*genetics', 'Female', 'Gene Deletion', '*Germ-Line Mutation', 'Hemophilia B/*genetics', 'Humans', 'Male', 'Mexico', 'Point Mutation']",https://pubmed.ncbi.nlm.nih.gov/10612837/
183,F9,1360613,Nucleotide sequences of the major subunits of F9 and F12 fimbriae of uropathogenic Escherichia coli.,"['Garcia E', 'Bergmans HE', 'van der Zeijst BA', 'Gaastra W']","['Amino Acid Sequence', 'Base Sequence', 'Escherichia coli/*genetics', '*Fimbriae, Bacterial/chemistry', 'Molecular Sequence Data', 'Sequence Homology, Amino Acid']",https://pubmed.ncbi.nlm.nih.gov/1360613/
184,F9,1787096,Hb Cleveland or alpha 2 beta 2(93)(F9)Cys----Arg;121(GH4)Glu----Gln.,"['Wilson JB', 'Ramachandran M', 'Webber BB', 'Kutlar F', 'Hazelwood LF', 'Barnett D', 'Hirschler NV', 'Huisman TH']","['Adult', 'Amino Acid Sequence', 'Blood Protein Electrophoresis', 'Female', 'Globins/*genetics', 'Hemoglobins, Abnormal/*genetics/isolation & purification/metabolism', 'Humans', 'Isoelectric Focusing', 'Molecular Sequence Data', 'Oxygen/metabolism', 'Oxyhemoglobins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/1787096/
185,F10,23872139,Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway.,"['Huang YC', 'Liu KC', 'Chiou YL', 'Yang CH', 'Chen TH', 'Li TT', 'Liu LL']","['Blotting, Western', 'Cell Line, Tumor', 'Cell Survival/drug effects', 'Fenofibrate/*pharmacology', 'Humans', 'Imidazoles/pharmacology', 'MAP Kinase Signaling System', 'Melanins/*biosynthesis', 'Melanoma, Experimental/*drug therapy/enzymology/*metabolism', 'Microphthalmia-Associated Transcription Factor/genetics/metabolism', 'Oxazoles/pharmacology', 'PPAR alpha/antagonists & inhibitors/metabolism', 'Pyridines/pharmacology', 'RNA/chemistry/genetics', 'Real-Time Polymerase Chain Reaction', 'Tyrosine/analogs & derivatives/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/23872139/
186,F10,26825069,Preliminary Studies on the Activity of Mixed Polyphenol-Heterocyclic Systems Against B16-F10 Melanoma Cancer Cells.,"['Duy Vo D', 'Rouaud I', 'Le Devehat F', 'Gautier F', 'Barille-Nion S', 'Juin P', 'Levoin N', 'Boustie J', 'Gree R']","['Antineoplastic Agents/chemical synthesis/*pharmacology', 'Apoptosis/drug effects', 'Bioluminescence Resonance Energy Transfer Techniques', 'Catechols/chemical synthesis/*pharmacology', 'Cell Line, Tumor', 'HeLa Cells', 'Humans', 'Melanoma, Experimental', 'Molecular Docking Simulation', 'Pyrazoles/chemical synthesis/*pharmacology', 'bcl-2-Associated X Protein/antagonists & inhibitors', 'bcl-X Protein/antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/26825069/
187,CAPN2,38844946,CAPN2 promotes apalutamide resistance in metastatic hormone-sensitive prostate cancer by activating protective autophagy.,"['Qi Z', 'Bai X', 'Wu L', 'Zhang P', 'Guo Z', 'Yu Y']","['Humans', 'Male', '*Autophagy/drug effects', 'Calcium/metabolism', '*Calpain/metabolism', 'Cell Line, Tumor', '*Drug Resistance, Neoplasm/drug effects/genetics', 'Endoplasmic Reticulum Stress/drug effects', 'Forkhead Box Protein O1/metabolism', 'Gene Expression Regulation, Neoplastic/drug effects', '*Neoplasm Metastasis', '*Prostatic Neoplasms/pathology/drug therapy/genetics/metabolism', '*Thiohydantoins/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/38844946/
188,CAPN2,21585285,Type V collagen-induced upregulation of capn2 (large subunit of m-calpain) gene expression and DNA fragmentation in 8701-BC breast cancer cells.,"['Luparello C', 'Sirchia R']","['Breast Neoplasms/*enzymology/metabolism/pathology', 'Calpain/*genetics', 'Cell Line, Tumor', 'Collagen Type V/*pharmacology', 'DNA Fragmentation/*drug effects', 'DNA, Neoplasm/*metabolism', 'Female', 'Gene Expression Profiling', 'Gene Expression Regulation, Enzymologic/*drug effects/genetics', 'Humans', 'Polymerase Chain Reaction', 'Up-Regulation/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/21585285/
189,CAPN2,39454972,Comprehensive bioinformatics analysis of the prognostic value and immune infiltration of CAPN2 in pancreatic adenocarcinoma.,"['Zhao Q', 'Xie H', 'Wang X', 'Xie J', 'Liu J', 'Bai Y', 'Liu B', 'Ding H', 'Kuang S', 'Zhang B']","['Humans', '*Calpain/genetics/metabolism', '*Pancreatic Neoplasms/genetics/immunology/mortality', 'Prognosis', '*Computational Biology/methods', '*Biomarkers, Tumor/genetics', '*Adenocarcinoma/genetics/immunology', '*Tumor Microenvironment/immunology/genetics', '*Gene Expression Regulation, Neoplastic', 'Male', 'Female', 'Databases, Genetic']",https://pubmed.ncbi.nlm.nih.gov/39454972/
190,CAPN2,31680308,CAPN2 acts as an indicator of hepatitis B virus to induce hepatic fibrosis.,"['Feng R', 'Du W', 'Lui P', 'Zhang J', 'Liu Y']","['Biomarkers/*analysis', 'Calpain/genetics/*metabolism', 'Computational Biology', 'Gene Expression Profiling', 'Hepatitis B/*complications/virology', 'Hepatitis B virus/*isolation & purification', 'Humans', 'Liver Cirrhosis/*diagnosis/etiology/metabolism/pathology', 'Prognosis', 'Protein Interaction Maps']",https://pubmed.ncbi.nlm.nih.gov/31680308/
191,CAPN2,33731671,hnRNPK-regulated LINC00263 promotes malignant phenotypes through miR-147a/CAPN2.,"['Lee WJ', 'Shin CH', 'Ji H', 'Jeong SD', 'Park MS', 'Won HH', 'Pandey PR', 'Tsitsipatis D', 'Gorospe M', 'Kim HH']","['HeLa Cells', 'Heterogeneous-Nuclear Ribonucleoprotein K/*metabolism', 'Humans', 'MicroRNAs/*metabolism', 'Oncogenes/*genetics', 'Phenotype', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/33731671/
192,CAPN2,38610028,CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis.,"['Luo X', 'Dong Y', 'Zheng H', 'Zhou X', 'Rong L', 'Liu X', 'Bai Y', 'Li Y', 'Wu Z']","['Humans', 'Female', '*Insulin Resistance/genetics', '*Polycystic Ovary Syndrome/genetics', '*RNA, Long Noncoding/genetics', 'Algorithms', 'Computational Biology', 'Calpain/genetics', '*MicroRNAs']",https://pubmed.ncbi.nlm.nih.gov/38610028/
193,CAPN2,32951272,Promotive effect of Talin-1 protein on gastric cancer progression through PTK2-PXN-VCL-E-Cadherin-CAPN2-MAPK1 signaling axis.,"['Yan H', 'Guo M', 'Zou J', 'Xiao F', 'Yi L', 'He Y', 'He B']","['Antigens, CD/metabolism', 'Cadherins/metabolism', 'Calpain/metabolism', 'Cell Line, Tumor', 'Disease Progression', 'Focal Adhesion Kinase 1/metabolism', 'Humans', 'Immunohistochemistry', 'MAP Kinase Signaling System/*physiology', 'Paxillin/metabolism', 'Stomach/chemistry/pathology', '*Stomach Neoplasms/metabolism/pathology', '*Talin/analysis/metabolism', 'Vinculin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32951272/
194,CAPN2,35525317,Cisplatin-induced pyroptosis is mediated via the CAPN1/CAPN2-BAK/BAX-caspase-9-caspase-3-GSDME axis in esophageal cancer.,"['Li RY', 'Zheng ZY', 'Li ZM', 'Heng JH', 'Zheng YQ', 'Deng DX', 'Xu XE', 'Liao LD', 'Lin W', 'Xu HY', 'Huang HC', 'Li EM', 'Xu LY']","['Calpain/metabolism', 'Caspase 3/metabolism', 'Caspase 9/metabolism', '*Cisplatin/metabolism/pharmacology/therapeutic use', '*Esophageal Neoplasms/drug therapy/metabolism', 'Humans', 'Pyroptosis', 'bcl-2-Associated X Protein/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35525317/
195,CAPN2,28002826,The CAPN2/CAPN8 Locus on Chromosome 1q Is Associated with Variation in Serum Alpha-Carotene Concentrations.,"[""D'Adamo CR"", 'Dawson VJ', 'Ryan KA', 'Yerges-Armstrong LM', 'Semba RD', 'Steinle NI', 'Mitchell BD', 'Shuldiner AR', 'McArdle PF']","['Adult', 'Amish/genetics', 'Calpain/*genetics', 'Carotenoids/*blood', '*Chromosomes, Human, Pair 1', 'Diet', 'Female', 'Gene-Environment Interaction', 'Genetic Association Studies', '*Genetic Loci', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/28002826/
196,CAPN2,28280729,Silencing CAPN2 Expression Inhibited Castration-Resistant Prostate Cancer Cells Proliferation and Invasion via AKT/mTOR Signal Pathway.,"['Li P', 'Miao C', 'Liang C', 'Shao P', 'Wang Z', 'Li J']","['Aged', 'Calpain/*genetics/metabolism', 'Cell Movement/genetics', 'Cell Proliferation/genetics', '*Gene Expression Regulation, Neoplastic', 'Gene Knockdown Techniques', '*Gene Silencing', 'Humans', 'Male', 'Matrix Metalloproteinase 2/metabolism', 'Matrix Metalloproteinase 9/metabolism', 'Middle Aged', 'Neoplasm Invasiveness', 'Prostatic Neoplasms, Castration-Resistant/enzymology/*genetics/*pathology', 'Proto-Oncogene Proteins c-akt/*metabolism', 'RNA, Messenger/genetics/metabolism', 'Real-Time Polymerase Chain Reaction', '*Signal Transduction/genetics', 'TOR Serine-Threonine Kinases/*metabolism', 'Wound Healing/genetics']",https://pubmed.ncbi.nlm.nih.gov/28280729/
197,CAPN2,22623320,Global profiling of proteolytically modified proteins in human metastatic hepatocellular carcinoma cell lines reveals CAPN2 centered network.,"['Shen C', 'Yu Y', 'Li H', 'Yan G', 'Liu M', 'Shen H', 'Yang P']","['Biomarkers, Tumor/analysis/chemistry/metabolism', 'Calpain/analysis/chemistry/*metabolism', 'Carcinoma, Hepatocellular/*chemistry/*metabolism', 'Cell Line, Tumor', 'Humans', 'Liver Neoplasms/*chemistry/*metabolism', 'Mass Spectrometry', 'Peptide Fragments/analysis/chemistry/*metabolism', 'Protein Interaction Maps', 'Proteolysis', 'Proteome/analysis/chemistry/metabolism', 'Proteomics/*methods', 'Reproducibility of Results']",https://pubmed.ncbi.nlm.nih.gov/22623320/
198,ESD,35370049,"EMR and ESD: Indications, techniques and results.","['Rashid MU', 'Alomari M', 'Afraz S', 'Erim T']","['*Endoscopic Mucosal Resection/methods', 'Humans', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/35370049/
199,ESD,24679232,Esophageal ESD: technique and prevention of complications.,['Oyama T'],"['Carcinoma, Squamous Cell/*surgery', 'Dissection/methods', 'Esophageal Neoplasms/*surgery', 'Esophageal Perforation/*prevention & control', 'Esophagoscopy/*methods', 'Esophagus/*surgery', 'Humans', 'Mucous Membrane/*surgery']",https://pubmed.ncbi.nlm.nih.gov/24679232/
200,ESD,25102996,Endoscopic resection: when is EMR/ESD sufficient?,['Messmann H'],"['Colorectal Neoplasms/pathology/*surgery', '*Endoscopy, Gastrointestinal', 'Humans', 'Intestinal Mucosa/*surgery']",https://pubmed.ncbi.nlm.nih.gov/25102996/
201,ESD,24679235,Colorectal ESD: current indications and latest technical advances.,"['Saito Y', 'Sakamoto T', 'Nakajima T', 'Matsuda T']","['Carcinoma/*surgery', 'Colonoscopy/*methods', 'Colorectal Neoplasms/*surgery', 'Dissection/methods', 'Humans', 'Intestinal Mucosa/*surgery']",https://pubmed.ncbi.nlm.nih.gov/24679235/
202,ESD,24679236,Submucosal endoscopy: from ESD to POEM and beyond.,"['Inoue H', 'Santi EG', 'Onimaru M', 'Kudo SE']","['Dissection/methods', 'Esophageal Achalasia/*surgery', 'Esophageal Sphincter, Lower/*surgery', 'Esophagoscopy/*methods', 'Esophagus/*surgery', 'Humans', 'Mucous Membrane/*surgery']",https://pubmed.ncbi.nlm.nih.gov/24679236/
203,ESD,24679229,Expanding indications for ESD: submucosal disease (SMT/carcinoid tumors).,"['Goto O', 'Uraoka T', 'Horii J', 'Yahagi N']","['Carcinoid Tumor/*surgery', 'Dissection/methods', 'Endoscopy, Gastrointestinal/*methods', 'Esophagus/surgery', 'Gastric Mucosa/surgery', 'Gastrointestinal Neoplasms/*surgery', 'Gastrointestinal Stromal Tumors/*surgery', 'Humans', 'Intestinal Mucosa/surgery', 'Intestinal Neoplasms/*surgery', 'Leiomyoma/*surgery', 'Lipoma/*surgery', 'Mucous Membrane/*surgery', 'Neurilemmoma/*surgery']",https://pubmed.ncbi.nlm.nih.gov/24679229/
204,ESD,38083269,A Robotized Soft Endoscope with Stereo Vision for Upper Gastrointestinal Endoscopic Submucosal Dissection (ESD).,"['Chen J', 'Wang S', 'Zhao Q', 'Chen M', 'Liu H']","['Humans', '*Endoscopic Mucosal Resection/methods', 'Endoscopes', 'Endoscopy', 'Gastric Mucosa/pathology/surgery', '*Stomach Neoplasms']",https://pubmed.ncbi.nlm.nih.gov/38083269/
205,ESD,27036900,"Endoscopic Submucosal Dissection (ESD) and Related Techniques as Precursors of ""New Notes"" Resection Methods for Gastric Neoplasms.","['Goto O', 'Takeuchi H', 'Kitagawa Y', 'Yahagi N']","['Dissection/methods', 'Endoscopic Mucosal Resection/*methods', 'Gastrectomy/methods', 'Gastric Mucosa/surgery', 'Gastroscopy/*methods', 'Humans', 'Laparoscopy/methods', 'Lymph Node Excision/methods', 'Stomach Neoplasms/*surgery']",https://pubmed.ncbi.nlm.nih.gov/27036900/
206,ESD,24679238,Regenerative medicine: tissue-engineered cell sheet for the prevention of post-esophageal ESD stricture.,"['Ohki T', 'Yamato M', 'Okano T', 'Yamamoto M']","['Cells, Cultured/*transplantation', 'Dissection/methods', 'Epithelial Cells/*transplantation', 'Esophageal Neoplasms/*surgery', 'Esophageal Stenosis/*prevention & control', 'Esophagoscopy/*methods', 'Esophagus/*surgery', 'Humans', 'Mouth Mucosa/*cytology', 'Mucous Membrane/*surgery', 'Postoperative Complications/*prevention & control', 'Tissue Engineering/*methods']",https://pubmed.ncbi.nlm.nih.gov/24679238/
207,ESD,38081744,Delayed healing of rectal mucosa after endoscopic submucosal dissection (ESD) with nintedanib use.,"['Yalamarthi N', 'Alipouriani A', 'Savage E', 'Gorgun E']","['Humans', '*Endoscopic Mucosal Resection/adverse effects', 'Rectum', 'Wound Healing', 'Mucous Membrane', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/38081744/
208,ESD,34651510,Electrostatic Discharge (ESD) as a Cause of Facial Nerve Stimulation After Cochlear Implantation: A Case Report.,"['Rath S', 'Glaun M', 'Emery C', 'Liu YC']","['*Cochlear Implantation/adverse effects', '*Cochlear Implants/adverse effects', 'Cochlear Nerve', 'Facial Nerve/surgery', 'Humans', 'Quality of Life', 'Static Electricity']",https://pubmed.ncbi.nlm.nih.gov/34651510/
209,ESD,32542462,"EMR/ESD: Techniques, Complications, and Evidence.","['Ahmed Y', 'Othman M']","['Dissection', '*Endoscopic Mucosal Resection/adverse effects/methods', 'Gastrointestinal Neoplasms/*surgery', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/32542462/
210,ESD,24679234,Duodenal ESD: conquering difficulties.,"['Yamamoto H', 'Miura Y']","['Adenocarcinoma/*surgery', 'Blood Loss, Surgical/*prevention & control', 'Dissection/methods', 'Duodenal Diseases/*prevention & control', 'Duodenal Neoplasms/*surgery', 'Endoscopy, Gastrointestinal/*methods', 'Gastrointestinal Hemorrhage/*prevention & control', 'Humans', 'Intestinal Mucosa/*surgery', 'Intestinal Perforation/*prevention & control', 'Patient Selection', 'Postoperative Hemorrhage/*prevention & control']",https://pubmed.ncbi.nlm.nih.gov/24679234/
211,ESD,28842057,Colorectal endoscopic submucosal dissection (ESD).,"['Fuccio L', 'Ponchon T']","['Adenomatous Polyposis Coli/pathology/*surgery', 'Dissection/*methods', '*Endoscopic Mucosal Resection', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/28842057/
212,ESD,17640577,"Novel techniques and instrumentation for EMR, ESD, and full-thickness endoscopic luminal resection.","['Sumiyama K', 'Gostout CJ']","['*Endoscopes, Gastrointestinal', 'Endoscopy, Gastrointestinal/*methods', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/17640577/
213,ESD,39079825,Application of balloon occluder for specimen collection after descending duodenal ESD.,"['Wang M', 'Jiang X', 'Wang X']","['Humans', '*Duodenal Neoplasms/surgery', '*Endoscopic Mucosal Resection/instrumentation/methods', 'Balloon Occlusion/methods/instrumentation', 'Specimen Handling/methods', 'Male', 'Female', 'Aged']",https://pubmed.ncbi.nlm.nih.gov/39079825/
214,ESD,39910700,Single-Cell Sequencing Reveals Heterogeneity and Interactions Between Epithelial Cells and Fibroblasts in Post-ESD Oesophageal Stricture.,"['Tao L', 'Xia J', 'Hu D', 'Zhang G', 'Gong Y', 'Yan J']","['Humans', '*Epithelial Cells/metabolism/pathology', '*Single-Cell Analysis/methods', '*Fibroblasts/metabolism/pathology', '*Esophageal Stenosis/metabolism/pathology/genetics/etiology', 'Male', 'Cell Communication', 'Sequence Analysis, RNA', 'Gene Expression Profiling']",https://pubmed.ncbi.nlm.nih.gov/39910700/
215,ESD,24679231,Endoscopic submucosal dissection (ESD) versus simplified/hybrid ESD.,"['Toyonaga T', 'Man-I M', 'Morita Y', 'Azuma T']","['Colonoscopy/*methods', 'Colorectal Neoplasms/*surgery', 'Dissection/methods', 'Humans', 'Intestinal Mucosa/*surgery']",https://pubmed.ncbi.nlm.nih.gov/24679231/
216,ESD,35701447,A pilot study of micro-CT-based whole tissue imaging (WTI) on endoscopic submucosal dissection (ESD) specimens.,"['Sakamoto H', 'Nishimura M', 'Teplov A', 'Leung G', 'Ntiamoah P', 'Cesmecioglu E', 'Kawata N', 'Ohnishi T', 'Kareem I', 'Shia J', 'Yagi Y']","['*Endoscopic Mucosal Resection/methods', 'Humans', 'Margins of Excision', 'Pilot Projects', 'Treatment Outcome', 'X-Ray Microtomography']",https://pubmed.ncbi.nlm.nih.gov/35701447/
217,F2,32013669,Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy.,"['Wang R', 'Zhu Y', 'Ren C', 'Yang S', 'Tian S', 'Chen H', 'Jin M', 'Zhou H']","['Autophagy/*immunology', 'Humans', 'Immunity, Innate/immunology', 'Influenza A virus/immunology', 'Mitochondria/immunology/*metabolism', 'Mitochondrial Membranes/metabolism', 'Mitophagy/immunology/*physiology', 'Viral Proteins/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/32013669/
218,F2,36446080,A General Catalyst Controlled Route to Prostaglandin F2(alpha).,"['Cunningham L', 'Mishra S', 'Matthews L', 'Fletcher SP']","['*Dinoprost/analogs & derivatives/chemical synthesis', 'Catalysis']",https://pubmed.ncbi.nlm.nih.gov/36446080/
219,F2,12012074,"Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes.","['Steensberg A', 'Morrow J', 'Toft AD', 'Bruunsgaard H', 'Pedersen BK']","['Adult', 'Apoptosis/*immunology', 'Epinephrine/blood', 'F2-Isoprostanes/*immunology', 'Humans', 'Hydrocortisone/blood', 'Lymphocyte Count', 'Lymphocytes/*cytology', 'Lymphopenia/physiopathology', 'Male', 'Middle Aged', 'Norepinephrine/blood', 'Oxidative Stress/immunology', 'Physical Endurance/*immunology', 'Reactive Oxygen Species/metabolism']",https://pubmed.ncbi.nlm.nih.gov/12012074/
220,F2,24529576,An antibacterial metabolite from Lasiodiplodia pseudotheobromae F2.,"['Wei W', 'Jiang N', 'Mei YN', 'Chu YL', 'Ge HM', 'Song YC', 'Ng SW', 'Tan RX']","['Anti-Bacterial Agents/chemistry/isolation & purification/*metabolism/*pharmacology', 'Ascomycota/*metabolism', 'Bacteria/drug effects', 'Diketopiperazines/chemistry/isolation & purification/*metabolism/*pharmacology', 'Microbial Sensitivity Tests', 'Models, Molecular', 'Molecular Conformation']",https://pubmed.ncbi.nlm.nih.gov/24529576/
221,F2,37871293,Constructing Double Cyclic Codes over F2 + uF2 for DNA Codes.,"['Kanlaya A', 'Klin-Eam C']","['*DNA/genetics', '*Genetic Code']",https://pubmed.ncbi.nlm.nih.gov/37871293/
222,F2,22565830,F(2) designs for QTL analysis.,['Zhang YM'],"['Bayes Theorem', '*Breeding', 'Chromosome Mapping', 'Likelihood Functions', 'Quantitative Trait Loci/*genetics', 'Software']",https://pubmed.ncbi.nlm.nih.gov/22565830/
223,F2,10582661,F2-isoprostane excretion rate and diurnal variation in human urine.,"['Helmersson J', 'Basu S']","['Adult', '*Circadian Rhythm', 'Dinoprost/*analogs & derivatives/urine', 'F2-Isoprostanes', 'Female', 'Humans', 'Male', 'Middle Aged', 'Radioimmunoassay', 'Smoking']",https://pubmed.ncbi.nlm.nih.gov/10582661/
224,F2,2896174,Prostaglandin F2 alpha and E2 release by peritoneum with and without endometriosis.,"['De Leon FD', 'Vijayakumar R', 'Rao CV', 'Yussman M']","['Analysis of Variance', 'Dinoprost', 'Dinoprostone', 'Endometriosis/*physiopathology', 'Female', 'Humans', 'Peritoneal Diseases/*physiopathology', 'Peritoneum/*metabolism/physiology', 'Prostaglandins E/*metabolism/physiology', 'Prostaglandins F/*metabolism/physiology']",https://pubmed.ncbi.nlm.nih.gov/2896174/
225,F2,8832692,"Production of [18F]F2 using the 16O(3He,p)18F reaction.","['Bishop A', 'Satyamurthy N', 'Bida G', 'Phelps M', 'Barrio JR']","['Fluorine Radioisotopes/*chemistry/isolation & purification', 'Gases', 'Helium/*chemistry', 'Isotope Labeling/methods', 'Oxygen/*chemistry', 'Radiochemistry/*methods']",https://pubmed.ncbi.nlm.nih.gov/8832692/
226,F2,7103476,Uptake of bacteriophage f2 through plant roots.,"['Ward RL', 'Mahler RJ']","['Coliphages/*physiology', 'Fabaceae', 'Kinetics', 'Plants/*microbiology', 'Plants, Medicinal', 'Zea mays']",https://pubmed.ncbi.nlm.nih.gov/7103476/
227,F2,6577521,Is prostaglandin F2 alpha involved in the increased myometrial contractility of primary dysmenorrhoea?,"['Lumsden MA', 'Kelly RW', 'Baird DT']","['Dinoprost', 'Dysmenorrhea/*physiopathology', 'Female', 'Humans', '*Menstruation', 'Myometrium/*physiopathology', 'Prostaglandins F/analysis/*physiology', '*Uterine Contraction', 'Uterus/*physiopathology']",https://pubmed.ncbi.nlm.nih.gov/6577521/
228,F2,24244726,A protocol for quantifying lipid peroxidation in cellular systems by F2-isoprostane analysis.,"['Labuschagne CF', 'van den Broek NJ', 'Postma P', 'Berger R', 'Brenkman AB']","['Arachidonic Acid/analysis/chemistry/metabolism', 'Chromatography, High Pressure Liquid', 'F2-Isoprostanes/*analysis/chemistry/metabolism', 'Hep G2 Cells', 'Humans', 'Lipid Peroxidation/physiology', 'Tandem Mass Spectrometry']",https://pubmed.ncbi.nlm.nih.gov/24244726/
229,F2,21914861,"Genome sequence of Agrobacterium tumefaciens strain F2, a bioflocculant-producing bacterium.","['Li A', 'Geng J', 'Cui D', 'Shu C', 'Zhang S', 'Yang J', 'Xing J', 'Wang J', 'Ma F', 'Hu S']","['Agrobacterium tumefaciens/*genetics/*metabolism', 'Genome, Bacterial/*genetics', 'Molecular Sequence Data', 'Polysaccharides, Bacterial/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/21914861/
230,F2,18037130,Elevated F2-isoprostanes in thalassemic patients.,"['Matayatsuk C', 'Lee CY', 'Kalpravidh RW', 'Sirankapracha P', 'Wilairat P', 'Fucharoen S', 'Halliwell B']","['Adult', 'Antioxidants/metabolism', 'Bilirubin/blood', 'Biomarkers/metabolism', 'Case-Control Studies', 'Erythrocyte Indices', 'Erythrocytes/metabolism', 'F2-Isoprostanes/blood/*metabolism/urine', 'Female', 'Ferritins/blood', 'Humans', 'Male', 'Middle Aged', 'Oxidative Stress', 'Thalassemia/blood/*metabolism/urine', 'Thiobarbituric Acid Reactive Substances/metabolism']",https://pubmed.ncbi.nlm.nih.gov/18037130/
231,GSN,15542240,Transmission disequilibrium analysis of the GSN gene in a cohort of family trios with schizophrenia.,"['Xi ZR', 'Qin W', 'Yang YF', 'He G', 'Gao SH', 'Ren MS', 'Peng YW', 'Zhang Z', 'He L']","['Adult', 'China/epidemiology', 'Cohort Studies', 'Female', 'Gelsolin/*genetics', 'Genetic Linkage', 'Genotype', 'Haplotypes', 'Heterozygote', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/genetics', 'Psychiatric Status Rating Scales', 'Reverse Transcriptase Polymerase Chain Reaction', 'Schizophrenia/*genetics', 'Schizophrenic Psychology']",https://pubmed.ncbi.nlm.nih.gov/15542240/
232,GSN,36650038,GSN gene frameshift mutations in Alzheimer's disease.,"['Jiang Y', 'Wan M', 'Xiao X', 'Lin Z', 'Liu X', 'Zhou Y', 'Liao X', 'Lin J', 'Zhou H', 'Zhou L', 'Weng L', 'Wang J', 'Guo J', 'Jiang H', 'Zhang Z', 'Xia K', 'Li J', 'Tang B', 'Jiao B', 'Shen L']","['Humans', '*Alzheimer Disease/diagnosis', 'Amyloid beta-Peptides/cerebrospinal fluid', 'Frameshift Mutation', '*Cognitive Dysfunction/cerebrospinal fluid', 'Biomarkers/cerebrospinal fluid', 'Peptide Fragments/cerebrospinal fluid']",https://pubmed.ncbi.nlm.nih.gov/36650038/
233,GSN,2567988,"The gelsolin (GSN) cDNA clone, from 9q32-34, identifies BclI and StuI RFLPs.","['Kwiatkowski DJ', 'Ozelius L', 'Schuback D', 'Gusella J', 'Breakefield XO']","['Blood Proteins/genetics', 'Calcium-Binding Proteins/*genetics', '*Chromosomes, Human, Pair 9', 'Cloning, Molecular', '*DNA Probes', '*Deoxyribonucleases, Type II Site-Specific', 'Gelsolin', 'Humans', 'Microfilament Proteins/*genetics', '*Polymorphism, Genetic', '*Polymorphism, Restriction Fragment Length']",https://pubmed.ncbi.nlm.nih.gov/2567988/
234,GSN,36192574,GSN synergies with actin-related transfer molecular chain to promote invasion and metastasis of HCC.,"['Zhou Y', 'He M']","['Humans', 'Gelsolin/genetics/metabolism', 'Actins', 'Matrix Metalloproteinase 2/genetics/metabolism', 'Matrix Metalloproteinase 14/metabolism', '*Carcinoma, Hepatocellular/pathology', '*Liver Neoplasms/pathology', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/36192574/
235,GSN,30148861,"Opposite functions of GSN and OAS2 on colorectal cancer metastasis, mediating perineural and lymphovascular invasion, respectively.","['Kim JC', 'Ha YJ', 'Tak KH', 'Roh SA', 'Kwon YH', 'Kim CW', 'Yoon YS', 'Lee JL', 'Park Y', 'Kim SK', 'Kim SY', 'Cho DH', 'Kim YS']","[""2',5'-Oligoadenylate Synthetase/genetics/*metabolism"", 'Apoptosis', 'Biomarkers, Tumor/genetics/*metabolism', 'Cell Movement', 'Cell Proliferation', 'Colorectal Neoplasms/genetics/metabolism/*pathology', 'Gelsolin/genetics/*metabolism', 'Humans', 'Neoplasm Invasiveness', 'Neoplasm Metastasis', 'Neoplasm Recurrence, Local/genetics/metabolism/*pathology', 'Prognosis', 'Survival Rate', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/30148861/
236,GSN,30771276,Regulation and related mechanism of GSN mRNA level by hnRNPK in lung adenocarcinoma cells.,"['Liu XH', 'Ma J', 'Feng JX', 'Feng Y', 'Zhang YF', 'Liu LX']","['Adenocarcinoma of Lung/genetics/*metabolism/pathology', 'Cell Line, Tumor', 'Gelsolin/*genetics', 'Heterogeneous-Nuclear Ribonucleoprotein K/*metabolism', 'Humans', 'Lung Neoplasms/genetics/*metabolism/pathology', 'Neoplasm Metastasis', 'RNA, Messenger/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30771276/
237,GSN,26915616,The First Korean Family With Hereditary Gelsolin Amyloidosis Caused by p.D214Y Mutation in the GSN Gene.,"['Park KJ', 'Park JH', 'Park JH', 'Cho EB', 'Kim BJ', 'Kim JW']","['Amyloidosis, Familial/diagnosis/*genetics', 'Asian People/*genetics', 'Base Sequence', 'DNA Mutational Analysis', 'Gelsolin/*genetics', 'Genotype', 'Heterozygote', 'Humans', 'Male', 'Middle Aged', 'Pedigree', 'Polymorphism, Single Nucleotide', 'Republic of Korea']",https://pubmed.ncbi.nlm.nih.gov/26915616/
238,GSN,29576848,The Ratio of Plasma and Urinary 8-oxo-Gsn Could Be a Novel Evaluation Index for Patients with Chronic Kidney Disease.,"['Mao YH', 'Xu LN', 'Weng QH', 'Li XY', 'Zhao B', 'Nie JJ', 'Hu JH', 'Zhang LQ', 'Chen Z', 'Zuo MZ', 'Ito S', 'Cai JP']","['Adult', 'Aged', 'Aged, 80 and over', 'Chromatography, Liquid/methods', 'Female', 'Guanosine/*analogs & derivatives/blood/urine', 'Humans', 'Male', 'Middle Aged', 'Reactive Oxygen Species/metabolism', 'Renal Insufficiency, Chronic/*blood/pathology/*urine', 'Tandem Mass Spectrometry/methods', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29576848/
239,GSN,24505034,Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation.,"['Hu WS', 'Ho TJ', 'Pai P', 'Chung LC', 'Kuo CH', 'Chang SH', 'Tsai FJ', 'Tsai CH', 'Jie YC', 'Liou YM', 'Huang CY']","['Cardiomegaly/*genetics/metabolism/pathology', 'DNA-Binding Proteins', 'GATA4 Transcription Factor/*biosynthesis', 'Gelsolin/*genetics/metabolism', 'Gene Expression Regulation', 'Humans', 'Hypertrophy/metabolism/pathology', 'Myocytes, Cardiac/metabolism/pathology', 'Natriuretic Peptide, Brain/*biosynthesis/genetics', 'Promoter Regions, Genetic', 'Signal Transduction/genetics', 'Transcriptional Activation/genetics', 'p38 Mitogen-Activated Protein Kinases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24505034/
240,GSN,31048503,Circadian clock regulation of the glycogen synthase (gsn) gene by WCC is critical for rhythmic glycogen metabolism in Neurospora crassa.,"['Baek M', 'Virgilio S', 'Lamb TM', 'Ibarra O', 'Andrade JM', 'Goncalves RD', 'Dovzhenok A', 'Lim S', 'Bell-Pedersen D', 'Bertolini MC', 'Hong CI']","['*Circadian Clocks', 'Fungal Proteins/metabolism', '*Gene Expression Regulation', 'Glycogen/*metabolism', 'Glycogen Synthase/genetics/*metabolism', 'Neurospora crassa/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31048503/
241,GSN,30118659,Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinoma.,"['Kelley DZ', 'Flam EL', 'Guo T', 'Danilova LV', 'Zamuner FT', 'Bohrson C', 'Considine M', 'Windsor EJ', 'Bishop JA', 'Zhang C', 'Koch WM', 'Sidransky D', 'Westra WH', 'Chung CH', 'Califano JA', 'Wheelan S', 'Favorov AV', 'Florea L', 'Fertig EJ', 'Gaykalova DA']","['Alternative Splicing', 'Cell Line, Tumor', 'Cell Movement/genetics', 'Cell Proliferation/genetics', 'Cell Survival/genetics', 'Gelsolin/*genetics/metabolism', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Models, Biological', 'Neoplasm Invasiveness', 'Neoplasm Metastasis', 'Squamous Cell Carcinoma of Head and Neck/genetics']",https://pubmed.ncbi.nlm.nih.gov/30118659/
242,GSN,11976968,Molecular and biochemical characterization of the Neurospora crassa glycogen synthase encoded by the gsn cDNA.,"['de Paula R', 'Azzariti de Pinho C', 'Terenzi HF', 'Bertolini MC']","['Amino Acid Sequence', 'Base Sequence', 'Cloning, Molecular', 'DNA, Complementary/genetics', 'DNA, Fungal/genetics', 'Escherichia coli/genetics', 'Gene Expression Regulation, Enzymologic', 'Gene Expression Regulation, Fungal', 'Genes, Fungal', 'Glycogen Synthase/*genetics/*metabolism', 'Molecular Sequence Data', 'Neurospora crassa/*enzymology/*genetics/growth & development', 'Sequence Homology, Amino Acid']",https://pubmed.ncbi.nlm.nih.gov/11976968/
243,GSN,33973672,A novel GSN variant outside the G2 calcium-binding domain associated with Amyloidosis of the Finnish type.,"['Mullany S', 'Souzeau E', 'Klebe S', 'Zhou T', 'Knight LSW', 'Qassim A', 'Berry EC', 'Marshall H', 'Hussey M', 'Dubowsky A', 'Breen J', 'Hassall MM', 'Mills RA', 'Craig JE', 'Siggs OM']","['*Amyloidosis/genetics', 'Calcium/metabolism', '*Corneal Dystrophies, Hereditary/genetics', 'Finland', 'Gelsolin/genetics/metabolism', 'Genetic Variation', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/33973672/
244,GSN,24607942,Is GSN significant for hip BMD in female Caucasians?,"['Deng FY', 'Zhu W', 'Zeng Y', 'Zhang JG', 'Yu N', 'Liu YZ', 'Liu YJ', 'Tian Q', 'Deng HW']","['Adult', 'Bone Density/genetics/*physiology', 'Female', 'Gelsolin/genetics/*metabolism', 'Hip Joint/metabolism', 'Humans', 'Leukocytes, Mononuclear/metabolism', 'Middle Aged', 'Polymorphism, Single Nucleotide/genetics', 'Premenopause/genetics/metabolism', 'White People']",https://pubmed.ncbi.nlm.nih.gov/24607942/
245,GSN,33844118,"Correlates of Geosocial Networking Applications (GSN Apps) Usage among Gay, Bisexual, and Other Men Who Have Sex with Men in Nigeria, Africa.","['Ogunbajo A', 'Lodge W 2nd', 'Restar AJ', 'Oginni OA', 'Iwuagwu S', 'Williams R', 'Biello K', 'Mimiaga MJ']","['*HIV Infections/prevention & control', 'Homosexuality, Male', 'Humans', 'Male', '*Mobile Applications', 'Nigeria', 'Sexual Behavior', 'Sexual Partners', '*Sexual and Gender Minorities', 'Social Networking']",https://pubmed.ncbi.nlm.nih.gov/33844118/
246,GSN,26434839,Expression of Cytoplasmic 8-oxo-Gsn and MTH1 Correlates with Pathological Grading in Human Gastric Cancer.,"['Song WJ', 'Jiang P', 'Cai JP', 'Zheng ZQ']","[""8-Hydroxy-2'-Deoxyguanosine"", 'Adenocarcinoma/*chemistry/*pathology', 'Adult', 'Aged', 'Aged, 80 and over', 'Cytoplasm/chemistry', 'DNA Repair Enzymes/*analysis', 'Deoxyguanosine/*analogs & derivatives/analysis', 'Female', 'Guanine/*analogs & derivatives/analysis', 'Humans', 'Male', 'Middle Aged', 'Mitochondria/chemistry', 'Neoplasm Grading', 'Phosphoric Monoester Hydrolases/*analysis', 'Stomach/chemistry', 'Stomach Neoplasms/*chemistry/*pathology']",https://pubmed.ncbi.nlm.nih.gov/26434839/
247,GSN,37365287,"Integrated bioinformatics and wet-lab analysis revealed cell adhesion prominent genes CDC42, TAGLN and GSN as prognostic biomarkers in colonic-polyp lesions.","['Tabatabaei ES', 'Mazloomnejad R', 'Rejali L', 'Forouzesh F', 'Naderi-Noukabadi F', 'Khanabadi B', 'Salehi Z', 'Nazemalhosseini-Mojarad E']","['Humans', '*Colonic Polyps/genetics/pathology', 'Prognosis', 'Cell Adhesion', 'Iran', '*Adenoma/genetics', '*Colorectal Neoplasms/pathology', 'Biomarkers', 'Computational Biology', 'Biomarkers, Tumor/genetics/analysis']",https://pubmed.ncbi.nlm.nih.gov/37365287/
248,GUCY2D,37327959,Comprehensive Genotyping and Phenotyping Analysis of GUCY2D-Associated Rod- and Cone-Dominated Dystrophies.,"['Rodilla C', 'Martin-Merida I', 'Blanco-Kelly F', 'Trujillo-Tiebas MJ', 'Avila-Fernandez A', 'Riveiro-Alvarez R', 'Del Pozo-Valero M', 'Perea-Romero I', 'Swafiri ST', 'Zurita O', 'Villaverde C', 'Lopez MA', 'Romero R', 'Iancu IF', 'Nunez-Moreno G', 'Jimenez-Rolando B', 'Martin-Gutierrez MP', 'Carreno E', 'Minguez P', 'Garcia-Sandoval B', 'Ayuso C', 'Corton M']","['Humans', '*Cone-Rod Dystrophies/diagnosis/genetics', 'Genotype', '*Leber Congenital Amaurosis/diagnosis/genetics', 'Mutation', '*Night Blindness/diagnosis/genetics', 'Pedigree', 'Phenotype', 'Retrospective Studies']",https://pubmed.ncbi.nlm.nih.gov/37327959/
249,GUCY2D,17684531,Population history and infrequent mutations: how old is a rare mutation? GUCY2D as a worked example.,"['Hanein S', 'Perrault I', 'Gerber S', 'Delphin N', 'Benezra D', 'Shalev S', 'Carmi R', 'Feingold J', 'Dufier JL', 'Munnich A', 'Kaplan J', 'Rozet JM', 'Jeanpierre M']","['Africa, Northern/ethnology', 'Bayes Theorem', 'DNA Primers/genetics', 'Female', 'Founder Effect', 'France', '*Genetics, Population', 'Guanylate Cyclase/*genetics', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', '*Models, Genetic', 'Models, Statistical', '*Mutation', 'Optic Atrophy, Hereditary, Leber/genetics', 'Polymorphism, Single Nucleotide', 'Portugal/ethnology', 'Receptors, Cell Surface/*genetics', 'Sequence Deletion', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/17684531/
250,GUCY2D,29061346,Genotype-functional-phenotype correlations in photoreceptor guanylate cyclase (GC-E) encoded by GUCY2D.,"['Sharon D', 'Wimberg H', 'Kinarty Y', 'Koch KW']","['Genetic Association Studies', 'Guanylate Cyclase/*genetics', 'Guanylate Cyclase-Activating Proteins/physiology', 'Humans', 'Leber Congenital Amaurosis/genetics', 'Mutation', 'Photoreceptor Cells, Vertebrate/*enzymology', 'Receptors, Cell Surface/*genetics', 'Retinal Diseases/genetics']",https://pubmed.ncbi.nlm.nih.gov/29061346/
251,GUCY2D,34048777,Novel variants in GUCY2D causing retinopathy and the genotype-phenotype correlation.,"['Yi Z', 'Sun W', 'Xiao X', 'Li S', 'Jia X', 'Li X', 'Yu B', 'Wang P', 'Zhang Q']","['DNA/*genetics', 'DNA Mutational Analysis', 'Electroretinography', 'Female', 'Genetic Association Studies', 'Guanylate Cyclase/*genetics/metabolism', 'Humans', 'Male', '*Mutation', 'Pedigree', 'Receptors, Cell Surface/*genetics/metabolism', 'Retinal Diseases/*genetics/metabolism/pathology', 'Rod Cell Outer Segment/*metabolism/pathology', '*Visual Acuity']",https://pubmed.ncbi.nlm.nih.gov/34048777/
252,GUCY2D,11135490,Autosomal dominant cone-rod dystrophy due to a missense mutation (R838C) in the guanylate cyclase 2D gene (GUCY2D) with preserved rod function in one branch of the family.,"['Van Ghelue M', 'Eriksen HL', 'Ponjavic V', 'Fagerheim T', 'Andreasson S', 'Forsman-Semb K', 'Sandgren O', 'Holmgren G', 'Tranebjaerg L']","['Adult', 'Aged', 'Child', 'Chromosomes, Human, Pair 17/genetics', 'Color Vision Defects/genetics/physiopathology', 'DNA Mutational Analysis', 'Electroretinography', 'Female', 'Genes, Dominant', 'Genetic Linkage', 'Guanylate Cyclase/*genetics', 'Humans', 'Lod Score', 'Male', 'Middle Aged', '*Mutation, Missense', 'Pedigree', 'Photoreceptor Cells, Vertebrate/enzymology/*pathology', 'Polymerase Chain Reaction', 'Retinal Degeneration/enzymology/*genetics/physiopathology', 'Retinal Rod Photoreceptor Cells/enzymology/physiology', 'Visual Acuity', 'Visual Fields']",https://pubmed.ncbi.nlm.nih.gov/11135490/
253,GUCY2D,12325031,Evidence of a founder effect for the RETGC1 (GUCY2D) 2943DelG mutation in Leber congenital amaurosis pedigrees of Finnish origin.,"['Hanein S', 'Perrault I', 'Olsen P', 'Lopponen T', 'Hietala M', 'Gerber S', 'Jeanpierre M', 'Barbet F', 'Ducroq D', 'Hakiki S', 'Munnich A', 'Rozet JM', 'Kaplan J']","['Blindness/congenital/enzymology/*genetics', 'Cyclic GMP/metabolism', 'Female', 'Finland', '*Founder Effect', '*Guanine', 'Guanylate Cyclase/genetics', 'Humans', 'Linkage Disequilibrium/genetics', 'Male', 'Mutation/*genetics', 'Nuclear Family', 'Optic Atrophies, Hereditary/enzymology/*genetics', '*Pedigree', 'Polymorphism, Single Nucleotide/genetics', 'Sequence Deletion/*genetics']",https://pubmed.ncbi.nlm.nih.gov/12325031/
254,GUCY2D,24875811,GUCY2D- or GUCA1A-related autosomal dominant cone-rod dystrophy: is there a phenotypic difference?,"['Zobor D', 'Zrenner E', 'Wissinger B', 'Kohl S', 'Jagle H']","['Adult', 'Aged', 'DNA Mutational Analysis', 'Dark Adaptation/physiology', 'Electroretinography', 'Female', 'Fluorescein Angiography', 'Genes, Dominant', 'Genetic Association Studies', 'Guanylate Cyclase/*genetics', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', 'Male', 'Middle Aged', 'Mutation', '*Polymorphism, Single Nucleotide', 'Receptors, Cell Surface/*genetics', 'Retinal Cone Photoreceptor Cells/physiology', 'Retinal Rod Photoreceptor Cells/physiology', 'Retinitis Pigmentosa/*genetics/physiopathology', 'Tomography, Optical Coherence', 'Visual Acuity/physiology']",https://pubmed.ncbi.nlm.nih.gov/24875811/
255,GUCY2D,37775646,A natural history study of autosomal dominant GUCY2D-associated cone-rod dystrophy.,"['Scopelliti AJ', 'Jamieson RV', 'Barnes EH', 'Nash B', 'Rajagopalan S', 'Cornish EL', 'Grigg JR']","['Humans', 'Child, Preschool', 'Child', 'Adolescent', 'Young Adult', 'Adult', 'Middle Aged', 'Aged', '*Cone-Rod Dystrophies/diagnosis/genetics', 'Retrospective Studies', 'Electroretinography', 'Visual Acuity', 'Australia', '*Retinitis Pigmentosa', 'Biomarkers', 'Tomography, Optical Coherence/methods']",https://pubmed.ncbi.nlm.nih.gov/37775646/
256,GUCY2D,35205358,GUCY2D-Related Retinal Dystrophy with Autosomal Dominant Inheritance-A Multicenter Case Series and Review of Reported Data.,"['Neubauer J', 'Hahn L', 'Birtel J', 'Boon CJF', 'Charbel Issa P', 'Fischer MD']","['Adult', '*Cone-Rod Dystrophies/genetics', 'Female', '*Guanylate Cyclase/genetics', 'Humans', 'Male', 'Prospective Studies', 'Receptors, Cell Surface/genetics', 'Retrospective Studies', 'Vision Disorders']",https://pubmed.ncbi.nlm.nih.gov/35205358/
257,GUCY2D,18487367,Mutation analysis identifies GUCY2D as the major gene responsible for autosomal dominant progressive cone degeneration.,"['Kitiratschky VB', 'Wilke R', 'Renner AB', 'Kellner U', 'Vadala M', 'Birch DG', 'Wissinger B', 'Zrenner E', 'Kohl S']","['Codon', 'DNA/*genetics', 'DNA Mutational Analysis', 'Disease Progression', 'Electroretinography', 'Female', '*Genetic Predisposition to Disease', 'Guanylate Cyclase/*genetics/metabolism', 'Haplotypes', 'Humans', 'Male', '*Mutation', 'Pedigree', 'Polymerase Chain Reaction', 'Prognosis', 'Receptors, Cell Surface/*genetics/metabolism', 'Retinal Degeneration/*genetics/metabolism/pathology', 'Rod Cell Outer Segment/*metabolism/pathology/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/18487367/
258,GUCY2D,26298565,GUCY2D mutations in a Chinese cohort with autosomal dominant cone or cone-rod dystrophies.,"['Jiang F', 'Xu K', 'Zhang X', 'Xie Y', 'Bai F', 'Li Y']","['Adolescent', 'Adult', 'Asian People/*genetics', 'Child', 'Child, Preschool', 'DNA Mutational Analysis', 'Electroretinography', 'Female', 'Guanylate Cyclase/*genetics', 'Humans', 'Male', 'Middle Aged', '*Mutation, Missense', 'Pedigree', 'Polymerase Chain Reaction', 'Polymorphism, Restriction Fragment Length', 'Receptors, Cell Surface/*genetics', 'Retinal Cone Photoreceptor Cells/*pathology', 'Retinal Degeneration/diagnosis/*genetics', 'Retinitis Pigmentosa/diagnosis/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26298565/
259,GUCY2D,20517349,A novel recessive GUCY2D mutation causing cone-rod dystrophy and not Leber's congenital amaurosis.,"['Ugur Iseri SA', 'Durlu YK', 'Tolun A']","['Adult', 'Aged', 'Blindness/genetics', 'Color Vision Defects/genetics', 'Genes, Recessive', 'Genetic Linkage', 'Guanylate Cyclase/chemistry/*genetics', 'Humans', 'Leber Congenital Amaurosis/*genetics', 'Middle Aged', '*Mutation, Missense', 'Night Blindness/genetics', 'Receptors, Cell Surface/chemistry/*genetics', 'Retinal Cone Photoreceptor Cells', 'Retinal Rod Photoreceptor Cells', 'Retinitis Pigmentosa/*genetics', 'Turkey', 'Visual Acuity']",https://pubmed.ncbi.nlm.nih.gov/20517349/
260,GUCY2D,17200655,Novel triple missense mutations of GUCY2D gene in Japanese family with cone-rod dystrophy: possible use of genotyping microarray.,"['Yoshida S', 'Yamaji Y', 'Yoshida A', 'Kuwahara R', 'Yamamoto K', 'Kubata T', 'Ishibashi T']","['Aged', 'Asian People/*genetics', 'Electroretinography', 'Fluorescein Angiography', 'Fundus Oculi', 'Genotype', 'Guanylate Cyclase/*genetics', 'Heterozygote', 'Humans', 'Male', 'Middle Aged', '*Mutation, Missense', 'Oligonucleotide Array Sequence Analysis', 'Pedigree', 'Polymorphism, Single Nucleotide', 'Receptors, Cell Surface/*genetics', 'Retinitis Pigmentosa/diagnosis/*genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/17200655/
261,GUCY2D,39244273,"Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation study.","['Yang P', 'Pardon LP', 'Ho AC', 'Lauer AK', 'Yoon D', 'Boye SE', 'Boye SL', 'Roman AJ', 'Wu V', 'Garafalo AV', 'Sumaroka A', 'Swider M', 'Viarbitskaya I', 'Aleman TS', 'Pennesi ME', 'Kay CN', 'Fujita KP', 'Cideciyan AV']","['Adolescent', 'Adult', 'Child', 'Humans', '*Genetic Therapy/methods', '*Guanylate Cyclase/genetics', 'Injections, Intraocular', '*Leber Congenital Amaurosis/genetics', 'Mutation', '*Receptors, Cell Surface/genetics', 'Treatment Outcome', 'Visual Acuity']",https://pubmed.ncbi.nlm.nih.gov/39244273/
262,GUCY2D,35314386,The Natural History of Leber Congenital Amaurosis and Cone-Rod Dystrophy Associated with Variants in the GUCY2D Gene.,"['Hahn LC', 'Georgiou M', 'Almushattat H', 'van Schooneveld MJ', 'de Carvalho ER', 'Wesseling NL', 'Ten Brink JB', 'Florijn RJ', 'Lissenberg-Witte BI', 'Strubbe I', 'van Cauwenbergh C', 'de Zaeytijd J', 'Walraedt S', 'de Baere E', 'Mukherjee R', 'McKibbin M', 'Meester-Smoor MA', 'Thiadens AAHJ', 'Al-Khuzaei S', 'Akyol E', 'Lotery AJ', 'van Genderen MM', 'Ossewaarde-van Norel J', 'van den Born LI', 'Hoyng CB', 'Klaver CCW', 'Downes SM', 'Bergen AA', 'Leroy BP', 'Michaelides M', 'Boon CJF']","['*Cone-Rod Dystrophies/diagnosis/genetics', 'Humans', '*Leber Congenital Amaurosis/diagnosis/genetics', 'Retrospective Studies', 'Vision Disorders', 'Visual Acuity']",https://pubmed.ncbi.nlm.nih.gov/35314386/
263,MBL2,27876780,A Meta-analysis of MBL2 Polymorphisms and Tuberculosis Risk.,"['Areeshi MY', 'Mandal RK', 'Akhter N', 'Dar SA', 'Jawed A', 'Wahid M', 'Mahto H', 'Panda AK', 'Lohani M', 'Haque S']","['*Alleles', 'Female', '*Genetic Predisposition to Disease', '*Genotype', 'Humans', 'Male', 'Mannose-Binding Lectin/*genetics', '*Polymorphism, Genetic', 'Risk Factors', 'Tuberculosis/epidemiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27876780/
264,MBL2,16046196,MBL2 polymorphisms screening in a regional Italian CF Center.,"['Trevisiol C', 'Boniotto M', 'Giglio L', 'Poli F', 'Morgutti M', 'Crovella S']","['Adult', 'Cystic Fibrosis/complications/*metabolism/physiopathology', 'Cystic Fibrosis Transmembrane Conductance Regulator/genetics/metabolism', 'Disease Progression', 'Disease Susceptibility', 'Female', 'Forced Expiratory Volume/physiology', 'Gene Frequency', 'Genetic Markers', '*Genetic Testing', 'Genotype', 'Humans', 'Italy', 'Male', 'Mannose-Binding Lectin/*genetics/metabolism', '*Polymorphism, Genetic', 'Pseudomonas Infections/complications/microbiology', 'Pseudomonas aeruginosa/isolation & purification', 'Sputum/microbiology']",https://pubmed.ncbi.nlm.nih.gov/16046196/
265,MBL2,19467940,An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study.,"['Tomaiuolo R', 'Degiorgio D', 'Coviello DA', 'Baccarelli A', 'Elce A', 'Raia V', 'Motta V', 'Seia M', 'Castaldo G', 'Colombo C']","['ATP Binding Cassette Transporter, Subfamily B/*genetics', 'Adolescent', 'Adult', 'Cystic Fibrosis/complications/*genetics', 'Female', 'Haplotypes', 'Humans', 'Liver Diseases/complications/*genetics', 'Male', 'Mannose-Binding Lectin/*genetics', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19467940/
266,MBL2,33146461,Association of MBL2 gene polymorphisms and systemic lupus erythematosus susceptibility: A meta-analysis.,"['Yuan ZC', 'Xu WD', 'Lan YY', 'Wang JM', 'Wu Q', 'Zhou J', 'Huang AF']","['Alleles', 'DNA/*genetics', 'Gene Frequency', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Lupus Erythematosus, Systemic/*genetics/metabolism', 'Mannose-Binding Lectin/*genetics/metabolism', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/33146461/
267,MBL2,24218255,Genotyping of FCN and MBL2 polymorphisms using pyrosequencing.,"['Munthe-Fog L', 'Madsen HO', 'Garred P']","['*Genotyping Techniques', 'Humans', 'Lectins/*genetics', 'Mannose-Binding Lectin/*genetics', 'Polymerase Chain Reaction/methods', '*Polymorphism, Single Nucleotide', '*Sequence Analysis, DNA/methods', 'Ficolins']",https://pubmed.ncbi.nlm.nih.gov/24218255/
268,MBL2,21895981,Mannose-binding lectin (MBL2) polymorphisms and inflammation in hypertensive patients.,"['Schreiber R', 'Campos-Coelho AV', 'Brandao L', 'Guimaraes RL', 'Kamada AJ', 'Ferreira-Sae MC', 'Matos-Souza JR', 'Cipolli JA', 'de Lima-Filho JL', 'Crovella S', 'Nadruz W Jr']","['Brazil', 'C-Reactive Protein/metabolism', 'Female', '*Genetic Predisposition to Disease', 'Humans', 'Hypertension/*complications/*genetics', 'Inflammation/*complications/*genetics', 'Male', 'Mannose-Binding Lectin/*genetics', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21895981/
269,MBL2,32913345,Complement protein levels and MBL2 polymorphisms are associated with dengue and disease severity.,"['Giang NT', 'van Tong H', 'Quyet D', 'Hoan NX', 'Nghia TH', 'Nam NM', 'Hung HV', 'Anh DT', 'Van Mao C', 'Son HA', 'Meyer CG', 'Velavan TP', 'Toan NL']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Biomarkers/*analysis', 'Complement C2/analysis', 'Complement C5/analysis', 'Complement C5a/analysis', 'Dengue Virus/*isolation & purification', 'Disease Progression', 'Female', 'Follow-Up Studies', 'Gene Expression Regulation', 'Genotype', 'Haplotypes', 'Humans', 'Immunologic Factors/*blood', 'Male', 'Mannose-Binding Lectin/*blood/*genetics', 'Middle Aged', '*Polymorphism, Genetic', 'Prognosis', 'Severe Dengue/blood/*epidemiology/genetics/virology', 'Severity of Illness Index', 'Vietnam/epidemiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32913345/
270,MBL2,37121343,MBL2 gene variants and susceptibility to meningitis in Egyptian patients.,"['Sokkar MF', 'Mosaad RM', 'Khalil M', 'Kamal L']","['Humans', 'Case-Control Studies', 'Disease Susceptibility', 'Egypt', '*Mannose-Binding Lectin/genetics', 'Genotype', '*Meningitis', 'Genetic Predisposition to Disease']",https://pubmed.ncbi.nlm.nih.gov/37121343/
271,MBL2,19501910,"MBL2, FCN1, FCN2 and FCN3-The genes behind the initiation of the lectin pathway of complement.","['Garred P', 'Honore C', 'Ma YJ', 'Munthe-Fog L', 'Hummelshoj T']","['Alleles', 'Complement Pathway, Mannose-Binding Lectin/*genetics/immunology', 'Complement System Proteins/genetics/immunology/metabolism', 'Exons/genetics', 'Glycoproteins/*genetics/immunology/metabolism', 'Humans', 'Immunity, Innate', 'Lectins/*genetics/immunology/metabolism', 'Mannose-Binding Lectin/*genetics/immunology/metabolism', 'Polymorphism, Single Nucleotide/genetics', 'Ficolins']",https://pubmed.ncbi.nlm.nih.gov/19501910/
272,MBL2,12141527,Single-tube genotyping of MBL-2 polymorphisms using melting temperature analysis.,"['Hladnik U', 'Braida L', 'Boniotto M', 'Pirulli D', 'Gerin F', 'Amoroso A', 'Crovella S']","['Carrier Proteins/*genetics', '*Genetic Techniques', 'Genotype', 'Humans', 'Mannose-Binding Lectins', '*Polymorphism, Genetic', 'Temperature']",https://pubmed.ncbi.nlm.nih.gov/12141527/
273,MBL2,37313996,The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy.,"['Scialo F', 'Cernera G', 'Esposito S', 'Pinchera B', 'Gentile I', 'Di Domenico M', 'Bianco A', 'Pastore L', 'Amato F', 'Castaldo G']","['Humans', '*COVID-19/genetics', 'SARS-CoV-2', 'Genotype', 'Genetic Predisposition to Disease', '*Mannose-Binding Lectin/genetics', 'Inflammation']",https://pubmed.ncbi.nlm.nih.gov/37313996/
274,MBL2,15516675,Impaired pulmonary status in cystic fibrosis adults with two mutated MBL-2 alleles.,"['Davies JC', 'Turner MW', 'Klein N']","['Adult', 'Burkholderia Infections/complications', 'Burkholderia cepacia', 'Child', 'Cystic Fibrosis/*genetics/*physiopathology', 'Female', 'Homozygote', 'Humans', 'Lung/*physiopathology', 'Male', 'Mannose-Binding Lectin/*analogs & derivatives/*genetics', '*Mutation', 'Pseudomonas Infections/complications']",https://pubmed.ncbi.nlm.nih.gov/15516675/
275,MBL2,24255984,"If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it?","['Eisen DP', 'Osthoff M']","['Atherosclerosis/genetics/immunology', 'Communicable Diseases/genetics/immunology', 'Gene Frequency', 'Haplotypes/*immunology', 'Humans', 'Mannose-Binding Lectin/genetics/*immunology', 'Mutation/immunology', 'Polymorphism, Genetic/*immunology', 'Selection, Genetic/*immunology']",https://pubmed.ncbi.nlm.nih.gov/24255984/
276,MBL2,27590640,MBL2 polymorphisms and the risk of asthma: A meta-analysis.,"['Shi J', 'Zhu X', 'Xie M', 'Wang J', 'He Y', 'Xu Y', 'Liu X']","['Asian People/genetics', 'Asthma/*genetics', 'Genetic Predisposition to Disease', 'Humans', 'Mannose-Binding Lectin/*genetics', 'Odds Ratio', 'Polymorphism, Genetic', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/27590640/
277,MBL2,27619685,Association of MBL2 exon1 polymorphisms with high-risk human papillomavirus infection and cervical cancers: a meta-analysis.,"['Wang HL', 'Lu X', 'Yang X', 'Xu N']","['*Exons', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Mannose-Binding Lectin/*genetics', 'Papillomavirus Infections/*genetics/*pathology', 'Polymorphism, Genetic', 'Uterine Cervical Neoplasms/*genetics/pathology/*virology']",https://pubmed.ncbi.nlm.nih.gov/27619685/
278,MBL2,27894112,Association of MBL2 Gene Polymorphism with Dental Caries in Saudi Children.,"['Alyousef YM', 'Borgio JF', 'AbdulAzeez S', 'Al-Masoud N', 'Al-Ali AA', 'Al-Shwaimi E', 'Al-Ali AK']","['Adolescent', 'Alleles', 'Child', 'Child, Preschool', 'Cohort Studies', 'DMF Index', 'Dental Caries/*epidemiology/*genetics', 'Dental Caries Susceptibility/*genetics', 'Female', 'Genetic Predisposition to Disease/*genetics', 'Haplotypes/genetics', 'Humans', 'Male', 'Mannose-Binding Lectin/*genetics', 'Matrix Metalloproteinase 2/genetics', 'Matrix Metalloproteinase 9/genetics', 'Oral Health', 'Polymorphism, Single Nucleotide', 'Prevalence', 'Saudi Arabia/epidemiology', 'Tissue Inhibitor of Metalloproteinase-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/27894112/
279,MBL2,36318338,MBL2 polymorphism may be a protective factor of autoimmune thyroid disease susceptibility.,"['Xu J', 'Suo L', 'Zhao J', 'Cai T', 'Mei N', 'Du P', 'Gao C', 'Fang Y', 'Jiang Y', 'Zhang JA']","['Humans', 'Protective Factors', 'Case-Control Studies', '*Hashimoto Disease/genetics', '*Autoimmune Diseases/genetics', '*Graves Disease/genetics', 'Genetic Predisposition to Disease', 'Genotype', 'Polymorphism, Single Nucleotide', 'Gene Frequency', '*Mannose-Binding Lectin/genetics']",https://pubmed.ncbi.nlm.nih.gov/36318338/
280,MBL2,36257838,MBL2 gene polymorphisms related to HIV-1 infection susceptibility and treatment response.,"['Bouqdayr M', 'Baba H', 'Saih A', 'Abbad A', 'Hamdi S', 'Marih L', 'Sodqi M', 'Ouladlahsen A', 'Marhoum El Filali K', 'Moussamih S', 'Saile R', 'Kettani A', 'Wakrim L']","['Humans', '*HIV-1', 'Genotype', 'Polymorphism, Genetic', 'Haplotypes', '*Mannose-Binding Lectin/genetics', '*HIV Infections/genetics', '*HIV Seropositivity', 'Genetic Predisposition to Disease']",https://pubmed.ncbi.nlm.nih.gov/36257838/
281,MBL2,34570692,Investigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (-) patients.,"['Pehlivan S', 'Kose M', 'Mese S', 'Serin I', 'Senkal N', 'Oyaci Y', 'Medetalibeyoglu A', 'Pehlivan M', 'Sayin GY', 'Isoglu-Alkac U', 'Tukek T']","['*COVID-19/diagnosis', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', '*Mannose-Binding Lectin/genetics', 'Nitric Oxide Synthase Type III/genetics', 'Polymerase Chain Reaction/methods']",https://pubmed.ncbi.nlm.nih.gov/34570692/
282,KCNIP3,35066335,KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/beta-catenin pathway.,"['Zhong J', 'Lin R', 'Wang G', 'Lin L', 'Ruan S', 'Liu W']","['Cell Line, Tumor', 'Cell Movement', 'Cell Proliferation', 'Epithelial-Mesenchymal Transition/genetics', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Kv Channel-Interacting Proteins/*genetics/metabolism', 'Repressor Proteins/*genetics/metabolism', 'Thyroid Cancer, Papillary/genetics/metabolism/pathology', '*Thyroid Neoplasms/genetics/metabolism/pathology', '*Wnt Signaling Pathway/genetics', 'beta Catenin/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35066335/
283,SHH,38191555,Developmental basis of SHH medulloblastoma heterogeneity.,"['Gold MP', 'Ong W', 'Masteller AM', 'Ghasemi DR', 'Galindo JA', 'Park NR', 'Huynh NC', 'Donde A', 'Pister V', 'Saurez RA', 'Vladoiu MC', 'Hwang GH', 'Eisemann T', 'Donovan LK', 'Walker AD', 'Benetatos J', 'Dufour C', 'Garzia L', 'Segal RA', 'Wechsler-Reya RJ', 'Mesirov JP', 'Korshunov A', 'Pajtler KW', 'Pomeroy SL', 'Ayrault O', 'Davidson SM', 'Cotter JA', 'Taylor MD', 'Fraenkel E']","['Humans', 'Hedgehog Proteins/genetics', '*Medulloblastoma/genetics', 'Proteomics', 'Cerebellum', '*Cerebellar Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/38191555/
284,SHH,29517209,Medulloblastoma with extensive nodularity (SHH medulloblastoma).,"['Fudyma IA', 'Wadhwani NR']","['Biomarkers, Tumor/*analysis', 'Biopsy', 'Cerebellar Neoplasms/*chemistry/diagnostic imaging/*pathology/surgery', 'Female', 'Hedgehog Proteins/*analysis', 'Humans', 'Immunohistochemistry', 'Infant', 'Magnetic Resonance Imaging', 'Medulloblastoma/*chemistry/diagnostic imaging/*pathology/surgery']",https://pubmed.ncbi.nlm.nih.gov/29517209/
285,SHH,29346746,Shh-ushing Midline Crossing through Remote Protein Transport.,"['Herrera E', 'Sitko AA', 'Bovolenta P']","['*Axon Guidance', 'Axons', 'Cues', '*Hedgehog Proteins', 'Optic Chiasm', 'Protein Transport', 'Retinal Ganglion Cells']",https://pubmed.ncbi.nlm.nih.gov/29346746/
286,SHH,37315133,Yap controls notochord formation and neural tube patterning by integrating mechanotransduction with FoxA2 and Shh expression.,"['Cheng C', 'Cong Q', 'Liu Y', 'Hu Y', 'Liang G', 'Dioneda KMM', 'Yang Y']","['Central Nervous System/embryology', 'Embryonic Development', '*Hedgehog Proteins', '*Mechanotransduction, Cellular', 'Neural Tube/embryology', '*YAP-Signaling Proteins', '*Hepatocyte Nuclear Factor 3-beta']",https://pubmed.ncbi.nlm.nih.gov/37315133/
287,F11,29407776,Biodegradation of Diclofenac by the bacterial strain Labrys portucalensis F11.,"['Moreira IS', 'Bessa VS', 'Murgolo S', 'Piccirillo C', 'Mascolo G', 'Castro PML']","['Acetates/metabolism', 'Alphaproteobacteria/*metabolism', 'Biodegradation, Environmental', 'Biotransformation', 'Diclofenac/*analysis/metabolism', 'Models, Theoretical', 'Tandem Mass Spectrometry', 'Water Pollutants, Chemical/*analysis/metabolism', 'Water Purification/*methods']",https://pubmed.ncbi.nlm.nih.gov/29407776/
288,F11,1096,Endo-arabinanase from Bacillus subtilis F-11.,"['Kaji A', 'Saheki T']","['Arabinose', 'Bacillus subtilis/*enzymology', 'Chromatography, Gel', 'Glucosides/metabolism', 'Glycoside Hydrolases/isolation & purification/*metabolism', 'Hydrogen-Ion Concentration', 'Mercury/pharmacology', 'Nitrophenylgalactosides/metabolism', 'Oligosaccharides/metabolism', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/1096/
289,F11,32977424,Neoglycosylated Collagen: Effect on Neuroblastoma F-11 Cell Lines.,"['Sgambato A', 'Pastori V', 'Russo L', 'Vesentini S', 'Lecchi M', 'Cipolla L']","['Cell Differentiation/drug effects', 'Cell Line, Tumor', 'Collagen/*chemistry/*pharmacology', 'Glycosylation', 'Humans', 'Neuroblastoma/*pathology', 'Neurons/cytology/drug effects', 'Regenerative Medicine']",https://pubmed.ncbi.nlm.nih.gov/32977424/
290,F11,16835901,Spectrum of factor XI (F11) mutations in the UK population--116 index cases and 140 mutations.,"['Mitchell M', 'Mountford R', 'Butler R', 'Alhaq A', 'Dai L', 'Savidge G', 'Bolton-Maggs PH']","['Factor XI/*genetics', 'Factor XI Deficiency/diagnosis/*genetics', 'Founder Effect', 'Gene Deletion', 'Genetic Heterogeneity', 'Humans', '*Mutation', 'United Kingdom']",https://pubmed.ncbi.nlm.nih.gov/16835901/
291,F11,34533648,The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.,"['Czubak-Prowizor K', 'Babinska A', 'Swiatkowska M']","['Cell Adhesion Molecules/genetics/*metabolism', '*Cell Movement', '*Epithelial-Mesenchymal Transition', 'Humans', 'Neoplasm Proteins/genetics/*metabolism', 'Neoplasms/*blood supply/genetics/*metabolism', 'Neovascularization, Pathologic/genetics/*metabolism', 'Receptors, Cell Surface/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34533648/
292,F11,22248032,Two new compounds from marine-derived fungus Penicillium sp. F11.,"['Zhuang P', 'Tang XX', 'Yi ZW', 'Qiu YK', 'Wu Z']","['Antineoplastic Agents/chemistry/*isolation & purification/pharmacology', 'Drug Screening Assays, Antitumor', 'Humans', 'Marine Biology', 'Molecular Structure', 'Nuclear Magnetic Resonance, Biomolecular', 'Penicillium/*chemistry', 'Pyrones/chemistry/*isolation & purification/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/22248032/
293,F11,16980423,Degradation of fluorobenzene by Rhizobiales strain F11 via ortho cleavage of 4-fluorocatechol and catechol.,"['Carvalho MF', 'Ferreira MI', 'Moreira IS', 'Castro PM', 'Janssen DB']","['Alphaproteobacteria/enzymology/growth & development/*metabolism', 'Biodegradation, Environmental', 'Catechols/chemistry/*metabolism', 'Culture Media', 'Fluorobenzenes/*metabolism', 'Oxygen Consumption', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/16980423/
294,F11,30685307,Copper-induced oxidative cleavage of glutathione transferase F1-1 from Zea mays.,"['Alqarni MH', 'Muharram MM', 'Alshahrani SM', 'Labrou NE']","['Binding Sites', 'Copper/metabolism/*pharmacology', 'Glutathione Transferase/chemistry/*metabolism', 'Models, Molecular', 'Oxidation-Reduction/drug effects', 'Protein Conformation', 'Proteolysis/*drug effects', 'Zea mays/*enzymology']",https://pubmed.ncbi.nlm.nih.gov/30685307/
295,F11,21668437,Population-specific spectrum of the F11 mutations in Koreans: evidence for a founder effect.,"['Kim J', 'Song J', 'Lyu CJ', 'Kim YR', 'Oh SH', 'Choi YC', 'Yoo JH', 'Choi JR', 'Kim H', 'Lee KA']","['Adolescent', 'Adult', 'Aged', 'Amino Acid Sequence', 'Asian People/*genetics', 'Base Sequence', 'Child', 'Factor XI/*genetics', 'Factor XI Deficiency/*genetics', 'Female', '*Founder Effect', 'Haplotypes', 'Humans', 'Male', 'Middle Aged', 'Molecular Sequence Data', '*Mutation', 'Phenotype', 'Polymorphism, Genetic', 'Republic of Korea', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21668437/
296,F11,16607084,Identification of five novel mutations in the factor XI gene (F11) of patients with factor XI deficiency.,"['Quelin F', 'Mathonnet F', 'Potentini-Esnault C', 'Trigui N', 'Peynet J', 'Bastenaire B', 'Guillon L', 'Bigel ML', 'Sauger A', 'Mazurier C', 'de Mazancourt P']","['Adult', 'Aged', 'Base Sequence/genetics', 'Factor XI/*genetics', 'Factor XI Deficiency/*genetics/metabolism', 'Female', 'Humans', 'Male', 'Molecular Sequence Data', 'Mutation/*genetics/physiology', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/16607084/
297,F11,39623525,Genome Mining of the Marine-Derived Fungus Trichoderma erinaceum F1-1 Unearths Bergamotene-Type Sesquiterpenoids.,"['Yang W', 'Tian S', 'Du YF', 'Zeng XL', 'Liang JJ', 'Lan WJ', 'Li H']","['*Sesquiterpenes/metabolism/chemistry', '*Trichoderma/chemistry/genetics/metabolism', 'Molecular Structure', 'Multigene Family', 'Alkyl and Aryl Transferases/metabolism/genetics', 'Genome, Fungal', 'Aspergillus nidulans/genetics']",https://pubmed.ncbi.nlm.nih.gov/39623525/
298,F11,2612218,Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4.,"['Kato A', 'Asakai R', 'Davie EW', 'Aoki N']","['Base Sequence', 'Chromosome Mapping', '*Chromosomes, Human, Pair 4', 'DNA Probes', 'Factor XI/*genetics', 'Female', 'Humans', 'Molecular Sequence Data', 'Nucleic Acid Hybridization']",https://pubmed.ncbi.nlm.nih.gov/2612218/
299,PRKCG,16547918,Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype.,"['Vlak MH', 'Sinke RJ', 'Rabelink GM', 'Kremer BP', 'van de Warrenburg BP']","['Adult', 'Aged', 'Aged, 80 and over', 'Amino Acid Substitution/genetics', 'Atrophy', 'Basal Ganglia Diseases/diagnosis/genetics', 'Cerebellum/pathology', '*DNA Mutational Analysis', 'Exons', 'Female', 'Glutamic Acid/genetics', 'Humans', 'Isoenzymes/*genetics', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Mutation, Missense', 'Myoclonus/diagnosis/genetics', 'Netherlands', 'Pedigree', '*Phenotype', 'Protein Kinase C/*genetics', 'Spinocerebellar Ataxias/diagnosis/*genetics', 'Tremor/diagnosis/genetics', 'Valine/genetics']",https://pubmed.ncbi.nlm.nih.gov/16547918/
300,PRKCG,12438709,"Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2.","['Buchet-Poyau K', 'Mehenni H', 'Radhakrishna U', 'Antonarakis SE']","['AMP-Activated Protein Kinase Kinases', 'Adaptor Proteins, Signal Transducing', 'Aurora Kinase C', 'Aurora Kinases', 'Base Sequence', '*Chromosomes, Human, Pair 2', 'DNA', 'Genetic Heterogeneity', 'Humans', 'Isoenzymes/genetics', 'Molecular Sequence Data', 'Mutation', 'Peutz-Jeghers Syndrome/*genetics', 'Protein Kinase C/genetics', 'Protein Serine-Threonine Kinases/genetics', '*Proteins']",https://pubmed.ncbi.nlm.nih.gov/12438709/
301,PRKCG,26921055,The interaction of combined effects of the BDNF and PRKCG genes and negative life events in major depressive disorder.,"['Yang C', 'Sun N', 'Liu Z', 'Li X', 'Xu Y', 'Zhang K']","['Adolescent', 'Adult', 'Alleles', 'Asian People/genetics', 'Brain-Derived Neurotrophic Factor/*genetics', 'Depressive Disorder, Major/*genetics/*psychology', 'Female', '*Gene-Environment Interaction', '*Genetic Predisposition to Disease', 'Genetic Variation', 'Humans', 'Life Change Events', 'Male', 'Middle Aged', 'Protein Kinase C/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26921055/
302,PRKCG,16291902,Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene.,"['Fahey MC', 'Knight MA', 'Shaw JH', 'Gardner RJ', 'du Sart D', 'Lockhart PJ', 'Delatycki MB', 'Gates PC', 'Storey E']","['Adult', 'Australia', 'DNA Mutational Analysis', 'Exons', 'Female', 'Humans', 'Male', 'Middle Aged', 'Pedigree', 'Protein Kinase C/*genetics', 'Spinocerebellar Ataxias/*genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/16291902/
303,PRKCG,18986758,Expansion of the phenotypic spectrum of SCA14 caused by the Gly128Asp mutation in PRKCG.,"['Miura S', 'Nakagawara H', 'Kaida H', 'Sugita M', 'Noda K', 'Motomura K', 'Ohyagi Y', 'Ayabe M', 'Aizawa H', 'Ishibashi M', 'Taniwaki T']","['Adult', 'Amino Acid Substitution', 'Brain/blood supply', 'Cerebrovascular Circulation', 'Diagnosis, Differential', 'Female', 'Gait Ataxia/etiology/physiopathology', 'Humans', 'Male', 'Middle Aged', 'Mutation/*genetics', 'Pedigree', 'Phenotype', 'Protein Kinase C/*genetics', 'Spinocerebellar Ataxias/complications/*diagnosis/genetics', 'Tomography, Emission-Computed, Single-Photon/methods', 'Vertigo/etiology/physiopathology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/18986758/
304,PRKCG,17149711,Spinocerebellar ataxia 14: novel mutation in exon 2 of PRKCG in a German family.,"['Nolte D', 'Landendinger M', 'Schmitt E', 'Muller U']","['DNA Mutational Analysis', 'Exons/*genetics', 'Germany', 'Humans', 'Male', 'Middle Aged', 'Pedigree', 'Point Mutation/*genetics', 'Protein Kinase C/*genetics', 'Rare Diseases', 'Signal Transduction', 'Spinocerebellar Ataxias/*classification/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17149711/
305,PRKCG,35091391,Early-onset Parkinson's disease with atypical molecular imaging abnormalities in a patient carrying the de novo PRKCG mutation.,"['Chen Y', 'Liu P', 'Cen Z', 'Liao Y', 'Lin Z', 'Luo W']","['Humans', 'Molecular Imaging', 'Mutation', '*Parkinson Disease/diagnostic imaging/genetics', '*Protein Kinase C/genetics', '*Spinocerebellar Ataxias/genetics']",https://pubmed.ncbi.nlm.nih.gov/35091391/
306,PRKCG,36803152,AZU1 (HBP/CAP37) and PRKCG (PKC-gamma) may be candidate genes affecting the severity of acute mountain sickness.,"['Xu Z', 'Li Q', 'Shen X']","['Humans', 'Acute Disease', 'Altitude', '*Altitude Sickness/genetics/complications/diagnosis', '*Protein Kinase C/genetics', '*Blood Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/36803152/
307,PRKCG,36274974,lncRNA IL-17RA-1 Attenuates LPS-Induced Sepsis via miR-7847-3p/PRKCG-Mediated MAPK Signaling Pathway.,"['Gan Y', 'Long J', 'Zeng Y', 'Zhang Y', 'Tao Y']","['Humans', 'Interleukin-6', 'Lipopolysaccharides/metabolism', 'Luciferases/metabolism', '*MicroRNAs/metabolism', '*RNA, Long Noncoding/metabolism', 'RNA, Messenger/genetics', '*Sepsis/metabolism', 'Signal Transduction', 'Sincalide', 'Tumor Necrosis Factor-alpha', '*Protein Kinase C', '*Receptors, Interleukin-17/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36274974/
308,PRKCG,25252845,Single-nucleotide polymorphisms of the PRKCG gene and osteosarcoma susceptibility.,"['Zhang Y', 'Hu X', 'Wang HK', 'Shen WW', 'Liao TQ', 'Chen P', 'Chu TW']","['Adolescent', 'Adult', 'Alleles', 'Case-Control Studies', 'Child', 'Female', 'Gene Frequency', '*Genetic Predisposition to Disease', 'Genotype', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Odds Ratio', 'Osteosarcoma/diagnosis/*genetics', '*Polymorphism, Single Nucleotide', 'Protein Kinase C/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25252845/
309,PRKCG,35760954,Comparison of two families with and without ataxia harboring novel variants in PRKCG.,"['Tada Y', 'Kume K', 'Noguchi S', 'Sekiya T', 'Nishinaka K', 'Ishiguchi H', 'Koh J', 'Emori S', 'Nakayama Y', 'Kurashige T', 'Izumi Y', 'Ito H', 'Sakai N', 'Kawakami H']","['Atrophy', '*Cerebellar Ataxia', 'HeLa Cells', 'Humans', 'Protein Kinase C', 'Spinocerebellar Ataxias']",https://pubmed.ncbi.nlm.nih.gov/35760954/
310,PRKCG,17508994,The human protein kinase C gamma gene (PRKCG) as a susceptibility locus for behavioral disinhibition.,"['Schlaepfer IR', 'Clegg HV', 'Corley RP', 'Crowley TJ', 'Hewitt JK', 'Hopfer CJ', 'Krauter K', 'Lessem J', 'Rhee SH', 'Stallings MC', 'Wehner JM', 'Young SE', 'Ehringer MA']","['Adolescent', 'Adult', 'Antisocial Personality Disorder/ethnology/genetics', 'Attention Deficit Disorder with Hyperactivity/ethnology/genetics', 'Black People/genetics', 'Chromosome Mapping', 'Conduct Disorder/ethnology/*genetics', 'Exploratory Behavior', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease/*genetics', 'Haplotypes', 'Hispanic or Latino/genetics', 'Humans', 'Impulsive Behavior/ethnology/*genetics', '*Inhibition, Psychological', 'Linkage Disequilibrium', 'Male', 'Phenotype', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Kinase C/*genetics', 'Substance-Related Disorders/ethnology/genetics', 'White People/genetics', 'Black or African American']",https://pubmed.ncbi.nlm.nih.gov/17508994/
311,PRKCG,17343273,PRKCG mutation (SCA-14) causing a Ramsay Hunt phenotype.,"['Visser JE', 'Bloem BR', 'van de Warrenburg BP']","['DNA Mutational Analysis', 'Herpes Zoster Oticus/*genetics/pathology', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', '*Mutation', 'Phenotype', 'Protein Kinase C/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17343273/
312,PRKCG,16763984,Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4.,"['Hiramoto K', 'Kawakami H', 'Inoue K', 'Seki T', 'Maruyama H', 'Morino H', 'Matsumoto M', 'Kurisu K', 'Sakai N']","['Adult', 'Aged', 'Amino Acid Substitution/genetics', 'Brain/pathology', '*DNA Mutational Analysis', 'Exons', 'Female', 'Genetic Testing', 'Humans', 'Introns', 'Japan', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Mutation, Missense', 'Pedigree', 'Phenylalanine/genetics', 'Point Mutation', 'Polymerase Chain Reaction', 'Polymorphism, Genetic/genetics', 'Protein Kinase C/*genetics', 'Serine/genetics', 'Spinocerebellar Ataxias/diagnosis/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16763984/
313,PRKCG,25663494,Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study.,"['Lu H', 'Zhu L', 'Lian L', 'Chen M', 'Shi D', 'Wang K']","['Adolescent', 'Asian People', 'Bone Neoplasms/*genetics/pathology', 'Case-Control Studies', 'Child', 'Child, Preschool', 'China', 'Female', 'Gene Frequency', '*Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Neoplasm Staging', 'Osteosarcoma/*genetics/pathology', 'Polymorphism, Single Nucleotide', 'Protein Kinase C/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/25663494/
314,PRKCG,21434874,"SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene.","['Koht J', 'Stevanin G', 'Durr A', 'Mundwiller E', 'Brice A', 'Tallaksen CM']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Cerebellar Ataxia/*genetics', 'DNA Mutational Analysis', 'Female', 'Humans', 'Male', 'Middle Aged', 'Mutation, Missense/*genetics', 'Norway', 'Protein Kinase C/*genetics', 'Spinocerebellar Ataxias', 'Spinocerebellar Degenerations/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21434874/
315,PRKCH,17206144,A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction.,"['Kubo M', 'Hata J', 'Ninomiya T', 'Matsuda K', 'Yonemoto K', 'Nakano T', 'Matsushita T', 'Yamazaki K', 'Ohnishi Y', 'Saito S', 'Kitazono T', 'Ibayashi S', 'Sueishi K', 'Iida M', 'Nakamura Y', 'Kiyohara Y']","['Case-Control Studies', 'Cerebral Infarction/*genetics', 'Coronary Artery Disease/genetics', 'Follow-Up Studies', 'Humans', '*Polymorphism, Single Nucleotide', 'Protein Kinase C/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17206144/
316,PRKCH,32985204,MicroRNA-185 reduces the expression of hepatitis B virus surface antigen by targeting PRKCH in HepG2 2.2.15 cells.,"['Zhang R', 'Liu Z', 'Hou X', 'Wang M', 'Xiong Y', 'Lu H', 'Wang Y', 'Su J', 'Liu Y', 'Zhang G', 'Liu Y']","['Gene Expression Regulation, Viral', 'Hep G2 Cells', 'Hepatitis B/*genetics/therapy', 'Hepatitis B Surface Antigens/*genetics', 'Hepatitis B virus/physiology', 'Humans', 'MicroRNAs/*genetics', 'Protein Kinase C/*genetics', 'Virus Replication']",https://pubmed.ncbi.nlm.nih.gov/32985204/
317,PRKCH,36377982,"Mechanisms of PALLD, PRKCH, AKAP12, PDK4, and CHIT1 Proteins in Serum Diagnosis of Neonatal Sepsis.","['Zhang Y', 'Li J', 'Qi H', 'Kong X']","['Infant, Newborn', 'Humans', '*Neonatal Sepsis', 'Prognosis', 'Biomarkers', 'Cell Cycle Proteins', 'A Kinase Anchor Proteins']",https://pubmed.ncbi.nlm.nih.gov/36377982/
318,PRKCH,17957454,Association and expression study of PRKCH gene in a French Caucasian population with rheumatoid arthritis.,"['Teixeira VH', 'Jacq L', 'Moore J', 'Lasbleiz S', 'Hilliquin P', 'Resende Oliveira C', 'Cornelis F', 'Petit-Teixeira E']","['Adult', 'Aged', 'Arthritis, Rheumatoid/enzymology/ethnology/*genetics', 'Female', 'France', 'Gene Expression Regulation, Enzymologic', 'Gene Frequency', 'Genetic Linkage', 'Genotype', 'Haplotypes', 'Heterozygote', 'Homozygote', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Protein Kinase C/blood/*genetics', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17957454/
319,PRKCH,35352613,Knockdown of circ-PRKCH alleviates IL-1beta-treated chondrocyte cell phenotypic changes through modulating miR-502-5p/ADAMTS5 axis.,"['Liu Z', 'Cao J', 'Zhang L', 'Li J', 'Yan T', 'Zhou P', 'Zhang S']","['ADAMTS5 Protein/genetics/metabolism', 'Apoptosis/genetics', 'Chondrocytes/metabolism', 'Humans', 'Interleukin-1beta/pharmacology', '*MicroRNAs/genetics/metabolism', '*Osteoarthritis/genetics/metabolism', 'RNA, Circular/genetics']",https://pubmed.ncbi.nlm.nih.gov/35352613/
320,PRKCH,36434855,Overexpression of PRKCH promotes tumorigenesis in patients with glioma and influences glioma stem cell properties.,"['Pang F', 'He W', 'Liu X', 'Zou Z', 'Wu W', 'Wang Y', 'Yang P', 'Wen B', 'Jiang J', 'Teng Y', 'Yang X', 'Chen L', 'Jia Q', 'Li M', 'Xu J']","['Humans', '*Cell Transformation, Neoplastic', 'Carcinogenesis', '*Glioma', 'Cell Differentiation', 'Neoplastic Stem Cells']",https://pubmed.ncbi.nlm.nih.gov/36434855/
321,PRKCH,28640647,Influence of PRKCH gene polymorphism on antihypertensive response to amlodipine and telmisartan.,"['Zhang ZL', 'Zhu MM', 'Li HL', 'Shi LH', 'Chen XP', 'Luo J', 'Zhao JF']","['Adult', 'Aged', 'Amlodipine/*therapeutic use', 'Antihypertensive Agents/*therapeutic use', 'Arterial Pressure/drug effects/genetics', 'Asian People', 'Benzimidazoles/*therapeutic use', 'Benzoates/*therapeutic use', 'Essential Hypertension/*drug therapy/*genetics', 'Female', 'Heart Rate/drug effects/genetics', 'Heterozygote', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Protein Kinase C/*genetics', 'Telmisartan']",https://pubmed.ncbi.nlm.nih.gov/28640647/
322,PRKCH,33880996,Silencing of circ-PRKCH protects against lipopolysaccharide (LPS)-evoked chondrocyte damage and extracellular matrix loss by the miR-140-3p/ADAM10 axis.,"['Zhao J', 'Li T', 'Luo W']","['Cell Proliferation', '*Chondrocytes', 'Extracellular Matrix', 'Lipopolysaccharides', '*MicroRNAs/genetics']",https://pubmed.ncbi.nlm.nih.gov/33880996/
323,PRKCH,20602195,PRKCH gene polymorphism is associated with the risk of severe gastric atrophy.,"['Goto Y', 'Hishida A', 'Matsuo K', 'Tajima K', 'Morita E', 'Naito M', 'Wakai K', 'Hamajima N']","['Adult', 'Aged', 'Aged, 80 and over', 'Case-Control Studies', 'Female', 'Gastritis, Atrophic/*genetics/microbiology', 'Genetic Predisposition to Disease', 'Genotype', 'Helicobacter Infections/complications', 'Helicobacter pylori/isolation & purification', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Protein Kinase C/*genetics', 'Risk Factors', 'Severity of Illness Index', 'Stomach Neoplasms/*genetics/microbiology/pathology']",https://pubmed.ncbi.nlm.nih.gov/20602195/
324,PRKCH,22808203,The SNP (rs2230500) in PRKCH decreases the risk of carotid intima-media thickness in a Chinese young adult population.,"['Wu L', 'Xi B', 'Hou D', 'Zhao X', 'Liu J', 'Cheng H', 'Zhou X', 'Shen Y', 'Wang X', 'Mi J']","['Adult', 'Asian People/*genetics', 'Atherosclerosis/complications/diagnosis/genetics/physiopathology', 'Blood Pressure/genetics', 'Body Mass Index', 'C-Reactive Protein/metabolism', '*Carotid Intima-Media Thickness', 'China', 'Complement C3/genetics', 'Female', '*Genetic Predisposition to Disease', 'Humans', 'Hypertension/complications/genetics/physiopathology', 'Lipids/blood', 'Male', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Kinase C/*genetics', 'Risk Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22808203/
325,PRKCH,22044875,Association between 1425G/A SNP in PRKCH and ischemic stroke among Chinese and Japanese populations: a meta-analysis including 3686 cases and 4589 controls.,"['Li J', 'Luo M', 'Xu X', 'Sheng W']","['Asian People/genetics', 'Case-Control Studies', 'Female', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans', 'Ischemia/complications/genetics', 'Isoenzymes/*genetics', 'Male', 'Odds Ratio', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Kinase C/*genetics', 'Publication Bias', 'Stroke/etiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22044875/
326,PRKCH,21625852,The role of PRKCH gene variants in coronary artery disease in a Chinese population.,"['Zhu J', 'Yan JJ', 'Kuai ZP', 'Gao W', 'Tang JJ', 'Jia EZ', 'Yang ZJ', 'Wang LS']","['Aged', 'Asian People/*genetics', 'China/epidemiology', 'Coronary Artery Disease/*epidemiology/*genetics', 'DNA Primers/genetics', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Polymerase Chain Reaction', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Kinase C/*genetics', 'Risk Factors', 'Sequence Analysis, DNA', 'Statistics, Nonparametric']",https://pubmed.ncbi.nlm.nih.gov/21625852/
327,PRKCH,31875586,PRKCH polymorphism is associated with rheumatoid arthritis in a Chinese population.,"['Zhuang Y', 'Di Y', 'Huang L', 'Zhu J']","['Adult', 'Aged', 'Alleles', 'Arthritis, Rheumatoid/*genetics', 'Asian People/genetics', 'Case-Control Studies', 'Female', 'Gene Frequency/genetics', 'Genetic Predisposition to Disease/genetics', 'Genome-Wide Association Study/*methods', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Kinase C/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31875586/
328,PRKCH,25272991,A quantitative assessment of the association between 1425G/A polymorphism in PRKCH and risk of stroke.,"['Sun L', 'Zhang Z', 'Ma M', 'Xu G', 'Liu X']","['Adult', 'Aged', 'Brain Ischemia/epidemiology/genetics', 'Case-Control Studies', 'Cerebral Hemorrhage/epidemiology/genetics', 'Cerebral Infarction/epidemiology/genetics', 'China/epidemiology', 'Female', 'Gene Frequency', 'Genotype', 'Humans', 'Japan/epidemiology', 'Male', 'Middle Aged', 'Neuroimaging', '*Polymorphism, Single Nucleotide', 'Protein Kinase C/*genetics', 'Risk', 'Stroke/epidemiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25272991/
329,PRKCH,32337697,Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph(+) Leukemia Cells.,"['Xu WF', 'Wang ZJ', 'Li K', 'Shen YQ', 'Lu K', 'Lv XY', 'Wen YX', 'Jin RM']","['Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Cell Survival/drug effects', 'Dose-Response Relationship, Drug', '*Down-Regulation', 'Drug Synergism', 'Drugs, Chinese Herbal/*pharmacology', 'Gene Expression Regulation, Neoplastic/drug effects', 'Humans', 'K562 Cells', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics/*metabolism', 'MAP Kinase Signaling System/drug effects', 'Protein Kinase C/genetics/*metabolism', 'Pyridones/*pharmacology', 'Pyrimidinones/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/32337697/
330,PRKCH,27351203,miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway.,"['Zhang MX', 'Zhang J', 'Zhang H', 'Tang H']","[""3' Untranslated Regions"", 'Carcinoma, Adenoid Cystic/genetics/*metabolism/pathology', 'Cell Line, Tumor', 'Cyclin-Dependent Kinase Inhibitor p21/genetics/metabolism', 'Eye Neoplasms/genetics/*metabolism/pathology', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Lacrimal Apparatus Diseases/genetics/*metabolism/pathology', 'MicroRNAs/*genetics', 'Protein Kinase C/*genetics/metabolism', 'Tumor Suppressor Protein p53/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/27351203/
331,PRKCH,24534126,Impact of the 1425G/A polymorphism of PRKCH on the recurrence of ischemic stroke: Fukuoka Stroke Registry.,"['Matsuo R', 'Ago T', 'Hata J', 'Kuroda J', 'Wakisaka Y', 'Sugimori H', 'Kitazono T', 'Kamouchi M']","['Aged', 'Aged, 80 and over', 'Alleles', 'Brain Ischemia/*genetics', 'Female', 'Follow-Up Studies', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Protein Kinase C/*genetics', 'Recurrence', 'Registries', 'Risk Factors', 'Stroke/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24534126/
332,PRKCD,37794137,Phenotypic Variability in PRKCD: a Review of the Literature.,"['Jefferson L', 'Ramanan AV', 'Jolles S', 'Bernatoniene J', 'Mathieu AL', 'Belot A', 'Roderick MR']","['Child', 'Humans', 'Protein Kinase C-delta/genetics', '*Lupus Erythematosus, Systemic/diagnosis/genetics', '*Autoimmune Lymphoproliferative Syndrome/genetics', 'Immune Tolerance', 'Biological Variation, Population']",https://pubmed.ncbi.nlm.nih.gov/37794137/
333,PRKCD,36279664,PRKCD as a potential therapeutic target for chronic obstructive pulmonary disease.,"['Li S', 'Huang Q', 'Zhou D', 'He B']","['Humans', '*Protein Kinase C-delta', '*Pulmonary Disease, Chronic Obstructive/pathology', 'Lung/pathology', 'Apoptosis']",https://pubmed.ncbi.nlm.nih.gov/36279664/
334,PRKCD,35001811,GAK and PRKCD kinases regulate basal mitophagy.,"['Munson MJ', 'Mathai BJ', 'Ng MYW', 'Trachsel-Moncho L', 'de la Ballina LR', 'Simonsen A']","['Autophagy/physiology', 'Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology', '*Mitophagy/genetics', '*Protein Kinase C-delta', 'Protein Kinases/metabolism', 'Ubiquitin-Protein Ligases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35001811/
335,PRKCD,37864033,TRIM69 suppressed the anoikis resistance and metastasis of gastric cancer through ubiquitin‒proteasome-mediated degradation of PRKCD.,"['Sun L', 'Chen Y', 'Xia L', 'Wang J', 'Zhu J', 'Li J', 'Wang K', 'Shen K', 'Zhang D', 'Zhang G', 'Shi T', 'Chen W']","['Humans', '*Anoikis', 'Brain-Derived Neurotrophic Factor', 'Cell Line, Tumor', 'Neoplasm Metastasis', 'Proteasome Endopeptidase Complex/genetics', 'Protein Kinase C-delta', '*Stomach Neoplasms/genetics/pathology', '*Tripartite Motif Proteins/genetics/metabolism', 'Ubiquitin', 'Ubiquitin-Protein Ligases/genetics']",https://pubmed.ncbi.nlm.nih.gov/37864033/
336,PRKCD,38747331,Metastasizing aneurysmal dermatofibroma initially diagnosed as angiosarcoma confirmed by CD63::PRKCD fusion gene detection with nanopore sequencing.,"['Takeda N', 'Makise N', 'Lin J', 'Kageyama H', 'Oikawa M', 'Sugiyama T', 'Kawana H', 'Araki A', 'Tuskanishi T', 'Kinoshita H', 'Hagiwara Y', 'Kamoda H', 'Motoi T', 'Yonemoto T', 'Kawazu M', 'Itami M']","['Adult', 'Female', 'Humans', '*Hemangiosarcoma/genetics/diagnosis/pathology', '*Histiocytoma, Benign Fibrous/genetics/diagnosis/pathology', '*Nanopore Sequencing/methods', '*Oncogene Proteins, Fusion/analysis/genetics', 'Skin Neoplasms/genetics/pathology/diagnosis', 'Tetraspanin 30/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38747331/
337,PRKCD,36782298,Genetic association of PRKCD and CARD9 polymorphisms with Vogt-Koyanagi-Harada disease in the Chinese Han population.,"['Zhou C', 'Cai S', 'Xie Y', 'Zeng Z', 'Zhang J', 'Su G', 'Wu Q', 'Ye X', 'Cao Q', 'Yang P', 'Hu J']","['Humans', '*Protein Kinase C-delta/genetics/metabolism', 'Gene Frequency', '*Uveomeningoencephalitic Syndrome/genetics/metabolism', 'Case-Control Studies', 'East Asian People', 'Genetic Predisposition to Disease', 'Polymorphism, Single Nucleotide/genetics', 'Cytokines/genetics/metabolism', 'RNA, Messenger', 'CARD Signaling Adaptor Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36782298/
338,PRKCD,34187243,Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD.,"['Gu H', 'Chen Z', 'Ma J', 'Wang J', 'Zhang R', 'Wu R', 'Wang T']","['Autoimmune Lymphoproliferative Syndrome/*drug therapy/genetics', 'Child', 'Genetic Variation', 'Homozygote', 'Humans', 'Immunosuppressive Agents/*therapeutic use', 'Male', 'Pedigree', 'Protein Kinase C-delta/*genetics', 'Sirolimus/*therapeutic use', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/34187243/
339,PRKCE,27312950,PRKCE gene encoding protein kinase C-epsilon-Dual roles at sarcomeres and mitochondria in cardiomyocytes.,"['Scruggs SB', 'Wang D', 'Ping P']","['Arachidonic Acid/pharmacology', 'Cardiomegaly/drug therapy/*enzymology/genetics/pathology', 'Cardiotonic Agents/pharmacology', 'Enzyme Activation', 'Gene Expression', 'Humans', 'Isoproterenol/pharmacology', 'Mitochondria, Heart/drug effects/*enzymology', 'Muscle Proteins/genetics/metabolism', 'Myocardial Contraction/drug effects', 'Myocardium/*enzymology/pathology', 'Myocytes, Cardiac/drug effects/*enzymology/pathology', 'Phenylephrine/pharmacology', 'Protein Kinase C-epsilon/*genetics/metabolism', 'Sarcomeres/drug effects/*enzymology', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/27312950/
340,PRKCE,36299231,PRKCE non-coding variants influence on transcription as well as translation of its gene.,"['Khan K', 'Zafar S', 'Hafeez A', 'Badshah Y', 'Shahid K', 'Mahmood Ashraf N', 'Shabbir M']","[""5' Untranslated Regions"", ""3' Untranslated Regions"", '*Protein Biosynthesis', 'Genetic Markers', 'RNA, Messenger/metabolism', '*MicroRNAs/genetics/metabolism', 'Transcription Factors/metabolism', 'Protein Serine-Threonine Kinases', 'Serine/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36299231/
341,PRKCE,35137073,Influence of PRKCE non-synonymous variants on protein dynamics and functionality.,"['Khan K', 'Shah H', 'Rehman A', 'Badshah Y', 'Ashraf NM', 'Shabbir M']","['Mutation', 'Phenotype', 'Phosphorylation', '*Protein Kinase C-epsilon/genetics/metabolism', '*Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/35137073/
342,PRKCE,25950488,"IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity.","['Kumar S', 'Ingle H', 'Mishra S', 'Mahla RS', 'Kumar A', 'Kawai T', 'Akira S', 'Takaoka A', 'Raut AA', 'Kumar H']","['Adaptor Proteins, Signal Transducing/*genetics', 'Apoptosis/immunology', 'Baculoviral IAP Repeat-Containing 3 Protein', 'Cancer Vaccines/immunology', 'Cell Line, Tumor', 'Down-Regulation', 'HEK293 Cells', 'Humans', 'Inhibitor of Apoptosis Proteins/biosynthesis/genetics', 'Interferon Regulatory Factor-3/genetics', 'Interferon Regulatory Factor-7/genetics', 'Interferon Type I/*immunology', 'Neoplasm Invasiveness/pathology', 'Neoplasms/*immunology', 'Newcastle disease virus/*immunology', 'Poly I-C/immunology', 'Protein Kinase C-epsilon/biosynthesis/genetics', 'Proto-Oncogene Proteins c-bcl-2/biosynthesis/genetics', 'RNA Interference', 'RNA, Small Interfering', 'Signal Transduction/immunology', 'TNF-Related Apoptosis-Inducing Ligand/*biosynthesis/genetics', 'Ubiquitin-Protein Ligases/biosynthesis/genetics', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/25950488/
343,PRKCE,34108094,Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters.,"['Pan X', 'Wu Y', 'Peng H', 'Cai X', 'Hu Z', 'Lin X', 'Peng XE']","['Alanine Transaminase/metabolism', 'Biomarkers', 'Carrier Proteins/*metabolism', 'CpG Islands/genetics', 'DNA Methylation', 'Humans', '*Non-alcoholic Fatty Liver Disease', 'Protein Kinase C-epsilon/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34108094/
344,PRKCE,28492560,miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.,"['Wang H', 'Zhan M', 'Xu SW', 'Chen W', 'Long MM', 'Shi YH', 'Liu Q', 'Mohan M', 'Wang J']","['ATP Binding Cassette Transporter, Subfamily B/biosynthesis/genetics', 'Deoxycytidine/*analogs & derivatives/pharmacology', 'Female', '*Gallbladder Neoplasms/drug therapy/genetics/metabolism/pathology', 'Gene Expression Regulation, Neoplastic/*drug effects', 'Humans', 'Male', '*MicroRNAs/genetics/metabolism', '*Neoplasm Proteins/biosynthesis/genetics', '*Protein Kinase C-epsilon/biosynthesis/genetics', '*RNA, Neoplasm/genetics/metabolism', 'Up-Regulation/*drug effects', 'Gemcitabine']",https://pubmed.ncbi.nlm.nih.gov/28492560/
345,PRKCE,35985686,A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality.,"['Panagopoulos I', 'Andersen K', 'Gorunova L', 'Davidson B', 'Micci F', 'Heim S']","['Chromosome Aberrations', 'Comparative Genomic Hybridization', 'Female', 'Humans', 'In Situ Hybridization, Fluorescence', 'Intracellular Signaling Peptides and Proteins', '*Leiomyoma/genetics', 'Middle Aged', '*Protein Kinase C-epsilon', 'Transcriptional Coactivator with PDZ-Binding Motif Proteins', 'Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/35985686/
346,PRKCE,28934384,SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase Cvarepsilon) impairing TORC2-dependent AKT activation.,"['Alcantara D', 'Elmslie F', 'Tetreault M', 'Bareke E', 'Hartley T', 'Majewski J', 'Boycott K', 'Innes AM', 'Dyment DA', ""O'Driscoll M""]","['Adaptor Proteins, Signal Transducing/genetics', 'Adolescent', 'Dwarfism/genetics', 'Female', 'Growth Disorders/*genetics/metabolism', 'HEK293 Cells', 'Humans', 'Hypercalcemia/*genetics/metabolism', 'Mechanistic Target of Rapamycin Complex 2/*metabolism', 'Metabolic Diseases/*genetics/metabolism', 'Mutation', 'Nephrocalcinosis/*genetics/metabolism', 'Phosphatidylinositol 3-Kinases/genetics', 'Phosphorylation', 'Protein Kinase C-epsilon/*genetics/metabolism', 'Proto-Oncogene Proteins c-akt/genetics/*metabolism', 'Signal Transduction', 'Sirolimus/pharmacology', 'TOR Serine-Threonine Kinases/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/28934384/
347,PRKCQ,27494091,CD3D and PRKCQ work together to discriminate between B-cell and T-cell acute lymphoblastic leukemia.,"['Ma D', 'Zhong S', 'Liu X', 'Mai H', 'Mai G', 'Xu C', 'Zhou F']","['Biomarkers, Tumor/*genetics', 'CD3 Complex/*genetics', 'Diagnosis, Differential', 'Gene Expression Profiling', 'Humans', '*Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics', '*Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics', 'Protein Kinase C-theta/*genetics', 'Real-Time Polymerase Chain Reaction', 'Transcriptome/genetics']",https://pubmed.ncbi.nlm.nih.gov/27494091/
348,PRKCQ,38679027,DNA methyltransferases-associated long non-coding RNA PRKCQ-AS1 regulate DNA methylation in myelodysplastic syndrome.,"['Wen J', 'Wu Y', 'Luo Q']","['Humans', '*Myelodysplastic Syndromes/genetics', '*DNA Methylation', '*RNA, Long Noncoding/genetics', 'Male', 'Female', 'Computational Biology/methods', 'Proto-Oncogene Proteins/genetics', 'DNA Modification Methylases/genetics/metabolism', 'Mixed Function Oxygenases']",https://pubmed.ncbi.nlm.nih.gov/38679027/
349,PRKCQ,38092752,Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma.,"['Zhang X', 'Zhong Y', 'Liu L', 'Jia C', 'Cai H', 'Yang J', 'Wu B', 'Lv Z']","['Humans', 'Thyroid Cancer, Papillary/metabolism', '*Thyroid Neoplasms/metabolism', '*RNA, Long Noncoding/genetics/metabolism', 'Protein Kinase C-theta/metabolism', 'Neoplasm Recurrence, Local/genetics', 'Fasting', 'Cell Proliferation/genetics', 'Gene Expression Regulation, Neoplastic', 'Cell Line, Tumor', '*MicroRNAs/genetics', 'Cell Movement/genetics', 'Protein-Arginine N-Methyltransferases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38092752/
350,PRKCQ,36732923,LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy.,"['Zheng S', 'Fu W', 'Huang Q', 'Zhou J', 'Lu K', 'Gu J', 'Ma R', 'Guo G']","['Humans', '*MicroRNAs/genetics', '*RNA, Long Noncoding/genetics', '*Triple Negative Breast Neoplasms/genetics', 'Protein Kinase C-theta/genetics/metabolism', 'Paclitaxel/pharmacology', 'Cell Proliferation', 'Cell Line, Tumor', 'Autophagy', 'RNA, Messenger', 'Gene Expression Regulation, Neoplastic']",https://pubmed.ncbi.nlm.nih.gov/36732923/
351,PRKCQ,31908401,PRKCQ rs4750316 is associated with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.,"['Xu L', 'Zhao T', 'Yuan G', 'Hou S', 'Zeng W', 'Chen F']","['Adult', 'Asian People/*genetics', 'Case-Control Studies', 'Ethnicity/*genetics', 'Female', 'Gene Frequency/genetics', '*Genetic Predisposition to Disease', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Kinase C-theta/*genetics', 'Uveomeningoencephalitic Syndrome/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31908401/
352,PRKCQ,35447530,Crocin attenuates NF-kappaB-mediated inflammation and proliferation in breast cancer cells by down-regulating PRKCQ.,"['Xu Q', 'Yu J', 'Jia G', 'Li Z', 'Xiong H']","['*Breast Neoplasms/drug therapy', '*Carotenoids/pharmacology', 'Cell Proliferation', 'Female', 'Humans', 'Inflammation/metabolism', '*NF-kappa B/metabolism', '*Protein Kinase C-theta/metabolism', 'Tumor Necrosis Factor-alpha/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/35447530/
353,PRKCQ,32600444,PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim.,"['Byerly JH', 'Port ER', 'Irie HY']","['Antibiotics, Antineoplastic/pharmacology', 'Antineoplastic Agents, Phytogenic/pharmacology', 'Apoptosis/drug effects', 'Bcl-2-Like Protein 11/genetics/*metabolism', 'Biomarkers, Tumor/metabolism', 'Cell Line, Tumor', 'Doxorubicin/*pharmacology', 'Female', 'Humans', 'Neoplasm Invasiveness', 'Paclitaxel/*pharmacology', 'Protein Kinase C-theta/*antagonists & inhibitors/genetics/metabolism', 'Triple Negative Breast Neoplasms/*drug therapy/metabolism/pathology', 'Tumor Cells, Cultured', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/32600444/
354,PRKCQ,37358216,MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer.,"['Jia Q', 'Liao X', 'Xu B', 'Li Y', 'Liang L']","['Humans', '*MicroRNAs/genetics/metabolism', 'Protein Kinase C-theta', 'Cell Line, Tumor', '*Colorectal Neoplasms/pathology', 'Cell Proliferation/genetics', 'Apoptosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/37358216/
355,PRKCQ,30828974,Missense mutation in PRKCQ is associated with Crohn's disease.,"['Zhang YW', 'Xu XY', 'Zhang J', 'Yao X', 'Lu C', 'Chen CX', 'Yu CH', 'Sun J']","['Adult', 'Case-Control Studies', 'Crohn Disease/*genetics', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', '*Mutation, Missense', 'Phenotype', 'Polymorphism, Restriction Fragment Length', 'Protein Kinase C-theta/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30828974/
356,PRKCQ,26784953,Genetic Variation in the REL Gene Increases Risk of Behcet's Disease in a Chinese Han Population but That of PRKCQ Does Not.,"['Chen F', 'Xu L', 'Zhao T', 'Xiao X', 'Pan Y', 'Hou S']","['Adult', 'Behcet Syndrome/epidemiology/*genetics', 'Case-Control Studies', 'China/epidemiology', 'Female', '*Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Isoenzymes/*genetics', 'Male', 'Polymerase Chain Reaction', 'Polymorphism, Restriction Fragment Length', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Kinase C/*genetics', 'Protein Kinase C-theta', 'Proto-Oncogene Proteins c-rel/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26784953/
357,PRKCQ,21252065,Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.,"['Jalagadugula G', 'Mao G', 'Kaur G', 'Dhanasekaran DN', 'Rao AK']","['Binding Sites', 'Blood Platelets/*enzymology', 'Cell Line, Tumor', 'Chromatin Immunoprecipitation', 'Consensus Sequence', 'Core Binding Factor Alpha 2 Subunit/blood/*genetics', 'Electrophoretic Mobility Shift Assay', '*Gene Expression Regulation, Enzymologic', 'Genes, Reporter', 'Humans', 'Isoenzymes/blood/deficiency/*genetics', 'Male', 'Megakaryocytes/*enzymology', '*Mutation', 'Promoter Regions, Genetic', 'Protein Kinase C/blood/deficiency/*genetics', 'Protein Kinase C-theta', 'RNA Interference', 'Recombinant Proteins/metabolism', 'Thrombocytopenia/blood/enzymology/*genetics', '*Transcription, Genetic', 'Transfection', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21252065/
358,NANP,16125188,Study on the NaNp/Al2O3-SiO2 system.,"['Maksimowski P', 'Skupinski W']","['Aluminum Oxide/*chemistry', 'Electron Spin Resonance Spectroscopy', 'Gels/chemistry', 'Naphthalenes/*chemistry', 'Sensitivity and Specificity', 'Silicon Dioxide/*chemistry', 'Surface Properties']",https://pubmed.ncbi.nlm.nih.gov/16125188/
359,NANP,17586073,Effect of exercise training on chromogranin A and relationship to N-ANP and inflammatory cytokines in patients with chronic heart failure.,"['Larsen AI', 'Helle KB', 'Christensen M', 'Kvaloy JT', 'Aarsland T', 'Dickstein K']","['Aged', 'Atrial Natriuretic Factor/*blood', 'Chromogranin A/*blood', 'Chronic Disease', 'Cytokines/*blood', '*Exercise Therapy', 'Heart Failure/*blood/physiopathology/*therapy', 'Humans', 'Male', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/17586073/
360,NANP,2440327,Detection of antibodies in human sera to the repeating epitope of the circumsporozoite protein of Plasmodium falciparum using the synthetic peptide (NANP)3 in an enzyme-linked immunosorbent assay (ELISA).,"['Campbell GH', 'Brandling-Bennett AD', 'Roberts JM', 'Collins FH', 'Kaseje DC', 'Barber AM', 'Turner A']","['Adolescent', 'Adult', 'Antibodies, Protozoan/*analysis', 'Antigens, Protozoan/*immunology', 'Child', 'Child, Preschool', '*Enzyme-Linked Immunosorbent Assay', 'Epitopes/immunology', 'Humans', 'Malaria/epidemiology', 'Middle Aged', 'Oligopeptides/*immunology', 'Plasmodium falciparum/*immunology']",https://pubmed.ncbi.nlm.nih.gov/2440327/
361,GUCA1A,24024198,"Novel GUCA1A mutations suggesting possible mechanisms of pathogenesis in cone, cone-rod, and macular dystrophy patients.","['Kamenarova K', 'Corton M', 'Garcia-Sandoval B', 'Fernandez-San Jose P', 'Panchev V', 'Avila-Fernandez A', 'Lopez-Molina MI', 'Chakarova C', 'Ayuso C', 'Bhattacharya SS']","['Female', '*Genetic Linkage', 'Genome, Human', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', 'Macular Degeneration/*genetics/pathology', 'Male', 'Mutation, Missense', 'Pedigree', 'Polymorphism, Single Nucleotide', 'Retinal Cone Photoreceptor Cells/pathology', 'Retinal Degeneration/*genetics/physiopathology', 'Retinal Rod Photoreceptor Cells/pathology', 'Retinitis Pigmentosa/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/24024198/
362,GUCA1A,9425234,A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1.,"['Payne AM', 'Downes SM', 'Bessant DA', 'Taylor R', 'Holder GE', 'Warren MJ', 'Bird AC', 'Bhattacharya SS']","['Amino Acid Sequence', 'Calcium-Binding Proteins/chemistry/*genetics', 'Chromosomes, Human, Pair 6/*genetics', 'DNA Mutational Analysis', '*Eye Proteins', 'Female', 'Genes', '*Genes, Dominant', 'Guanylate Cyclase-Activating Proteins', 'Hippocalcin', 'Humans', '*Lipoproteins', 'Lod Score', 'Male', 'Models, Molecular', 'Molecular Sequence Data', '*Nerve Tissue Proteins', 'Pedigree', '*Point Mutation', 'Polymerase Chain Reaction', 'Protein Conformation', 'Recoverin', 'Retinal Cone Photoreceptor Cells/*pathology', 'Retinal Degeneration/enzymology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/9425234/
363,GUCA1A,24875811,GUCY2D- or GUCA1A-related autosomal dominant cone-rod dystrophy: is there a phenotypic difference?,"['Zobor D', 'Zrenner E', 'Wissinger B', 'Kohl S', 'Jagle H']","['Adult', 'Aged', 'DNA Mutational Analysis', 'Dark Adaptation/physiology', 'Electroretinography', 'Female', 'Fluorescein Angiography', 'Genes, Dominant', 'Genetic Association Studies', 'Guanylate Cyclase/*genetics', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', 'Male', 'Middle Aged', 'Mutation', '*Polymorphism, Single Nucleotide', 'Receptors, Cell Surface/*genetics', 'Retinal Cone Photoreceptor Cells/physiology', 'Retinal Rod Photoreceptor Cells/physiology', 'Retinitis Pigmentosa/*genetics/physiopathology', 'Tomography, Optical Coherence', 'Visual Acuity/physiology']",https://pubmed.ncbi.nlm.nih.gov/24875811/
364,GUCA1A,28442884,Cone dystrophy or macular dystrophy associated with novel autosomal dominant GUCA1A mutations.,"['Manes G', 'Mamouni S', 'Herald E', 'Richard AC', 'Senechal A', 'Aouad K', 'Bocquet B', 'Meunier I', 'Hamel CP']","['Adult', 'Child', 'Cone-Rod Dystrophies/diagnosis/*genetics/physiopathology', 'DNA Mutational Analysis', 'Electroretinography', 'Female', 'Genes, Dominant', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', 'Macular Degeneration/diagnosis/*genetics/physiopathology', 'Male', 'Middle Aged', '*Mutation, Missense', 'Optical Imaging', 'Pedigree', 'Retinal Cone Photoreceptor Cells/*pathology', 'Retinal Degeneration/diagnosis/*genetics/physiopathology', '*Sequence Deletion', 'Tomography, Optical Coherence', 'Visual Acuity/physiology', 'Visual Fields/physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28442884/
365,GUCA1A,19459154,Mutations in the GUCA1A gene involved in hereditary cone dystrophies impair calcium-mediated regulation of guanylate cyclase.,"['Kitiratschky VB', 'Behnen P', 'Kellner U', 'Heckenlively JR', 'Zrenner E', 'Jagle H', 'Kohl S', 'Wissinger B', 'Koch KW']","['Calcium/*metabolism', 'Female', 'Genotype', 'Guanylate Cyclase/*metabolism', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', 'Male', '*Mutation', 'Pedigree', 'Phenotype', 'Retinal Cone Photoreceptor Cells/*pathology', 'Retinal Degeneration/enzymology/*genetics/metabolism', 'Spectrometry, Fluorescence']",https://pubmed.ncbi.nlm.nih.gov/19459154/
366,GUCA1A,31728034,Characterization of GUCA1A-associated dominant cone/cone-rod dystrophy: low prevalence among Japanese patients with inherited retinal dystrophies.,"['Mizobuchi K', 'Hayashi T', 'Katagiri S', 'Yoshitake K', 'Fujinami K', 'Yang L', 'Kuniyoshi K', 'Shinoda K', 'Machida S', 'Kondo M', 'Ueno S', 'Terasaki H', 'Matsuura T', 'Tsunoda K', 'Iwata T', 'Nakano T']","['Adolescent', 'Adult', 'Age of Onset', 'Aged', 'Amino Acid Sequence', 'Cone Dystrophy/diagnosis/epidemiology/*genetics/pathology', 'Cone-Rod Dystrophies/diagnosis/epidemiology/*genetics/pathology', 'DNA Mutational Analysis', 'Electroretinography', 'Female', 'Fluorescein Angiography', 'Gene Expression', 'Genes, Dominant', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', '*Inheritance Patterns', 'Japan/epidemiology', 'Male', 'Middle Aged', 'Pedigree', '*Polymorphism, Genetic', 'Prevalence', 'Retina/metabolism/pathology', 'Sequence Alignment']",https://pubmed.ncbi.nlm.nih.gov/31728034/
367,GUCA1A,24352742,Disease progression in autosomal dominant cone-rod dystrophy caused by a novel mutation (D100G) in the GUCA1A gene.,"['Nong E', 'Lee W', 'Merriam JE', 'Allikmets R', 'Tsang SH']","['Adult', 'Aged', 'Disease Progression', 'Electroretinography', 'Exons/genetics', 'Female', 'Fundus Oculi', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', 'Introns/genetics', 'Male', '*Mutation, Missense', 'Pedigree', 'Photoreceptor Cells, Vertebrate/pathology', 'Polymerase Chain Reaction', 'Retinitis Pigmentosa/diagnosis/*genetics', 'Visual Acuity/physiology']",https://pubmed.ncbi.nlm.nih.gov/24352742/
368,GUCA1A,34639157,A Novel GUCA1A Variant Associated with Cone Dystrophy Alters cGMP Signaling in Photoreceptors by Strongly Interacting with and Hyperactivating Retinal Guanylate Cyclase.,"['Biasi A', 'Marino V', 'Dal Cortivo G', 'Maltese PE', 'Modarelli AM', 'Bertelli M', 'Colombo L', ""Dell'Orco D""]","['Adolescent', 'Calcium/metabolism', 'Child', 'Cone Dystrophy/genetics/metabolism/*pathology', 'Cyclic GMP/*metabolism', 'Female', 'Guanylate Cyclase/*metabolism', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', 'Light Signal Transduction', 'Male', 'Middle Aged', '*Mutation', 'Pedigree', 'Retina/*enzymology', 'Retinal Rod Photoreceptor Cells/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/34639157/
369,GUCA1A,23428504,Novel GUCA1A mutation identified in a Chinese family with cone-rod dystrophy.,"['Huang L', 'Li S', 'Xiao X', 'Jia X', 'Sun W', 'Gao Y', 'Li L', 'Wang P', 'Guo X', 'Zhang Q']","['Adolescent', 'Adult', '*Asian People', 'Case-Control Studies', 'Child', 'Female', 'Genetic Predisposition to Disease', 'Guanylate Cyclase-Activating Proteins/*genetics', 'Humans', 'Male', 'Middle Aged', 'Mutation', 'Pedigree', 'Retinitis Pigmentosa/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23428504/
370,GUCA1A,30184081,A novel p.(Glu111Val) missense mutation in GUCA1A associated with cone-rod dystrophy leads to impaired calcium sensing and perturbed second messenger homeostasis in photoreceptors.,"['Marino V', 'Dal Cortivo G', 'Oppici E', 'Maltese PE', ""D'Esposito F"", 'Manara E', 'Ziccardi L', 'Falsini B', 'Magli A', 'Bertelli M', ""Dell'Orco D""]","['Biophysical Phenomena', 'Calcium/metabolism', 'Cone-Rod Dystrophies/*genetics/pathology', 'Cyclic GMP/biosynthesis/chemistry', 'Gene Expression Regulation/genetics', 'Guanylate Cyclase-Activating Proteins/chemistry/*genetics', 'Humans', 'Magnesium/metabolism', 'Molecular Dynamics Simulation', 'Mutation, Missense/genetics', 'Pedigree', 'Protein Aggregation, Pathological/genetics', 'Protein Binding', 'Retinal Cone Photoreceptor Cells/*chemistry/metabolism/pathology', 'Retinal Degeneration/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/30184081/
371,GUCA1A,32298085,Neuronal Calcium Sensor GCAP1 Encoded by GUCA1A Exhibits Heterogeneous Functional Properties in Two Cases of Retinitis Pigmentosa.,"['Abbas S', 'Marino V', 'Weisschuh N', 'Kieninger S', 'Solaki M', ""Dell'Orco D"", 'Koch KW']","['Calcium/metabolism', 'Guanylate Cyclase/genetics/metabolism', '*Guanylate Cyclase-Activating Proteins/genetics/metabolism', 'Humans', 'Phenotype', '*Retinitis Pigmentosa/genetics']",https://pubmed.ncbi.nlm.nih.gov/32298085/
372,GUCA1A,15953638,"Mutation in the gene GUCA1A, encoding guanylate cyclase-activating protein 1, causes cone, cone-rod, and macular dystrophy.","['Michaelides M', 'Wilkie SE', 'Jenkins S', 'Holder GE', 'Hunt DM', 'Moore AT', 'Webster AR']","['Adult', 'Aged', 'Calcium-Binding Proteins/*genetics', 'Color Perception Tests', 'Color Vision Defects/genetics', 'DNA Mutational Analysis', 'Electrooculography', 'Electroretinography', 'Female', 'Guanylate Cyclase/*genetics', 'Guanylate Cyclase-Activating Proteins', 'Humans', 'Male', 'Middle Aged', '*Mutation, Missense', 'Pedigree', 'Phenotype', 'Photoreceptor Cells, Vertebrate/*pathology', 'Polymerase Chain Reaction', 'Prospective Studies', 'Retinal Degeneration/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/15953638/
373,GUCA1A,32025184,Functional characterization of a novel GUCA1A missense mutation (D144G) in autosomal dominant cone dystrophy: A novel pathogenic GUCA1A variant in COD.,"['Tang S', 'Xia Y', 'Dai Y', 'Liu Y', 'Li J', 'Pan X', 'Chen P']","['Adult', 'Aged', 'Aged, 80 and over', 'Amino Acid Sequence', 'Base Sequence', 'Child', 'Cone Dystrophy/*genetics', 'Female', '*Genes, Dominant', 'Guanylate Cyclase-Activating Proteins/chemistry/*genetics', 'HEK293 Cells', 'Humans', 'Male', 'Middle Aged', 'Mutation, Missense/*genetics', 'Pedigree', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/32025184/
374,GUCA1A,15735604,Autosomal dominant cone dystrophy caused by a novel mutation in the GCAP1 gene (GUCA1A).,"['Jiang L', 'Katz BJ', 'Yang Z', 'Zhao Y', 'Faulkner N', 'Hu J', 'Baird J', 'Baehr W', 'Creel DJ', 'Zhang K']","['Adult', 'Aged', 'Aged, 80 and over', 'Blindness/genetics', 'Calcium-Binding Proteins/*genetics', 'Child', 'Color Vision Defects/genetics', 'DNA Mutational Analysis', 'Electroretinography', 'Female', 'Fluorescein Angiography', 'Genes, Dominant', 'Genotype', 'Guanylate Cyclase/*genetics', 'Guanylate Cyclase-Activating Proteins', 'Humans', 'Male', 'Middle Aged', '*Mutation, Missense', 'Pedigree', 'Polymerase Chain Reaction', 'Retinal Cone Photoreceptor Cells/*physiopathology', 'Retinal Degeneration/*genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/15735604/
375,GUCA1A,39969478,"Clinical, Genetic, Imaging and Electrophysiological Findings in a Cohort of Patients With GUCA1A-Associated Retinopathy.","['Allon G', 'Lin S', 'Robson AG', 'Arno G', 'Neveu MM', 'Hysi PG', 'Michaelides M', 'Webster AR', 'Mahroo OA']","['Humans', 'Male', 'Female', 'Middle Aged', 'Adult', '*Visual Acuity/physiology', 'Retrospective Studies', '*Tomography, Optical Coherence/methods', '*Electroretinography', 'Aged', 'Pedigree', 'Young Adult', 'Guanylate Cyclase/genetics', 'Mutation', 'DNA Mutational Analysis', 'Fluorescein Angiography/methods', 'Adolescent', 'Retinal Diseases/genetics/physiopathology/diagnosis']",https://pubmed.ncbi.nlm.nih.gov/39969478/
376,PRKCA,39341147,Unveiling four axes ADAMTS9-AS2|MEG3/hsa-miR-150/PRKCA|MMP14 within prostate cancer through establishment of the ceRNA network.,"['Taheri M', 'Safarzadeh A', 'Baniahmad A']","['Humans', 'Male', '*Prostatic Neoplasms/genetics/pathology', '*MicroRNAs/genetics', '*Gene Regulatory Networks/genetics', '*Gene Expression Regulation, Neoplastic/genetics', 'ADAMTS9 Protein/genetics', 'Biomarkers, Tumor/genetics', 'Prognosis', 'RNA, Competitive Endogenous', 'Matrix Metalloproteinase 14']",https://pubmed.ncbi.nlm.nih.gov/39341147/
377,PRKCA,34482802,Coordination of PRKCA/PRKCA-AS1 interplay facilitates DNA methyltransferase 1 recruitment on DNA methylation to affect protein kinase C alpha transcription in mitral valve of rheumatic heart disease.,"['Xie Z', 'Wang Q', 'Hu S']","['Aged', 'DNA (Cytosine-5-)-Methyltransferase 1/*genetics/metabolism', 'DNA Methylation/genetics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Mitral Valve/metabolism', 'Promoter Regions, Genetic/genetics', 'Protein Kinase C-alpha/*genetics/metabolism', 'RNA, Long Noncoding/*genetics/metabolism', '*Rheumatic Heart Disease/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34482802/
378,PRKCA,29915258,A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas.,"['Rosenberg S', 'Simeonova I', 'Bielle F', 'Verreault M', 'Bance B', 'Le Roux I', 'Daniau M', 'Nadaradjane A', 'Gleize V', 'Paris S', 'Marie Y', 'Giry M', 'Polivka M', 'Figarella-Branger D', 'Aubriot-Lorton MH', 'Villa C', 'Vasiljevic A', 'Lechapt-Zalcman E', 'Kalamarides M', 'Sharif A', 'Mokhtari K', 'Pagnotta SM', 'Iavarone A', 'Lasorella A', 'Huillard E', 'Sanson M']","['Adult', 'Aged', 'Cell Proliferation', 'Cells, Cultured', 'Cerebral Ventricle Neoplasms/*genetics/metabolism', 'Female', 'Glioma/*genetics/metabolism', 'Humans', 'Male', 'Middle Aged', 'Point Mutation', 'Protein Kinase C-alpha/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29915258/
379,PRKCA,26260115,SLC44A1-PRKCA fusion in papillary and rosette-forming glioneuronal tumors.,"['Nagaishi M', 'Nobusawa S', 'Matsumura N', 'Kono F', 'Ishiuchi S', 'Abe T', 'Ebato M', 'Wang Y', 'Hyodo A', 'Yokoo H', 'Nakazato Y']","['Antigens, CD/genetics/*metabolism', 'Biomarkers, Tumor/genetics/*metabolism', 'Brain Neoplasms/diagnosis/genetics/*metabolism', 'Female', 'Humans', 'In Situ Hybridization, Fluorescence', 'Male', 'Neoplasms, Neuroepithelial/diagnosis/genetics/*metabolism', 'Organic Cation Transport Proteins/genetics/*metabolism', 'Protein Kinase C-alpha/genetics/*metabolism', '*Rosette Formation']",https://pubmed.ncbi.nlm.nih.gov/26260115/
380,PRKCA,25080502,Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.,"['Paraboschi EM', 'Rimoldi V', 'Solda G', 'Tabaglio T', ""Dall'Osso C"", 'Saba E', 'Vigliano M', 'Salviati A', 'Leone M', 'Benedetti MD', 'Fornasari D', 'Saarela J', 'De Jager PL', 'Patsopoulos NA', ""D'Alfonso S"", 'Gemmati D', 'Duga S', 'Asselta R']","['Alleles', '*Alternative Splicing', 'Cell Line', 'Chromosomes, Human, Pair 17/chemistry', 'Exons', 'Female', 'Genetic Loci', '*Genetic Predisposition to Disease', 'Humans', 'INDEL Mutation', 'Introns', 'Male', 'Middle Aged', 'Multiple Sclerosis/*genetics/metabolism/pathology', 'Promoter Regions, Genetic', 'Protein Kinase C-alpha/chemistry/*genetics/metabolism', 'RNA Stability', 'RNA, Messenger/chemistry/*genetics/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/25080502/
381,PRKCA,27696692,"Gene-Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril.","['Oliveira-Paula GH', 'Luizon MR', 'Lacchini R', 'Fontana V', 'Silva PS', 'Biagi C', 'Tanus-Santos JE']","['Adult', 'Angiotensin-Converting Enzyme Inhibitors/*pharmacology/therapeutic use', 'Antihypertensive Agents/*pharmacology/therapeutic use', 'Blood Pressure/drug effects', 'Enalapril/*pharmacology/therapeutic use', '*Epistasis, Genetic', 'Female', 'Genotype', 'Haplotypes', 'Humans', 'Hypertension/*drug therapy', 'Male', 'Middle Aged', 'Nitric Oxide Synthase Type III/*genetics/metabolism', 'Pharmacogenomic Variants', 'Polymorphism, Single Nucleotide', 'Protein Kinase C-alpha/*genetics/metabolism', 'Receptor, Bradykinin B2/*genetics/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/27696692/
382,PRKCA,32019797,Genome-Wide Association Study of Cryptosporidiosis in Infants Implicates PRKCA.,"['Wojcik GL', 'Korpe P', 'Marie C', 'Mentzer AJ', 'Carstensen T', 'Mychaleckyj J', 'Kirkpatrick BD', 'Rich SS', 'Concannon P', 'Faruque ASG', 'Haque R', 'Petri WA Jr', 'Duggal P']","['Bangladesh/epidemiology', 'Cryptosporidiosis/epidemiology/*genetics', 'Cryptosporidium/pathogenicity', 'Diarrhea/epidemiology/microbiology', 'Disease Susceptibility/epidemiology/*microbiology', 'Feces/microbiology', 'Female', '*Genome, Human', 'Genome-Wide Association Study', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Meta-Analysis as Topic', '*Polymorphism, Single Nucleotide', 'Prospective Studies', 'Protein Kinase C-alpha/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/32019797/
383,PRKCA,15155525,Association of protein kinase C alpha (PRKCA) gene with multiple sclerosis in a UK population.,"['Barton A', 'Woolmore JA', 'Ward D', 'Eyre S', 'Hinks A', 'Ollier WE', 'Strange RC', 'Fryer AA', 'John S', 'Hawkins CP', 'Worthington J']","['Adult', 'Case-Control Studies', 'Chromosomes, Human, Pair 17/genetics', 'Female', 'Gene Frequency', 'Genetic Markers', '*Genetic Predisposition to Disease', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Multiple Sclerosis/*genetics', 'Polymorphism, Single Nucleotide', 'Protein Kinase C/*genetics', 'Protein Kinase C-alpha', 'United Kingdom']",https://pubmed.ncbi.nlm.nih.gov/15155525/
384,PRKCA,19576566,PRKCA: a positional candidate gene for body mass index and asthma.,"['Murphy A', 'Tantisira KG', 'Soto-Quiros ME', 'Avila L', 'Klanderman BJ', 'Lake S', 'Weiss ST', 'Celedon JC']","['Asthma/*genetics', '*Body Mass Index', 'Child', 'Costa Rica', 'Family', 'Female', 'Humans', 'Longitudinal Studies', 'Male', 'Polymorphism, Single Nucleotide', 'Protein Kinase C-alpha/*genetics', 'Sex Characteristics']",https://pubmed.ncbi.nlm.nih.gov/19576566/
385,PRKCA,26676968,Pigment-Synthesizing Melanocytic Neoplasm With Protein Kinase C Alpha (PRKCA) Fusion.,"['Bahrami A', 'Lee S', 'Wu G', 'Kerstetter J', 'Rahvar M', 'Li X', 'Easton J', 'Zhang J', 'Barnhill RL']","['Female', 'Humans', 'Infant', 'Melanocytes/pathology', 'Melanoma/*genetics/pathology', 'Membrane Fusion Proteins/*genetics', 'Nevus, Pigmented/*genetics/pathology', 'Protein Kinase C-alpha/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Sarcoplasmic Reticulum Calcium-Transporting ATPases/*genetics', '*Scalp', 'Sequence Analysis, RNA', 'Skin Neoplasms/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/26676968/
386,PRKCA,28212793,miR-634 is a Pol III-dependent intronic microRNA regulating alternative-polyadenylated isoforms of its host gene PRKCA.,"['Paraboschi EM', 'Cardamone G', 'Rimoldi V', 'Duga S', 'Solda G', 'Asselta R']","['Cell Line', 'Cell Line, Tumor', 'Down-Regulation/genetics', 'Gene Expression Regulation/genetics', 'Genes, Reporter/genetics', 'HEK293 Cells', 'HeLa Cells', 'Humans', 'Introns/*genetics', 'MicroRNAs/*genetics', 'Polyadenylation/*genetics', 'Promoter Regions, Genetic/genetics', 'Protein Isoforms/*genetics', 'Protein Kinase C-alpha/*genetics', 'RNA Polymerase III/genetics/*metabolism', 'Transcription, Genetic/genetics', 'Transcriptome/genetics']",https://pubmed.ncbi.nlm.nih.gov/28212793/
387,PRKCA,28120175,Regulatory Variants Modulate Protein Kinase C alpha (PRKCA) Gene Expression in Human Heart.,"['Li L', 'Zhang L', 'Binkley PF', 'Sadee W', 'Wang D']","['Cell Line', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genotype', 'Heart Diseases/*genetics', 'Heart Failure/metabolism', 'Humans', 'Mutation', 'Myocardium/metabolism', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Protein Kinase C-alpha/*genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28120175/
388,PRKCA,24842701,PRKCA polymorphism changes the neural basis of episodic remembering in healthy individuals.,"['MacLeod CA', 'Donaldson DI']","['Analysis of Variance', 'Discrimination, Psychological/physiology', 'Evoked Potentials/physiology', 'Humans', '*Memory, Episodic', 'Mental Recall/*physiology', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Kinase C-alpha/*genetics/*physiology']",https://pubmed.ncbi.nlm.nih.gov/24842701/
389,PRKACG,1339328,Localization of the catalytic subunit C gamma of the cAMP-dependent protein kinase gene (PRKACG) to human chromosome region 9q13.,"['Foss KB', 'Simard J', 'Berube D', 'Beebe SJ', 'Sandberg M', 'Grzeschik KH', 'Gagne R', 'Hansson V', 'Jahnsen T']","['Blotting, Southern', 'Chromosome Mapping', '*Chromosomes, Human, Pair 9', 'DNA Probes/genetics', 'Humans', 'Hybrid Cells', 'Protein Kinases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/1339328/
390,PRKACG,25061177,A new form of macrothrombocytopenia induced by a germ-line mutation in the PRKACG gene.,"['Manchev VT', 'Hilpert M', 'Berrou E', 'Elaib Z', 'Aouba A', 'Boukour S', 'Souquere S', 'Pierron G', 'Rameau P', 'Andrews R', 'Lanza F', 'Bobe R', 'Vainchenker W', 'Rosa JP', 'Bryckaert M', 'Debili N', 'Favier R', 'Raslova H']","['Adult', 'Blood Platelets/metabolism/*pathology', 'Child, Preschool', 'Cyclic AMP-Dependent Protein Kinase Catalytic Subunits/*genetics', 'Cytoskeleton/genetics/pathology', '*Germ-Line Mutation', 'Humans', 'Infant', 'Male', 'Megakaryocytes/metabolism/*pathology', 'Pedigree', 'Platelet Count', 'Thrombocytopenia/complications/*genetics/pathology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25061177/
391,PRKACB,37871652,Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms.,"['Itoh T', 'Omori Y', 'Seino M', 'Hirose K', 'Date F', 'Ono Y', 'Mizukami Y', 'Aoki S', 'Ishida M', 'Mizuma M', 'Morikawa T', 'Higuchi R', 'Honda G', 'Okamura Y', 'Kinoshita K', 'Unno M', 'Furukawa T']","['Humans', 'Tumor Suppressor Protein p53/genetics', 'Protein Kinases/genetics', 'Catalytic Domain', 'Cyclic AMP Response Element-Binding Protein/genetics', 'Proto-Oncogene Proteins p21(ras)/genetics', '*Pancreatic Neoplasms/pathology', 'Chromosome Aberrations', '*Adenocarcinoma, Mucinous/pathology', 'Gene Rearrangement', 'RNA, Messenger', '*Carcinoma, Pancreatic Ductal/pathology', 'HSP40 Heat-Shock Proteins/genetics', 'Cyclic AMP-Dependent Protein Kinase Catalytic Subunits/genetics']",https://pubmed.ncbi.nlm.nih.gov/37871652/
392,PRKACB,29669941,Activating PRKACB somatic mutation in cortisol-producing adenomas.,"['Espiard S', 'Knape MJ', 'Bathon K', 'Assie G', 'Rizk-Rabin M', 'Faillot S', 'Luscap-Rondof W', 'Abid D', 'Guignat L', 'Calebiro D', 'Herberg FW', 'Stratakis CA', 'Bertherat J']","['Adenoma/*enzymology/metabolism', 'Adrenal Gland Neoplasms/diagnostic imaging/pathology/surgery', 'Adrenal Insufficiency/etiology', 'Adrenalectomy/methods', 'Adult', 'Catalytic Domain/genetics', 'Cushing Syndrome/*diagnostic imaging/pathology/surgery', 'Cyclic AMP Receptor Protein/metabolism', 'Cyclic AMP-Dependent Protein Kinase Catalytic Subunits', 'Cyclic AMP-Dependent Protein Kinases/*genetics', 'Female', 'Holoenzymes/metabolism', 'Humans', 'Hydrocortisone/*metabolism', 'Mutation', 'Treatment Outcome', 'Exome Sequencing/methods']",https://pubmed.ncbi.nlm.nih.gov/29669941/
393,PRKACB,38841868,PRKACA/PRKACB Fusions in Pancreatobiliary Intraductal Oncocytic Papillary Neoplasms Including Those With Atypical Morphology: An Analysis of 22 Cases Expanding Morphologic Spectrum.,"['Tanaka M', 'Takeshita K', 'Kunita A', 'Hasegawa K', 'Ushiku T']","['Adult', 'Aged', 'Aged, 80 and over', 'Female', 'Humans', 'Male', 'Middle Aged', 'Bile Duct Neoplasms/genetics/pathology', '*Biomarkers, Tumor/genetics', 'Carcinoma, Pancreatic Ductal/genetics/pathology', '*Cyclic AMP-Dependent Protein Kinase Catalytic Subunits/genetics', 'In Situ Hybridization, Fluorescence', '*Pancreatic Intraductal Neoplasms/genetics/pathology', '*Pancreatic Neoplasms/genetics/pathology', 'Phenotype', '*Gene Fusion']",https://pubmed.ncbi.nlm.nih.gov/38841868/
394,PRKACB,36152045,Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.,"['Maimaitiaili Y', 'Fukumura Y', 'Hirabayashi K', 'Kinowaki Y', 'Naito Y', 'Saito A', 'Rong L', 'Nakahodo J', 'Yao T']","['Humans', 'Carcinoma, Pancreatic Ductal/genetics/pathology', '*Cyclic AMP-Dependent Protein Kinase Catalytic Subunits/genetics/metabolism', 'In Situ Hybridization, Fluorescence', '*Pancreatic Intraductal Neoplasms/genetics', 'Pancreatic Neoplasms/genetics/pathology', '*Oncogene Proteins, Fusion/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36152045/
395,PRKACB,31678302,Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.,"['Singhi AD', 'Wood LD', 'Parks E', 'Torbenson MS', 'Felsenstein M', 'Hruban RH', 'Nikiforova MN', 'Wald AI', 'Kaya C', 'Nikiforov YE', 'Favazza L', 'He J', 'McGrath K', 'Fasanella KE', 'Brand RE', 'Lennon AM', 'Furlan A', 'Dasyam AK', 'Zureikat AH', 'Zeh HJ', 'Lee K', 'Bartlett DL', 'Slivka A']","['Adult', 'Aged', 'Bile Duct Neoplasms/*genetics/pathology', 'Bile Ducts, Intrahepatic', 'Carcinoma, Pancreatic Ductal/*genetics', 'Cholangiocarcinoma/*genetics', 'Cyclic AMP-Dependent Protein Kinase Catalytic Subunits/*genetics', 'Female', 'Gene Fusion', 'Gene Rearrangement', 'HSP40 Heat-Shock Proteins/genetics', 'Humans', 'Male', 'Middle Aged', 'Pancreatic Cyst/genetics', 'Pancreatic Intraductal Neoplasms/*genetics/pathology', 'Pancreatic Neoplasms/*genetics/pathology', 'Sodium-Potassium-Exchanging ATPase/genetics']",https://pubmed.ncbi.nlm.nih.gov/31678302/
396,PRKACB,24916040,Upregulation of miR-23b enhances the autologous therapeutic potential for degenerative arthritis by targeting PRKACB in synovial fluid-derived mesenchymal stem cells from patients.,"['Ham O', 'Lee CY', 'Song BW', 'Lee SY', 'Kim R', 'Park JH', 'Lee J', 'Seo HH', 'Lee CY', 'Chung YA', 'Maeng LS', 'Lee MY', 'Kim J', 'Hwang J', 'Woo DK', 'Chang W']","['Cell Differentiation/drug effects', 'Cells, Cultured', 'Chondrocytes/metabolism', 'Collagenases/metabolism', 'Cyclic AMP-Dependent Protein Kinase Catalytic Subunits/*antagonists & inhibitors', 'Gene Expression Regulation', 'HeLa Cells', 'Humans', 'Isoquinolines/*pharmacology', 'Mesenchymal Stem Cell Transplantation/*methods', 'MicroRNAs/*genetics', 'Osteoarthritis/genetics/*therapy', 'Sulfonamides/*pharmacology', 'Synovial Fluid/*cytology']",https://pubmed.ncbi.nlm.nih.gov/24916040/
397,CNGA1,33633220,A case of retinitis pigmentosa homozygous for a rare CNGA1 causal variant.,"['Saito K', 'Gotoh N', 'Kang I', 'Shimada T', 'Usui T', 'Terao C']","['Consanguinity', 'Cyclic Nucleotide-Gated Cation Channels/*genetics', 'Female', '*Homozygote', 'Humans', 'Japan', 'Male', 'Mutation, Missense', 'Pedigree', 'Retinitis Pigmentosa/*genetics', 'Whole Genome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/33633220/
398,CNGA1,38340451,Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient.,"['Wu Y', 'Zhang T', 'Chen Z', 'Tang L', 'Zhang L', 'Chen J', 'Wan X', 'Sun X']","['Adult', 'Humans', 'Male', 'Cyclic Nucleotide-Gated Cation Channels/genetics/metabolism', '*Induced Pluripotent Stem Cells/metabolism', 'Leukocytes, Mononuclear/metabolism', 'Mutation', '*Retinitis Pigmentosa/pathology']",https://pubmed.ncbi.nlm.nih.gov/38340451/
399,CNGA1,26802146,Novel compound heterozygous mutation in the CNGA1 gene underlie autosomal recessive retinitis pigmentosa in a Chinese family.,"['Jin X', 'Qu LH', 'Hou BK', 'Xu HW', 'Meng XH', 'Pang CP', 'Yin ZQ']","['Amino Acid Substitution', 'Asian People', 'Cyclic Nucleotide-Gated Cation Channels/*genetics', '*Family', 'Female', '*Heterozygote', 'Humans', 'Male', '*Mutation, Missense', 'Retinitis Pigmentosa/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26802146/
400,CNGA1,32705276,Identification of a novel homozygous variant in the CNGA1 gene in a Chinese family with autosomal recessive retinitis pigmentosa.,"['Wang L', 'Zou T', 'Lin Y', 'Li L', 'Zhang P', 'Gong B', 'Hao J', 'Zhang H']","['Adult', 'Asian People/*genetics', 'China', 'Cyclic Nucleotide-Gated Cation Channels/*genetics', 'Female', '*Frameshift Mutation', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Pedigree', 'Retinitis Pigmentosa/*genetics', 'Exome Sequencing/*methods', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32705276/
401,CNGA1,33651975,Structural mechanisms of gating and selectivity of human rod CNGA1 channel.,"['Xue J', 'Han Y', 'Zeng W', 'Wang Y', 'Jiang Y']","['Binding Sites', 'Calcium/metabolism', 'Cyclic GMP/metabolism', 'Cyclic Nucleotide-Gated Cation Channels/*metabolism', 'HEK293 Cells', 'Humans', 'Ion Channel Gating/*physiology', 'Protein Conformation']",https://pubmed.ncbi.nlm.nih.gov/33651975/
402,CNGA1,25268133,Whole exome analysis identifies frequent CNGA1 mutations in Japanese population with autosomal recessive retinitis pigmentosa.,"['Katagiri S', 'Akahori M', 'Sergeev Y', 'Yoshitake K', 'Ikeo K', 'Furuno M', 'Hayashi T', 'Kondo M', 'Ueno S', 'Tsunoda K', 'Shinoda K', 'Kuniyoshi K', 'Tsurusaki Y', 'Matsumoto N', 'Tsuneoka H', 'Iwata T']","['Adult', 'Aged', 'Asian People', 'Base Sequence', 'Cyclic Nucleotide-Gated Cation Channels/*genetics', '*Exome', 'Exons', 'Extracellular Matrix Proteins/genetics', 'Eye Proteins/genetics', 'Female', 'Genes, Recessive', 'High-Throughput Nucleotide Sequencing', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Molecular Sequence Data', '*Mutation Rate', 'Pedigree', 'Phosphotransferases (Alcohol Group Acceptor)/genetics', 'Retinitis Pigmentosa/ethnology/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/25268133/
403,CNGA1,34971760,Structural basis of the partially open central gate in the human CNGA1/CNGB1 channel explained by additional density for calmodulin in cryo-EM map.,"['Barret DCA', 'Schertler GFX', 'Kaupp UB', 'Marino J']","['Binding Sites', '*Calmodulin/metabolism', 'Cryoelectron Microscopy', '*Cyclic Nucleotide-Gated Cation Channels/chemistry/metabolism', 'Humans', 'Retinal Rod Photoreceptor Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34971760/
404,C1QB,10471215,C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis.,"['Grewal RP', 'Morgan TE', 'Finch CE']","['Adolescent', 'Aged', 'Aged, 80 and over', 'Amyotrophic Lateral Sclerosis/*genetics/pathology', 'Cerebral Cortex/*metabolism/pathology', 'Clusterin', 'Complement C1q/*genetics', 'Complement Inactivator Proteins/*genetics', '*Gene Expression Regulation', 'Glycoproteins/*genetics', 'Humans', '*Molecular Chaperones', 'Nerve Degeneration/etiology/*genetics/pathology', 'RNA, Messenger/genetics', 'Reference Values', 'Somatosensory Cortex/metabolism', 'Spinal Cord/*metabolism/pathology', 'Temporal Lobe/metabolism', '*Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/10471215/
405,C1QB,36443341,"C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment.","['Liang Z', 'Pan L', 'Shi J', 'Zhang L']","['Humans', 'Granzymes', '*Melanoma/genetics', 'Prognosis', '*Skin Neoplasms/genetics', 'Tumor Microenvironment/genetics', 'Melanoma, Cutaneous Malignant']",https://pubmed.ncbi.nlm.nih.gov/36443341/
406,C1QB,29331040,"Jun, Gal, Cd74, and C1qb as potential indicator for neuropathic pain.","['Yang JA', 'He JM', 'Lu JM', 'Jie LJ']","['Antigens, Differentiation, B-Lymphocyte/*metabolism', 'Biomarkers/metabolism', 'Carrier Proteins/*metabolism', 'Galanin/*metabolism', 'Gene Expression Regulation', 'Histocompatibility Antigens Class II/*metabolism', 'Humans', 'Mitochondrial Proteins/*metabolism', 'Neuralgia/*metabolism/pathology', 'Peripheral Nerve Injuries/*metabolism', 'Proto-Oncogene Proteins c-jun/*metabolism', 'Software']",https://pubmed.ncbi.nlm.nih.gov/29331040/
407,C1QB,38890370,Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma.,"['Yan ZX', 'Dong Y', 'Qiao N', 'Zhang YL', 'Wu W', 'Zhu Y', 'Wang L', 'Cheng S', 'Xu PP', 'Zhou ZS', 'Sheng LS', 'Zhao WL']","['Humans', '*Lymphoma, Large B-Cell, Diffuse/therapy/immunology/metabolism/genetics', '*Macrophages/metabolism/immunology', '*Immunotherapy, Adoptive/methods', 'Middle Aged', 'Female', 'Male', '*Cholesterol/metabolism', '*Receptors, Chimeric Antigen/metabolism/immunology/genetics', 'Aged', 'CD8-Positive T-Lymphocytes/immunology/metabolism', 'Adult', 'Drug Resistance, Neoplasm']",https://pubmed.ncbi.nlm.nih.gov/38890370/
408,C1QB,22209113,Anti-C1q autoantibodies specific against the globular domain of the C1qB-chain from patient with lupus nephritis inhibit C1q binding to IgG and CRP.,"['Radanova M', 'Vasilev V', 'Deliyska B', 'Kishore U', 'Ikonomov V', 'Ivanova D']","['Adult', 'Autoantibodies/blood/*immunology/pharmacology', 'Binding Sites, Antibody', 'C-Reactive Protein/antagonists & inhibitors/immunology/metabolism', 'Complement C1q/antagonists & inhibitors/*immunology/metabolism', 'Epitopes', 'Female', 'Humans', 'Immunoglobulin G/blood/*immunology', 'Lupus Nephritis/blood/*immunology/pathology', 'Male', 'Middle Aged', 'Protein Binding', 'Protein Structure, Tertiary', 'Protein Subunits', 'Recombinant Proteins/*immunology/metabolism', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/22209113/
409,C1QB,34915882,IRF4-activated TEX41 promotes the malignant behaviors of melanoma cells by targeting miR-103a-3p/C1QB axis.,"['Zheng Y', 'Zhou W', 'Li M', 'Xu R', 'Zhang S', 'Liu Y', 'Cen Y']","['Carrier Proteins/*metabolism', 'Cell Line, Tumor', 'Cell Proliferation/genetics', 'Humans', 'Interferon Regulatory Factors/*metabolism', 'Melanocytes/metabolism', 'Melanoma/*genetics', 'MicroRNAs/*metabolism', 'Mitochondrial Proteins/*metabolism', 'Promoter Regions, Genetic/genetics', 'RNA, Long Noncoding', 'Real-Time Polymerase Chain Reaction', 'Skin Neoplasms/*genetics', 'Transcriptional Activation/genetics', 'Up-Regulation/genetics', 'Melanoma, Cutaneous Malignant']",https://pubmed.ncbi.nlm.nih.gov/34915882/
410,C1QB,21951915,Association of C1QB gene polymorphism with schizophrenia in Armenian population.,"['Zakharyan R', 'Khoyetsyan A', 'Arakelyan A', 'Boyajyan A', 'Gevorgyan A', 'Stahelova A', 'Mrazek F', 'Petrek M']","['Adult', 'Alleles', 'Armenia', 'Complement C1q/*genetics', 'Female', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Schizophrenia/epidemiology/*genetics', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21951915/
411,C1QB,25454803,Identification of a novel non-coding mutation in C1qB in a Dutch child with C1q deficiency associated with recurrent infections.,"['van Schaarenburg RA', 'Daha NA', 'Schonkeren JJ', 'Nivine Levarht EW', 'van Gijlswijk-Janssen DJ', 'Kurreeman FA', 'Roos A', 'van Kooten C', 'Koelman CA', 'Ernst-Kruis MR', 'Toes RE', 'Huizinga TW', 'Lankester AC', 'Trouw LA']","['Base Sequence', 'Child, Preschool', 'Complement C1q/*deficiency/*genetics/immunology', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Lupus Erythematosus, Systemic/genetics', 'Male', 'Netherlands', 'RNA Splice Sites/*genetics', 'RNA, Messenger/genetics', 'Recurrence', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/25454803/
412,C1QB,21698244,Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma.,"['Luo Y', 'Robinson S', 'Fujita J', 'Siconolfi L', 'Magidson J', 'Edwards CK', 'Wassmann K', 'Storm K', 'Norris DA', 'Bankaitis-Davis D', 'Robinson WA', 'Fujita M']","['Base Sequence', 'Case-Control Studies', 'Complement C1q/*genetics', 'DNA Primers', '*Gene Expression Profiling', 'Humans', 'Melanoma/blood/*genetics', 'Membrane Proteins/*genetics', 'Oligonucleotide Array Sequence Analysis', 'Reverse Transcriptase Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/21698244/
413,C1QA,38030709,C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors.,"['Gorai PK', 'Bharti PS', 'Kumar S', 'Rajacharya GH', 'Bandyopadhyay S', 'Pal S', 'Dhingra R', 'Kumar R', 'Nikolajeff F', 'Kumar S', 'Rani N']","['Humans', '*Neuroendocrine Tumors/pathology', '*Pancreatic Neoplasms/pathology', 'Proteomics', 'Early Detection of Cancer', 'Biomarkers, Tumor/analysis']",https://pubmed.ncbi.nlm.nih.gov/38030709/
414,C1QA,36443341,"C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment.","['Liang Z', 'Pan L', 'Shi J', 'Zhang L']","['Humans', 'Granzymes', '*Melanoma/genetics', 'Prognosis', '*Skin Neoplasms/genetics', 'Tumor Microenvironment/genetics', 'Melanoma, Cutaneous Malignant']",https://pubmed.ncbi.nlm.nih.gov/36443341/
415,C1QA,33133060,"Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia.","['Purves-Tyson TD', 'Robinson K', 'Brown AM', 'Boerrigter D', 'Cai HQ', 'Weissleder C', 'Owens SJ', 'Rothmond DA', 'Shannon Weickert C']","['Adult', 'Aged', 'Cohort Studies', 'Complement C1q/genetics/*metabolism', 'Complement C3/genetics/*metabolism', 'Complement C4/genetics/metabolism', 'Female', 'Humans', 'Macrophages/*physiology', 'Male', 'Mesencephalon/*physiology', 'Middle Aged', 'Schizophrenia/*immunology', 'Up-Regulation', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33133060/
416,C1QA,35733178,Potential biomarkers of spinal dural arteriovenous fistula: C4BPA and C1QA.,"['Wang Y', 'Ma Y', 'Yang C', 'Huang X', 'Yang K', 'Lan F', 'Fu J', 'Song Z', 'Tian A', 'Feng Y', 'Tu T', 'Li H', 'Hong T', 'Wang Y', 'Zhang H']","['Biomarkers', '*Central Nervous System Vascular Malformations/diagnosis', '*Complement C1q/analysis', '*Complement C4b-Binding Protein/analysis', 'Humans', '*Hypertension', 'Magnetic Resonance Imaging', '*Spinal Cord Diseases']",https://pubmed.ncbi.nlm.nih.gov/35733178/
417,C1QA,31019999,C1QA and C1QC modify age-at-onset in familial amyloid polyneuropathy patients.,"['Dias A', 'Santos D', 'Coelho T', 'Alves-Ferreira M', 'Sequeiros J', 'Alonso I', 'Sousa A', 'Lemos C']","['Adult', 'Age of Onset', 'Aged', 'Amyloid/genetics/metabolism', 'Amyloid Neuropathies, Familial/complications/diagnosis/*metabolism', 'Female', 'Genotype', 'Humans', 'Male', 'Membrane Glycoproteins/*genetics', 'Middle Aged', 'Mutation/genetics', 'Polymorphism, Single Nucleotide/genetics', 'Prealbumin/*genetics', 'Receptors, Complement/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31019999/
418,C1QA,39096524,Monogenic lupus with neuroregression in an infant due to rare compound heterozygous variants in C1QA gene: Case-based review.,"['Jain H', 'Kartik S', 'Kumar A', 'Dwivedi A', 'Jayaprakash S', 'Vasdev V', 'Chandwani A']","['Humans', '*Complement C1q/genetics', 'Female', '*Lupus Erythematosus, Systemic/diagnosis/genetics/complications', 'Infant', 'Heterozygote', 'Mutation', 'Rituximab/therapeutic use/administration & dosage', 'Autoantibodies/blood', 'Glucocorticoids/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/39096524/
419,C1QA,22236909,Association study of C1qA polymorphisms with systemic lupus erythematosus in a Han population.,"['Cao CW', 'Li P', 'Luan HX', 'Chen W', 'Li CH', 'Hu CJ', 'Zhang SL', 'Zeng XF', 'Zhang FC', 'Li YZ', 'Zeng CQ']","['Adult', 'Alleles', 'Asian People/genetics', 'Case-Control Studies', 'China', 'Complement C1q/*genetics', 'Female', 'Gene Frequency', 'Genotype', 'Haplotypes', 'Humans', 'Lupus Erythematosus, Systemic/*genetics', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22236909/
420,C1QA,22472776,Identification of novel coding mutation in C1qA gene in an African-American pedigree with lupus and C1q deficiency.,"['Namjou B', 'Keddache M', 'Fletcher D', 'Dillon S', 'Kottyan L', 'Wiley G', 'Gaffney PM', 'Wakeland BE', 'Liang C', 'Wakeland EK', 'Scofield RH', 'Kaufman K', 'Harley JB']","['Adult', 'Black or African American/genetics', 'Amino Acid Substitution', 'Base Sequence', 'Codon, Initiator/genetics', 'Complement C1q/*deficiency/*genetics', 'DNA Mutational Analysis', 'Female', 'Genes, Recessive', 'Homozygote', 'Humans', 'Lupus Erythematosus, Systemic/*blood/*genetics', 'Male', 'Pedigree', '*Point Mutation', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22472776/
421,C1QA,20332777,Common germ-line polymorphism of C1QA and breast cancer survival.,"['Azzato EM', 'Lee AJ', 'Teschendorff A', 'Ponder BA', 'Pharoah P', 'Caldas C', 'Maia AT']","['Adult', 'Aged', 'Breast Neoplasms/*genetics/*mortality', 'Case-Control Studies', 'Complement C1q/*genetics', 'Female', 'Gene Frequency', 'Genome-Wide Association Study', 'Humans', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/20332777/
422,C1QA,16465510,The pattern of clinical breast cancer metastasis correlates with a single nucleotide polymorphism in the C1qA component of complement.,"['Racila E', 'Racila DM', 'Ritchie JM', 'Taylor C', 'Dahle C', 'Weiner GJ']","['Adult', 'Aged', 'Aged, 80 and over', 'Bone Neoplasms/secondary', 'Brain Neoplasms/secondary', 'Breast Neoplasms/blood/*pathology', 'Carcinoma/*pathology', 'Complement C1q/*genetics', 'Estrogen Receptor alpha/metabolism', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Liver Neoplasms/secondary', 'Lymphatic Metastasis/genetics', 'Middle Aged', 'Neoplasm Metastasis/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Progesterone/metabolism', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/16465510/
423,TNNC2,33755597,Pathogenic variants in TNNC2 cause congenital myopathy due to an impaired force response to calcium.,"['van de Locht M', 'Donkervoort S', 'de Winter JM', 'Conijn S', 'Begthel L', 'Kusters B', 'Mohassel P', 'Hu Y', 'Medne L', 'Quinn C', 'Moore SA', 'Foley AR', 'Seo G', 'Hwee DT', 'Malik FI', 'Irving T', 'Ma W', 'Granzier HL', 'Kamsteeg EJ', 'Immadisetty K', 'Kekenes-Huskey P', 'Pinto JR', 'Voermans N', 'Bonnemann CG', 'Ottenheijm CA']","['Binding Sites', '*Calcium/chemistry/metabolism', 'Humans', '*Molecular Dynamics Simulation', '*Muscle Contraction', '*Myotonia Congenita/genetics/metabolism', '*Sarcomeres/chemistry/genetics/metabolism', '*Troponin C/chemistry/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33755597/
424,TNNC2,9459007,Assignment of the human fast skeletal muscle troponin C gene (TNNC2) between D20S721 and GCT10F11 on chromosome 20 by somatic cell hybrid analysis.,"['Townsend PJ', 'Yacoub MH', 'Barton PJ']","['Chromosome Mapping', 'Chromosomes, Human, Pair 20/*genetics', 'DNA/analysis', 'Genetic Markers', 'Humans', 'Hybrid Cells/*chemistry', 'Muscle Fibers, Fast-Twitch/*chemistry', 'Polymerase Chain Reaction', 'Troponin C/*genetics']",https://pubmed.ncbi.nlm.nih.gov/9459007/
425,TNNC2,31324732,Bioinformatics-based discovery of PYGM and TNNC2 as potential biomarkers of head and neck squamous cell carcinoma.,"['Jin Y', 'Yang Y']","['Biomarkers, Tumor/*genetics/metabolism', 'Carcinoma, Squamous Cell/*genetics/metabolism', '*Computational Biology', 'Databases, Nucleic Acid', 'Glycogen Phosphorylase/*genetics/metabolism', 'Head and Neck Neoplasms/*genetics/metabolism', 'Humans', 'Neoplasm Proteins/*genetics/metabolism', 'Troponin C/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31324732/
426,TNNC2,33052895,"A Mechanism Underlying Sex-Associated Differences in Ankylosing Spondylitis: Troponin C2, Fast Skeletal Type (TNNC2) and Calcium Signaling Pathway.","['Yu C', 'Zhan X', 'Liu C', 'Zhang Z', 'Jiang J', 'Xu G', 'Xue J']","['*Calcium Signaling', '*Databases, Factual', 'Female', '*Gene Expression Regulation', 'Humans', 'Male', '*Sex Characteristics', 'Spondylitis, Ankylosing/genetics/*metabolism/pathology', '*Transcriptome', 'Troponin C/*biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/33052895/
427,PRKAR2B,31986411,Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.,"['Xia L', 'Han Q', 'Chi C', 'Zhu Y', 'Pan J', 'Dong B', 'Huang Y', 'Xia W', 'Xue W', 'Sha J']","['Apoptosis/genetics', 'Cell Line, Tumor', 'Cell Proliferation/genetics', 'Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit/*genetics', 'Disease Progression', 'Down-Regulation', 'Epithelial-Mesenchymal Transition/genetics', 'Gene Expression Regulation, Neoplastic', 'Gene Knockdown Techniques', 'Humans', 'Male', 'MicroRNAs/*genetics', 'Prostatic Neoplasms/*genetics/pathology', 'X-Box Binding Protein 1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31986411/
428,PRKAR2B,25268545,"Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cells.","['Basso F', 'Rocchetti F', 'Rodriguez S', 'Nesterova M', 'Cormier F', 'Stratakis CA', 'Ragazzon B', 'Bertherat J', 'Rizk-Rabin M']","['Adrenal Glands/*cytology/*enzymology', 'Apoptosis', '*Cell Cycle Checkpoints', 'Cell Line, Tumor', 'Cell Proliferation', 'Cyclic AMP-Dependent Protein Kinase RIalpha Subunit/*metabolism', 'Cyclic AMP-Dependent Protein Kinase RIbeta Subunit/*metabolism', 'Cyclin-Dependent Kinases/metabolism', 'Cyclins/metabolism', 'Humans', 'MAP Kinase Signaling System', 'NF-kappa B/metabolism', 'Protein Subunits/metabolism', '*Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/25268545/
429,PRKAR2B,24737441,Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.,"['Gagliano SA', 'Tiwari AK', 'Freeman N', 'Lieberman JA', 'Meltzer HY', 'Kennedy JL', 'Knight J', 'Muller DJ']","['Adolescent', 'Adult', 'Aged', 'Alleles', 'Antipsychotic Agents/*adverse effects/therapeutic use', 'Benzodiazepines/adverse effects/therapeutic use', 'Clozapine/adverse effects/therapeutic use', 'Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit/*genetics', 'Female', 'Genetic Predisposition to Disease', 'Genotyping Techniques', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Olanzapine', '*Polymorphism, Single Nucleotide', 'Psychotic Disorders/drug therapy/genetics', 'Schizophrenia/drug therapy/genetics', 'Weight Gain/*drug effects/*genetics', 'White People/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24737441/
430,PRKAR2A,9676433,Mapping of the gene encoding the regulatory subunit RII alpha of cAMP-dependent protein kinase (locus PRKAR2A) to human chromosome region 3p21.3-p21.2.,"['Tasken K', 'Naylor SL', 'Solberg R', 'Jahnsen T']","['Blotting, Southern', '*Chromosome Mapping', '*Chromosomes, Human, Pair 3', 'Cyclic AMP-Dependent Protein Kinases/*genetics', 'Humans', 'Lod Score', 'Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/9676433/
431,PRKAR2A,32379091,Epithelioid Fibrous Histiocytoma With Dot-Like Perinuclear ALK Expression and PRKAR2A-ALK Fusion.,"['Dawson K', 'Bridge JA', 'Sumegi J', 'Royce T', 'Gardner JM', 'Shalin SC']","['Adult', 'Anaplastic Lymphoma Kinase/*genetics', 'Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit/*genetics', 'Epithelioid Cells/pathology', 'Female', 'Histiocytoma, Benign Fibrous/*genetics/pathology', 'Humans', 'Oncogene Fusion', 'Oncogene Proteins, Fusion/genetics', 'Skin Neoplasms/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/32379091/
432,PRKAR2A,19818097,Epigenetic modulation of the protein kinase A RIIalpha (PRKAR2A) gene by histone deacetylases 1 and 2 in human smooth muscle cells.,"['Karolczak-Bayatti M', 'Loughney AD', 'Robson SC', 'Europe-Finner GN']","['Blotting, Western', 'Cell Nucleus/genetics/metabolism', 'Cells, Cultured', 'Chromatin Immunoprecipitation', 'Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit/*genetics', 'Cytoplasm/metabolism', '*Epigenesis, Genetic', 'Female', 'Histone Deacetylase 1/*metabolism', 'Histone Deacetylase 2/*metabolism', 'Humans', 'Immunoprecipitation', 'Luciferases/metabolism', 'Myocytes, Smooth Muscle/*enzymology', 'Myometrium/cytology/metabolism', 'Promoter Regions, Genetic', 'RNA, Messenger/genetics', 'Regulatory Sequences, Nucleic Acid', 'Reverse Transcriptase Polymerase Chain Reaction', 'Sp1 Transcription Factor/metabolism', 'Sp3 Transcription Factor/metabolism', 'Transcription, Genetic', 'Uterine Contraction']",https://pubmed.ncbi.nlm.nih.gov/19818097/
433,PRKAR2A,37137901,Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss.,"['Ruland L', 'Andreatta F', 'Massalini S', 'Chuva de Sousa Lopes S', 'Clevers H', 'Hendriks D', 'Artegiani B']","['Humans', '*Liver Neoplasms/metabolism', 'Cell Transdifferentiation/genetics', '*Carcinoma, Hepatocellular/metabolism', 'Mutation', 'Hepatocytes/metabolism', 'Organoids/metabolism', 'HSP40 Heat-Shock Proteins/metabolism', 'Tumor Suppressor Proteins/genetics', 'Ubiquitin Thiolesterase/genetics', 'Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit/genetics']",https://pubmed.ncbi.nlm.nih.gov/37137901/
434,ITPKA,32015686,TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma.,"['Guoren Z', 'Zhaohui F', 'Wei Z', 'Mei W', 'Yuan W', 'Lin S', 'Xiaoyue X', 'Xiaomei Z', 'Bo S']","['Adenocarcinoma of Lung/genetics/*metabolism', 'Blotting, Western', 'Cell Line, Tumor', 'Cell Movement/genetics/*physiology', 'Cell Proliferation/genetics/physiology', 'Epithelial-Mesenchymal Transition', 'Flow Cytometry', 'Gene Expression Regulation, Neoplastic/genetics/physiology', 'Humans', 'Immunohistochemistry', 'Immunoprecipitation', 'Lung Neoplasms/genetics/*metabolism', 'Neuropeptides/genetics/*metabolism', 'Phosphotransferases (Alcohol Group Acceptor)/genetics/*metabolism', 'Protein Binding', 'Transcription Factor AP-2/genetics/*metabolism', 'Wound Healing/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/32015686/
435,ITPKA,33624455,Relationship of ITPKA expression with the prognosis of breast cancer.,"['Zhang J', 'Zhang S', 'Li X', 'Pi H']","['Biomarkers, Tumor/*genetics/metabolism', 'Breast Neoplasms/*genetics/metabolism/pathology', 'Female', 'Humans', 'Lymphatic Metastasis/genetics', 'Middle Aged', 'Phosphotransferases (Alcohol Group Acceptor)/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33624455/
436,ITPKA,36688944,The actin bundling activity of ITPKA mainly accounts for its migration-promoting effect in lung cancer cells.,"['Kuster L', 'Paraschiakos T', 'Karakurt KE', 'Schumacher U', 'Diercks BP', 'Windhorst S']","['Humans', '*Actins/genetics/metabolism', 'Adenosine Triphosphate', 'Cell Line, Tumor', '*Lung Neoplasms/genetics', '*Phosphotransferases (Alcohol Group Acceptor)/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36688944/
437,ITPKA,37664985,Commentary on: The actin bundling activity of ITPKA mainly accounts for its migration-promoting effect in lung cancer cells.,"['Zhang X', 'He J', 'Ren D']","['Humans', 'Actin Cytoskeleton', '*Actins/genetics', 'Cell Movement/genetics', '*Lung Neoplasms/drug therapy/genetics', 'Signal Transduction', '*Phosphotransferases (Alcohol Group Acceptor)/genetics']",https://pubmed.ncbi.nlm.nih.gov/37664985/
438,ITPKA,26249031,ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.,"['Li J', 'Zhu YH', 'Huang P', 'Zhang B', 'Sun J', 'Guan XY']","['Adult', 'Aged', 'Biomarkers, Tumor/*analysis', 'Blotting, Western', 'Carcinoma, Hepatocellular/metabolism/mortality/*pathology', 'Disease-Free Survival', 'Female', 'Humans', 'Kaplan-Meier Estimate', 'Liver Neoplasms/metabolism/mortality/*pathology', 'Male', 'Middle Aged', 'Phosphotransferases (Alcohol Group Acceptor)/analysis/*biosynthesis', 'Prognosis', 'Proportional Hazards Models', 'Real-Time Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/26249031/
439,ITPKA,27234602,ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers.,"['Wang YW', 'Ma X', 'Zhang YA', 'Wang MJ', 'Yatabe Y', 'Lam S', 'Girard L', 'Chen JY', 'Gazdar AF']","['Biomarkers, Tumor', 'Cell Line, Tumor', '*DNA Methylation', '*Early Detection of Cancer', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Lung Neoplasms/diagnosis/*genetics', 'Phosphotransferases (Alcohol Group Acceptor)/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27234602/
440,ITPKA,25620569,"The catalytic domain of inositol-1,4,5-trisphosphate 3-kinase-a contributes to ITPKA-induced modulation of F-actin.","['Ashour DJ', 'Pelka B', 'Jaaks P', 'Wundenberg T', 'Blechner C', 'Zobiak B', 'Failla AV', 'Windhorst S']","['Actins/*metabolism', 'Catalytic Domain', 'Phosphotransferases (Alcohol Group Acceptor)/chemistry/*metabolism', 'Protein Binding', 'Protein Structure, Tertiary', 'Recombinant Fusion Proteins/chemistry/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/25620569/
441,TNNC1,25277212,Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.,"['Leung CS', 'Yeung TL', 'Yip KP', 'Pradeep S', 'Balasubramanian L', 'Liu J', 'Wong KK', 'Mangala LS', 'Armaiz-Pena GN', 'Lopez-Berestein G', 'Sood AK', 'Birrer MJ', 'Mok SC']","['Actins/metabolism', 'Adenocarcinoma/metabolism', 'Calcium/metabolism', 'Cell Line, Tumor', 'Cell Movement', 'Contractile Proteins/*metabolism', 'Cyclic AMP Response Element-Binding Protein/*metabolism', 'Female', 'Focal Adhesion Protein-Tyrosine Kinases/*metabolism', 'Gene Expression Regulation, Neoplastic', 'Gene Silencing', 'Glycoproteins/*metabolism', 'Humans', 'Immunohistochemistry', 'Intercellular Signaling Peptides and Proteins', 'Neoplasm Metastasis', 'Ovarian Neoplasms/*metabolism', 'Prognosis', 'RNA, Small Interfering/metabolism', '*Signal Transduction', 'Stromal Cells/cytology', 'Treatment Outcome', 'Troponin C/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25277212/
442,TNNC1,39248034,Investigating TNNC1 gene inheritance and clinical outcomes through a comprehensive familial study.,"['Patsalis C', 'Kyriakou S', 'Georgiadou M', 'Ioannou L', 'Constantinou L', 'Soteriou V', 'Jossif A', 'Evangelidou P', 'Sismani C', 'Kypri E', 'Ioannides M', 'Koumbaris G']","['Humans', 'Infant', '*Cardiomyopathy, Hypertrophic/genetics/diagnosis/pathology', 'Genetic Predisposition to Disease', 'Genetic Testing', 'Homozygote', 'Mutation/genetics', 'Pedigree', 'Phenotype', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/39248034/
443,TNNC1,32946432,TNNC1 Reduced Gemcitabine Sensitivity of Nonsmall-Cell Lung Cancer by Increasing Autophagy.,"['Ye X', 'Xie G', 'Liu Z', 'Tang J', 'Cui M', 'Wang C', 'Guo C', 'Tang J']","['A549 Cells', 'Carcinoma, Non-Small-Cell Lung/drug therapy/genetics/*metabolism/pathology', 'Deoxycytidine/*analogs & derivatives/pharmacology', '*Drug Resistance, Neoplasm', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Lung Neoplasms/drug therapy/genetics/*metabolism/pathology', 'Neoplasm Proteins/*biosynthesis/genetics', 'Troponin C/*biosynthesis/genetics', 'Gemcitabine']",https://pubmed.ncbi.nlm.nih.gov/32946432/
444,TNNC1,33592378,TNNC1 knockout reverses metastatic potential of ovarian cancer cells by inactivating epithelial-mesenchymal transition and suppressing F-actin polymerization.,"['Yin JH', 'Elumalai P', 'Kim SY', 'Zhang SZ', 'Shin S', 'Lee M', 'Chung YJ']","['Actins/*metabolism', 'Antigens, CD/metabolism', 'CRISPR-Cas Systems', 'Cadherins/metabolism', 'Cell Line, Tumor', 'Cell Proliferation', 'Epithelial-Mesenchymal Transition', 'Female', 'Gene Knockdown Techniques/methods', 'Glycogen Synthase Kinase 3 beta/metabolism', 'Humans', 'Neoplasm Metastasis', 'Ovarian Neoplasms/genetics/metabolism/pathology/*prevention & control', 'Proto-Oncogene Proteins c-akt/metabolism', 'Troponin I/genetics/*metabolism', 'Vimentin/metabolism', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/33592378/
445,TNNC1,9365790,Assignment of the human cardiac/slow skeletal muscle troponin C gene (TNNC1) between D3S3118 and GCT4B10 on the short arm of chromosome 3 by somatic cell hybrid analysis.,"['Townsend PJ', 'Yacoub MH', 'Barton PJ']","['*Chromosome Mapping', 'Chromosomes, Human, Pair 3/*genetics', 'Genes/genetics', 'Humans', 'Hybrid Cells', 'Lod Score', 'Troponin C/*genetics']",https://pubmed.ncbi.nlm.nih.gov/9365790/
446,TNNC1,27604170,Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy.,"['Ploski R', 'Rydzanicz M', 'Ksiazczyk TM', 'Franaszczyk M', 'Pollak A', 'Kosinska J', 'Michalak E', 'Stawinski P', 'Ziolkowska L', 'Bilinska ZT', 'Werner B']","['Alleles', 'Cardiomyopathy, Restrictive/*diagnosis/*genetics', 'Electrocardiography', 'Fatal Outcome', 'Female', '*Genes, Recessive', 'Genetic Association Studies', 'Genotype', 'Heart Function Tests', 'Humans', 'Infant', 'Magnetic Resonance Imaging', '*Mutation', 'Phenotype', 'Radiography, Thoracic', 'Troponin C/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27604170/
447,TNNC1,27713166,MFAP5 and TNNC1: Potential markers for predicting occult cervical lymphatic metastasis and prognosis in early stage tongue cancer.,"['Yang X', 'Wu K', 'Li S', 'Hu L', 'Han J', 'Zhu D', 'Tian X', 'Liu W', 'Tian Z', 'Zhong L', 'Yan M', 'Zhang C', 'Zhang Z']","['Biomarkers, Tumor/*genetics/metabolism', 'Carcinoma, Squamous Cell/genetics/metabolism/*pathology', 'Cervix Uteri', 'Contractile Proteins/*genetics/metabolism', 'Female', 'Gene Expression Profiling', 'Gene Expression Regulation, Neoplastic', 'Glycoproteins/*genetics/metabolism', 'Humans', 'Intercellular Signaling Peptides and Proteins', 'Lymphatic Metastasis', 'Neoplasm Staging', 'Oligonucleotide Array Sequence Analysis', 'Prognosis', 'Survival Analysis', 'Tongue Neoplasms/genetics/metabolism/*pathology', 'Troponin C/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/27713166/
448,TNNC1,22815480,"A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.","['Parvatiyar MS', 'Landstrom AP', 'Figueiredo-Freitas C', 'Potter JD', 'Ackerman MJ', 'Pinto JR']","['Alleles', 'Binding Sites', 'Calcium/chemistry/metabolism', 'Cardiomyopathy, Hypertrophic/*genetics/physiopathology', 'Circular Dichroism', 'Cloning, Molecular', 'Cohort Studies', '*Genetic Predisposition to Disease', 'Humans', 'Molecular Conformation', '*Mutation', 'Myocardium/*metabolism', 'Myofibrils/metabolism', 'Myosins/chemistry', 'Troponin C/*genetics/*metabolism', 'Ventricular Fibrillation/*genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/22815480/
449,TNNC1,38265681,"Paeonol upregulates expression of tumor suppressors TNNC1 and SCARA5, exerting anti-tumor activity in non-small cell lung cancer cells.","['Zhang C', 'Zhang J', 'Guo K']","['Humans', '*Acetophenones/pharmacology', 'Antineoplastic Agents, Phytogenic/pharmacology/therapeutic use', '*Apoptosis/drug effects', '*Carcinoma, Non-Small-Cell Lung/drug therapy/genetics/pathology', 'Caspase 3/metabolism/genetics', 'Cell Line, Tumor', 'Cell Survival/drug effects', 'Gene Expression Regulation, Neoplastic/drug effects', '*Lung Neoplasms/drug therapy/genetics/pathology', 'Proto-Oncogene Proteins c-akt/metabolism', '*Up-Regulation/drug effects']",https://pubmed.ncbi.nlm.nih.gov/38265681/
450,TNNC1,20215591,"Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy.","['Hershberger RE', 'Norton N', 'Morales A', 'Li D', 'Siegfried JD', 'Gonzalez-Quintana J']","['Amino Acid Substitution', 'Cardiac Myosins/*genetics', 'Cardiomyopathy, Dilated/*genetics', 'Carrier Proteins/*genetics', 'Cohort Studies', 'Haplotypes', 'Humans', 'Myosin Heavy Chains/*genetics', 'Polymorphism, Single Nucleotide', 'RNA Splicing', 'Sequence Analysis, DNA', 'Tropomyosin/*genetics', 'Troponin C/*genetics', 'Troponin I/*genetics']",https://pubmed.ncbi.nlm.nih.gov/20215591/
451,TNNC1,36814108,A novel variant of TNNC1 associated with severe dilated cardiomyopathy causing infant mortality and stillbirth: a case of germline mosaicism.,"['Udani R', 'Schilter KF', 'Tyler RC', 'Smith BA', 'Wendtandrae JL', 'Kappes UP', 'Scharer G', 'Lehman A', 'Steinraths M', 'Reddi HV']","['Female', 'Humans', 'Infant, Newborn', 'Pregnancy', '*Cardiomyopathy, Dilated/genetics/mortality', 'Infant Mortality', 'Mosaicism', 'Mutation', 'Stillbirth/genetics', '*Troponin C/genetics']",https://pubmed.ncbi.nlm.nih.gov/36814108/
452,TNNC1,34502534,De Novo Missense Mutations in TNNC1 and TNNI3 Causing Severe Infantile Cardiomyopathy Affect Myofilament Structure and Function and Are Modulated by Troponin Targeting Agents.,"['Hassoun R', 'Budde H', 'Mannherz HG', 'Lodi M', 'Fujita-Becker S', 'Laser KT', 'Gartner A', 'Klingel K', 'Mohner D', 'Stehle R', 'Sultana I', 'Schaaf T', 'Majchrzak M', 'Krause V', 'Herrmann C', 'Nowaczyk MM', 'Mugge A', 'Pfitzer G', 'Schroder RR', 'Hamdani N', 'Milting H', 'Jaquet K', 'Cimiotti D']","['Adenosine Triphosphatases/metabolism', 'Adult', 'Calcium/metabolism', 'Cardiomyopathies/*genetics/metabolism/pathology', 'Catechin/analogs & derivatives/pharmacology', 'Humans', 'Infant', 'Male', 'Microscopy, Electron, Transmission', '*Mutation, Missense', 'Myofibrils/drug effects/*metabolism/ultrastructure', 'Sarcomeres/drug effects/metabolism', 'Severity of Illness Index', 'Simendan/pharmacology', 'Tropomyosin/metabolism', 'Troponin I/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34502534/
453,TNNC1,21262074,Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death.,"['Chung WK', 'Kitner C', 'Maron BJ']","['Adolescent', 'Cardiomyopathy, Hypertrophic/*genetics', 'Death, Sudden, Cardiac', 'Female', 'Frameshift Mutation/*genetics', '*Genetic Predisposition to Disease', 'Genetic Testing', 'Humans', 'Male', 'Middle Aged', 'Mutation/genetics', 'Pedigree', 'Troponin C/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21262074/
454,TNNC1,35838319,The effect of Mg(2+) on Ca(2+) binding to cardiac troponin C in hypertrophic cardiomyopathy associated TNNC1 variants.,"['Rayani K', 'Hantz ER', 'Haji-Ghassemi O', 'Li AY', 'Spuches AM', 'Van Petegem F', 'Solaro RJ', 'Lindert S', 'Tibbits GF']","['Humans', '*Cardiomyopathy, Hypertrophic/genetics']",https://pubmed.ncbi.nlm.nih.gov/35838319/
455,PLA2G4A,38454407,PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer.,"['Chen M', 'Zhang C', 'Li H', 'Zheng S', 'Li Y', 'Yuan M', 'Chen Y', 'Wu J', 'Sun Q']","['Humans', 'Biomarkers', 'Discriminant Analysis', 'Glycerophospholipids', 'Group III Phospholipases A2', 'Group IV Phospholipases A2', 'Lipid Metabolism/genetics', 'Lipids', '*Stomach Neoplasms/drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/38454407/
456,PLA2G4A,15041036,A study of a genetic association between the PTGS2/PLA2G4A locus and schizophrenia.,"['Wei J', 'Hemmings GP']","['Adult', 'Alleles', 'Cyclooxygenase 2', 'Female', 'Genetic Predisposition to Disease/*genetics', 'Haplotypes/genetics', 'Humans', 'Male', 'Membrane Proteins', 'Phospholipases A/*genetics', 'Polymerase Chain Reaction', 'Polymorphism, Single Nucleotide/genetics', 'Prostaglandin-Endoperoxide Synthases/*genetics', 'Schizophrenia/*genetics', 'United Kingdom', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/15041036/
457,PLA2G4A,33040229,LncRNA NEAT1 regulates chondrocyte proliferation and apoptosis via targeting miR-543/PLA2G4A axis.,"['Xiao P', 'Zhu X', 'Sun J', 'Zhang Y', 'Qiu W', 'Li J', 'Wu X']","['Aged', 'Apoptosis/*genetics', 'Cartilage, Articular/cytology/pathology', 'Cell Proliferation/*genetics', 'Cells, Cultured', 'Chondrocytes/pathology/*physiology', 'Disease Progression', 'Female', 'Gene Expression/*genetics', 'Gene Expression Regulation, Developmental/*genetics', 'Group IV Phospholipases A2/*genetics/*metabolism', 'Humans', 'Male', 'MicroRNAs/*genetics/*metabolism', 'Middle Aged', 'Osteoarthritis/*genetics/*pathology', 'RNA, Long Noncoding/*physiology']",https://pubmed.ncbi.nlm.nih.gov/33040229/
458,PLA2G4A,22358383,PLA2G4A mutants modified protective effect of tea consumption against colorectal cancer.,"['Yu Y', 'Zhang M', 'Pan Y', 'Jin M', 'Jiang X', 'Zhang S', 'Wu Y', 'Ni Q', 'Li Q', 'Chen K']","['Colorectal Neoplasms/*enzymology/*genetics', 'Demography', '*Drinking Behavior', 'Female', 'Genetic Predisposition to Disease', 'Group IV Phospholipases A2/*genetics', 'Haplotypes/genetics', 'Humans', 'Male', 'Middle Aged', 'Mutation/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Protective Agents/*metabolism', 'Risk Factors', 'Tea/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/22358383/
459,PLA2G4A,34502319,A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.,"['Hassan JJ', 'Lieske A', 'Dorpmund N', 'Klatt D', 'Hoffmann D', 'Kleppa MJ', 'Kustikova OS', 'Stahlhut M', 'Schwarzer A', 'Schambach A', 'Maetzig T']","['Apoptosis', 'Biomarkers, Tumor/genetics/*metabolism', '*CRISPR-Cas Systems', 'Cell Proliferation', '*Gene Expression Regulation, Neoplastic', 'Group IV Phospholipases A2/*antagonists & inhibitors/genetics', 'High-Throughput Screening Assays', 'Homeodomain Proteins/genetics/*metabolism', 'Humans', 'Leukemia, Myeloid, Acute/genetics/metabolism/*pathology', 'Myeloid Ecotropic Viral Integration Site 1 Protein/genetics/*metabolism', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/34502319/
460,PLA2G4A,30103930,An association between the BanI polymorphism of the PLA2G4A gene for calcium-dependent phospholipase A2 and plasma glucose levels among females with schizophrenia.,"['Nadalin S', 'Buretic-Tomljanovic A']","['Adult', 'Blood Glucose/*metabolism', 'Croatia', 'Female', 'Genetic Association Studies', 'Group IV Phospholipases A2/*genetics/*metabolism', 'Humans', 'Lipid Metabolism', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Schizophrenia/blood/*genetics/metabolism', 'Sex Factors']",https://pubmed.ncbi.nlm.nih.gov/30103930/
461,PLA2G4A,31492557,Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway.,"['Sun R', 'Liu Z', 'Qiu B', 'Chen T', 'Li Z', 'Zhang X', 'Xu Y', 'Zhang Z']","['Adult', 'Aged', 'Annexins/*genetics', 'Bile Duct Neoplasms/*etiology/*metabolism/mortality/pathology', 'Biomarkers', 'Cell Line, Tumor', 'Cholangiocarcinoma/*etiology/*metabolism/mortality/pathology', 'Dinoprostone', 'Epithelial-Mesenchymal Transition/*genetics', 'Female', 'Gene Expression', 'Gene Expression Profiling', 'Group IV Phospholipases A2', 'Humans', 'Immunohistochemistry', 'Male', 'Middle Aged', 'Neoplasm Grading', 'Neoplasm Staging', 'Prognosis', 'STAT3 Transcription Factor', '*Signal Transduction', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/31492557/
462,PLA2G4A,35089606,ATF6alpha promotes prostate cancer progression by enhancing PLA2G4A-mediated arachidonic acid metabolism and protecting tumor cells against ferroptosis.,"['Zhao R', 'Lv Y', 'Feng T', 'Zhang R', 'Ge L', 'Pan J', 'Han B', 'Song G', 'Wang L']","['Activating Transcription Factor 6/*metabolism', 'Androgen Antagonists/therapeutic use', 'Arachidonic Acid/therapeutic use', 'Cell Line, Tumor', 'Dinoprostone', '*Ferroptosis', 'Group IV Phospholipases A2', 'Humans', 'Male', 'Neoplasm Recurrence, Local', '*Prostatic Neoplasms, Castration-Resistant/drug therapy', 'Receptors, Androgen/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35089606/
463,PLA2G4A,22378731,Association of PLA2G4A with myocardial infarction is modulated by dietary PUFAs.,"['Hartiala J', 'Gilliam E', 'Vikman S', 'Campos H', 'Allayee H']","['Aged', 'Aorta/cytology/metabolism', 'Case-Control Studies', 'Cells, Cultured', 'Costa Rica/epidemiology', '*Diet', 'Endothelium, Vascular/cytology/metabolism', 'Fatty Acids, Omega-6/*administration & dosage', 'Female', 'Gene Expression Regulation, Enzymologic', 'Genetic Association Studies', 'Group IV Phospholipases A2/*genetics', 'Humans', 'Male', 'Middle Aged', 'Myocardial Infarction/epidemiology/*genetics', '*Polymorphism, Single Nucleotide', 'RNA, Messenger/metabolism', 'Risk', 'Surveys and Questionnaires']",https://pubmed.ncbi.nlm.nih.gov/22378731/
464,PLA2G4A,32077754,PLA2G4A Is a Potential Biomarker Predicting Shorter Overall Survival in Patients with Non-M3/NPM1 Wildtype Acute Myeloid Leukemia.,"['Bai H', 'Zhou M', 'Zeng M', 'Han L']","['ATPases Associated with Diverse Cellular Activities/metabolism', 'Biomarkers, Tumor/*genetics', 'Carrier Proteins/metabolism', 'Cell Cycle Proteins/metabolism', 'Computational Biology', 'Cytoskeletal Proteins/metabolism', 'DNA Helicases/metabolism', 'DNA-Binding Proteins/metabolism', 'Disease-Free Survival', 'Female', 'Group IV Phospholipases A2/*genetics/*metabolism', 'Humans', 'Leukemia, Myeloid, Acute/*genetics/mortality/pathology', 'Male', 'Nuclear Proteins/genetics', 'Nucleophosmin', 'STAT3 Transcription Factor/metabolism', 'Transcription Factors/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32077754/
465,PLA2G4A,23145155,HERV-E-mediated modulation of PLA2G4A transcription in urothelial carcinoma.,"['Gosenca D', 'Gabriel U', 'Steidler A', 'Mayer J', 'Diem O', 'Erben P', 'Fabarius A', 'Leib-Mosch C', 'Hofmann WK', 'Seifarth W']","['Carcinoma/genetics/pathology/*virology', 'Cell Line, Tumor', 'Endogenous Retroviruses/*genetics', 'Gene Expression Regulation, Neoplastic', 'Group IV Phospholipases A2/*genetics', 'Humans', 'Oligonucleotide Array Sequence Analysis', 'RNA, Messenger/metabolism', '*Transcription, Genetic', 'Urologic Neoplasms/genetics/pathology/*virology', 'Urothelium/metabolism/virology']",https://pubmed.ncbi.nlm.nih.gov/23145155/
466,PLA2G4A,26398624,"Association study of genetic variants in PLA2G4A, PLCG1, LAT, SYK, and TNFRS11A genes in NSAIDs-induced urticaria and/or angioedema patients.","['Ayuso P', 'Plaza-Seron Mdel C', 'Dona I', 'Blanca-Lopez N', 'Campo P', 'Cornejo-Garcia JA', 'Perkins JR', 'Torres MJ', 'Blanca M', 'Canto G']","['Adaptor Proteins, Signal Transducing/*genetics', 'Adult', 'Alleles', 'Angioedema/*chemically induced/genetics', 'Anti-Inflammatory Agents, Non-Steroidal/*adverse effects', 'Case-Control Studies', 'Female', 'Genetic Association Studies', 'Group IV Phospholipases A2/*genetics', 'Haplotypes', 'Humans', 'Intracellular Signaling Peptides and Proteins/*genetics', 'Male', 'Membrane Proteins/*genetics', 'Phospholipase C gamma/*genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Protein-Tyrosine Kinases/*genetics', 'Receptor Activator of Nuclear Factor-kappa B/*genetics', 'Syk Kinase', 'Urticaria/*chemically induced/genetics']",https://pubmed.ncbi.nlm.nih.gov/26398624/
467,PLA2G4A,23219238,"The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients.","['Nadalin S', 'Giacometti J', 'Jonovska S', 'Tomljanovic D', 'Buretic-Tomljanovic A']","['Adult', 'Cyclooxygenase 2/*genetics', 'Erythrocytes/*metabolism', 'Fatty Acids, Unsaturated/*deficiency', 'Female', 'Genotype', 'Genotyping Techniques', 'Group IV Phospholipases A2/*genetics', 'Humans', 'Male', 'Middle Aged', '*Niacin', 'Polymorphism, Genetic/*genetics', 'Schizophrenia/*genetics/*metabolism', 'Skin/*metabolism', 'Skin Tests/methods', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23219238/
468,CTSG,34017121,"Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation.","['Cheung P', 'Schaffert S', 'Chang SE', 'Dvorak M', 'Donato M', 'Macaubas C', 'Foecke MH', 'Li TM', 'Zhang L', 'Coan JP', 'Schulert GS', 'Grom AA', 'Henderson LA', 'Nigrovic PA', 'Elias JE', 'Gozani O', 'Mellins ED', 'Khatri P', 'Utz PJ', 'Kuo AJ']","['Adolescent', 'Arthritis, Juvenile/blood/genetics/*immunology', 'CRISPR-Cas Systems/genetics', 'Cathepsin G/genetics/metabolism', 'Cell Differentiation/genetics/*immunology', 'Cell Nucleus/metabolism', 'Child', 'Child, Preschool', 'Chromatin/metabolism', 'Enzyme Assays', 'Epigenesis, Genetic/*immunology', 'Epigenomics', 'Female', 'Gene Knockout Techniques', 'Histones/*metabolism', 'Humans', 'Jurkat Cells', 'Leukocyte Elastase/genetics/metabolism', 'Leukocytes, Mononuclear/immunology/*metabolism', 'Macrophages/*immunology/metabolism', 'Male', 'Myeloblastin/genetics/metabolism', 'Primary Cell Culture', 'Proteolysis', 'RNA-Seq', 'Recombinant Proteins/genetics/metabolism', 'THP-1 Cells', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34017121/
469,CTSG,37151875,CTSG Suppresses Colorectal Cancer Progression through Negative Regulation of Akt/mTOR/Bcl2 Signaling Pathway.,"['Chan S', 'Wang X', 'Wang Z', 'Du Y', 'Zuo X', 'Chen J', 'Sun R', 'Zhang Q', 'Lin L', 'Yang Y', 'Yu Z', 'Zhao H', 'Zhang H', 'Chen W']","['Humans', '*Proto-Oncogene Proteins c-akt/metabolism', 'Cathepsin G/genetics/metabolism', '*Colorectal Neoplasms/metabolism', 'Signal Transduction/genetics', 'TOR Serine-Threonine Kinases/genetics/metabolism', 'Cell Proliferation', 'Gene Expression Regulation, Neoplastic', 'Cell Line, Tumor', 'Proto-Oncogene Proteins c-bcl-2/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37151875/
470,CTSG,39122654,CTSG polymorphisms in Chinese children with type 1 diabetes mellitus.,"['Li J', 'Zhang M', 'Zhang S', 'Wang R', 'Cai Y', 'Chen X', 'Dong Y', 'Wang P', 'Shu J', 'Lv L', 'Cai C']","['Adolescent', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Male', 'Alleles', 'Biomarkers/blood', 'Case-Control Studies', 'China/epidemiology', '*Diabetes Mellitus, Type 1/genetics', 'East Asian People', 'Enzyme-Linked Immunosorbent Assay', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Polymerase Chain Reaction', 'Polymorphism, Single Nucleotide', '*Cathepsin G/genetics']",https://pubmed.ncbi.nlm.nih.gov/39122654/
471,CTSG,32813288,Role of DNA methylation on human CTSG in dermatomyositic myoideum.,"['Peng Y', 'Sun X', 'Liang Y']","['Adult', 'Cathepsin G/genetics/*metabolism', 'Cell Line', 'China', 'CpG Islands/genetics', 'Cytokines/metabolism', 'DNA (Cytosine-5-)-Methyltransferase 1/genetics', 'DNA (Cytosine-5-)-Methyltransferases/genetics/metabolism', 'DNA Methylation/*genetics', 'DNA Methyltransferase 3A', 'Dermatomyositis/*genetics/metabolism', 'Epigenesis, Genetic/genetics', 'Female', 'Gene Expression/genetics', 'Gene Expression Regulation/genetics', 'Humans', 'I-kappa B Proteins/metabolism', 'Male', 'NF-kappa B/metabolism', 'Promoter Regions, Genetic/genetics', 'Signal Transduction/genetics', 'DNA Methyltransferase 3B']",https://pubmed.ncbi.nlm.nih.gov/32813288/
472,CTSG,33245176,Gene body methylation facilitates the transcription of CTSG via antisense lncRNA AL136018.1 in dermatomyositic myoideum.,"['Liang Y', 'Peng Y']","['Cathepsin G/*metabolism', 'Cell Line', 'DNA Methylation', '*Dermatomyositis/genetics/metabolism', 'Epigenesis, Genetic', 'Humans', 'RNA, Long Noncoding/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33245176/
473,CANT1,38369265,"Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.","['Yang W', 'Liu Z', 'Liu T']","['Humans', 'Prognosis', '*Carcinoma, Transitional Cell', '*Urinary Bladder Neoplasms', '*Adenocarcinoma of Lung', '*Carcinoma, Renal Cell', '*Lung Neoplasms', '*Kidney Neoplasms', 'Biomarkers', 'RNA, Messenger/genetics', 'Nucleotidases']",https://pubmed.ncbi.nlm.nih.gov/38369265/
474,CANT1,20425819,Mutation of CANT1 causes Desbuquois dysplasia.,"['Faden M', 'Al-Zahrani F', 'Arafah D', 'Alkuraya FS']","['Abnormalities, Multiple/diagnostic imaging/*genetics', 'Base Sequence', 'DNA Mutational Analysis', 'Facies', 'Female', 'Hand Deformities, Congenital/diagnostic imaging/genetics', 'Homozygote', 'Humans', 'Infant, Newborn', 'Male', 'Molecular Sequence Data', 'Mutation/*genetics', 'Nucleotidases/*genetics', 'Pregnancy', 'Radiography']",https://pubmed.ncbi.nlm.nih.gov/20425819/
475,CANT1,33675611,The effect and mechanism of miR-607/CANT1 axis in lung squamous carcinoma.,"['Qiao G', 'Wang HB', 'Duan XN', 'Yan XF']","['Biomarkers, Tumor', 'Carcinoma, Squamous Cell/*pathology', 'Cell Line, Tumor', 'Cell Survival', 'Down-Regulation', 'Fibronectins/biosynthesis', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Lung Neoplasms/*pathology', 'MicroRNAs/*metabolism', 'Nucleotidases/*metabolism', 'Vimentin/biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/33675611/
476,CANT1,22539336,Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis.,"['Nizon M', 'Huber C', 'De Leonardis F', 'Merrina R', 'Forlino A', 'Fradin M', 'Tuysuz B', 'Abu-Libdeh BY', 'Alanay Y', 'Albrecht B', 'Al-Gazali L', 'Basaran SY', 'Clayton-Smith J', 'Desir J', 'Gill H', 'Greally MT', 'Koparir E', 'van Maarle MC', 'MacKay S', 'Mortier G', 'Morton J', 'Sillence D', 'Vilain C', 'Young I', 'Zerres K', 'Le Merrer M', 'Munnich A', 'Le Goff C', 'Rossi A', 'Cormier-Daire V']","['Cells, Cultured', 'Chromatography, Gel', 'Craniofacial Abnormalities/genetics/metabolism', 'Dwarfism/genetics/metabolism', 'Glycosides/metabolism', 'Humans', 'Joint Instability/genetics/metabolism', 'Mutation', 'Nucleotidases/genetics/*metabolism', 'Ossification, Heterotopic/genetics/metabolism', 'Polydactyly/genetics/metabolism', 'Proteoglycans/*metabolism', 'Sulfotransferases', 'Carbohydrate Sulfotransferases']",https://pubmed.ncbi.nlm.nih.gov/22539336/
477,CANT1,32366932,LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kgamma promoter.,"['Ni H', 'Chai P', 'Yu J', 'Xing Y', 'Wang S', 'Fan J', 'Ge S', 'Wang Y', 'Jia R', 'Fan X']","['Carcinogenesis/genetics/pathology', 'Cell Line', 'Class Ib Phosphatidylinositol 3-Kinase/*metabolism', '*Disease Progression', 'Down-Regulation/genetics', 'Gene Expression Regulation, Neoplastic', 'Histone-Lysine N-Methyltransferase/*metabolism', 'Histones/metabolism', 'Humans', 'Lysine/metabolism', 'Methylation', '*Promoter Regions, Genetic', 'Protein Binding', 'Proto-Oncogene Proteins c-akt/metabolism', 'RNA, Long Noncoding/genetics/*metabolism', 'Retinoblastoma/*genetics/*pathology', 'Signal Transduction', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/32366932/
478,CANT1,37858061,Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.,"['Liu T', 'Li ZZ', 'Sun L', 'Yang K', 'Chen JM', 'Han XY', 'Qi LM', 'Zhou XG', 'Wang P']","['Humans', '*Carcinoma, Hepatocellular/genetics', '*Liver Neoplasms/genetics', 'Hydrolases', 'Oncogenes', 'Phosphoric Monoester Hydrolases', 'Prognosis', 'Nucleotidases']",https://pubmed.ncbi.nlm.nih.gov/37858061/
479,CANT1,35090419,CANT1 serves as a potential prognostic factor for lung adenocarcinoma and promotes cell proliferation and invasion in vitro.,"['Yao Q', 'Yu Y', 'Wang Z', 'Zhang M', 'Ma J', 'Wu Y', 'Zheng Q', 'Li J']","['Adenocarcinoma of Lung/*genetics/*mortality', 'Aged', 'Biomarkers, Tumor/genetics', 'Cell Proliferation/genetics', 'DNA Damage/genetics', 'DNA Methylation/genetics', 'Female', 'Gene Ontology', 'Humans', 'Lung Neoplasms/*genetics/*mortality', 'Male', 'Nucleotidases/*metabolism', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/35090419/
480,CANT1,21412251,A founder mutation of CANT1 common in Korean and Japanese Desbuquois dysplasia.,"['Dai J', 'Kim OH', 'Cho TJ', 'Miyake N', 'Song HR', 'Karasugi T', 'Sakazume S', 'Ikema M', 'Matsui Y', 'Nagai T', 'Matsumoto N', 'Ohashi H', 'Kamatani N', 'Nishimura G', 'Furuichi T', 'Takahashi A', 'Ikegawa S']","['Bone Diseases, Developmental/*genetics', '*Founder Effect', 'Haplotypes', 'Humans', 'Japan', 'Korea', 'Mutation/*genetics', 'Nucleotidases/*genetics', 'Polymorphism, Single Nucleotide/genetics']",https://pubmed.ncbi.nlm.nih.gov/21412251/
481,CANT1,28742282,MED resulting from recessively inherited mutations in the gene encoding calcium-activated nucleotidase CANT1.,"['Balasubramanian K', 'Li B', 'Krakow D', 'Nevarez L', 'Ho PJ', 'Ainsworth JA', 'Nickerson DA', 'Bamshad MJ', 'Immken L', 'Lachman RS', 'Cohn DH']","['Adult', 'Base Sequence', 'Child', 'Child, Preschool', 'Exome/genetics', 'Female', '*Genes, Recessive', 'Humans', 'Male', 'Mutation, Missense/genetics', 'Nucleotidases/*genetics', 'Osteochondrodysplasias/diagnostic imaging/*genetics/physiopathology', 'Pedigree', 'Radiography']",https://pubmed.ncbi.nlm.nih.gov/28742282/
482,CANT1,25486376,A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type.,"['Singh A', 'Kim OH', 'Iida A', 'Park WY', 'Ikegawa S', 'Kapoor S']","['Adolescent', 'Child', 'Craniofacial Abnormalities/*genetics', 'Dwarfism/*genetics', 'Female', 'Humans', 'India', 'Joint Instability/*genetics', 'Male', 'Mutation', 'Nucleotidases/*genetics', 'Ossification, Heterotopic/*genetics', 'Polydactyly/*genetics', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/25486376/
483,CANT1,19853239,Identification of CANT1 mutations in Desbuquois dysplasia.,"['Huber C', 'Oules B', 'Bertoli M', 'Chami M', 'Fradin M', 'Alanay Y', 'Al-Gazali LI', 'Ausems MG', 'Bitoun P', 'Cavalcanti DP', 'Krebs A', 'Le Merrer M', 'Mortier G', 'Shafeghati Y', 'Superti-Furga A', 'Robertson SP', 'Le Goff C', 'Muda AO', 'Paterlini-Brechot P', 'Munnich A', 'Cormier-Daire V']","[""5' Untranslated Regions"", 'Adolescent', 'Adult', 'Amino Acid Sequence', 'Amino Acid Substitution', 'Arginine/metabolism', 'Bone Diseases, Developmental/diagnostic imaging/*genetics', 'Calcium/*metabolism', 'Cells, Cultured', 'Child, Preschool', 'Chondrocytes/metabolism', 'Chromosomes, Human, Pair 17', 'Codon, Nonsense', 'Consanguinity', 'Endoplasmic Reticulum, Rough/ultrastructure', 'Exons', 'Fatal Outcome', 'Female', 'Fibroblasts/ultrastructure', 'Homozygote', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Molecular Sequence Data', '*Mutation', 'Mutation, Missense', 'Nuclear Family', 'Nucleotidases/*genetics', 'RNA, Messenger/metabolism', 'Radiography']",https://pubmed.ncbi.nlm.nih.gov/19853239/
484,CANT1,21435463,The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro.,"['Gerhardt J', 'Steinbrech C', 'Buchi O', 'Behnke S', 'Bohnert A', 'Fritzsche F', 'Liewen H', 'Stenner F', 'Wild P', 'Hermanns T', 'Muntener M', 'Dietel M', 'Jung K', 'Stephan C', 'Kristiansen G']","['Aged', 'Androgens/metabolism', 'Biomarkers, Tumor', 'Cell Line, Tumor', 'Cell Movement', 'Cell Proliferation', 'G1 Phase', 'Gene Expression Profiling', '*Gene Expression Regulation, Neoplastic', 'Humans', 'In Vitro Techniques', 'Male', 'Middle Aged', 'Nucleotidases/*biosynthesis', 'Prognosis', 'Prostatic Intraepithelial Neoplasia/*metabolism', 'Prostatic Neoplasms/*metabolism', 'RNA Interference']",https://pubmed.ncbi.nlm.nih.gov/21435463/
485,ADCY9,33326832,The ADCY9 genetic variants are associated with glioma susceptibility and patient prognosis.,"['Zhang G', 'Xi M', 'Li Y', 'Wang L', 'Gao L', 'Zhang L', 'Yang Z', 'Shi H']","['Adenylyl Cyclases/*genetics', 'Adult', 'Brain Neoplasms/*genetics/pathology', 'Female', 'Glioma/*genetics/pathology', 'Humans', 'Male', '*Polymorphism, Single Nucleotide', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/33326832/
486,ADCY9,34609279,A sex-specific evolutionary interaction between ADCY9 and CETP.,"['Gamache I', 'Legault MA', 'Grenier JC', 'Sanchez R', 'Rheaume E', 'Asgari S', 'Barhdadi A', 'Zada YF', 'Trochet H', 'Luo Y', 'Lecca L', 'Murray M', 'Raychaudhuri S', 'Tardif JC', 'Dube MP', 'Hussin J']","['Adenylyl Cyclases/*genetics/metabolism', 'Adult', 'Aged', 'Amides/*pharmacology', 'Anticholesteremic Agents/*pharmacology', 'Biological Evolution', 'Cholesterol Ester Transfer Proteins/*genetics/metabolism', 'Esters/*pharmacology', 'Female', 'Gene Expression Profiling', 'Humans', '*Linkage Disequilibrium', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Sex Factors', 'Sulfhydryl Compounds/*pharmacology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34609279/
487,ADCY9,33232543,Assessment of ADCY9 polymorphisms and colorectal cancer risk in the Chinese Han population.,"['Li H', 'Liu Y', 'Liu J', 'Sun Y', 'Wu J', 'Xiong Z', 'Zhang Y', 'Li B', 'Jin T']","['Adenylyl Cyclases/*genetics', 'Aged', 'Alleles', 'Asian People/genetics', 'Case-Control Studies', 'China', 'Colorectal Neoplasms/*genetics', 'Female', 'Gene Frequency', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Logistic Models', 'Male', 'Middle Aged', 'Odds Ratio', '*Polymorphism, Single Nucleotide', 'Risk Assessment']",https://pubmed.ncbi.nlm.nih.gov/33232543/
488,ADCY9,37579959,The rs2601796 variant in ADCY9 gene is associated with severe asthma and less bronchodilator response.,"['Teixeira HMP', 'Cruz AA', 'Jesus TS', 'de Santana MBR', 'Jesus MS', 'Tugores R', 'Araujo WS', 'Reis RCC', 'Pinheiro GP', 'Figueiredo CA', 'Costa RS']","['Humans', '*Asthma/drug therapy/genetics', '*Bronchodilator Agents/pharmacology/therapeutic use', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/37579959/
489,ADCY9,34173811,Advancing Beyond Failed High-density Lipoprotein Clinical Trials to Pharmacogenetic Studies of ADCY9 and Cholesterol Ester Transfer Protein Inhibition.,"['Black DM', 'Miller M', 'Heinonen TM', 'Zhang G']","['Adenylyl Cyclases/*genetics/metabolism', 'Amides/*therapeutic use', 'Anticholesteremic Agents/*therapeutic use', 'Atherosclerosis/blood/*drug therapy/genetics', 'Biomarkers/blood', 'Cholesterol Ester Transfer Proteins/*antagonists & inhibitors/metabolism', 'Clinical Decision-Making', 'Clinical Trials as Topic', 'Esters/*therapeutic use', 'Humans', 'Lipoproteins, HDL/*blood', 'Pharmacogenetics', 'Pharmacogenomic Testing', '*Pharmacogenomic Variants', '*Polymorphism, Single Nucleotide', 'Predictive Value of Tests', 'Research Design', 'Sulfhydryl Compounds/*therapeutic use', 'Treatment Failure', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/34173811/
490,ADCY9,21545619,Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy.,"['Kim SH', 'Ye YM', 'Lee HY', 'Sin HJ', 'Park HS']","['Adenylyl Cyclases/*genetics', 'Administration, Inhalation', 'Adrenergic beta-2 Receptor Agonists/administration & dosage/metabolism/*therapeutic use', 'Adult', 'Asthma/*drug therapy/metabolism/physiopathology', 'Bronchodilator Agents/administration & dosage/metabolism/*therapeutic use', 'Budesonide/administration & dosage/metabolism/therapeutic use', 'Drug Therapy, Combination', 'Ethanolamines/administration & dosage/metabolism/therapeutic use', 'Female', 'Formoterol Fumarate', 'Genetic Association Studies', 'Glucocorticoids/administration & dosage/metabolism/*therapeutic use', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Receptors, Adrenergic, beta-2/*genetics', 'Republic of Korea', 'Respiratory System/drug effects/physiopathology', 'Retrospective Studies', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/21545619/
491,ADCY9,29525816,ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study.,"['Nissen SE', 'Pillai SG', 'Nicholls SJ', 'Wolski K', 'Riesmeyer JS', 'Weerakkody GJ', 'Foster WM', 'McErlean E', 'Li L', 'Bhatnagar P', 'Ruotolo G', 'Lincoff AM']","['Adenylyl Cyclases/*genetics', 'Aged', 'Anticholesteremic Agents/*therapeutic use', 'Benzodiazepines/*therapeutic use', 'Cardiovascular Diseases/genetics/*prevention & control', 'Case-Control Studies', 'Cholesterol Ester Transfer Proteins/*antagonists & inhibitors', 'Female', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/*genetics', 'Risk Factors', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/29525816/
492,ADCY9,11840511,"Molecular analysis, mutation screening, and association study of adenylate cyclase type 9 gene (ADCY9) in mood disorders.","['Toyota T', 'Hattori E', 'Meerabux J', 'Yamada K', 'Saito K', 'Shibuya H', 'Nankai M', 'Yoshikawa T']","['Adenylyl Cyclases/chemistry/*genetics', 'Base Sequence', 'Bipolar Disorder/enzymology/*genetics', 'Chromosomes, Human, Pair 16', 'DNA Mutational Analysis', 'DNA, Complementary', 'Depressive Disorder/enzymology/*genetics', 'Female', 'Genetic Testing', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Molecular Sequence Data', 'Polymorphism, Genetic', 'Repetitive Sequences, Nucleic Acid', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/11840511/
493,ADCY8,27651839,"Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.","['Shen-Gunther J', 'Wang CM', 'Poage GM', 'Lin CL', 'Perez L', 'Banks NA', 'Huang TH']","['Adenylyl Cyclases/*genetics', 'Adult', 'Cadherins/*genetics', 'Cell Line, Tumor', 'Cross-Sectional Studies', '*DNA Methylation', 'DNA, Viral/analysis', 'Early Detection of Cancer', 'Female', 'Genotype', 'Humans', 'Kruppel-Like Transcription Factors/*genetics', 'Middle Aged', 'Neoplasm Grading', 'Papanicolaou Test/methods', 'Papillomaviridae/*genetics', 'Papillomavirus Infections/*diagnosis/epidemiology', 'Promoter Regions, Genetic', 'Prospective Studies', 'Sequence Analysis, DNA/methods', 'Squamous Intraepithelial Lesions of the Cervix/epidemiology/genetics/pathology/virology', 'Uterine Cervical Neoplasms/*epidemiology/genetics/*pathology/virology', 'Vaginal Smears/methods', 'Young Adult', 'Uterine Cervical Dysplasia/epidemiology/genetics/pathology/virology']",https://pubmed.ncbi.nlm.nih.gov/27651839/
494,ADCY5,33934385,"An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease.","['Ferrini A', 'Steel D', 'Barwick K', 'Kurian MA']","['Adenylyl Cyclases/genetics', '*Dyskinesias', '*Dystonic Disorders/genetics', 'Genotype', 'Humans', '*Movement Disorders', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/33934385/
495,ADCY5,38230756,ADCY5-related dyskinesia - case series with literature review.,"['Kozon K', 'Lysikowska W', 'Olszewski J', 'Milanowski L', 'Figura M', 'Mazurczak T', 'Hoffman-Zacharska D', 'Koziorowski D']","['Humans', '*Adenylyl Cyclases/genetics', 'Male', 'Middle Aged', 'Child', 'Chorea/genetics', 'Dyskinesias/genetics/etiology', 'Mutation', 'Female']",https://pubmed.ncbi.nlm.nih.gov/38230756/
496,ADCY5,33684620,"By inhibiting ADCY5, miR-18a-3p promotes osteoporosis and possibly contributes to spinal fracture.","['Wang L', 'Dong J', 'Ma J', 'Lu Q', 'Shan B', 'Han T', 'Xie P', 'Zuo X']","['Adenylyl Cyclases/*deficiency/*genetics', 'Base Sequence', 'Calcium/metabolism', 'Genes, Reporter', 'Humans', 'Mesenchymal Stem Cells/cytology/metabolism', 'MicroRNAs/*genetics', 'Osteoblasts/cytology/metabolism', 'Osteogenesis/*genetics', 'Osteoporosis/*genetics/*pathology', 'Spinal Fractures/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/33684620/
497,ADCY5,33704598,Homozygous ADCY5 mutation causes early-onset movement disorder with severe intellectual disability.,"['Okamoto N', 'Miya F', 'Kitai Y', 'Tsunoda T', 'Kato M', 'Saitoh S', 'Kanemura Y', 'Kosaki K']","['Adenylyl Cyclases/genetics', 'Child', '*Dystonic Disorders', 'Humans', '*Intellectual Disability/genetics', '*Movement Disorders/genetics', 'Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/33704598/
498,ADCY5,30172639,Depression and psychosis in ADCY5-related dyskinesia-part of the phenotypic spectrum?,"['Vijiaratnam N', 'Newby R', 'Kempster PA']","['Adenylyl Cyclases/*genetics', 'Adult', 'Depression/complications/*diagnosis/genetics', 'Dyskinesias/complications/*diagnosis/genetics', 'Humans', 'Male', 'Mutation', '*Phenotype', 'Psychotic Disorders/complications/*diagnosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/30172639/
499,ADCY5,36112278,ADCY5 gene mutation: a case report.,"['Tezen D', 'Gunduz A', 'Erdemir Kiziltan M', 'Yalcinkaya C', 'Kiziltan G']","['Humans', 'Female', 'Child, Preschool', '*Adenylyl Cyclases/genetics', '*Dyskinesias', 'Mutation/genetics', 'Muscle Hypotonia', 'Sleep']",https://pubmed.ncbi.nlm.nih.gov/36112278/
500,ADCY5,30345538,PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.,"['Niccolini F', 'Mencacci NE', 'Yousaf T', 'Rabiner EA', 'Salpietro V', 'Pagano G', 'Balint B', 'Efthymiou S', 'Houlden H', 'Gunn RN', 'Wood N', 'Bhatia KP', 'Politis M']","['Adenylyl Cyclases/*genetics', 'Basal Ganglia/metabolism/*pathology', 'Corpus Striatum/metabolism', 'Dopamine Plasma Membrane Transport Proteins/metabolism', 'Globus Pallidus/metabolism', 'Humans', 'Mutation/*genetics', 'Neostriatum/metabolism', 'Neurons/metabolism', 'Parkinsonian Disorders/genetics/pathology', 'Phosphoric Diester Hydrolases/*genetics', 'Substantia Nigra/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/30345538/
501,ADCY5,35384065,Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.,"['Meneret A', 'Mohammad SS', 'Cif L', 'Doummar D', 'DeGusmao C', 'Anheim M', 'Barth M', 'Damier P', 'Demonceau N', 'Friedman J', 'Gallea C', 'Gras D', 'Gurgel-Giannetti J', 'Innes EA', 'Necpal J', 'Riant F', 'Sagnes S', 'Sarret C', 'Seliverstov Y', 'Paramanandam V', 'Shetty K', 'Tranchant C', 'Doulazmi M', 'Vidailhet M', 'Pringsheim T', 'Roze E']","['Adenylyl Cyclases/genetics', 'Caffeine/therapeutic use', 'Child', '*Dyskinesias/etiology/genetics', 'Humans', '*Movement Disorders/genetics', 'Retrospective Studies']",https://pubmed.ncbi.nlm.nih.gov/35384065/
502,ADCY5,28229249,ADCY5-related dyskinesia presenting as familial myoclonus-dystonia.,"['Douglas AG', 'Andreoletti G', 'Talbot K', 'Hammans SR', 'Singh J', 'Whitney A', 'Ennis S', 'Foulds NC']","['Adenylyl Cyclases/*genetics', 'Adolescent', 'Adult', 'Child, Preschool', 'Dyskinesias/complications/*genetics', 'Dystonic Disorders/complications/*genetics', 'Family', 'Female', 'Humans', 'Middle Aged', 'Mutation, Missense', 'Pedigree', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/28229249/
503,ADCY5,27061943,Phenotypic insights into ADCY5-associated disease.,"['Chang FC', 'Westenberger A', 'Dale RC', 'Smith M', 'Pall HS', 'Perez-Duenas B', 'Grattan-Smith P', 'Ouvrier RA', 'Mahant N', 'Hanna BC', 'Hunter M', 'Lawson JA', 'Max C', 'Sachdev R', 'Meyer E', 'Crimmins D', 'Pryor D', 'Morris JG', 'Munchau A', 'Grozeva D', 'Carss KJ', 'Raymond L', 'Kurian MA', 'Klein C', 'Fung VS']","['Adenylyl Cyclases/*genetics', 'Aftercare', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Male', 'Movement Disorders/*genetics/*physiopathology', 'Pedigree']",https://pubmed.ncbi.nlm.nih.gov/27061943/
504,ADCY5,24740569,ADCY5 couples glucose to insulin secretion in human islets.,"['Hodson DJ', 'Mitchell RK', 'Marselli L', 'Pullen TJ', 'Gimeno Brias S', 'Semplici F', 'Everett KL', 'Cooper DM', 'Bugliani M', 'Marchetti P', 'Lavallard V', 'Bosco D', 'Piemonti L', 'Johnson PR', 'Hughes SJ', 'Li D', 'Li WH', 'Shapiro AM', 'Rutter GA']","['Adenylyl Cyclases/*physiology', 'Calcium/metabolism', 'Diabetes Mellitus, Type 2/genetics', 'Glucagon-Like Peptide 1/physiology', 'Glucose/*metabolism/pharmacology', 'Humans', 'Insulin/*metabolism', 'Insulin Secretion', 'Insulin-Secreting Cells/*metabolism', 'Polymorphism, Single Nucleotide', 'RNA, Messenger/metabolism', 'Risk']",https://pubmed.ncbi.nlm.nih.gov/24740569/
505,ADCY5,30975617,Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.,"['Bohlega SA', 'Abou-Al-Shaar H', 'AlDakheel A', 'Alajlan H', 'Bohlega BS', 'Meyer BF', 'Monies D', 'Cupler EJ', 'Al-Saif AM']","['Adenylyl Cyclases/*genetics', 'Adolescent', 'Child', 'Dystonia/*genetics', 'Female', 'Genetic Association Studies', 'Genotype', 'Humans', 'Male', 'Movement Disorders/*genetics', 'Mutation, Missense', 'Myoclonus/*genetics', 'Pedigree', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30975617/
506,ADCY5,32163478,Common genetic variants in ADCY5 and gestational glycemic traits.,"['Lin R', 'Yuan Z', 'Zhang C', 'Ju H', 'Sun Y', 'Huang N', 'Chen L', 'Jin L']","['Adenylyl Cyclases/*genetics', 'Adult', 'Asian People/genetics', 'Blood Glucose/analysis', 'China', 'Diabetes, Gestational/genetics/*pathology', 'Female', 'Genotype', 'Glucose Tolerance Test', 'Humans', 'Insulin/metabolism', 'Insulin Resistance', 'Linkage Disequilibrium', 'Polymorphism, Single Nucleotide', 'Pregnancy', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32163478/
507,ADCY5,36233117,"Association of MARC1, ADCY5, and BCO1 Variants with the Lipid Profile, Suggests an Additive Effect for Hypertriglyceridemia in Mexican Adult Men.","['Rivera-Paredez B', 'Aparicio-Bautista DI', 'Argoty-Pantoja AD', 'Patino N', 'Flores Morales J', 'Salmeron J', 'Leon-Reyes G', 'Velazquez-Cruz R']","['*Adenylyl Cyclases/genetics', 'Adult', 'Alleles', 'Cohort Studies', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', '*Hypertriglyceridemia/ethnology/genetics', 'Lipids', 'Male', 'Mexico', 'Polymorphism, Single Nucleotide', ""*beta-Carotene 15,15'-Monooxygenase/genetics""]",https://pubmed.ncbi.nlm.nih.gov/36233117/
508,ADCY5,34169461,"Association of diabetes-related variants in ADCY5 and CDKAL1 with neonatal insulin, C-peptide, and birth weight.","['Aguilera-Venegas IG', 'Mora-Pena JD', 'Velazquez-Villafana M', 'Gonzalez-Dominguez MI', 'Barbosa-Sabanero G', 'Gomez-Zapata HM', 'Lazo-de-la-Vega-Monroy ML']","['Adenylyl Cyclases/*genetics', 'Adult', 'Birth Weight', 'C-Peptide', '*Diabetes Mellitus, Type 2/genetics', 'Female', 'Humans', 'Infant, Newborn', '*Insulin', 'Pregnancy', '*tRNA Methyltransferases/genetics']",https://pubmed.ncbi.nlm.nih.gov/34169461/
509,ADCY5,36610259,Deep brain stimulation effect in genetic dyskinetic cerebral palsy: The case of ADCY5- related disease.,"['Cif L', 'Demailly D', 'Gehin C', 'Chan Seng E', 'Dornadic M', 'Huby S', 'Poulen G', 'Roubertie A', 'Villessot M', 'Roujeau T', 'Coubes P']","['Humans', '*Cerebral Palsy/genetics/therapy/complications', '*Chorea/complications/therapy', '*Deep Brain Stimulation', '*Dystonia', '*Dystonic Disorders/genetics', 'Globus Pallidus', '*Movement Disorders/genetics', '*Myoclonus', 'Retrospective Studies', 'Treatment Outcome', 'Child', 'Adolescent']",https://pubmed.ncbi.nlm.nih.gov/36610259/
510,ADCY6,24319099,Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects.,"['Laquerriere A', 'Maluenda J', 'Camus A', 'Fontenas L', 'Dieterich K', 'Nolent F', 'Zhou J', 'Monnier N', 'Latour P', 'Gentil D', 'Heron D', 'Desguerres I', 'Landrieu P', 'Beneteau C', 'Delaporte B', 'Bellesme C', 'Baumann C', 'Capri Y', 'Goldenberg A', 'Lyonnet S', 'Bonneau D', 'Estournet B', 'Quijano-Roy S', 'Francannet C', 'Odent S', 'Saint-Frison MH', 'Sigaudy S', 'Figarella-Branger D', 'Gelot A', 'Mussini JM', 'Lacroix C', 'Drouin-Garraud V', 'Malinge MC', 'Attie-Bitach T', 'Bessieres B', 'Bonniere M', 'Encha-Razavi F', 'Beaufrere AM', 'Khung-Savatovsky S', 'Perez MJ', 'Vasiljevic A', 'Mercier S', 'Roume J', 'Trestard L', 'Saugier-Veber P', 'Cordier MP', 'Layet V', 'Legendre M', 'Vigouroux-Castera A', 'Lunardi J', 'Bayes M', 'Jouk PS', 'Rigonnot L', 'Granier M', 'Sternberg D', 'Warszawski J', 'Gut I', 'Gonzales M', 'Tawk M', 'Melki J']","['Adenylyl Cyclases/*genetics', 'Arthrogryposis/*genetics/*pathology', 'Axons/pathology/ultrastructure', 'Cell Adhesion Molecules, Neuronal/*genetics', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Microscopy, Electron, Transmission', 'Mutation/genetics', 'Myelin Sheath/pathology', 'Peripheral Nervous System/pathology/ultrastructure', 'Pregnancy', 'Schwann Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/24319099/
511,ADCY6,31886586,Gene expression and DNA methylation analyses suggest that immune process-related ADCY6 is a prognostic factor of luminal-like breast cancer.,"['Li W', 'Sang M', 'Hao X', 'Jia L', 'Wang Y', 'Shan B']","['Adenylyl Cyclases/*metabolism', 'Algorithms', 'Biomarkers, Tumor/genetics', 'Breast Neoplasms/*genetics/*immunology', 'Computational Biology', '*DNA Methylation', 'Databases, Genetic', 'Disease-Free Survival', 'Female', 'Gene Expression Profiling', '*Gene Expression Regulation, Neoplastic', 'Gene Ontology', 'Gene Regulatory Networks', 'Humans', 'Immune System', 'Kaplan-Meier Estimate', 'Lectins, C-Type/metabolism', 'Prognosis', 'Protein Interaction Mapping', 'Protein Interaction Maps/genetics', 'Software', 'Survival Analysis']",https://pubmed.ncbi.nlm.nih.gov/31886586/
512,ADCY6,34257610,Knockdown of GPSM1 Inhibits the Proliferation and Promotes the Apoptosis of B-Cell Acute Lymphoblastic Leukemia Cells by Suppressing the ADCY6-RAPGEF3-JNK Signaling Pathway.,"['Zhang Y', 'Zhou B', 'Sun J', 'He Q', 'Zhao Y']","['Adenylyl Cyclases/genetics/*metabolism', '*Apoptosis', 'Biomarkers, Tumor/genetics/metabolism', 'Cell Cycle Checkpoints', '*Cell Proliferation', 'Gene Expression Regulation, Neoplastic', 'Guanine Nucleotide Dissociation Inhibitors/antagonists & inhibitors/genetics/*metabolism', 'Guanine Nucleotide Exchange Factors/genetics/*metabolism', 'Humans', 'MAP Kinase Kinase 4/genetics/*metabolism', 'Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics/metabolism/*pathology', 'Prognosis', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/34257610/
513,ADCY6,31846058,Expanding the clinical and molecular spectrum of lethal congenital contracture syndrome 8 associated with biallelic variants of ADCY6.,"['Agolini E', 'Cherchi C', 'Bellacchio E', 'Martinelli D', 'Cocciadiferro D', 'Cutrera R', 'Chiarini Testa MB', 'Barone C', 'Bianca S', 'Novelli A']","['Adenylyl Cyclases/*genetics', 'Arthrogryposis/*genetics/physiopathology', 'Child, Preschool', 'Female', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans', 'Infant', 'Male', 'Mutation, Missense/genetics', 'Pedigree', 'Phenotype', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/31846058/
514,ADCY4,31584294,Epigenetic identification of ADCY4 as a biomarker for breast cancer: an integrated analysis of adenylate cyclases.,"['Fan Y', 'Mu J', 'Huang M', 'Imani S', 'Wang Y', 'Lin S', 'Fan J', 'Wen Q']","['Adenylyl Cyclases/*genetics', 'Biomarkers, Tumor/*genetics', 'Breast Neoplasms/*genetics/pathology', 'DNA Methylation/genetics', 'Down-Regulation/genetics', 'Epigenesis, Genetic/*genetics', 'Epigenomics/methods', 'Female', 'Humans', 'Prognosis', 'Promoter Regions, Genetic/genetics', 'Receptors, G-Protein-Coupled/genetics', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/31584294/
515,PLCB2,27465150,Nuclear factor-kappaB regulates expression of platelet phospholipase C-beta2 (PLCB2).,"['Mao G', 'Jin J', 'Kunapuli SP', 'Rao AK']","['Binding Sites', 'Blood Platelets/*enzymology', 'Consensus Sequence', 'Female', 'Gene Expression Regulation, Enzymologic', 'Humans', 'Male', 'Megakaryocytes/enzymology', 'NF-kappa B/genetics/*metabolism', 'Phospholipase C beta/genetics/*metabolism', 'Promoter Regions, Genetic', 'Sequence Deletion']",https://pubmed.ncbi.nlm.nih.gov/27465150/
516,PLCB2,31746389,Knockdown of PLCB2 expression reduces melanoma cell viability and promotes melanoma cell apoptosis by altering Ras/Raf/MAPK signals.,"['Zhang H', 'Xie T', 'Shui Y', 'Qi Y']","['Apoptosis/genetics', 'Cell Line, Tumor', 'Cell Proliferation/*genetics', 'Cell Survival/genetics', 'Gene Expression Regulation, Neoplastic/genetics', 'Gene Knockdown Techniques', 'Genes, ras/genetics', 'Humans', 'MAP Kinase Kinase 1/genetics', 'Melanoma/*genetics/pathology', 'Microarray Analysis', 'Neoplasm Proteins/*genetics', 'Phospholipase C beta/*genetics', 'Protein Interaction Maps', 'Proto-Oncogene Proteins c-raf/genetics', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/31746389/
517,PLCB2,24903829,"Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.","['Lo Vasco VR', 'Leopizzi M', 'Puggioni C', 'Della Rocca C', 'Businaro R']","['Blotting, Western', 'Cells, Cultured', 'Dose-Response Relationship, Drug', 'Enzyme Repression', 'Human Umbilical Vein Endothelial Cells/*drug effects/enzymology', 'Humans', 'Neuropeptide Y/*pharmacology', 'Phospholipase C beta/genetics/*metabolism', 'Phospholipase C delta/genetics/*metabolism', 'RNA, Messenger/metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/24903829/
518,PLCD1,31543210,PLCD1 and Pilar Cysts.,"['Shimomura Y', ""O'Shaughnessy R"", 'Rajan N']","['*Epidermal Cyst', 'Hair Follicle', 'Humans', 'Phospholipase C delta', 'Scalp']",https://pubmed.ncbi.nlm.nih.gov/31543210/
519,PLCD1,36987828,Identification of a Novel PLCD1 Variant in a Danish Family with Hereditary Leukonychia.,"['Lieberoth S', 'Kumar S', 'Brusgaard K', 'Ousager LB', 'Betz RC', 'Bygum A']","['Female', 'Humans', 'Infant', 'Denmark', '*Hemangioma', '*Nail Diseases/diagnosis/genetics', 'Nails', '*Nails, Malformed', 'Phospholipase C delta', 'Male']",https://pubmed.ncbi.nlm.nih.gov/36987828/
520,PLCD1,31082376,A Monoallelic Two-Hit Mechanism in PLCD1 Explains the Genetic Pathogenesis of Hereditary Trichilemmal Cyst Formation.,"['Horer S', 'Marrakchi S', 'Radner FPW', 'Zolles G', 'Heinz L', 'Eichmann TO', 'Has C', 'Salavei P', 'Mahfoudh N', 'Turki H', 'Zimmer AD', 'Fischer J']","['Alleles', 'Biopsy, Needle', 'Epidermal Cyst/*genetics/*pathology', 'Female', '*Genetic Predisposition to Disease', 'Germ-Line Mutation', 'Hair Follicle/pathology', 'Humans', 'Immunohistochemistry', 'Male', 'Pedigree', 'Phospholipase C delta/*genetics', 'Real-Time Polymerase Chain Reaction/methods', 'Scalp/pathology', 'Skin Diseases/*genetics/*pathology', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/31082376/
521,PLCD1,9345909,Genomic structure of the human PLCD1 (phospholipase C delta 1) locus on 3p22-->p21.3.,"['Ishikawa S', 'Takahashi T', 'Ogawa M', 'Nakamura Y']","['Alternative Splicing/genetics', '*Chromosomes, Human, Pair 3', 'DNA Mutational Analysis', 'Exons/genetics', '*Genome, Human', 'Humans', 'Introns/genetics', 'Isoenzymes/*genetics', 'Lung Neoplasms/*genetics', 'Phospholipase C delta', 'Tumor Cells, Cultured', 'Type C Phospholipases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/9345909/
522,PLCD1,37228901,"lncRNA MIR503HG Targets miR-191-5p/PLCD1 Axis and Negatively Modulates Apoptosis, Extracellular Matrix Disruption, and Inflammation in Abdominal Aortic Aneurysm.","['Tian Y', 'Li X', 'Bai C', 'Yang Z', 'Zhang L', 'Luo J', 'Zhang W']","['Humans', '*MicroRNAs/genetics/metabolism', '*RNA, Long Noncoding/genetics/metabolism', 'Phospholipase C delta/metabolism', '*Aortic Aneurysm, Abdominal/genetics/metabolism', 'Inflammation/metabolism', 'Apoptosis/genetics', 'Extracellular Matrix/metabolism', 'Myocytes, Smooth Muscle/metabolism', 'Cell Proliferation']",https://pubmed.ncbi.nlm.nih.gov/37228901/
523,PLCD1,20657189,PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer.,"['Xiang T', 'Li L', 'Fan Y', 'Jiang Y', 'Ying Y', 'Putti TC', 'Tao Q', 'Ren G']","['Breast Neoplasms/*genetics/metabolism/pathology', '*Cell Division', 'Cell Line, Tumor', 'Chromosomes, Human, Pair 3', 'DNA Methylation', 'Epigenesis, Genetic', 'Female', '*G2 Phase', '*Gene Expression Regulation, Neoplastic', 'Gene Silencing', 'Humans', 'Phospholipase C delta/*genetics/metabolism', 'Polymerase Chain Reaction', 'Prognosis', 'Promoter Regions, Genetic', 'Signal Transduction', 'Tumor Suppressor Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/20657189/
524,PLCD1,36367621,MiR-17-3p Facilitates Aggressive Cell Phenotypes in Colon Cancer by Targeting PLCD1 Through Affecting KIF14.,"['Ji J', 'Fu J']","['Humans', 'Phospholipase C delta/genetics/metabolism', 'Cell Line, Tumor', '*MicroRNAs/genetics/metabolism', 'Cell Proliferation/genetics', '*Colonic Neoplasms/genetics', 'Phenotype', 'Cell Movement/genetics', 'Gene Expression Regulation, Neoplastic', 'Oncogene Proteins/genetics/metabolism', 'Kinesins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36367621/
525,PLCD1,21665001,"Hereditary leukonychia, or porcelain nails, resulting from mutations in PLCD1.","['Kiuru M', 'Kurban M', 'Itoh M', 'Petukhova L', 'Shimomura Y', 'Wajid M', 'Christiano AM']","['Chromosomes, Human, Pair 3/*genetics', 'Humans', 'Hypopigmentation/enzymology/genetics/pathology', 'Mutation', 'Nail Diseases/congenital/enzymology/genetics/pathology', 'Nails/embryology/enzymology/*pathology', 'Pedigree', 'Phospholipase C delta/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/21665001/
526,PLCD1,35301686,Circular RNA circ-PLCD1 functions as a tumor suppressor in non-small cell lung cancer by inactivation of PI3K/AKT signaling pathway.,"['Si J', 'Jin J', 'Sai J', 'Liu X', 'Luo X', 'Fu Z', 'Wang J']","['Carcinogenesis/genetics', '*Carcinoma, Non-Small-Cell Lung/genetics/pathology', 'Cell Line, Tumor', 'Cell Proliferation/genetics', 'Gene Expression Regulation, Neoplastic/genetics', 'Humans', '*Lung Neoplasms/pathology', '*MicroRNAs/genetics/metabolism', 'Phosphatidylinositol 3-Kinases/genetics/metabolism', 'Phospholipase C delta/genetics/metabolism', 'Proto-Oncogene Proteins c-akt/genetics/metabolism', 'RNA, Circular/genetics', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/35301686/
527,PLCD1,23149345,"Mutations in the gene phospholipase C, delta-1 (PLCD1) underlying hereditary leukonychia.","['Mir H', 'Khan S', 'Arif MS', 'Ali G', 'Wali A', 'Ansar M', 'Ahmad W']","['Case-Control Studies', 'Codon, Nonsense', 'Frameshift Mutation', 'Genotype', 'Humans', 'Hypopigmentation/*genetics', 'Microsatellite Repeats', 'Nail Diseases/*congenital/genetics', 'Phospholipase C delta/*genetics', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/23149345/
528,PLCD1,22576628,Epigenetic inactivation of PLCD1 in chronic myeloid leukemia.,"['Song JJ', 'Liu Q', 'Li Y', 'Yang ZS', 'Yang L', 'Xiang TX', 'Ren GS', 'Chen JB']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Azacitidine/analogs & derivatives/pharmacology', 'Biomarkers, Tumor/genetics', 'Bone Marrow Cells', 'CpG Islands', '*DNA Methylation', 'Decitabine', 'Female', 'G1 Phase Cell Cycle Checkpoints/genetics', 'Gene Expression Regulation, Neoplastic', 'Humans', 'K562 Cells', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics', 'Male', 'Middle Aged', 'Phospholipase C delta/*genetics/*metabolism', '*Promoter Regions, Genetic', 'RNA, Messenger/genetics/metabolism', 'Tumor Suppressor Proteins/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22576628/
529,PLCD1,34727930,"The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1.","['Sanchez-Solana B', 'Wang D', 'Qian X', 'Velayoudame P', 'Simanshu DK', 'Acharya JK', 'Lowy DR']","['Binding Sites', 'Carrier Proteins', 'Caveolin 1/chemistry/*metabolism', 'Cell Line, Tumor', 'Cell Movement', 'Cell Proliferation', 'GTPase-Activating Proteins/genetics/*metabolism', 'Humans', 'Models, Molecular', 'Mutation', 'Phosphatidylserines/*metabolism', 'Phospholipase C delta/chemistry/*metabolism', 'Protein Binding', 'Protein Conformation', '*Protein Interaction Domains and Motifs', 'Structure-Activity Relationship', 'Tumor Suppressor Proteins/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34727930/
530,PLCD1,33786625,Identification of two novel mutations in the PLCD1 gene in Chinese patients with hereditary leukonychia.,"['Shen S', 'Shao M', 'Keyal U', 'Wang X', 'Li M', 'Zhang G']","['Adult', 'Child', 'Female', 'Humans', 'Hypopigmentation/*genetics/pathology', 'Male', 'Mutation, Missense', 'Nail Diseases/*congenital/genetics/pathology', 'Nails, Malformed/*genetics/pathology', 'Pedigree', 'Phospholipase C delta/*genetics']",https://pubmed.ncbi.nlm.nih.gov/33786625/
531,PLCD1,32265483,Hereditary Trichilemmal Cysts are Caused by Two Hits to the Same Copy of the Phospholipase C Delta 1 Gene (PLCD1).,"['Kolodney MS', 'Coman GC', 'Smolkin MB', 'Hagen R', 'Katzman JA', 'Katzman SN', 'Holliday AC', 'Kolodney JA']","['Cross-Sectional Studies', 'Epidermal Cyst/*genetics', 'Genetic Predisposition to Disease', 'Germ-Line Mutation', 'Heterozygote', 'Humans', 'Phospholipase C delta/*genetics', 'Point Mutation']",https://pubmed.ncbi.nlm.nih.gov/32265483/
532,PLCD1,24903829,"Neuropeptide Y reduces the expression of PLCB2, PLCD1 and selected PLC genes in cultured human endothelial cells.","['Lo Vasco VR', 'Leopizzi M', 'Puggioni C', 'Della Rocca C', 'Businaro R']","['Blotting, Western', 'Cells, Cultured', 'Dose-Response Relationship, Drug', 'Enzyme Repression', 'Human Umbilical Vein Endothelial Cells/*drug effects/enzymology', 'Humans', 'Neuropeptide Y/*pharmacology', 'Phospholipase C beta/genetics/*metabolism', 'Phospholipase C delta/genetics/*metabolism', 'RNA, Messenger/metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/24903829/
533,PLCD1,30003652,Identification of a novel PLCD1 mutation in Chinese Han pedigree with hereditary leukonychia and koilonychia.,"['Xue K', 'Zheng Y', 'Shen C', 'Cui Y']","['Asian People/genetics', 'Female', 'Humans', 'Hypopigmentation/*genetics', 'Male', 'Middle Aged', 'Mutation, Missense', 'Nail Diseases/*congenital/genetics', 'Nails, Malformed/*genetics', 'Pedigree', 'Phospholipase C delta/*genetics', 'Exome Sequencing', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30003652/
534,HRH1,39037273,Identification of HRH1 as an alternative receptor for SARS-CoV-2: insights from viral inhibition by repurposable antihistamines.,"['Zhong G', 'Li J', 'Wang H']","['*SARS-CoV-2/drug effects', 'Humans', '*Drug Repositioning', '*Virus Internalization/drug effects', 'COVID-19 Drug Treatment', 'Histamine Antagonists/pharmacology', 'Spike Glycoprotein, Coronavirus/metabolism/genetics/antagonists & inhibitors', 'Antiviral Agents/pharmacology', 'Receptors, Histamine H1/metabolism/genetics', 'COVID-19/virology', 'Receptors, Virus/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39037273/
535,HRH1,31406237,Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.,"['Li J', 'Chen W', 'Peng C', 'Zhu W', 'Liu Z', 'Zhang W', 'Su J', 'Li J', 'Chen X']","['Adult', 'China/epidemiology', 'Chronic Disease', 'Drug-Related Side Effects and Adverse Reactions/diagnosis/epidemiology/*genetics', 'Female', 'Histamine H1 Antagonists, Non-Sedating/*adverse effects', 'Humans', 'Loratadine/adverse effects/*analogs & derivatives', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Histamine H1/*genetics', 'Severity of Illness Index', 'Sleepiness', 'Treatment Outcome', 'Urticaria/drug therapy/epidemiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31406237/
536,HRH1,36688618,Integrative analysis of small non-coding RNAs predicts a piRNA/miRNA-CCND1/BRAF/HRH1/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma.,"['Nayak R', 'Chattopadhyay T', 'Gupta P', 'Mallick B']","['Humans', '*MicroRNAs/genetics', '*Glioblastoma/genetics/pathology', 'Piwi-Interacting RNA', 'Proto-Oncogene Proteins B-raf', 'RNA, Untranslated/genetics', 'Carcinogenesis', 'Cell Transformation, Neoplastic', 'Ataxin-3', 'Repressor Proteins', 'Cyclin D1/genetics']",https://pubmed.ncbi.nlm.nih.gov/36688618/
537,HRH1,24236486,"Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs.","['Ayuso P', 'Blanca M', 'Cornejo-Garcia JA', 'Torres MJ', 'Dona I', 'Salas M', 'Blanca-Lopez N', 'Canto G', 'Rondon C', 'Campo P', 'Laguna JJ', 'Fernandez J', 'Martinez C', 'Agundez JA', 'Garcia-Martin E']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Anti-Inflammatory Agents, Non-Steroidal/*adverse effects', 'Case-Control Studies', 'Child', 'Child, Preschool', 'DNA Copy Number Variations/*genetics', 'Drug Hypersensitivity/*genetics', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H2/*genetics', 'Receptors, Histamine H4', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24236486/
538,HRH1,7935475,"Identification of a putative RNA helicase (HRH1), a human homolog of yeast Prp22.","['Ono Y', 'Ohno M', 'Shimura Y']","['Amino Acid Sequence', 'Base Sequence', 'DEAD-box RNA Helicases', 'DNA/genetics', 'DNA Primers/genetics', 'DNA, Fungal/genetics', 'Fungal Proteins/*genetics', 'Genes, Fungal', 'Genetic Complementation Test', 'HeLa Cells', 'Humans', 'Molecular Sequence Data', 'Mutation', 'Polymerase Chain Reaction', 'RNA Helicases', 'RNA Nucleotidyltransferases/*genetics', 'RNA Precursors/metabolism', 'RNA Splicing/genetics', 'RNA Splicing Factors', '*Saccharomyces cerevisiae Proteins', 'Sequence Homology, Amino Acid', 'Species Specificity', 'Spliceosomes/metabolism']",https://pubmed.ncbi.nlm.nih.gov/7935475/
539,HRH1,30742585,Effect of the Fexofenadine on the expression of HRH-1 and HRH-4 receptor in Peripheral Blood Mononuclear Cell isolated from children with diagnosed allergy - in vitro study Short communication.,"['Kordulewska N', 'Cieslinska A', 'Fiedorowicz E', 'Jarmolowska B', 'Kostyra E']","['Anti-Allergic Agents/*pharmacology', 'Cells, Cultured', 'Child', 'Child, Preschool', 'Female', 'Gene Expression Regulation/drug effects', 'Histamine H1 Antagonists, Non-Sedating/*pharmacology', 'Humans', 'Hypersensitivity/diagnosis/genetics/immunology', 'Leukocytes, Mononuclear/*drug effects/metabolism', 'Male', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H4/*genetics', 'Terfenadine/*analogs & derivatives/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/30742585/
540,TBXA2R,25483406,"Regulatory SNPs and transcriptional factor binding sites in ADRBK1, AKT3, ATF3, DIO2, TBXA2R and VEGFA.",['Buroker NE'],"['Activating Transcription Factor 3/chemistry/genetics/metabolism', 'Binding Sites', 'G-Protein-Coupled Receptor Kinase 2/chemistry/genetics/metabolism', 'Genome-Wide Association Study', 'Humans', 'Iodide Peroxidase/chemistry/genetics/metabolism', '*Polymorphism, Single Nucleotide', 'Proto-Oncogene Proteins c-akt/chemistry/genetics/metabolism', 'Receptors, Thromboxane A2, Prostaglandin H2/genetics', 'Transcription Factors/chemistry/genetics/*metabolism', 'Untranslated Regions', 'Vascular Endothelial Growth Factor A/chemistry/genetics/metabolism', 'Iodothyronine Deiodinase Type II']",https://pubmed.ncbi.nlm.nih.gov/25483406/
541,TBXA2R,30089223,TBXA2R gene variants associated with bleeding.,"['Mundell SJ', 'Mumford A']","['Alleles', '*Genetic Association Studies', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Genotype', 'Hemorrhage/*blood/diagnosis/*genetics', 'Humans', 'Phenotype', 'Receptors, Thromboxane A2, Prostaglandin H2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30089223/
542,TBXA2R,27487152,Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs).,"['Orr K', 'Buckley NE', 'Haddock P', 'James C', 'Parent JL', 'McQuaid S', 'Mullan PB']","['Cell Line, Tumor', 'Cell Movement', 'Female', 'Genes, BRCA1', 'Genes, myc', 'Humans', 'Neoplasm Invasiveness', 'Reactive Oxygen Species/metabolism', 'Receptors, Thromboxane A2, Prostaglandin H2/genetics/*physiology', 'Signal Transduction/physiology', 'Triple Negative Breast Neoplasms/*mortality/pathology', 'rho-Associated Kinases/antagonists & inhibitors/physiology']",https://pubmed.ncbi.nlm.nih.gov/27487152/
543,TBXA2R,32971583,"Association of TBXA2R, P2Y12 and ADD1 genes polymorphisms with ischemic stroke susceptibility: A metaanalysis.","['Liang X', 'Zhou Y', 'Li S']","['*Brain Ischemia/genetics', 'Genetic Predisposition to Disease', 'Humans', '*Ischemic Stroke', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Purinergic P2Y12', 'Receptors, Thromboxane A2, Prostaglandin H2', 'Sterol Regulatory Element Binding Protein 1', '*Stroke/genetics']",https://pubmed.ncbi.nlm.nih.gov/32971583/
544,TBXA2R,22017802,"Association of ORMDL3, STAT6 and TBXA2R gene polymorphisms with asthma.","['Kavalar MS', 'Balantic M', 'Silar M', 'Kosnik M', 'Korosec P', 'Rijavec M']","['Adolescent', 'Alleles', 'Asthma/*genetics', 'Case-Control Studies', 'Child', 'Child, Preschool', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Male', 'Membrane Proteins/*genetics', 'Phenotype', '*Polymorphism, Genetic', 'Receptors, Thromboxane A2, Prostaglandin H2/*genetics', 'Respiratory Sounds/genetics', 'Rhinitis/genetics', 'Risk Factors', 'STAT6 Transcription Factor/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22017802/
545,TBXA2R,18031559,TBXA2R gene polymorphism and responsiveness to leukotriene receptor antagonist in children with asthma.,"['Kim JH', 'Lee SY', 'Kim HB', 'Jin HS', 'Yu JH', 'Kim BJ', 'Kim BS', 'Kang MJ', 'Jang SO', 'Hong SJ']","['Asthma/*drug therapy/*genetics/pathology', 'Case-Control Studies', 'Child', 'Exercise/physiology', 'Female', 'Genotype', 'Humans', 'Immunoglobulin E/blood/immunology', 'Leukotriene Antagonists/*therapeutic use', 'Male', 'Methacholine Chloride/*therapeutic use', 'Polymorphism, Genetic/*genetics', 'Receptors, Thromboxane A2, Prostaglandin H2/*genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/18031559/
546,TBXA2R,36936944,"In silico analysis of single nucleotide polymorphism (rs34377097) of TBXA2R gene and pollen induced bronchial asthma susceptibility in West Bengal population, India.","['Ganai I', 'Saha I', 'Banerjee P', 'Laha A', 'Sultana S', 'Sultana N', 'Biswas H', 'Moitra S', 'Podder S']","['Adolescent', 'Humans', 'Young Adult', '*Asthma/genetics/epidemiology', 'Genotype', 'Pollen', '*Polymorphism, Single Nucleotide', '*Receptors, Thromboxane A2, Prostaglandin H2/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36936944/
547,TBXA2R,30179800,TBXA2R rs4523 G allele is associated with decreased susceptibility to Kawasaki disease.,"['Che D', 'Pi L', 'Xu Y', 'Fu L', 'Zhou H', 'Wang Z', 'Huang P', 'Zhang L', 'Gu X']","['Alleles', 'Asian People/genetics', 'Case-Control Studies', 'Child, Preschool', 'Female', 'Gene Frequency/genetics', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Mucocutaneous Lymph Node Syndrome/*genetics', 'Odds Ratio', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Thromboxane A2, Prostaglandin H2/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/30179800/
548,TBXA2R,21070398,Association of thromboxane A2 receptor (TBXA2R) gene polymorphism in patients with aspirin-intolerant acute urticaria.,"['Palikhe NS', 'Kim SH', 'Lee HY', 'Kim JH', 'Ye YM', 'Park HS']","['Acute Disease', 'Adult', 'Alleles', 'Aspirin/*adverse effects', 'Female', 'Genotype', 'Humans', 'Male', 'Phenotype', 'Polymorphism, Genetic/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Thromboxane A2, Prostaglandin H2/*genetics', 'Urticaria/*chemically induced/drug therapy/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21070398/
549,TBXA2R,27641736,"Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.","['Peng LL', 'Zhao YQ', 'Zhou ZY', 'Jin J', 'Zhao M', 'Chen XM', 'Chen LY', 'Cai YF', 'Li JL', 'Huang M']","['1-Alkyl-2-acetylglycerophosphocholine Esterase/*genetics', 'ATP Binding Cassette Transporter, Subfamily B/genetics', 'Aged', 'Asian People', 'Aspirin/*therapeutic use', 'Blood Platelets/*drug effects', 'Brain Ischemia/blood/*drug therapy/genetics', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Platelet Aggregation Inhibitors/*therapeutic use', 'Polymorphism, Single Nucleotide', 'Receptors, Cell Surface/*genetics', 'Receptors, Thromboxane A2, Prostaglandin H2/*genetics', 'Stroke/blood/*drug therapy/genetics', 'Thromboxane B2/biosynthesis/blood', 'Treatment Failure']",https://pubmed.ncbi.nlm.nih.gov/27641736/
550,TBXA2R,8288221,Linkage mapping of the human thromboxane A2 receptor (TBXA2R) to chromosome 19p13.3 using transcribed 3' untranslated DNA sequence polymorphisms.,"['Schwengel DA', 'Nouri N', 'Meyers DA', 'Levitt RC']","['Base Sequence', 'Chromosome Mapping', '*Chromosomes, Human, Pair 19', 'DNA', 'Humans', 'Introns', 'Lod Score', 'Molecular Sequence Data', 'Polymerase Chain Reaction', 'Polymorphism, Genetic', 'Receptors, Thromboxane/*genetics', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/8288221/
551,CHRM1,34705126,Magnolol upregulates CHRM1 to attenuate Amyloid-beta-triggered neuronal injury through regulating the cAMP/PKA/CREB pathway.,"['Zhu G', 'Fang Y', 'Cui X', 'Jia R', 'Kang X', 'Zhao R']","['*Alzheimer Disease', 'Amyloid beta-Peptides', 'Apoptosis', 'Biphenyl Compounds', 'Humans', 'Lignans', '*Neurodegenerative Diseases', 'Neurons', 'Receptor, Muscarinic M1']",https://pubmed.ncbi.nlm.nih.gov/34705126/
552,CHRM1,36475335,"Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances.","['Sanfilippo C', 'Giuliano L', 'Castrogiovanni P', 'Imbesi R', 'Ulivieri M', 'Fazio F', 'Blennow K', 'Zetterberg H', 'Di Rosa M']","['Male', 'Female', 'Humans', '*Alzheimer Disease/genetics', 'Sleep', 'Brain', 'Biopsy', 'Receptor, Muscarinic M1/genetics', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/36475335/
553,CHRM1,36155524,"Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival.","['Sabbir MG', 'Speth RC', 'Albensi BC']","['Humans', '*Alzheimer Disease/metabolism', '*Parkinson Disease/metabolism', '*Frontotemporal Dementia', 'Hippocampus/metabolism', 'Temporal Lobe/metabolism', 'Cholinergic Agents', 'Receptors, Cholinergic/metabolism', 'Receptor, Muscarinic M1/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36155524/
554,CHRM1,24430298,CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.,"['Jimenez-Morales S', 'Jimenez-Ruiz JL', 'Del Rio-Navarro BE', 'Navarro-Olivos E', 'Escamilla-Guerrero G', 'Savan R', 'Dean M', 'Orozco L']","['Adolescent', 'Alleles', 'Asthma/diagnosis/*genetics', 'Case-Control Studies', 'Child', 'Female', 'Gene Frequency', 'Gene Order', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Mexico', 'Odds Ratio', '*Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M1/*genetics', 'Receptor, Muscarinic M2/*genetics', 'Receptor, Muscarinic M3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24430298/
555,CHRM1,39605182,Chemogenomic Screening in a Patient-Derived 3D Fatty Liver Disease Model Reveals the CHRM1-TRPM8 Axis as a Novel Module for Targeted Intervention.,"['Youhanna S', 'Kemas AM', 'Wright SC', 'Zhong Y', 'Klumpp B', 'Klein K', 'Motso A', 'Michel M', 'Ziegler N', 'Shang M', 'Sabatier P', 'Kannt A', 'Sheng H', 'Oliva-Vilarnau N', 'Buttner FA', 'Seashore-Ludlow B', 'Schreiner J', 'Windbergs M', 'Cornillet M', 'Bjorkstrom NK', 'Hulsmeier AJ', 'Hornemann T', 'Olsen JV', 'Wang Y', 'Gramignoli R', 'Sundstrom M', 'Lauschke VM']","['Humans', '*TRPM Cation Channels/genetics/metabolism', 'Receptor, Muscarinic M1/genetics/metabolism', 'Fatty Liver/metabolism/genetics/drug therapy', 'Hepatocytes/metabolism/drug effects', 'Signal Transduction/drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/39605182/
556,CHRM1,36244968,Network toxicology and molecular docking analyses on strychnine indicate CHRM1 is a potential neurotoxic target.,"['Dai J', 'Liu J', 'Zhang M', 'Yu Y', 'Wang J']","['*Drugs, Chinese Herbal/pharmacology', 'Medicine, Chinese Traditional', 'Molecular Docking Simulation', 'Protein Interaction Maps', '*Strychnine/toxicity']",https://pubmed.ncbi.nlm.nih.gov/36244968/
557,CHRM1,30623717,Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors.,"['Boiko AS', 'Ivanova SA', 'Pozhidaev IV', 'Freidin MB', 'Osmanova DZ', 'Fedorenko OY', 'Semke AV', 'Bokhan NA', 'Wilffert B', 'Loonen AJM']","['Adult', 'Alleles', 'Antipsychotic Agents/*adverse effects', 'Dyskinesia, Drug-Induced/complications/*genetics', 'Female', 'Genetic Predisposition to Disease', 'Hospitals, Psychiatric', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M1/*genetics', 'Receptor, Muscarinic M2/*genetics', 'Schizophrenia/complications/drug therapy/*genetics', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/30623717/
558,CHRM1,19404243,Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.,"['Salah-Uddin H', 'Scarr E', 'Pavey G', 'Harris K', 'Hagan JJ', 'Dean B', 'Challiss RA', 'Watson JM']","['Adult', 'Aged', 'Cell Membrane/drug effects/metabolism', 'Female', 'GTP-Binding Protein alpha Subunits, Gq-G11/metabolism', ""Guanosine 5'-O-(3-Thiotriphosphate)/metabolism"", 'Humans', 'Male', 'Middle Aged', 'Muscarinic Agonists/pharmacology', 'Muscarinic Antagonists/pharmacology', 'Oxotremorine/analogs & derivatives/pharmacology', 'Phenotype', 'Piperidines/pharmacology', 'Pirenzepine/pharmacology', 'Prefrontal Cortex/drug effects/*metabolism', 'Protein Binding/drug effects', 'Receptor, Muscarinic M1', 'Receptors, Muscarinic/*metabolism', 'Schizophrenia/drug therapy/*metabolism', 'Sulfur Radioisotopes', 'Tritium', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19404243/
559,CHRM1,16874522,Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcholine receptor (CHRM1) with vulnerability for nicotine dependence.,"['Lou XY', 'Ma JZ', 'Payne TJ', 'Beuten J', 'Crew KM', 'Li MD']","['Adult', 'Black or African American/genetics', 'DNA Mutational Analysis', 'Female', '*Genetic Predisposition to Disease', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M1', 'Receptors, Muscarinic/*genetics', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/16874522/
560,HRH2,39462031,Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor.,"['Pehar M', 'Hewitt M', 'Wagner A', 'Sandhu JK', 'Khalili A', 'Wang X', 'Cho JY', 'Sim VL', 'Kulka M']","['Humans', '*Microglia/metabolism/drug effects', '*Histamine/pharmacology/metabolism', 'Cell Line', '*Receptors, Histamine H2/metabolism/genetics', '*Calcium/metabolism', 'PrPC Proteins/metabolism/genetics', 'Cytokines/metabolism', 'Gene Expression Regulation/drug effects', 'Receptors, Histamine/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39462031/
561,HRH2,26989676,"Associations of Polymorphisms in HRH2, HRH3, DAO, and HNMT Genes with Risk of Chronic Heart Failure.","['He GH', 'Cai WK', 'Zhang JB', 'Ma CY', 'Yan F', 'Lu J', 'Xu GL']","['Adult', 'Aged', 'Chronic Disease', 'D-Amino-Acid Oxidase/*genetics', 'Female', 'Genetic Association Studies', 'Genotype', 'Haplotypes', 'Heart Failure/*genetics/pathology', 'Histamine/genetics', 'Histamine N-Methyltransferase/*genetics', 'Humans', 'Male', 'Middle Aged', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H3/*genetics', 'Receptors, Histamine H4']",https://pubmed.ncbi.nlm.nih.gov/26989676/
562,HRH2,24236486,"Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs.","['Ayuso P', 'Blanca M', 'Cornejo-Garcia JA', 'Torres MJ', 'Dona I', 'Salas M', 'Blanca-Lopez N', 'Canto G', 'Rondon C', 'Campo P', 'Laguna JJ', 'Fernandez J', 'Martinez C', 'Agundez JA', 'Garcia-Martin E']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Anti-Inflammatory Agents, Non-Steroidal/*adverse effects', 'Case-Control Studies', 'Child', 'Child, Preschool', 'DNA Copy Number Variations/*genetics', 'Drug Hypersensitivity/*genetics', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H2/*genetics', 'Receptors, Histamine H4', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24236486/
563,HRH2,22615049,Association between common genetic variant of HRH2 and gastric cancer risk.,"['Arisawa T', 'Tahara T', 'Ozaki K', 'Matsue Y', 'Minato T', 'Yamada H', 'Nomura T', 'Hayashi R', 'Matsunaga K', 'Fukumura A', 'Nakamura M', 'Toshikuni N', 'Shiroeda H', 'Shibata T']","['Aged', 'Female', 'Gastritis/genetics', 'Gene Frequency', 'Genetic Association Studies', 'Genotype', 'Helicobacter Infections/complications', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Pepsinogen A/blood', '*Polymorphism, Single Nucleotide', 'Receptors, Histamine H2/*genetics', 'Risk Factors', 'Stomach Neoplasms/blood/*genetics/microbiology']",https://pubmed.ncbi.nlm.nih.gov/22615049/
564,HRH2,23280118,Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium.,"['Nomura T', 'Tahara T', 'Shiroeda H', 'Minato T', 'Matsue Y', 'Hayashi R', 'Matsunaga K', 'Otsuka T', 'Nakamura M', 'Toshikuni N', 'Shibata T', 'Arisawa T']","['Aged', 'Antigens, CD', 'Apoptosis Regulatory Proteins/*genetics', 'Cadherins/*genetics', 'Calcium-Calmodulin-Dependent Protein Kinases/*genetics', 'Case-Control Studies', 'DNA Methylation/*genetics', 'Death-Associated Protein Kinases', 'Epithelium/metabolism/pathology', 'Female', 'Gastric Mucosa/metabolism/pathology', 'Genotype', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic/*genetics', 'Promoter Regions, Genetic/*genetics', 'Receptors, Histamine H2/*genetics', 'Risk Factors', 'Stomach/pathology', 'Stomach Neoplasms/epidemiology/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/23280118/
565,HRH2,22720301,Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy.,"['Yamada H', 'Tahara T', 'Shiroeda H', 'Hayashi R', 'Saito T', 'Nakamura M', 'Tsuchishima M', 'Tsutsumi M', 'Shibata T', 'Arisawa T']","['Adult', 'Age Factors', 'Aged', 'Female', 'Gastric Mucosa/pathology', 'Gastritis, Atrophic/enzymology/*genetics/microbiology', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Helicobacter Infections/complications/enzymology', 'Helicobacter pylori', 'Heterozygote', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Pepsinogen A/blood', '*Polymorphism, Genetic', 'Polymorphism, Single-Stranded Conformational', 'Receptors, Histamine H2/*genetics', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/22720301/
566,DRD2,28104410,The DRD2 rs1076560 polymorphism and schizophrenia-related intermediate phenotypes: A systematic review and meta-analysis.,"['Luykx JJ', 'Broersen JL', 'de Leeuw M']","['Genotype', 'Humans', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Receptors, Dopamine D2/*genetics', '*Schizophrenia']",https://pubmed.ncbi.nlm.nih.gov/28104410/
567,DRD2,35411010,Clustering of Parkinson subtypes reveals strong influence of DRD2 polymorphism and gender.,"['Pelzer EA', 'Sturmer S', 'Feis DL', 'Melzer C', 'Schwartz F', 'Scharge M', 'Eggers C', 'Tittgemeyer M', 'Timmermann L']","['Cluster Analysis', 'Female', 'Humans', 'Levodopa/genetics/therapeutic use', 'Male', '*Parkinson Disease/drug therapy/genetics', 'Polymorphism, Genetic', 'Receptors, Dopamine D2/genetics']",https://pubmed.ncbi.nlm.nih.gov/35411010/
568,DRD2,28372879,DRD2: Bridging the Genome and Ingestive Behavior.,"['Sun X', 'Luquet S', 'Small DM']","['Alpha-Ketoglutarate-Dependent Dioxygenase FTO/*genetics', 'Dopamine', '*Gene-Environment Interaction', 'Genetic Predisposition to Disease', 'Humans', 'Obesity/*genetics', 'Protein Serine-Threonine Kinases/*genetics', 'Receptors, Dopamine D2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28372879/
569,DRD2,36689171,DRD2 expression based on (18)F-fallypride PET/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study.,"['Tang H', 'Cheng Y', 'Lou X', 'Yao H', 'Xie J', 'Gu W', 'Huang X', 'Liu Y', 'Lin S', 'Dai Y', 'Xue L', 'Lin X', 'Wu ZB']","['Humans', '*Prolactinoma/diagnostic imaging/drug therapy', 'Dopamine Agonists/therapeutic use', 'Pilot Projects', 'Receptors, Dopamine D2/metabolism', '*Pituitary Neoplasms/diagnostic imaging/drug therapy/metabolism', 'Positron-Emission Tomography']",https://pubmed.ncbi.nlm.nih.gov/36689171/
570,DRD2,16183199,Association of DRD2 gene variant with schizophrenia.,"['Kukreti R', 'Tripathi S', 'Bhatnagar P', 'Gupta S', 'Chauhan C', 'Kubendran S', 'Janardhan Reddy YC', 'Jain S', 'Brahmachari SK']","['Adolescent', 'Adult', 'Age of Onset', 'Case-Control Studies', 'Chi-Square Distribution', 'Female', 'Gene Frequency', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Genotype', 'Histidine/genetics', 'Humans', 'Male', 'Polymorphism, Genetic', 'Psychiatric Status Rating Scales', 'Receptors, Dopamine D2/*genetics', 'Schizophrenia/*genetics', 'Valine/genetics']",https://pubmed.ncbi.nlm.nih.gov/16183199/
571,DRD2,32815424,DRD2 C957T genotype modulates the time-on-task effect during total sleep deprivation.,"['Muck RA', 'Van Dongen HPA', 'Schmidt MA', 'Wisor JP', 'Layton ME', 'DePriest DM', 'Honn KA', 'Satterfield BC']","['*Circadian Rhythm', 'Genotype', 'Humans', 'Psychomotor Performance', 'Reaction Time', 'Receptors, Dopamine D2/genetics', '*Sleep Deprivation/genetics', 'Wakefulness']",https://pubmed.ncbi.nlm.nih.gov/32815424/
572,DRD2,26501178,On the genetics of loss aversion: An interaction effect of BDNF Val66Met and DRD2/ANKK1 Taq1a.,"['Voigt G', 'Montag C', 'Markett S', 'Reuter M']","['Affective Symptoms/*genetics', 'Brain-Derived Neurotrophic Factor/*genetics', 'Choice Behavior', 'Female', 'Gambling/*genetics', 'Genotyping Techniques', 'Humans', 'Male', '*Polymorphism, Single Nucleotide', 'Protein Serine-Threonine Kinases/*genetics', 'Psychological Tests', 'White People/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26501178/
573,DRD2,29564530,Influence of the DRD2/ANKK1 Taq1A polymorphism on caudate volume in older adults without dementia.,"['Li X', 'Papenberg G', 'Kalpouzos G', 'Backman L', 'Persson J']","['Age Factors', 'Aged', 'Aged, 80 and over', 'Aging/*genetics/*pathology', 'Caudate Nucleus/diagnostic imaging/*pathology', 'Cognition/physiology', 'Female', 'Genotype', 'Gray Matter/diagnostic imaging/pathology', 'Humans', 'Image Processing, Computer-Assisted', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Neuropsychological Tests', 'Polymorphism, Single Nucleotide/*genetics', 'Protein Serine-Threonine Kinases/*genetics', 'Receptors, Dopamine D2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29564530/
574,DRD2,11261743,No association between dopamine D2 receptor gene (DRD2) and human intelligence.,"['Moises HW', 'Frieboes RM', 'Spelzhaus P', 'Yang L', 'Kohnke M', 'Herden-Kirchhoff O', 'Vetter P', 'Neppert J', 'Gottesman II']","['Adult', 'Cerebral Cortex/metabolism/physiopathology', 'Dopamine/metabolism', 'Humans', 'Intellectual Disability/*genetics/physiopathology/psychology', 'Intelligence/*genetics', 'Intelligence Tests', 'Neurons/metabolism', 'Psychomotor Performance/physiology', 'Receptors, Dopamine D2/*deficiency/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11261743/
575,DRD2,30799513,Filamin A and DRD2 expression in corticotrophinomas.,"['Sickler T', 'Trarbach EB', 'Frassetto FP', 'Dettoni JB', 'Alves VAF', 'Fragoso MCBV', 'Machado MC', 'Cardoso EF', 'Bronstein MD', 'Glezer A']","['ACTH-Secreting Pituitary Adenoma/*metabolism', 'Adolescent', 'Adult', 'Aged', 'Female', 'Filamins/*metabolism', 'Humans', 'Immunohistochemistry', 'Male', 'Middle Aged', 'Receptors, Dopamine D2/*metabolism', 'Retrospective Studies', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30799513/
576,DRD2,8874837,Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication.,"['Comings DE', 'Muhleman D', 'Gysin R']","['Adult', 'Aged', 'Alcoholism/genetics/psychology', 'Alleles', 'Cluster Analysis', 'Combat Disorders/psychology', 'Genetic Carrier Screening', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Psychiatric Status Rating Scales', 'Receptors, Dopamine D2/*genetics/metabolism', 'Risk Factors', 'Stress Disorders, Post-Traumatic/*genetics/metabolism', 'Substance-Related Disorders/genetics/psychology', 'United States', 'Veterans']",https://pubmed.ncbi.nlm.nih.gov/8874837/
577,DRD2,26666695,Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response.,"['Huang E', 'Maciukiewicz M', 'Zai CC', 'Tiwari AK', 'Li J', 'Potkin SG', 'Lieberman JA', 'Meltzer HY', 'Muller DJ', 'Kennedy JL']","['Antipsychotic Agents/*therapeutic use', 'Clozapine/*therapeutic use', 'Female', 'Genetic Association Studies', 'Humans', 'Male', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D2/*genetics', 'Risk', 'Schizophrenia/drug therapy/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26666695/
578,CHRM4,37142586,CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.,"['Wen YC', 'Tram VTN', 'Chen WH', 'Li CH', 'Yeh HL', 'Thuy Dung PV', 'Jiang KC', 'Li HR', 'Huang J', 'Hsiao M', 'Chen WY', 'Liu YN']","['Male', 'Humans', '*Prostatic Neoplasms/drug therapy/genetics/metabolism', 'N-Myc Proto-Oncogene Protein/metabolism', 'Proto-Oncogene Proteins c-akt', 'Androgen Antagonists/therapeutic use', 'Interferon-alpha/therapeutic use', 'Tumor Microenvironment', 'Cell Line, Tumor', 'Cell Differentiation', 'Receptors, Androgen/metabolism', 'Receptor, Muscarinic M4/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/37142586/
579,CHRM4,33398073,Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance.,"['Chen WY', 'Wen YC', 'Lin SR', 'Yeh HL', 'Jiang KC', 'Chen WH', 'Lin YS', 'Zhang Q', 'Liew PL', 'Hsiao M', 'Huang J', 'Liu YN']","['Adenocarcinoma/drug therapy/*metabolism', 'Androgen Antagonists/adverse effects', 'Carcinoma, Neuroendocrine/*etiology/metabolism/pathology', 'Case-Control Studies', 'Drug Resistance, Neoplasm', 'Humans', 'Male', 'Nerve Growth Factor/*metabolism', 'PC-3 Cells', 'Prostate/pathology', 'Prostatic Neoplasms/drug therapy/*metabolism/pathology', 'Receptor, Muscarinic M4/metabolism', 'Transcription Factors/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33398073/
580,CHRM3,31441039,A homozygous missense variant in CHRM3 associated with familial urinary bladder disease.,"['Beaman GM', 'Galata G', 'Teik KW', 'Urquhart JE', 'Aishah A', ""O'Sullivan J"", 'Bhaskar SS', 'Wood KA', 'Thomas HB', ""O'Keefe RT"", 'Woolf AS', 'Stuart HM', 'Newman WG']","['Base Sequence', 'Family', 'Female', 'Homozygote', 'Humans', 'Malaysia', 'Male', 'Mutation, Missense/*genetics', 'Receptor, Muscarinic M3/*genetics', 'Urinary Bladder Diseases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31441039/
581,CHRM3,36475335,"Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances.","['Sanfilippo C', 'Giuliano L', 'Castrogiovanni P', 'Imbesi R', 'Ulivieri M', 'Fazio F', 'Blennow K', 'Zetterberg H', 'Di Rosa M']","['Male', 'Female', 'Humans', '*Alzheimer Disease/genetics', 'Sleep', 'Brain', 'Biopsy', 'Receptor, Muscarinic M1/genetics', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/36475335/
582,CHRM3,34935917,Methylation-reprogrammed CHRM3 results in vascular dysfunction in the human umbilical vein following IVF-ETdagger.,"['Shi Y', 'Liu J', 'Zhu D', 'Lu L', 'Zhang M', 'Li W', 'Zeng H', 'Yu X', 'Guo J', 'Zhang Y', 'Zhou X', 'Gao Q', 'Xia F', 'Chen Y', 'Li M', 'Sun M']","['Acetylcholine', 'DNA Methylation', '*Embryo Transfer/methods', 'Female', 'Fertilization in Vitro/methods', 'Humans', 'Pregnancy', '*Receptor, Muscarinic M3/metabolism', '*Reproductive Techniques, Assisted', 'Umbilical Veins']",https://pubmed.ncbi.nlm.nih.gov/34935917/
583,CHRM3,36754848,MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3.,"['Asai S', 'Goto Y', 'Tanigawa K', 'Tomioka Y', 'Kato M', 'Mizuno K', 'Sakamoto S', 'Seki N']","['Male', 'Humans', '*MicroRNAs/genetics', '*Prostatic Neoplasms, Castration-Resistant/genetics/metabolism', 'Androgen Antagonists', 'Cell Proliferation/physiology', 'Castration', 'Cell Line, Tumor', 'Receptors, Cholinergic/metabolism', 'Cholinergic Agents', 'Gene Expression Regulation, Neoplastic', 'Receptor, Muscarinic M3/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36754848/
584,CHRM3,36919835,CHRM3-Associated miRNAs May Play a Role in Bile Acid-Induced Proliferation of H508 Colon Cancer Cells.,"['Aktan C', 'Tekin F', 'Oruc N', 'Ozutemiz O']","['Humans', 'Taurolithocholic Acid', '*MicroRNAs/genetics/metabolism', '*Colonic Neoplasms/genetics', 'Cell Proliferation/genetics', 'Receptor, Muscarinic M3']",https://pubmed.ncbi.nlm.nih.gov/36919835/
585,CHRM3,24430298,CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.,"['Jimenez-Morales S', 'Jimenez-Ruiz JL', 'Del Rio-Navarro BE', 'Navarro-Olivos E', 'Escamilla-Guerrero G', 'Savan R', 'Dean M', 'Orozco L']","['Adolescent', 'Alleles', 'Asthma/diagnosis/*genetics', 'Case-Control Studies', 'Child', 'Female', 'Gene Frequency', 'Gene Order', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Mexico', 'Odds Ratio', '*Polymorphism, Single Nucleotide', 'Receptor, Muscarinic M1/*genetics', 'Receptor, Muscarinic M2/*genetics', 'Receptor, Muscarinic M3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24430298/
586,CHRM3,39163289,CHRM3 (rs2165870) gene polymorphism is related to postoperative vomiting in female patients undergoing laparoscopic surgery. Prospective observational study.,"['Cai M', 'Gan L', 'Li J', 'Lei X', 'Yu J']","['Female', 'Humans', 'Genotype', '*Laparoscopy/adverse effects', '*Polymorphism, Single Nucleotide', '*Postoperative Nausea and Vomiting/genetics/etiology/epidemiology', 'Prospective Studies', '*Receptor, Muscarinic M3/genetics', 'Adult', 'Middle Aged']",https://pubmed.ncbi.nlm.nih.gov/39163289/
587,CHRM3,35967390,Impaired sweating in patients with cholinergic urticaria is linked to low expression of acetylcholine receptor CHRM3 and acetylcholine esterase in sweat glands.,"['Wang Y', 'Scheffel J', 'Vera CA', 'Liu W', 'Gunzel D', 'Terhorst-Molawi D', 'Maurer M', 'Altrichter S']","['Acetylcholine/metabolism', '*Acetylcholinesterase/biosynthesis/metabolism', 'Cholinergic Agents', 'Humans', '*Receptor, Muscarinic M3/metabolism', 'Receptors, Cholinergic', '*Sweat Glands/metabolism/pathology', '*Sweating/physiology', '*Urticaria/complications/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35967390/
588,CHRM3,26959877,The CHRM3 gene is implicated in abnormal thalamo-orbital frontal cortex functional connectivity in first-episode treatment-naive patients with schizophrenia.,"['Wang Q', 'Cheng W', 'Li M', 'Ren H', 'Hu X', 'Deng W', 'Ma X', 'Zhao L', 'Wang Y', 'Xiang B', 'Wu HM', 'Sham PC', 'Feng J', 'Li T']","['Adult', '*Connectome', 'Female', 'Fragile X Mental Retardation Protein', 'Genome-Wide Association Study', 'Humans', 'Male', 'Prefrontal Cortex/*physiopathology', 'Quantitative Trait Loci', 'Receptor, Muscarinic M3', '*Receptors, Muscarinic', 'Schizophrenia/*genetics/*physiopathology', 'Thalamus/*physiopathology']",https://pubmed.ncbi.nlm.nih.gov/26959877/
589,CHRM3,28053981,The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City.,"['Wang CT', 'Chen TM', 'Mei CT', 'Chang CF', 'Liu LL', 'Chiu KH', 'Wu TM', 'Lan YC', 'Liu WS', 'Chen YH', 'Lin YJ']","['Aged', 'Female', 'Gene Expression Regulation, Neoplastic', '*Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'RNA, Messenger/genetics', 'Receptor, Muscarinic M3', 'Receptors, Muscarinic/*genetics', 'Taiwan', 'Urinary Bladder Neoplasms/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/28053981/
590,ADRA2C,38951961,"Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.","['Duarte JD', 'Thomas CD', 'Lee CR', 'Huddart R', 'Agundez JAG', 'Baye JF', 'Gaedigk A', 'Klein TE', 'Lanfear DE', 'Monte AA', 'Nagy M', 'Schwab M', 'Stein CM', 'Uppugunduri CRS', 'van Schaik RHN', 'Donnelly RS', 'Caudle KE', 'Luzum JA']","['Humans', '*Adrenergic beta-Antagonists/pharmacokinetics/therapeutic use', '*Cytochrome P-450 CYP2D6/genetics/metabolism', '*G-Protein-Coupled Receptor Kinase 5/genetics', '*Genotype', 'Metoprolol/pharmacokinetics', '*Pharmacogenetics/methods/standards', 'Pharmacogenomic Variants', 'Receptors, Adrenergic, alpha-2/genetics', '*Receptors, Adrenergic, beta-1/genetics', '*Receptors, Adrenergic, beta-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/38951961/
591,ADRA2C,10334470,"Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects.","['Comings DE', 'Gade-Andavolu R', 'Gonzalez N', 'Blake H', 'Wu S', 'MacMurray JP']","['Adolescent', 'Adult', 'Attention Deficit Disorder with Hyperactivity/complications/*genetics', 'Dopamine beta-Hydroxylase/genetics', 'Female', 'Genes/*genetics', 'Genotype', 'Humans', 'Learning Disabilities/complications/*genetics', 'Male', 'Middle Aged', 'Norepinephrine/metabolism', 'Receptors, Adrenergic, alpha-2/genetics', 'Regression Analysis', 'Tourette Syndrome/complications/*genetics']",https://pubmed.ncbi.nlm.nih.gov/10334470/
592,HTR7,25070732,"Association between HTR7 genetic polymorphisms and alcohol dependence, using the alcohol use disorders identification test (AUDIT).","['Kim JH', 'Park BL', 'Cheong HS', 'Bae JS', 'Kim LH', 'Kim JW', 'Lee BC', 'Seo CH', 'Kang TC', 'Park SH', 'Choi IG', 'Shin HD']","['Adult', 'Aged', 'Aged, 80 and over', 'Alcoholism/*diagnosis/*genetics', 'Case-Control Studies', 'Female', '*Genome-Wide Association Study/methods', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Serotonin/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25070732/
593,HTR7,19233240,Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients.,"['Wei Z', 'Wang L', 'Xuan J', 'Che R', 'Du J', 'Qin S', 'Xing Y', 'Gu B', 'Yang L', 'Li H', 'Li J', 'Feng G', 'He L', 'Xing Q']","['Adult', 'Antipsychotic Agents/*therapeutic use', 'China/ethnology', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study/methods', 'Humans', 'Male', 'Middle Aged', '*Pharmacogenetics', 'Psychiatric Status Rating Scales', 'Receptors, Serotonin/*genetics', 'Risperidone/*therapeutic use', 'Schizophrenia/*drug therapy/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19233240/
594,HTR7,7601444,Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome.,"['Gelernter J', 'Rao PA', 'Pauls DL', 'Hamblin MW', 'Sibley DR', 'Kidd KK']","['Blotting, Southern', 'Chromosome Mapping', '*Chromosomes, Human, Pair 10', '*Genes', 'Humans', 'Lod Score', 'Polymorphism, Restriction Fragment Length', 'Receptors, Serotonin/*genetics', 'Tourette Syndrome/*genetics']",https://pubmed.ncbi.nlm.nih.gov/7601444/
595,HTR7,21184583,Genome-wide association study of theta band event-related oscillations identifies serotonin receptor gene HTR7 influencing risk of alcohol dependence.,"['Zlojutro M', 'Manz N', 'Rangaswamy M', 'Xuei X', 'Flury-Wetherill L', 'Koller D', 'Bierut LJ', 'Goate A', 'Hesselbrock V', 'Kuperman S', 'Nurnberger J Jr', 'Rice JP', 'Schuckit MA', 'Foroud T', 'Edenberg HJ', 'Porjesz B', 'Almasy L']","['Adult', 'Alcoholism/diagnosis/*genetics/*physiopathology', 'Case-Control Studies', 'Chromosomes, Human/genetics', 'DNA-Binding Proteins', 'Event-Related Potentials, P300/*genetics', 'Family', 'Female', '*Genetic Predisposition to Disease', 'Genetics, Population', '*Genome-Wide Association Study', 'Haplotypes/genetics', 'Humans', 'Male', 'Models, Genetic', 'Nuclear Proteins/*genetics', 'Phenotype', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Serotonin/*genetics', 'Reproducibility of Results', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/21184583/
596,HTR7,10490701,"Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder.","['Lassig JP', 'Vachirasomtoon K', 'Hartzell K', 'Leventhal M', 'Courchesne E', 'Courchesne R', 'Lord C', 'Leventhal BL', 'Cook EH Jr']","['Autistic Disorder/ethnology/*genetics', '*Chromosomes, Human, Pair 10', '*Chromosomes, Human, Pair 12', 'Female', 'Genetic Markers', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Linkage Disequilibrium/*genetics', 'Male', 'Parents', '*Physical Chromosome Mapping', 'Polymorphism, Restriction Fragment Length', 'Pseudogenes/*genetics', 'Receptors, Serotonin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/10490701/
597,HTR7,27380831,Whole genome sequencing of a dizygotic twin suggests a role for the serotonin receptor HTR7 in autism spectrum disorder.,"['Helsmoortel C', 'Swagemakers SM', 'Vandeweyer G', 'Stubbs AP', 'Palli I', 'Mortier G', 'Kooy RF', 'van der Spek PJ']","['Alleles', 'Autism Spectrum Disorder/*genetics/metabolism', 'Autistic Disorder/genetics', 'Child', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Male', 'Mutation', 'Receptors, Serotonin/*genetics/physiology', 'Sequence Analysis, DNA', 'Serotonin/genetics/metabolism', 'Twins, Dizygotic/genetics/psychology']",https://pubmed.ncbi.nlm.nih.gov/27380831/
598,ADRA2A,37828025,ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon.,"['Hartmann S', 'Yasmeen S', 'Jacobs BM', 'Denaxas S', 'Pirmohamed M', 'Gamazon ER', 'Caulfield MJ', 'Hemingway H', 'Pietzner M', 'Langenberg C']","['Humans', '*Genome-Wide Association Study', 'Ulcer', '*Raynaud Disease/genetics/complications', 'Pain/complications', 'Transcription Factors/genetics', 'Homeodomain Proteins', 'Receptors, Adrenergic, alpha-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/37828025/
599,ADRA2A,16854373,Identification of ADRA2A polymorphisms related to shear-mediated platelet function.,"['Yabe M', 'Matsubara Y', 'Takahashi S', 'Ishihara H', 'Shibano T', 'Miyaki K', 'Omae K', 'Watanabe G', 'Murata M', 'Ikeda Y']","['Asian People', 'Base Sequence', 'Blood Platelets/*physiology', 'Epinephrine/metabolism/pharmacology', 'Humans', 'Japan', 'Male', 'Platelet Aggregation/drug effects/physiology', 'Polymorphism, Genetic/*physiology', 'Receptors, Adrenergic, alpha-2/*genetics/physiology', 'Shear Strength']",https://pubmed.ncbi.nlm.nih.gov/16854373/
600,ADRA2A,17034020,No association between ADRA2A polymorphisms and schizophrenia.,"['Clark DA', 'Mata I', 'Kerwin RW', 'Munro J', 'Arranz MJ']","['Adult', 'Case-Control Studies', 'Female', 'Gene Frequency', '*Genetic Linkage', 'Genotype', 'Humans', 'Male', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-2/*genetics', 'Schizophrenia/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17034020/
601,ADRA2A,39136088,ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.,"['Moreno P', 'Ohara Y', 'Craig AJ', 'Liu H', 'Yang S', 'Dorsey TH', 'Zhang L', 'Panigrahi G', 'Cawley H', 'Azizian A', 'Gaedcke J', 'Ghadimi M', 'Hanna N', 'Hussain SP']","['Humans', '*Pancreatic Neoplasms/pathology/genetics/metabolism', '*Carcinoma, Pancreatic Ductal/pathology/genetics/metabolism', '*Receptors, Adrenergic, alpha-2/genetics/metabolism', '*Gene Expression Regulation, Neoplastic', 'Cell Line, Tumor', 'Male', 'Female', 'Carnitine/analogs & derivatives/metabolism', 'Transcriptome', 'Neoplasm Invasiveness', 'Metabolome', 'Lymphatic Metastasis', 'Middle Aged', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/39136088/
602,ADRA2A,16389583,Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder.,"['Wang B', 'Wang Y', 'Zhou R', 'Li J', 'Qian Q', 'Yang L', 'Guan L', 'Faraone SV']","['Adolescent', 'Alleles', 'Attention Deficit Disorder with Hyperactivity/*genetics/psychology', 'Child', 'Female', 'Gene Frequency', 'Genotype', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Polymorphism, Genetic', 'Receptors, Adrenergic, alpha-2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16389583/
603,ADRA2A,29482474,Potential Role of ADRA2A Genetic Variants in the Etiology of ADHD Comorbid With Tic Disorders.,"['Xu D', 'Liu L', 'Li H', 'Sun L', 'Yang L', 'Qian Q', 'Wang Y']","['*Attention Deficit Disorder with Hyperactivity/epidemiology/genetics', 'Genotype', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Adrenergic, alpha-2/genetics', '*Tic Disorders/epidemiology/genetics']",https://pubmed.ncbi.nlm.nih.gov/29482474/
604,ADRA2A,39278467,The implication of ADRA2A and AVPRIB gene variants in the aetiology of stress-related bipolar disorder.,"['Ejiohuo O', 'Bilska K', 'Narozna B', 'Skibinska M', 'Kapelski P', 'Dmitrzak-Weglarz M', 'Szczepankiewicz A', 'Pawlak J']","['Humans', '*Bipolar Disorder/genetics', 'Female', '*Polymorphism, Single Nucleotide', 'Male', 'Adult', '*Receptors, Adrenergic, alpha-2/genetics', '*Receptors, Vasopressin/genetics', '*Stress, Psychological/genetics/complications', '*Genotype', '*Genetic Predisposition to Disease/genetics', 'Middle Aged', 'Bayes Theorem']",https://pubmed.ncbi.nlm.nih.gov/39278467/
605,ADRA2A,26234518,"Perception of emotion in facial stimuli: The interaction of ADRA2A and COMT genotypes, and sex.","['Tamm G', 'Kreegipuu K', 'Harro J']","['Adult', 'Catechol O-Methyltransferase/*genetics', '*Emotions', 'Estonia', 'Face', 'Facial Recognition/*physiology', 'Female', 'Follow-Up Studies', 'Genotype', 'Genotyping Techniques', 'Humans', 'Male', 'Models, Genetic', 'Models, Psychological', 'Neuropsychological Tests', 'Photic Stimulation', 'Probability', 'Receptors, Adrenergic, alpha-2/*genetics', '*Sex Characteristics']",https://pubmed.ncbi.nlm.nih.gov/26234518/
606,ADRA2A,23751900,No association between MspI allele of the ADRA2A polymorphism and ADHD: meta-analysis of family-based studies.,"['Shiffrin ND', 'Gruber J', 'Glatt SJ', 'Faraone SV']","['*Alleles', 'Attention Deficit Disorder with Hyperactivity/*genetics', 'Deoxyribonuclease HpaII/*genetics', 'Family', '*Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans', 'Models, Genetic', 'Receptors, Adrenergic, alpha-2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23751900/
607,ADRA2A,34948773,The Predictive Role of ADRA2A rs1800544 and HTR3B rs3758987 Polymorphisms in Motion Sickness Susceptibility.,"['Zhang X', 'Sun Y']","['Genetic Predisposition to Disease', 'Genotype', 'Heterozygote', 'Humans', '*Motion Sickness/genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-2', '*Receptors, Serotonin, 5-HT3']",https://pubmed.ncbi.nlm.nih.gov/34948773/
608,ADRA2A,25818344,ADRA2A is involved in neuro-endocrine regulation of bone resorption.,"['Mlakar V', 'Jurkovic Mlakar S', 'Zupan J', 'Komadina R', 'Prezelj J', 'Marc J']","['Biomarkers/metabolism', 'Bone Remodeling', 'Bone Resorption/genetics/*pathology/physiopathology', 'Bone and Bones/metabolism/pathology', 'Cell Line, Tumor', 'Computational Biology', 'Enzyme Assays', 'Gene Expression Regulation', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Immunohistochemistry', 'Luciferases/metabolism', 'Neurosecretory Systems/*metabolism/pathology', 'Osteoarthritis/genetics/pathology/physiopathology', 'Osteoporosis/genetics/pathology/physiopathology', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Adrenergic, alpha-2/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25818344/
609,ADRA2A,30791043,The relationship between MMP9 and ADRA2A gene polymorphisms and mothers-newborns' nutritional status: an exploratory path model (STROBE compliant article).,"['Marginean CO', 'Marginean C', 'Banescu C', 'Melit LE', 'Tripon F', 'Iancu M']","['Adult', 'Birth Weight/genetics', 'Cross-Sectional Studies', 'Female', 'Gestational Weight Gain/genetics', 'Humans', 'Infant Nutritional Physiological Phenomena/genetics', 'Infant, Newborn', 'Male', 'Maternal Nutritional Physiological Phenomena/genetics', 'Maternal-Fetal Exchange/genetics', 'Matrix Metalloproteinase 9/*genetics', 'Models, Genetic', 'Nutritional Status/*genetics', 'Polymorphism, Single Nucleotide', 'Pregnancy', 'Receptors, Adrenergic, alpha-2/*genetics', 'Romania', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30791043/
610,ADRA2A,35429176,A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients.,"['Gallaway KA', 'Skaar TC', 'Biju A', 'Slaven J', 'Tillman EM']","['Adult', 'Child', '*Dexmedetomidine/administration & dosage', 'Genotype', 'Humans', 'Hypnotics and Sedatives/administration & dosage', 'Intensive Care Units', 'Pilot Projects', '*Receptors, Adrenergic, alpha-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/35429176/
611,ADRA2A,17612790,Tobacco smoking and the ADRA2A C-1291G polymorphism.,"['Prestes AP', 'Marques FZ', 'Hutz MH', 'Roman T', 'Bau CH']","['Adult', 'Alcoholism/complications/genetics', 'Alleles', 'DNA/genetics', 'Female', 'Gene Frequency', 'Genetic Testing', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic/*genetics', 'Psychiatric Status Rating Scales', 'Receptors, Adrenergic, alpha-2/*genetics', 'Smoking/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17612790/
612,ADRA2A,31922215,Genetic variant rs3750625 in the 3'UTR of ADRA2A affects the sleep quality of patients in the ICU by promoting miR‑34a binding to ADRA2A.,"['Huang Q', 'Chen G', 'Huang Y', 'Li J', 'Ding Y', 'Zhang S', 'Chi X', 'Xie Q', 'Ning Q', 'Xu L', 'Zhang J']","[""3' Untranslated Regions/genetics"", 'Female', 'Humans', 'Intensive Care Units', 'Male', 'MicroRNAs/*metabolism', 'Middle Aged', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Adrenergic, alpha-2/*genetics/*metabolism', 'Sleep/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31922215/
613,ADRA2A,23462695,Association of the ADRA2A polymorphisms with the risk of type 2 diabetes: a meta-analysis.,"['Chen X', 'Liu L', 'He W', 'Lu Y', 'Ma D', 'Du T', 'Liu Q', 'Chen C', 'Yu X']","['Case-Control Studies', 'Diabetes Mellitus, Type 2/*genetics', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', '*Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-2/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/23462695/
614,ADRA2A,33915198,The effect of alpha-2A adrenergic receptor (ADRA2A) genetic polymorphisms on the depth of sedation of dexmedetomidine: a genetic observational pilot study.,"['Choi YJ', 'Park KH', 'Park JY', 'Min WK', 'Lee YS']","['*Dexmedetomidine/pharmacology', 'Humans', 'Hypnotics and Sedatives/pharmacology', 'Pilot Projects', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-2/genetics']",https://pubmed.ncbi.nlm.nih.gov/33915198/
615,ADRA2A,18842695,ADRA2A polymorphism and smoking in a Turkish population.,"['Karahalil B', 'Coskun E', 'Emerce E']","['Adult', 'Aged', 'Aged, 80 and over', 'Female', 'Gene Frequency', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Receptors, Adrenergic, alpha-2/blood/*genetics/physiology', 'Smoking/ethnology/*genetics', 'Turkey', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/18842695/
616,DRD5,32907377,Hypermethylation of DRD5 Promoter Is a Biomarker Across 12 Cancer Types.,"['Bai R', 'Mei J', 'Hu W']","['Biomarkers, Tumor/*genetics', 'CpG Islands/genetics', 'DNA Methylation/*genetics', 'Epigenesis, Genetic/genetics', 'Female', 'Humans', 'Male', 'Neoplasms/classification/*genetics/pathology', 'Promoter Regions, Genetic/genetics', 'Receptors, Dopamine D5/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32907377/
617,DRD5,11781417,A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm.,"['Misbahuddin A', 'Placzek MR', 'Chaudhuri KR', 'Wood NW', 'Bhatia KP', 'Warner TT']","['Adult', 'Alleles', 'Blepharospasm/*genetics', 'Dinucleotide Repeats', 'Female', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Receptors, Dopamine D1/*genetics', 'Receptors, Dopamine D5']",https://pubmed.ncbi.nlm.nih.gov/11781417/
618,DRD5,35961947,Relationship of DRD5 and MAO-B VNTR polymorphisms with paranoid and antisocial personality disorders in polydrug users.,"[""O'Higgins M"", 'Benito A', 'Real-Lopez M', 'Gil-Miravet I', 'Ochoa E', 'Haro G']","['Humans', '*Antisocial Personality Disorder/genetics', '*Polymorphism, Genetic', 'Monoamine Oxidase/genetics', 'Minisatellite Repeats', 'Cross-Sectional Studies', 'Receptors, Dopamine D5/genetics']",https://pubmed.ncbi.nlm.nih.gov/35961947/
619,DRD5,10578238,"Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5.","['Kirov G', 'Jones I', 'McCandless F', 'Craddock N', 'Owen MJ']","['Adult', 'Bipolar Disorder/*genetics', 'Brain/enzymology', 'Brain Chemistry/*genetics', 'Carrier Proteins/genetics', 'Catechol O-Methyltransferase/genetics', 'DNA Primers', 'Dopamine/*genetics', 'Dopamine Plasma Membrane Transport Proteins', 'Dopamine beta-Hydroxylase/genetics', 'England', '*Family Health', 'Female', 'Genotype', 'Humans', 'Linkage Disequilibrium', 'Male', '*Membrane Glycoproteins', '*Membrane Transport Proteins', 'Middle Aged', '*Nerve Tissue Proteins', 'Penetrance', 'Receptors, Dopamine D1/genetics', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D3', 'Receptors, Dopamine D5', 'Synaptic Transmission/genetics', 'Wales', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/10578238/
620,DRD5,8540565,Linkage study of the D5 dopamine receptor gene (DRD5) in multiplex Icelandic and English schizophrenia pedigrees.,"['Kalsi G', 'Sherrington R', 'Mankoo BS', 'Brynjolfsson J', 'Sigmundsson T', 'Curtis D', 'Read T', 'Murphy P', 'Butler R', 'Petursson H', 'Gurling HM']","['Base Sequence', 'England', 'Genetic Linkage', 'Genetic Markers', 'Genetic Variation', 'Humans', 'Iceland', 'Lod Score', 'Molecular Sequence Data', 'Mutation', 'Pedigree', 'Receptors, Dopamine D1/*genetics', 'Receptors, Dopamine D5', 'Schizophrenia/*genetics']",https://pubmed.ncbi.nlm.nih.gov/8540565/
621,DRD5,27480019,Meta-analysis of the DRD5 VNTR in persistent ADHD.,"['Klein M', 'Berger S', 'Hoogman M', 'Dammers J', 'Makkinje R', 'Heister AJGAM', 'Galesloot TE', 'Kiemeney LALM', 'Weber H', 'Kittel-Schneider S', 'Lesch KP', 'Reif A', 'Ribase S M', 'Ramos-Quiroga JA', 'Cormand B', 'Zayats T', 'Hegvik TA', 'Jacobsen KK', 'Johansson S', 'Haavik J', 'Mota NR', 'Bau CHD', 'Grevet EH', 'Doyle A', 'Faraone SV', 'Arias-Va Squez A', 'Franke B']","['Attention Deficit Disorder with Hyperactivity/*genetics', 'Genetic Predisposition to Disease', 'Humans', '*Minisatellite Repeats', 'Receptors, Dopamine D5/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27480019/
622,DRD5,17133500,Assessing the role of DRD5 and DYT1 in two different case-control series with primary blepharospasm.,"['Clarimon J', 'Brancati F', 'Peckham E', 'Valente EM', 'Dallapiccola B', 'Abruzzese G', 'Girlanda P', 'Defazio G', 'Berardelli A', 'Hallett M', 'Singleton AB']","['Blepharospasm/diagnosis/*genetics/*physiopathology', 'Case-Control Studies', 'DNA Primers/genetics', 'Female', 'Gene Frequency', 'Genotype', 'Humans', 'Linkage Disequilibrium/genetics', 'Male', 'Microsatellite Repeats/genetics', 'Middle Aged', 'Molecular Chaperones/genetics/*physiology', 'Polymerase Chain Reaction', 'Polymorphism, Genetic/genetics', 'Receptors, Dopamine D5/genetics/*physiology', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/17133500/
623,DRD5,19397556,SNP discovery and haplotype analysis in the segmentally duplicated DRD5 coding region.,"['Housley DJ', 'Nikolas M', 'Venta PJ', 'Jernigan KA', 'Waldman ID', 'Nigg JT', 'Friderici KH']","['Base Sequence', 'Chromosome Mapping', '*Gene Duplication', '*Genetic Techniques', 'Haplotypes', 'Humans', 'Molecular Sequence Data', '*Open Reading Frames', '*Polymorphism, Single Nucleotide', 'Pseudogenes', 'Receptors, Dopamine D5/*genetics', 'Triplets/genetics']",https://pubmed.ncbi.nlm.nih.gov/19397556/
624,DRD5,18081165,"Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs.","['Johansson S', 'Halleland H', 'Halmoy A', 'Jacobsen KK', 'Landaas ET', 'Dramsdahl M', 'Fasmer OB', 'Bergsholm P', 'Lundervold AJ', 'Gillberg C', 'Hugdahl K', 'Knappskog PM', 'Haavik J']","['Adult', 'Alleles', 'Attention Deficit Disorder with Hyperactivity/diagnosis/*genetics', 'Case-Control Studies', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Female', 'Gene Frequency', 'Genetic Markers', 'Humans', 'Male', '*Microsatellite Repeats', 'Polymorphism, Genetic', 'Receptors, Dopamine D4/*genetics', 'Receptors, Dopamine D5/*genetics', 'Retrospective Studies']",https://pubmed.ncbi.nlm.nih.gov/18081165/
625,DRD5,15578613,"Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B.","['Mill J', 'Xu X', 'Ronald A', 'Curran S', 'Price T', 'Knight J', 'Craig I', 'Sham P', 'Plomin R', 'Asherson P']","['Alleles', 'Attention Deficit Disorder with Hyperactivity/*genetics', 'Child', 'Dopamine Plasma Membrane Transport Proteins', 'Gene Frequency', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Linkage Disequilibrium', 'Male', 'Membrane Glycoproteins/genetics', 'Membrane Proteins/genetics', 'Membrane Transport Proteins/genetics', 'Meta-Analysis as Topic', 'Nerve Tissue Proteins/genetics', 'Polymorphism, Genetic', 'Quantitative Trait Loci/*genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptors, Dopamine D1/genetics', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D4', 'Receptors, Dopamine D5', 'Synaptosomal-Associated Protein 25', 'Twins, Dizygotic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15578613/
626,DRD5,11304828,Markers close to the dopamine D5 receptor gene (DRD5) show significant association with schizophrenia but not bipolar disorder.,"['Muir WJ', 'Thomson ML', 'McKeon P', 'Mynett-Johnson L', 'Whitton C', 'Evans KL', 'Porteous DJ', 'Blackwood DH']","['Alleles', 'Bipolar Disorder/*genetics', 'Case-Control Studies', 'Chromosomes, Human, Pair 4', 'Family Health', 'Female', 'Gene Frequency', 'Genetic Linkage', 'Genotype', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', '*Microsatellite Repeats', 'Odds Ratio', 'Parents', 'Polymorphism, Genetic', 'Receptors, Dopamine D1/*genetics', 'Receptors, Dopamine D5', 'Schizophrenia/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11304828/
627,DRD5,24668635,Relationship between genetic polymorphisms in the DRD5 gene and paranoid schizophrenia in northern Han Chinese.,"['Zhao Y', 'Ding M', 'Pang H', 'Xu XM', 'Wang BJ']","['Adult', 'Alleles', 'Asian People/genetics', 'Female', '*Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D5/*genetics', 'Schizophrenia, Paranoid/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/24668635/
628,DRD5,25556472,Dopamine receptor gene (DRD1-DRD5) expression changes as stress factors associated with breast cancer.,"['Pornour M', 'Ahangari G', 'Hejazi SH', 'Ahmadkhaniha HR', 'Akbari ME']","['Adult', 'Breast Neoplasms/*genetics', 'Carcinoma/*genetics', 'Case-Control Studies', 'Female', 'Gene Expression Regulation, Neoplastic/*genetics', 'Humans', 'Leukocytes, Mononuclear/metabolism', 'MCF-7 Cells', 'RNA, Messenger/*metabolism', 'Receptors, Dopamine/*genetics', 'Receptors, Dopamine D1/genetics', 'Receptors, Dopamine D2/genetics', 'Receptors, Dopamine D3/genetics', 'Receptors, Dopamine D4/genetics', 'Receptors, Dopamine D5/genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Stress, Psychological/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25556472/
629,DRD5,8288248,Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1.,"['Sherrington R', 'Mankoo B', 'Attwood J', 'Kalsi G', 'Curtis D', 'Buetow K', 'Povey S', 'Gurling H']","['Base Sequence', '*Chromosomes, Human, Pair 4', 'Cloning, Molecular', 'DNA', 'DNA, Satellite/*genetics', 'Female', 'Genetic Linkage', 'Genetic Markers', 'Humans', 'Male', 'Molecular Sequence Data', '*Polymorphism, Genetic', 'Receptors, Dopamine/*genetics', '*Receptors, Dopamine D1', 'Receptors, Dopamine D5']",https://pubmed.ncbi.nlm.nih.gov/8288248/
630,DRD5,11353446,An association study of DRD5 with smoking initiation and progression to nicotine dependence.,"['Sullivan PF', 'Neale MC', 'Silverman MA', 'Harris-Kerr C', 'Myakishev MV', 'Wormley B', 'Webb BT', 'Ma Y', 'Kendler KS', 'Straub RE']","['Adolescent', 'Adult', 'Alleles', 'Behavior, Addictive/epidemiology/etiology/genetics', 'Case-Control Studies', 'Female', 'Gene Frequency', 'Genotype', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Microsatellite Repeats', 'Polymorphism, Genetic', 'Receptors, Dopamine D1/*genetics/physiology', 'Receptors, Dopamine D5', 'Smoking/epidemiology/*genetics', 'Statistics, Nonparametric', 'Tobacco Use Disorder/epidemiology/etiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11353446/
631,ADRA1B,30785334,Fine mapping and subphenotyping implicates ADRA1B gene variants in psoriasis susceptibility in a Chinese population.,"['Fan X', 'Wang H', 'Sun L', 'Zheng X', 'Yin X', 'Zuo X', 'Peng Q', 'Standish KA', 'Cheng H', 'Zhang Y', 'Wang Z', 'Xiao F', 'Yang S', 'Zhang X', 'Schork NJ']","['Adult', 'Age of Onset', 'Alleles', 'Asian People/genetics', 'Case-Control Studies', 'China', '*Chromosome Mapping', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', '*Genetic Variation', 'Humans', 'Inheritance Patterns', 'Linkage Disequilibrium', 'Male', 'Middle Aged', '*Phenotype', 'Polymorphism, Single Nucleotide', 'Psoriasis/*diagnosis/*genetics', 'Quantitative Trait Loci', 'ROC Curve', 'Receptors, Adrenergic, alpha-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30785334/
632,ADRA1B,23052569,"A high density linkage disequilibrium mapping in 14 noradrenergic genes: evidence of association between SLC6A2, ADRA1B and ADHD.","['Hawi Z', 'Matthews N', 'Barry E', 'Kirley A', 'Wagner J', 'Wallace RH', 'Heussler HS', 'Vance A', 'Gill M', 'Bellgrove MA']","['Adolescent', 'Attention Deficit Disorder with Hyperactivity/diagnosis/epidemiology/*genetics', 'Child', 'Chromosome Mapping/*methods', 'Female', 'Genetic Association Studies/*methods', 'Humans', 'Linkage Disequilibrium/*genetics', 'Male', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Adrenergic/genetics', 'Receptors, Adrenergic, alpha-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23052569/
633,CHRM5,17608938,Variation in the gene coding for the M5 muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults.,"['Anney RJ', 'Lotfi-Miri M', 'Olsson CA', 'Reid SC', 'Hemphill SA', 'Patton GC']","['Adolescent', 'Alcohol Drinking/*genetics', 'Chromatography, High Pressure Liquid', 'Cohort Studies', 'Gene Frequency', '*Genetic Variation', 'Humans', 'Marijuana Abuse/*genetics', 'Polymorphism, Single Nucleotide', 'Prospective Studies', 'Receptor, Muscarinic M5/*genetics', 'Tobacco Use Disorder/*genetics', 'Victoria', 'White People']",https://pubmed.ncbi.nlm.nih.gov/17608938/
634,ADRA1A,21519279,Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population.,"['Grassi G', 'Padmanabhan S', 'Menni C', 'Seravalle G', 'Lee WK', 'Bombelli M', 'Brambilla G', 'Quarti-Trevano F', 'Giannattasio C', 'Cesana G', 'Dominiczak A', 'Mancia G']","['Adult', 'Aged', 'Cohort Studies', 'Female', 'Humans', 'Male', 'Metabolic Syndrome/*genetics', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21519279/
635,ADRA1A,36344764,ADRA1A-Galpha(q) signalling potentiates adipocyte thermogenesis through CKB and TNAP.,"['Rahbani JF', 'Scholtes C', 'Lagarde DM', 'Hussain MF', 'Roesler A', 'Dykstra CB', 'Bunk J', 'Samborska B', ""O'Brien SL"", 'Tripp E', 'Pacis A', 'Angueira AR', 'Johansen OS', 'Cinkornpumin J', 'Hossain I', 'Lynes MD', 'Zhang Y', 'White AP', 'Pastor WA', 'Chondronikola M', 'Sidossis L', 'Klein S', 'Kralli A', 'Cypess AM', 'Pedersen SB', 'Jessen N', 'Tseng YH', 'Gerhart-Hines Z', 'Seale P', 'Calebiro D', 'Giguere V', 'Kazak L']","['*Creatine/metabolism', '*Thermogenesis/genetics', 'Adipocytes/metabolism', 'Energy Metabolism/genetics', 'Creatine Kinase/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36344764/
636,ADRA1A,35964682,Hypermethylation in the promoter region of the ADRA1A gene is associated with opioid use disorder in Han Chinese.,"['Zhang J', 'Fu X', 'Lu Y', 'Cheng C', 'Wang K', 'Zhu Y', 'Xie Q']","['China', 'CpG Islands/genetics', 'DNA Methylation', '*Heroin', 'Humans', 'Methadone/therapeutic use', '*Opioid-Related Disorders/genetics', 'Promoter Regions, Genetic/genetics', 'Receptors, Adrenergic, alpha-1']",https://pubmed.ncbi.nlm.nih.gov/35964682/
637,ADRA1A,36012699,Vascular Reactions of the Diving Reflex in Men and Women Carrying Different ADRA1A Genotypes.,"['Baranova T', 'Podyacheva E', 'Zemlyanukhina T', 'Berlov D', 'Danilova M', 'Glotov O', 'Glotov A']","['Adolescent', 'Adult', 'Apnea/genetics', 'Bradycardia', '*Diving Reflex', 'Female', 'Genotype', 'Heart Rate/physiology', 'Humans', 'Hypoxia/genetics', 'Male', 'Oxygen', '*Receptors, Adrenergic, alpha-1/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/36012699/
638,ADRA1A,34706275,MiR-3682 promotes the progression of hepatocellular carcinoma (HCC) via inactivating AMPK signaling by targeting ADRA1A.,"['Zhao W', 'Liu X']","['AMP-Activated Protein Kinases/genetics/metabolism', '*Carcinoma, Hepatocellular/pathology', 'Cell Line, Tumor', 'Cell Movement/genetics', 'Cell Proliferation/genetics', 'Gene Expression Regulation, Neoplastic', 'Humans', '*Liver Neoplasms/pathology', '*MicroRNAs/genetics/metabolism', 'Receptors, Adrenergic, alpha-1/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34706275/
639,ADRA1A,31933413,Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma.,"['Chen G', 'Fan X', 'Li Y', 'He L', 'Wang S', 'Dai Y', 'Bin C', 'Zhou D', 'Lin H']","['Biomarkers, Tumor/*genetics/metabolism', 'Carcinoma, Hepatocellular/*genetics/pathology', '*DNA Methylation', 'Epigenesis, Genetic', 'Female', 'Gene Expression Regulation, Neoplastic', 'HEK293 Cells', 'Hep G2 Cells', 'Humans', 'Liver Neoplasms/*genetics/pathology', 'Male', 'Middle Aged', 'Promoter Regions, Genetic', 'Receptors, Adrenergic, alpha-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31933413/
640,ADRA1A,17408692,No association found between the promoter variants of ADRA1A and schizophrenia in the Chinese population.,"['Huang K', 'Shi Y', 'Tang W', 'Tang R', 'Guo S', 'Xu Y', 'Meng J', 'Li X', 'Feng G', 'He L']","['Adult', 'Asian People/*genetics', 'China/epidemiology', 'Control Groups', 'DNA Mutational Analysis', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease/genetics', 'Genetic Variation/*genetics', 'Genotype', 'Haplotypes/genetics', 'Humans', 'Linkage Disequilibrium', 'Male', 'Polymorphism, Genetic/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Promoter Regions, Genetic/*genetics', 'Receptors, Adrenergic, alpha-1/*genetics', 'Schizophrenia/diagnosis/epidemiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17408692/
641,ADRA1A,22037178,Association of the ADRA1A gene and the severity of metabolic abnormalities in patients with schizophrenia.,"['Cheng C', 'Chiu HJ', 'Loh el-W', 'Chan CH', 'Hwu TM', 'Liu YR', 'Lan TH']","['Adult', 'Arginine/genetics', 'Cysteine/genetics', 'Female', 'Gene Frequency', '*Genetic Association Studies/methods', 'Humans', 'Male', 'Metabolic Syndrome/diagnosis/epidemiology/*genetics', 'Middle Aged', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Adrenergic, alpha-1/*genetics', 'Risk Factors', 'Schizophrenia/epidemiology/*genetics/metabolism', '*Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/22037178/
642,ADRA1A,19918262,ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics.,"['Liu YR', 'Loh EW', 'Lan TH', 'Chen SF', 'Yu YH', 'Chang YH', 'Huang CJ', 'Hu TM', 'Lin KM', 'Yao YT', 'Chiu HJ']","['Adult', 'Aged', 'Aged, 80 and over', 'Antipsychotic Agents/*therapeutic use', 'Base Sequence', '*Body Mass Index', 'Female', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Obesity/etiology', 'Polymorphism, Single Nucleotide', 'Prospective Studies', 'Receptors, Adrenergic, alpha-1/*genetics', 'Schizophrenia/complications/*drug therapy/*genetics', 'Weight Gain/genetics']",https://pubmed.ncbi.nlm.nih.gov/19918262/
643,ADRA1A,27379509,The alpha-1 adrenoceptor (ADRA1A) genotype moderates the magnitude of acute cocaine-induced subjective effects in cocaine-dependent individuals.,"['Shorter D', 'Nielsen DA', 'Hamon SC', 'Nielsen EM', 'Kosten TR', 'Newton TF', 'De La Garza R 2nd']","['Administration, Intravenous', 'Adult', 'Amino Acid Substitution', 'Cocaine/*administration & dosage/adverse effects', 'Cocaine-Related Disorders/*genetics', 'Double-Blind Method', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Pharmacogenomic Variants', '*Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-1/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27379509/
644,ADRA1A,15136785,"A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH.","['Klotsman M', 'Weinberg CR', 'Davis K', 'Binnie CG', 'Hartmann KE']","['3-Oxo-5-alpha-Steroid 4-Dehydrogenase/*genetics', 'Aged', 'Codon/genetics', 'Humans', 'Male', 'Muscle Tonus/physiology', 'Muscle, Smooth/physiology', 'Polymorphism, Genetic', 'Polymorphism, Single Nucleotide/genetics', 'Prostate/anatomy & histology', 'Prostatic Hyperplasia/enzymology/*genetics', 'Receptors, Androgen/*genetics', 'Trinucleotide Repeats']",https://pubmed.ncbi.nlm.nih.gov/15136785/
645,ADRA1A,19352218,Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A.,"['Elia J', 'Capasso M', 'Zaheer Z', 'Lantieri F', 'Ambrosini P', 'Berrettini W', 'Devoto M', 'Hakonarson H']","['Adolescent', 'Attention Deficit Disorder with Hyperactivity/*genetics', 'Child', '*Genome-Wide Association Study', 'Humans', 'Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/19352218/
646,HTR2C,36373384,Depressive patient-derived GABA interneurons reveal abnormal neural activity associated with HTR2C.,"['Lu K', 'Hong Y', 'Tao M', 'Shen L', 'Zheng Z', 'Fang K', 'Yuan F', 'Xu M', 'Wang C', 'Zhu D', 'Guo X', 'Liu Y']","['Humans', '*Depressive Disorder, Major/metabolism', 'Interneurons/metabolism', 'Neurons/metabolism', 'Cell Differentiation', 'gamma-Aminobutyric Acid/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36373384/
647,HTR2C,25457638,A functional polymorphism in the HTR2C gene associated with stress responses: a validation study.,"['Brummett BH', 'Babyak MA', 'Kuhn CM', 'Siegler IC', 'Williams RB']","['Adult', 'Alleles', 'Female', 'Genetic Association Studies', 'Humans', 'Hydrocortisone/*analysis', 'Hypothalamo-Hypophyseal System/*physiopathology', 'Male', 'Pituitary-Adrenal System/*physiopathology', '*Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT2C/*genetics', 'Stress, Psychological/*genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/25457638/
648,HTR2C,21717509,Bioinformatic analyses to select phenotype affecting polymorphisms in HTR2C gene.,"['Piva F', 'Giulietti M', 'Baldelli L', 'Nardi B', 'Bellantuono C', 'Armeni T', 'Saccucci F', 'Principato G']","['Computational Biology/*methods', 'Humans', 'MicroRNAs/metabolism', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Protein Conformation', 'RNA Splicing', 'Receptor, Serotonin, 5-HT2C/*genetics', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/21717509/
649,HTR2C,10412190,Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder.,"['Burnet PW', 'Smith KA', 'Cowen PJ', 'Fairburn CG', 'Harrison PJ']","['Adolescent', 'Adult', 'Alleles', 'Bulimia/*genetics', 'Case-Control Studies', 'Codon', 'Cysteine', 'Ethnicity', 'Feeding and Eating Disorders/*genetics', 'Female', '*Genetic Variation', 'Humans', 'Receptor, Serotonin, 5-HT2C', 'Receptors, Serotonin/*genetics', 'Serine']",https://pubmed.ncbi.nlm.nih.gov/10412190/
650,HTR2C,26359410,Acute Necrotizing Pancreatitis Following Olanzapine Treatment and 759C/T Polymorphism of HTR2C Gene: A Case Report.,"['Rizos E', 'Tournikioti K', 'Alevyzakis E', 'Peppa M', 'Papazaxos K', 'Zorbas G', 'Michopoulos I', 'Liappas I', 'Papageorgiou C', 'Douzenis A']","['*Alleles', 'Antipsychotic Agents/*adverse effects/therapeutic use', 'Benzodiazepines/*adverse effects/therapeutic use', 'Drug Substitution', '*Haplotypes', 'Humans', 'Male', 'Olanzapine', 'Pancreatitis, Acute Necrotizing/diagnosis/*etiology', '*Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT2C/*genetics', 'Schizophrenia/complications/drug therapy', 'Treatment Outcome', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26359410/
651,HTR2C,32231051,"HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia.","['Grubor M', 'Zivkovic M', 'Sagud M', 'Nikolac Perkovic M', 'Mihaljevic-Peles A', 'Pivac N', 'Muck-Seler D', 'Svob Strac D']","['Adult', 'Antipsychotic Agents/*adverse effects/therapeutic use', 'Haloperidol/*adverse effects/therapeutic use', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptor, Serotonin, 5-HT2A/genetics', 'Receptor, Serotonin, 5-HT2C/genetics', 'Receptors, Serotonin/*genetics', 'Schizophrenia/*drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/32231051/
652,HTR2C,20045196,Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.,"['Thompson A', 'Lavedan C', 'Volpi S']","['Analysis of Variance', 'Antipsychotic Agents/*therapeutic use', 'Female', 'Follow-Up Studies', 'Gene Frequency', 'Genotype', 'Humans', 'Isoxazoles/*therapeutic use', 'Male', 'Piperazines/therapeutic use', 'Piperidines/*therapeutic use', 'Polymorphism, Genetic/*genetics', 'Receptor, Serotonin, 5-HT2C/*genetics', '*Schizophrenia/drug therapy/genetics/physiopathology', 'Thiazoles/therapeutic use', '*Weight Gain/drug effects/genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/20045196/
653,HTR2C,17192951,HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers.,"['Serretti A', 'Mandelli L', 'Giegling I', 'Schneider B', 'Hartmann AM', 'Schnabel A', 'Maurer K', 'Moller HJ', 'Rujescu D']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Female', 'Germany', 'Humans', 'Impulsive Behavior/genetics', 'Italy', 'Linkage Disequilibrium', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Receptor, Serotonin, 5-HT2C/*genetics', '*Suicide', '*Suicide, Attempted', 'Violence']",https://pubmed.ncbi.nlm.nih.gov/17192951/
654,HTR2C,27211696,Nonsynonymous HTR2C polymorphism predicts cortisol response to psychosocial stress II: Evidence from two samples.,"['Way BM', 'Brown KW', 'Quaglia J', 'McCain N', 'Taylor SE']","['Adolescent', 'Adult', 'Alleles', 'Case-Control Studies', 'Female', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Genotype', 'Humans', 'Hydrocortisone/*genetics/*metabolism', 'Male', 'Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT2C/*genetics/metabolism', 'Receptors, Serotonin/genetics/metabolism', 'Saliva', 'Serotonin/genetics/metabolism', 'Serotonin Plasma Membrane Transport Proteins/*genetics/metabolism', 'Stress, Psychological/*genetics/*metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27211696/
655,HTR2C,29049139,The role of the Cys23Ser (rs6318) polymorphism of the HTR2C gene in suicidal behavior: systematic review and meta-analysis.,"['Gonzalez-Castro TB', 'Hernandez-Diaz Y', 'Juarez-Rojop IE', 'Lopez-Narvaez L', 'Tovilla-Zarate CA', 'Rodriguez-Perez JM', 'Sanchez-de la Cruz JP']","['Alleles', 'Case-Control Studies', 'Female', 'Gene Frequency/genetics', 'Genetic Predisposition to Disease/genetics', 'Genotype', 'Humans', 'Male', 'Odds Ratio', 'Polymorphism, Single Nucleotide/genetics', 'Receptor, Serotonin, 5-HT2C/*genetics/metabolism', 'Risk Factors', 'Self-Injurious Behavior/*genetics', 'Suicidal Ideation', 'Suicide/*psychology', 'Suicide, Attempted/psychology']",https://pubmed.ncbi.nlm.nih.gov/29049139/
656,HTR2C,19439249,"Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.","['Al Hadithy AF', 'Ivanova SA', 'Pechlivanoglou P', 'Semke A', 'Fedorenko O', 'Kornetova E', 'Ryadovaya L', 'Brouwers JR', 'Wilffert B', 'Bruggeman R', 'Loonen AJ']","['Adult', 'Aged', 'Akathisia, Drug-Induced/classification/etiology/*genetics/pathology', 'Chlorpromazine/adverse effects', 'Cross-Sectional Studies', 'Cystine/genetics', 'Disability Evaluation', 'Extremities/physiopathology', 'Face/physiopathology', 'Female', 'Gene Frequency', 'Genotype', 'Glycine/genetics', 'Humans', 'Male', 'Middle Aged', 'Models, Statistical', 'Mouth/physiopathology', 'Pharmacogenetics', 'Polymorphism, Genetic/*genetics', 'Psychiatric Status Rating Scales', 'Receptor, Serotonin, 5-HT2A/*genetics', 'Receptor, Serotonin, 5-HT2C/*genetics', 'Receptors, Dopamine D3/*genetics', 'Schizophrenia/drug therapy/genetics', 'Serine/genetics', 'Severity of Illness Index', 'Siberia/epidemiology/ethnology']",https://pubmed.ncbi.nlm.nih.gov/19439249/
657,HTR2C,29924134,Association between serotonin 2C receptor gene (HTR2C) polymorphisms and psychopathological symptoms in children and adolescents.,"['Paes LA', 'Torre OHD', 'Henriques TB', 'de Mello MP', 'Celeri EHRV', 'Dalgalarrondo P', 'Guerra Junior G', 'Dos Santos Junior A']","['Adolescent', 'Alleles', 'Checklist', 'Chi-Square Distribution', 'Child', 'Child Behavior Disorders/diagnosis/*genetics', 'Cross-Sectional Studies', 'Female', 'Gene Frequency/genetics', 'Gene-Environment Interaction', 'Genotype', 'Humans', 'Male', 'Mental Disorders/diagnosis/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Psychiatric Status Rating Scales', 'Receptor, Serotonin, 5-HT2C/*genetics', 'Sex Factors', 'Surveys and Questionnaires']",https://pubmed.ncbi.nlm.nih.gov/29924134/
658,DRD3,25224105,"Autism, DRD3 and repetitive and stereotyped behavior, an overview of the current knowledge.",['Staal WG'],"['Autism Spectrum Disorder/drug therapy/genetics/*physiopathology', 'Basal Ganglia/physiopathology', 'Humans', 'Polymorphism, Genetic', 'Receptors, Dopamine D3/genetics/*metabolism', 'Stereotyped Behavior/drug effects/*physiology']",https://pubmed.ncbi.nlm.nih.gov/25224105/
659,DRD3,34237276,DRD3-dependent plasticity within the VP drives subcircuit activity critical for cocaine seeking.,"['Campbell RR', 'Lobo MK']","['*Basal Forebrain', '*Cocaine', 'Drug-Seeking Behavior', 'Neurons', 'Reward']",https://pubmed.ncbi.nlm.nih.gov/34237276/
660,DRD3,21691864,Brief report: the dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in autism spectrum disorder (ASD).,"['Staal WG', 'de Krom M', 'de Jonge MV']","['Adolescent', 'Adult', 'Alleles', 'Child', 'Child Development Disorders, Pervasive/*genetics', 'Child, Preschool', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D3/*genetics', 'Stereotyped Behavior/*physiology']",https://pubmed.ncbi.nlm.nih.gov/21691864/
661,DRD3,25262640,Significant association between DRD3 gene body methylation and schizophrenia.,"['Dai D', 'Cheng J', 'Zhou K', 'Lv Y', 'Zhuang Q', 'Zheng R', 'Zhang K', 'Jiang D', 'Gao S', 'Duan S']","['Adult', 'DNA Methylation/*physiology', 'Female', 'Genetic Association Studies/*methods', 'Humans', 'Male', 'Methylation', 'Receptors, Dopamine D3/*genetics/*metabolism', 'Schizophrenia/*genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25262640/
662,DRD3,9149327,No association between particular DRD3 and DAT gene polymorphisms and manic-depressive illness in a Spanish sample.,"['Gomez-Casero E', 'Perez de Castro I', 'Saiz-Ruiz J', 'Llinares C', 'Fernandez-Piqueras J']","['Bipolar Disorder/*genetics', 'Carrier Proteins/*genetics', 'Chromosome Mapping', 'Chromosomes, Human, Pair 3', 'Chromosomes, Human, Pair 5', 'Dopamine Plasma Membrane Transport Proteins', 'Gene Frequency', 'Genetic Linkage', 'Genotype', 'Humans', '*Membrane Glycoproteins', '*Membrane Transport Proteins', '*Nerve Tissue Proteins', '*Polymorphism, Genetic', 'Receptors, Dopamine D2/*genetics', 'Receptors, Dopamine D3', 'Reference Values', 'Repetitive Sequences, Nucleic Acid', 'Spain']",https://pubmed.ncbi.nlm.nih.gov/9149327/
663,DRD3,21737144,Association study of DRD3 gene in schizophrenia in Mexican sib-pairs.,"['Urraca N', 'Camarena B', 'Aguilar A', 'Fresan A', 'Apiquian R', 'Orozco L', 'Carnevale A', 'Nicolini H']","['Adult', 'Female', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Glycine/genetics', 'Humans', 'Male', 'Mexico', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Dopamine D3/*genetics', 'Schizophrenia/*genetics', 'Serine/genetics', '*Siblings', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21737144/
664,DRD3,30051166,DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study.,"['Fageera W', 'Sengupta SM', 'Labbe A', 'Grizenko N', 'Joober R']","['Alleles', 'Amino Acid Substitution', 'Attention Deficit Disorder with Hyperactivity/drug therapy/*genetics/psychology', 'Central Nervous System Stimulants/therapeutic use', 'Child', 'Child Behavior/drug effects', 'Cross-Over Studies', 'Double-Blind Method', 'Female', 'Genetic Association Studies', 'Humans', 'Interview, Psychological', 'Male', 'Methylphenidate/therapeutic use', '*Polymorphism, Single Nucleotide', 'Quantitative Trait Loci', 'Receptors, Dopamine D3/*genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/30051166/
665,DRD3,35835396,DRD3 Ser9Gly polymorphism and treatment response to antipsychotics in schizophrenia: A meta-analysis.,"['Liu C', 'Xu X', 'Liu X', 'Zhang T', 'Li Y', 'Yan P']","['*Antipsychotic Agents/therapeutic use', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Polymorphism, Genetic/genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D3/genetics', '*Schizophrenia/complications/drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/35835396/
666,DRD3,38363619,DRD3 Predicts Cognitive Impairment and Anxiety in Parkinson's Disease: Susceptibility and Protective Effects.,"['Goncalves A', 'Mendes A', 'Damasio J', 'Vila-Cha N', 'Boleixa D', 'Leal B', 'Cavaco S']","['Humans', 'Receptors, Dopamine D3/genetics', '*Parkinson Disease/complications/genetics/drug therapy', '*Cognitive Dysfunction/genetics/complications', 'Polymorphism, Genetic', 'Anxiety/genetics']",https://pubmed.ncbi.nlm.nih.gov/38363619/
667,DRD3,35285297,HUMAN STUDY COMT and DRD3 haplotype-associated pain intensity and acute care utilization in adult sickle cell disease.,"['Powell-Roach KL', 'Yao Y', 'Wallace MR', 'Chamala S', 'Cruz-Almeida Y', 'Jhun E', 'Molokie RE', 'Wang ZJ', 'Wilkie DJ']","['Adult', 'Humans', '*Anemia, Sickle Cell/complications/genetics/therapy', '*Catechol O-Methyltransferase/genetics', 'Genotype', 'Haplotypes/genetics', 'Pain/genetics', 'Pain Measurement', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Dopamine D3/genetics']",https://pubmed.ncbi.nlm.nih.gov/35285297/
668,DRD3,25792691,DRD3 gene and striatum in autism spectrum disorder.,"['Staal WG', 'Langen M', 'van Dijk S', 'Mensen VT', 'Durston S']","['Adolescent', 'Adult', 'Alleles', 'Autism Spectrum Disorder/*genetics', 'Child', 'Corpus Striatum/*physiopathology', 'Female', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Dopamine D3/*genetics', 'Stereotyped Behavior', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25792691/
669,DRD3,21948748,No evidence for association between DRD3 and COMT with schizophrenia in a Malay population.,"['Tee SF', 'Tang PY', 'Loh HC']","['Adult', 'Aged', 'Catechol O-Methyltransferase/*genetics', 'Female', 'Genetic Variation', 'Genotype', 'Humans', 'Malaysia', 'Male', 'Middle Aged', 'Polymorphism, Restriction Fragment Length', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D3/*genetics', 'Schizophrenia/ethnology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21948748/
670,DRD3,29249220,DRD3 Ser9Gly Polymorphism and Its Influence on Risperidone Response in Autistic Children.,"['Firouzabadi N', 'Nazariat A', 'Zomorrodian K']","['Adolescent', 'Alleles', 'Autistic Disorder/diagnosis/*drug therapy/*genetics', 'Child', 'Child, Preschool', 'Female', 'Genotype', 'Glycine/*genetics', 'Humans', 'Iran', 'Male', 'Polymorphism, Genetic/*genetics', 'Receptors, Dopamine D3/*genetics', 'Risperidone/administration & dosage/*therapeutic use', 'Serine/*genetics', 'Software', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/29249220/
671,DRD3,19439249,"Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.","['Al Hadithy AF', 'Ivanova SA', 'Pechlivanoglou P', 'Semke A', 'Fedorenko O', 'Kornetova E', 'Ryadovaya L', 'Brouwers JR', 'Wilffert B', 'Bruggeman R', 'Loonen AJ']","['Adult', 'Aged', 'Akathisia, Drug-Induced/classification/etiology/*genetics/pathology', 'Chlorpromazine/adverse effects', 'Cross-Sectional Studies', 'Cystine/genetics', 'Disability Evaluation', 'Extremities/physiopathology', 'Face/physiopathology', 'Female', 'Gene Frequency', 'Genotype', 'Glycine/genetics', 'Humans', 'Male', 'Middle Aged', 'Models, Statistical', 'Mouth/physiopathology', 'Pharmacogenetics', 'Polymorphism, Genetic/*genetics', 'Psychiatric Status Rating Scales', 'Receptor, Serotonin, 5-HT2A/*genetics', 'Receptor, Serotonin, 5-HT2C/*genetics', 'Receptors, Dopamine D3/*genetics', 'Schizophrenia/drug therapy/genetics', 'Serine/genetics', 'Severity of Illness Index', 'Siberia/epidemiology/ethnology']",https://pubmed.ncbi.nlm.nih.gov/19439249/
672,DRD3,9674978,Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians.,"['Dubertret C', 'Gorwood P', 'Ades J', 'Feingold J', 'Schwartz JC', 'Sokoloff P']","['Deoxyribonucleases, Type II Site-Specific', 'Humans', 'Odds Ratio', 'Polymorphism, Genetic', 'Receptors, Dopamine D2/*genetics', 'Receptors, Dopamine D3', 'Schizophrenia/ethnology/*genetics', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/9674978/
673,DRD3,19645064,Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor.,"['Garcia-Martin E', 'Martinez C', 'Alonso-Navarro H', 'Benito-Leon J', 'Puertas I', 'Rubio L', 'Lopez-Alburquerque T', 'Agundez JA', 'Jimenez-Jimenez FJ']","['Adult', 'Age of Onset', 'Aged', 'Aged, 80 and over', 'Case-Control Studies', 'DNA Mutational Analysis', 'Essential Tremor/*etiology/*genetics/physiopathology', 'Female', 'Gene Frequency', '*Genetic Predisposition to Disease', 'Genetic Variation/*genetics', 'Genotype', 'Glycine/genetics', 'Humans', 'Male', 'Middle Aged', 'Odds Ratio', 'Receptors, Dopamine D3/*genetics', 'Serine/genetics', 'Spain', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19645064/
674,DRD3,11104840,DRD3 and DAT1 genes in schizophrenia: an association study.,"['Joober R', 'Toulouse A', 'Benkelfat C', 'Lal S', 'Bloom D', 'Labelle A', 'Lalonde P', 'Turecki G', 'Rouleau GA']","['Adult', 'Alleles', 'Antipsychotic Agents/therapeutic use', 'Biological Transport', 'DNA-Binding Proteins/*genetics', 'Female', 'Gene Expression/*genetics', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Phenotype', 'Polymorphism, Genetic/genetics', 'Receptors, Dopamine/*genetics', 'Schizophrenia/drug therapy/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/11104840/
675,DRD3,12860355,Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders.,"['Joyce PR', 'Rogers GR', 'Miller AL', 'Mulder RT', 'Luty SE', 'Kennedy MA']","['Adult', 'Alleles', 'Character', 'Exons/genetics', 'Exploratory Behavior/physiology', 'Female', 'Fluoxetine/administration & dosage/*therapeutic use', 'Genotype', 'Humans', 'Male', 'Nortriptyline/administration & dosage/*therapeutic use', 'Obsessive-Compulsive Disorder/*drug therapy/*genetics', 'Personality Disorders/*drug therapy/*genetics', 'Polymerase Chain Reaction', 'Polymorphism, Genetic/*genetics', 'Receptors, Dopamine D2/*genetics', 'Receptors, Dopamine D3', 'Receptors, Dopamine D4', 'Risk Factors', 'Selective Serotonin Reuptake Inhibitors/administration & dosage/*therapeutic use', 'Temperament', 'Trinucleotide Repeats/genetics']",https://pubmed.ncbi.nlm.nih.gov/12860355/
676,TLR7,38982195,Human red blood cells express the RNA sensor TLR7.,"['Metthew Lam LK', 'Oatman E', 'Eckart KA', 'Klingensmith NJ', 'Flowers E', 'Sayegh L', 'Yuen J', 'Clements RL', 'Meyer NJ', 'Jurado KA', 'Vaughan AE', 'Eisenbarth SC', 'Mangalmurti NS']","['Humans', '*Toll-Like Receptor 7/metabolism/genetics', '*Erythrocytes/metabolism', '*COVID-19/virology/metabolism', '*SARS-CoV-2/metabolism', 'Sepsis/metabolism/blood/genetics', 'Erythrocyte Membrane/metabolism', 'Male', 'RNA/metabolism/genetics', 'Female']",https://pubmed.ncbi.nlm.nih.gov/38982195/
677,TLR7,29374079,TLR7 escapes X chromosome inactivation in immune cells.,"['Souyris M', 'Cenac C', 'Azar P', 'Daviaud D', 'Canivet A', 'Grunenwald S', 'Pienkowski C', 'Chaumeil J', 'Mejia JE', 'Guery JC']","['B-Lymphocytes/immunology', 'Cell Differentiation/immunology', 'Cell Proliferation/physiology', 'Dendritic Cells/immunology', 'Female', 'Humans', 'Immunoglobulin Class Switching/immunology', 'Immunoglobulin G/immunology', 'Ligands', 'Lupus Erythematosus, Systemic/immunology', 'Lymphocyte Activation/*immunology', 'Male', 'Toll-Like Receptor 7/*immunology', 'Tumor Necrosis Factor Receptor Superfamily, Member 7/immunology', 'X Chromosome Inactivation/*immunology']",https://pubmed.ncbi.nlm.nih.gov/29374079/
678,TLR7,38324161,Interface Gain-of-Function Mutations in TLR7 Cause Systemic and Neuro-inflammatory Disease.,"['David C', 'Badonyi M', 'Kechiche R', 'Insalaco A', 'Zecca M', 'De Benedetti F', 'Orcesi S', 'Chiapparini L', 'Comoli P', 'Federici S', 'Gattorno M', 'Ginevrino M', 'Giorgio E', 'Matteo V', 'Moran-Alvarez P', 'Politano D', 'Prencipe G', 'Sirchia F', 'Volpi S', 'Masson C', 'Rice GI', 'Fremond ML', 'Lepelley A', 'Marsh JA', 'Crow YJ']","['Female', 'Male', 'Humans', '*Gain of Function Mutation', 'Toll-Like Receptor 7', 'Mutation', 'Dimerization', '*Lupus Erythematosus, Systemic', 'RNA']",https://pubmed.ncbi.nlm.nih.gov/38324161/
679,TLR7,37733447,The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE.,"['Crawford JD', 'Wang H', 'Trejo-Zambrano D', 'Cimbro R', 'Talbot CC Jr', 'Thomas MA', 'Curran AM', 'Girgis AA', 'Schroeder JT', 'Fava A', 'Goldman DW', 'Petri M', 'Rosen A', 'Antiochos B', 'Darrah E']","['Male', 'Humans', 'Female', '*RNA, Long Noncoding/genetics', 'Toll-Like Receptor 7', '*Lupus Erythematosus, Systemic', '*Interferon Type I/genetics', 'Gene Expression', 'Ligands']",https://pubmed.ncbi.nlm.nih.gov/37733447/
680,TLR7,36053897,Middle East respiratory syndrome coronavirus ORF4b protein inhibits TLR7- and TLR9-dependent alpha interferon induction.,"['Kitagawa Y', 'Tsukamoto T', 'Itoh M', 'Gotoh B']","['Dendritic Cells/metabolism', '*I-kappa B Kinase/genetics/metabolism', 'Interferon-alpha/metabolism', '*Middle East Respiratory Syndrome Coronavirus/genetics/metabolism', 'Nuclear Localization Signals/metabolism', 'Toll-Like Receptor 7/genetics/metabolism', 'Toll-Like Receptor 9/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36053897/
681,TLR7,26803623,Assessing the Inhibitory Activity of Oligonucleotides on TLR7 Sensing.,"['Ferrand J', 'Gantier MP']","['Cell Culture Techniques', 'Cell Line', 'Enzyme-Linked Immunosorbent Assay/methods', 'Humans', 'Immunomodulation/drug effects', 'Ligands', 'Oligonucleotides/genetics/*metabolism/*pharmacology', 'Protein Binding', 'RNA/genetics/immunology', 'Toll-Like Receptor 7/*antagonists & inhibitors/*metabolism', 'Transfection', 'Tumor Necrosis Factor-alpha/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26803623/
682,ADORA2B,37187740,The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.,"['Strickland LN', 'Faraoni EY', 'Ruan W', 'Yuan X', 'Eltzschig HK', 'Bailey-Lundberg JM']","['Humans', 'Adenosine/metabolism', '*CD8-Positive T-Lymphocytes/metabolism', 'Hypoxia', 'Immunotherapy', '*Pancreatic Neoplasms/therapy', 'Tumor Microenvironment', '*Receptor, Adenosine A2B/drug effects/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37187740/
683,ADORA2B,7558011,Cloning and chromosomal localization of the human A2b adenosine receptor gene (ADORA2B) and its pseudogene.,"['Jacobson MA', 'Johnson RG', 'Luneau CJ', 'Salvatore CA']","['Chromosome Mapping', '*Chromosomes, Human, Pair 17', 'Cloning, Molecular', 'Humans', 'In Situ Hybridization, Fluorescence', 'Molecular Sequence Data', '*Pseudogenes', 'Receptors, Purinergic P1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/7558011/
684,HTR1E,37078547,Characterization of serotonin-5-HTR1E signaling pathways and its role in cell survival.,"['Sharma VK', 'Campbell K', 'Yang X', 'Dale R', 'Loh YP']","['Humans', '*Serotonin/pharmacology/metabolism', 'Cell Survival', 'HEK293 Cells', '*Neuroblastoma', 'Signal Transduction', 'Extracellular Signal-Regulated MAP Kinases/metabolism', 'Phosphorylation', 'MAP Kinase Signaling System']",https://pubmed.ncbi.nlm.nih.gov/37078547/
685,HTR1A,28793232,Interaction effect between 5-HTTLPR and HTR1A rs6295 polymorphisms on the frontoparietal network.,"['Long H', 'Liu B', 'Wang C', 'Zhang X', 'Li J', 'Yu C', 'Jiang T']","['Brain Mapping', 'Female', 'Frontal Lobe/diagnostic imaging/*physiology', 'Genotyping Techniques', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Memory, Short-Term', 'Neural Pathways/diagnostic imaging/physiology', 'Neuropsychological Tests', 'Parietal Lobe/diagnostic imaging/*physiology', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Serotonin Plasma Membrane Transport Proteins/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28793232/
686,HTR1A,36214900,Association between the HTR1A rs6295 gene polymorphism and suicidal behavior: an updated meta-analysis.,"['Hernandez-Diaz Y', 'Tovilla-Zarate CA', 'Castillo-Avila RG', 'Juarez-Rojop IE', 'Genis-Mendoza AD', 'Lopez-Narvaez ML', 'Villar-Juarez GE', 'Gonzalez-Castro TB']","['Humans', '*Suicidal Ideation', '*Polymorphism, Single Nucleotide', 'Case-Control Studies', 'Odds Ratio', 'Genetic Predisposition to Disease', 'Receptor, Serotonin, 5-HT1A/genetics']",https://pubmed.ncbi.nlm.nih.gov/36214900/
687,HTR1A,27939355,5-HT1A receptor (HTR1A) 5' region haplotypes significantly affect protein expression in vitro.,"['Wu X', 'Yao J', 'Ding M', 'Shi ZS', 'Xu FL', 'Zhang JJ', 'Wang BJ']","['Cell Line', 'Haplotypes', 'Humans', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Receptor, Serotonin, 5-HT1A/*genetics/metabolism', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/27939355/
688,HTR1A,22392387,No association between the HTR1A gene and suicidal behavior: a meta-analysis.,"['Angles MR', 'Ocana DB', 'Medellin BC', 'Tovilla-Zarate C']","['Case-Control Studies', 'Genome-Wide Association Study', 'Humans', 'Polymorphism, Single Nucleotide/*genetics', 'Receptor, Serotonin, 5-HT1A/*genetics', '*Suicidal Ideation', 'Suicide/*psychology']",https://pubmed.ncbi.nlm.nih.gov/22392387/
689,HTR1A,26568455,HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis.,"['Takekita Y', 'Fabbri C', 'Kato M', 'Koshikawa Y', 'Tajika A', 'Kinoshita T', 'Serretti A']","['Antipsychotic Agents/*therapeutic use', 'Chi-Square Distribution', 'Gene Frequency', 'Humans', 'Pharmacogenetics', '*Pharmacogenomic Variants', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Remission Induction', 'Schizophrenia/diagnosis/*drug therapy/genetics', '*Schizophrenic Psychology', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/26568455/
690,HTR1A,23537781,Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients.,"['Antypa N', 'Calati R', 'Souery D', 'Pellegrini S', 'Sentissi O', 'Amital D', 'Moser U', 'Montgomery S', 'Kasper S', 'Zohar J', 'De Ronchi D', 'Mendlewicz J', 'Serretti A']","['Adult', 'Aged', 'Alleles', 'Depressive Disorder, Major/*genetics/*psychology', 'Female', 'Genetic Variation', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Receptor, Serotonin, 5-HT2A/*genetics', 'Serotonin Plasma Membrane Transport Proteins/genetics', '*Social Adjustment']",https://pubmed.ncbi.nlm.nih.gov/23537781/
691,HTR1A,18268499,Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression.,"['Neff CD', 'Abkevich V', 'Packer JC', 'Chen Y', 'Potter J', 'Riley R', 'Davenport C', 'DeGrado Warren J', 'Jammulapati S', 'Bhathena A', 'Choi WS', 'Kroeger PE', 'Metzger RE', 'Gutin A', 'Skolnick MH', 'Shattuck D', 'Katz DA']","['Chromosomes, Human, Pair 10', 'Depressive Disorder, Major/*epidemiology/*genetics', 'Female', '*Genetic Linkage', 'Genotype', 'Humans', 'Inorganic Pyrophosphatase/*genetics', 'Jews/genetics/statistics & numerical data', 'Male', 'Pedigree', 'Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Risk Factors', 'Utah/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/18268499/
692,HTR1A,34773671,The impact of HTR1A and HTR1B methylation combined with stress/genotype on early antidepressant efficacy.,"['Xu Z', 'Chen Z', 'Shen T', 'Chen L', 'Tan T', 'Gao C', 'Chen B', 'Yuan Y', 'Zhang Z']","['*Antidepressive Agents/pharmacology', 'Case-Control Studies', 'DNA Methylation', '*Depressive Disorder, Major/drug therapy/genetics', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide/genetics', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Stress, Psychological/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/34773671/
693,HTR1A,32231051,"HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia.","['Grubor M', 'Zivkovic M', 'Sagud M', 'Nikolac Perkovic M', 'Mihaljevic-Peles A', 'Pivac N', 'Muck-Seler D', 'Svob Strac D']","['Adult', 'Antipsychotic Agents/*adverse effects/therapeutic use', 'Haloperidol/*adverse effects/therapeutic use', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptor, Serotonin, 5-HT2A/genetics', 'Receptor, Serotonin, 5-HT2C/genetics', 'Receptors, Serotonin/*genetics', 'Schizophrenia/*drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/32231051/
694,HTR1A,36150307,Combined HTR1A/1B methylation and human functional connectome to recognize patients with MDD.,"['Xu Z', 'Gao C', 'Tan T', 'Jiang W', 'Wang T', 'Chen Z', 'Shen T', 'Chen L', 'Tang H', 'Chen W', 'Chen B', 'Zhang Z', 'Yuan Y']","['Humans', '*Connectome', '*Depressive Disorder, Major', 'Magnetic Resonance Imaging/methods', '*Receptor, Serotonin, 5-HT1A/genetics', '*DNA Methylation', 'Epigenesis, Genetic', '*Receptor, Serotonin, 5-HT1B/genetics']",https://pubmed.ncbi.nlm.nih.gov/36150307/
695,HTR1A,35199941,HTR1A Inhibits the Progression of Triple-Negative Breast Cancer via TGF-beta Canonical and Noncanonical Pathways.,"['Liu Q', 'Sun H', 'Liu Y', 'Li X', 'Xu B', 'Li L', 'Jin W']","['Humans', 'Prognosis', '*Receptor, Serotonin, 5-HT1A/metabolism', 'Transforming Growth Factor beta/metabolism', '*Triple Negative Breast Neoplasms/genetics/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/35199941/
696,HTR1A,37161455,Influence of TPH2 and HTR1A polymorphisms on lifelong premature ejaculation risk among the chinese Han population.,"['Wang F', 'Luo D', 'Chen J', 'Pan C', 'Wang Z', 'Fu H', 'Xu J', 'Yang M', 'Mo S', 'Zhuang L', 'Wang W']","['Adolescent', 'Adult', 'Humans', 'Male', 'Middle Aged', 'Young Adult', 'Asian People/genetics', '*East Asian People', 'Polymorphism, Single Nucleotide/genetics', '*Premature Ejaculation/genetics', 'Receptor, Serotonin, 5-HT1A/genetics', 'Serotonin', 'Tryptophan Hydroxylase/genetics']",https://pubmed.ncbi.nlm.nih.gov/37161455/
697,HTR1A,21459095,Predicting cortisol stress responses in older individuals: influence of serotonin receptor 1A gene (HTR1A) and stressful life events.,"['Armbruster D', 'Mueller A', 'Strobel A', 'Lesch KP', 'Brocke B', 'Kirschbaum C']","['Aged', 'Female', 'Humans', 'Hydrocortisone/analysis/*metabolism', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/*genetics', 'Saliva/chemistry', 'Stress, Psychological/*genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/21459095/
698,HTR1A,37525034,ADRA2B and HTR1A: An Updated Study of the Biogenic Amine Receptors Reveals Novel Conserved Motifs Which Play Key Role in Mental Disorders.,"['Papageorgiou L', 'Christou E', 'Louka E', 'Papakonstantinou E', 'Diakou I', 'Pierouli K', 'Dragoumani K', 'Bacopoulou F', 'Chrousos GP', 'Eliopoulos E', 'Vlachakis D']","['Humans', '*Mental Disorders/genetics/metabolism', '*Receptor, Serotonin, 5-HT1A/genetics', 'Receptors, Adrenergic, alpha-2', '*Receptors, Biogenic Amine/genetics/metabolism', 'Serotonin', 'Feeding and Eating Disorders/genetics', 'Suicidal Ideation']",https://pubmed.ncbi.nlm.nih.gov/37525034/
699,HTR1A,27897266,Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function.,"['Guan F', 'Lin H', 'Chen G', 'Li L', 'Chen T', 'Liu X', 'Han J', 'Li T']","['Adolescent', 'Adult', 'Female', '*Haplotypes', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT1A/*genetics/metabolism', 'Schizophrenia/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/27897266/
700,HTR1A,8333729,Segregation and linkage analysis in five manic depression pedigrees excludes the 5HT1a receptor gene (HTR1A).,"['Curtis D', 'Brynjolfsson J', 'Petursson H', 'Holmes S', 'Sherrington R', 'Brett P', 'Rifkin L', 'Murphy P', 'Moloney E', 'Holmes DS']","['Bipolar Disorder/*genetics', 'Female', '*Genetic Linkage', 'Humans', 'Male', 'Models, Genetic', 'Pedigree', 'Receptors, Serotonin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/8333729/
701,NMBR,27092952,"PDE7B, NMBR and EPM2A Variants and Schizophrenia: A Case-Control and Pharmacogenetics Study.","['Porcelli S', 'Balzarro B', 'Lee SJ', 'Han C', 'Patkar AA', 'Pae CU', 'Serretti A']","['Adult', 'Antipsychotic Agents/therapeutic use', 'Case-Control Studies', 'Cyclic Nucleotide Phosphodiesterases, Type 7/*genetics', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Middle Aged', 'Pharmacogenomic Variants/genetics', 'Protein Tyrosine Phosphatases, Non-Receptor/*genetics', 'Receptors, Bombesin/*genetics', 'Schizophrenia/drug therapy/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27092952/
702,HTR5A,27897266,Evaluation of association of common variants in HTR1A and HTR5A with schizophrenia and executive function.,"['Guan F', 'Lin H', 'Chen G', 'Li L', 'Chen T', 'Liu X', 'Han J', 'Li T']","['Adolescent', 'Adult', 'Female', '*Haplotypes', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptor, Serotonin, 5-HT1A/*genetics/metabolism', 'Schizophrenia/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/27897266/
703,HTR5A,24903772,Serotonin-related polymorphisms in TPH1 and HTR5A genes are not associated with escitalopram treatment response in Korean patients with major depression.,"['Kim YG', 'Chang HS', 'Won ES', 'Ham BJ', 'Lee MS']","['Antidepressive Agents/*therapeutic use', 'Asian People/genetics', 'Citalopram/*therapeutic use', 'Depressive Disorder, Major/*drug therapy/*genetics', 'Female', 'Humans', 'Korea', 'Linear Models', 'Logistic Models', 'Male', 'Middle Aged', 'Pharmacogenetics', 'Polymorphism, Genetic', 'Psychiatric Status Rating Scales', 'Psychopharmacology', 'Receptors, Serotonin/*genetics', 'Time Factors', 'Treatment Outcome', 'Tryptophan Hydroxylase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24903772/
704,HTR5A,19328558,Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population.,"['Yosifova A', 'Mushiroda T', 'Stoianov D', 'Vazharova R', 'Dimova I', 'Karachanak S', 'Zaharieva I', 'Milanova V', 'Madjirova N', 'Gerdjikov I', 'Tolev T', 'Velkova S', 'Kirov G', 'Owen MJ', ""O'Donovan MC"", 'Toncheva D', 'Nakamura Y']","['Adult', 'Bipolar Disorder/diagnosis/epidemiology/*genetics', 'Bulgaria/epidemiology', 'Case-Control Studies', 'Female', 'Genetic Association Studies/*methods/*statistics & numerical data', 'Genetic Predisposition to Disease/*genetics', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Serotonin/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/19328558/
705,HTR6,38086448,Peripheral 5-HT/HTR6 axis is responsible for obesity-associated hypertension.,"['Chechekhin VI', 'Ivanova AM', 'Kulebyakin KY', 'Antropova YG', 'Karagyaur MN', 'Skryabina MN', 'Chechekhina ES', 'Basalova NA', 'Grigorieva OA', 'Sysoeva VY', 'Kalinina NI', 'Tkachuk VA', 'Tyurin-Kuzmin PA']","['Humans', '*Serotonin', 'Norepinephrine/pharmacology', '*Hypertension/etiology', 'Obesity/complications', 'Protein Isoforms']",https://pubmed.ncbi.nlm.nih.gov/38086448/
706,HTR6,32231051,"HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia.","['Grubor M', 'Zivkovic M', 'Sagud M', 'Nikolac Perkovic M', 'Mihaljevic-Peles A', 'Pivac N', 'Muck-Seler D', 'Svob Strac D']","['Adult', 'Antipsychotic Agents/*adverse effects/therapeutic use', 'Haloperidol/*adverse effects/therapeutic use', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT1B/genetics', 'Receptor, Serotonin, 5-HT2A/genetics', 'Receptor, Serotonin, 5-HT2C/genetics', 'Receptors, Serotonin/*genetics', 'Schizophrenia/*drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/32231051/
707,HTR6,11725820,Association analysis of HTR6 and HTR2A polymorphisms in sporadic Alzheimer's disease.,"['Thome J', 'Retz W', 'Baader M', 'Pesold B', 'Hu M', 'Cowen M', 'Durany N', 'Adler G', 'Henn FA', 'Rosler M']","['Alleles', 'Alzheimer Disease/*genetics', 'Chi-Square Distribution', 'Genetic Variation/genetics', 'Genotype', 'Humans', 'Polymorphism, Genetic/*genetics', 'Promoter Regions, Genetic/genetics', 'Receptor, Serotonin, 5-HT2A', 'Receptors, Serotonin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11725820/
708,HTR6,31587366,Correlation of 5-HTR6 gene polymorphism with vestibular migraine.,"['Wu X', 'Qiu F', 'Wang Z', 'Liu B', 'Qi X']","['Adult', 'Caloric Tests', 'Case-Control Studies', 'Female', 'Gene Frequency', 'Humans', 'Male', 'Middle Aged', 'Migraine Disorders/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Serotonin/*genetics', 'Serotonin/blood', 'Vertigo/genetics/physiopathology', '*Vestibular Function Tests']",https://pubmed.ncbi.nlm.nih.gov/31587366/
709,HTR6,35359970,Systematic Analysis of Neurotransmitter Receptors in Human Breast Cancer Reveals a Strong Association With Outcome and Uncovers HTR6 as a Survival-Associated Gene Potentially Regulating the Immune Microenvironment.,"['Zhang W', 'Li L', 'Li J', 'Yu H', 'Zheng F', 'Yan B', 'Cai W', 'Chen Y', 'Yin L', 'Tang D', 'Xu Y', 'Dai Y']","['*Breast Neoplasms/genetics/pathology', 'Female', 'Humans', 'Neoplasm Recurrence, Local', 'Receptors, Neurotransmitter/genetics', 'Tumor Microenvironment/genetics']",https://pubmed.ncbi.nlm.nih.gov/35359970/
710,HTR6,19590397,"5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression.","['Illi A', 'Setala-Soikkeli E', 'Viikki M', 'Poutanen O', 'Huhtala H', 'Mononen N', 'Lehtimaki T', 'Leinonen E', 'Kampman O']","['Adolescent', 'Adult', 'Aged', 'Citalopram/therapeutic use', 'Depressive Disorder, Major/*drug therapy/*genetics', 'Fluoxetine/therapeutic use', 'Humans', 'Middle Aged', 'Paroxetine/therapeutic use', '*Polymorphism, Single Nucleotide', 'Psychiatric Status Rating Scales', 'Receptor, Serotonin, 5-HT1A/genetics', 'Receptor, Serotonin, 5-HT2A/genetics', 'Receptors, Serotonin/genetics', 'Selective Serotonin Reuptake Inhibitors/*therapeutic use', 'Treatment Outcome', 'Tryptophan Hydroxylase/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19590397/
711,HTR6,15531082,Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese.,"['Kan R', 'Wang B', 'Zhang C', 'Yang Z', 'Ji S', 'Lu Z', 'Zheng C', 'Jin F', 'Wang L']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/*genetics', 'Asian People/*genetics', 'Chi-Square Distribution', 'Female', 'Gene Frequency/genetics', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic/*genetics', 'Receptors, Serotonin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15531082/
712,HTR6,19782122,Male specific association between the 5-HTR6 gene 267C/T SNP and suicide in the Portuguese population.,"['Azenha D', 'Alves M', 'Matos R', 'Santa JF', 'Silva B', 'Cordeiro C', 'Vieira DN', 'Ambrosio AM']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Portugal', 'Receptors, Serotonin/*genetics', 'Sex Factors', '*Suicide', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19782122/
713,HTR6,11163544,Lack of association between the T-->C 267 serotonin 5-HT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia.,"['Masellis M', 'Basile VS', 'Meltzer HY', 'Lieberman JA', 'Sevy S', 'Goldman DA', 'Hamblin MW', 'Macciardi FM', 'Kennedy JL']","['Adult', 'Alleles', 'Amino Acid Substitution/genetics', 'Clozapine/adverse effects/*therapeutic use', 'Female', 'Genetic Carrier Screening', 'Genotype', 'Humans', 'Male', 'Polymerase Chain Reaction', 'Polymorphism, Genetic/*genetics', 'Prognosis', 'Psychiatric Status Rating Scales', 'Receptors, Serotonin/*genetics', 'Schizophrenia/diagnosis/drug therapy/*genetics', 'Schizophrenic Psychology', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/11163544/
714,GRPR,38279185,Advances of radiolabeled GRPR ligands for PET/CT imaging of cancers.,"['Ma Y', 'Gao F']","['Male', 'Humans', 'Positron Emission Tomography Computed Tomography/methods', 'Receptors, Bombesin/metabolism', 'Bombesin/metabolism', '*Prostatic Neoplasms/diagnostic imaging/pathology', '*Breast Neoplasms']",https://pubmed.ncbi.nlm.nih.gov/38279185/
715,GRPR,38442298,Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer.,"['Zhang H', 'Qi L', 'Cai Y', 'Gao X']","['Male', 'Humans', '*Receptors, Bombesin', '*Prostatic Neoplasms/diagnosis/drug therapy', 'Biomarkers', 'Up-Regulation', 'Radioisotopes']",https://pubmed.ncbi.nlm.nih.gov/38442298/
716,GRPR,35668669,GRPr Theranostics: Current Status of Imaging and Therapy using GRPr Targeting Radiopharmaceuticals.,"['Kurth J', 'Potratz M', 'Heuschkel M', 'Krause BJ', 'Schwarzenbock SM']","['Bombesin/therapeutic use', 'Cell Line, Tumor', 'Humans', 'Male', 'Positron-Emission Tomography/methods', 'Precision Medicine', '*Prostatic Neoplasms/pathology', 'Radiopharmaceuticals/therapeutic use', '*Receptors, Bombesin']",https://pubmed.ncbi.nlm.nih.gov/35668669/
717,GRPR,36933382,Novel insight on GRP/GRPR axis in diseases.,"['Sun HL', 'Ma QY', 'Bian HG', 'Meng XM', 'Jin J']","['Humans', '*Receptors, Bombesin/metabolism', 'Gastrin-Releasing Peptide', '*Cardiovascular Diseases', 'Signal Transduction', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/36933382/
718,GRPR,33674398,PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer.,"['Baratto L', 'Song H', 'Duan H', 'Hatami N', 'Bagshaw HP', 'Buyyounouski M', 'Hancock S', 'Shah S', 'Srinivas S', 'Swift P', 'Moradi F', 'Davidzon G', 'Iagaru A']","['Humans', 'Male', '*Prostatic Neoplasms/diagnostic imaging/metabolism', 'Aged', '*Gallium Radioisotopes', '*Glutamate Carboxypeptidase II/metabolism', '*Receptors, Bombesin/metabolism', 'Middle Aged', '*Antigens, Surface/metabolism', 'Gallium Isotopes', 'Aged, 80 and over', 'Oligopeptides/chemistry', 'Positron Emission Tomography Computed Tomography', 'Recurrence', 'Lysine/analogs & derivatives', 'Positron-Emission Tomography', 'Urea/analogs & derivatives', 'Edetic Acid/analogs & derivatives', 'Neoplasm Recurrence, Local/diagnostic imaging', 'Radiopharmaceuticals']",https://pubmed.ncbi.nlm.nih.gov/33674398/
719,GRPR,37522391,Descending dopaminergic pathway facilitates itch signal processing via activating spinal GRPR(+) neurons.,"['Zhang ZJ', 'Shao HY', 'Liu C', 'Song HL', 'Wu XB', 'Cao DL', 'Zhu M', 'Fu YY', 'Wang J', 'Gao YJ']","['Humans', '*Receptors, Bombesin/genetics/metabolism', 'Gastrin-Releasing Peptide/genetics/metabolism', '*Spinal Cord/metabolism', 'Glutamic Acid/metabolism', 'Dopamine/metabolism', 'Pruritus/genetics/metabolism', 'Dopaminergic Neurons/metabolism', 'Receptors, AMPA/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37522391/
720,GRPR,19519524,Reduced NGF secretion by HT-29 human colon cancer cells treated with a GRPR antagonist.,"['de Farias CB', 'Stertz L', 'Lima RC', 'Kapczinski F', 'Schwartsmann G', 'Roesler R']","['Analysis of Variance', 'Bombesin/*analogs & derivatives/pharmacology', 'Dose-Response Relationship, Drug', 'Enzyme-Linked Immunosorbent Assay', 'HT29 Cells', 'Humans', 'Nerve Growth Factor/*metabolism', 'Peptide Fragments/*pharmacology', 'Receptors, Bombesin/*antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/19519524/
721,SSTR2,38048045,Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.,"['Kurz SC', 'Zan E', 'Cordova C', 'Troxel AB', 'Barbaro M', 'Silverman JS', 'Snuderl M', 'Zagzag D', 'Kondziolka D', 'Golfinos JG', 'Chi AS', 'Sulman EP']","['Adult', 'Humans', 'Male', 'Female', 'Middle Aged', 'Aged', '*Meningioma/diagnostic imaging/radiotherapy/drug therapy', 'Radiopharmaceuticals', '*Organometallic Compounds/adverse effects', 'Positron-Emission Tomography/methods', '*Meningeal Neoplasms/diagnostic imaging/radiotherapy/drug therapy', 'Biomarkers', '*Neuroendocrine Tumors/pathology', 'Positron Emission Tomography Computed Tomography', 'Octreotide/*analogs & derivatives', '*Receptors, Somatostatin']",https://pubmed.ncbi.nlm.nih.gov/38048045/
722,SSTR2,17631550,Nuclear uptake and dosimetry of 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line.,"['Eiblmaier M', 'Andrews R', 'Laforest R', 'Rogers BE', 'Anderson CJ']","['Cell Line, Tumor', 'Cell Nucleus/*metabolism', 'Chelating Agents/*metabolism', '*Copper Radioisotopes', 'Humans', 'Isotope Labeling', 'Radiometry', 'Radiopharmaceuticals/*metabolism', 'Receptors, Somatostatin/*metabolism', 'Somatostatin/analogs & derivatives/*metabolism', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/17631550/
723,SSTR2,36959237,Molecular simulations of SSTR2 dynamics and interaction with ligands.,"['Gervasoni S', 'Guccione C', 'Fanti V', 'Bosin A', 'Cappellini G', 'Golosio B', 'Ruggerone P', 'Malloci G']","['Humans', '*Receptors, Somatostatin/metabolism', 'Octreotide/therapeutic use', 'Somatostatin/metabolism', 'GTP-Binding Proteins/metabolism', 'Ligands', '*Neuroendocrine Tumors/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/36959237/
724,SSTR2,33929681,SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.,"['Cracolici V', 'Wang EW', 'Gardner PA', 'Snyderman C', 'Gargano SM', 'Chiosea S', 'Singhi AD', 'Seethala RR']","['Biomarkers, Tumor/metabolism', 'Esthesioneuroblastoma, Olfactory/*metabolism/pathology', 'Humans', 'Immunohistochemistry', 'Nose Neoplasms/*metabolism/pathology', 'Receptors, Somatostatin/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33929681/
725,SSTR2,38036157,"Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas.","['Fan S', 'Zheng H', 'Zhan Y', 'Luo J', 'Zang H', 'Wang H', 'Wang W', 'Xu Y']","['Humans', 'Squamous Cell Carcinoma of Head and Neck/diagnosis/genetics/therapy', 'Prognosis', '*Head and Neck Neoplasms/diagnosis/genetics/therapy', 'Biomarkers, Tumor/genetics', '*Carcinoma, Squamous Cell/diagnosis/genetics/therapy', 'Somatostatin']",https://pubmed.ncbi.nlm.nih.gov/38036157/
726,SSTR2,28782576,"DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer.","['Li J', 'Chen C', 'Bi X', 'Zhou C', 'Huang T', 'Ni C', 'Yang P', 'Chen S', 'Ye M', 'Duan S']","['Bcl-2-Like Protein 11/genetics', 'Biomarkers, Tumor/*genetics', 'Colorectal Neoplasms/*genetics/pathology', 'Contactins/*genetics', '*DNA Methylation', 'Female', 'Humans', 'Male', 'Middle Aged', 'Muscle Proteins/genetics', 'Myogenic Regulatory Factors/*genetics', 'Nerve Tissue Proteins/genetics', 'Receptors, Somatostatin/*genetics', 'Transforming Growth Factor beta2/genetics']",https://pubmed.ncbi.nlm.nih.gov/28782576/
727,SSTR2,37758305,SSTR2 positively associates with EGFR and predicts poor prognosis in nasopharyngeal carcinoma.,"['Xu Y', 'Quan Z', 'Zhan Y', 'Wang H', 'Luo J', 'Wang W', 'Fan S']","['Humans', '*Receptors, Somatostatin/metabolism', '*ErbB Receptors/metabolism', 'Female', 'Male', '*Nasopharyngeal Carcinoma/pathology/metabolism/therapy/mortality', '*Nasopharyngeal Neoplasms/pathology/metabolism/therapy/mortality', 'Middle Aged', '*Biomarkers, Tumor/metabolism/analysis', 'Prognosis', 'Adult', 'Aged', 'Immunohistochemistry', 'Computational Biology', 'Progression-Free Survival']",https://pubmed.ncbi.nlm.nih.gov/37758305/
728,SSTR2,30334904,Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma.,"['Alexander N', 'Marrano P', 'Thorner P', 'Naranjo A', 'Van Ryn C', 'Martinez D', 'Batra V', 'Zhang L', 'Irwin MS', 'Baruchel S']","['3-Iodobenzylguanidine/analysis', 'Disease Progression', 'Female', 'Humans', 'Immunohistochemistry', 'Male', 'Molecular Imaging/methods', 'Molecular Targeted Therapy/methods', 'Neuroblastoma/*chemistry/diagnostic imaging/radiotherapy', 'Norepinephrine Plasma Membrane Transport Proteins/analysis', 'Prevalence', 'Radiopharmaceuticals/therapeutic use', 'Receptors, Somatostatin/analysis/*metabolism', 'Recurrence']",https://pubmed.ncbi.nlm.nih.gov/30334904/
729,SSTR2,16570185,Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.,"['Dimitrakopoulou-Strauss A', 'Georgoulias V', 'Eisenhut M', 'Herth F', 'Koukouraki S', 'Macke HR', 'Haberkorn U', 'Strauss LG']","['Biomarkers, Tumor/*metabolism', 'Carcinoma, Non-Small-Cell Lung/diagnostic imaging/*metabolism', 'Fluorodeoxyglucose F18/*pharmacokinetics', 'Humans', 'Lung Neoplasms/diagnostic imaging/*metabolism', 'Neoplasm Proteins/*metabolism', 'Octreotide/*analogs & derivatives/pharmacokinetics', 'Organometallic Compounds/*pharmacokinetics', 'Radionuclide Imaging', 'Radiopharmaceuticals/pharmacokinetics', 'Receptors, Somatostatin/*metabolism', 'Reproducibility of Results', 'Sensitivity and Specificity', 'Tissue Distribution']",https://pubmed.ncbi.nlm.nih.gov/16570185/
730,HTR2B,38037454,Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.,"['Tu RH', 'Wu SZ', 'Huang ZN', 'Zhong Q', 'Ye YH', 'Zheng CH', 'Xie JW', 'Wang JB', 'Lin JX', 'Chen QY', 'Huang CM', 'Lin M', 'Lu J', 'Cao LL', 'Li P']","['Humans', '*Adenocarcinoma', 'Cell Line, Tumor', 'Cell Proliferation/genetics', '*Ferroptosis', 'Lipid Metabolism', 'Phosphatidylinositol 3-Kinases/metabolism', 'Proto-Oncogene Proteins c-akt/metabolism', 'Receptors, Neurotransmitter/metabolism', 'Serotonin/metabolism/pharmacology', '*Stomach Neoplasms/pathology', 'TOR Serine-Threonine Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38037454/
731,HTR2B,38851806,HTR2B as a novel biomarker of chronic obstructive pulmonary disease with lung squamous cell carcinoma.,"['Li Y', 'Wang Y', 'Wu R', 'Li P', 'Cheng Z']","['Humans', '*Pulmonary Disease, Chronic Obstructive/genetics/metabolism', '*Lung Neoplasms/genetics/pathology/metabolism', '*Biomarkers, Tumor/genetics/metabolism', '*Carcinoma, Squamous Cell/genetics/pathology/metabolism', '*Epithelial-Mesenchymal Transition/genetics', 'Receptor, Serotonin, 5-HT2B/genetics/metabolism', 'Gene Expression Regulation, Neoplastic', 'Cell Proliferation/genetics', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/38851806/
732,HTR2B,35163491,Contribution of the STAT Family of Transcription Factors to the Expression of the Serotonin 2B (HTR2B) Receptor in Human Uveal Melanoma.,"['Benhassine M', 'Le-Bel G', 'Guerin SL']","[""5' Flanking Region/genetics"", 'Cell Line, Tumor', 'DNA/metabolism', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Interleukin-4/pharmacology', 'Interleukin-6/pharmacology', 'Melanoma/*metabolism', 'Nuclear Proteins/metabolism', 'Phosphorylation/drug effects', 'Promoter Regions, Genetic/genetics', 'Protein Isoforms/metabolism', 'Receptor, Serotonin, 5-HT2B/*genetics/metabolism', 'STAT Transcription Factors/genetics/*metabolism', 'Uveal Neoplasms/*metabolism', 'Uveal Melanoma']",https://pubmed.ncbi.nlm.nih.gov/35163491/
733,HTR2B,37480094,Variant rs17619600 in the gene encoding serotonin receptor 2B (HTR2B) increases the risk of gestational diabetes mellitus: a case-control study.,"['Penno JRCZ', 'Santos-Bezerra DP', 'Cavaleiro AM', 'da Silva Sousa AM', 'Zaccara TA', 'da Costa RA', 'Francisco RPV', 'Correa-Giannella ML']","['Female', 'Humans', 'Pregnancy', 'Alleles', 'Case-Control Studies', '*Diabetes, Gestational/genetics', 'Insulin/genetics', 'Receptor, Serotonin, 5-HT2B']",https://pubmed.ncbi.nlm.nih.gov/37480094/
734,HTR2B,27437919,Influence of a HTR2B Stop Codon on Glucagon Homeostasis and Glucose Excursion in Non-Diabetic Men.,"['Tikkanen R', 'Saukkonen T', 'Fex M', 'Bennet H', 'Rautiainen MR', 'Paunio T', 'Koskinen M', 'Panarsky R', 'Bevilacqua L', 'Sjoberg RL', 'Tiihonen J', 'Virkkunen M']","['Adult', 'Blood Glucose/*metabolism', 'Cohort Studies', 'Finland', 'Glucagon/*blood', 'Glucose Tolerance Test', 'Humans', 'Insulin/*blood', 'Insulin Resistance/*genetics', 'Male', 'Receptor, Serotonin, 5-HT2B/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27437919/
735,HTR2B,27420381,The effects of a HTR2B stop codon and testosterone on energy metabolism and beta cell function among antisocial Finnish males.,"['Tikkanen R', 'Saukkonen T', 'Fex M', 'Bennet H', 'Rautiainen MR', 'Paunio T', 'Koskinen M', 'Panarsky R', 'Bevilacqua L', 'Sjoberg RL', 'Tiihonen J', 'Virkkunen M']","['Adult', '*Antisocial Personality Disorder/genetics/metabolism/pathology', 'Area Under Curve', 'Blood Glucose/genetics', 'Body Mass Index', 'Codon, Terminator/*genetics', 'Cohort Studies', 'Energy Metabolism/*genetics', 'Finland', 'Glucose Tolerance Test', 'Humans', 'Indoles/cerebrospinal fluid', 'Insulin/blood', 'Insulin-Secreting Cells/*physiology', 'Male', 'Psychiatric Status Rating Scales', 'Receptor, Serotonin, 5-HT2B/*genetics', 'Testosterone/*blood', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27420381/
736,PTGIR,32531060,Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia.,"['Georges A', 'Albuisson J', 'Berrandou T', 'Dupre D', 'Lorthioir A', ""D'Escamard V"", 'Di Narzo AF', 'Kadian-Dodov D', 'Olin JW', 'Warchol-Celinska E', 'Prejbisz A', 'Januszewicz A', 'Bruneval P', 'Baranowska AA', 'Webb TR', 'Hamby SE', 'Samani NJ', 'Adlam D', 'Fendrikova-Mahlay N', 'Hazen S', 'Wang Y', 'Yang ML', 'Hunker K', 'Combaret N', 'Motreff P', 'Chedid A', 'Fiquet B', 'Plouin PF', 'Mousseaux E', 'Azarine A', 'Amar L', 'Azizi M', 'Gornik HL', 'Ganesh SK', 'Kovacic JC', 'Jeunemaitre X', 'Bouatia-Naji N']","['Adult', 'Aged', 'Australia', 'Coronary Vessel Anomalies/diagnosis/*genetics/metabolism', 'DNA Mutational Analysis', 'Databases, Genetic', 'Europe', 'Female', 'Fibromuscular Dysplasia/diagnosis/*genetics/metabolism', 'Genetic Predisposition to Disease', 'HEK293 Cells', 'Humans', '*Loss of Function Mutation', 'Male', 'Middle Aged', '*Mutation, Missense', 'Phenotype', 'Predictive Value of Tests', 'Receptors, Epoprostenol/*genetics/metabolism', 'Risk Assessment', 'Risk Factors', 'United States', 'Vascular Diseases/*congenital/diagnosis/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32531060/
737,PTGIR,17481829,Arginine (CGC) codon targeting in the human prostacyclin receptor gene (PTGIR) and G-protein coupled receptors (GPCR).,"['Stitham J', 'Arehart EJ', 'Gleim S', 'Douville K', 'MacKenzie T', 'Hwa J']","['Amino Acid Sequence', 'Arginine/*genetics', 'Base Sequence', 'Codon/*genetics', 'Cytoplasm/metabolism', 'Databases, Genetic', 'Genome, Human/genetics', 'Humans', 'Molecular Sequence Data', 'Nucleotides', 'Polymorphism, Single Nucleotide/genetics', 'Protein Structure, Secondary', 'Protein Structure, Tertiary', 'Receptors, Epoprostenol', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Prostaglandin/chemistry/*genetics', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/17481829/
738,HRH3,11956964,Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations.,"['Wiedemann P', 'Bonisch H', 'Oerters F', 'Bruss M']","['Alternative Splicing/genetics', 'Exons/genetics', 'Humans', 'Introns/genetics', '*Mutation, Missense/genetics', 'Protein Isoforms/chemistry/genetics', 'Receptors, Histamine H3/*chemistry/*genetics', 'Shy-Drager Syndrome/genetics']",https://pubmed.ncbi.nlm.nih.gov/11956964/
739,HRH3,26989676,"Associations of Polymorphisms in HRH2, HRH3, DAO, and HNMT Genes with Risk of Chronic Heart Failure.","['He GH', 'Cai WK', 'Zhang JB', 'Ma CY', 'Yan F', 'Lu J', 'Xu GL']","['Adult', 'Aged', 'Chronic Disease', 'D-Amino-Acid Oxidase/*genetics', 'Female', 'Genetic Association Studies', 'Genotype', 'Haplotypes', 'Heart Failure/*genetics/pathology', 'Histamine/genetics', 'Histamine N-Methyltransferase/*genetics', 'Humans', 'Male', 'Middle Aged', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H3/*genetics', 'Receptors, Histamine H4']",https://pubmed.ncbi.nlm.nih.gov/26989676/
740,HRH3,21652606,A pharmacogenetic study of risperidone on histamine H3 receptor gene (HRH3) in Chinese Han schizophrenia patients.,"['Wei Z', 'Wang L', 'Zhang M', 'Xuan J', 'Wang Y', 'Liu B', 'Shao L', 'Li J', 'Zeng Z', 'Li T', 'Liu J', 'Wang T', 'Zhang M', 'Qin S', 'Xu Y', 'Feng G', 'He L', 'Xing Q']","['Adult', 'Antipsychotic Agents/*therapeutic use', 'Asian People/genetics', 'Brief Psychiatric Rating Scale', 'Female', 'Genotype', 'Humans', 'Male', 'Pharmacogenetics/methods', 'Polymorphism, Single Nucleotide', 'Receptors, Histamine H3/*genetics', 'Risperidone/*therapeutic use', 'Schizophrenia/*drug therapy/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21652606/
741,PTGS2,19488068,PTGS2-899G>C and prostate cancer risk: a population-based nested case-control study (ProtecT) and a systematic review with meta-analysis.,"['Murad A', 'Lewis SJ', 'Smith GD', 'Collin SM', 'Chen L', 'Hamdy FC', 'Neal DE', 'Donovan J', 'Martin RM']","['Aged', 'Case-Control Studies', 'Cyclooxygenase 2/*genetics', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Prostatic Neoplasms/*genetics']",https://pubmed.ncbi.nlm.nih.gov/19488068/
742,PTGS2,33974977,Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis.,"['Zhou Y', 'Zhou H', 'Hua L', 'Hou C', 'Jia Q', 'Chen J', 'Zhang S', 'Wang Y', 'He S', 'Jia E']","['*Atherosclerosis/genetics', 'Coronary Vessels', 'Cyclooxygenase 2/genetics', '*Ferroptosis', 'Humans', 'Pyroptosis']",https://pubmed.ncbi.nlm.nih.gov/33974977/
743,PTGS2,38858305,Integrated bioinformatics and validation reveal PTGS2 and its related molecules to alleviate TNF-alpha-induced endothelial senescence.,"['Xu H', 'Wang H', 'Ning X', 'Xu Z', 'Zhang G']","['Humans', '*Cellular Senescence/drug effects', '*Tumor Necrosis Factor-alpha/pharmacology/metabolism', '*Human Umbilical Vein Endothelial Cells/metabolism/drug effects', '*Computational Biology', '*Cyclooxygenase 2/metabolism/genetics', 'Ferroptosis/drug effects/genetics', 'Protein Interaction Maps/drug effects', 'Gene Regulatory Networks/drug effects', 'Reproducibility of Results']",https://pubmed.ncbi.nlm.nih.gov/38858305/
744,PTGS2,38524634,"Unravelling the role of HAS2, GREM1, and PTGS2 gene expression in cumulus cells: implications for human oocyte development competency - a systematic review and integrated bioinformatic analysis.","['Faizal AM', 'Elias MH', 'Jin NM', 'Abu MA', 'Syafruddin SE', 'Zainuddin AA', 'Suzuki N', 'Karim AKA']","['Humans', 'Male', 'Female', 'Cyclooxygenase 2/genetics/metabolism', '*Cumulus Cells/metabolism', '*Semen', 'Oocytes/metabolism', 'Gene Expression', 'Intercellular Signaling Peptides and Proteins/genetics/metabolism', 'Hyaluronan Synthases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38524634/
745,PTGS2,25166592,"Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.","['Vogel LK', 'Saebo M', 'Hoyer H', 'Kopp TI', 'Vogel U', 'Godiksen S', 'Frenzel FB', 'Hamfjord J', 'Bowitz-Lothe IM', 'Johnson E', 'Kure EH', 'Andersen V']","['Adenocarcinoma/*genetics/metabolism/pathology', 'Adenoma/*genetics/metabolism/pathology', 'Aged', 'Alleles', 'Carcinogenesis/*genetics/metabolism/pathology', 'Case-Control Studies', 'Colorectal Neoplasms/*genetics/metabolism/pathology', 'Cyclooxygenase 2/*genetics/metabolism', 'Female', 'Genotype', 'Humans', 'Intestinal Mucosa/*metabolism', 'Intestines/pathology', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'RNA, Messenger/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/25166592/
746,PTGS2,26957558,MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.,"['Mima K', 'Nishihara R', 'Yang J', 'Dou R', 'Masugi Y', 'Shi Y', 'da Silva A', 'Cao Y', 'Song M', 'Nowak J', 'Gu M', 'Li W', 'Morikawa T', 'Zhang X', 'Wu K', 'Baba H', 'Giovannucci EL', 'Meyerhardt JA', 'Chan AT', 'Fuchs CS', 'Qian ZR', 'Ogino S']","['Aged', 'Biomarkers, Tumor', 'Colorectal Neoplasms/*genetics/*mortality', 'Cyclooxygenase 2/*genetics', 'DNA Methylation', 'Female', 'Follow-Up Studies', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Kaplan-Meier Estimate', 'Male', 'MicroRNAs/*genetics', 'Microsatellite Instability', 'Middle Aged', 'Mutation', 'Neoplasm Grading', 'Neoplasm Staging', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/26957558/
747,PTGS2,35733068,Studying the potential of upregulated PTGS2 and VEGF-C besides hyper-methylation of PTGS2 promoter as biomarkers of Acute myeloid leukemia.,"['Kiani-Zadeh M', 'Rezvany MR', 'Namjoo S', 'Barati M', 'Mohammadi MH', 'Ghasemi B', 'Tabatabaei T', 'Ghavamzadeh A', 'Zaker F', 'Teimoori-Toolabi L']","['Adult', 'Biomarkers', 'Cyclooxygenase 2/genetics', 'DNA Methylation/genetics', 'Female', 'Humans', '*Leukemia, Myeloid, Acute/genetics', 'Male', 'Middle Aged', '*Vascular Endothelial Growth Factor C/genetics']",https://pubmed.ncbi.nlm.nih.gov/35733068/
748,PTGS2,36555290,"Elsholtzia bodinieri Vaniot Ameliorated Acute Lung Injury by NQO1, BCL2 and PTGS2 In Silico and In Vitro Analyses.","['Sun J', 'Jiang X', 'Chen Y', 'Guo S', 'Zhao Z', 'Cao J', 'Liu Y', 'Cheng G', 'Li Y', 'Tian L']","['Humans', '*Acute Lung Injury/etiology', '*Cyclooxygenase 2/genetics', 'Inflammation/complications', '*NAD(P)H Dehydrogenase (Quinone)/genetics', 'Oxidative Stress', '*Proto-Oncogene Proteins c-bcl-2/genetics', '*Lamiaceae/chemistry', '*Plant Extracts/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/36555290/
749,PTGS2,37705740,The PTGS2/COX2-PGE(2) signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus.,"['Martin-Vazquez E', 'Cobo-Vuilleumier N', 'Lopez-Noriega L', 'Lorenzo PI', 'Gauthier BR']","['Humans', '*Dinoprostone', 'Cyclooxygenase 2/genetics', '*Diabetes Mellitus, Type 1', 'Signal Transduction', 'Inflammation']",https://pubmed.ncbi.nlm.nih.gov/37705740/
750,PTGS2,22464751,SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors.,"['Rausch SM', 'Gonzalez BD', 'Clark MM', 'Patten C', 'Felten S', 'Liu H', 'Li Y', 'Sloan J', 'Yang P']","['Adult', 'Aged', 'Aged, 80 and over', 'Cyclooxygenase 2/*genetics', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Humans', 'Linear Models', 'Linkage Disequilibrium', 'Logistic Models', 'Lung Neoplasms/*genetics/physiopathology/psychology', 'Lymphotoxin-alpha/*genetics', 'Male', 'Middle Aged', 'Multivariate Analysis', 'Pain/*genetics', '*Polymorphism, Single Nucleotide', '*Quality of Life', 'Sequence Analysis, DNA', '*Survivors']",https://pubmed.ncbi.nlm.nih.gov/22464751/
751,PTGS1,38000027,Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous Ptgs1 induction.,"['Kim J', 'Kim S', 'Lee SY', 'Jo BK', 'Oh JY', 'Kwon EJ', 'Kim KT', 'Adpaikar AA', 'Kim EJ', 'Jung HS', 'Kim HR', 'Roe JS', 'Hong CP', 'Kim JK', 'Koo BK', 'Cha HJ']","['*Cellular Reprogramming/genetics', '*Induced Pluripotent Stem Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38000027/
752,PTGS1,38507887,"Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways.","['Ni L', 'Zhu X', 'Zhao Q', 'Shen Y', 'Tao L', 'Zhang J', 'Lin H', 'Zhuge W', 'Cho YC', 'Cui R', 'Zhu W']","['Humans', 'Apoptosis', '*Artemisinins/pharmacology/therapeutic use', '*Carcinoma, Non-Small-Cell Lung/drug therapy/genetics/metabolism', 'Cell Death', 'Cell Line, Tumor', 'Cisplatin/pharmacology', 'Cyclooxygenase 1/metabolism', '*Lung Neoplasms/pathology', 'p38 Mitogen-Activated Protein Kinases/metabolism', '*Reactive Oxygen Species/metabolism', 'Signal Transduction', 'Cyclooxygenase Inhibitors/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/38507887/
753,PTGS1,33800915,MYLK and PTGS1 Genetic Variations Associated with Osteoporosis and Benign Breast Tumors in Korean Women.,"['Cho HW', 'Jin HS', 'Eom YB']","['Breast Neoplasms/*genetics', 'Calcium-Binding Proteins/*genetics', 'Case-Control Studies', 'Cyclooxygenase 1/*genetics', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Middle Aged', 'Myosin-Light-Chain Kinase/*genetics', 'Osteoporosis/*genetics', 'Ovariectomy/adverse effects', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Republic of Korea']",https://pubmed.ncbi.nlm.nih.gov/33800915/
754,PTGS1,23967159,A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.,"['Nagao M', 'Sato Y', 'Yamauchi A']","['Anti-Inflammatory Agents, Non-Steroidal/administration & dosage/*adverse effects', 'Cyclooxygenase 1/*genetics', 'Cyclooxygenase 2/*genetics', 'Female', 'Humans', 'Male', 'Neoplasms/epidemiology/*etiology', 'Odds Ratio', '*Polymorphism, Single Nucleotide', 'Publication Bias', 'Risk']",https://pubmed.ncbi.nlm.nih.gov/23967159/
755,PTGS1,36056535,The PTGS1 (rs1330344) CC Genotype Contributes to Susceptibility to Kawasaki Disease in Southern Chinese Children.,"['Zheng H', 'Fu L', 'Xu Y', 'Zhang TF', 'Che D', 'Li JQ', 'Zhou H', 'Jiang Z', 'Lin K', 'Zhang L', 'Pi L', 'Gu X']","['Child', 'Humans', '*Coronary Aneurysm/complications', 'Coronary Vessels/pathology', '*Cyclooxygenase 1/genetics', 'East Asian People', 'Genetic Predisposition to Disease', 'Genotype', '*Mucocutaneous Lymph Node Syndrome/diagnosis/genetics/complications', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/36056535/
756,PTGS1,25721048,"Genetic variants in TNFalpha, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.","['Yucesoy B', 'Kashon ML', 'Johnson VJ', 'Lummus ZL', 'Fluharty K', 'Gautrin D', 'Cartier A', 'Boulet LP', 'Sastre J', 'Quirce S', 'Tarlo SM', 'Cruz MJ', 'Munoz X', 'Luster MI', 'Bernstein DI']","['Adult', 'Asthma, Occupational/chemically induced/*immunology/*metabolism', 'Case-Control Studies', 'Cyclooxygenase 1/genetics', 'Cyclooxygenase 2/genetics', 'DNA Mutational Analysis', 'Environmental Exposure/adverse effects', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Inflammation/genetics', 'Male', 'Polymorphism, Single Nucleotide', 'Toluene 2,4-Diisocyanate/*immunology', 'Transforming Growth Factor beta1/genetics', 'Tumor Necrosis Factor-alpha/genetics']",https://pubmed.ncbi.nlm.nih.gov/25721048/
757,PTGS1,24694232,Gene variants and haplotypes modifying transcription factor binding sites in the human cyclooxygenase 1 and 2 (PTGS1 and PTGS2) genes.,"['Agundez JA', 'Gonzalez-Alvarez DL', 'Vega-Rodriguez MA', 'Botello E', 'Garcia-Martin E']","['Base Sequence', 'Binding Sites', 'Cyclooxygenase 1/*genetics', 'Cyclooxygenase 2/*genetics', 'Genetic Variation', 'Genome', 'Haplotypes', 'Humans', 'Polymorphism, Single Nucleotide', 'Transcription Factors/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/24694232/
758,PTGS1,36282419,EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells.,"['Vinothkumar K', 'Chanda S', 'Singh VK', 'Biswas S', 'Mohapatra S', 'Biswas G', 'Chakraborty S']","['Humans', 'Apoptosis', 'Cyclooxygenase 1/pharmacology/therapeutic use', 'Drug Resistance, Neoplasm/genetics', 'Fusion Proteins, bcr-abl', 'Imatinib Mesylate/pharmacology/therapeutic use', 'K562 Cells', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics/metabolism', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', '*Tyrosine Kinase Inhibitors']",https://pubmed.ncbi.nlm.nih.gov/36282419/
759,PTGS1,39863019,Beta-sitosterol regulates PTGS1 to inhibit gastric cancer cell proliferation and angiogenesis.,"['Wang J', 'Zhou M', 'Zhou Q', 'Sun G', 'Zhang Y', 'Tao F', 'Ye M']","['Humans', '*Stomach Neoplasms/pathology/drug therapy/metabolism/genetics', '*Cell Proliferation/drug effects', '*Sitosterols/pharmacology', '*Neovascularization, Pathologic/drug therapy/metabolism', '*Cyclooxygenase 1/metabolism/genetics', 'Cell Line, Tumor', '*Molecular Docking Simulation', 'Apoptosis/drug effects', 'Angiogenesis']",https://pubmed.ncbi.nlm.nih.gov/39863019/
760,PTGS1,17301694,Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1).,"['Lee CR', 'Bottone FG Jr', 'Krahn JM', 'Li L', 'Mohrenweiser HW', 'Cook ME', 'Petrovich RM', 'Bell DA', 'Eling TE', 'Zeldin DC']","['Amino Acid Sequence', 'Arachidonic Acid/metabolism', 'Cyclooxygenase 1/chemistry/*genetics/*metabolism', 'Dimerization', 'Enzyme Inhibitors/pharmacology', 'Humans', 'Indomethacin', 'Inhibitory Concentration 50', 'Linkage Disequilibrium', 'Membrane Proteins/antagonists & inhibitors/chemistry/*genetics/*metabolism', 'Microsomes/enzymology', 'Molecular Sequence Data', 'Mutant Proteins/genetics/metabolism', '*Polymorphism, Single Nucleotide', 'Protein Structure, Secondary']",https://pubmed.ncbi.nlm.nih.gov/17301694/
761,PTGS1,24022467,"COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.","['Makar KW', 'Poole EM', 'Resler AJ', 'Seufert B', 'Curtin K', 'Kleinstein SE', 'Duggan D', 'Kulmacz RJ', 'Hsu L', 'Whitton J', 'Carlson CS', 'Rimorin CF', 'Caan BJ', 'Baron JA', 'Potter JD', 'Slattery ML', 'Ulrich CM']","['Aged', 'Anti-Inflammatory Agents, Non-Steroidal/*pharmacology', 'Case-Control Studies', 'Colonic Neoplasms/drug therapy/epidemiology/*genetics', 'Cyclooxygenase 1/*genetics/metabolism', 'Cyclooxygenase 2/*genetics/metabolism', 'DNA, Neoplasm/genetics', 'Female', 'Follow-Up Studies', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymerase Chain Reaction', 'Polymorphism, Single Nucleotide/*genetics', 'Prognosis', 'Rectal Neoplasms/drug therapy/epidemiology/*genetics', 'Risk Factors', 'Washington/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/24022467/
762,PTGS1,25339146,"Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients.","['Gao LC', 'Wang D', 'Liu FQ', 'Huang ZY', 'Huang HG', 'Wang GH', 'Chen X', 'Shi QZ', 'Hong L', 'Wu LP', 'Tang J']","['Adult', 'Antihypertensive Agents/*pharmacology', 'Asian People/*genetics', 'Cyclooxygenase 1/genetics', 'Female', 'Glaucoma, Open-Angle/*genetics/physiopathology', 'Humans', 'Intraocular Pressure/*drug effects', 'Latanoprost', 'Male', 'Middle Aged', 'Multidrug Resistance-Associated Proteins/genetics', 'Polymorphism, Single Nucleotide', 'Prostaglandins F, Synthetic/*pharmacology', 'Receptors, Prostaglandin/genetics']",https://pubmed.ncbi.nlm.nih.gov/25339146/
763,PTGS1,38728491,"Effect of PEAR1, PTGS1 gene polymorphisms on the recurrence of aspirin-treated patients with ischemic stroke in the Han population of China: A 4-year follow-up study.","['Zhang L', 'Meng Z', 'Wang H', 'Miao Y']","['Aged', 'Female', 'Humans', 'Male', 'Middle Aged', 'Asian People/genetics', '*Aspirin/therapeutic use', 'China/epidemiology', '*Cyclooxygenase 1/genetics', 'Follow-Up Studies', 'Genotype', '*Ischemic Stroke/genetics/drug therapy', '*Platelet Aggregation Inhibitors/therapeutic use', '*Polymorphism, Single Nucleotide', 'Receptors, Cell Surface/genetics', '*Recurrence']",https://pubmed.ncbi.nlm.nih.gov/38728491/
764,PTGS1,26672987,"Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation.","['Berthelot CC', 'Kamita SG', 'Sacchi R', 'Yang J', 'Nording ML', 'Georgi K', 'Hegedus Karbowski C', 'German JB', 'Weiss RH', 'Hogg RJ', 'Hammock BD', 'Zivkovic AM']","['Arachidonate 12-Lipoxygenase/*genetics/metabolism', 'Arachidonic Acid/*metabolism', 'Body Mass Index', 'Cyclooxygenase 1/*genetics/metabolism', '*Dietary Supplements', 'Fatty Acids, Omega-3/*pharmacology', 'Gene Expression Regulation, Enzymologic/*drug effects', 'Humans', 'Leukocytes, Mononuclear/drug effects/*enzymology', 'Oxylipins/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/26672987/
765,PTGS1,28431615,Association between PTGS1 polymorphisms and functional outcomes in Chinese patients with stroke during aspirin therapy: Interaction with smoking.,"['Cai H', 'Cai B', 'Sun L', 'Zhang H', 'Zhou S', 'Cao L', 'Guo H', 'Sun W', 'Yan B', 'Davis SM', 'Zhang Z', 'Liu X']","['Asian People/genetics', 'Aspirin/*therapeutic use', 'Brain Ischemia/complications/drug therapy/genetics', 'China', 'Cyclooxygenase 1/*genetics', 'Female', 'Fibrinolytic Agents/*therapeutic use', 'Follow-Up Studies', 'Gene-Environment Interaction', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Prospective Studies', 'Registries', 'Secondary Prevention', 'Smoking/*genetics', 'Stroke/complications/*drug therapy/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/28431615/
766,PTGS1,32299908,Identification of a homozygous recessive variant in PTGS1 resulting in a congenital aspirin-like defect in platelet function.,"['Chan MV', 'Hayman MA', 'Sivapalaratnam S', 'Crescente M', 'Allan HE', 'Edin ML', 'Zeldin DC', 'Milne GL', 'Stephens J', 'Greene D', 'Hanif M', ""O'Donnell VB"", 'Dong L', 'Malkowski MG', 'Lentaigne C', 'Wedderburn K', 'Stubbs M', 'Downes K', 'Ouwehand WH', 'Turro E', 'BioResource N', 'Hart DP', 'Freson K', 'Laffan MA', 'Warner TD']","['*Aspirin', 'Blood Platelets', 'Cyclooxygenase 1/genetics', 'Female', 'Humans', 'Platelet Aggregation/genetics', '*Platelet Function Tests', 'Thromboxane A2']",https://pubmed.ncbi.nlm.nih.gov/32299908/
767,CA9,24854043,Networks development between nicotinic chemical probes and Ca9-22 oral cancer cells by general proteomics analyses.,"['Li RN', 'Wu CJ', 'Yu ZJ', 'Chang HW', 'Liang SS']","['Biomarkers, Tumor/analysis/chemistry/metabolism', 'Carcinoma, Squamous Cell/chemistry/*metabolism', 'Cell Line, Tumor', 'Humans', 'Molecular Probe Techniques', 'Mouth Neoplasms/chemistry/*metabolism', 'Niacin/analysis/chemistry/*metabolism', 'Protein Interaction Maps/*physiology', 'Proteome/*analysis/chemistry/*metabolism', 'Proteomics']",https://pubmed.ncbi.nlm.nih.gov/24854043/
768,CA9,29745265,Determination and diagnostic value of CA9 mRNA in peripheral blood of patients with oral leukoplakia.,"['Torres Lopez M', 'Perez Sayans M', 'Chamorro Petronacci C', 'Barros Angueira F', 'Gandara Vila P', 'Lorenzo Pouso A', 'Garcia Garcia A']","['Adult', 'Aged', 'Antigens, Neoplasm/*genetics', 'Carbonic Anhydrase IX/*genetics', 'Carcinoma, Squamous Cell/blood/*diagnosis/genetics', 'Dose-Response Relationship, Drug', 'Female', 'Humans', 'Leukoplakia, Oral/*blood/*diagnosis/genetics', 'Male', 'Middle Aged', 'Molecular Structure', 'RNA, Messenger/*blood/genetics/isolation & purification', 'Real-Time Polymerase Chain Reaction', 'Structure-Activity Relationship', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29745265/
769,CA9,11953885,The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer.,"['Turner KJ', 'Crew JP', 'Wykoff CC', 'Watson PH', 'Poulsom R', 'Pastorek J', 'Ratcliffe PJ', 'Cranston D', 'Harris AL']","['*Antigens, Neoplasm', 'Biomarkers, Tumor/genetics/metabolism', 'Blotting, Western', 'Carbonic Anhydrase IX', 'Carbonic Anhydrases/*genetics/*metabolism', 'Endothelial Growth Factors/*genetics/*metabolism', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Immunohistochemistry', 'In Situ Hybridization', 'Lymphokines/*genetics/*metabolism', 'Neoplasm Invasiveness', 'Neoplasm Proteins/*genetics/*metabolism', 'Prognosis', 'RNA, Messenger/genetics/metabolism', 'Recurrence', 'Tumor Cells, Cultured', 'Urinary Bladder Neoplasms/diagnosis/*genetics/*pathology/physiopathology', 'Vascular Endothelial Growth Factor A', 'Vascular Endothelial Growth Factors']",https://pubmed.ncbi.nlm.nih.gov/11953885/
770,CA9,29749469,"Association between SOX9 and CA9 in glioma, and its effects on chemosensitivity to TMZ.","['Xu X', 'Wang Z', 'Liu N', 'Cheng Y', 'Jin W', 'Zhang P', 'Wang X', 'Yang H', 'Liu H', 'Zhang Y', 'Tu Y']","['Antigens, Neoplasm/*genetics', 'Apoptosis/drug effects', 'Carbonic Anhydrase IX/antagonists & inhibitors/*genetics', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Dacarbazine/administration & dosage/adverse effects/*analogs & derivatives', 'Drug Resistance, Neoplasm/genetics', 'Enzyme Inhibitors/administration & dosage', 'Gene Expression Regulation, Neoplastic/drug effects', 'Glioma/*drug therapy/genetics/pathology', 'Humans', 'SOX9 Transcription Factor/antagonists & inhibitors/*genetics', 'Signal Transduction/drug effects', 'Temozolomide']",https://pubmed.ncbi.nlm.nih.gov/29749469/
771,CA9,31929132,Proliferation of Saos-2 and Ca9-22 cells on grooved and pillared titanium surfaces.,"['Kaga N', 'Akasaka T', 'Matsuura T', 'Yokoyama A', 'Yoshida Y']","['Bone-Implant Interface/physiology', 'Cell Adhesion/drug effects/*physiology', 'Cell Line', 'Cell Proliferation/drug effects/*physiology', 'Coated Materials, Biocompatible/chemical synthesis/*chemistry/pharmacology', '*Dental Implants', 'Epithelial Cells/drug effects/physiology', 'Humans', 'Materials Testing', 'Microtechnology', 'Osseointegration/drug effects/*physiology', 'Osteoblasts/drug effects/physiology', 'Surface Properties', 'Tissue Scaffolds/chemistry', 'Titanium/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/31929132/
772,CA9,20819065,Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.,"['Said HM', 'Supuran CT', 'Hageman C', 'Staab A', 'Polat B', 'Katzer A', 'Scozzafava A', 'Anacker J', 'Flentje M', 'Vordermark D']","['Antigens, Neoplasm/*drug effects/metabolism', 'Antineoplastic Agents/*therapeutic use', 'Brain Neoplasms/*drug therapy/*enzymology', 'Carbonic Anhydrase IX', 'Carbonic Anhydrase Inhibitors/*therapeutic use', 'Carbonic Anhydrases/*drug effects/metabolism', 'Glycolysis/drug effects/genetics', 'Humans', 'Hypoxia/enzymology/genetics', 'Models, Biological', 'Sulfonamides/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/20819065/
773,CA9,22968475,Antiproliferation and induction of apoptosis in Ca9-22 oral cancer cells by ethanolic extract of Gracilaria tenuistipitata.,"['Yeh CC', 'Tseng CN', 'Yang JI', 'Huang HW', 'Fang Y', 'Tang JY', 'Chang FR', 'Chang HW']","['Antineoplastic Agents, Phytogenic/*pharmacology', 'Apoptosis/*drug effects', 'Caspases/metabolism', 'Cell Line, Tumor', 'Cell Proliferation/*drug effects', 'Cell Survival/drug effects', 'Ethanol', 'Glutathione/analysis', '*Gracilaria', 'Humans', 'Membrane Potential, Mitochondrial/*drug effects', 'Mitochondria/drug effects', 'Mouth Neoplasms/*drug therapy', 'Oxidative Stress/drug effects', 'Plant Extracts/*pharmacology', 'Reactive Oxygen Species/metabolism']",https://pubmed.ncbi.nlm.nih.gov/22968475/
774,CA9,35874663,Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.,"['Tatari N', 'Zhang X', 'Chafe SC', 'McKenna D', 'Lawson KA', 'Subapanditha M', 'Shaikh MV', 'Seyfrid M', 'Savage N', 'Venugopal C', 'Moffat J', 'Singh SK']","['Adult', 'Antigens, Neoplasm/therapeutic use', '*Brain Neoplasms/metabolism', 'Carbonic Anhydrase IX/metabolism', '*Carbonic Anhydrases/metabolism/therapeutic use', '*Carcinoma, Renal Cell/therapy', '*Glioblastoma/therapy', 'Humans', 'Hypoxia', 'Immunotherapy', '*Kidney Neoplasms/therapy', 'T-Lymphocytes/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35874663/
775,CA9,32639054,Carbonic anhydrase IX (CA9) expression in multiple renal epithelial tumour subtypes.,"['Baniak N', 'Flood TA', 'Buchanan M', 'Dal Cin P', 'Hirsch MS']","['Antigens, Neoplasm/*analysis/*biosynthesis', 'Biomarkers, Tumor/analysis/*metabolism', 'Carbonic Anhydrase IX/*analysis/*biosynthesis', 'Carcinoma, Renal Cell/classification/*enzymology/pathology', 'Humans', 'Kidney Neoplasms/classification/*enzymology/pathology', 'Sensitivity and Specificity']",https://pubmed.ncbi.nlm.nih.gov/32639054/
776,CA9,19342157,"PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines.","['Shafee N', 'Kaluz S', 'Ru N', 'Stanbridge EJ']","['Antigens, Neoplasm/*genetics', 'Carbonic Anhydrase IX', 'Carbonic Anhydrases/*genetics', 'Cell Line, Tumor', 'DNA Primers', 'Fibrosarcoma/genetics', '*Gene Expression Regulation, Neoplastic', 'Genes, ras', 'Humans', 'Hypoxia-Inducible Factor 1/*physiology', 'Hypoxia-Inducible Factor 1, alpha Subunit/*genetics', 'Oxygen Consumption', 'Phosphatidylinositol 3-Kinases/*metabolism', 'Promoter Regions, Genetic', 'Proto-Oncogene Proteins c-akt/*metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', 'Transfection', 'Vascular Endothelial Growth Factor A/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/19342157/
777,CA9,27630286,The Utility of Serum CA9 for Prognostication in Prostate Cancer.,"['Smith AD', 'Truong M', 'Bristow R', 'Yip P', 'Milosevic MF', 'Joshua AM']","['Aged', 'Antigens, Neoplasm/*blood', 'Antineoplastic Agents/therapeutic use', 'Biomarkers, Tumor', 'Carbonic Anhydrase IX/*blood', 'Docetaxel', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Male', 'Middle Aged', 'Neoplasm Metastasis', 'Neoplasm Recurrence, Local/*blood/*diagnosis', 'Phenotype', 'Prognosis', 'Prostate-Specific Antigen/blood', 'Prostatectomy', 'Prostatic Neoplasms/*blood/*diagnosis/mortality', 'Prostatic Neoplasms, Castration-Resistant/*blood/*diagnosis/mortality', 'Taxoids/therapeutic use', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/27630286/
778,CA9,25755787,CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma.,['Gu M'],"['Adult', 'Aged', 'Antigens, Neoplasm/analysis/*biosynthesis', 'Bile Duct Neoplasms/metabolism/mortality/*pathology', 'Bile Ducts, Intrahepatic/pathology', 'Biomarkers, Tumor/*analysis', 'Carbonic Anhydrase IX', 'Carbonic Anhydrases/analysis/*biosynthesis', 'Cholangiocarcinoma/metabolism/mortality/*pathology', 'Female', 'Humans', 'Immunohistochemistry', 'Kaplan-Meier Estimate', 'Male', 'Middle Aged', 'Prognosis', 'Proportional Hazards Models', 'Tissue Array Analysis', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/25755787/
779,CA9,37973221,CA9 and PRELID2; hypoxia-responsive potential therapeutic targets for pancreatic ductal adenocarcinoma as per bioinformatics analyses.,"['Imanishi M', 'Inoue T', 'Fukushima K', 'Yamashita R', 'Nakayama R', 'Nojima M', 'Kondo K', 'Gomi Y', 'Tsunematsu H', 'Goto K', 'Miyamoto L', 'Funamoto M', 'Denda M', 'Ishizawa K', 'Otaka A', 'Fujino H', 'Ikeda Y', 'Tsuchiya K']","['Humans', 'Carbonic Anhydrase IX/genetics/metabolism', 'Antigens, Neoplasm/genetics/metabolism/therapeutic use', '*Carcinoma, Pancreatic Ductal/drug therapy/genetics', '*Pancreatic Neoplasms/drug therapy/genetics', 'Hypoxia/metabolism', 'RNA, Small Interfering', 'Computational Biology']",https://pubmed.ncbi.nlm.nih.gov/37973221/
780,CA9,28554753,"Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1alpha, CXCR4 and CA9 in colorectal carcinoma.","['Saka B', 'Ekinci O', 'Dursun A', 'Akyurek N']","['Adenocarcinoma/*chemistry/mortality/secondary/surgery', 'Adult', 'Aged', 'Antigens, Neoplasm/*analysis', 'Biomarkers, Tumor/*analysis', 'Carbonic Anhydrase IX/*analysis', 'Colorectal Neoplasms/*chemistry/mortality/pathology/surgery', 'Female', 'Humans', 'Hypoxia-Inducible Factor 1, alpha Subunit/*analysis', '*Immunohistochemistry', 'Kaplan-Meier Estimate', 'Male', 'Middle Aged', 'Neoplasm Grading', 'Predictive Value of Tests', 'Receptors, CXCR4/*analysis', 'Retrospective Studies', 'Risk Factors', 'Sex Factors', 'Tumor Burden']",https://pubmed.ncbi.nlm.nih.gov/28554753/
781,CA9,33675747,Oxygen-independent disulfide bond formation in VEGF-A and CA9.,"['Levitin F', 'Lee SCS', 'Hulme S', 'Rumantir RA', 'Wong AS', 'Meester MR', 'Koritzinsky M']","['Antigens, Neoplasm/*chemistry/metabolism', 'Carbonic Anhydrase IX/*chemistry/metabolism', '*Cell Hypoxia', 'Disulfides/*chemistry/metabolism', 'Endoplasmic Reticulum/*metabolism', 'HeLa Cells', 'Humans', 'Oxygen/*metabolism', 'Signal Transduction', 'Vascular Endothelial Growth Factor A/*chemistry/metabolism']",https://pubmed.ncbi.nlm.nih.gov/33675747/
782,CA12,35229335,Correlation between CA12 and TFF3 and their prediction value of neoadjuvant chemotherapy response in breast cancer.,"['Shen M', 'Yang L', 'Lei T', 'Zhang P', 'Xiao L', 'Cao S', 'Chen F', 'Li L', 'Ye F', 'Bu H']","['Antineoplastic Combined Chemotherapy Protocols/pharmacology/therapeutic use', '*Breast Neoplasms/drug therapy/genetics/pathology', 'Carbonic Anhydrases', 'Docetaxel/pharmacology', 'Doxorubicin/therapeutic use', 'Female', 'Humans', '*Neoadjuvant Therapy', 'RNA, Messenger', 'Receptors, Estrogen/metabolism/therapeutic use', 'Trefoil Factor-3/genetics']",https://pubmed.ncbi.nlm.nih.gov/35229335/
783,CA12,9050253,A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.,"['Cao B', 'Tsang PW', 'Tsang DN', 'Samaranayake LP', 'Wang J']","['Amphotericin B/*pharmacology', 'Antifungal Agents/*pharmacology', 'Candida albicans/*drug effects/growth & development', '*Drug Antagonism', 'Fluconazole/*pharmacology', 'Ketoconazole/*pharmacology', 'Microbial Sensitivity Tests/*methods']",https://pubmed.ncbi.nlm.nih.gov/9050253/
784,CA12,33387040,Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-kappaB signaling.,"['Du Y', 'Xin Z', 'Liu T', 'Xu P', 'Mao F', 'Yao J']","['Adenocarcinoma/genetics/pathology', 'Apoptosis/*genetics', 'Carbonic Anhydrases/*genetics', 'Cell Line, Tumor', 'Cell Proliferation/genetics', 'Down-Regulation/genetics', 'Female', 'G1 Phase Cell Cycle Checkpoints/genetics', 'Gene Expression Regulation, Neoplastic/genetics', 'Humans', 'Male', 'Middle Aged', 'NF-kappa B/*genetics', 'Pancreatic Neoplasms/*genetics/pathology', 'Prognosis', 'Resting Phase, Cell Cycle/genetics', 'Signal Transduction/*genetics']",https://pubmed.ncbi.nlm.nih.gov/33387040/
785,CA12,12676895,Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma.,"['Liao SY', 'Ivanov S', 'Ivanova A', 'Ghosh S', 'Cote MA', 'Keefe K', 'Coca-Prados M', 'Stanbridge EJ', 'Lerman MI']","['Blotting, Northern', 'Carbonic Anhydrases/*genetics/metabolism', 'Cell Membrane/*enzymology', 'Cells, Cultured', 'Ciliary Body/cytology/enzymology', 'Epithelial Cells/enzymology', 'Gene Expression Regulation, Enzymologic', 'Glaucoma/enzymology/*genetics/pathology', 'Humans', 'Immunohistochemistry', 'Isoenzymes/genetics/metabolism', 'RNA, Messenger/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/12676895/
786,CA12,30784287,High expression of carbonic anhydrase 12 (CA12) is associated with good prognosis in breast cancer.,"['Li Y', 'Lei B', 'Zou J', 'Wang W', 'Chen A', 'Zhang J', 'Fu Y', 'Li Z']","['*Breast Neoplasms/diagnosis/enzymology/genetics', '*Carbonic Anhydrases/genetics', 'Disease-Free Survival', 'Female', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Lymphatic Metastasis', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/30784287/
787,CA12,38515178,"Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.","['Deben C', 'Boullosa LF', 'Fortes FR', 'De La Hoz EC', 'Le Compte M', 'Seghers S', 'Peeters M', 'Vanlanduit S', 'Lin A', 'Dijkstra KK', 'Van Schil P', 'Hendriks JMH', 'Prenen H', 'Roeyen G', 'Lardon F', 'Smits E']","['Humans', 'Auranofin/pharmacology/therapeutic use', '*Carcinoma, Non-Small-Cell Lung/pathology', 'Proto-Oncogene Proteins c-akt/metabolism', '*Lung Neoplasms/genetics', 'Drug Repositioning', '*Pancreatic Neoplasms/pathology', '*Carcinoma, Pancreatic Ductal/drug therapy', '*Adenocarcinoma/drug therapy', '*Antineoplastic Agents/pharmacology/therapeutic use', 'Lung/pathology', 'Biomarkers', 'Organoids/metabolism', '*Carbonic Anhydrases']",https://pubmed.ncbi.nlm.nih.gov/38515178/
788,CA12,34510398,"Optimization of bioprocess of Schleiferilactobacillus harbinensis Ca12 and its viability in frozen Brazilian berries (Acai, Euterpe oleracea Mart.).","['Colares HC', 'Guimaraes GM', 'Couto CAP', 'Gil PO', 'Santos SLEN', 'Silva TNL', 'de Carvalho ILQ', 'da Fonseca FG', 'Gagnon M', 'Roy D', 'de Magalhaes JT', 'Goncalves DB', 'Granjeiro PA']","['Antioxidants', '*Euterpe/microbiology', 'Food Handling', '*Freezing', '*Fruit/microbiology', '*Lactobacillus/physiology', '*Microbial Viability']",https://pubmed.ncbi.nlm.nih.gov/34510398/
789,CA12,21035102,"Hyperchlorhidrosis caused by homozygous mutation in CA12, encoding carbonic anhydrase XII.","['Feldshtein M', 'Elkrinawi S', 'Yerushalmi B', 'Marcus B', 'Vullo D', 'Romi H', 'Ofir R', 'Landau D', 'Sivan S', 'Supuran CT', 'Birk OS']","['Carbonic Anhydrases/*genetics', 'Chromosome Mapping', 'Chromosomes, Human, Pair 15', 'Female', 'Homozygote', 'Humans', 'Hyperhidrosis/*genetics', 'Male', 'Mutation', 'Pedigree', 'Sodium Chloride/*metabolism', 'Sweat/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/21035102/
790,CA12,28667025,"Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.","['Chen C', 'Chen Q', 'Zhao Q', 'Liu M', 'Guo J']","['Aged', 'Antigens, Tumor-Associated, Carbohydrate/*blood', 'Biomarkers, Tumor/blood', 'Carcinoembryonic Antigen/*blood', 'Case-Control Studies', 'Early Detection of Cancer/methods', 'Female', 'Humans', 'Male', 'Middle Aged', 'Mucin-1/*blood', 'Stomach Diseases/blood', 'Stomach Neoplasms/*blood/diagnosis']",https://pubmed.ncbi.nlm.nih.gov/28667025/
791,CA12,26923758,"Novel optical properties of Ca(12) Al(10.6) Si(3.4) O(32) Cl(5.4) :Ce(3)(+) ,Li(+) phosphor for solid-state lighting.","['Kolte M', 'Pawade VB', 'Dhoble SJ']","['Aluminum/*chemistry', 'Calcium/*chemistry', 'Cerium/*chemistry', '*Lighting', 'Lithium/*chemistry', 'Luminescence', 'Luminescent Agents/*chemistry', 'Silicon/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/26923758/
792,CA12,28116834,Synthesis and luminescence properties of blue-emitting phosphor Ca(12) Al(14) O(32) F(2) :Eu(2+) for white light-emitting diode.,"['Chen W', 'Zhang X', 'Wang L']","['Color', 'Europium/*chemistry', 'Luminescence', 'Luminescent Agents/*chemical synthesis/chemistry']",https://pubmed.ncbi.nlm.nih.gov/28116834/
793,CA12,17320454,"Population genetic data on four STR loci, PAI (CA)n, GpIIIa (CT)n, PLAT (TG)14 (CA)12, and NOS2A (CCTTT)n, in Mediterranean populations.","['Falchi A', 'Piras IS', 'Giovannoni L', 'Moral P', 'Vona G', 'Varesi L']","['Africa, Northern', 'Alleles', 'Chi-Square Distribution', 'Data Interpretation, Statistical', 'France', 'Gene Frequency', '*Genetics, Population', 'Humans', 'Integrin beta3/*genetics', 'Italy', 'Mediterranean Region', '*Microsatellite Repeats', 'Nitric Oxide Synthase Type II/*genetics', 'Plasminogen Activator Inhibitor 1/*genetics', 'Polymerase Chain Reaction', '*Polymorphism, Genetic', 'Sicily', 'Spain', 'Tissue Plasminogen Activator/*genetics', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17320454/
794,CA12,3163149,"A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer.","['Benini L', 'Cavallini G', 'Zordan D', 'Rizzotti P', 'Rigo L', 'Brocco G', 'Perobelli L', 'Zanchetta M', 'Pederzoli P', 'Scuro LA']","['Adult', 'Aged', 'Antibodies', '*Antibodies, Monoclonal', 'Antigens/analysis', 'Antigens, Neoplasm/*analysis', 'Antigens, Tumor-Associated, Carbohydrate', 'Biomarkers, Tumor/*analysis', 'Carcinoembryonic Antigen/analysis', 'Female', 'Humans', 'Male', 'Middle Aged', 'Pancreatic Neoplasms/*diagnosis', 'Thromboplastin']",https://pubmed.ncbi.nlm.nih.gov/3163149/
795,CA12,39287252,"Malignant transformation of ovarian mature cystic teratoma with rupture, elevated serum CA199, CA12, CEA: A case report.","['Chen L', 'Dong L']","['Humans', 'Female', '*Ovarian Neoplasms/blood/surgery/pathology/diagnosis', 'Aged, 80 and over', '*Teratoma/blood/surgery/pathology/diagnosis', '*Cell Transformation, Neoplastic', 'Carcinoembryonic Antigen/blood', 'Antigens, Tumor-Associated, Carbohydrate/blood', 'Mucin-1/blood', 'CA-19-9 Antigen/blood', 'Rupture, Spontaneous']",https://pubmed.ncbi.nlm.nih.gov/39287252/
796,CA4,32155790,Exploring Diverse-Ring Analogues on Combretastatin A4 (CA-4) Olefin as Microtubule-Targeting Agents.,"['Song MY', 'He QR', 'Wang YL', 'Wang HR', 'Jiang TC', 'Tang JJ', 'Gao JM']","['Antineoplastic Agents, Phytogenic/chemistry/pharmacology', 'Apoptosis', 'Cell Proliferation', 'Hep G2 Cells', 'Humans', 'Microtubules/*drug effects', 'Molecular Docking Simulation', 'Molecular Structure', 'Stilbenes/*chemistry/*pharmacology', 'Tubulin/*chemistry', 'Tubulin Modulators/chemistry/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/32155790/
797,CA4,8001765,Ethylbenzene degradation by Pseudomonas fluorescens strain CA-4.,"['Corkery DM', ""O'Connor KE"", 'Buckley CM', 'Dobson AD']","['Alcohol Oxidoreductases/metabolism', 'Aldehyde Oxidoreductases/metabolism', 'Benzene Derivatives/*metabolism', 'Biodegradation, Environmental', 'Cloning, Molecular', 'DNA Transposable Elements', 'Escherichia coli Proteins', 'Genes, Bacterial', 'Genetic Complementation Test', 'Genomic Library', 'Oxygen Consumption', 'Pseudomonas fluorescens/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/8001765/
798,CA4,36291109,Decreased Oligodendrocyte Number in Hippocampal Subfield CA4 in Schizophrenia: A Replication Study.,"['Schmitt A', 'Tatsch L', 'Vollhardt A', 'Schneider-Axmann T', 'Raabe FJ', 'Roell L', 'Heinsen H', 'Hof PR', 'Falkai P', 'Schmitz C']","['Humans', 'Astrocytes/pathology', 'Neurons/pathology', '*Oligodendroglia/pathology', '*Schizophrenia/pathology', '*Dentate Gyrus/pathology']",https://pubmed.ncbi.nlm.nih.gov/36291109/
799,CA4,28355989,Reduced volumes of the CA1 and CA4-dentate gyrus hippocampal subfields in systemic lupus erythematosus.,"['Bodi N', 'Polgar A', 'Kiss E', 'Mester A', 'Poor G', 'Keri S']","['Adult', 'CA1 Region, Hippocampal/*pathology', 'Cognitive Dysfunction/etiology', 'Dentate Gyrus/*pathology', 'Female', 'Humans', 'Image Processing, Computer-Assisted', 'Lupus Erythematosus, Systemic/diagnostic imaging/*pathology', 'Magnetic Resonance Imaging/*methods', 'Middle Aged']",https://pubmed.ncbi.nlm.nih.gov/28355989/
800,CA4,31326273,CRISPR-Cas III-A Csm6 CARF Domain Is a Ring Nuclease Triggering Stepwise cA(4) Cleavage with ApA>p Formation Terminating RNase Activity.,"['Jia N', 'Jones R', 'Yang G', 'Ouerfelli O', 'Patel DJ']","['Adenine Nucleotides/*chemistry', 'Archaeal Proteins/*chemistry', 'Binding Sites', 'CRISPR-Associated Proteins/*chemistry', '*CRISPR-Cas Systems', 'Oligoribonucleotides/*chemistry', 'Protein Domains', 'Ribonucleases/*chemistry', 'Thermococcus/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/31326273/
801,CA4,31326272,Second Messenger cA(4) Formation within the Composite Csm1 Palm Pocket of Type III-A CRISPR-Cas Csm Complex and Its Release Path.,"['Jia N', 'Jones R', 'Sukenick G', 'Patel DJ']","['Adenine Nucleotides/*chemistry/metabolism', 'Archaeal Proteins/*chemistry/metabolism', '*CRISPR-Cas Systems', 'Cryoelectron Microscopy', 'Oligoribonucleotides/*chemistry/metabolism', 'Ribonucleases/*chemistry/metabolism', '*Second Messenger Systems', 'Thermococcus/*chemistry/metabolism/ultrastructure']",https://pubmed.ncbi.nlm.nih.gov/31326272/
802,CA4,32146566,Carbonic anhydrases CA1 and CA4 function in atmospheric CO(2)-modulated disease resistance.,"['Zhou Y', 'Vroegop-Vos IA', 'Van Dijken AJH', 'Van der Does D', 'Zipfel C', 'Pieterse CMJ', 'Van Wees SCM']","['Arabidopsis/genetics/microbiology', 'Arabidopsis Proteins/genetics/*metabolism', 'Carbon Dioxide/*metabolism', 'Carbonic Anhydrases/genetics/*metabolism', 'Disease Resistance', '*Plant Diseases', 'Plant Immunity', 'Pseudomonas syringae/metabolism', 'Reactive Oxygen Species/metabolism', 'Transcription Factors/genetics/metabolism', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/32146566/
803,CA4,34970997,"Singlet Oxygen Activatable Prodrugs of Paclitaxel, SN-38, MMC and CA4: Nonmitochondria-Targeted Prodrugs.","['Rahman KMM', 'Thapa P', 'Hurst R', 'Woo S', 'You Y']","['*Antineoplastic Agents/pharmacology', 'Cell Line, Tumor', 'Irinotecan', 'Mitomycin', 'Paclitaxel/pharmacology', '*Photochemotherapy', 'Photosensitizing Agents/pharmacology', '*Prodrugs/pharmacology', 'Singlet Oxygen']",https://pubmed.ncbi.nlm.nih.gov/34970997/
804,CA4,33600615,In-air self-reduction synthesis and luminescence properties from Mg(21) Ca(4) Na(4) (PO(4) )(18) :Eu(2+) -Eu(3+) excited using ultraviolet light.,"['Wu Y', 'Peng K', 'Huang S', 'Zhao Y', 'Deng Y', 'Ai J', 'Yang Y', 'Hu M', 'Min X', 'Yu L']","['Europium', 'Light', '*Luminescence', '*Luminescent Agents', 'Ultraviolet Rays']",https://pubmed.ncbi.nlm.nih.gov/33600615/
805,CA4,9770272,Reverse transcription-PCR analysis of the regulation of ethylbenzene dioxygenase gene expression in Pseudomonas fluorescens CA-4.,"['Corkery DM', 'Dobson AD']","['Benzene Derivatives/*metabolism', 'Biodegradation, Environmental', '*Gene Expression Regulation, Bacterial', 'Genes, Bacterial', 'Molecular Sequence Data', 'Oxygen Consumption', 'Oxygenases/*genetics/metabolism', 'Pseudomonas fluorescens/enzymology/*genetics/growth & development', 'RNA, Bacterial/analysis', 'Reverse Transcriptase Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/9770272/
806,CA4,28616978,Synthesis and Preclinical Characterization of a Cationic Iodinated Imaging Contrast Agent (CA4+) and Its Use for Quantitative Computed Tomography of Ex Vivo Human Hip Cartilage.,"['Stewart RC', 'Patwa AN', 'Lusic H', 'Freedman JD', 'Wathier M', 'Snyder BD', 'Guermazi A', 'Grinstaff MW']","['Cartilage, Articular/*diagnostic imaging', 'Cations/administration & dosage/chemistry/pharmacokinetics', 'Contrast Media/administration & dosage/chemistry/*pharmacokinetics', 'Humans', 'Molecular Structure', 'Tissue Distribution', '*Tomography, X-Ray Computed']",https://pubmed.ncbi.nlm.nih.gov/28616978/
807,CA4,31784823,The role of carbonic anhydrase alpha-CA4 in the adaptive reactions of photosynthetic apparatus: the study with alpha-CA4 knockout plants.,"['Rudenko NN', 'Fedorchuk TP', 'Terentyev VV', 'Dymova OV', 'Naydov IA', 'Golovko TK', 'Borisova-Mubarakshina MM', 'Ivanov BN']","['Carbonic Anhydrases/*metabolism', 'Photosynthesis/*physiology', 'Plant Leaves/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/31784823/
808,CA4,38989619,Molecular basis for cA6 synthesis by a type III-A CRISPR-Cas enzyme and its conversion to cA4 production.,"['Goswami HN', 'Ahmadizadeh F', 'Wang B', 'Addo-Yobo D', 'Zhao Y', 'Whittington AC', 'He H', 'Terns MP', 'Li H']","['*CRISPR-Cas Systems', '*CRISPR-Associated Proteins/metabolism/genetics', 'Adenine Nucleotides/metabolism/biosynthesis', 'Binding Sites', 'Models, Molecular', 'Oligoribonucleotides/metabolism/genetics/biosynthesis', 'Bacterial Proteins/metabolism/genetics/chemistry']",https://pubmed.ncbi.nlm.nih.gov/38989619/
809,CA4,27146228,Analysis of electron-vibrational interaction in interconfigurational 5d➔4f transition of Eu(2)(+) ions in Na(5) Ca(4) (PO(4) )(4) F.,"['Bhoyar PD', 'Dhoble SJ']","['Calcium Phosphates/*chemistry', 'Coordination Complexes/*chemistry', 'Crystallography, X-Ray', '*Electrons', 'Europium/*chemistry', 'Ions', '*Vibration']",https://pubmed.ncbi.nlm.nih.gov/27146228/
810,CA2,35512637,LEC to CA2: A circuit to remember.,"['Pannoni KE', 'Farris S']","['*CA2 Region, Hippocampal/physiology', 'Neurons', '*Pyramidal Cells/physiology']",https://pubmed.ncbi.nlm.nih.gov/35512637/
811,CA2,17303830,Examining Ca2+ extrusion of Na+/Ca2+-K+ exchangers.,"['Altimimi HF', 'Schnetkamp PP']","['Calcium/*metabolism', 'Cell Line', 'Electrochemistry', 'Humans', 'Sodium-Calcium Exchanger/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/17303830/
812,CA2,24019485,Ca2+ channel nanodomains boost local Ca2+ amplitude.,"['Tadross MR', 'Tsien RW', 'Yue DT']","['Calcium/metabolism', 'Calcium Channels/*chemistry/*metabolism', '*Calcium Signaling', 'Calibration', 'HEK293 Cells', 'Humans', 'Ion Channel Gating', 'Models, Biological', 'Protein Structure, Tertiary']",https://pubmed.ncbi.nlm.nih.gov/24019485/
813,CA2,16415789,Ca2+ shuttling between endoplasmic reticulum and mitochondria underlying Ca2+ oscillations.,"['Ishii K', 'Hirose K', 'Iino M']","['Calcium/chemistry/*metabolism', '*Calcium Signaling', 'Cations, Divalent/chemistry', 'Cytosol/metabolism', 'Endoplasmic Reticulum/*metabolism', 'HeLa Cells', 'Humans', 'Mitochondria/*metabolism', 'Models, Biological']",https://pubmed.ncbi.nlm.nih.gov/16415789/
814,CA2,22491326,Nanodomain Ca(2)(+) of Ca(2)(+) channels detected by a tethered genetically encoded Ca(2)(+) sensor.,"['Tay LH', 'Dick IE', 'Yang W', 'Mank M', 'Griesbeck O', 'Yue DT']","['Calcium/*metabolism', 'Calcium Channels, N-Type/*chemistry/*genetics/*metabolism', 'Cytoplasm/chemistry/metabolism', 'Electrophysiology', 'Fluorescence Resonance Energy Transfer', 'Genetic Engineering', 'HEK293 Cells', 'Humans', 'Kinetics']",https://pubmed.ncbi.nlm.nih.gov/22491326/
815,CA3,25002463,CA3 size predicts the precision of memory recall.,"['Chadwick MJ', 'Bonnici HM', 'Maguire EA']","['Adolescent', 'Adult', 'CA3 Region, Hippocampal/*anatomy & histology/*physiology', 'Female', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Mental Recall/*physiology', 'Models, Neurological', 'Organ Size', 'Photic Stimulation', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25002463/
816,CA3,37897725,Recalling gist memory depends on CA1 hippocampal neurons for lifetime retention and CA3 neurons for memory precision.,"['Atucha E', 'Ku SP', 'Lippert MT', 'Sauvage MM']","['*Hippocampus/metabolism', '*Mental Recall/physiology', 'Temporal Lobe/physiology', 'Memory, Long-Term', 'Neurons']",https://pubmed.ncbi.nlm.nih.gov/37897725/
817,CA3,31917351,Metabotropic Glutamate Receptors at the Aged Mossy Fiber - CA3 Synapse of the Hippocampus.,"['Griego E', 'Galvan EJ']","['CA3 Region, Hippocampal/*cytology', 'Humans', '*Mossy Fibers, Hippocampal', '*Receptors, Metabotropic Glutamate/metabolism', 'Synapses/metabolism', 'Synaptic Transmission']",https://pubmed.ncbi.nlm.nih.gov/31917351/
818,CA3,29348512,CA1 and CA3 differentially support spontaneous retrieval of episodic contexts within human hippocampal subfields.,"['Dimsdale-Zucker HR', 'Ritchey M', 'Ekstrom AD', 'Yonelinas AP', 'Ranganath C']","['Brain Mapping', 'CA1 Region, Hippocampal/*physiology', 'CA3 Region, Hippocampal/*physiology', 'Female', 'Humans', 'Magnetic Resonance Imaging', 'Male', '*Memory, Episodic', 'Mental Recall/physiology', 'Space Perception/*physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29348512/
819,CA3,28342999,Hippocampal CA3-dentate gyrus volume uniquely linked to improvement in associative memory from childhood to adulthood.,"['Daugherty AM', 'Flinn R', 'Ofen N']","['Adolescent', 'Adult', '*Aging', '*Association Learning', 'CA3 Region, Hippocampal/*anatomy & histology/growth & development', 'Child', 'Dentate Gyrus/*anatomy & histology/growth & development', 'Female', 'Humans', 'Male', '*Memory', 'Models, Neurological', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28342999/
820,CA3,31405925,Holistic Recollection via Pattern Completion Involves Hippocampal Subfield CA3.,"['Grande X', 'Berron D', 'Horner AJ', 'Bisby JA', 'Duzel E', 'Burgess N']","['Adult', 'Brain Mapping', 'CA3 Region, Hippocampal/diagnostic imaging/metabolism/*physiology', 'Cues', 'Dentate Gyrus/physiology', 'Female', 'Functional Neuroimaging', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Memory, Episodic', 'Mental Recall/*physiology', 'Pattern Recognition, Visual/*physiology', 'Photic Stimulation', 'Psychomotor Performance/physiology', 'Reading', 'Temporal Lobe/physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/31405925/
821,CA7,37895185,"Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early Detection of Colorectal Cancer: A Comprehensive Analysis of RNA-Seq Data by Utilizing Machine Learning Algorithms.","['Maurya NS', 'Kushwaha S', 'Vetukuri RR', 'Mani A']","['Humans', 'Algorithms', 'Bayes Theorem', '*Colorectal Neoplasms/diagnosis/genetics', '*Early Detection of Cancer', 'Machine Learning', 'RNA-Seq']",https://pubmed.ncbi.nlm.nih.gov/37895185/
822,CA7,30957640,Long noncoding RNA CA7-4 promotes autophagy and apoptosis via sponging MIR877-3P and MIR5680 in high glucose-induced vascular endothelial cells.,"['Zhao X', 'Su L', 'He X', 'Zhao B', 'Miao J']","['Apoptosis/*genetics', 'Apoptosis Regulatory Proteins/metabolism', 'Autophagy/*genetics/physiology', 'Endothelial Cells/*metabolism', 'Glucose/metabolism', 'Humans', 'RNA, Long Noncoding/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30957640/
823,CA7,32609916,Synthesis and luminescence characterization of Eu(3+) -doped Ca(7) Mg(2) (PO(4) )(6) phosphor for eco-friendly white light-emitting diodes and thermoluminescence dosimetric applications.,"['Parauha YR', 'Dhoble SJ']","['*Europium', 'Light', '*Luminescence', 'Thermoluminescent Dosimetry']",https://pubmed.ncbi.nlm.nih.gov/32609916/
824,SLC6A4,37032427,"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.","['Bousman CA', 'Stevenson JM', 'Ramsey LB', 'Sangkuhl K', 'Hicks JK', 'Strawn JR', 'Singh AB', 'Ruano G', 'Mueller DJ', 'Tsermpini EE', 'Brown JT', 'Bell GC', 'Leeder JS', 'Gaedigk A', 'Scott SA', 'Klein TE', 'Caudle KE', 'Bishop JR']","['Humans', '*Selective Serotonin Reuptake Inhibitors', 'Cytochrome P-450 CYP2D6/genetics/metabolism', 'Cytochrome P-450 CYP2B6/genetics', 'Pharmacogenetics', '*Depressive Disorder, Major/drug therapy/genetics', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Serotonin', 'Antidepressive Agents/therapeutic use', 'Citalopram/therapeutic use', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/37032427/
825,SLC6A4,24385047,"SLC6A4 polymorphism, population genetics, and psychiatric traits.",['Gelernter J'],"['*Genetics, Population', 'Humans', 'Mental Disorders/*genetics/psychology', '*Polymorphism, Genetic', 'Serotonin Plasma Membrane Transport Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24385047/
826,SLC6A4,26556226,A pharmacogenomic study revealed an association between SLC6A4 and risperidone-induced weight gain in Chinese Han population.,"['Wang F', 'Mi W', 'Ma W', 'Ma C', 'Yang Y', 'Zhang H', 'Du B', 'Li K', 'Liu C', 'Wang L', 'Lu T', 'Zhang H', 'Lv L', 'Zhang D', 'Yue W']","['Adult', 'Antipsychotic Agents/*adverse effects', 'Asian People/*genetics', 'China', 'Female', 'Follow-Up Studies', 'Genetic Association Studies/methods', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/genetics', 'Risperidone/*adverse effects', 'Schizophrenia/drug therapy/genetics', 'Serotonin Plasma Membrane Transport Proteins/*genetics', 'Weight Gain/drug effects/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26556226/
827,SLC6A4,36377555,"Evaluation of DNA methylation in BDNF, SLC6A4, NR3C1 and FKBP5 before and after treatment with selective serotonin-reuptake inhibitor in major depressive disorder.","['Mohammadi S', 'Beh-Pajooh A', 'Ahmadimanesh M', 'Amini M', 'Ghazi-Khansari M', 'Moallem SA', 'Hosseini R', 'Nourian YH', 'Ghahremani MH']","['Humans', 'Brain-Derived Neurotrophic Factor/genetics/metabolism', '*Depressive Disorder, Major/drug therapy/genetics', '*DNA Methylation', 'Promoter Regions, Genetic', 'Receptors, Glucocorticoid/genetics', 'Serotonin/metabolism', 'Serotonin Plasma Membrane Transport Proteins/genetics/metabolism', '*Selective Serotonin Reuptake Inhibitors/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/36377555/
828,SLC6A4,19995670,Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia.,"['Bloch B', 'Reshef A', 'Cohen T', 'Tafla A', 'Gathas S', 'Israel S', 'Gritsenko I', 'Kremer I', 'Ebstein RP']","['Adult', 'Bupropion/*therapeutic use', 'Cognitive Behavioral Therapy/methods', 'Dopamine Uptake Inhibitors/*therapeutic use', 'Double-Blind Method', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic/*genetics', 'Promoter Regions, Genetic/*genetics', 'Psychiatric Status Rating Scales', 'Schizophrenia/complications/genetics', 'Schizophrenic Psychology', 'Serotonin Plasma Membrane Transport Proteins/*genetics', 'Smoking/*genetics/therapy']",https://pubmed.ncbi.nlm.nih.gov/19995670/
829,SLC6A4,19268543,"Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features.","['Bergen SE', 'Fanous AH', 'Walsh D', ""O'Neill FA"", 'Kendler KS']","['Delusions/genetics', 'Family', 'Gene Frequency', 'Genetic Markers/genetics', 'Genetic Predisposition to Disease/genetics', 'Genetic Variation', 'Genome-Wide Association Study', 'Genotype', 'Hallucinations/genetics', 'Humans', 'Membrane Transport Proteins/genetics', 'Monoamine Oxidase/*genetics', 'Phenylalanine Hydroxylase/*genetics', '*Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Psychotic Disorders/diagnosis/*genetics/psychology', 'Receptors, GABA/genetics', 'Schizophrenia/diagnosis/genetics', 'Serotonin Plasma Membrane Transport Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/19268543/
830,SLC6A4,27655391,"Prevention of Early Substance Use Mediates, and Variation at SLC6A4 Moderates, SAAF Intervention Effects on OXTR Methylation.","['Beach SRH', 'Lei MK', 'Brody GH', 'Philibert RA']","['Adolescent', 'Black or African American/*genetics', 'Child', 'DNA Methylation/*genetics', 'Female', 'Genotype', 'Georgia', 'Humans', 'Male', 'Outcome Assessment, Health Care', 'Preventive Health Services', 'Receptors, Oxytocin/*genetics', 'Rural Population', 'Serotonin Plasma Membrane Transport Proteins/*genetics', 'Substance-Related Disorders/*genetics/*prevention & control', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27655391/
831,SLC6A4,12218657,Major psychiatric disorders and the serotonin transporter gene (SLC6A4): family-based association studies.,"['Dimitrova A', 'Georgieva L', 'Nikolov I', 'Poriazova N', 'Krastev S', 'Toncheva D', 'Owen MJ', 'Kirov G']","['Adult', 'Alleles', 'Bipolar Disorder/genetics', 'Bulgaria/ethnology', 'Carrier Proteins/*genetics', 'Family', 'Female', 'Genetic Carrier Screening', 'Humans', 'Introns', 'Male', 'Membrane Glycoproteins/*genetics', '*Membrane Transport Proteins', 'Minisatellite Repeats', '*Nerve Tissue Proteins', 'Psychotic Disorders/*genetics', 'Schizophrenia/genetics', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/12218657/
832,SLC6A4,17101915,Variation of the serotonin transporter gene SLC6A4 in the susceptibility to migraine with aura.,"['Todt U', 'Freudenberg J', 'Goebel I', 'Heinze A', 'Heinze-Kuhn K', 'Rietschel M', 'Gobel H', 'Kubisch C']","['Adult', 'Brain/metabolism/physiopathology', 'Brain Chemistry/genetics', 'Case-Control Studies', 'DNA Mutational Analysis', 'Female', 'Gene Frequency/genetics', 'Genetic Predisposition to Disease/*genetics', 'Genetic Testing', 'Genetic Variation/genetics', 'Germany/epidemiology', 'Haplotypes', 'Humans', 'Male', 'Migraine with Aura/epidemiology/*genetics/physiopathology', 'Mutation/genetics', 'Polymorphism, Genetic/*genetics', 'Serotonin/*metabolism', 'Serotonin Plasma Membrane Transport Proteins/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/17101915/
833,SLC6A4,23973251,SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.,"['Shiroma PR', 'Drews MS', 'Geske JR', 'Mrazek DA']","['Age of Onset', 'Aged', 'Antidepressive Agents, Second-Generation/*therapeutic use', 'Citalopram/*therapeutic use', 'Depressive Disorder, Major/*drug therapy/genetics', 'Female', 'Genotype', 'Humans', 'Introns/genetics', 'Male', 'Middle Aged', 'Minisatellite Repeats/genetics', 'Polymorphism, Genetic/genetics', 'Promoter Regions, Genetic/genetics', 'Serotonin Plasma Membrane Transport Proteins/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/23973251/
834,SLC6A4,16395127,Hardy-Weinberg disequilibrium identified genotyping error of the serotonin transporter (SLC6A4) promoter polymorphism.,"['Yonan AL', 'Palmer AA', 'Gilliam TC']","['Autistic Disorder/genetics', 'Base Sequence', 'Case-Control Studies', 'DNA Primers', '*Genotype', 'Humans', '*Linkage Disequilibrium', 'Magnesium', 'Polymerase Chain Reaction', '*Polymorphism, Genetic', '*Promoter Regions, Genetic', 'Serotonin Plasma Membrane Transport Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16395127/
835,SLC6A4,25889020,Methylation of NR3C1 and SLC6A4 and internalizing problems. The TRAILS study.,"['van der Knaap LJ', 'van Oort FV', 'Verhulst FC', 'Oldehinkel AJ', 'Riese H']","['Adolescent', 'Cross-Sectional Studies', 'DNA Methylation/*genetics', 'Diagnostic and Statistical Manual of Mental Disorders', 'Female', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Male', 'Mental Disorders/*genetics', 'Prospective Studies', 'Receptors, Glucocorticoid/*genetics', 'Serotonin Plasma Membrane Transport Proteins/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25889020/
836,SLC6A4,7789954,Linkage mapping of serotonin transporter protein gene SLC6A4 on chromosome 17.,"['Gelernter J', 'Pakstis AJ', 'Kidd KK']","['Carrier Proteins/*genetics', 'Chromosome Mapping', 'Chromosomes, Human, Pair 17/*genetics', 'Genetic Linkage', 'Humans', 'Membrane Glycoproteins/*genetics', '*Membrane Transport Proteins', 'Mental Disorders/genetics', '*Nerve Tissue Proteins', 'Serotonin/*metabolism', 'Serotonin Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/7789954/
837,SLC6A4,38671329,Serotonin Transporter (SLC6A4) and FK506-Binding Protein 5 (FKBP5) Genotype and Methylation Relationships with Response to Meditation in Veterans with PTSD.,"['Lee A', 'Thuras P', 'Baller J', 'Jiao C', 'Guo B', 'Erbes CR', 'Polusny MA', 'Liu C', 'Wu B', 'Lim KO', 'Bishop JR']","['Adult', 'Female', 'Humans', 'Male', 'Middle Aged', '*DNA Methylation', 'Genotype', '*Meditation', 'Polymorphism, Single Nucleotide/genetics', 'Promoter Regions, Genetic/genetics', '*Serotonin Plasma Membrane Transport Proteins/genetics', '*Stress Disorders, Post-Traumatic/genetics/therapy', '*Tacrolimus Binding Proteins/genetics', 'Treatment Outcome', '*Veterans']",https://pubmed.ncbi.nlm.nih.gov/38671329/
838,SLC6A4,23032942,The association of attempted suicide with genetic variants in the SLC6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analysis.,"['Clayden RC', 'Zaruk A', 'Meyre D', 'Thabane L', 'Samaan Z']","['Genetic Predisposition to Disease/genetics', 'Humans', 'Odds Ratio', 'Polymorphism, Genetic/*genetics', 'Serotonin Plasma Membrane Transport Proteins/*genetics', '*Suicidal Ideation', '*Suicide, Attempted', 'Tryptophan Hydroxylase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23032942/
839,SLC6A4,36114180,Maternal and infant NR3C1 and SLC6A4 epigenetic signatures of the COVID-19 pandemic lockdown: when timing matters.,"['Nazzari S', 'Grumi S', 'Mambretti F', 'Villa M', 'Giorda R', 'Provenzi L']","['*COVID-19/epidemiology/prevention & control', 'Child', 'Communicable Disease Control', '*Epigenesis, Genetic/genetics', 'Female', 'Humans', 'Infant', 'Mouth Mucosa/metabolism', 'Pandemics/prevention & control', 'Pregnancy', '*Quarantine/psychology', '*Receptors, Glucocorticoid/genetics/metabolism', '*Serotonin Plasma Membrane Transport Proteins/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36114180/
840,SLC6A4,34910986,Sex-dependent DNA hypermethylation of SLC6A4 in patients with schizophrenia.,"['Liu L', 'Hu Y', 'Lu Y', 'Hu L', 'Gao C', 'Nie S']","['Adult', 'CpG Islands', '*DNA Methylation', 'Female', 'Humans', 'Male', 'Middle Aged', 'Schizophrenia/*genetics/pathology', 'Serotonin Plasma Membrane Transport Proteins/*genetics', 'Sex Factors']",https://pubmed.ncbi.nlm.nih.gov/34910986/
841,ABL1,32289275,Response and Resistance to BCR-ABL1-Targeted Therapies.,"['Braun TP', 'Eide CA', 'Druker BJ']","['Drug Resistance, Neoplasm/*genetics', 'Fusion Proteins, bcr-abl/*antagonists & inhibitors/*genetics', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy/genetics/pathology', '*Molecular Targeted Therapy', 'Protein Kinase Inhibitors/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/32289275/
842,ABL1,30370478,Chronic Myeloid Leukemia: Beyond BCR-ABL1.,"['Zhou T', 'Medeiros LJ', 'Hu S']","['Fusion Proteins, bcr-abl/*genetics', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*diagnosis/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/30370478/
843,ABL1,31644323,BCR-ABL1-like B-Acute Lymphoblastic Leukemia/Lymphoma: A Comprehensive Review.,"['Jain S', 'Abraham A']","['Fusion Proteins, bcr-abl/genetics', 'Humans', 'Mutation', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/*diagnosis/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/31644323/
844,ABL1,39214096,Overcoming clinical BCR-ABL1 compound mutant resistance with combined ponatinib and asciminib therapy.,"['Eide CA', 'Brewer D', 'Xie T', 'Schultz AR', 'Savage SL', 'Muratcioglu S', 'Merz N', 'Press RD', ""O'Hare T"", 'Jacob T', 'Vu TQ', 'Tognon CE', 'Macey TA', 'Kuriyan J', 'Kalodimos CG', 'Druker BJ']","['Humans', '*Pyridazines/therapeutic use/pharmacology', '*Fusion Proteins, bcr-abl/genetics/antagonists & inhibitors', '*Imidazoles/pharmacology/therapeutic use', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics', '*Drug Resistance, Neoplasm/genetics/drug effects', '*Mutation', '*Protein Kinase Inhibitors/therapeutic use/pharmacology', 'Antineoplastic Combined Chemotherapy Protocols/therapeutic use/pharmacology', 'Male', 'Female', 'Niacinamide/analogs & derivatives', 'Pyrazoles']",https://pubmed.ncbi.nlm.nih.gov/39214096/
845,ABL1,35021069,"Development of asciminib, a novel allosteric inhibitor of BCR-ABL1.","['Rea D', 'Hughes TP']","['*Drug Resistance, Neoplasm/genetics', 'Fusion Proteins, bcr-abl/genetics/metabolism', 'Humans', 'Niacinamide/analogs & derivatives/pharmacology/therapeutic use', '*Protein Kinase Inhibitors/pharmacology/therapeutic use', 'Pyrazoles/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/35021069/
846,ABL1,26637844,Long-term BCR-ABL1 Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia.,"['Pinilla-Ibarz J', 'Sweet K', 'Emole J', 'Fradley M']","['Fusion Proteins, bcr-abl/*metabolism', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy/genetics/metabolism', 'Protein Kinase Inhibitors/administration & dosage/pharmacology/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/26637844/
847,ABL1,37337105,Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia.,"['Kim JC', 'Chan-Seng-Yue M', 'Ge S', 'Zeng AGX', 'Ng K', 'Gan OI', 'Garcia-Prat L', 'Flores-Figueroa E', 'Woo T', 'Zhang AXW', 'Arruda A', 'Chithambaram S', 'Dobson SM', 'Khoo A', 'Khan S', 'Ibrahimova N', 'George A', 'Tierens A', 'Hitzler J', 'Kislinger T', 'Dick JE', 'McPherson JD', 'Minden MD', 'Notta F']","['Humans', '*Fusion Proteins, bcr-abl/genetics/metabolism', 'Transcriptome/genetics', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics', 'Gene Expression Profiling', 'Cell Differentiation/genetics', 'Protein Kinase Inhibitors/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/37337105/
848,ABL1,33096322,"The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase.","['Manley PW', 'Barys L', 'Cowan-Jacob SW']","['Binding Sites', 'Cell Proliferation/*drug effects', 'Drug Resistance, Neoplasm/*drug effects/genetics', '*Fusion Proteins, bcr-abl/antagonists & inhibitors/genetics/metabolism', 'Humans', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/enzymology/genetics/pathology', '*Mutation', 'Niacinamide/*analogs & derivatives/pharmacokinetics/therapeutic use', '*Pyrazoles/pharmacokinetics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/33096322/
849,ABL1,37183966,Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1.,"['Short NJ', 'Jabbour E', 'Macaron W', 'Ravandi F', 'Jain N', 'Kanagal-Shamanna R', 'Patel KP', 'Loghavi S', 'Haddad FG', 'Yilmaz M', 'Issa GC', 'Kebriaei P', 'Kornblau SM', 'Pelletier S', 'Flores W', 'Matthews J', 'Garris R', 'Kantarjian H']","['Humans', '*Fusion Proteins, bcr-abl/genetics', 'Prognosis', 'Reverse Transcriptase Polymerase Chain Reaction', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics/drug therapy', 'Neoplasm, Residual/diagnosis/genetics', 'High-Throughput Nucleotide Sequencing', 'Recurrence']",https://pubmed.ncbi.nlm.nih.gov/37183966/
850,ABL1,32270699,Basic knowledge on BCR-ABL1-positive extracellular vesicles.,"['Jurj A', 'Pasca S', 'Teodorescu P', 'Tomuleasa C', 'Berindan-Neagoe I']","['Extracellular Vesicles/*genetics', 'Fusion Proteins, bcr-abl/*genetics', 'Humans', 'K562 Cells', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics/pathology', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/32270699/
851,ABL1,23575066,BCR-ABL1 in leukemia: disguise master outplays riding shotgun.,"['Rana A', 'Ali GM', 'Ali S', 'Khan A', 'Mansoor S', 'Malik S', 'Farooqi AA']","['Disease Progression', 'Drug Resistance, Neoplasm/genetics', 'Fusion Proteins, bcr-abl/*genetics/*metabolism', 'Humans', 'Leukemia/drug therapy/*genetics/*metabolism', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/23575066/
852,ABL1,38153913,Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.,"['Bastian L', 'Beder T', 'Barz MJ', 'Bendig S', 'Bartsch L', 'Walter W', 'Wolgast N', 'Brandl B', 'Rohrandt C', 'Hansen BT', 'Hartmann AM', 'Iben K', 'Das Gupta D', 'Denker M', 'Zimmermann J', 'Wittig M', 'Chitadze G', 'Neumann M', 'Schneller F', 'Fiedler W', 'Steffen B', 'Stelljes M', 'Faul C', 'Schwartz S', 'Muller FJ', 'Cario G', 'Harder L', 'Haferlach C', 'Pfeifer H', 'Gokbuget N', 'Bruggemann M', 'Baldus CD']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Humans', 'Middle Aged', 'Young Adult', 'Acute Disease', 'Chromosome Deletion', '*Fusion Proteins, bcr-abl/genetics', 'Genomics', 'In Situ Hybridization, Fluorescence', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics']",https://pubmed.ncbi.nlm.nih.gov/38153913/
853,ABL1,37660636,A rare BCR-ABL1 transcript in chronic myeloid leukemia: Case report and literature review.,"['Zhao ZY', 'Tang N', 'Lin LE']","['Male', 'Humans', 'Young Adult', 'Adult', '*Fusion Proteins, bcr-abl/genetics', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis/drug therapy/genetics', 'Blast Crisis/genetics/drug therapy', 'Prognosis', 'Protein Kinase Inhibitors']",https://pubmed.ncbi.nlm.nih.gov/37660636/
854,ABL1,22672996,ABL1 joins the cadre of spindle orientation machinery.,"['Matsumura S', 'Toyoshima F']","['Cell Division', 'Humans', 'Integrin beta1/metabolism', 'Proto-Oncogene Proteins c-abl/antagonists & inhibitors/genetics/*metabolism', 'RNA Interference', 'Signal Transduction', 'Spindle Apparatus/*physiology']",https://pubmed.ncbi.nlm.nih.gov/22672996/
855,ABL1,38643492,BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.,"['Leyte-Vidal A', 'Garrido Ruiz D', 'DeFilippis R', 'Leske IB', 'Rea D', 'Phan S', 'Miller KB', 'Hu F', 'Mase A', 'Shan Y', 'Hantschel O', 'Jacobson MP', 'Shah NP']","['Humans', '*Drug Resistance, Neoplasm/genetics', '*Protein Kinase Inhibitors/pharmacology/therapeutic use', '*Fusion Proteins, bcr-abl/genetics/chemistry', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics', 'Mutation', 'Adenosine Triphosphate/metabolism', 'Proto-Oncogene Proteins c-abl/genetics/metabolism/chemistry', 'Niacinamide/analogs & derivatives', 'Pyrazoles']",https://pubmed.ncbi.nlm.nih.gov/38643492/
856,ABL1,33038988,CML - Not only BCR-ABL1 matters.,"['Rinke J', 'Hochhaus A', 'Ernst T']","['*DNA (Cytosine-5-)-Methyltransferases/biosynthesis/genetics', 'DNA Methyltransferase 3A', '*DNA-Binding Proteins/biosynthesis/genetics', 'Dioxygenases', '*Epigenesis, Genetic', '*Fusion Proteins, bcr-abl/biosynthesis/genetics', '*Gene Expression Regulation, Leukemic', 'Humans', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics/metabolism/pathology', '*Proto-Oncogene Proteins/biosynthesis/genetics', '*Repressor Proteins/biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/33038988/
857,PDGFRB,29434033,PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia.,"['Zhang Y', 'Gao Y', 'Zhang H', 'Zhang J', 'He F', 'Hnizda A', 'Qian M', 'Liu X', 'Gocho Y', 'Pui CH', 'Cheng T', 'Wang Q', 'Yang JJ', 'Zhu X', 'Liu X']","['Angiogenic Proteins/genetics', 'Antineoplastic Agents/*pharmacology/therapeutic use', 'Cell Line, Tumor', 'Child, Preschool', 'Drug Resistance, Neoplasm/*genetics', 'Humans', 'Male', '*Mutation', 'Oncogene Proteins, Fusion', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/*genetics/metabolism/pathology', 'Protein Kinase Inhibitors/*pharmacology/therapeutic use', 'Receptor, Platelet-Derived Growth Factor beta/*genetics', 'Recurrence', 'Treatment Outcome', 'Whole Genome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/29434033/
858,PDGFRB,32068648,B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review.,"['Sakurai Y', 'Sarashina T', 'Toriumi N', 'Hatakeyama N', 'Kanayama T', 'Imamura T', 'Osumi T', 'Ohki K', 'Kiyokawa N', 'Azuma H']","['Child', 'Combined Modality Therapy', 'Female', 'Hematopoietic Stem Cell Transplantation/*methods', 'Humans', 'Imatinib Mesylate/*therapeutic use', 'Oncogene Proteins, Fusion/*genetics', 'Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics/pathology/*therapy', 'Prognosis', 'Protein Kinase Inhibitors/*therapeutic use', 'Receptor, Platelet-Derived Growth Factor beta/*genetics', 'Trans-Activators/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32068648/
859,PDGFRB,23489324,"Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.","['Savage N', 'George TI', 'Gotlib J']","['Eosinophilia/*complications/*genetics', 'Humans', 'Myeloproliferative Disorders/*complications/*genetics/therapy', 'Oncogene Proteins, Fusion/genetics', 'Receptor, Fibroblast Growth Factor, Type 1/*genetics', 'Receptor, Platelet-Derived Growth Factor alpha/*genetics', 'Receptor, Platelet-Derived Growth Factor beta/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23489324/
860,PDGFRB,36788105,"PDGFRB and NOTCH3 Mutations are Detectable in a Wider Range of Pericytic Tumors, Including Myopericytomas, Angioleiomyomas, Glomus Tumors, and Their Combined Tumors.","['Iwamura R', 'Komatsu K', 'Kusano M', 'Kubo C', 'Inaba Y', 'Shiba E', 'Nawata A', 'Tajiri R', 'Matsuyama A', 'Matoba H', 'Koga K', 'Takeda M', 'Itami H', 'Hisaoka M']","['Humans', '*Myopericytoma/genetics/pathology', '*Angiomyoma/genetics/pathology', '*Glomus Tumor/genetics/pathology', '*Myofibroma/genetics', 'Receptor, Platelet-Derived Growth Factor beta/genetics', 'Mutation', 'Receptor, Notch3/genetics']",https://pubmed.ncbi.nlm.nih.gov/36788105/
861,PDGFRB,21938754,Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm.,"['Chmielecki J', 'Peifer M', 'Viale A', 'Hutchinson K', 'Giltnane J', 'Socci ND', 'Hollis CJ', 'Dean RS', 'Yenamandra A', 'Jagasia M', 'Kim AS', 'Dave UP', 'Thomas RK', 'Pao W']","['Adult', 'Algorithms', 'Amino Acid Sequence', 'Base Sequence', 'Cell Line, Tumor', 'Computational Biology', 'Cytoskeletal Proteins', 'Gene Order', 'HEK293 Cells', 'Humans', 'K562 Cells', 'Karyotyping', 'Male', 'Molecular Sequence Data', 'Myeloproliferative Disorders/complications/*genetics', 'Oncogene Proteins, Fusion/*genetics', 'Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/complications/*genetics', 'Protein-Tyrosine Kinases/*genetics', 'Sequence Alignment', 'Sequence Analysis, DNA', '*Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/21938754/
862,PDGFRB,36753059,Novel ANKRD26 and PDGFRB gene mutations in pediatric case of non-Langerhans cell histiocytosis: Case report and literature review.,"['Fayiga FF', 'Reyes-Hadsall SC', 'Moreno BA', 'Oh KS', 'Brathwaite C', 'Duarte AM']","['Child', 'Female', 'Humans', 'Infant', '*Histiocytosis, Non-Langerhans-Cell/genetics/pathology', 'Intercellular Signaling Peptides and Proteins/genetics', 'Mutation', 'Proto-Oncogene Proteins B-raf/genetics', '*Receptor, Platelet-Derived Growth Factor beta/genetics', 'Soft Tissue Neoplasms', 'Xanthomatosis']",https://pubmed.ncbi.nlm.nih.gov/36753059/
863,PDGFRB,33367495,"Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.","['Pozdnyakova O', 'Orazi A', 'Kelemen K', 'King R', 'Reichard KK', 'Craig FE', 'Quintanilla-Martinez L', 'Rimsza L', 'George TI', 'Horny HP', 'Wang SA']","['Diagnosis, Differential', '*Eosinophilia/etiology/pathology', '*Hematologic Neoplasms/diagnosis/genetics/pathology', 'Humans', 'Leukemia, Myeloid, Acute/diagnosis/genetics/pathology', 'Myelodysplastic Syndromes/diagnosis/genetics/pathology', 'Oncogene Proteins, Fusion/genetics', 'Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics/pathology', 'Receptor, Fibroblast Growth Factor, Type 1/genetics', 'Receptor, Platelet-Derived Growth Factor alpha/genetics', 'Receptor, Platelet-Derived Growth Factor beta/genetics']",https://pubmed.ncbi.nlm.nih.gov/33367495/
864,PDGFRB,36657267,Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children.,"['Berking AC', 'Flaadt T', 'Behrens YL', 'Yoshimi A', 'Leipold A', 'Holzer U', 'Lang P', 'Quintanilla-Martinez L', 'Schlegelberger B', 'Reiter A', 'Niemeyer C', 'Strahm B', 'Gohring G']","['Adult', 'Humans', 'Child', 'Receptor, Platelet-Derived Growth Factor beta/genetics', 'Comparative Genomic Hybridization', '*Myeloproliferative Disorders/genetics/drug therapy', '*Eosinophilia/genetics', '*Neoplasms', 'Oncogene Proteins, Fusion/genetics', 'DNA-Binding Proteins/genetics', 'Receptor, Fibroblast Growth Factor, Type 1/genetics']",https://pubmed.ncbi.nlm.nih.gov/36657267/
865,PDGFRB,28298627,Novel mutations of PDGFRB cause primary familial brain calcification in Chinese families.,"['Wang C', 'Yao XP', 'Chen HT', 'Lai JH', 'Guo XX', 'Su HZ', 'Dong EL', 'Zhang QJ', 'Wang N', 'Chen WJ']","['Amino Acid Sequence', 'Asian People/*genetics', 'Base Sequence', 'Brain/diagnostic imaging/*pathology', 'Calcinosis/diagnostic imaging/*genetics', 'Family', 'Female', 'Humans', 'Male', 'Mutation/*genetics', 'Pedigree', 'Proto-Oncogene Proteins c-sis/chemistry/*genetics', 'Xenotropic and Polytropic Retrovirus Receptor']",https://pubmed.ncbi.nlm.nih.gov/28298627/
866,PDGFRB,28725989,Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.,"['Jawhar M', 'Naumann N', 'Schwaab J', 'Baurmann H', 'Casper J', 'Dang TA', 'Dietze L', 'Dohner K', 'Hanel A', 'Lathan B', 'Link H', 'Lotfi S', 'Maywald O', 'Mielke S', 'Muller L', 'Platzbecker U', 'Prummer O', 'Thomssen H', 'Topelt K', 'Panse J', 'Vieler T', 'Hofmann WK', 'Haferlach T', 'Haferlach C', 'Fabarius A', 'Hochhaus A', 'Cross NCP', 'Reiter A', 'Metzgeroth G']","['Abnormal Karyotype', 'Adult', 'Aged', 'Aged, 80 and over', '*Blast Crisis/drug therapy/genetics/mortality/pathology', 'Disease-Free Survival', '*Eosinophilia/drug therapy/genetics/mortality/pathology', 'Female', 'Follow-Up Studies', '*Gene Rearrangement', '*Hematologic Neoplasms/drug therapy/genetics/mortality/pathology', 'Humans', 'Imatinib Mesylate/*administration & dosage', 'Male', 'Middle Aged', 'Receptor, Platelet-Derived Growth Factor beta/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Risk Factors', 'Sex Factors', 'Survival Rate']",https://pubmed.ncbi.nlm.nih.gov/28725989/
867,PDGFRB,31566039,A Distinctive Genomic and Immunohistochemical Profile for NOTCH3 and PDGFRB in Myofibroma With Diagnostic and Therapeutic Implications.,"['Koo SC', 'Janeway KA', 'Harris MH', 'Fryer CJ', 'Aster JC', 'Al-Ibraheemi A', 'Church AJ']","['Adolescent', 'Bone Neoplasms/genetics/*metabolism', 'Child', 'Child, Preschool', 'DNA Copy Number Variations', 'Female', 'Humans', 'Immunohistochemistry', 'Infant', 'Male', 'Myofibroma/genetics/*metabolism', 'Parotid Neoplasms/genetics/*metabolism', 'Receptor, Notch3/genetics/*metabolism', 'Receptor, Platelet-Derived Growth Factor beta/genetics/*metabolism', 'Soft Tissue Neoplasms/genetics/*metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/31566039/
868,PDGFRB,24772479,Identification and functional characterization of imatinib-sensitive DTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/lymphoid neoplasms.,"['Gosenca D', 'Kellert B', 'Metzgeroth G', 'Haferlach C', 'Fabarius A', 'Schwaab J', 'Kneba M', 'Scheid C', 'Topelt K', 'Erben P', 'Haferlach T', 'Cross NC', 'Hofmann WK', 'Seifarth W', 'Reiter A']","['Adult', 'Amino Acid Sequence', 'Antineoplastic Agents/*therapeutic use', 'Benzamides/*therapeutic use', 'Chromosomes, Human, Pair 5/*genetics', 'Chronic Disease', 'DNA-Binding Proteins/*genetics/metabolism', 'Eosinophilia/drug therapy/*genetics', '*Gene Fusion', 'Humans', 'Imatinib Mesylate', 'Intracellular Signaling Peptides and Proteins', 'Leukemia/drug therapy/*genetics', 'Male', 'Microfilament Proteins/*genetics/metabolism', 'Molecular Sequence Data', 'Myeloproliferative Disorders/drug therapy/*genetics', 'Piperazines/*therapeutic use', 'Pyrimidines/*therapeutic use', 'Receptor, Platelet-Derived Growth Factor beta/*genetics/metabolism', 'Remission Induction', '*Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/24772479/
869,PDGFRB,30103666,Infantile Myofibromatosis With Intracranial Extradural Involvement and PDGFRB Mutation: A Case Report and Review of the Literature.,"['Al Qawahmed R', 'Sawyer SL', 'Vassilyadi M', 'Qin W', 'Boycott KM', 'Michaud J']","['Adolescent', 'Female', 'Germ-Line Mutation', 'Humans', 'Myofibromatosis/*congenital/diagnostic imaging/genetics/pathology', 'Point Mutation', 'Receptor, Platelet-Derived Growth Factor beta/*genetics', 'Soft Tissue Neoplasms/diagnostic imaging/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/30103666/
870,PDGFRB,37847945,A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification.,"['Gao Y', 'Wu C', 'Huang J', 'Huang Z', 'Jin Z', 'Guo S', 'Tao X', 'Lu S', 'Zhang J', 'Zhang F', 'Zhai Y', 'Shi R', 'Ye P', 'Wu J']","['Humans', '*ADAM12 Protein/genetics/metabolism', 'Alkaloids/pharmacology', '*Biomarkers, Tumor/genetics/metabolism', 'Cell Line, Tumor', 'Computational Biology/methods', 'Data Mining/methods', 'Gene Expression Regulation, Neoplastic', 'Matrines', 'Prognosis', 'Quinolizines/pharmacology', '*Receptor, Platelet-Derived Growth Factor beta/genetics/metabolism', '*Stomach Neoplasms/genetics/metabolism/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/37847945/
871,PDGFRB,31204374,miRNA-PDGFRB/HIF1A-lncRNA CTEPHA1 Network Plays Important Roles in the Mechanism of Chronic Thromboembolic Pulmonary Hypertension.,"['Wang M', 'Gu S', 'Liu Y', 'Yang Y', 'Yan J', 'Zhang X', 'An X', 'Gao J', 'Hu X', 'Su P']","['Chronic Disease', 'Gene Expression Profiling', 'Gene Regulatory Networks', 'Humans', 'Hypertension, Pulmonary/etiology/*genetics/metabolism', 'Hypoxia-Inducible Factor 1, alpha Subunit/*genetics/metabolism', 'MicroRNAs/*genetics/metabolism', 'Proto-Oncogene Proteins c-sis/*genetics/metabolism', 'Pulmonary Embolism/*complications/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31204374/
872,PDGFRB,28147311,SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB.,"['Song G', 'Liu K', 'Yang X', 'Mu B', 'Yang J', 'He L', 'Hu X', 'Li Q', 'Zhao Y', 'Cai X', 'Feng G']","['Carcinogenesis/genetics', 'Cell Line, Tumor', 'Cell Movement/genetics', 'Cell Proliferation/*genetics', 'Cell Survival/genetics', 'Disease Progression', 'Esophageal Neoplasms/*genetics/pathology', 'Fibronectins/*biosynthesis', 'Gene Expression Regulation, Neoplastic/*genetics', 'Humans', 'Lymphatic Metastasis/genetics/pathology', 'Matrix Attachment Region Binding Proteins/*genetics/metabolism', 'Neoplasm Invasiveness/genetics/pathology', 'RNA Interference', 'RNA, Small Interfering/genetics', 'Receptor, Platelet-Derived Growth Factor beta/*biosynthesis', 'Transcriptional Activation', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/28147311/
873,PDGFRB,23769926,"Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.","['Wang X', 'Zhang Z', 'Liu W', 'Xiong Y', 'Sun W', 'Huang X', 'Jiang Y', 'Ni G', 'Sun W', 'Zhou L', 'Wu L', 'Zhu W', 'Li H', 'Liu X', 'Xu G']","['Adenosine Triphosphatases', 'Adult', 'Alleles', 'Asian People/*genetics', 'Case-Control Studies', 'China', 'Epistasis, Genetic', 'Female', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Matrix Metalloproteinase 3/*genetics', 'Middle Aged', 'Moyamoya Disease/*genetics', '*Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Receptor, Platelet-Derived Growth Factor beta/*genetics', 'Tissue Inhibitor of Metalloproteinase-2/*genetics', 'Ubiquitin-Protein Ligases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23769926/
874,SYK,37897551,Itaconate inhibits SYK through alkylation and suppresses inflammation against hvKP induced intestinal dysbiosis.,"['Li Y', 'Xu Y', 'Li W', 'Li J', 'Wu W', 'Kang J', 'Jiang H', 'Liu P', 'Liu J', 'Gong W', 'Li X', 'Ni C', 'Liu M', 'Chen L', 'Li S', 'Wu X', 'Zhao Y', 'Ren J']","['Humans', '*Klebsiella pneumoniae/genetics', 'Dysbiosis/drug therapy', '*Klebsiella Infections/drug therapy', 'Inflammation/drug therapy', 'Alkylation', 'Syk Kinase']",https://pubmed.ncbi.nlm.nih.gov/37897551/
875,SYK,36306731,Microglia are SYK of Abeta and cell debris.,"['Schafer DP', 'Stillman JM']","['Humans', '*Microglia/metabolism', '*Neurodegenerative Diseases/metabolism', 'Macrophages', 'Syk Kinase/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36306731/
876,SYK,23994797,Syk inhibitors.,"['Chihara K', 'Kimura Y', 'Honjo C', 'Takeuchi K', 'Sada K']","['Aminopyridines', 'Humans', 'Intracellular Signaling Peptides and Proteins/*antagonists & inhibitors/physiology', 'Mast Cells/enzymology', 'Morpholines', 'Oxazines/therapeutic use', 'Protein-Tyrosine Kinases/*antagonists & inhibitors/physiology', 'Pyridines/therapeutic use', 'Pyrimidines', 'Syk Kinase']",https://pubmed.ncbi.nlm.nih.gov/23994797/
877,SYK,36331249,"Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib.","['Cooper N', 'Ghanima W', 'Hill QA', 'Nicolson PL', 'Markovtsov V', 'Kessler C']","['Humans', 'Aminopyridines/pharmacology/therapeutic use', '*COVID-19', '*Oxazines/pharmacology', 'Protein Kinase Inhibitors/pharmacology', '*Purpura, Thrombocytopenic, Idiopathic/drug therapy', '*Pyridines/pharmacology', 'Syk Kinase']",https://pubmed.ncbi.nlm.nih.gov/36331249/
878,SYK,22425453,Pyrazine-based Syk kinase inhibitors.,"['Forns P', 'Esteve C', 'Taboada L', 'Alonso JA', 'Orellana A', 'Maldonado M', 'Carreno C', 'Ramis I', 'Lopez M', 'Miralpeix M', 'Vidal B']","['Adamantane/analogs & derivatives/chemistry/pharmacology', 'Cell Line, Tumor', 'Crystallography, X-Ray', 'Enzyme Activation/drug effects', 'Enzyme Inhibitors/pharmacology', 'Humans', 'Inhibitory Concentration 50', 'Intracellular Signaling Peptides and Proteins/*antagonists & inhibitors', 'Molecular Structure', 'Protein-Tyrosine Kinases/*antagonists & inhibitors', 'Pyrazines/*chemical synthesis/chemistry/*pharmacology', 'Syk Kinase']",https://pubmed.ncbi.nlm.nih.gov/22425453/
879,SYK,33486152,Trem2 mediated Syk-dependent ROS amplification is essential for osteoclastogenesis in periodontitis microenvironment.,"['Weng Y', 'Wang H', 'Li L', 'Feng Y', 'Xu S', 'Wang Z']","['Humans', 'Membrane Glycoproteins/genetics', 'Osteoclasts', '*Osteogenesis', '*Periodontitis/genetics', 'RANK Ligand', 'Reactive Oxygen Species', 'Receptors, Immunologic/genetics', 'Syk Kinase/genetics']",https://pubmed.ncbi.nlm.nih.gov/33486152/
880,SYK,35398488,SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies.,"['Leveille E', 'Chan LN', 'Mirza AS', 'Kume K', 'Muschen M']","['Adult', '*Autoimmune Diseases', 'Autoimmunity', 'Humans', '*Leukemia, Lymphocytic, Chronic, B-Cell/pathology', 'Phosphatidylinositol 3-Kinases/metabolism', 'Receptors, Antigen, B-Cell', 'Syk Kinase', 'ZAP-70 Protein-Tyrosine Kinase']",https://pubmed.ncbi.nlm.nih.gov/35398488/
881,SYK,37984216,Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK).,"['Wang Z', 'Qu S', 'Yuan J', 'Tian W', 'Xu J', 'Tao R', 'Sun S', 'Lu T', 'Tang W', 'Zhu Y']","['Humans', 'Syk Kinase', '*Protein Kinase Inhibitors/pharmacology/therapeutic use', '*Autoimmune Diseases/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/37984216/
882,PDGFRA,20129251,"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.","['Verhaak RG', 'Hoadley KA', 'Purdom E', 'Wang V', 'Qi Y', 'Wilkerson MD', 'Miller CR', 'Ding L', 'Golub T', 'Mesirov JP', 'Alexe G', 'Lawrence M', ""O'Kelly M"", 'Tamayo P', 'Weir BA', 'Gabriel S', 'Winckler W', 'Gupta S', 'Jakkula L', 'Feiler HS', 'Hodgson JG', 'James CD', 'Sarkaria JN', 'Brennan C', 'Kahn A', 'Spellman PT', 'Wilson RK', 'Speed TP', 'Gray JW', 'Meyerson M', 'Getz G', 'Perou CM', 'Hayes DN']","['Adult', 'Aged', 'Brain Neoplasms/classification/*genetics/pathology', 'DNA Mutational Analysis', 'ErbB Receptors/*genetics', 'Factor Analysis, Statistical', 'Gene Dosage', 'Gene Expression', 'Gene Expression Profiling', 'Glioblastoma/classification/*genetics/pathology', 'Humans', 'Isocitrate Dehydrogenase/*genetics', 'Middle Aged', 'Mutation', 'Neurofibromatosis 1/*genetics', 'Oligonucleotide Array Sequence Analysis', 'Prognosis', 'Receptor, Platelet-Derived Growth Factor alpha/*genetics']",https://pubmed.ncbi.nlm.nih.gov/20129251/
883,PDGFRA,28187274,PDGFRA Antibody for Soft Tissue Sarcoma.,"['Klug LR', 'Heinrich MC']","['Antibodies, Monoclonal/*therapeutic use', 'Antineoplastic Agents/*therapeutic use', 'Clinical Trials, Phase II as Topic', 'Drug Approval', 'Humans', 'Neoplasms/*drug therapy', 'Randomized Controlled Trials as Topic']",https://pubmed.ncbi.nlm.nih.gov/28187274/
884,PDGFRA,35105853,EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.,"['Gai QJ', 'Fu Z', 'He J', 'Mao M', 'Yao XX', 'Qin Y', 'Lan X', 'Zhang L', 'Miao JY', 'Wang YX', 'Zhu J', 'Yang FC', 'Lu HM', 'Yan ZX', 'Chen FL', 'Shi Y', 'Ping YF', 'Cui YH', 'Zhang X', 'Liu X', 'Yao XH', 'Lv SQ', 'Bian XW', 'Wang Y']","['Biomarkers, Tumor/genetics/*metabolism', 'Cell Line, Tumor', 'Glioblastoma/diagnosis/genetics/*metabolism', 'Humans', 'Neoplasm Proteins/genetics/*metabolism', 'Platelet-Derived Growth Factor/genetics/*metabolism', 'Prognosis', 'Receptor, EphA2/genetics/*metabolism', 'Receptor, Platelet-Derived Growth Factor alpha/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/35105853/
885,PDGFRA,33465704,Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial.,"['Jones RL', 'Serrano C', 'von Mehren M', 'George S', 'Heinrich MC', 'Kang YK', 'Schoffski P', 'Cassier PA', 'Mir O', 'Chawla SP', 'Eskens FALM', 'Rutkowski P', 'Tap WD', 'Zhou T', 'Roche M', 'Bauer S']","['Adult', 'Aged', 'Aged, 80 and over', 'Antineoplastic Agents/adverse effects/*therapeutic use', 'Female', 'Gastrointestinal Neoplasms/*drug therapy/genetics/mortality/pathology', 'Gastrointestinal Stromal Tumors/*drug therapy/genetics/mortality/secondary', 'Humans', 'Male', 'Middle Aged', '*Mutation', 'Progression-Free Survival', 'Protein Kinase Inhibitors/adverse effects/*therapeutic use', 'Pyrazoles/adverse effects/*therapeutic use', 'Pyrroles/adverse effects/*therapeutic use', 'Receptor, Platelet-Derived Growth Factor alpha/*genetics', 'Time Factors', 'Triazines/adverse effects/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/33465704/
886,PDGFRA,32615108,"Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.","['Heinrich MC', 'Jones RL', 'von Mehren M', 'Schoffski P', 'Serrano C', 'Kang YK', 'Cassier PA', 'Mir O', 'Eskens F', 'Tap WD', 'Rutkowski P', 'Chawla SP', 'Trent J', 'Tugnait M', 'Evans EK', 'Lauz T', 'Zhou T', 'Roche M', 'Wolf BB', 'Bauer S', 'George S']","['Aged', 'Female', 'Follow-Up Studies', 'Gastrointestinal Neoplasms/*drug therapy/genetics/pathology', 'Gastrointestinal Stromal Tumors/*drug therapy/genetics/pathology', 'Humans', 'Male', 'Middle Aged', '*Mutation', 'Prognosis', 'Pyrazoles/*therapeutic use', 'Pyrroles/*therapeutic use', 'Receptor, Platelet-Derived Growth Factor alpha/*genetics', 'Triazines/*therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/32615108/
887,PDGFRA,25975287,PDGFRA-mutant syndrome.,"['Ricci R', 'Martini M', 'Cenci T', 'Carbone A', 'Lanza P', 'Biondi A', 'Rindi G', 'Cassano A', 'Larghi A', 'Persiani R', 'Larocca LM']","['Adult', 'Aged', 'Colonic Polyps/*genetics/pathology', 'Female', 'Gastrointestinal Neoplasms/*genetics/pathology', 'Gastrointestinal Stromal Tumors/*genetics/pathology', 'Humans', 'Male', 'Middle Aged', '*Mutation', 'Pedigree', 'Receptor, Platelet-Derived Growth Factor alpha/*genetics', 'Syndrome']",https://pubmed.ncbi.nlm.nih.gov/25975287/
888,PDGFRA,26257279,Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.,"['Weyand AC', 'Yanik GA', 'Bailey NG', 'Wu YM', 'Mody RJ', 'Castle VP']","['Child, Preschool', 'Female', 'Humans', 'Hypereosinophilic Syndrome/*drug therapy/genetics', 'Imatinib Mesylate/*therapeutic use', 'Protein Kinase Inhibitors/therapeutic use', 'Receptor, Platelet-Derived Growth Factor alpha/*analysis', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/26257279/
889,PDGFRA,26095243,BCR-PDGFRA fusion in a T lymphoblastic leukemia/lymphoma.,"['Yigit N', 'Wu WW', 'Subramaniyam S', 'Mathew S', 'Geyer JT']","['Chromosome Banding', 'Chromosomes, Human, Pair 22/genetics', 'Chromosomes, Human, Pair 4/genetics', 'Humans', 'In Situ Hybridization, Fluorescence', 'Karyotype', 'Male', 'Middle Aged', 'Oncogene Proteins, Fusion/*genetics', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/*genetics', 'Proto-Oncogene Proteins c-bcr/*genetics', 'Receptor, Platelet-Derived Growth Factor alpha/*genetics', 'Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/26095243/
890,PDGFRA,34297434,"Myxoid glioneuronal tumor, PDGFRA p.K385L-mutant, arising in midbrain tectum with multifocal CSF dissemination.","['Kleinschmidt-DeMasters BK', 'Chiang J', 'Donson AM', 'Borges T', 'Gilani A']","['*Brain Neoplasms/pathology', '*Central Nervous System Neoplasms/pathology', 'Humans', 'Mesencephalon/pathology', '*Neoplasms, Neuroepithelial/pathology', 'Septum Pellucidum/pathology']",https://pubmed.ncbi.nlm.nih.gov/34297434/
891,PDGFRA,21605429,The role of mutational analysis of KIT and PDGFRA in gastrointestinal stromal tumors in a clinical setting.,"['Maleddu A', 'Pantaleo MA', 'Nannini M', 'Biasco G']","['DNA Mutational Analysis', 'Gastrointestinal Stromal Tumors/diagnosis/drug therapy/*enzymology/*genetics', 'Humans', 'Prognosis', 'Proto-Oncogene Proteins c-kit/*genetics', 'Receptor, Platelet-Derived Growth Factor alpha/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21605429/
892,PDGFRA,38344849,KIT/PDGFRA inhibitors for the treatment of gastrointestinal stromal tumors: getting to the gist of the problem.,"['Cicala CM', 'Olivares-Rivas I', 'Aguirre-Carrillo JA', 'Serrano C']","['Humans', 'Imatinib Mesylate/pharmacology/therapeutic use', '*Gastrointestinal Stromal Tumors/drug therapy/genetics', 'Proto-Oncogene Proteins c-kit/genetics/metabolism', 'Enzyme Inhibitors/pharmacology', 'Mutation', 'Tyrosine/genetics/therapeutic use', '*Antineoplastic Agents/pharmacology/therapeutic use', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', 'Drug Resistance, Neoplasm/genetics']",https://pubmed.ncbi.nlm.nih.gov/38344849/
893,PDGFRA,36613947,Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines.,"['Hamada T', 'Yokoyama S', 'Akahane T', 'Matsuo K', 'Tanimoto A']","['Humans', '*Gene Editing/methods', 'CRISPR-Cas Systems/genetics', '*Glioblastoma/genetics', 'Ribonucleoproteins/genetics/metabolism', 'Cell Line', 'Nucleotides/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36613947/
894,PDGFRA,37610648,"PDGFRA, KIT, and KDR Gene Amplification in Glioblastoma: Heterogeneity and Clinical Significance.","['Carlotto BS', 'Trevisan P', 'Provenzi VO', 'Soares FP', 'Rosa RFM', 'Varella-Garcia M', 'Zen PRG']","['Humans', 'Middle Aged', 'Central Nervous System', 'Chromosome Aberrations', 'Clinical Relevance', 'Gene Amplification', '*Glioblastoma/genetics', 'Receptor Protein-Tyrosine Kinases', 'Vascular Endothelial Growth Factor Receptor-2/genetics', 'Receptor, Platelet-Derived Growth Factor alpha/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37610648/
895,KIT,26900112,Travel Medical Kit.,"['Terry AC', 'Haulman NJ']","['Altitude Sickness/prevention & control', 'Antiemetics/therapeutic use', 'Antimalarials/therapeutic use', 'Drug Prescriptions', 'Female', 'First Aid', 'Gastrointestinal Agents/therapeutic use', 'Health Records, Personal', 'Histamine Antagonists/therapeutic use', 'Humans', 'Hypersensitivity/prevention & control', 'Insect Repellents', 'Malaria/prevention & control', 'Male', 'Motion Sickness/prevention & control', 'Ophthalmic Solutions', 'Respiratory Tract Infections/prevention & control', 'Sexually Transmitted Diseases/prevention & control', 'Skin Diseases/prevention & control', 'Sunscreening Agents/therapeutic use', 'Travel', '*Travel Medicine', 'Urinary Tract Infections/prevention & control', ""Women's Health""]",https://pubmed.ncbi.nlm.nih.gov/26900112/
896,KIT,27207321,Beyond KIT in CBF-AML: chromatin and cohesin.,['Rau RE'],"['Cell Cycle Proteins', '*Chromatin', 'Chromosomal Proteins, Non-Histone', 'Core Binding Factors/genetics', '*Leukemia, Myeloid, Acute', 'Cohesins']",https://pubmed.ncbi.nlm.nih.gov/27207321/
897,KIT,31659338,Diagnostic kit for rice blight resistance.,"['Eom JS', 'Luo D', 'Atienza-Grande G', 'Yang J', 'Ji C', 'Thi Luu V', 'Huguet-Tapia JC', 'Char SN', 'Liu B', 'Nguyen H', 'Schmidt SM', 'Szurek B', 'Vera Cruz C', 'White FF', 'Oliva R', 'Yang B', 'Frommer WB']","['Bacterial Proteins/genetics', 'Binding Sites', 'CRISPR-Cas Systems', 'Databases, Genetic', '*Disease Resistance', 'Gene Editing', 'Gene Expression Regulation, Plant', 'Membrane Transport Proteins/chemistry/*genetics/metabolism', 'Mutation', 'Oryza/genetics/*growth & development/microbiology', 'Plant Proteins/genetics', 'Promoter Regions, Genetic', 'Sequence Analysis, DNA', 'Transcription Activator-Like Effectors/*metabolism', 'Xanthomonas/metabolism/*pathogenicity']",https://pubmed.ncbi.nlm.nih.gov/31659338/
898,KIT,23366136,Asphyxia screening kit.,"['Zabidi A', 'Khuan LY', 'Mansor W']","['Algorithms', 'Asphyxia Neonatorum/*diagnosis/physiopathology', 'Crying/physiology', 'Early Diagnosis', 'Humans', 'Infant, Newborn', 'Mass Screening/methods', '*Neural Networks, Computer', 'ROC Curve', '*Signal Processing, Computer-Assisted', 'User-Computer Interface']",https://pubmed.ncbi.nlm.nih.gov/23366136/
899,KIT,17607922,"C-kit, GIST, and imatinib.","['Siehl J', 'Thiel E']","['Antineoplastic Agents/pharmacology/*therapeutic use', 'Benzamides', 'Drug Resistance, Neoplasm', 'Gastrointestinal Stromal Tumors/*drug therapy/metabolism/pathology', 'Humans', 'Imatinib Mesylate', 'Indoles/therapeutic use', 'Male', 'Middle Aged', 'Piperazines/pharmacology/*therapeutic use', 'Protein Kinase Inhibitors/*therapeutic use', 'Proto-Oncogene Proteins c-kit/*drug effects/genetics', 'Pyrimidines/pharmacology/*therapeutic use', 'Pyrroles/therapeutic use', 'Sunitinib']",https://pubmed.ncbi.nlm.nih.gov/17607922/
900,KIT,18718876,Performance of the BioPlex 2200 Autoimmune Vasculitis kit.,"['Kaul R', 'Johnson K', 'Scholz H', 'Marr G']","['Antibodies, Antineutrophil Cytoplasmic/*immunology', 'Diagnosis, Differential', 'Diagnostic Equipment', 'Enzyme-Linked Immunosorbent Assay', 'Flow Cytometry', 'Glomerulonephritis/*diagnosis/immunology', 'Granulocyte Colony-Stimulating Factor/*immunology', 'Humans', 'Immunomagnetic Separation', 'Interleukin-3/*immunology', 'Peroxidase/*immunology', '*Reagent Kits, Diagnostic', 'Recombinant Fusion Proteins/*immunology', 'Recombinant Proteins', 'Reproducibility of Results', 'Sensitivity and Specificity', 'Vasculitis/*diagnosis/immunology']",https://pubmed.ncbi.nlm.nih.gov/18718876/
901,KIT,36735979,The Universal Dermatology Bandage Kit: A Succinct Collection of Supplies.,"['Hall EL', 'Ardila CE', 'Hamel RK', 'Goldberg LH']","['Humans', '*Dermatology', 'Bandages', 'Skin', 'Biopsy']",https://pubmed.ncbi.nlm.nih.gov/36735979/
902,KIT,11919418,Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts.,"['Feger F', 'Ribadeau Dumas A', 'Leriche L', 'Valent P', 'Arock M']","['Humans', 'Mastocytosis/classification/*genetics', '*Point Mutation', 'Proto-Oncogene Proteins c-kit/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11919418/
903,KIT,30707374,KIT as an Oncogenic Driver in Melanoma: An Update on Clinical Development.,"['Meng D', 'Carvajal RD']","['Antineoplastic Agents, Immunological/therapeutic use', 'Antineoplastic Combined Chemotherapy Protocols/pharmacology/*therapeutic use', 'Carcinogenesis/drug effects/*genetics', 'Clinical Trials as Topic', 'Dermatology/standards', 'Humans', 'Medical Oncology/standards', 'Melanoma/*drug therapy/genetics/pathology', 'Molecular Targeted Therapy/methods', 'Practice Guidelines as Topic', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', 'Proto-Oncogene Proteins c-kit/*antagonists & inhibitors/genetics', 'Skin Neoplasms/*drug therapy/genetics/pathology', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/30707374/
904,KIT,32608199,KIT and Melanoma: Biological Insights and Clinical Implications.,"['Pham DDM', 'Guhan S', 'Tsao H']","['Antineoplastic Agents/*therapeutic use', 'Biomarkers, Tumor/*metabolism', 'Drug Resistance, Neoplasm/*genetics', 'Female', 'Humans', 'Male', 'Melanoma/*drug therapy/genetics/*metabolism', 'Mucous Membrane/metabolism', 'Mutation', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-kit/genetics/metabolism/*therapeutic use', 'Receptor Protein-Tyrosine Kinases/genetics', 'Signal Transduction/*drug effects', 'Skin Neoplasms/*drug therapy/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/32608199/
905,KIT,31497890,Novel KIT mutation presenting as marked lentiginosis.,"['Tran AK', 'Pearce A', 'Lopez-Sanchez M', 'Perez-Jurado LA', 'Barnett C']","['Child', 'Female', 'Humans', 'Lentigo/*genetics', '*Mutation, Missense', 'Proto-Oncogene Proteins c-kit/*genetics', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/31497890/
906,KIT,24931862,Evaluation of a 'decontamination kit' in NSW.,"['Stark MM', 'Nittis M']","['DNA Contamination', 'Decontamination/*instrumentation', 'Equipment Contamination/prevention & control', 'Forensic Medicine/*instrumentation', 'Humans', 'New South Wales', '*Sex Offenses', 'Specimen Handling/*instrumentation', 'Surveys and Questionnaires']",https://pubmed.ncbi.nlm.nih.gov/24931862/
907,CSF1R,36335744,CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.,"['Wen J', 'Wang S', 'Guo R', 'Liu D']","['Humans', '*Antineoplastic Agents/chemistry/pharmacology/therapeutic use', 'Cytokines/metabolism', '*Immunotherapy/methods', '*Neoplasms/therapy', '*Receptor Protein-Tyrosine Kinases/antagonists & inhibitors', '*Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/antagonists & inhibitors', 'Tumor Microenvironment/drug effects', '*Tyrosine Kinase Inhibitors/chemistry/pharmacology/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/36335744/
908,CSF1R,28716061,Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.,"['Cannarile MA', 'Weisser M', 'Jacob W', 'Jegg AM', 'Ries CH', 'Ruttinger D']","['Antineoplastic Agents, Immunological/*therapeutic use', 'Antineoplastic Combined Chemotherapy Protocols/therapeutic use', 'Clinical Trials as Topic', 'Humans', 'Immunotherapy/*methods', 'Macrophages/drug effects', 'Neoplasms/*therapy', 'Patient Safety', 'Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/*antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/28716061/
909,CSF1R,31768065,Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.,"['Durham BH', 'Lopez Rodrigo E', 'Picarsic J', 'Abramson D', 'Rotemberg V', 'De Munck S', 'Pannecoucke E', 'Lu SX', 'Pastore A', 'Yoshimi A', 'Mandelker D', 'Ceyhan-Birsoy O', 'Ulaner GA', 'Walsh M', 'Yabe M', 'Petrova-Drus K', 'Arcila ME', 'Ladanyi M', 'Solit DB', 'Berger MF', 'Hyman DM', 'Lacouture ME', 'Erickson C', 'Saganty R', 'Ki M', 'Dunkel IJ', 'Santa-Maria Lopez V', 'Mora J', 'Haroche J', 'Emile JF', 'Decaux O', 'Geissmann F', 'Savvides SN', 'Drilon A', 'Diamond EL', 'Abdel-Wahab O']","['Adolescent', 'Adult', 'Aminopyridines/pharmacology', 'Anaplastic Lymphoma Kinase/*genetics', 'Benzothiazoles/pharmacology', 'Child', 'Child, Preschool', 'Female', 'Genome, Human', 'Hematologic Neoplasms/drug therapy/genetics/pathology', 'Histiocytosis/drug therapy/*genetics/pathology', 'Humans', 'Infant', 'Male', 'Mutation', 'Picolinic Acids/pharmacology', 'Protein Kinase Inhibitors/pharmacology', 'Proto-Oncogene Proteins c-ret/*genetics', 'Pyrazoles/pharmacology', 'Pyridines/pharmacology', 'Pyrroles/pharmacology', 'Receptor Protein-Tyrosine Kinases/genetics', 'Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/*genetics', 'Twins, Monozygotic', 'Exome Sequencing', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/31768065/
910,CSF1R,26743272,Overexpression of CSF-1R in nasopharyngeal carcinoma.,"['Huang L', 'Xu X', 'Hao Y', 'Chen J', 'Li L', 'Cheng J', 'Chen Z', 'Liang W', 'Yang J', 'Ao W', 'Hao X', 'Gao W']","['Adult', 'Aged', 'Carcinoma', 'Disease-Free Survival', 'Female', 'Humans', 'Immunohistochemistry', 'Male', 'Middle Aged', 'Multivariate Analysis', 'Nasopharyngeal Carcinoma', 'Nasopharyngeal Neoplasms/*metabolism/*pathology', 'Nasopharyngitis/metabolism/pathology', 'Neoplasm Metastasis', 'Receptor, Macrophage Colony-Stimulating Factor/*metabolism', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/26743272/
911,CSF1R,30968732,CSF1R mutation presenting as dementia with Lewy bodies.,"['Sharma R', 'Graff-Radford J', 'Rademakers R', 'Boeve BF', 'Petersen RC', 'Jones DT']","['Humans', '*Lewy Body Disease/diagnostic imaging/genetics/pathology/physiopathology', 'Male', 'Middle Aged', 'Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30968732/
912,CSF1R,39317456,Metabolic reprogramming of hypoxic tumor-associated macrophages through CSF-1R targeting favors treatment efficiency in colorectal cancers.,"['Gharzeddine K', 'Gonzalez Prieto C', 'Malier M', 'Hennot C', 'Grespan R', 'Yamaryo-Botte Y', 'Botte CY', 'Thomas F', 'Laverriere MH', 'Girard E', 'Roth G', 'Millet A']","['Humans', '*Colorectal Neoplasms/drug therapy/metabolism/pathology', '*Tumor-Associated Macrophages/metabolism', 'Receptor, Macrophage Colony-Stimulating Factor/metabolism', 'Fluorouracil/pharmacology/therapeutic use', 'Metabolic Reprogramming']",https://pubmed.ncbi.nlm.nih.gov/39317456/
913,RET,31715421,RET fusions in solid tumors.,"['Li AY', 'McCusker MG', 'Russo A', 'Scilla KA', 'Gittens A', 'Arensmeyer K', 'Mehra R', 'Adamo V', 'Rolfo C']","['Antineoplastic Agents/pharmacology/*therapeutic use', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Lung Neoplasms/genetics', 'Molecular Targeted Therapy', 'Oncogene Proteins, Fusion/*genetics/metabolism', 'Protein Kinase Inhibitors/pharmacology/*therapeutic use', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-ret/*antagonists & inhibitors/*genetics/metabolism', 'Thyroid Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/31715421/
914,RET,32846061,Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.,"['Wirth LJ', 'Sherman E', 'Robinson B', 'Solomon B', 'Kang H', 'Lorch J', 'Worden F', 'Brose M', 'Patel J', 'Leboulleux S', 'Godbert Y', 'Barlesi F', 'Morris JC', 'Owonikoko TK', 'Tan DSW', 'Gautschi O', 'Weiss J', 'de la Fouchardiere C', 'Burkard ME', 'Laskin J', 'Taylor MH', 'Kroiss M', 'Medioni J', 'Goldman JW', 'Bauer TM', 'Levy B', 'Zhu VW', 'Lakhani N', 'Moreno V', 'Ebata K', 'Nguyen M', 'Heirich D', 'Zhu EY', 'Huang X', 'Yang L', 'Kherani J', 'Rothenberg SM', 'Drilon A', 'Subbiah V', 'Shah MH', 'Cabanillas ME']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Female', 'Humans', 'Hypertension/chemically induced', 'Intention to Treat Analysis', 'Kaplan-Meier Estimate', 'Male', 'Middle Aged', 'Mutation', 'Progression-Free Survival', 'Protein Kinase Inhibitors/*administration & dosage/adverse effects', 'Proto-Oncogene Proteins c-ret/analysis/*antagonists & inhibitors/genetics', 'Pyrazoles/*administration & dosage/adverse effects', 'Pyridines/*administration & dosage/adverse effects', 'Thyroid Neoplasms/*drug therapy', 'Transaminases/blood', 'Treatment Outcome', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32846061/
915,RET,33603219,The importance of the RET gene in thyroid cancer and therapeutic implications.,"['Salvatore D', 'Santoro M', 'Schlumberger M']","['Antineoplastic Agents/*therapeutic use', 'Carcinoma, Neuroendocrine/*genetics/metabolism/therapy', 'DNA/*genetics', 'DNA Mutational Analysis', 'Humans', 'Molecular Targeted Therapy/*methods', '*Mutation', 'Proto-Oncogene Proteins c-ret/*genetics/metabolism', 'Thyroid Neoplasms/*genetics/metabolism/therapy']",https://pubmed.ncbi.nlm.nih.gov/33603219/
916,RET,29134959,Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.,"['Drilon A', 'Hu ZI', 'Lai GGY', 'Tan DSW']","['Anaplastic Lymphoma Kinase/genetics', 'Carcinogenesis/*genetics', 'ErbB Receptors/genetics', 'Gene Rearrangement/genetics', 'Humans', '*Molecular Targeted Therapy', 'Mutation', 'Neoplasms/*drug therapy/genetics', 'Protein-Tyrosine Kinases/genetics', 'Proto-Oncogene Proteins/genetics', 'Proto-Oncogene Proteins B-raf/genetics', 'Proto-Oncogene Proteins c-ret/antagonists & inhibitors/*genetics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/29134959/
917,RET,29912274,Selective RET kinase inhibition for patients with RET-altered cancers.,"['Subbiah V', 'Velcheti V', 'Tuch BB', 'Ebata K', 'Busaidy NL', 'Cabanillas ME', 'Wirth LJ', 'Stock S', 'Smith S', 'Lauriault V', 'Corsi-Travali S', 'Henry D', 'Burkard M', 'Hamor R', 'Bouhana K', 'Winski S', 'Wallace RD', 'Hartley D', 'Rhodes S', 'Reddy M', 'Brandhuber BJ', 'Andrews S', 'Rothenberg SM', 'Drilon A']","['Adult', 'Brain Neoplasms/*drug therapy/secondary', 'Carbazoles/pharmacology/therapeutic use', 'Carcinoma, Neuroendocrine/*drug therapy/pathology', 'Cell Line, Tumor', 'Drug Resistance, Neoplasm/drug effects/genetics', 'Female', 'Humans', 'Liver Neoplasms/*drug therapy/secondary', 'Lung Neoplasms/*drug therapy/pathology', 'Male', 'Middle Aged', 'Mutation', 'Oncogene Proteins, Fusion/antagonists & inhibitors/genetics', 'Piperidines/pharmacology/therapeutic use', 'Proof of Concept Study', 'Protein Kinase Inhibitors/pharmacology/*therapeutic use', 'Proto-Oncogene Proteins c-ret/*antagonists & inhibitors/genetics', 'Pyrazoles/pharmacology/*therapeutic use', 'Pyridines/pharmacology/*therapeutic use', 'Thyroid Neoplasms/*drug therapy/pathology', 'Treatment Outcome', 'Xenograft Model Antitumor Assays']",https://pubmed.ncbi.nlm.nih.gov/29912274/
918,RET,24296167,Central role of RET in thyroid cancer.,"['Santoro M', 'Carlomagno F']","['Carcinoma/drug therapy/*enzymology/genetics', 'Carcinoma, Neuroendocrine', 'Carcinoma, Papillary', 'Humans', 'Mutation', 'Protein Kinase Inhibitors/therapeutic use', 'Proto-Oncogene Proteins c-ret/antagonists & inhibitors/genetics/*metabolism', 'Thyroid Cancer, Papillary', 'Thyroid Neoplasms/drug therapy/*enzymology/genetics']",https://pubmed.ncbi.nlm.nih.gov/24296167/
919,RET,18502331,Dysregulated RET signaling in thyroid cancer.,"['Castellone MD', 'Santoro M']","['Carcinoma, Medullary/*genetics', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Models, Biological', 'Oncogene Proteins, Fusion/genetics/physiology', 'Proto-Oncogene Proteins c-ret/*genetics/physiology', 'Signal Transduction/*genetics', 'Thyroid Neoplasms/*genetics']",https://pubmed.ncbi.nlm.nih.gov/18502331/
920,RET,15583857,Dysfunction of the RET receptor in human cancer.,"['Santoro M', 'Carlomagno F', 'Melillo RM', 'Fusco A']","['Carcinoma, Papillary/metabolism', 'Cell Transformation, Neoplastic', 'Humans', 'Ligands', 'Models, Biological', 'Models, Genetic', 'Neoplasms/*metabolism', 'Phosphorylation', 'Protein Structure, Tertiary', 'Proto-Oncogene Proteins/*physiology', 'Proto-Oncogene Proteins c-ret', 'Receptor Protein-Tyrosine Kinases/*physiology', 'Signal Transduction', 'Thyroid Neoplasms/metabolism']",https://pubmed.ncbi.nlm.nih.gov/15583857/
921,RET,31489961,Current surgical management in RET mutation carriers [Aktualne postepowanie chirurgiczne u nosicieli mutacji proto-onkogenu RET].,"['Czarniecka A', 'Oczko-Wojciechowska M', 'Hajduk A', 'Zeman M', 'Jarzab B']","['Calcitonin/blood', 'Carcinoma, Medullary/blood/*congenital/genetics/surgery', 'Disease Management', 'Humans', 'Multiple Endocrine Neoplasia Type 2a/blood/genetics/*surgery', '*Mutation', 'Practice Guidelines as Topic', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-ret/*genetics', 'Thyroid Neoplasms/blood/genetics/*surgery', '*Thyroidectomy']",https://pubmed.ncbi.nlm.nih.gov/31489961/
922,RET,22286373,RET TKI: potential role in thyroid cancers.,"['Antonelli A', 'Fallahi P', 'Ferrari SM', 'Mancusi C', 'Colaci M', 'Santarpia L', 'Ferri C']","['Antineoplastic Agents/*therapeutic use', 'Carcinoma, Medullary/drug therapy', 'Carcinoma, Papillary/drug therapy', 'Humans', 'Molecular Targeted Therapy/methods', 'Proto-Oncogene Proteins c-ret/*antagonists & inhibitors', 'Receptor Protein-Tyrosine Kinases/*antagonists & inhibitors', 'Thyroid Neoplasms/*drug therapy']",https://pubmed.ncbi.nlm.nih.gov/22286373/
923,RET,36632846,RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives.,"['Addeo A', 'Miranda-Morales E', 'den Hollander P', 'Friedlaender A', 'O Sintim H', 'Wu J', 'Mani SA', 'Subbiah V']","['Humans', '*Carcinoma, Non-Small-Cell Lung/drug therapy/genetics', '*Lung Neoplasms/genetics', 'Precision Medicine', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', 'Proto-Oncogene Proteins c-ret/genetics/metabolism', '*Thyroid Neoplasms/drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/36632846/
924,FLT3,34774343,A review of FLT3 inhibitors in acute myeloid leukemia.,"['Zhao JC', 'Agarwal S', 'Ahmad H', 'Amin K', 'Bewersdorf JP', 'Zeidan AM']","['*Antineoplastic Agents/pharmacology/therapeutic use', 'Humans', '*Leukemia, Myeloid, Acute/drug therapy/genetics', 'Mutation', 'Prognosis', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', 'fms-Like Tyrosine Kinase 3/genetics']",https://pubmed.ncbi.nlm.nih.gov/34774343/
925,FLT3,30651634,Targeting FLT3 mutations in AML: review of current knowledge and evidence.,"['Daver N', 'Schlenk RF', 'Russell NH', 'Levis MJ']","['Humans', 'Leukemia, Myeloid, Acute/*drug therapy/genetics/pathology', '*Molecular Targeted Therapy', '*Mutation', 'Prognosis', 'Protein Kinase Inhibitors/*therapeutic use', 'fms-Like Tyrosine Kinase 3/*antagonists & inhibitors/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30651634/
926,FLT3,37173186,Ferroptosis vulnerability in FLT3-mutant leukemia.,"['Lee H', 'Zhuang L', 'Gan B']","['Humans', '*Ferroptosis/genetics', 'Mutation', 'Protein Kinase Inhibitors/therapeutic use', '*Leukemia, Myeloid, Acute/drug therapy/genetics', 'fms-Like Tyrosine Kinase 3/genetics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/37173186/
927,FLT3,36808557,An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape.,"['Bystrom R', 'Levis MJ']","['Humans', 'Nuclear Proteins/genetics', 'Nucleophosmin', '*Leukemia, Myeloid, Acute/genetics/therapy', 'Mutation', '*Hematopoietic Stem Cell Transplantation', 'fms-Like Tyrosine Kinase 3/genetics', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/36808557/
928,FLT3,37246158,Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy.,"['Ge SS', 'Qiu QC', 'Dai HP', 'Shen XD', 'Wu TM', 'Du JH', 'Wan CL', 'Shen HJ', 'Wu DP', 'Xue SL', 'Liu SB']","['Humans', 'fms-Like Tyrosine Kinase 3/genetics', 'Mutation', '*Leukemia, Myeloid, Acute/genetics', 'Point Mutation', '*Hematologic Neoplasms']",https://pubmed.ncbi.nlm.nih.gov/37246158/
929,FLT3,37696819,Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors.,"['Short NJ', 'Nguyen D', 'Ravandi F']","['Humans', 'Middle Aged', 'Aged', '*Sulfonamides', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', '*Leukemia, Myeloid, Acute/drug therapy/genetics', 'Mutation', 'fms-Like Tyrosine Kinase 3/genetics']",https://pubmed.ncbi.nlm.nih.gov/37696819/
930,FLT3,28546144,Midostaurin approved for FLT3-mutated AML.,['Levis M'],"['Antineoplastic Agents/therapeutic use', 'Drug Approval', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy', 'Mutation', 'Protein Kinase Inhibitors/therapeutic use', 'Staurosporine/*analogs & derivatives/therapeutic use', 'fms-Like Tyrosine Kinase 3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28546144/
931,FLT3,30466756,What FLT3 inhibitor holds the greatest promise?,['Stone RM'],"['Humans', '*Leukemia, Myeloid, Acute/drug therapy/enzymology/genetics', '*Mutation', 'Protein Kinase Inhibitors/*therapeutic use', '*fms-Like Tyrosine Kinase 3/antagonists & inhibitors/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30466756/
932,FLT3,21082990,Lestaurtinib: a multi-targeted FLT3 inhibitor.,"['Fathi AT', 'Levis M']","['Carbazoles/pharmacokinetics/pharmacology/*therapeutic use', 'Furans', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/enzymology', 'Protein Kinase Inhibitors/pharmacokinetics/pharmacology/*therapeutic use', 'fms-Like Tyrosine Kinase 3/*antagonists & inhibitors/genetics']",https://pubmed.ncbi.nlm.nih.gov/21082990/
933,FLT3,35680852,Resistance to targeted therapies: delving into FLT3 and IDH.,"['Desikan SP', 'Daver N', 'DiNardo C', 'Kadia T', 'Konopleva M', 'Ravandi F']","['Drug Resistance, Neoplasm/genetics', 'Humans', '*Leukemia, Myeloid, Acute/drug therapy/genetics/metabolism', 'Mutation', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', 'Tumor Microenvironment', 'fms-Like Tyrosine Kinase 3/genetics']",https://pubmed.ncbi.nlm.nih.gov/35680852/
934,FLT3,7519507,"The expression of FMS, KIT and FLT3 in hematopoietic malignancies.","['Birg F', 'Rosnet O', 'Carbuccia N', 'Birnbaum D']","['Acute Disease', 'Enzyme Induction', '*Gene Expression Regulation, Leukemic', 'Hematopoietic Cell Growth Factors/*biosynthesis/genetics/physiology', 'Hematopoietic Stem Cells/enzymology', 'Humans', 'Leukemia/*enzymology/genetics', 'Macrophage Colony-Stimulating Factor/*biosynthesis/genetics/physiology', 'Neoplasm Proteins/*biosynthesis/genetics/physiology', 'Neoplastic Stem Cells/enzymology', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins/*biosynthesis/genetics/physiology', 'Receptor Protein-Tyrosine Kinases/*biosynthesis/genetics/physiology', 'Receptors, Cell Surface/*biosynthesis/genetics', 'Stem Cell Factor', 'fms-Like Tyrosine Kinase 3']",https://pubmed.ncbi.nlm.nih.gov/7519507/
935,FLT3,37558736,FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML.,"['Othman J', 'Potter N', 'Mokretar K', 'Taussig D', 'Khan A', 'Krishnamurthy P', 'Latif AL', 'Cahalin P', 'Aries J', 'Amer M', 'Belsham E', 'Conneally E', 'Craddock C', 'Culligan D', 'Dennis M', 'Duncan C', 'Freeman SD', 'Furness C', 'Gilkes A', 'Gkreka P', 'Hodgson K', 'Ingram W', 'Jain M', 'King A', 'Knapper S', 'Kottaridis P', 'McMullin MF', 'Mohite U', 'Ngu L', ""O'Nions J"", 'Patrick K', 'Rider T', 'Roberts W', 'Severinsen MT', 'Storrar N', 'Taylor T', 'Russell NH', 'Dillon R']","['Humans', 'fms-Like Tyrosine Kinase 3/antagonists & inhibitors/genetics', '*Leukemia, Myeloid, Acute/drug therapy/genetics', 'Mutation', 'Neoplasm Recurrence, Local', 'Prospective Studies', 'Protein Kinase Inhibitors/therapeutic use', '*Salvage Therapy']",https://pubmed.ncbi.nlm.nih.gov/37558736/
936,FLT3,27872057,How I treat FLT3-mutated AML.,"['Pratz KW', 'Levis M']","['Female', 'Gene Duplication', 'Humans', 'Leukemia, Myeloid, Acute/*drug therapy/*genetics', 'Male', 'Middle Aged', 'Mutation', 'Protein Kinase Inhibitors/*therapeutic use', 'fms-Like Tyrosine Kinase 3/*antagonists & inhibitors/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27872057/
937,FLT3,12951584,The role of FLT3 in haematopoietic malignancies.,"['Stirewalt DL', 'Radich JP']","['Acute Disease', 'Cell Division/genetics/immunology', 'Cell Transformation, Neoplastic/genetics/immunology', 'Hematologic Neoplasms/*genetics/immunology', 'Humans', 'Immune System/immunology', 'Leukemia, Myeloid/genetics/immunology', 'Ligands', 'Membrane Proteins/biosynthesis/*genetics/immunology', 'Mutation/genetics', 'Proto-Oncogene Proteins/biosynthesis/*genetics/immunology', 'Receptor Protein-Tyrosine Kinases/biosynthesis/*genetics/immunology', 'Receptors, Cell Surface/*genetics/immunology', 'Signal Transduction/genetics/immunology', 'fms-Like Tyrosine Kinase 3']",https://pubmed.ncbi.nlm.nih.gov/12951584/
938,FLT1,19029957,FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?,"['Fischer C', 'Mazzone M', 'Jonckx B', 'Carmeliet P']","['Angiogenesis Inhibitors/*therapeutic use', 'Glycosylphosphatidylinositols/physiology', 'Humans', 'Macular Degeneration/drug therapy', 'Membrane Proteins/physiology', 'Neoplasms/*blood supply/*drug therapy', 'Neovascularization, Pathologic/prevention & control', 'Placenta Growth Factor', 'Pregnancy Proteins/physiology', 'Receptors, Vascular Endothelial Growth Factor/physiology', 'Vascular Endothelial Growth Factor A/physiology', 'Vascular Endothelial Growth Factor B/*physiology', 'Vascular Endothelial Growth Factor Receptor-1/*physiology', 'Vascular Endothelial Growth Factor Receptor-2/physiology']",https://pubmed.ncbi.nlm.nih.gov/19029957/
939,FLT1,32899690,Role of Arginine Methylation in Alternative Polyadenylation of VEGFR-1 (Flt-1) pre-mRNA.,"['Ikeda T', 'Saito-Takatsuji H', 'Yoshitomi Y', 'Yonekura H']","['Arginine/metabolism', 'Methylation', 'Polyadenylation/*genetics', 'RNA Precursors/metabolism', 'RNA Stability/genetics', 'RNA, Messenger/genetics/metabolism', 'Vascular Endothelial Growth Factor Receptor-1/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32899690/
940,FLT1,26437810,Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.,"['Grieger JC', 'Soltys SM', 'Samulski RJ']","['Batch Cell Culture Techniques/*methods', 'Bioreactors', 'Cell Adhesion', 'Culture Media, Serum-Free', 'Dependovirus/genetics/*growth & development/isolation & purification', 'Genetic Vectors/*isolation & purification', 'HEK293 Cells', 'Humans', 'Vascular Endothelial Growth Factor Receptor-1/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26437810/
941,FLT1,34470574,HOTAIR regulates colorectal cancer stem cell properties and promotes tumorigenicity by sponging miR-211-5p and modulating FLT-1.,"['Huang Y', 'Wang L', 'Liu D']","['Cell Line, Tumor', 'Cell Proliferation/genetics', '*Colorectal Neoplasms/genetics/pathology', 'Gene Expression Regulation, Neoplastic', 'Humans', '*MicroRNAs/genetics/metabolism', 'Neoplastic Stem Cells/metabolism', '*RNA, Long Noncoding/genetics/metabolism', '*Vascular Endothelial Growth Factor Receptor-1/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34470574/
942,FLT1,23801279,Evidence for angiogenesis-independent contribution of VEGFR1 (FLT1) in gastric cancer recurrence.,"['Suspitsin EN', 'Kashyap A', 'Shelekhova KV', 'Sokolenko AP', 'Kuligina ESh', 'Iyevleva AG', 'Kornilov AV', 'Ehemann V', 'Yanus GA', 'Aleksakhina SN', 'Preobrazhenskaya EV', 'Zaitseva OA', 'Yatsuk OS', 'Klimashevsky VF', 'Togo AV', 'Imyanitov EN']","['Adult', 'Aged', 'Aged, 80 and over', 'Humans', 'Microvessels/pathology', 'Middle Aged', 'Neoplasm Recurrence, Local/*genetics/*pathology', 'Neovascularization, Pathologic/*genetics/*pathology', 'RNA, Messenger/genetics', 'Stomach Neoplasms/*genetics/*pathology', 'Vascular Endothelial Growth Factor A/genetics', 'Vascular Endothelial Growth Factor Receptor-1/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23801279/
943,FLT1,26728997,Regulation of soluble Flt-1 (VEGFR-1) production by hnRNP D and protein arginine methylation.,"['Ikeda T', 'Yoshitomi Y', 'Saito H', 'Shimasaki T', 'Yamaya H', 'Kobata T', 'Ishigaki Y', 'Tomosugi N', 'Yoshitake Y', 'Yonekura H']","['Arginine/*metabolism', 'Cell Line', 'Endothelial Cells/metabolism', '*Gene Expression Regulation', 'Heterogeneous Nuclear Ribonucleoprotein D0', 'Heterogeneous-Nuclear Ribonucleoprotein D/*metabolism', 'Humans', 'Methylation', 'Microvessels/cytology', 'Polyadenylation', 'RNA, Messenger/metabolism', 'Vascular Endothelial Growth Factor Receptor-1/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26728997/
944,FLT1,32978411,Bioenergetic effects of hydrogen sulfide suppress soluble Flt-1 and soluble endoglin in cystathionine gamma-lyase compromised endothelial cells.,"['Sanchez-Aranguren LC', 'Ahmad S', 'Dias IHK', 'Alzahrani FA', 'Rezai H', 'Wang K', 'Ahmed A']","['Air Pollutants/pharmacology', 'Cystathionine gamma-Lyase/genetics/*metabolism', 'Endoglin/*antagonists & inhibitors/metabolism', 'Endothelium, Vascular/cytology/drug effects/*metabolism', '*Energy Metabolism', 'Human Umbilical Vein Endothelial Cells', 'Humans', 'Hydrogen Sulfide/*pharmacology', 'Mitochondria/drug effects/*metabolism', 'Reactive Oxygen Species/metabolism', 'Vascular Endothelial Growth Factor Receptor-1/*antagonists & inhibitors/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32978411/
945,FLT1,15970348,Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis.,"['Kim WJ', 'Yockman JW', 'Lee M', 'Jeong JH', 'Kim YH', 'Kim SW']","['Angiogenesis Inhibitors/*administration & dosage/genetics', 'Cell Proliferation/drug effects', 'Cells, Cultured', 'Drug Carriers', 'Endothelial Cells/cytology/drug effects', 'Gene Expression', 'Genetic Therapy/*methods', 'Humans', 'Oligopeptides/chemistry', 'Peptides, Cyclic/*administration & dosage/chemical synthesis', 'Plasmids', 'Polyethylene Glycols/*administration & dosage/chemical synthesis/chemistry', 'Polyethyleneimine/chemistry', 'Transfection/*methods', 'Vascular Endothelial Growth Factor A/metabolism', 'Vascular Endothelial Growth Factor Receptor-1/*administration & dosage/genetics']",https://pubmed.ncbi.nlm.nih.gov/15970348/
946,FLT4,34632918,FLT4/VEGFR3 activates AMPK to coordinate glycometabolic reprogramming with autophagy and inflammasome activation for bacterial elimination.,"['Ma L', 'Li W', 'Zhang Y', 'Qi L', 'Zhao Q', 'Li N', 'Lu Y', 'Zhang L', 'Zhou F', 'Wu Y', 'He Y', 'Yu H', 'He Y', 'Wei B', 'Wang H']","['AMP-Activated Protein Kinases/metabolism', 'Adenosine Monophosphate', '*Autophagy/physiology', 'Bacteria/metabolism', 'Caspase 1', 'Humans', '*Inflammasomes/metabolism', 'Ligands', 'Lipopolysaccharides', 'Vascular Endothelial Growth Factor C', 'Vascular Endothelial Growth Factor Receptor-3']",https://pubmed.ncbi.nlm.nih.gov/34632918/
947,FLT4,25109169,A novel FLT4 mutation identified in a patient with Milroy disease.,"['DiGiovanni RM', 'Erickson RP', 'Ohlson EC', 'Bernas M', 'Witte MH']","['Adolescent', 'DNA Mutational Analysis', 'Genetic Predisposition to Disease', 'Heredity', 'Humans', 'Lymphedema/diagnostic imaging/*genetics', 'Lymphoscintigraphy', 'Male', '*Mutation, Missense', 'Pedigree', 'Phenotype', 'Vascular Endothelial Growth Factor Receptor-3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25109169/
948,FLT4,15904433,Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation.,"['Mizuno S', 'Yamada Y', 'Yamada K', 'Nomura N', 'Wakamatsu N']","['Family Health', 'Female', 'Foot Diseases/congenital/genetics/pathology', 'Genotype', 'Humans', 'Lymphedema/*congenital/*genetics/pathology', 'Male', 'Mutation, Missense', 'Pedigree', 'Vascular Endothelial Growth Factor Receptor-3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15904433/
949,FLT4,36763100,Therapeutic potential of FLT4-targeting peptide in acute myeloid leukemia.,"['Lee JY', 'Park S', 'Han AR', 'Hwang HS', 'Kim HJ']","['Humans', '*Leukemia, Myeloid, Acute/drug therapy', 'Killer Cells, Natural', 'Interferon-gamma/metabolism', 'Vascular Endothelial Growth Factor Receptor-3']",https://pubmed.ncbi.nlm.nih.gov/36763100/
950,FLT4,26714373,A NOVEL FLT4 GENE MUTATION AND MR LYMPHANGIOGRAPHY IN A CHINESE FAMILY WITH MILROY DISEASE.,"['Liu NF', 'Yu Z', 'Luo Y', 'Sun D', 'Yan Z']","['Adult', 'Asian People/*genetics', 'Child, Preschool', 'China', 'DNA Mutational Analysis', 'Female', 'Genetic Predisposition to Disease', 'Heredity', 'Humans', 'Lower Extremity/*pathology', 'Lymphedema/ethnology/*genetics/*pathology', 'Lymphography/*methods', '*Magnetic Resonance Imaging', 'Male', '*Mutation', 'Pedigree', 'Phenotype', 'Predictive Value of Tests', 'Vascular Endothelial Growth Factor Receptor-3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26714373/
951,FLT4,26091406,FOXC2 and FLT4 Gene Variants in Lymphatic Filariasis.,"['Sheik Y', 'Qureshi SF', 'Mohhammed B', 'Nallari P']","['Adult', 'Alleles', 'Cohort Studies', 'Elephantiasis, Filarial/diagnosis/*genetics', 'Female', 'Forkhead Transcription Factors/*genetics', 'Gene Frequency', 'Genetic Predisposition to Disease', '*Genetic Variation', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Odds Ratio', 'Polymorphism, Single Nucleotide', 'Vascular Endothelial Growth Factor Receptor-3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26091406/
952,FLT4,34681005,FLT4 Mutations Are Associated with Segmental Lymphatic Dysfunction and Initial Lymphatic Aplasia in Patients with Milroy Disease.,"['Liu N', 'Gao M']","['Adolescent', 'Adult', 'Ankle/diagnostic imaging/pathology', 'Child', 'Child, Preschool', 'Female', '*Genetic Predisposition to Disease', 'Humans', 'Infant', 'Knee/diagnostic imaging/pathology', 'Lower Extremity/*diagnostic imaging/pathology', 'Lymphedema/diagnostic imaging/epidemiology/*genetics/pathology', 'Lymphography', 'Male', 'Mutation, Missense/genetics', 'Protein Isoforms/genetics', 'Vascular Endothelial Growth Factor Receptor-3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/34681005/
953,FLT4,36538874,Two novel variations p.(Ser1275Thr) and p.(Ser1275Arg) in FLT4 causing prenatal hereditary lymphedema type 1.,"['Lajmi Y', 'Loeuillet L', 'Petrilli G', 'Egloff C', 'Nectoux J', 'Molac C', 'Roux N', 'Pannier E', 'Achaiaa A', 'Arkoub ZA', 'Chuon S', 'Coussement A', 'Dupont JM', 'Malan V', 'Spaggiari E', 'Razavi F', 'Amiel J', 'Bessieres B', 'Grotto S', 'Attie-Bitach T']","['Humans', 'Pregnancy', 'Female', '*Hydrops Fetalis/diagnosis/genetics', 'Comparative Genomic Hybridization', '*Lymphedema/congenital/diagnosis/genetics', 'Ultrasonography, Prenatal', 'Mutation', 'Vascular Endothelial Growth Factor Receptor-3/genetics']",https://pubmed.ncbi.nlm.nih.gov/36538874/
954,FLT4,25864386,The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.,"['Cornejo KM', 'Deng A', 'Wu H', 'Cosar EF', 'Khan A', 'St Cyr M', 'Tomaszewicz K', 'Dresser K', ""O'Donnell P"", 'Hutchinson L']","['Adult', 'Aged', 'Breast/pathology', 'Breast Neoplasms/*diagnosis/*therapy', 'Female', 'Hemangiosarcoma/*diagnosis/*therapy', 'Humans', 'Immunohistochemistry/methods', 'Middle Aged', 'Neoplasms, Radiation-Induced/metabolism', 'Proto-Oncogene Proteins c-myc/*metabolism', 'Vascular Diseases/diagnosis/therapy', 'Vascular Endothelial Growth Factor Receptor-3/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25864386/
955,KDR,34224514,Angiosarcoma of the Pancreas in a Pediatric Patient With an Activating KDR-Internal Tandem Duplication: A Case Report and Review of the Literature.,"['Whitlock RS', 'Ebare K', 'Cheng LS', 'Fishman DS', 'Mills JL', 'Nguyen HN', 'Nuchtern JG', 'Ruan W', 'Smith VE', 'Patel KA', 'Fisher KE', 'Vasudevan SA']","['Adolescent', 'Female', '*Hemangiosarcoma/genetics/pathology/surgery', 'Humans', 'Pancreas/pathology/surgery', 'Pancreatectomy', '*Pancreatic Neoplasms/genetics/surgery', 'Pancreaticoduodenectomy', 'Vascular Endothelial Growth Factor Receptor-2']",https://pubmed.ncbi.nlm.nih.gov/34224514/
956,KDR,27453397,Common variants upstream of KDR encoding VEGFR2 and in TTC39B associate with endometriosis.,"['Steinthorsdottir V', 'Thorleifsson G', 'Aradottir K', 'Feenstra B', 'Sigurdsson A', 'Stefansdottir L', 'Kristinsdottir AM', 'Zink F', 'Halldorsson GH', 'Munk Nielsen N', 'Geller F', 'Melbye M', 'Gudbjartsson DF', 'Geirsson RT', 'Thorsteinsdottir U', 'Stefansson K']","['Chromosomes, Human, Pair 17/genetics', 'Endometriosis/*genetics', 'Female', 'Genetic Loci', '*Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Lipoproteins, HDL/*genetics', 'Neoplasm Proteins/*genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Vascular Endothelial Growth Factor Receptor-2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27453397/
957,KDR,26831649,Decreased Number of Circulating Endothelial Progenitor Cells (CD133+/KDR+) in Patients with Psoriatic Arthritis.,"['Batycka-Baran A', 'Paprocka M', 'Baran W', 'Szepietowski JC']","['Adult', 'Arthritis, Psoriatic/*blood', 'Cardiovascular Diseases/*blood', 'Case-Control Studies', 'Endothelial Progenitor Cells/*metabolism', 'Endothelium, Vascular/*metabolism', 'Female', 'Flow Cytometry', 'Humans', 'Male', 'Risk Factors', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/26831649/
958,KDR,10381576,Differential expression of KDR/VEGFR-2 and CD34 during mesoderm development of the early human embryo.,"['Cortes F', 'Debacker C', 'Peault B', 'Labastie MC']","['Antigens, CD34/analysis/*metabolism', 'Embryo, Mammalian/*anatomy & histology/*metabolism', 'Humans', 'Mesoderm/*metabolism', 'Receptor Protein-Tyrosine Kinases/analysis/*metabolism', 'Receptors, Growth Factor/analysis/*metabolism', 'Receptors, Vascular Endothelial Growth Factor', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/10381576/
959,KDR,20607359,"A fusion fragment from Flt-1 and KDR, acted as VEGF decoy receptor and exhibited anti-tumor function.","['Li ZL', 'Yao XJ', 'Liu WF', 'Chen GJ']","['Antineoplastic Agents/*metabolism', 'Biological Products/genetics/*metabolism', 'Cell Proliferation/drug effects', 'Cells, Cultured', 'Endothelial Cells/drug effects', 'Humans', 'Kinetics', 'Protein Binding', 'Recombinant Fusion Proteins/genetics/metabolism', 'Vascular Endothelial Growth Factor A/*metabolism', 'Vascular Endothelial Growth Factor Receptor-1/genetics/*metabolism', 'Vascular Endothelial Growth Factor Receptor-2/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/20607359/
960,KDR,37610648,"PDGFRA, KIT, and KDR Gene Amplification in Glioblastoma: Heterogeneity and Clinical Significance.","['Carlotto BS', 'Trevisan P', 'Provenzi VO', 'Soares FP', 'Rosa RFM', 'Varella-Garcia M', 'Zen PRG']","['Humans', 'Middle Aged', 'Central Nervous System', 'Chromosome Aberrations', 'Clinical Relevance', 'Gene Amplification', '*Glioblastoma/genetics', 'Receptor Protein-Tyrosine Kinases', 'Vascular Endothelial Growth Factor Receptor-2/genetics', 'Receptor, Platelet-Derived Growth Factor alpha/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37610648/
961,KDR,17869515,Discovery of N-phenyl nicotinamides as potent inhibitors of Kdr.,"['Dominguez C', 'Smith L', 'Huang Q', 'Yuan C', 'Ouyang X', 'Cai L', 'Chen P', 'Kim J', 'Harvey T', 'Syed R', 'Kim TS', 'Tasker A', 'Wang L', 'Zhang M', 'Coxon A', 'Bready J', 'Starnes C', 'Chen D', 'Gan Y', 'Neervannan S', 'Kumar G', 'Polverino A', 'Kendall R']","['Cell Line, Tumor', 'Humans', 'Niacinamide/*pharmacology', 'Protein Kinase Inhibitors/*pharmacology', 'Vascular Endothelial Growth Factor Receptor-2/*antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/17869515/
962,RPS6KA3,26354035,625 kb microduplication at Xp22.12 including RPS6KA3 in a child with mild intellectual disability.,"['Bertini V', 'Cambi F', 'Bruno R', 'Toschi B', 'Forli F', 'Berrettini S', 'Simi P', 'Valetto A']","['Child', '*Chromosome Duplication', 'Chromosomes, Human, X/*genetics', 'Genetic Diseases, X-Linked/enzymology/*genetics', 'Humans', 'Intellectual Disability/enzymology/*genetics', 'Male', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26354035/
963,RPS6KA3,21614984,A novel mutation in the RPS6KA3 gene in a patient with Coffin-Lowry syndrome.,"['Senel S', 'Ceylaner S', 'Ceylaner G', 'Sahin AH', 'Andrieux J', 'Delaunoy JP']","['Child', 'Codon/genetics', 'Coffin-Lowry Syndrome/diagnostic imaging/*genetics', 'Comparative Genomic Hybridization', 'Exons/genetics', 'Humans', 'Lumbar Vertebrae/abnormalities/diagnostic imaging', 'Male', 'Mutation, Missense/*genetics', 'Radiography', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', 'Sacrum/abnormalities/diagnostic imaging', 'Spinal Dysraphism/diagnostic imaging/genetics']",https://pubmed.ncbi.nlm.nih.gov/21614984/
964,RPS6KA3,29678278,Periventricular small cystic lesions in a patient with Coffin-Lowry syndrome who exhibited a novel mutation in the RPS6KA3 gene.,"['Miyata Y', 'Saida K', 'Kumada S', 'Miyake N', 'Mashimo H', 'Nishida Y', 'Shirai I', 'Kurihara E', 'Nakata Y', 'Matsumoto N']","['Brain/*diagnostic imaging', 'Child, Preschool', 'Coffin-Lowry Syndrome/*diagnosis/*genetics/pathology', 'Diagnosis, Differential', 'Face/abnormalities', 'Humans', 'Magnetic Resonance Imaging', 'Male', '*Mutation, Missense', 'Phenotype', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29678278/
965,RPS6KA3,23261961,Identification of the first deep intronic mutation in the RPS6KA3 gene in a patient with a severe form of Coffin-Lowry syndrome.,"['Schneider A', 'Maas SM', 'Hennekam RC', 'Hanauer A']","['Alleles', 'Base Sequence', 'Coffin-Lowry Syndrome/*diagnosis/*genetics', 'Exons', 'Humans', 'Introns', 'Male', 'Molecular Sequence Data', '*Mutation', 'RNA, Messenger/genetics', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', 'Sequence Analysis, DNA', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23261961/
966,RPS6KA3,36125370,Novel RPS6KA3 mutations cause Coffin-Lowry syndrome in two patients and concurrent compulsive eyebrow-pulling behavior in one of them.,"['Gursoy S', 'Hazan F', 'Cetinoglu E']","['*Coffin-Lowry Syndrome/genetics', 'Compulsive Behavior', 'Eyebrows', 'Female', 'Humans', '*Intellectual Disability/genetics', 'Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/36125370/
967,RPS6KA3,14986828,"Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome.","['Martinez-Garay I', 'Ballesta MJ', 'Oltra S', 'Orellana C', 'Palomeque A', 'Molto MD', 'Prieto F', 'Martinez F']","['Adult', 'Blotting, Southern', 'Child', 'Codon, Nonsense/genetics', 'Coffin-Lowry Syndrome/*genetics', 'DNA Mutational Analysis', 'DNA Primers', 'Gene Components', 'Humans', 'Long Interspersed Nucleotide Elements/genetics', 'Mutation, Missense/genetics', 'Pedigree', 'Polymorphism, Single-Stranded Conformational', 'Reverse Transcriptase Polymerase Chain Reaction', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/14986828/
968,RPS6KA3,35888677,Coffin-Lowry Syndrome Induced by RPS6KA3 Gene Variation in China: A Case Report in Twins.,"['Jin H', 'Li H', 'Qiang S']","['*Coffin-Lowry Syndrome/diagnosis/genetics', 'Exons', 'Humans', 'Male', 'Mutation', 'Ribosomal Protein S6 Kinases, 90-kDa/genetics', 'Siblings']",https://pubmed.ncbi.nlm.nih.gov/35888677/
969,RPS6KA3,30945684,Spectrum of X-linked intellectual disabilities and psychiatric symptoms in a family harbouring a Xp22.12 microduplication encompassing the RPS6KA3 gene.,"['Uliana V', 'Bonatti F', 'Zanatta V', 'Mozzoni P', 'Martorana D', 'Percesepe A']","['Adult', 'Chromosome Duplication', 'Chromosomes, Human, X/*genetics', 'DNA Copy Number Variations', 'Female', 'Genetic Diseases, X-Linked/diagnosis/*genetics', 'Humans', 'Intellectual Disability/diagnosis/*genetics', 'Male', 'Middle Aged', 'Pedigree', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', 'Schizophrenia/diagnosis/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30945684/
970,RPS6KA3,17100996,Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation.,"['Field M', 'Tarpey P', 'Boyle J', 'Edkins S', 'Goodship J', 'Luo Y', 'Moon J', 'Teague J', 'Stratton MR', 'Futreal PA', 'Wooster R', 'Raymond FL', 'Turner G']","['Amino Acid Sequence', 'Base Sequence', 'Coffin-Lowry Syndrome/*genetics', 'Female', 'Genetic Testing/methods', 'Humans', 'Male', 'X-Linked Intellectual Disability/*genetics', 'Molecular Sequence Data', 'Mutation/*genetics', 'Pedigree', '*Phenotype', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/17100996/
971,RPS6KA3,16879200,Identification of novel mutations in the RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome.,"['Delaunoy JP', 'Dubos A', 'Marques Pereira P', 'Hanauer A']","['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Coffin-Lowry Syndrome/*genetics', 'Female', 'Humans', 'Male', '*Mutation', 'Polymorphism, Single-Stranded Conformational', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16879200/
972,RPS6KA3,31512387,An unusual cause for Coffin-Lowry syndrome: Three brothers with a novel microduplication in RPS6KA3.,"['Castelluccio VJ', 'Vetrini F', 'Lynnes T', 'Jones J', 'Holloway L', 'Belonis A', 'Breman AM', 'Graham BH', 'Sapp K', 'Wilson T', 'Schwartz CE', 'Pratt VM', 'Weaver DD']","['Child', '*Chromosome Duplication', 'Coffin-Lowry Syndrome/*diagnosis/*genetics', 'Facies', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Male', 'Mutation', 'Pedigree', 'Phenotype', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', '*Siblings']",https://pubmed.ncbi.nlm.nih.gov/31512387/
973,RPS6KA3,11180593,Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome.,"['Delaunoy J', 'Abidi F', 'Zeniou M', 'Jacquot S', 'Merienne K', 'Pannetier S', 'Schmitt M', 'Schwartz C', 'Hanauer A']","['Abnormalities, Multiple/*genetics/pathology', 'Genetic Linkage', 'Genotype', 'Humans', 'Intellectual Disability/*genetics', 'Mutation', 'Phenotype', 'Review Literature as Topic', 'Ribosomal Protein S6 Kinases/*genetics', 'Syndrome', 'X Chromosome/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11180593/
974,RPS6KA3,23985797,An Xp22.12 microduplication including RPS6KA3 identified in a family with variably affected intellectual and behavioral disabilities.,"['Matsumoto A', 'Kuwajima M', 'Miyake K', 'Kojima K', 'Nakashima N', 'Jimbo EF', 'Kubota T', 'Momoi MY', 'Yamagata T']","['Adolescent', 'Adult', 'Attention Deficit Disorder with Hyperactivity/complications/*genetics', 'Child', 'Child Development Disorders, Pervasive/complications/*genetics', 'Child, Preschool', 'Chromosomes, Human, X/*genetics', 'Epilepsies, Partial/complications/*genetics', 'Female', 'Gene Duplication', 'Humans', 'Male', 'Pedigree', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23985797/
975,RPS6KA3,37477894,A 6-year-old boy with an atypical liver neoplasm harboring a novel RPS6KA3 variant.,"['Bustamante D', 'Abadie J']","['Humans', 'Male', 'Child', '*Liver Neoplasms/genetics/diagnosis/pathology', '*Ribosomal Protein S6 Kinases, 90-kDa/genetics/metabolism', 'Hepatoblastoma/genetics/diagnosis/pathology', 'Carcinoma, Hepatocellular/diagnosis/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/37477894/
976,RPS6KA3,16691578,A novel RSK2 (RPS6KA3) gene mutation associated with abnormal brain MRI findings in a family with Coffin-Lowry syndrome.,"['Wang Y', 'Martinez JE', 'Wilson GL', 'He XY', 'Tuck-Muller CM', 'Maertens P', 'Wertelecki W', 'Chen TJ']","['Alleles', 'Brain/*abnormalities/*diagnostic imaging', 'Coffin-Lowry Syndrome/*genetics', 'Exons', 'Female', 'Humans', 'Intellectual Disability/genetics', '*Magnetic Resonance Imaging', 'Male', 'Mutagenesis, Insertional', '*Mutation', 'Nuclear Family', 'Radiography', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', 'Sequence Deletion', 'Severity of Illness Index', 'Siblings', 'Syndrome', 'X Chromosome Inactivation/genetics']",https://pubmed.ncbi.nlm.nih.gov/16691578/
977,RPS6KA3,26297997,Concomitant partial exon skipping by a unique missense mutation of RPS6KA3 causes Coffin-Lowry syndrome.,"['Labonne JD', 'Chung MJ', 'Jones JR', 'Anand P', 'Wenzel W', 'Iacoboni D', 'Layman LC', 'Kim HG']","['Coffin-Lowry Syndrome/*genetics/metabolism', '*Exons', 'Female', 'Humans', 'Male', '*Mutation, Missense', '*RNA Splice Sites', '*RNA Splicing', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26297997/
978,RPS6KA3,25044551,The historical Coffin-Lowry syndrome family revisited: identification of two novel mutations of RPS6KA3 in three male patients.,"['Nishimoto HK', 'Ha K', 'Jones JR', 'Dwivedi A', 'Cho HM', 'Layman LC', 'Kim HG']","['Amino Acid Sequence', 'Base Sequence', 'Cell Line', 'Child', 'Child, Preschool', 'Coffin-Lowry Syndrome/*genetics', 'Family', 'Humans', 'Infant', 'Male', 'Molecular Sequence Data', 'Mutation/*genetics', 'Ribosomal Protein S6 Kinases, 90-kDa/chemistry/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25044551/
979,RPS6KA3,21930553,A child with mild X-linked intellectual disability and a microduplication at Xp22.12 including RPS6KA3.,"['Tejada MI', 'Martinez-Bouzas C', 'Garcia-Ribes A', 'Larrucea S', 'Acquadro F', 'Cigudosa JC', 'Belet S', 'Froyen G', 'Lopez-Ariztegui MA']","['Child', 'Chromosomes, Human, X/*genetics', '*Gene Duplication', 'Humans', 'Immunoblotting', 'In Situ Hybridization, Fluorescence', 'Male', 'X-Linked Intellectual Disability/diagnosis/*genetics', 'Oligonucleotide Array Sequence Analysis', 'Pedigree', 'Polymerase Chain Reaction', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', '*Sex Chromosome Aberrations']",https://pubmed.ncbi.nlm.nih.gov/21930553/
980,RPS6KB1,23739915,"MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.","['Lill CM', 'Schjeide BM', 'Graetz C', 'Ban M', 'Alcina A', 'Ortiz MA', 'Perez J', 'Damotte V', 'Booth D', 'Lopez de Lapuente A', 'Broer L', 'Schilling M', 'Akkad DA', 'Aktas O', 'Alloza I', 'Antiguedad A', 'Arroyo R', 'Blaschke P', 'Buttmann M', 'Chan A', 'Compston A', 'Cournu-Rebeix I', 'Dorner T', 'Epplen JT', 'Fernandez O', 'Gerdes LA', 'Guillot-Noel L', 'Hartung HP', 'Hoffjan S', 'Izquierdo G', 'Kemppinen A', 'Kroner A', 'Kubisch C', 'Kumpfel T', 'Li SC', 'Lindenberger U', 'Lohse P', 'Lubetzki C', 'Luessi F', 'Malhotra S', 'Mescheriakova J', 'Montalban X', 'Papeix C', 'Paredes LF', 'Rieckmann P', 'Steinhagen-Thiessen E', 'Winkelmann A', 'Zettl UK', 'Hintzen R', 'Vandenbroeck K', 'Stewart G', 'Fontaine B', 'Comabella M', 'Urcelay E', 'Matesanz F', 'Sawcer S', 'Bertram L', 'Zipp F']","['Case-Control Studies', 'Databases, Genetic', 'Female', 'Genetic Loci/genetics', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Male', 'Multiple Sclerosis/diagnosis/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, CXCR5/*genetics', 'Ribosomal Protein S6 Kinases, 70-kDa/*genetics', 'SOXE Transcription Factors/*genetics', 'Transcription Factors/*genetics', 'alpha-Mannosidase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23739915/
981,RPS6KB1,36803362,Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma.,"['Youssef SS', 'El-Araby RE', 'Abbas EAE', 'Hassany M', 'Elbaz T']","['Humans', 'Biomarkers, Tumor/genetics', '*Carcinoma, Hepatocellular/etiology/genetics', '*Cell-Free Nucleic Acids/genetics', 'DNA', 'DNA Copy Number Variations', '*Liver Neoplasms/etiology/genetics', 'Prognosis', 'Transcription Factors/genetics']",https://pubmed.ncbi.nlm.nih.gov/36803362/
982,RPS6KB1,34668023,Functional variants of RPS6KB1 and PIK3R1 in the autophagy pathway genes and risk of bladder cancer.,"['Ma L', 'Zhang D', 'Huang Z', 'Zheng R', 'Du M', 'Lv Q', 'Qin C', 'Chu H', 'Yuan L', 'Zhang Z']","['Autophagy/genetics', 'Case-Control Studies', 'Class Ia Phosphatidylinositol 3-Kinase/genetics', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide', 'Quantitative Trait Loci', '*Urinary Bladder Neoplasms/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/34668023/
983,RPS6KB1,34727092,"MiRNA-30e downregulation increases cancer cell proliferation, invasion and tumor growth through targeting RPS6KB1.","['Wang L', 'Ji XB', 'Wang LH', 'Xia ZK', 'Xie YX', 'Liu WJ', 'Qiu JG', 'Jiang BH', 'Liu LZ']","['Cell Line, Tumor', 'Cell Proliferation/genetics', 'Down-Regulation/genetics', '*Esophageal Neoplasms/genetics/metabolism/mortality/pathology', 'Esophagus/metabolism/pathology', 'Gene Expression Regulation, Neoplastic/genetics', 'Humans', 'MicroRNAs/*genetics/metabolism', 'Neoplasm Invasiveness/genetics', 'Ribosomal Protein S6 Kinases, 70-kDa/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34727092/
984,RPS6KB1,28792981,"Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients.","['Chen B', 'Yang L', 'Zhang R', 'Gan Y', 'Zhang W', 'Liu D', 'Chen H', 'Tang H']","['Adenocarcinoma/*metabolism/mortality/pathology', 'Apoptosis', 'Biomarkers, Tumor/metabolism', 'Carcinoma, Squamous Cell/*metabolism/mortality/pathology', 'Cell Line, Tumor', 'Cell Proliferation', 'Humans', 'Immunohistochemistry', 'Lung/metabolism/pathology', 'Lung Neoplasms/*metabolism/mortality/pathology', 'Phosphorylation', 'Predictive Value of Tests', 'Prognosis', 'Ribosomal Protein S6 Kinases, 70-kDa/*metabolism', 'Survival Rate']",https://pubmed.ncbi.nlm.nih.gov/28792981/
985,RPS6KB1,23330000,Amplified RPS6KB1 and CDC2 genes are potential biomarkers for aggressive HIV+/EBV+ diffuse large B-cell lymphomas.,"['Zhao XF', 'Zhao MY', 'Chai L', 'Kukuruga D', 'Tan M', 'Stass SA']","['Biomarkers, Tumor/genetics', 'CDC2 Protein Kinase', 'Cell Division/genetics', 'Cyclin B/*genetics', 'Cyclin-Dependent Kinases', 'Epstein-Barr Virus Infections/*complications', 'G2 Phase/genetics', 'HIV Infections/*complications', 'Humans', 'Lymphoma, AIDS-Related/*genetics/pathology/virology', 'Lymphoma, Large B-Cell, Diffuse/*genetics/pathology/virology', 'ROC Curve', 'Ribosomal Protein S6 Kinases, 70-kDa/*genetics', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/23330000/
986,RPS6KB1,21035469,"Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.","['Slattery ML', 'Lundgreen A', 'Herrick JS', 'Wolff RK']","['Adult', 'Aged', 'Case-Control Studies', 'Colonic Neoplasms/*genetics', 'Epistasis, Genetic', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Genotype', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Protein Serine-Threonine Kinases/*genetics', 'Proto-Oncogene Proteins c-akt/genetics', 'Pyruvate Dehydrogenase Acetyl-Transferring Kinase', 'Rectal Neoplasms/*genetics', 'Ribosomal Protein S6 Kinases, 70-kDa/*genetics', 'Ribosomal Protein S6 Kinases, 90-kDa/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/21035469/
987,RPS6KB1,22684641,Overexpression of RPS6KB1 predicts worse prognosis in primary HCC patients.,"['Li PD', 'Zhang WJ', 'Zhang MY', 'Yuan LJ', 'Cha YL', 'Ying XF', 'Wu G', 'Wang HY']","['Biomarkers, Tumor/*analysis', 'Blotting, Western', 'Carcinoma, Hepatocellular/*enzymology/mortality/pathology', 'Female', 'Humans', 'Immunohistochemistry', 'Kaplan-Meier Estimate', 'Liver Neoplasms/*enzymology/mortality/pathology', 'Male', 'Middle Aged', 'Prognosis', 'Real-Time Polymerase Chain Reaction', 'Reverse Transcriptase Polymerase Chain Reaction', 'Ribosomal Protein S6 Kinases, 70-kDa/analysis/*biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/22684641/
988,RPS6KB1,23886172,Prognostic value of phosphorylated mTOR/RPS6KB1 in non- small cell lung cancer.,"['Zhang Y', 'Ni HJ', 'Cheng DY']","['Adenocarcinoma/metabolism/*mortality/pathology', 'Adult', 'Aged', 'Aged, 80 and over', 'Biomarkers, Tumor/*metabolism', 'Blotting, Western', 'Carcinoma, Non-Small-Cell Lung/metabolism/*mortality/pathology', 'Carcinoma, Squamous Cell/metabolism/*mortality/pathology', 'Female', 'Fluorescent Antibody Technique', 'Follow-Up Studies', 'Humans', 'Immunoenzyme Techniques', 'Lung Neoplasms/metabolism/*mortality/pathology', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Phosphorylation', 'Prognosis', 'Ribosomal Protein S6 Kinases, 70-kDa/*metabolism', 'Signal Transduction', 'Survival Rate', 'TOR Serine-Threonine Kinases/*metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23886172/
989,RPS6KB1,15236312,"ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.","['Adem C', 'Soderberg CL', 'Hafner K', 'Reynolds C', 'Slezak JM', 'Sinclair CS', 'Sellers TA', 'Schaid DJ', 'Couch F', 'Hartmann LC', 'Jenkins RB']","['Adult', 'Aged', 'Aged, 80 and over', 'BRCA1 Protein/*genetics', 'BRCA2 Protein/*genetics', 'Breast/metabolism', 'Breast Neoplasms/physiopathology', 'Female', 'Heterozygote', 'Humans', 'Middle Aged', 'Mutation', 'Proto-Oncogene Proteins c-myc/*genetics', 'Receptor, ErbB-2/*genetics', 'Ribosomal Protein S6 Kinases, 70-kDa/*genetics', 'T-Box Domain Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15236312/
990,RPS6KB1,28079472,Polymorphisms of RPS6KB1 and CD86 associates with susceptibility to multiple sclerosis in Iranian population.,"['Abdollah Zadeh R', 'Jalilian N', 'Sahraian MA', 'Kasraian Z', 'Noori-Daloii MR']","['Adult', 'B7-2 Antigen/*genetics', 'Case-Control Studies', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Iran', 'Male', 'Multiple Sclerosis/*genetics', 'Polymorphism, Single Nucleotide', 'Ribosomal Protein S6 Kinases, 70-kDa/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28079472/
991,CDK5,39232161,CDK5-cyclin B1 regulates mitotic fidelity.,"['Zheng XF', 'Sarkar A', 'Lotana H', 'Syed A', 'Nguyen H', 'Ivey RG', 'Kennedy JJ', 'Whiteaker JR', 'Tomasik B', 'Huang K', 'Li F', ""D'Andrea AD"", 'Paulovich AG', 'Shah K', 'Spektor A', 'Chowdhury D']","['Humans', 'Coenzymes/metabolism', '*Cyclin B1/metabolism', '*Cyclin-Dependent Kinase 5/antagonists & inhibitors/deficiency/genetics/metabolism', 'HeLa Cells', '*Mitosis', 'Models, Molecular', '*Multiprotein Complexes/metabolism', 'Mutation', 'Phosphoproteins/metabolism', 'Protein Binding', 'Proteome/metabolism', 'Reproducibility of Results']",https://pubmed.ncbi.nlm.nih.gov/39232161/
992,CDK5,34814918,Three decades of Cdk5.,"['Pao PC', 'Tsai LH']","['Cell Cycle/*genetics', 'Circadian Clocks/*physiology', 'Cyclin-Dependent Kinase 5/*genetics/metabolism', 'DNA Damage/*genetics', 'Humans', 'Neurodegenerative Diseases/*genetics', 'Neurons/*physiology', 'Synapses/*physiology']",https://pubmed.ncbi.nlm.nih.gov/34814918/
993,CDK5,37993880,CDK5: an oncogene or an anti-oncogene: location location location.,"['Nikhil K', 'Shah K']","['Humans', '*Nerve Tissue Proteins/genetics', '*Apoptosis', 'Oncogenes', 'Cytoplasm/metabolism', 'Genes, Tumor Suppressor', 'Cyclin-Dependent Kinase 5/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37993880/
994,CDK5,18325333,CDK5 activator p35 downregulates E-cadherin precursor independently of CDK5.,"['Lin S', 'Wang J', 'Ye Z', 'Ip NY', 'Lin SC']","['Cell Line', 'Cyclin-Dependent Kinase 5/*physiology', 'Down-Regulation/*physiology', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/18325333/
995,CDK5,29076761,CDK5 in oncology: recent advances and future prospects.,"['Lenjisa JL', 'Tadesse S', 'Khair NZ', 'Kumarasiri M', 'Yu M', 'Albrecht H', 'Milne R', 'Wang S']","['Antineoplastic Agents/*chemistry/*pharmacology', 'Cell Cycle', 'Cyclin-Dependent Kinase 5/antagonists & inhibitors/*metabolism', 'Humans', 'Molecular Structure', 'Molecular Targeted Therapy/methods', 'Neoplastic Stem Cells/drug effects/metabolism', 'Protein Binding', 'Protein Conformation', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/29076761/
996,CDK5,31534152,A mitotic CDK5-PP4 phospho-signaling cascade primes 53BP1 for DNA repair in G1.,"['Zheng XF', 'Acharya SS', 'Choe KN', 'Nikhil K', 'Adelmant G', 'Satapathy SR', 'Sharma S', 'Viccaro K', 'Rana S', 'Natarajan A', 'Sicinski P', 'Marto JA', 'Shah K', 'Chowdhury D']","['Cell Line, Tumor', 'Cyclin-Dependent Kinase 5/*metabolism', 'DNA Damage/genetics', 'DNA Repair/*genetics', 'G1 Phase/*genetics', 'HEK293 Cells', 'HeLa Cells', 'Humans', 'Mitosis/genetics', 'Phosphoprotein Phosphatases/*metabolism', 'Phosphorylation', 'RNA Interference', 'RNA, Small Interfering/genetics', 'Tumor Suppressor p53-Binding Protein 1/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31534152/
997,AXL,37328828,AXL in cancer: a modulator of drug resistance and therapeutic target.,"['Tang Y', 'Zang H', 'Wen Q', 'Fan S']","['Humans', '*Axl Receptor Tyrosine Kinase', 'c-Mer Tyrosine Kinase/metabolism', 'Drug Resistance, Neoplasm', '*Neoplasms/drug therapy/genetics', 'Proto-Oncogene Proteins/metabolism', 'Receptor Protein-Tyrosine Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37328828/
998,AXL,27703029,New twists in the AXL(e) of tumor progression.,"['Halmos B', 'Haura EB']","['Female', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Ovarian Neoplasms/genetics/*metabolism', 'Proto-Oncogene Proteins/genetics/*metabolism', 'Receptor Protein-Tyrosine Kinases/genetics/*metabolism', 'Axl Receptor Tyrosine Kinase']",https://pubmed.ncbi.nlm.nih.gov/27703029/
999,AXL,33954117,"AXL, an Important Host Factor for DENV and ZIKV Replication.","['Xie S', 'Zhang H', 'Liang Z', 'Yang X', 'Cao R']","['Carrier Proteins', '*Dengue Virus', '*Flavivirus', 'Humans', 'Virus Replication', '*Zika Virus', '*Zika Virus Infection']",https://pubmed.ncbi.nlm.nih.gov/33954117/
1000,AXL,34244439,"The GAS6-AXL signaling pathway triggers actin remodeling that drives membrane ruffling, macropinocytosis, and cancer-cell invasion.","['Zdzalik-Bielecka D', 'Poswiata A', 'Kozik K', 'Jastrzebski K', 'Schink KO', 'Brewinska-Olchowik M', 'Piwocka K', 'Stenmark H', 'Miaczynska M']","['Actin Cytoskeleton/metabolism', 'Actins/*metabolism', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Cell Surface Extensions/*metabolism', 'Enzyme Activation/drug effects', 'Focal Adhesions/drug effects/metabolism', 'Glioblastoma/pathology', 'Glutamine/pharmacology', 'HEK293 Cells', 'Humans', 'Intercellular Signaling Peptides and Proteins/*metabolism', 'Models, Biological', 'Neoplasm Invasiveness', 'Neoplasms/*metabolism/*pathology', 'Phosphatidylinositol 3-Kinases/metabolism', '*Pinocytosis', 'Protein Binding', 'Proto-Oncogene Proteins/*metabolism', 'Receptor Protein-Tyrosine Kinases/*metabolism', '*Signal Transduction', 'rac1 GTP-Binding Protein/metabolism', 'Axl Receptor Tyrosine Kinase']",https://pubmed.ncbi.nlm.nih.gov/34244439/
1001,AXL,38493215,Axl and MerTK regulate synovial inflammation and are modulated by IL-6 inhibition in rheumatoid arthritis.,"['Nerviani A', 'Boutet MA', 'Ghirardi GM', 'Goldmann K', 'Sciacca E', 'Rivellese F', 'Pontarini E', 'Prediletto E', 'Abatecola F', 'Caliste M', 'Pagani S', 'Mauro D', 'Bellan M', 'Cubuk C', 'Lau R', 'Church SE', 'Hudson BM', 'Humby F', 'Bombardieri M', 'Lewis MJ', 'Pitzalis C']","['Humans', '*Arthritis, Rheumatoid', 'Axl Receptor Tyrosine Kinase', 'c-Mer Tyrosine Kinase/genetics/metabolism', 'Inflammation/metabolism', 'Interleukin-6/metabolism', 'Proto-Oncogene Proteins/genetics/metabolism', '*Receptor Protein-Tyrosine Kinases/genetics/metabolism', 'Synovial Membrane/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38493215/
1002,AXL,34598944,An Evolving Role for AXL in Metastatic Renal Cell Carcinoma.,"['Hahn AW', 'George DJ', 'Agarwal N']","['B7-H1 Antigen', '*Carcinoma, Renal Cell/drug therapy/genetics', 'Humans', '*Kidney Neoplasms/drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/34598944/
1003,AXL,36920638,AXL Inhibitors: Status of Clinical Development.,"['Bhalla S', 'Gerber DE']","['Humans', '*Axl Receptor Tyrosine Kinase', 'Receptor Protein-Tyrosine Kinases', 'Proto-Oncogene Proteins/therapeutic use', 'Signal Transduction', '*Neoplasms/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/36920638/
1004,AXL,34600239,Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors.,"['Ng PS', 'Foo K', 'Sim S', 'Wang G', 'Huang C', 'Tan LH', 'Poulsen A', 'Liu B', 'Tee DHY', 'Ahmad NHB', 'Wang S', 'Ke Z', 'Lee MA', 'Kwek ZP', 'Joy J', 'Anantharajan J', 'Baburajendran N', 'Pendharkar V', 'Manoharan V', 'Vuddagiri S', 'Sangthongpitag K', 'Hill J', 'Keller TH', 'Hung AW']","['Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Dose-Response Relationship, Drug', '*Drug Discovery', 'Humans', 'Indazoles/chemical synthesis/chemistry/*pharmacology', 'Models, Molecular', 'Molecular Structure', 'Protein Kinase Inhibitors/chemical synthesis/chemistry/*pharmacology', 'Proto-Oncogene Proteins/*antagonists & inhibitors/metabolism', 'Receptor Protein-Tyrosine Kinases/*antagonists & inhibitors/metabolism', 'Structure-Activity Relationship', 'Axl Receptor Tyrosine Kinase']",https://pubmed.ncbi.nlm.nih.gov/34600239/
1005,AXL,37864955,AXL - a new player in resistance to HER2 blockade.,"['Adam-Artigues A', 'Arenas EJ', 'Arribas J', 'Prat A', 'Cejalvo JM']","['Female', 'Humans', '*Axl Receptor Tyrosine Kinase/metabolism', '*Breast Neoplasms/drug therapy/genetics/pathology', 'Cell Line, Tumor', 'Drug Resistance, Neoplasm/genetics', 'Proto-Oncogene Proteins/genetics', 'Receptor Protein-Tyrosine Kinases']",https://pubmed.ncbi.nlm.nih.gov/37864955/
1006,AXL,31218961,Research Progress of Axl Inhibitors.,"['Sun ZG', 'Liu JH', 'Zhang JM', 'Qian Y']","['Humans', 'Molecular Structure', 'Neoplasms/*drug therapy/metabolism', 'Protein Kinase Inhibitors/chemistry/*pharmacology', 'Proto-Oncogene Proteins/*antagonists & inhibitors/genetics/metabolism', 'Receptor Protein-Tyrosine Kinases/*antagonists & inhibitors/genetics/metabolism', 'Structure-Activity Relationship', 'Axl Receptor Tyrosine Kinase']",https://pubmed.ncbi.nlm.nih.gov/31218961/
1007,AXL,22071539,Axl of evil?,['Aplin AE'],"['Humans', 'Melanoma/*metabolism', 'Melanoma-Specific Antigens/*metabolism', 'Microphthalmia-Associated Transcription Factor/*metabolism', 'Proto-Oncogene Proteins/*metabolism', 'Receptor Protein-Tyrosine Kinases/*metabolism', 'Skin Neoplasms/*metabolism', 'Axl Receptor Tyrosine Kinase']",https://pubmed.ncbi.nlm.nih.gov/22071539/
1008,AXL,38342232,AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.,"['Morimoto K', 'Yamada T', 'Hirai S', 'Katayama Y', 'Fukui S', 'Sawada R', 'Tachibana Y', 'Matsui Y', 'Nakamura R', 'Ishida M', 'Kawachi H', 'Kunimasa K', 'Sasaki T', 'Nishida M', 'Furuya N', 'Watanabe S', 'Shiotsu S', 'Nishioka N', 'Horinaka M', 'Sakai T', 'Uehara H', 'Yano S', 'Son BK', 'Tokuda S', 'Takayama K']","['Humans', '*Carcinoma, Non-Small-Cell Lung/drug therapy/genetics', '*Lung Neoplasms/drug therapy/genetics', 'Proto-Oncogene Proteins p21(ras)/genetics', 'Signal Transduction', 'Apoptosis', 'Pathologic Complete Response', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/38342232/
1009,AXL,29967225,Synergistic inactivation of AXL: a (cross)road to cure ovarian cancer?,['Zurzolo C'],"['Cell Adhesion Molecules', 'Female', 'GPI-Linked Proteins', 'Humans', '*Ovarian Neoplasms', 'Phosphoric Monoester Hydrolases', '*Proto-Oncogene Proteins', 'Receptor-Like Protein Tyrosine Phosphatases, Class 5']",https://pubmed.ncbi.nlm.nih.gov/29967225/
1010,AXL,32457442,Axl and immune checkpoints inhibitors from fruiting bodies of Pleurocybella porrigens.,"['Ridwan AY', 'Wu J', 'Harada E', 'D Alessandro-Gabazza CN', 'Toda M', 'Yasuma T', 'Gabazza EC', 'Choi JH', 'Hirai H', 'Kawagishi H']","['4-Butyrolactone/*analogs & derivatives/chemistry/isolation & purification/pharmacology', 'A549 Cells/drug effects', 'Agaricales/*chemistry', 'Antineoplastic Agents/chemistry/*isolation & purification/pharmacology', 'Fruiting Bodies, Fungal/*chemistry', 'Humans', 'Immune Checkpoint Inhibitors/chemistry/*isolation & purification/pharmacology', 'Magnetic Resonance Spectroscopy', 'Molecular Structure', 'Proto-Oncogene Proteins/*antagonists & inhibitors', 'Receptor Protein-Tyrosine Kinases/*antagonists & inhibitors', 'Axl Receptor Tyrosine Kinase']",https://pubmed.ncbi.nlm.nih.gov/32457442/
1011,PIM1,38016478,PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.,"['Torres-Ayuso P', 'Katerji M', 'Mehlich D', 'Lookingbill SA', 'Sabbasani VR', 'Liou H', 'Casillas AL', 'Chauhan SS', 'Serwa R', 'Rubin MR', 'Marusiak AA', 'Swenson RE', 'Warfel NA', 'Brognard J']","['Male', 'Humans', '*Drug Resistance, Neoplasm', '*Prostatic Neoplasms/drug therapy/pathology', 'Phosphorylation', 'Apoptosis', 'Cell Proliferation', 'Protein Kinase Inhibitors/pharmacology/therapeutic use', 'Proto-Oncogene Proteins c-pim-1']",https://pubmed.ncbi.nlm.nih.gov/38016478/
1012,PIM1,36195600,Multicellular immune dynamics implicate PIM1 as a potential therapeutic target for uveitis.,"['Li H', 'Xie L', 'Zhu L', 'Li Z', 'Wang R', 'Liu X', 'Huang Z', 'Chen B', 'Gao Y', 'Wei L', 'He C', 'Ju R', 'Liu Y', 'Liu X', 'Zheng Y', 'Su W']","['*Autoimmune Diseases', 'Humans', 'Proto-Oncogene Proteins c-akt/metabolism', 'Proto-Oncogene Proteins c-pim-1/genetics/metabolism', 'Th17 Cells', '*Uveitis/drug therapy/genetics', '*Uveomeningoencephalitic Syndrome/drug therapy/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36195600/
1013,PIM1,37797010,PIM1 controls GBP1 activity to limit self-damage and to guard against pathogen infection.,"['Fisch D', 'Pfleiderer MM', 'Anastasakou E', 'Mackie GM', 'Wendt F', 'Liu X', 'Clough B', 'Lara-Reyna S', 'Encheva V', 'Snijders AP', 'Bando H', 'Yamamoto M', 'Beggs AD', 'Mercer J', 'Shenoy AR', 'Wollscheid B', 'Maslowski KM', 'Galej WP', 'Frickel EM']","['Humans', '*GTP-Binding Proteins/genetics/metabolism', '*Immunity, Innate', '*Interferon-gamma/metabolism', '*Proto-Oncogene Proteins c-pim-1/metabolism', '*Toxoplasma', '*Toxoplasmosis/immunology', 'Virulence Factors/metabolism', 'Macrophages/immunology', '14-3-3 Proteins/metabolism', '*Host-Pathogen Interactions/immunology']",https://pubmed.ncbi.nlm.nih.gov/37797010/
1014,PIM1,36068222,PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest.,"['Yuan Y', 'Wang C', 'Zhuang X', 'Lin S', 'Luo M', 'Deng W', 'Zhou J', 'Liu L', 'Mao L', 'Peng W', 'Chen J', 'Wang Q', 'Shu Y', 'Xue Y', 'Huang P']","['Cell Cycle', 'Cell Cycle Checkpoints/genetics', 'Drug Resistance, Neoplasm', '*Ferroptosis/genetics', 'Humans', 'Phosphorylation', 'Protein Serine-Threonine Kinases', 'Proto-Oncogene Proteins c-pim-1/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36068222/
1015,PIM1,8427586,Transcriptional attenuation of PIM-1 gene.,"['Nagarajan L', 'Narayana L']","['Exons', '*Gene Expression Regulation', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism', 'Luciferases/genetics', 'Promoter Regions, Genetic', 'Protein Serine-Threonine Kinases/*genetics', 'Proto-Oncogene Proteins/*genetics', 'Proto-Oncogene Proteins c-pim-1', 'RNA, Messenger/metabolism', '*Transcription, Genetic', 'Transfection', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/8427586/
1016,PIM1,21734463,An RNA G-quadruplex in the 3' UTR of the proto-oncogene PIM1 represses translation.,"['Arora A', 'Suess B']","[""3' Untranslated Regions/*genetics"", 'Cell Line, Tumor', 'Circular Dichroism', 'Fungal Proteins', '*G-Quadruplexes', 'Genes, Reporter', 'HeLa Cells', 'Humans', 'Mitogen-Activated Protein Kinases/*genetics', 'Nucleic Acid Conformation', 'Protein Biosynthesis', 'Proto-Oncogene Mas', '*RNA Processing, Post-Transcriptional', 'RNA, Messenger/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/21734463/
1017,PIM1,21743487,The proto-oncogene Pim-1 is a target of miR-33a.,"['Thomas M', 'Lange-Grunweller K', 'Weirauch U', 'Gutsch D', 'Aigner A', 'Grunweller A', 'Hartmann RK']","[""3' Untranslated Regions/*genetics"", 'Apoptosis', 'Base Sequence', 'Binding Sites/genetics', 'Blotting, Western', 'Cell Line, Tumor', 'Cell Proliferation', 'Gene Expression Profiling', 'Genes, Tumor Suppressor', 'HEK293 Cells', 'Hep G2 Cells', 'Humans', 'K562 Cells', 'MicroRNAs/*genetics/metabolism', 'Molecular Mimicry/genetics', 'Neoplasms/genetics/metabolism/pathology', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-pim-1/*genetics/metabolism', 'RNA Interference', 'Reverse Transcriptase Polymerase Chain Reaction', 'Sequence Homology, Nucleic Acid', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/21743487/
1018,PIM1,35298007,"Synthesis of Fused Quinoline Derivatives With Antiproliferative Activities and Tyrosine Kinases, Pim-1 Kinase Inhibitions.","['Mohareb RM', 'Ibrahim RA', 'Elmetwally AM', 'Gamaan MS']","['Cell Line, Tumor', 'Cell Proliferation', 'Drug Screening Assays, Antitumor', 'Molecular Structure', 'Protein Kinase Inhibitors/pharmacology', '*Proto-Oncogene Proteins c-pim-1', '*Quinolines/pharmacology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/35298007/
1019,PIM1,25040935,PIM-1 modulates cellular senescence and links IL-6 signaling to heterochromatin formation.,"['Jin B', 'Wang Y', 'Wu CL', 'Liu KY', 'Chen H', 'Mao ZB']","['Cellular Senescence/physiology', 'Fibroblasts/cytology/metabolism', 'Heterochromatin/*metabolism', 'Humans', 'Interleukin-6/*metabolism', 'Phosphorylation', 'Proto-Oncogene Mas', 'Proto-Oncogene Proteins c-pim-1/*metabolism', 'STAT3 Transcription Factor/metabolism', 'Signal Transduction', 'Transcriptional Activation', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/25040935/
1020,PIM1,32407627,Structure-Based Optimization of 10-DEBC Derivatives as Potent and Selective Pim-1 Kinase Inhibitors.,"['Li G', 'Zhang W', 'Xie Y', 'Li Y', 'Cao R', 'Zheng G', 'Huang N', 'Zhou Y']","['*Antineoplastic Agents/pharmacology', 'Protein Kinase Inhibitors/pharmacology', '*Proto-Oncogene Proteins c-pim-1/metabolism', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/32407627/
1021,ADRB3,34260097,Association between the Trp64Arg polymorphism of the ADRB3 gene and overactive bladder.,"['Cirakoglu A', 'Fejzullahu A', 'Benli E', 'Yuce A', 'Ayyildiz A', 'Aynacioglu AS']","['Alleles', 'Female', 'Humans', 'Male', 'Polymorphism, Genetic', 'Receptors, Adrenergic, beta-3/genetics', '*Urinary Bladder, Overactive/genetics']",https://pubmed.ncbi.nlm.nih.gov/34260097/
1022,ADRB3,30580338,Adipocyte ADRB3 Down-Regulated in Chinese Overweight Individuals Adipocyte ADRB3 in Overweight.,"['Cao WY', 'Liu Z', 'Guo F', 'Yu J', 'Li H', 'Yin X']","['Adipocytes/*metabolism', 'Adipose Tissue/metabolism', 'Adult', 'Aged', 'Asian People/genetics', 'Cells, Cultured', 'Down-Regulation/genetics', 'Female', 'Humans', 'Insulin Resistance/genetics', 'Male', 'Middle Aged', 'Obesity/ethnology/genetics/metabolism', 'Overweight/ethnology/*genetics/metabolism', 'Primary Cell Culture', 'Receptors, Adrenergic, beta-3/*genetics/metabolism', 'Uncoupling Protein 1/genetics/metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30580338/
1023,ADRB3,32430022,"The Trp64Arg polymorphism in beta3 adrenergic receptor (ADRB3) gene is associated with adipokines and plasma lipids: a systematic review, meta-analysis, and meta-regression.","['Luo Z', 'Zhang T', 'Wang S', 'He Y', 'Ye Q', 'Cao W']","['Female', 'Humans', 'Male', '*Adiponectin/blood/genetics/metabolism', 'Cholesterol/blood', 'Cholesterol, HDL/blood', '*Dyslipidemias/blood/epidemiology/genetics/metabolism', 'Gene Expression Regulation', 'Genetic Predisposition to Disease', '*Leptin/blood/genetics/metabolism', 'Lipids/blood', '*Obesity/blood/genetics/metabolism', '*Polymorphism, Single Nucleotide', '*Receptors, Adrenergic, beta-3/genetics/metabolism', 'Sex Factors', 'Triglycerides/blood']",https://pubmed.ncbi.nlm.nih.gov/32430022/
1024,ADRB3,32008426,The ADRB3 rs4994 polymorphism increases risk of childhood and adolescent overweight/obesity for East Asia's population: an evidence-based meta-analysis.,"['Xie C', 'Hua W', 'Zhao Y', 'Rui J', 'Feng J', 'Chen Y', 'Liu Y', 'Liu J', 'Yang X', 'Xu X']","['Adolescent', 'Child', 'Asia, Eastern', 'Genotype', 'Humans', 'Obesity/*genetics', 'Overweight/*genetics', 'Polymorphism, Single Nucleotide/*drug effects', 'Receptors, Adrenergic, beta-3/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/32008426/
1025,ADRB3,17570158,Is the beta3-adrenoceptor (ADRB3) a potential target for uterorelaxant drugs?,"['Bardou M', 'Rouget C', 'Breuiller-Fouche M', 'Loustalot C', 'Naline E', 'Sagot P', 'Frydman R', 'Morcillo EJ', 'Advenier C', 'Leroy MJ', 'Morrison JJ']","['*Adrenergic beta-3 Receptor Agonists', 'Adrenergic beta-Agonists/metabolism/*pharmacology', 'Female', 'Humans', 'Muscle Relaxation/drug effects', 'Myometrium/*drug effects', 'Obstetric Labor, Premature/*drug therapy/prevention & control', 'Pregnancy', 'Receptors, Adrenergic, beta-3/metabolism', 'Uterine Contraction/*drug effects', 'Uterus/metabolism']",https://pubmed.ncbi.nlm.nih.gov/17570158/
1026,ADRB3,18574485,The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals.,"['Kurokawa N', 'Young EH', 'Oka Y', 'Satoh H', 'Wareham NJ', 'Sandhu MS', 'Loos RJ']","['Anthropometry', '*Body Mass Index', 'Female', 'Genotype', 'Heterozygote', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Receptors, Adrenergic, beta-3/*genetics/physiology']",https://pubmed.ncbi.nlm.nih.gov/18574485/
1027,ADRB3,31977906,"Stratified meta-analysis by ethnicity revealed that ADRB3 Trp64Arg polymorphism was associated with coronary artery disease in Asians, but not in Caucasians.","['Chen Y', 'Liao Y', 'Sun S', 'Lin F', 'Li R', 'Lan S', 'Zhao X', 'Qin J', 'Rao S']","['Asian People/statistics & numerical data', 'Case-Control Studies', 'Coronary Artery Disease/ethnology/*genetics', '*Genetic Predisposition to Disease', 'Humans', 'Polymorphism, Single Nucleotide', '*Receptors, Adrenergic, beta-3', 'White People/statistics & numerical data']",https://pubmed.ncbi.nlm.nih.gov/31977906/
1028,ADRB3,23113754,ADRB3 and PPARgamma2 gene polymorphisms and their association with cardiovascular disease risk in postmenopausal women.,"['Lwow F', 'Dunajska K', 'Milewicz A', 'Laczmanski L', 'Jedrzejuk D', 'Trzmiel-Bira A', 'Szmigiero L']","['Adiposity/genetics', 'Body Fat Distribution', 'Body Mass Index', 'Cardiovascular Diseases/*genetics', 'Female', 'Genetic Predisposition to Disease/*genetics', 'Humans', 'Insulin Resistance/genetics', 'Lipids/blood', 'Middle Aged', 'Obesity/genetics', 'PPAR gamma/*genetics', 'Poland', 'Polymorphism, Genetic/*genetics', 'Postmenopause/*genetics', 'Receptors, Adrenergic, beta-3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23113754/
1029,ADRB3,29606859,PPARgamma-2 and ADRB3 polymorphisms in connective tissue diseases and lipid disorders.,"['Grygiel-Gorniak B', 'Ziolkowska-Suchanek I', 'Kaczmarek E', 'Mosor M', 'Nowak J', 'Puszczewicz M']","['Adult', 'Aged', 'Alleles', 'Case-Control Studies', 'Connective Tissue Diseases/complications/*genetics', 'Dyslipidemias/complications/drug therapy/*genetics', 'Genotype', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use', 'Lipoproteins, HDL/blood', 'Lipoproteins, LDL/blood', 'Middle Aged', 'PPAR gamma/*genetics', 'Poland', 'Polymorphism, Genetic', 'Receptors, Adrenergic, beta-3/*genetics', 'Triglycerides/blood']",https://pubmed.ncbi.nlm.nih.gov/29606859/
1030,ADRB3,36989522,Association of an ADRB3 Variant with Coronary Artery Disease Within the Chinese Han Population: Construction of a Predictive Nomogram Model.,"['Zhang JY', 'Zhao Q', 'Li XM', 'Liu F', 'Zhao Q', 'Men L', 'Chen QJ', 'Zhai H', 'Yang YN']","['Humans', 'Case-Control Studies', 'China', '*Coronary Artery Disease/genetics', 'East Asian People/genetics', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Nomograms', 'Polymorphism, Single Nucleotide', '*Receptors, Adrenergic, beta-3/genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/36989522/
1031,ADRB3,31802204,"Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder.","['Firat E', 'Aybek Z', 'Akgun S', 'Kucuker K', 'Akca H', 'Aybek H']","['DNA-Binding Proteins/*genetics', 'Humans', '*Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, beta-3/*genetics', 'Transcription Factors/*genetics', 'Urinary Bladder, Overactive/*diagnosis/*genetics', 'rho-Associated Kinases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31802204/
1032,ADRB3,30954083,Methylation profile of the ADRB3 gene and its association with lipid profile and nutritional status in adults.,"['Lima RPA', 'Ribeiro MR', 'de Farias Lima KQ', 'Sena EA', 'de Oliveira Costa D', 'Luna RCP', 'do Nascimento RAF', 'da Conceicao Rodrigues Goncalves M', 'de Toledo Vianna RP', 'de Moraes RM', 'de Oliveira NFP', 'de Almeida ATC', 'de Carvalho Costa MJ']","['Adult', 'Cross-Sectional Studies', 'DNA Methylation/*physiology', 'Energy Intake', 'Feeding Behavior', 'Female', 'Humans', 'Life Style', 'Lipids/*blood', 'Male', 'Middle Aged', 'Nutritional Status', 'Obesity/blood/*genetics/metabolism', 'Receptors, Adrenergic, beta-3/*genetics', 'Socioeconomic Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30954083/
1033,ADRB3,24579945,ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in men.,"['Guay SP', 'Brisson D', 'Lamarche B', 'Biron S', 'Lescelleur O', 'Biertho L', 'Marceau S', 'Vohl MC', 'Gaudet D', 'Bouchard L']","['Cholesterol, LDL/metabolism', '*DNA Methylation', 'Epigenesis, Genetic', 'Genetic Association Studies', 'Genome, Human', 'Humans', 'Hyperlipoproteinemia Type II/*genetics/pathology', 'Hypertension/*genetics', 'Intra-Abdominal Fat/*metabolism', 'Male', 'Obesity, Morbid/complications/*genetics/pathology', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Quantitative Trait Loci', 'RNA, Messenger/genetics', 'Receptors, Adrenergic, beta-3/*blood/*genetics', 'Waist-Hip Ratio', 'White People']",https://pubmed.ncbi.nlm.nih.gov/24579945/
1034,ADRB3,22550477,ADRB3 polymorphism associated with BMI gain in Japanese men.,"['Takeuchi S', 'Katoh T', 'Yamauchi T', 'Kuroda Y']","['Adult', 'Alleles', 'Asian People/*genetics', '*Body Mass Index', 'Body Weight/*genetics', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Japan', 'Life Style', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, beta-3/*genetics', 'Surveys and Questionnaires']",https://pubmed.ncbi.nlm.nih.gov/22550477/
1035,ADRB3,24201118,Significant role of ADRB3 rs4994 towards the development of coronary artery disease.,"['Kumar S', 'Mishra A', 'Srivastava A', 'Mittal T', 'Garg N', 'Mittal B']","['Amplified Fragment Length Polymorphism Analysis', 'Case-Control Studies', 'Chi-Square Distribution', 'Coronary Angiography', 'Coronary Artery Disease/diagnostic imaging/*genetics/physiopathology', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Odds Ratio', 'Phenotype', 'Polymorphism, Restriction Fragment Length', '*Polymorphism, Single Nucleotide', 'Receptors, Adrenergic, alpha-2/genetics', 'Receptors, Adrenergic, beta-1/genetics', 'Receptors, Adrenergic, beta-3/*genetics', 'Risk Factors', 'Stroke Volume', 'Ventricular Function, Left']",https://pubmed.ncbi.nlm.nih.gov/24201118/
1036,PPARG,35466752,Spindle Cell/Sclerosing Rhabdomyosarcoma With PAX8::PPARG Fusion.,"['Rakheja D', 'Park JY', 'Alhasan M', 'Uddin N']","['Male', 'Humans', 'Child, Preschool', 'PPAR gamma/genetics', '*Rhabdomyosarcoma/diagnosis/genetics/pathology', 'Gene Fusion', '*Rhabdomyosarcoma, Embryonal/genetics', 'PAX8 Transcription Factor/genetics', 'DNA-Binding Proteins/genetics', 'Transcription Factors/genetics']",https://pubmed.ncbi.nlm.nih.gov/35466752/
1037,PPARG,29441810,PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.,"['Gonzalez-Castro TB', 'Tovilla-Zarate CA', 'Juarez-Rojop IE', 'Hernandez-Diaz Y', 'Lopez-Narvaez ML', 'Rodriguez-Perez C', 'Gonzalez-Hernandez YK', 'Ramos-Mendez MA']","['Aryldialkylphosphatase/*genetics', 'Biomarkers/*metabolism', 'Coronary Disease/*diagnosis/genetics', 'Genetic Predisposition to Disease', 'Humans', 'Meta-Analysis as Topic', 'Odds Ratio', 'PPAR gamma/*genetics', 'Polymorphism, Single Nucleotide', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/29441810/
1038,PPARG,23100223,PPARGC1A and PPARG genotyping: beginner's guide to genotyping with unlabeled probes.,"['Habalova V', 'Zidzik J']","['DNA Primers/genetics', 'Genotyping Techniques/*methods', 'Heat-Shock Proteins/*genetics', 'Oligonucleotide Probes/metabolism', 'PPAR gamma/*genetics', 'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha', 'Polymerase Chain Reaction', 'Transcription Factors/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23100223/
1039,PPARG,27749844,Prospective functional classification of all possible missense variants in PPARG.,"['Majithia AR', 'Tsuda B', 'Agostini M', 'Gnanapradeepan K', 'Rice R', 'Peloso G', 'Patel KA', 'Zhang X', 'Broekema MF', 'Patterson N', 'Duby M', 'Sharpe T', 'Kalkhoven E', 'Rosen ED', 'Barroso I', 'Ellard S', 'Kathiresan S', ""O'Rahilly S"", 'Chatterjee K', 'Florez JC', 'Mikkelsen T', 'Savage DB', 'Altshuler D']","['Amino Acid Substitution', 'Case-Control Studies', 'Diabetes Mellitus, Type 2/*genetics', 'Female', 'Humans', 'Lipodystrophy/*genetics', 'Macrophages/metabolism/pathology', 'Male', 'Mutation, Missense/*genetics', 'Myocardial Infarction/*genetics', 'PPAR gamma/*genetics', 'Prospective Studies']",https://pubmed.ncbi.nlm.nih.gov/27749844/
1040,PPARG,39417931,A Case of Acinic Cell Carcinoma with SYN2::PPARG Fusion.,"['Dimbleby G', 'Rettino A', 'Jogai S', 'Harinayanan S', 'Patel N', 'Battison S', 'Moutasim K']","['Female', 'Humans', 'Middle Aged', '*Carcinoma, Acinar Cell/genetics/pathology', 'Gene Fusion', 'Oncogene Proteins, Fusion/genetics', 'Parotid Neoplasms/genetics/pathology', 'Salivary Gland Neoplasms/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/39417931/
1041,PPARG,39854214,An Alternatively Translated Isoform of PPARG Suggests AF-1 Domain Inhibition as an Insulin Sensitization Target.,"['Du X', 'Mendez-Lara K', 'Hu S', 'Diao R', 'Bhavimani G', 'Hernandez R', 'Glass K', 'De Arruda Saldanha C', 'Flannick J', 'Heinz S', 'Majithia AR']","['Humans', '*PPAR gamma/genetics/metabolism', '*Protein Isoforms/genetics/metabolism', '*Insulin Resistance/genetics/physiology', 'Protein Domains', 'Insulin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39854214/
1042,PPARG,29402778,Interaction of Vitamin E Intake and Pro12Ala Polymorphism of PPARG with Adiponectin Levels.,"['Campos-Perez W', 'Torres-Castillo N', 'Perez-Robles M', 'Munoz-Valle JF', 'Vizmanos-Lamotte B', 'Martinez-Lopez E']","['Adiponectin/*blood', 'Adolescent', 'Adult', 'Amino Acid Substitution', 'Cross-Sectional Studies', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Nutrigenomics', 'PPAR gamma/*genetics', '*Polymorphism, Single Nucleotide', 'Vitamin E/*administration & dosage', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29402778/
1043,PPARG,39034037,Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study.,"['Xue Y', 'Xia Y', 'Cheng D', 'Shi T', 'Mei P', 'Hong S']","['Humans', '*Psoriasis/drug therapy/genetics/pathology', '*Mendelian Randomization Analysis', '*PPAR gamma/genetics/agonists', 'Genome-Wide Association Study', 'Cholesterol, LDL/blood', 'Pioglitazone/pharmacology', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/39034037/
1044,PPARG,36806620,"Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy.","['Gosseaume C', 'Fournier T', 'Jeru I', 'Vignaud ML', 'Missotte I', 'Archambeaud F', 'Debussche X', 'Droumaguet C', 'Feve B', 'Grillot S', 'Guerci B', 'Hieronimus S', 'Horsmans Y', 'Nobecourt E', 'Pienkowski C', 'Poitou C', 'Thissen JP', 'Lascols O', 'Degrelle S', 'Tsatsaris V', 'Vigouroux C', 'Vatier C']","['Infant, Newborn', 'Humans', 'Female', 'Pregnancy', 'Adult', 'PPAR gamma/genetics', 'Retrospective Studies', 'Acute Disease', '*Pancreatitis', 'Placenta', '*Lipodystrophy', 'Parturition', '*Hypertriglyceridemia', '*Hypertension']",https://pubmed.ncbi.nlm.nih.gov/36806620/
1045,PPARG,22056426,Mechanism of regulation of PPARG expression of mesenchymal stem cells by osteogenesis-mimicking extracellular matrices.,"['Hoshiba T', 'Kawazoe N', 'Chen G']","['Cell Differentiation', 'Chondroitin Sulfates/metabolism', 'Extracellular Matrix/*metabolism', 'Gene Expression Regulation', 'Humans', 'Mesenchymal Stem Cells/cytology/*metabolism', 'Osteogenesis/genetics', 'PPAR gamma/genetics/*metabolism', 'Wnt Signaling Pathway', 'Wnt3A Protein/metabolism', 'beta Catenin/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/22056426/
1046,PPARG,35292786,Relationship of PPARG overexpression with prognostic parameters in papillary thyroid carcinoma.,"['Asya O', 'Yumusakhuylu AC', 'Bagci P', 'Kaya H', 'Gonen A', 'Gundogdu Y', 'Muradov T', 'Sahin A', 'Oysu C']","['Humans', '*PPAR gamma/metabolism', 'Prognosis', 'Thyroid Cancer, Papillary', '*Thyroid Neoplasms/pathology']",https://pubmed.ncbi.nlm.nih.gov/35292786/
1047,HPGD,29282707,A novel mutation in the HPGD gene causing primary hypertrophic osteoarthropathy with digital clubbing in a Pakistani family.,"['Khan AK', 'Muhammad N', 'Khan SA', 'Ullah W', 'Nasir A', 'Afzal S', 'Ramzan K', 'Basit S', 'Khan S']","['Aged', 'Child', 'Consanguinity', 'Female', 'Humans', 'Hydroxyprostaglandin Dehydrogenases/*genetics', 'Male', 'Middle Aged', '*Mutation, Missense', 'Osteoarthropathy, Primary Hypertrophic/*genetics', 'Pakistan', 'Pedigree', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/29282707/
1048,HPGD,33550138,Establishment of a novel human iPSC line (SDQLCHi032-A) derived from a patient with primary hypertrophic osteoarthropathy caused by HPGD homozygous mutation.,"['Li Y', 'Dong R', 'Wang G', 'Zhang H', 'Yang X', 'Li Z', 'Guan J', 'Gai Z', 'Liu Y']","['Female', 'Homozygote', 'Humans', '*Induced Pluripotent Stem Cells', 'Infant', 'Leukocytes, Mononuclear', 'Mutation', '*Osteoarthropathy, Primary Hypertrophic']",https://pubmed.ncbi.nlm.nih.gov/33550138/
1049,HPGD,24760190,Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).,"['Fink SP', 'Yamauchi M', 'Nishihara R', 'Jung S', 'Kuchiba A', 'Wu K', 'Cho E', 'Giovannucci E', 'Fuchs CS', 'Ogino S', 'Markowitz SD', 'Chan AT']","['Aspirin/pharmacology/*therapeutic use', 'Colorectal Neoplasms/*drug therapy/*enzymology/genetics', 'Demography', 'Female', '*Gene Expression Regulation, Enzymologic/drug effects', 'Humans', 'Hydroxyprostaglandin Dehydrogenases/genetics/*metabolism', 'Incidence', 'Intestinal Mucosa/enzymology/pathology', 'Male', 'Middle Aged', 'RNA, Messenger/genetics/metabolism', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/24760190/
1050,HPGD,37055764,Hpgd affects the progression of hypoxic pulmonary hypertension by regulating vascular remodeling.,"['He M', 'Tao K', 'Xiang M', 'Sun J']","['Humans', '*Vascular Remodeling/genetics', '*Hypertension, Pulmonary/etiology', 'Endothelial Cells/metabolism', 'Hypoxia/complications', 'Pulmonary Artery', 'Cell Proliferation/genetics']",https://pubmed.ncbi.nlm.nih.gov/37055764/
1051,HPGD,35813463,Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations.,"['Lu Q', 'Xu Y', 'Li S', 'Zhang Z', 'Sheng J', 'Zhang Z']","['Child, Preschool', 'China', 'DNA Mutational Analysis', 'Dinoprostone', 'Female', 'Humans', 'Hydroxyprostaglandin Dehydrogenases/*genetics', 'Male', 'Mutation', '*Organic Anion Transporters/genetics', '*Osteoarthropathy, Primary Hypertrophic/genetics/urine']",https://pubmed.ncbi.nlm.nih.gov/35813463/
1052,HPGD,20406614,A novel homozygous splice site mutation in the HPGD gene causes mild primary hypertrophic osteoarthropathy.,"['Sinibaldi L', 'Harifi G', 'Bottillo I', 'Iannicelli M', 'El Hassani S', 'Brancati F', 'Dallapiccola B']","['Adolescent', 'Homozygote', 'Humans', 'Hydroxyprostaglandin Dehydrogenases/*genetics', 'Male', 'Osteoarthropathy, Primary Hypertrophic/diagnostic imaging/*genetics', 'Osteoarthropathy, Secondary Hypertrophic/genetics', 'RNA Splice Sites/*genetics', 'Radiography', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/20406614/
1053,HPGD,20299379,Common and recurrent HPGD mutations in Caucasian individuals with primary hypertrophic osteoarthropathy.,"['Diggle CP', 'Carr IM', 'Zitt E', 'Wusik K', 'Hopkin RJ', 'Prada CE', 'Calabrese O', 'Rittinger O', 'Punaro MG', 'Markham AF', 'Bonthron DT']","['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Consanguinity', 'Female', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Hydroxyprostaglandin Dehydrogenases/*genetics', 'Infant', 'Infant, Newborn', 'Male', '*Mutation', 'Osteoarthropathy, Primary Hypertrophic/*genetics/physiopathology', 'Pedigree', 'Phenotype', 'White People/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/20299379/
1054,HPGD,36721997,Follicular fluid progesterone downregulated HPGD and COX2 in granulosa cells via suppressing NF-kB in endometriosisdagger.,"['Li JY', 'Chen JP', 'Qian YL', 'Ma JY', 'Ni FD', 'Lin YF', 'Zhang RJ', 'Ying Y', 'Zhang YY', 'Wang SW', 'Huang Y', 'Liu J', 'Tu MX', 'Ying YY', 'Wu YQ', 'Wu XC', 'Wu BB', 'Zhu B', 'Zhang D']","['Female', 'Humans', 'Progesterone/pharmacology/metabolism', 'Follicular Fluid/metabolism', '*Endometriosis/genetics/metabolism', 'Cyclooxygenase 2/genetics/metabolism', 'NF-kappa B/genetics/metabolism', 'Prospective Studies', 'Granulosa Cells/metabolism', '*Infertility, Female/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36721997/
1055,HPGD,40095474,Predictive role of HPGD gene in carcinogenesis and immune environment monitoring in human cervical cancer.,"['Zhai M', 'Yang W', 'Zou C', 'Du S', 'Wu B', 'Wang C', 'Lu Y', 'Zheng Y']","['Humans', '*Uterine Cervical Neoplasms/genetics/immunology/pathology', 'Female', 'Prognosis', '*Biomarkers, Tumor/genetics', '*Hydroxyprostaglandin Dehydrogenases/genetics/metabolism', 'Tumor Microenvironment/immunology/genetics', 'Carcinogenesis/genetics/immunology', 'Gene Expression Regulation, Neoplastic', 'Middle Aged', 'Computational Biology/methods']",https://pubmed.ncbi.nlm.nih.gov/40095474/
1056,HPGD,37591693,Reclassification of the HPGD p.Ala13Glu variant causing primary hypertrophic osteoarthropathy.,"['Alban JJ', 'Arango-Ramirez A', 'Olave-Rodriguez JA', 'Nastasi-Catanese JA', 'Rodriguez LX']","['Male', 'Humans', '*Osteoarthropathy, Primary Hypertrophic/diagnosis/genetics', 'Hydroxyprostaglandin Dehydrogenases/genetics', 'Homozygote', 'Phenotype', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/37591693/
1057,HPGD,25003827,miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.,"['He N', 'Zheng H', 'Li P', 'Zhao Y', 'Zhang W', 'Song F', 'Chen K']","[""3' Untranslated Regions"", 'Binding Sites', 'Breast Neoplasms/*genetics', 'Case-Control Studies', 'Female', 'Gene Expression Regulation, Enzymologic', 'Gene Expression Regulation, Neoplastic', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Hydroxyprostaglandin Dehydrogenases/*genetics/metabolism', 'MicroRNAs/*genetics', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'RNA Interference', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/25003827/
1058,HPGD,40140750,Two cases of primary hypertrophic osteoarthropathy caused by HPGD variants: a case report and literature review.,"['Li J', 'Jia S', 'Guo J', 'Xie W', 'Ma Y', 'Gao X', 'Gao M']","['Humans', '*Osteoarthropathy, Primary Hypertrophic/genetics/diagnosis', 'Male', 'Hydroxyprostaglandin Dehydrogenases/genetics', 'Female', 'Infant', 'Exome Sequencing', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/40140750/
1059,HPGD,18805827,Mutation in the HPGD gene encoding NAD+ dependent 15-hydroxyprostaglandin dehydrogenase underlies isolated congenital nail clubbing (ICNC).,"['Tariq M', 'Azeem Z', 'Ali G', 'Chishti MS', 'Ahmad W']","['Base Sequence', 'Chromosomes, Human, Pair 4/genetics', 'Consanguinity', 'Dinoprostone/urine', 'Female', 'Genes, Recessive', 'Genetic Linkage', 'Genotype', 'Haplotypes', 'Humans', 'Hydroxyprostaglandin Dehydrogenases/*genetics/metabolism', 'Male', 'Molecular Sequence Data', '*Mutation', 'Nail Diseases/congenital/*genetics/pathology', 'Nails, Malformed/*genetics/*pathology', 'Pedigree', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/18805827/
1060,HPGD,30333561,"Down-regulation of HPGD by miR-146b-3p promotes cervical cancer cell proliferation, migration and anchorage-independent growth through activation of STAT3 and AKT pathways.","['Yao S', 'Xu J', 'Zhao K', 'Song P', 'Yan Q', 'Fan W', 'Li W', 'Lu C']","['Base Sequence', 'Cell Line, Tumor', 'Cell Movement', 'Cell Proliferation', 'Disease Progression', 'Female', '*Gene Expression Regulation, Neoplastic', 'HEK293 Cells', 'HeLa Cells', 'Host-Pathogen Interactions/genetics', 'Human papillomavirus 16/genetics/pathogenicity', 'Human papillomavirus 18/genetics/pathogenicity', 'Humans', 'Hydroxyprostaglandin Dehydrogenases/*genetics/metabolism', 'MicroRNAs/*genetics/metabolism', 'Oncogene Proteins, Viral/genetics/metabolism', 'Papillomavirus E7 Proteins/genetics/metabolism', 'Papillomavirus Infections/*genetics/metabolism/pathology/virology', 'Proto-Oncogene Proteins c-akt/*genetics/metabolism', 'Repressor Proteins/genetics/metabolism', 'STAT3 Transcription Factor/*genetics/metabolism', 'Signal Transduction', 'Uterine Cervical Neoplasms/*genetics/metabolism/pathology/virology']",https://pubmed.ncbi.nlm.nih.gov/30333561/
1061,MPO,29611345,Are PR3 positive and MPO positive GPA the same disease?,"['Fordham S', 'Mukhtyar C']","['Autoantibodies/*blood', 'Biomarkers/blood', 'Diagnosis, Differential', 'Genetic Predisposition to Disease', 'Granulomatosis with Polyangiitis/blood/*diagnosis/genetics/immunology', 'Humans', 'Myeloblastin/*immunology', 'Peroxidase/*immunology', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Predictive Value of Tests', 'Prognosis', 'Risk Factors', 'Toll-Like Receptor 9/genetics/immunology']",https://pubmed.ncbi.nlm.nih.gov/29611345/
1062,MPO,34840232,MPO-ANCA-positive Microscopic Polyangiitis Following COVID-19 Infection.,"['Kawashima S', 'Kishimoto M', 'Hibino T', 'Lee H', 'Sato Y', 'Komagata Y', 'Kaname S']","['*Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis', 'Antibodies, Antineutrophil Cytoplasmic', '*COVID-19', 'Humans', '*Microscopic Polyangiitis/complications/diagnosis', 'Peroxidase', 'SARS-CoV-2']",https://pubmed.ncbi.nlm.nih.gov/34840232/
1063,MPO,39019601,Late-onset Neutropenia after Rituximab Treatment for MPO-ANCA-associated Vasculitis.,"['Watanabe K', 'Shimada N', 'Kanzaki M', 'Fukuoka K', 'Asano K']","['Humans', '*Rituximab/adverse effects/therapeutic use', 'Female', '*Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy/chemically induced/complications', 'Aged, 80 and over', '*Peroxidase/immunology', 'Neutropenia/chemically induced/drug therapy', 'Antibodies, Antineutrophil Cytoplasmic/blood', 'Granulocyte Colony-Stimulating Factor/therapeutic use/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/39019601/
1064,MPO,27339566,"Serum myeloperoxidase (MPO) activity, oxidative and antioxidative parameters in operating room personnel.","['Cegin MB', 'Aslan M', 'Goktas U', 'Isik Y', 'Soyoral L', 'Aksoy N', 'Taskin A', 'Kati I']","['Cross-Sectional Studies', 'Humans', '*Operating Rooms', '*Oxidative Stress', 'Peroxidase/*metabolism', '*Personnel, Hospital', 'Turkey']",https://pubmed.ncbi.nlm.nih.gov/27339566/
1065,MPO,39301845,Generalized pustular psoriasis patient with a heterozygous hypomorphic MPO variant refractory to intravenous spesolimab.,"['Ogawa Y', 'Maejima E', 'Takeichi T', 'Okamoto T', 'Mitsui H', 'Shimada S', 'Akiyama M', 'Kawamura T']","['Humans', '*Psoriasis/genetics/drug therapy/diagnosis', '*Peroxidase/genetics/immunology', 'Heterozygote', 'Male', 'Drug Resistance/genetics', 'Female', 'Interleukin-1/genetics', 'Antibodies, Monoclonal, Humanized/administration & dosage', 'Middle Aged', 'Skin/pathology', 'Interleukins']",https://pubmed.ncbi.nlm.nih.gov/39301845/
1066,MPO,35790206,A Case Report of MPO-ANCA-Associated Vasculitis Following Heterologous mRNA1273 COVID-19 Booster Vaccination.,"['Kim BC', 'Kim HS', 'Han KH', 'Han SY', 'Jo HA']","['Aged', '*Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis/drug therapy/etiology', 'Antibodies, Antineutrophil Cytoplasmic', '*COVID-19', 'Female', '*Glomerulonephritis/pathology', 'Humans', 'Vaccination/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/35790206/
1067,MPO,34620637,Epstein-Barr virus reactivation induced myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis.,"['Noonan TP', 'Konstantinov KN', 'Echevarria L']","['*Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications/diagnosis/drug therapy', 'Antibodies, Antineutrophil Cytoplasmic', '*Epstein-Barr Virus Infections/complications/diagnosis/drug therapy', 'Herpesvirus 4, Human', 'Humans', 'Male', 'Peroxidase']",https://pubmed.ncbi.nlm.nih.gov/34620637/
1068,MPO,21651778,Anti-hLAMP2-antibodies and dual positivity for anti-GBM and MPO-ANCA in a patient with relapsing pulmonary-renal syndrome.,"['Etter C', 'Gaspert A', 'Regenass S', 'Wuthrich RP', 'Kistler T', 'Kain R', 'Cohen CD']","['Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology', 'Antibodies, Anti-Idiotypic/*blood', 'Antibodies, Antineutrophil Cytoplasmic/*blood', 'Autoantibodies/*blood', 'Female', 'Glomerulonephritis/blood/*immunology/therapy', 'Hemorrhage/blood/*immunology/therapy', 'Humans', 'Immunosuppressive Agents/therapeutic use', 'Lung Diseases/blood/*immunology/therapy', 'Lysosomal-Associated Membrane Protein 2', 'Lysosomal Membrane Proteins/*immunology', 'Middle Aged', 'Plasmapheresis', 'Recurrence', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/21651778/
1069,MPO,8296651,Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study.,"['Gregorini G', 'Ferioli A', 'Donato F', 'Tira P', 'Morassi L', 'Tardanico R', 'Lancini L', 'Maiorca R']","['Antibodies, Antineutrophil Cytoplasmic', 'Autoantibodies/*blood', 'Case-Control Studies', 'Glomerulonephritis/*chemically induced/epidemiology/*immunology', 'Humans', 'Immunoglobulin G/*blood', 'Male', 'Middle Aged', 'Necrosis', 'Occupational Diseases/*chemically induced/immunology', 'Peroxidase/immunology', 'Silicon Dioxide/*poisoning']",https://pubmed.ncbi.nlm.nih.gov/8296651/
1070,MPO,39434323,Determination of Serum Myeloperoxidase (MPO) and lactate dehydrogenase (LDH) as a tumour Marker in Chronic Myeloid Leukaemia (CML).,"['Wahhab Ali KA', 'Ahmed AA', 'Mohammed ST']","['Humans', '*Peroxidase/blood', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood/drug therapy', 'Adult', 'Male', 'Female', 'Case-Control Studies', 'Middle Aged', '*L-Lactate Dehydrogenase/blood', '*Biomarkers, Tumor/blood', 'Protein Kinase Inhibitors/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/39434323/
1071,MPO,16053470,MPO-ANCA-associated pseudovasculitis in cardiac myxoma.,"['Nishio Y', 'Ito Y', 'Iguchi Y', 'Sato H']","['Adult', 'Antibodies, Antineutrophil Cytoplasmic/*metabolism', 'Autoantibodies/analysis', 'Granulocyte Colony-Stimulating Factor', 'Heart Neoplasms/*immunology/physiopathology', 'Hematopoietic Cell Growth Factors/*metabolism', 'Humans', 'Interleukin-3', 'Interleukin-6/*metabolism', 'Male', 'Monocytes/pathology', 'Myxoma/*immunology/physiopathology', 'Neutrophils/pathology', 'Peroxidase/*immunology', 'Recombinant Fusion Proteins/*metabolism', 'Recombinant Proteins', 'Vasculitis/*diagnosis/etiology']",https://pubmed.ncbi.nlm.nih.gov/16053470/
1072,MPO,11422808,Histological diversity of vasculitic lesions in MPO-ANCA-positive autopsy cases.,"['Sano K', 'Sakaguchi N', 'Ito M', 'Koyama M', 'Kobayashi M', 'Hotchi M']","['Aged', 'Aged, 80 and over', '*Antibodies, Antineutrophil Cytoplasmic/blood', 'Female', 'Glomerulonephritis/complications/metabolism/pathology', 'Hemorrhage/complications/metabolism/pathology', 'Humans', 'Kidney Glomerulus/immunology/pathology', 'Lung Diseases/complications/metabolism/pathology', 'Male', 'Middle Aged', '*Peroxidase/immunology', 'Polyarteritis Nodosa/immunology/pathology', 'Pulmonary Alveoli/immunology/pathology', 'Syndrome', 'Vasculitis/blood/immunology/*pathology']",https://pubmed.ncbi.nlm.nih.gov/11422808/
1073,MPO,38564324,Avacopan's potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitis.,"['Taniguchi T', 'Hiwa R', 'Shoji M', 'Yamaguchi E', 'Shirakashi M', 'Onizawa H', 'Tsuji H', 'Kitagori K', 'Nakashima R', 'Akizuki S', 'Onishi A', 'Yoshifuji H', 'Tanaka M', 'Morinobu A']","['Humans', 'Aged', '*Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnostic imaging/immunology', 'Positron Emission Tomography Computed Tomography', '*Peroxidase/immunology', 'Neutrophils/immunology', 'Cytoplasm/immunology', 'Immunoassay']",https://pubmed.ncbi.nlm.nih.gov/38564324/
1074,MPO,9631850,MPO-ANCA-positive crescentic necrotizing glomerulonephritis and tubulointerstitial nephritis with renal eosinophilic infiltration and peripheral blood eosinophilia.,"['Yamamoto T', 'Yoshihara S', 'Suzuki H', 'Nagase M', 'Oka M', 'Hishida A']","['Aged', 'Antibodies, Antineutrophil Cytoplasmic/*analysis', 'Autoantibodies/*analysis', 'Eosinophilia/*complications', 'Eosinophils/*pathology', 'Female', 'Glomerulonephritis/*complications/immunology/pathology', 'Humans', 'Kidney/*pathology', 'Nephritis, Interstitial/*complications/pathology', 'Peroxidase/*immunology']",https://pubmed.ncbi.nlm.nih.gov/9631850/
1075,MPO,36389826,Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.,"['Hu X', 'Shen C', 'Meng T', 'Ooi JD', 'Eggenhuizen PJ', 'Zhou YO', 'Luo H', 'Chen JB', 'Lin W', 'Gong Y', 'Xiong Q', 'Xu J', 'Liu N', 'Xiao X', 'Tang R', 'Zhong Y']","['Humans', 'Antibodies, Antineutrophil Cytoplasmic', 'Peroxidase', '*Anti-Glomerular Basement Membrane Disease/diagnosis/therapy/complications', 'Creatinine', 'Retrospective Studies', '*Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis', 'Prognosis', '*Kidney Failure, Chronic/etiology']",https://pubmed.ncbi.nlm.nih.gov/36389826/
1076,GLO1,39434012,GLO1 regulates hepatocellular carcinoma proliferation and migration through the cell cycle pathway.,"['Zhang Y', 'Tang X', 'Liu L', 'Cai D', 'Gou S', 'Hao S', 'Li Y', 'Shen J', 'Chen Y', 'Zhao Y', 'Wu X', 'Li M', 'Chen M', 'Li X', 'Sun Y', 'Gu L', 'Li W', 'Wang F', 'Zhang Z', 'Wang X', 'Deng S', 'Xiao Z', 'Yao L', 'Du F']","['Humans', '*Carcinoma, Hepatocellular/genetics/pathology/metabolism', '*Liver Neoplasms/genetics/pathology/metabolism', '*Lactoylglutathione Lyase/genetics/metabolism', '*Cell Proliferation/genetics', '*Cell Movement/genetics', '*Cell Cycle/genetics', 'Gene Expression Regulation, Neoplastic', 'Prognosis', 'Protein Interaction Maps', 'Cell Line, Tumor', 'Computational Biology/methods', 'Biomarkers, Tumor/genetics/metabolism', 'Female']",https://pubmed.ncbi.nlm.nih.gov/39434012/
1077,GLO1,39142179,Loss of NAMPT and SIRT2 but not SIRT1 attenuate GLO1 expression and activity in human skeletal muscle.,"['Miranda ER', 'Varshney P', 'Mazo CE', 'Shadiow J', 'Ludlow AT', 'Haus JM']","['Humans', '*Muscle, Skeletal/metabolism', '*Lactoylglutathione Lyase/metabolism/genetics', '*Nicotinamide Phosphoribosyltransferase/metabolism/genetics', '*Sirtuin 2/metabolism/genetics', '*Cytokines/metabolism', 'Male', '*Obesity/metabolism/genetics', 'Diabetes Mellitus, Type 2/metabolism/genetics', 'NF-E2-Related Factor 2/metabolism/genetics', 'Female', 'Adult', 'Kelch-Like ECH-Associated Protein 1/metabolism/genetics', 'Gene Expression Regulation', 'Middle Aged', 'Sirtuin 1/metabolism/genetics']",https://pubmed.ncbi.nlm.nih.gov/39142179/
1078,GLO1,31738028,High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients.,"['Tian X', 'Wang Y', 'Ding X', 'Cheng W']","['Biomarkers, Tumor/genetics/metabolism', '*Brain Neoplasms/genetics/pathology', '*Carcinoma, Hepatocellular', 'Cell Line, Tumor', 'Cell Proliferation', '*Glioma/genetics/pathology', 'Humans', '*Lactoylglutathione Lyase/genetics', '*Liver Neoplasms/pathology', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/31738028/
1079,GLO1,30470837,MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells.,"['Xie Z', 'Chooi JY', 'Toh SHM', 'Yang D', 'Basri NB', 'Ho YS', 'Chng WJ']","['Apoptosis/genetics', 'Carcinogenesis/genetics', 'Cell Line, Tumor', 'Cell Survival/genetics', 'Chromatin Immunoprecipitation/methods', 'Chromosomes, Human, Pair 14/*genetics', 'Chromosomes, Human, Pair 4/*genetics', 'Gene Expression Regulation, Neoplastic/genetics', 'Glycolysis/genetics', 'Histone-Lysine N-Methyltransferase/*genetics', 'Humans', 'Lactoylglutathione Lyase/*genetics', 'Multiple Myeloma/*genetics', 'Oncogene Proteins/*genetics', 'Protein Isoforms/genetics', 'Repressor Proteins/*genetics', 'Translocation, Genetic/genetics']",https://pubmed.ncbi.nlm.nih.gov/30470837/
1080,GLO1,8767723,Glyoxalase 1 (GLO1) polymorphism in eight geographical regions of Turkey.,"['Togan I', 'Yilmaz A', 'Erguven A', 'Dereli I', 'Ozbas F']","['Alleles', 'Ethnicity/*genetics', 'Gene Frequency/genetics', '*Genetics, Population', 'Humans', 'Lactoylglutathione Lyase/*genetics', 'Phenotype', 'Polymorphism, Genetic/*genetics', 'Turkey']",https://pubmed.ncbi.nlm.nih.gov/8767723/
1081,GLO1,29307109,miR-137 inhibits melanoma cell proliferation through downregulation of GLO1.,"['Lv N', 'Hao S', 'Luo C', 'Abukiwan A', 'Hao Y', 'Gai F', 'Huang W', 'Huang L', 'Xiao X', 'Eichmuller SB', 'He D']","[""3' Untranslated Regions"", 'Cell Line, Tumor', 'Cell Proliferation/physiology', 'Gene Expression Regulation, Neoplastic/*genetics', 'Gene Knockdown Techniques', 'Humans', 'Lactoylglutathione Lyase/*genetics', 'Melanoma/*metabolism/*pathology', 'MicroRNAs/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29307109/
1082,GLO1,38027126,Association between GLO1 variants and gestational diabetes mellitus susceptibility in a Chinese population: a preliminary study.,"['Zeng Q', 'Yang T', 'Wei W', 'Zou D', 'Wei Y', 'Han F', 'He J', 'Huang J', 'Guo R']","['Pregnancy', 'Female', 'Infant, Newborn', 'Humans', '*Diabetes, Gestational/epidemiology/genetics', 'Blood Glucose/metabolism', 'East Asian People', 'Polymorphism, Single Nucleotide', '*Lactoylglutathione Lyase/genetics/metabolism', 'Weight Gain']",https://pubmed.ncbi.nlm.nih.gov/38027126/
1083,GLO1,38577936,Butyrate increases methylglyoxal production through regulation of the JAK2/Stat3/Nrf2/Glo1 pathway in castration‑resistant prostate cancer cells.,"['Hsia YJ', 'Lin ZM', 'Zhang T', 'Chou TC']","['Humans', 'Male', 'Butyric Acid/pharmacology', 'Janus Kinase 2/metabolism', 'Magnesium Oxide/metabolism', 'NF-E2-Related Factor 2/metabolism', '*Prostatic Neoplasms, Castration-Resistant', 'Pyruvaldehyde/metabolism', 'STAT3 Transcription Factor/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38577936/
1084,GLO1,1840292,"ESD, GLO1, PGD, PGM1 and PGM2 gene frequencies in the Salerno Province (Italy).","['Rickards O', 'Biondi G', 'Tartaglia M', 'De Stefano GF', 'Walter H']","['*Carboxylesterase', 'Carboxylic Ester Hydrolases/genetics', 'Enzymes/*genetics', 'Female', 'Gene Frequency/*genetics', 'Humans', 'Isoenzymes/genetics', 'Italy', 'Lactoylglutathione Lyase/genetics', 'Male', 'Phenotype', 'Phosphoglucomutase/genetics', 'Phosphogluconate Dehydrogenase/genetics', 'Polymorphism, Genetic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/1840292/
1085,GLO1,28929505,High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.,"['Burdelski C', 'Shihada R', 'Hinsch A', 'Angerer A', 'Gobel C', 'Friedrich E', 'Hube-Magg C', 'Burdak-Rothkamm S', 'Kluth M', 'Simon R', 'Moller-Koop C', 'Sauter G', 'Buscheck F', 'Wittmer C', 'Clauditz TS', 'Krech T', 'Tsourlakis MC', 'Minner S', 'Graefen M', 'Schlomm T', 'Wilczak W', 'Jacobsen F']","['Aged', 'Biomarkers, Tumor/biosynthesis', 'Humans', 'Immunohistochemistry', 'Kallikreins/metabolism', 'Lactoylglutathione Lyase/*biosynthesis', 'Male', 'Middle Aged', 'Neoplasm Recurrence, Local/enzymology', 'Prognosis', 'Prostate-Specific Antigen/metabolism', 'Prostatic Neoplasms/*enzymology', 'Tissue Array Analysis']",https://pubmed.ncbi.nlm.nih.gov/28929505/
1086,HRH4,26823878,Association between HRH4 polymorphisms and ankylosing spondylitis susceptibility.,"['Ran B', 'Wang Y', 'Zhang Y', 'Mao K', 'Wang Y']","['Adult', 'Case-Control Studies', 'Chi-Square Distribution', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Haplotypes', 'Heterozygote', 'Homozygote', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Odds Ratio', 'Phenotype', 'Polymerase Chain Reaction', 'Polymorphism, Genetic', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H4', 'Risk Assessment', 'Risk Factors', 'Spondylitis, Ankylosing/diagnosis/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26823878/
1087,HRH4,22653292,Asthma endophenotypes and polymorphisms in the histamine receptor HRH4 gene.,"['Simon T', 'Semsei AF', 'Ungvari I', 'Hadadi E', 'Virag V', 'Nagy A', 'Vangor MS', 'Laszlo V', 'Szalai C', 'Falus A']","['Adolescent', 'Asthma/etiology/*genetics', 'Base Sequence', 'Case-Control Studies', 'Child', 'Child, Preschool', 'Endophenotypes', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Haplotypes', 'Humans', 'Infections/complications', 'Linkage Disequilibrium', 'Male', '*Polymorphism, Single Nucleotide', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H4', 'Risk Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22653292/
1088,HRH4,22363581,Deletion and down-regulation of HRH4 gene in gastric carcinomas: a potential correlation with tumor progression.,"['Zhang C', 'Xiong Y', 'Li J', 'Yang Y', 'Liu L', 'Wang W', 'Wang L', 'Li M', 'Fang Z']","['Case-Control Studies', 'Cell Cycle Proteins/metabolism', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'DNA Copy Number Variations/genetics', '*Disease Progression', 'Down-Regulation/drug effects/*genetics', '*Gene Deletion', 'Gene Dosage/genetics', '*Gene Expression Regulation, Neoplastic/drug effects', 'Genes, Neoplasm/genetics', 'Histamine/pharmacology', 'Humans', 'In Situ Hybridization, Fluorescence', 'RNA, Messenger/genetics/metabolism', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H4', 'Stomach Neoplasms/*genetics/*pathology']",https://pubmed.ncbi.nlm.nih.gov/22363581/
1089,HRH4,21609450,Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression.,"['Fang Z', 'Yao W', 'Xiong Y', 'Li J', 'Liu L', 'Shi L', 'Zhang W', 'Zhang C', 'Nie L', 'Wan J']","['Antimetabolites, Antineoplastic/pharmacology', 'Apoptosis/drug effects', 'Cell Cycle', 'Cell Cycle Proteins/metabolism', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'Colorectal Neoplasms/*physiopathology', 'Cyclic AMP-Dependent Protein Kinases/metabolism', 'Fluorouracil/pharmacology', 'Gene Expression/genetics', 'Gene Expression Regulation, Neoplastic/genetics', 'Histamine H3 Antagonists/pharmacology', 'Humans', 'Imidazoles/pharmacology', 'RNA, Messenger/metabolism', 'Receptors, G-Protein-Coupled/agonists/*metabolism', 'Receptors, Histamine/*metabolism', 'Receptors, Histamine H4', 'Signal Transduction', 'Thiourea/analogs & derivatives/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/21609450/
1090,HRH4,21390145,Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells.,"['Oksaharju A', 'Kankainen M', 'Kekkonen RA', 'Lindstedt KA', 'Kovanen PT', 'Korpela R', 'Miettinen M']","['Adult', 'Down-Regulation', 'Gene Expression Profiling', 'Gene Expression Regulation/*drug effects', 'Humans', 'Inflammation/immunology', 'Lacticaseibacillus rhamnosus/*immunology', 'Mast Cells/cytology/*drug effects/immunology/*physiology', 'Microarray Analysis', 'Probiotics/*pharmacology', 'Receptors, G-Protein-Coupled/*metabolism', 'Receptors, Histamine/*metabolism', 'Receptors, Histamine H4', 'Receptors, IgE/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/21390145/
1091,HRH4,24236486,"Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs.","['Ayuso P', 'Blanca M', 'Cornejo-Garcia JA', 'Torres MJ', 'Dona I', 'Salas M', 'Blanca-Lopez N', 'Canto G', 'Rondon C', 'Campo P', 'Laguna JJ', 'Fernandez J', 'Martinez C', 'Agundez JA', 'Garcia-Martin E']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Anti-Inflammatory Agents, Non-Steroidal/*adverse effects', 'Case-Control Studies', 'Child', 'Child, Preschool', 'DNA Copy Number Variations/*genetics', 'Drug Hypersensitivity/*genetics', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Histamine/*genetics', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H2/*genetics', 'Receptors, Histamine H4', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24236486/
1092,HRH4,30742585,Effect of the Fexofenadine on the expression of HRH-1 and HRH-4 receptor in Peripheral Blood Mononuclear Cell isolated from children with diagnosed allergy - in vitro study Short communication.,"['Kordulewska N', 'Cieslinska A', 'Fiedorowicz E', 'Jarmolowska B', 'Kostyra E']","['Anti-Allergic Agents/*pharmacology', 'Cells, Cultured', 'Child', 'Child, Preschool', 'Female', 'Gene Expression Regulation/drug effects', 'Histamine H1 Antagonists, Non-Sedating/*pharmacology', 'Humans', 'Hypersensitivity/diagnosis/genetics/immunology', 'Leukocytes, Mononuclear/*drug effects/metabolism', 'Male', 'Receptors, Histamine H1/*genetics', 'Receptors, Histamine H4/*genetics', 'Terfenadine/*analogs & derivatives/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/30742585/
1093,PTGER2,38242120,"Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors.","['Pettinella F', 'Mariotti B', 'Lattanzi C', 'Bruderek K', 'Donini M', 'Costa S', 'Marini O', 'Iannoto G', 'Gasperini S', 'Caveggion E', 'Castellucci M', 'Calzetti F', 'Bianchetto-Aguilera F', 'Gardiman E', 'Giani M', 'Dusi S', 'Cantini M', 'Vassanelli A', 'Pavone D', 'Milella M', 'Pilotto S', 'Biondani P', 'Hoing B', 'Schleupner MC', 'Hussain T', 'Hadaschik B', 'Kaspar C', 'Visco C', 'Tecchio C', 'Koenderman L', 'Bazzoni F', 'Tamassia N', 'Brandau S', 'Cassatella MA', 'Scapini P']","['Humans', 'Neutrophils', '*Myeloid-Derived Suppressor Cells/metabolism/pathology', 'Receptors, Prostaglandin E, EP2 Subtype/metabolism', 'Granulocyte Colony-Stimulating Factor/pharmacology/metabolism', '*Neoplasms/pathology', 'CD52 Antigen/metabolism', 'Signaling Lymphocytic Activation Molecule Family/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38242120/
1094,PTGER2,37796697,N6-methyladenosine Methyltransferase METTL3 Enhances PTGER2 Expression to Increase Ovarian Cancer Stemness and Chemoresistance.,"['Lin YB', 'Xu BH']","['Humans', 'Female', '*Receptors, Prostaglandin E, EP2 Subtype', 'Drug Resistance, Neoplasm/genetics', 'Cell Line, Tumor', 'Methyltransferases/genetics/metabolism', '*Ovarian Neoplasms/drug therapy/genetics', 'Adenosine/metabolism', 'RNA']",https://pubmed.ncbi.nlm.nih.gov/37796697/
1095,PTGER2,33545665,Polymorphisms rs2745557 in PTGS2 and rs2075797 in PTGER2 are associated with the risk of chronic obstructive pulmonary disease development in a Tunisian cohort.,"['Mani S', 'Norel X', 'Varret M', 'Bchir S', 'Ben Anes A', 'Garrouch A', 'Tabka Z', 'Longrois D', 'Chahed K']","['Aged', 'Alleles', 'Case-Control Studies', 'Cohort Studies', 'Cyclooxygenase 2/*genetics', 'Cytokines/blood', 'Dinoprostone/blood', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Male', 'Middle Aged', 'Patient Acuity', '*Polymorphism, Single Nucleotide', 'Prostaglandin D2/blood', 'Pulmonary Disease, Chronic Obstructive/blood/*epidemiology/*genetics', 'Receptors, Prostaglandin E, EP2 Subtype/*genetics', 'Receptors, Prostaglandin E, EP4 Subtype/genetics', 'Risk Factors', 'Tunisia/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/33545665/
1096,PTGER2,18666211,"Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation.","['Tian L', 'Suzuki M', 'Nakajima T', 'Kubo R', 'Sekine Y', 'Shibuya K', 'Hiroshima K', 'Nakatani Y', 'Fujisawa T', 'Yoshino I']","['Adenocarcinoma/genetics/mortality/secondary', 'Aged', 'Biomarkers, Tumor/genetics', 'Carcinoma, Non-Small-Cell Lung/*genetics/mortality/secondary', '*DNA Methylation', 'ErbB Receptors/*genetics', 'Female', 'Humans', 'Lung Neoplasms/*genetics/mortality/pathology', 'Male', 'Mutation/*genetics', 'Prognosis', 'RNA, Messenger/genetics/metabolism', 'RNA, Neoplasm/genetics/metabolism', 'Receptors, Prostaglandin E/*genetics', 'Receptors, Prostaglandin E, EP2 Subtype', 'Reverse Transcriptase Polymerase Chain Reaction', 'Survival Rate', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/18666211/
1097,PTGER2,17533365,Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas.,"['Sugino Y', 'Misawa A', 'Inoue J', 'Kitagawa M', 'Hosoi H', 'Sugimoto T', 'Imoto I', 'Inazawa J']","['8-Bromo Cyclic Adenosine Monophosphate/pharmacology', 'Alprostadil/analogs & derivatives/pharmacology', 'Cell Growth Processes/drug effects/genetics', 'Cell Line, Tumor', 'Chromatin Immunoprecipitation', 'CpG Islands', 'DNA Methylation', 'Dinoprostone/pharmacology', 'Disease Progression', 'Epigenesis, Genetic', 'Gene Expression Regulation, Neoplastic', 'Gene Silencing', '*Genes, Tumor Suppressor', 'Humans', 'Neuroblastoma/*genetics/metabolism/*pathology', 'Promoter Regions, Genetic', 'RNA, Messenger/biosynthesis/genetics', 'Receptors, Immunologic/biosynthesis/genetics', 'Receptors, Prostaglandin/biosynthesis/genetics', 'Receptors, Prostaglandin E/biosynthesis/*genetics', 'Receptors, Prostaglandin E, EP2 Subtype']",https://pubmed.ncbi.nlm.nih.gov/17533365/
1098,PTGER2,17761898,PTGER1 and PTGER2 receptors mediate regulation of progesterone synthesis and type 1 11beta-hydroxysteroid dehydrogenase activity by prostaglandin E2 in human granulosa lutein cells.,"['Chandras C', 'Harris TE', 'Bernal AL', 'Abayasekara DR', 'Michael AE']","['11-beta-Hydroxysteroid Dehydrogenase Type 1/*metabolism', 'Alprostadil/analogs & derivatives/pharmacology', 'Cells, Cultured', 'Cortisone/metabolism', 'Cyclic AMP/metabolism', 'Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide/pharmacology', 'Dinoprostone/*pharmacology', 'Dose-Response Relationship, Drug', 'Female', 'Humans', 'Hydrocortisone/metabolism', 'Luteal Cells/drug effects/*metabolism', 'Progesterone/*biosynthesis', 'Prostaglandin Antagonists/pharmacology', 'Prostaglandins E, Synthetic/pharmacology', 'Receptors, Prostaglandin E/*metabolism', 'Receptors, Prostaglandin E, EP1 Subtype', 'Receptors, Prostaglandin E, EP2 Subtype', 'Xanthones/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/17761898/
1099,PTGER2,20200425,"PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.","['Baba Y', 'Nosho K', 'Shima K', 'Goessling W', 'Chan AT', 'Ng K', 'Chan JA', 'Giovannucci EL', 'Fuchs CS', 'Ogino S']","['Biomarkers, Tumor/genetics', 'Colorectal Neoplasms/*genetics/metabolism/mortality', 'CpG Islands/*genetics', 'Cyclooxygenase 2/biosynthesis', 'DNA Methylation/*genetics', 'Female', 'Humans', 'Immunohistochemistry', 'Kaplan-Meier Estimate', 'Male', '*Microsatellite Instability', 'Phenotype', 'Prognosis', 'Receptors, Prostaglandin E/*biosynthesis/genetics', 'Receptors, Prostaglandin E, EP2 Subtype', 'Reverse Transcriptase Polymerase Chain Reaction', 'Tumor Suppressor Protein p53/biosynthesis', 'beta Catenin/biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/20200425/
1100,PTGER2,24827772,Association between length of gestation and cervical DNA methylation of PTGER2 and LINE 1-HS.,"['Burris HH', 'Baccarelli AA', 'Motta V', 'Byun HM', 'Just AC', 'Mercado-Garcia A', 'Schwartz J', 'Svensson K', 'Tellez-Rojo MM', 'Wright RO']","['Adult', 'Cervix Uteri/*metabolism', 'Cohort Studies', '*DNA Methylation', 'Female', 'Genetic Association Studies', 'Humans', '*Long Interspersed Nucleotide Elements', 'Pregnancy/*physiology', 'Premature Birth/genetics/metabolism', 'Promoter Regions, Genetic', 'Receptors, Prostaglandin E, EP2 Subtype/*genetics/metabolism', 'Risk Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24827772/
1101,PTGER2,34886911,Identification of ACOT13 and PTGER2 as novel candidate genes of autosomal dominant polycystic kidney disease through whole exome sequencing.,"['Du N', 'Dong D', 'Sun L', 'Che L', 'Li X', 'Liu Y', 'Wang B']","['Female', '*Gene Expression Regulation', 'Humans', 'Male', 'Pedigree', 'Polycystic Kidney, Autosomal Dominant/diagnosis/*genetics/metabolism', 'RNA/*genetics', 'Receptors, Prostaglandin E, EP2 Subtype/biosynthesis/*genetics', 'Thiolester Hydrolases/biosynthesis/*genetics', 'Tomography, X-Ray Computed', 'Exome Sequencing/*methods']",https://pubmed.ncbi.nlm.nih.gov/34886911/
1102,TBXAS1,35395429,Novel TBXAS1 variants in two Indian children with Ghosal hematodiaphyseal dysplasia: A concise report.,"['Sudhakar M', 'Sharma M', 'Kandasamy S', 'Gummadi A', 'Rawat A', 'Vignesh P']","['*Anemia, Refractory/diagnostic imaging/genetics', 'Bone and Bones', 'Child', 'Humans', '*Osteochondrodysplasias/diagnostic imaging/genetics', 'Radiography']",https://pubmed.ncbi.nlm.nih.gov/35395429/
1103,TBXAS1,8325653,Mapping of the human thromboxane synthase gene (TBXAS1) to chromosome 7q34-q35 by two-color fluorescence in situ hybridization.,"['Chase MB', 'Baek SJ', 'Purtell DC', 'Schwartz S', 'Shen RF']","['*Chromosomes, Human, Pair 7', 'Humans', 'In Situ Hybridization, Fluorescence', 'Restriction Mapping', 'Thromboxane-A Synthase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/8325653/
1104,TBXAS1,35923246,TBXAS1 Gene Polymorphism Is Associated with the Risk of Ischemic Stroke of Metabolic Syndrome in a Chinese Han Population.,"['Peng J', 'Lu F', 'Zhong M', 'Zhao Y', 'Wang Z', 'Zhang W']","['China/epidemiology', 'Humans', '*Ischemic Stroke', '*Metabolic Syndrome', 'Polymorphism, Genetic', 'Risk Factors', 'Thromboxane-A Synthase/*genetics', 'Waist Circumference']",https://pubmed.ncbi.nlm.nih.gov/35923246/
1105,TBXAS1,33595912,Novel compound heterozygous variants of TBXAS1 presenting with Ghosal hematodiaphyseal dysplasia treated with steroids.,"['Kim SY', 'Ing A', 'Gong S', 'Yap KL', 'Bhat R']","['Anemia, Refractory/drug therapy/*genetics/pathology', 'Bone Density', 'Child', 'Child, Preschool', 'Female', 'Hematopoiesis', 'Heterozygote', 'Humans', 'Male', 'Mutation', 'Osteochondrodysplasias/drug therapy/*genetics/pathology', 'Pedigree', 'Steroids/therapeutic use', 'Thromboxane-A Synthase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/33595912/
1106,TBXAS1,38320993,Genome-wide association study implicates the role of TBXAS1 in the pathogenesis of depressive symptoms among the Korean population.,"['Park K', 'Do AR', 'Chung Y', 'Kim MJ', 'Rhee SJ', 'Yoon DH', 'Choi SH', 'Cho SJ', 'Kim HN', 'Ahn YM', 'Won S']","['Humans', '*Genome-Wide Association Study', '*Depression/genetics', 'Genetic Predisposition to Disease', 'Thromboxane-A Synthase/genetics', 'Republic of Korea', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/38320993/
1107,TBXAS1,16134166,Thromboxane synthase (TBXAS1) polymorphisms in African-American and Caucasian populations: evidence for selective pressure.,"['Ulrich CM', 'Carlson CS', 'Sibert J', 'Poole EM', 'Yu JH', 'Wang LH', 'Sparks R', 'Potter JD', 'Bigler J']","['Black or African American/*genetics', 'Amino Acid Substitution/genetics', 'Genetic Variation', 'Haplotypes', 'Humans', '*Polymorphism, Genetic', '*Selection, Genetic', 'Thromboxane-A Synthase/*genetics', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16134166/
1108,TBXAS1,28108096,"Variants in COX-2, PTGIS, and TBXAS1 Are Associated with Carotid Artery or Intracranial Arterial Stenosis and Neurologic Deterioration in Ischemic Stroke Patients.","['Yi X', 'Ming B', 'Wang C', 'Chen H', 'Ma C']","['Aged', 'Aged, 80 and over', 'Brain Ischemia/diagnosis/enzymology/*genetics/physiopathology', 'Carotid Stenosis/diagnostic imaging/enzymology/*genetics/physiopathology', 'Cerebral Arterial Diseases/diagnostic imaging/enzymology/*genetics/physiopathology', 'China', 'Cyclooxygenase 2/*genetics', 'Cytochrome P-450 Enzyme System/*genetics', 'Disease Progression', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Middle Aged', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Risk Factors', 'Stroke/diagnosis/enzymology/*genetics/physiopathology', 'Thromboxane-A Synthase/*genetics', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/28108096/
1109,SLCO1B1,35152405,"The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.","['Cooper-DeHoff RM', 'Niemi M', 'Ramsey LB', 'Luzum JA', 'Tarkiainen EK', 'Straka RJ', 'Gong L', 'Tuteja S', 'Wilke RA', 'Wadelius M', 'Larson EA', 'Roden DM', 'Klein TE', 'Yee SW', 'Krauss RM', 'Turner RM', 'Palaniappan L', 'Gaedigk A', 'Giacomini KM', 'Caudle KE', 'Voora D']","['ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics', 'Cytochrome P-450 CYP2C9/genetics', 'Genotype', 'Humans', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects', 'Liver-Specific Organic Anion Transporter 1/genetics', 'Neoplasm Proteins/genetics', 'Pharmacogenetics', 'Rosuvastatin Calcium/adverse effects', 'Simvastatin/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/35152405/
1110,SLCO1B1,18650507,SLCO1B1 variants and statin-induced myopathy--a genomewide study.,"['Link E', 'Parish S', 'Armitage J', 'Bowman L', 'Heath S', 'Matsuda F', 'Gut I', 'Lathrop M', 'Collins R']","['Aged', 'Arterial Occlusive Diseases/drug therapy', 'Chromosomes, Human, Pair 12', 'Diabetes Mellitus/drug therapy', 'Female', 'Genetic Markers', 'Genotype', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects/pharmacokinetics/therapeutic use', 'Liver-Specific Organic Anion Transporter 1', 'Male', 'Middle Aged', 'Muscular Diseases/*chemically induced/genetics', 'Myocardial Infarction/drug therapy/prevention & control', 'Organic Anion Transporters/*genetics', '*Polymorphism, Single Nucleotide', 'Risk', 'Simvastatin/*adverse effects/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/18650507/
1111,SLCO1B1,35797228,PharmVar GeneFocus: SLCO1B1.,"['Ramsey LB', 'Gong L', 'Lee SB', 'Wagner JB', 'Zhou X', 'Sangkuhl K', 'Adams SM', 'Straka RJ', 'Empey PE', 'Boone EC', 'Klein TE', 'Niemi M', 'Gaedigk A']","['Humans', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects', 'Haplotypes', 'Cytochrome P-450 Enzyme System/genetics', 'Alleles', 'Pharmacogenetics', 'Liver-Specific Organic Anion Transporter 1/genetics']",https://pubmed.ncbi.nlm.nih.gov/35797228/
1112,SLCO1B1,28813770,Point-Counterpoint: SLCO1B1 Genotyping for Statins.,"['Wilke RA', 'Fanciullo J']","['*Genotype', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Muscular Diseases/*chemically induced', '*Pharmacogenomic Testing']",https://pubmed.ncbi.nlm.nih.gov/28813770/
1113,SLCO1B1,24762081,"SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.","['Bui HT', 'Fujimoto N', 'Kubo T', 'Inatomi H', 'Matsumoto T']","['Aged', 'Aged, 80 and over', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Liver-Specific Organic Anion Transporter 1', 'Male', 'Middle Aged', 'Organic Anion Transporters/*genetics', 'Organic Anion Transporters, Sodium-Independent/*genetics', 'Polymorphism, Single Nucleotide', 'Risk Factors', 'Solute Carrier Organic Anion Transporter Family Member 1B3', 'Urinary Bladder Neoplasms/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/24762081/
1114,SLCO1B1,37232094,SLCO1B1 gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatin.,"['Massmann A', 'Van Heukelom J', 'Green RC', 'Hajek C', 'Hickingbotham MR', 'Larson EA', 'Lu CY', 'Wu AC', 'Zoltick ES', 'Christensen KD', 'Schultz A']","['Humans', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects', 'Simvastatin/adverse effects', 'Retrospective Studies', '*Decision Support Systems, Clinical', 'Muscles', 'Liver-Specific Organic Anion Transporter 1/genetics']",https://pubmed.ncbi.nlm.nih.gov/37232094/
1115,SLCO1B1,36377985,Analysis of APOE and SLCO1B1 Gene Polymorphism and Correlation with Dyslipidemia in China.,"['Long L', 'Sun Q']","['Humans', '*Apolipoproteins E/genetics', 'China', 'Cholesterol, HDL', 'Cholesterol, LDL', '*Dyslipidemias/diagnosis/genetics', 'Genotype', 'Liver-Specific Organic Anion Transporter 1/genetics', 'Polymorphism, Genetic', 'Retrospective Studies', 'Triglycerides']",https://pubmed.ncbi.nlm.nih.gov/36377985/
1116,SLCO1B1,35501760,Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population.,"['Atasilp C', 'Kanjanapipak J', 'Vichayaprasertkul J', 'Jinda P', 'Tiyasirichokchai R', 'Srisawasdi P', 'Prempunpong C', 'Chamnanphon M', 'Puangpetch A', 'Vanwong N', 'Klongthalay S', 'Jantararoungtong T', 'Sukasem C']","['Bilirubin', 'Glucuronosyltransferase', 'Humans', '*Hyperbilirubinemia, Neonatal/genetics', 'Infant, Newborn', '*Jaundice, Neonatal/complications/genetics', 'Liver-Specific Organic Anion Transporter 1/genetics', 'Polymorphism, Genetic', 'Thailand']",https://pubmed.ncbi.nlm.nih.gov/35501760/
1117,SLCO1B1,15548849,Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors.,"['Tachibana-Iimori R', 'Tabara Y', 'Kusuhara H', 'Kohara K', 'Kawamoto R', 'Nakura J', 'Tokunaga K', 'Kondo I', 'Sugiyama Y', 'Miki T']","['Aged', 'Alleles', 'Cholesterol/blood', 'DNA/biosynthesis/genetics', 'Female', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology', 'Hypolipidemic Agents/*pharmacology', 'Japan', 'Lipids/blood', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Male', 'Polymorphism, Genetic', 'Retrospective Studies', 'Reverse Transcriptase Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/15548849/
1118,SLCO1B1,21851379,The effects of a single nucleotide polymorphism in SLCO1B1 on the pharmacodynamics of pravastatin.,"['Martin NG', 'Li KW', 'Murray H', 'Putt W', 'Packard CJ', 'Humphries SE']","['Analysis of Variance', 'Anticholesteremic Agents/*pharmacology', 'Cholesterol/blood/genetics', 'Humans', 'Liver-Specific Organic Anion Transporter 1', 'Male', 'Middle Aged', 'Organic Anion Transporters/*genetics', 'Polymerase Chain Reaction', '*Polymorphism, Single Nucleotide', 'Pravastatin/*pharmacology', 'Scotland', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/21851379/
1119,SLCO1B1,15681900,A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy.,"['Morimoto K', 'Oishi T', 'Ueda S', 'Ueda M', 'Hosokawa M', 'Chiba K']","['Alleles', 'DNA/biosynthesis/genetics', 'DNA Primers', 'Exons/genetics', 'Humans', 'Introns/genetics', 'Japan', 'Liver-Specific Organic Anion Transporter 1/*metabolism', 'Muscular Diseases/*chemically induced/*metabolism', 'Mutation', 'Pravastatin/*pharmacology', 'Reverse Transcriptase Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/15681900/
1120,SLCO1B1,36964102,SLCO1B1 and SLCO1B3 genetic mutations in Taiwanese patients with Rotor syndrome.,"['Cheng YY', 'Chang KC', 'Chen PL', 'Yeung CY', 'Liou BY', 'Chen HL']","['Adult', 'Infant, Newborn', 'Humans', 'Child', 'Organic Anion Transporters, Sodium-Independent/genetics', '*Organic Anion Transporters/genetics', 'Liver-Specific Organic Anion Transporter 1/genetics', 'Solute Carrier Organic Anion Transporter Family Member 1B3/genetics', '*Hyperbilirubinemia, Hereditary/genetics', 'Hyperbilirubinemia', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/36964102/
1121,SLCO1B1,34726639,Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis.,"['Han JM', 'Choi KH', 'Lee HH', 'Gwak HS']","['Alleles', 'Antimetabolites, Antineoplastic/*adverse effects/therapeutic use', 'Chemical and Drug Induced Liver Injury/*genetics', 'Dose-Response Relationship, Drug', 'Humans', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Methotrexate/*adverse effects/therapeutic use', 'Neoplasms/drug therapy', 'Polymorphism, Genetic', 'Randomized Controlled Trials as Topic']",https://pubmed.ncbi.nlm.nih.gov/34726639/
1122,SLCO1B1,30734632,Association between SLCO1B1 rs4149056 and tegafur-uracil-induced hepatic dysfunction in breast cancer.,"['Kamio H', 'Uchiyama T', 'Kanno H', 'Onoe Y', 'Saito K', 'Kameoka S', 'Kamio T', 'Okamoto T']","['Aged', 'Alanine Transaminase/blood', 'Aspartate Aminotransferases/blood', 'Breast Neoplasms/*drug therapy/*genetics/metabolism', 'Chemical and Drug Induced Liver Injury/*genetics/metabolism', 'Drug Combinations', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Liver-Specific Organic Anion Transporter 1/*genetics/metabolism', 'Middle Aged', 'Pharmacogenomic Testing', 'Polymorphism, Single Nucleotide', 'Tegafur/administration & dosage/*adverse effects', 'Uracil/administration & dosage/*adverse effects']",https://pubmed.ncbi.nlm.nih.gov/30734632/
1123,SLCO1B1,39511784,SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin-induced rhabdomyolysis: A case report.,"['Medwid S', 'Deckert R', 'Gryn SE', 'Kim RB']","['Female', 'Humans', '*Black People/genetics', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects', '*Liver-Specific Organic Anion Transporter 1/genetics', '*Rhabdomyolysis/chemically induced/genetics/diagnosis', '*Rosuvastatin Calcium/adverse effects/administration & dosage', 'Adult']",https://pubmed.ncbi.nlm.nih.gov/39511784/
1124,SLCO1B1,38674010,"SLCO1B1 Exome Sequencing and Statin Treatment Response in 64,000 UK Biobank Patients.","['Turkmen D', 'Bowden J', 'Masoli JAH', 'Melzer D', 'Pilling LC']","['Aged', 'Female', 'Humans', 'Male', 'Middle Aged', 'Atorvastatin/therapeutic use', '*Exome Sequencing/methods', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use/adverse effects', '*Liver-Specific Organic Anion Transporter 1/genetics', 'Polymorphism, Single Nucleotide', 'Simvastatin/therapeutic use', 'Treatment Outcome', 'UK Biobank', 'United Kingdom']",https://pubmed.ncbi.nlm.nih.gov/38674010/
1125,SLCO1B1,36382878,ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population.,"['Bozina T', 'Ganoci L', 'Karacic E', 'Simicevic L', 'Vrkic-Kirhmajer M', 'Klarica-Domjanovic I', 'Kriz T', 'Sertic Z', 'Bozina N']","['Female', 'Humans', 'Alleles', '*ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics', 'Croatia', 'Gene Frequency', 'Genotype', '*Liver-Specific Organic Anion Transporter 1/genetics', '*Neoplasm Proteins/genetics', '*Polymorphism, Single Nucleotide', 'Real-Time Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/36382878/
1126,SLCO1B1,27936281,Interindividual and interethnic variability in drug disposition: polymorphisms in organic anion transporting polypeptide 1B1 (OATP1B1; SLCO1B1).,"['Lee HH', 'Ho RH']","['Ethnicity', 'Genotype', 'Humans', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Pharmaceutical Preparations/*metabolism', '*Polymorphism, Genetic/genetics', 'Tissue Distribution/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27936281/
1127,SLCO1B1,26482301,Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis.,"['Hennig S', 'Naiker S', 'Reddy T', 'Egan D', 'Kellerman T', 'Wiesner L', 'Owen A', 'McIlleron H', 'Pym A']","['Adult', 'Antitubercular Agents/administration & dosage/blood/*pharmacokinetics', 'Area Under Curve', 'CD4 Lymphocyte Count', 'Coinfection', 'Ethambutol/administration & dosage', 'Female', 'Gene Expression', 'HIV Infections/pathology/virology', 'Humans', 'Isoniazid/administration & dosage', 'Liver-Specific Organic Anion Transporter 1', 'Male', 'Monte Carlo Method', 'Organic Anion Transporters/*genetics/metabolism', '*Polymorphism, Single Nucleotide', 'Pyrazinamide/administration & dosage', 'Rifabutin/administration & dosage/blood/*pharmacokinetics', 'Rifampin/administration & dosage', 'Sex Factors', 'Tuberculosis, Pulmonary/blood/*drug therapy/microbiology/pathology']",https://pubmed.ncbi.nlm.nih.gov/26482301/
1128,HMGCR,29480216,Anti-HMGCR Myopathy.,"['Mohassel P', 'Mammen AL']","['Autoantibodies/*immunology', 'Autoimmune Diseases/chemically induced/drug therapy/*immunology/physiopathology', 'Humans', 'Hydroxymethylglutaryl CoA Reductases/*immunology', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects', 'Immunosuppressive Agents/therapeutic use', 'Muscular Diseases/chemically induced/drug therapy/immunology/physiopathology', 'Myositis/chemically induced/drug therapy/*immunology/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/29480216/
1129,HMGCR,37884200,Anti-HMGCR immune-mediated necrotising myopathy: Addressing the remaining issues.,"['Khoo T', 'Chinoy H']","['Adult', 'Humans', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects', 'Oxidoreductases', 'Necrosis/pathology', '*Myositis', '*Autoimmune Diseases', 'Autoantibodies', 'Hydroxymethylglutaryl CoA Reductases', '*Muscular Diseases/diagnosis', 'Muscle, Skeletal']",https://pubmed.ncbi.nlm.nih.gov/37884200/
1130,HMGCR,38178583,BRCC36 Deubiquitinates HMGCR to Regulate the Interplay Between Ferroptosis and Pyroptosis.,"['Wang H', 'Shu L', 'Lv C', 'Liu N', 'Long Y', 'Peng X', 'Ling H', 'Tao T', 'Tang J', 'Cheng Y', 'Liu S', 'Xiao D', 'Tao Y']","['Humans', 'Pyroptosis', '*Carcinoma, Hepatocellular', 'Oxidoreductases', '*Ferroptosis', '*Liver Neoplasms', 'Hydroxymethylglutaryl CoA Reductases']",https://pubmed.ncbi.nlm.nih.gov/38178583/
1131,HMGCR,23519993,Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.,"['Mohassel P', 'Mammen AL']","['Autoantibodies/*biosynthesis', 'Autoimmune Diseases/*chemically induced/immunology/metabolism', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/*adverse effects', 'Muscular Diseases/*chemically induced/immunology/metabolism']",https://pubmed.ncbi.nlm.nih.gov/23519993/
1132,HMGCR,35487868,Mitochondrial dysfunction in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotising myopathy.,"['Acosta IJ', 'Hofer M', 'Brady S']","['Autoantibodies', '*Autoimmune Diseases/pathology', 'Case-Control Studies', 'Coenzymes', 'Humans', 'Hydroxymethylglutaryl CoA Reductases', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors', 'Mitochondria/pathology', 'Muscle, Skeletal/pathology', '*Muscular Diseases/pathology', '*Myositis/pathology', 'Necrosis/pathology']",https://pubmed.ncbi.nlm.nih.gov/35487868/
1133,HMGCR,31631207,Anticancer auranofin engages 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) as a target.,"['Tian S', 'Siu FM', 'Lok CN', 'Fung YME', 'Che CM']","['Antineoplastic Agents/*pharmacology', 'Auranofin/*pharmacology', 'Cell Line, Tumor', 'E2F Transcription Factors/metabolism', 'Gold/pharmacology', 'Humans', 'Hydroxymethylglutaryl CoA Reductases/*metabolism', '*Molecular Targeted Therapy', 'Signal Transduction/drug effects', 'Time Factors', 'Tumor Suppressor Protein p14ARF/metabolism', 'Tumor Suppressor Protein p53/metabolism', 'Up-Regulation/drug effects']",https://pubmed.ncbi.nlm.nih.gov/31631207/
1134,HMGCR,34456255,"Anti-HMGCR myopathy: clinical and histopathological features, and prognosis.",['Kurashige T'],"['Autoantibodies', '*Autoimmune Diseases', 'Humans', 'Hydroxymethylglutaryl CoA Reductases', 'Muscle, Skeletal', '*Muscular Diseases/diagnosis', '*Myositis/diagnosis', 'Necrosis', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/34456255/
1135,HMGCR,36130887,Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy.,"['Munekane A', 'Ohsawa Y', 'Okubo M', 'Nagai T', 'Nishimura H', 'Nishino I', 'Sunada Y']","['Humans', 'Autoantibodies', '*Autoimmune Diseases/complications/diagnosis', 'Muscle Weakness/etiology', '*Muscular Diseases/pathology', '*Muscular Dystrophy, Duchenne/complications/drug therapy', '*Myositis/complications/diagnosis/drug therapy', 'Necrosis']",https://pubmed.ncbi.nlm.nih.gov/36130887/
1136,HMGCR,26598836,Navigating the Shallows and Rapids of Cholesterol Synthesis Downstream of HMGCR.,"['Sharpe LJ', 'Howe V', 'Prabhu AV', 'Luu W', 'Brown AJ']","['*Biosynthetic Pathways', 'Cholesterol/*biosynthesis', '*Gene Expression Regulation', 'Humans', 'Hydroxymethylglutaryl CoA Reductases/*metabolism', 'Nerve Tissue Proteins/genetics/metabolism', 'Oxidoreductases Acting on CH-CH Group Donors/genetics/*metabolism', 'Phosphorylation', 'Squalene Monooxygenase/metabolism']",https://pubmed.ncbi.nlm.nih.gov/26598836/
1137,HMGCR,27959767,Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.,"['Ference BA', 'Robinson JG', 'Brook RD', 'Catapano AL', 'Chapman MJ', 'Neff DR', 'Voros S', 'Giugliano RP', 'Davey Smith G', 'Fazio S', 'Sabatine MS']","['Cardiovascular Diseases/*genetics', 'Cholesterol, LDL/*blood', 'Diabetes Mellitus/*genetics', 'Female', '*Genetic Predisposition to Disease', 'Genetic Variation', 'Humans', 'Hydroxymethylglutaryl CoA Reductases/*genetics', 'Male', 'Middle Aged', 'Proprotein Convertase 9/*genetics', 'Random Allocation', 'Risk']",https://pubmed.ncbi.nlm.nih.gov/27959767/
1138,HMGCR,32400023,"Statin Intolerance, Anti-HMGCR Antibodies, and Immune Checkpoint Inhibitor-Associated Myositis: A ""Two-Hit"" Autoimmune Toxicity or Clinical Predisposition?","['von Itzstein MS', 'Khan S', 'Popat V', 'Lu R', 'Khan SA', 'Fattah FJ', 'Park JY', 'Bermas BL', 'Karp DR', 'Ahmed M', 'Saltarski JM', 'Gloria-McCutchen Y', 'Xie Y', 'Li QZ', 'Wakeland EK', 'Gerber DE']","['*Carcinoma, Non-Small-Cell Lung', 'Humans', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects', 'Immune Checkpoint Inhibitors', '*Lung Neoplasms', '*Myositis/chemically induced/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/32400023/
1139,HMGCR,21355415,Human hydroxymethylglutaryl-coenzyme A reductase (HMGCR) and statin sensitivity.,"['Jawaid S', 'Gertz M', 'Corsino C', 'Cheung J', 'Seidle H', 'Couch RD']","['Amino Acid Sequence', 'Base Sequence', 'DNA Primers/genetics', 'Humans', 'Hydroxymethylglutaryl CoA Reductases/*chemistry/genetics/*metabolism', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacology', 'In Vitro Techniques', 'Kinetics', 'Models, Molecular', 'Molecular Sequence Data', 'Mutagenesis', 'Pharmacogenetics', 'Protein Engineering', 'Recombinant Proteins/chemistry/genetics/metabolism', 'Sequence Homology, Amino Acid']",https://pubmed.ncbi.nlm.nih.gov/21355415/
1140,HMGCR,37167966,Bi-allelic variants in HMGCR cause an autosomal-recessive progressive limb-girdle muscular dystrophy.,"['Morales-Rosado JA', 'Schwab TL', 'Macklin-Mantia SK', 'Foley AR', 'Pinto E Vairo F', 'Pehlivan D', 'Donkervoort S', 'Rosenfeld JA', 'Boyum GE', 'Hu Y', 'Cong ATQ', 'Lotze TE', 'Mohila CA', 'Saade D', 'Bharucha-Goebel D', 'Chao KR', 'Grunseich C', 'Bruels CC', 'Littel HR', 'Estrella EA', 'Pais L', 'Kang PB', 'Zimmermann MT', 'Lupski JR', 'Lee B', 'Schellenberg MJ', 'Clark KJ', 'Wierenga KJ', 'Bonnemann CG', 'Klee EW']","['Humans', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use', 'Mevalonic Acid', '*Muscular Dystrophies, Limb-Girdle/genetics/diagnosis', '*Muscular Diseases/genetics', '*Muscular Dystrophies', 'Oxidoreductases', 'Hydroxymethylglutaryl CoA Reductases/genetics/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/37167966/
1141,OPRD1,37660978,Methylation and expression quantitative trait loci rs1799971 in the OPRM1 gene and rs4654327 in the OPRD1 gene are associated with opioid use disorder.,"['Yu J', 'Zhang Y', 'Xun Y', 'Tang H', 'Fu X', 'Zhang R', 'Zhu F', 'Zhang J']","['Humans', '*Quantitative Trait Loci', 'Methylation', 'Genotype', '*Opioid-Related Disorders/genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Opioid, mu/genetics', 'Receptors, Opioid, delta/genetics']",https://pubmed.ncbi.nlm.nih.gov/37660978/
1142,OPRD1,28253273,Elevated OPRD1 promoter methylation in Alzheimer's disease patients.,"['Ji H', 'Wang Y', 'Liu G', 'Chang L', 'Chen Z', 'Zhou D', 'Xu X', 'Cui W', 'Hong Q', 'Jiang L', 'Li J', 'Zhou X', 'Li Y', 'Guo Z', 'Zha Q', 'Niu Y', 'Weng Q', 'Duan S', 'Wang Q']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/*genetics', 'Base Sequence', 'Case-Control Studies', '*DNA Methylation', 'Female', 'HEK293 Cells', 'Humans', 'Male', 'Middle Aged', 'Promoter Regions, Genetic/*genetics', 'Receptors, Opioid, delta/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28253273/
1143,OPRD1,37146669,OPRD1 rs569356 polymorphism has an effect on plasma norbuprenorphine levels and dose/kg-normalized norbuprenorphine values in individuals with opioid use disorder.,"['Kaya-Akyuzlu D', 'Ozkan-Kotiloglu S', 'Danisman M', 'Bal C', 'Ogur B', 'Ispir GZ']","['Humans', 'Chromatography, Liquid', 'Tandem Mass Spectrometry', '*Buprenorphine/therapeutic use', '*Opioid-Related Disorders/genetics/drug therapy', 'Receptors, Opioid, delta/genetics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/37146669/
1144,OPRD1,17622222,The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.,"['Zhang H', 'Kranzler HR', 'Yang BZ', 'Luo X', 'Gelernter J']","['Adolescent', 'Adult', 'Aged', 'Alcoholism/*genetics', 'Case-Control Studies', 'Cocaine-Related Disorders/genetics', 'Europe/ethnology', 'Exons/genetics', 'Female', 'Genetic Predisposition to Disease', 'Haplotypes/genetics', 'Heroin Dependence/genetics', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptors, Opioid, delta/genetics/*physiology', 'Receptors, Opioid, kappa/genetics/*physiology', 'Risk', 'Substance-Related Disorders/*genetics', 'United States/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/17622222/
1145,OPRD1,34638633,Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways.,"['Wu B', 'Hand W', 'Alexov E']","['Dimerization', 'Humans', 'Mutation/genetics', 'Opioid-Related Disorders/*genetics', 'Receptors, Opioid/*genetics', 'Receptors, Opioid, delta/*genetics', 'Receptors, Opioid, mu/*genetics', 'Signal Transduction/*genetics', 'beta-Arrestins/genetics']",https://pubmed.ncbi.nlm.nih.gov/34638633/
1146,OPRD1,30171993,OPRD1 gene affects disease vulnerability and environmental stress in patients with heroin dependence in Han Chinese.,"['Huang CC', 'Kuo SC', 'Yeh TC', 'Yeh YW', 'Chen CY', 'Liang CS', 'Tsou CC', 'Lin CL', 'Ho PS', 'Huang SY']","['Adult', 'Asian People/genetics', 'Case-Control Studies', 'China', 'Female', 'Gene Frequency', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Haplotypes', 'Heroin Dependence/complications/*genetics/*psychology', 'Heterozygote', 'Homozygote', 'Humans', 'Male', '*Polymorphism, Single Nucleotide', 'Receptors, Opioid, delta/*genetics', 'Stress, Psychological/complications/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30171993/
1147,OPRD1,33953123,The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients.,"['Thomas PS Jr', 'Nielsen EM', 'Spellicy CJ', 'Harding MJ', 'Ye A', 'Patriquin M', 'Hamon SC', 'Kosten TR', 'Nielsen DA']","['Adult', 'Alleles', 'Cocaine/urine', 'Cocaine-Related Disorders/*drug therapy/*genetics', 'Disulfiram/therapeutic use', 'Female', 'Genotype', 'Humans', 'Male', 'Methadone/therapeutic use', 'Middle Aged', 'Opioid-Related Disorders/*drug therapy/*genetics', 'Receptors, Opioid, delta/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/33953123/
1148,OPRD1,34031368,"OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics.","['Levran O', 'Randesi M', 'Adelson M', 'Kreek MJ']","['*Actins', 'Follow-Up Studies', 'Haplotypes', 'Humans', '*Opioid-Related Disorders/genetics', 'Phosphoric Monoester Hydrolases', 'Polymorphism, Single Nucleotide', 'Receptors, Opioid, delta/genetics']",https://pubmed.ncbi.nlm.nih.gov/34031368/
1149,OPRD1,29173032,"Impact of SNP-SNP interaction among ABCB1, ARRB2, DRD1 and OPRD1 on methadone dosage requirement in Han Chinese patients.","['Luo R', 'Li X', 'Qin S', 'Luo Z', 'Luo X', 'Hu P', 'Liu Z', 'Feng X', 'Li X']","['ATP Binding Cassette Transporter, Subfamily B/genetics', 'Adult', 'Analgesics, Opioid/adverse effects', 'Asian People/*genetics', 'Female', 'Genotype', 'Humans', 'Male', 'Methadone/*administration & dosage', 'Middle Aged', 'Opiate Substitution Treatment/methods', 'Opioid-Related Disorders/drug therapy/genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Dopamine D1/*genetics', 'Receptors, Opioid, delta/*genetics', 'beta-Arrestin 2/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29173032/
1150,OPRD1,22500942,Association of OPRD1 polymorphisms with heroin dependence in a large case-control series.,"['Nelson EC', 'Lynskey MT', 'Heath AC', 'Wray N', 'Agrawal A', 'Shand FL', 'Henders AK', 'Wallace L', 'Todorov AA', 'Schrage AJ', 'Madden PA', 'Degenhardt L', 'Martin NG', 'Montgomery GW']","['Adult', 'Case-Control Studies', 'Control Groups', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease/*genetics', 'HapMap Project', 'Haplotypes/genetics', 'Heroin Dependence/*genetics', 'Humans', 'Linkage Disequilibrium', 'Logistic Models', 'Male', 'Middle Aged', 'New South Wales', 'Polymorphism, Single Nucleotide/genetics', 'Principal Component Analysis', 'Receptors, Opioid/drug effects/*genetics', 'Receptors, Opioid, delta/*genetics', 'Twins']",https://pubmed.ncbi.nlm.nih.gov/22500942/
1151,OPRD1,17374034,"Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study.","['Gelernter J', 'Gueorguieva R', 'Kranzler HR', 'Zhang H', 'Cramer J', 'Rosenheck R', 'Krystal JH']","['Adult', 'Alcoholism/*drug therapy/*genetics', 'Confidence Intervals', 'DNA/genetics', 'Double-Blind Method', 'Exons/genetics', 'Female', 'Genetic Variation', 'Genotype', 'Humans', 'Linear Models', 'Logistic Models', 'Male', 'Middle Aged', 'Naltrexone/*therapeutic use', 'Narcotic Antagonists/*therapeutic use', 'Odds Ratio', 'Proportional Hazards Models', 'Psychiatric Status Rating Scales', 'Receptors, Opioid, delta/*genetics', 'Receptors, Opioid, kappa/*genetics', 'Receptors, Opioid, mu/*genetics', 'Smoking/epidemiology/genetics', 'Treatment Outcome', 'United States', 'United States Department of Veterans Affairs']",https://pubmed.ncbi.nlm.nih.gov/17374034/
1152,OPRD1,24126707,Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females.,"['Clarke TK', 'Crist RC', 'Ang A', 'Ambrose-Lanci LM', 'Lohoff FW', 'Saxon AJ', 'Ling W', 'Hillhouse MP', 'Bruce RD', 'Woody G', 'Berrettini WH']","['Buprenorphine/*therapeutic use', 'Female', '*Genetic Variation', 'Humans', 'Opioid-Related Disorders/*drug therapy/genetics', 'Receptors, Opioid, delta/*genetics', 'White People']",https://pubmed.ncbi.nlm.nih.gov/24126707/
1153,OPRD1,20300121,Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region.,"['Zhang H', 'Gelernter J', 'Gruen JR', 'Kranzler HR', 'Herman AI', 'Simen AA']","['Alleles', 'Cell Line', 'Electrophoretic Mobility Shift Assay', 'Gene Expression Regulation', 'Humans', 'Luciferases/genetics/metabolism', 'Nuclear Proteins/metabolism', 'Oligonucleotide Probes/genetics/metabolism', '*Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic/*genetics', 'Protein Binding', 'Receptors, Opioid, delta/*genetics', 'Recombinant Fusion Proteins/genetics/metabolism', 'Transcription Factors/metabolism', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/20300121/
1154,OPRD1,23427138,"A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations.","['Roussotte FF', 'Jahanshad N', 'Hibar DP', 'Sowell ER', 'Kohannim O', 'Barysheva M', 'Hansell NK', 'McMahon KL', 'de Zubicaray GI', 'Montgomery GW', 'Martin NG', 'Wright MJ', 'Toga AW', 'Jack CR Jr', 'Weiner MW', 'Thompson PM']","['Aged', 'Aging/genetics/*pathology', 'Alzheimer Disease/cerebrospinal fluid/genetics/*pathology', 'Biomarkers/cerebrospinal fluid', 'Brain/*pathology', 'Cognitive Dysfunction/cerebrospinal fluid/genetics/*pathology', 'Databases, Factual', 'Female', 'Genotyping Techniques', 'Humans', 'Image Processing, Computer-Assisted', 'Linkage Disequilibrium', 'Magnetic Resonance Imaging', 'Male', 'Organ Size', '*Polymorphism, Single Nucleotide', 'Receptors, Opioid, delta/*genetics', 'Twin Studies as Topic', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23427138/
1155,OPRD1,31907389,Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence.,"['Fang CP', 'Wang SC', 'Tsou HH', 'Chung RH', 'Hsu YT', 'Liu SC', 'Kuo HW', 'Liu TH', 'Chen ACH', 'Liu YL']","['Adult', 'Female', '*Heroin Dependence/blood/drug therapy/genetics', 'Humans', 'Male', '*Methadone/administration & dosage/pharmacokinetics', '*Opiate Substitution Treatment', '*Polymorphism, Single Nucleotide', 'Receptors, Opioid, delta/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31907389/
1156,OPRD1,28084056,"Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi-Modal, Multi-Tissue Human Experimental Pain Model.","['Nielsen LM', 'Christrup LL', 'Sato H', 'Drewes AM', 'Olesen AE']","['Adult', 'Analgesia/methods', 'Analgesics, Opioid/*pharmacology/therapeutic use', 'Biological Variation, Population/genetics', 'Catechol O-Methyltransferase/*genetics', 'Cross-Over Studies', 'Double-Blind Method', 'Female', 'Genotype', 'Human Experimentation', 'Humans', 'Male', 'Morphine/*pharmacology/therapeutic use', 'Pain/drug therapy/etiology/*genetics', 'Pain Management/methods', 'Pain Measurement', 'Polymorphism, Single Nucleotide', 'Receptors, Opioid, delta/*genetics', 'Receptors, Opioid, kappa/genetics', 'Receptors, Opioid, mu/*genetics', 'Sex Factors']",https://pubmed.ncbi.nlm.nih.gov/28084056/
1157,OPRD1,34407719,Differential expression and transcription factor binding associated with genotype at a pharmacogenetic variant in OPRD1.,"['Crist RC', 'Arauco-Shapiro G', 'Zhang A', 'Reiner BC', 'Berrettini WH', 'Doyle GA']","['Alleles', 'Electrophoretic Mobility Shift Assay', 'Genotype', 'Heterogeneous Nuclear Ribonucleoprotein D0/*metabolism', 'Humans', 'Ku Autoantigen/*metabolism', 'Luciferases, Firefly', '*Pharmacogenomic Variants', 'Protein Binding/genetics', 'Quantitative Trait Loci/genetics', 'Receptors, Opioid, delta/*genetics', 'Transcription Factors/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/34407719/
1158,OPRD1,28632076,Association of OPRD1 Gene Variants with Opioid Dependence in Addicted Male Individuals Undergoing Methadone Treatment in the North of Iran.,"['Sharafshah A', 'Fazel H', 'Albonaim A', 'Omarmeli V', 'Rezaei S', 'Mirzajani E', 'Ajamian F', 'Keshavarz P']","['Adult', 'Humans', 'Iran', 'Libido/drug effects', 'Male', 'Methadone/*therapeutic use', 'Narcotics/*therapeutic use', 'Opiate Substitution Treatment/*methods', 'Opium Dependence/drug therapy/*genetics', 'Receptors, Opioid, delta/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28632076/
1159,SLC6A2,25724484,"Association of norepinephrine transporter (NET, SLC6A2) genotype with ADHD-related phenotypes: findings of a longitudinal study from birth to adolescence.","['Hohmann S', 'Hohm E', 'Treutlein J', 'Blomeyer D', 'Jennen-Steinmetz C', 'Schmidt MH', 'Esser G', 'Banaschewski T', 'Brandeis D', 'Laucht M']","['Adolescent', 'Attention Deficit Disorder with Hyperactivity/diagnosis/*genetics/physiopathology', 'Child', 'Child, Preschool', 'Female', 'Genotype', 'Humans', 'Infant', 'Infant, Newborn', 'Longitudinal Studies', 'Male', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/25724484/
1160,SLC6A2,39158690,Evaluation of SLC6A2 and CYP2D6 polymorphisms' effects on atomoxetine treatment in attention deficit and hyperactivity disorder.,"['Kole IH', 'Vural P', 'Yurdacan B', 'Alemdar A', 'Mutlu C']","['Humans', '*Atomoxetine Hydrochloride/therapeutic use/adverse effects', '*Attention Deficit Disorder with Hyperactivity/drug therapy/genetics', '*Cytochrome P-450 CYP2D6/genetics', 'Male', 'Female', '*Polymorphism, Single Nucleotide', '*Adrenergic Uptake Inhibitors/therapeutic use/adverse effects', 'Child', '*Genotype', 'Adolescent', 'Norepinephrine Plasma Membrane Transport Proteins/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/39158690/
1161,SLC6A2,22533655,Effect of the rs168924 single-nucleotide polymorphism in the SLC6A2 catecholamine transporter gene on blood pressure in Caucasians.,"['Zolk O', 'Ott C', 'Fromm MF', 'Schmieder RE']","['Adult', 'Blood Pressure/*genetics', 'Case-Control Studies', 'Cohort Studies', 'Echocardiography', 'Genotype', 'Humans', 'Hypertension/epidemiology/*ethnology/*genetics', 'Linkage Disequilibrium/genetics', 'Male', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Phenotype', 'Polymorphism, Single Nucleotide/*genetics', 'Prevalence', 'Regression Analysis', 'White People/*ethnology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22533655/
1162,SLC6A2,14620922,Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension.,"['Ono K', 'Iwanaga Y', 'Mannami T', 'Kokubo Y', 'Tomoike H', 'Komamura K', 'Shioji K', 'Yasui N', 'Tago N', 'Iwai N']","['Blood Pressure/*genetics', 'Female', 'Gene Frequency', 'Genetic Variation', 'Genotype', 'Humans', 'Hypertension/*epidemiology/*genetics', 'Japan/epidemiology', 'Logistic Models', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins', '*Polymorphism, Genetic', 'Symporters/*genetics']",https://pubmed.ncbi.nlm.nih.gov/14620922/
1163,SLC6A2,15362567,Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations.,"['Belfer I', 'Phillips G', 'Taubman J', 'Hipp H', 'Lipsky RH', 'Enoch MA', 'Max MB', 'Goldman D']","['Black or African American/genetics', 'Finland', 'Gene Frequency', 'Genetic Markers', 'Genotype', 'Haplotypes/*genetics', 'Humans', 'Indians, North American/genetics', 'Linkage Disequilibrium', 'Norepinephrine Plasma Membrane Transport Proteins', 'Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Symporters/*genetics', 'United States', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/15362567/
1164,SLC6A2,28454051,"No association between SLC6A2, SLC6A3, DRD2 polymorphisms and schizophrenia in the Han Chinese population.","['Bi Y', 'Huang X', 'Niu W', 'Chen S', 'Wu X', 'Cao Y', 'Zhang R', 'Yang F', 'Wang L', 'Li W', 'Xu Y', 'He L', 'Yu T', 'He G', 'Li X']","['Adult', 'Alleles', 'Asian People/*genetics', 'Case-Control Studies', 'China', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Epistasis, Genetic', 'Female', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D2/*genetics', 'Schizophrenia/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28454051/
1165,SLC6A2,19727679,Further evidence of association between amphetamine response and SLC6A2 gene variants.,"['Dlugos AM', 'Hamidovic A', 'Palmer AA', 'de Wit H']","['Adolescent', 'Adult', 'Central Nervous System Stimulants/*pharmacology', 'Cross-Over Studies', 'Dextroamphetamine/*pharmacology', 'Double-Blind Method', 'Female', 'Genetic Variation', 'Haplotypes', 'Humans', 'Male', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide', 'White People', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19727679/
1166,SLC6A2,38166870,Relationship between SLC6A2 gene polymorphisms and brain volume in Han Chinese adults who lost their sole child.,"['Xia Z', 'Cao Z', 'Surento W', 'Zhang L', 'Qiu L', 'Xu Q', 'Zhang L', 'Li L', 'Cao Y', 'Luo Y', 'Lu G', 'Qi R']","['Adult', '*Gray Matter/pathology', 'Brain/diagnostic imaging/pathology', 'China', 'Prefrontal Cortex', 'Child', 'Magnetic Resonance Imaging/methods', 'Humans', '*Norepinephrine Plasma Membrane Transport Proteins/genetics', '*Stress Disorders, Post-Traumatic/genetics', 'Polymorphism, Single Nucleotide', 'East Asian People']",https://pubmed.ncbi.nlm.nih.gov/38166870/
1167,SLC6A2,19844206,"Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.","['Dong C', 'Wong ML', 'Licinio J']","['ATP Binding Cassette Transporter 1', 'ATP-Binding Cassette Transporters/genetics', 'Adult', 'Antidepressive Agents/*therapeutic use', 'Cyclic AMP Response Element-Binding Protein/genetics', '*Depressive Disorder, Major/drug therapy/genetics', 'Dopamine Plasma Membrane Transport Proteins/genetics', 'Female', 'Gene Frequency', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Membrane Transport Proteins/classification/*genetics', 'Mexican Americans/*genetics', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/genetics', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide/*genetics', 'Psychiatric Status Rating Scales', 'Receptor, trkB/genetics', 'Receptors, Corticotropin-Releasing Hormone/genetics', 'Sequence Analysis/methods', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'CRF Receptor, Type 1']",https://pubmed.ncbi.nlm.nih.gov/19844206/
1168,SLC6A2,31075414,Association study of SLC6A2 gene Thr99Ile variant (rs1805065) with athletic status in the Brazilian population.,"['Guilherme JPLF', 'Bigliassi M', 'Lancha Junior AH']","['Adult', 'Amino Acid Substitution', 'Athletes', '*Athletic Performance', 'Brazil', 'Case-Control Studies', 'Female', 'Gene Frequency', 'Genetic Association Studies/*methods', 'Genotype', 'Humans', 'Male', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/31075414/
1169,SLC6A2,24655776,Association between norepinephrine transporter gene (SLC6A2) polymorphisms and suicide in patients with major depressive disorder.,"['Kim YK', 'Hwang JA', 'Lee HJ', 'Yoon HK', 'Ko YH', 'Lee BH', 'Jung HY', 'Hahn SW', 'Na KS']","['Adult', 'Case-Control Studies', 'Depressive Disorder, Major/*genetics/*psychology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Risk Assessment', 'Suicide, Attempted/*statistics & numerical data', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24655776/
1170,SLC6A2,33340618,Association between genetic variants of the norepinephrine transporter gene (SLC6A2) and bipolar I disorder.,"['Kim SY', 'Kim HN', 'Jeon SW', 'Lim WJ', 'Kim SI', 'Lee YJ', 'Kim SY', 'Kim YK']","['Adult', 'Bipolar Disorder/diagnosis/*epidemiology/*genetics', 'Female', 'Genetic Association Studies/*methods', 'Genetic Variation/*genetics', 'Humans', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Republic of Korea/epidemiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33340618/
1171,SLC6A2,34203885,Rare Variant in the SLC6A2 Encoding a Norepinephrine Transporter Is Associated with Elite Athletic Performance in the Polish Population.,"['Fichna JP', 'Huminska-Lisowska K', 'Safranow K', 'Adamczyk JG', 'Cieszczyk P', 'Zekanowski C', 'Berdynski M']","['Athletes', '*Athletic Performance', 'Female', 'Humans', 'Male', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Poland', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/34203885/
1172,SLC6A2,27844334,Polymorphism of SLC6A2 gene does not influence outcome of myocardial (123)I-mIBG scintigraphy in patients with chronic heart failure.,"['Verschure DO', 'Baas F', 'van Eck-Smit BLF', 'Somsen GA', 'Verberne HJ']","['*3-Iodobenzylguanidine', 'Aged', 'Chronic Disease', 'Female', 'Heart Failure/*diagnostic imaging/*genetics', 'Humans', 'Iodine Radioisotopes', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Polymorphism, Genetic/*genetics', '*Radionuclide Imaging', 'Radiopharmaceuticals', 'Stroke Volume']",https://pubmed.ncbi.nlm.nih.gov/27844334/
1173,SLC6A2,24312678,Methylation of the SLC6a2 gene promoter in major depression and panic disorder.,"['Bayles R', 'Baker EK', 'Jowett JB', 'Barton D', 'Esler M', 'El-Osta A', 'Lambert G']","['Adult', 'DNA Methylation/*genetics', 'Depressive Disorder, Major/*genetics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Panic Disorder/*genetics', 'Promoter Regions, Genetic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24312678/
1174,SLC6A2,24381062,No association of the norepinephrine transporter gene (SLC6A2) and cognitive and behavioural phenotypes of patients with autism spectrum disorder.,"['Park S', 'Park JE', 'Cho SC', 'Kim BN', 'Shin MS', 'Kim JW', 'Cho IH', 'Kim SA', 'Park M', 'Park TW', 'Son JW', 'Chung US', 'Yoo HJ']","['Adolescent', 'Behavioral Symptoms/*etiology/*genetics', 'Child', 'Child Development Disorders, Pervasive/*complications/genetics', 'Child, Preschool', 'Cognition Disorders/*etiology/*genetics', 'Female', 'Genetic Association Studies', 'Humans', 'Infant', 'Intelligence', 'Male', 'Mutation/genetics', 'Neuropsychological Tests', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Phenotype', 'Psychiatric Status Rating Scales', 'Severity of Illness Index', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24381062/
1175,SLC6A2,25512257,SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.,"['Yeh YW', 'Chen CJ', 'Jang FL', 'Kuo SC', 'Chen CY', 'Liang CS', 'Ho PS', 'Yen CH', 'Shyu JF', 'Wan FJ', 'Lu RB', 'Huang SY']","['Adult', 'Asian People', 'Cyclohexanols/*therapeutic use', 'Depressive Disorder, Major/*drug therapy/genetics', 'Female', 'Genetic Testing', 'Humans', 'Male', 'Middle Aged', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide', 'Regression Analysis', 'Remission Induction', 'Selective Serotonin Reuptake Inhibitors/*therapeutic use', 'Treatment Outcome', 'Venlafaxine Hydrochloride', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25512257/
1176,SLC6A2,25229170,"Association of SNAP-25, SLC6A2, and LPHN3 with OROS methylphenidate treatment response in attention-deficit/hyperactivity disorder.","['Song J', 'Kim SW', 'Hong HJ', 'Lee MG', 'Lee BW', 'Choi TK', 'Lee SH', 'Yook KH']","['Administration, Oral', 'Adolescent', 'Asian People/genetics', 'Attention Deficit Disorder with Hyperactivity/*drug therapy/*genetics', 'Central Nervous System Stimulants/therapeutic use', 'Child', 'Drug Delivery Systems', 'Female', 'Humans', 'Male', 'Methylphenidate/administration & dosage/*therapeutic use', 'Norepinephrine Plasma Membrane Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, G-Protein-Coupled/*genetics', 'Receptors, Peptide/*genetics', 'Synaptosomal-Associated Protein 25/*genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/25229170/
1177,SLC6A2,34112854,Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors.,"['Sijben HJ', 'van Oostveen WM', 'Hartog PBR', 'Stucchi L', 'Rossignoli A', 'Maresca G', 'Scarabottolo L', 'IJzerman AP', 'Heitman LH']","['Biosensing Techniques', 'Dopamine/metabolism', 'Doxycycline/pharmacology', 'Epinephrine/metabolism', 'Fluoxetine/*analogs & derivatives/chemistry/isolation & purification', '*High-Throughput Screening Assays', 'Humans', 'Norepinephrine/metabolism', 'Norepinephrine Plasma Membrane Transport Proteins/*antagonists & inhibitors/metabolism', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/34112854/
1178,CACNA1C,36598608,CACNA1C-Related Channelopathies.,"['Herold KG', 'Hussey JW', 'Dick IE']","['Syndactyly', 'Calcium Channels, L-Type/genetics', 'Humans', 'Autistic Disorder', '*Long QT Syndrome/genetics', 'Mutation', '*Channelopathies/genetics']",https://pubmed.ncbi.nlm.nih.gov/36598608/
1179,CACNA1C,34163037,Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations.,"['Rodan LH', 'Spillmann RC', 'Kurata HT', 'Lamothe SM', 'Maghera J', 'Jamra RA', 'Alkelai A', 'Antonarakis SE', 'Atallah I', 'Bar-Yosef O', 'Bilan F', 'Bjorgo K', 'Blanc X', 'Van Bogaert P', 'Bolkier Y', 'Burrage LC', 'Christ BU', 'Granadillo JL', 'Dickson P', 'Donald KA', 'Dubourg C', 'Eliyahu A', 'Emrick L', 'Engleman K', 'Gonfiantini MV', 'Good JM', 'Kalser J', 'Kloeckner C', 'Lachmeijer G', 'Macchiaiolo M', 'Nicita F', 'Odent S', ""O'Heir E"", 'Ortiz-Gonzalez X', 'Pacio-Miguez M', 'Palomares-Bralo M', 'Pena L', 'Platzer K', 'Quinodoz M', 'Ranza E', 'Rosenfeld JA', 'Roulet-Perez E', 'Santani A', 'Santos-Simarro F', 'Pode-Shakked B', 'Skraban C', 'Slaugh R', 'Superti-Furga A', 'Thiffault I', 'van Jaabrsveld RH', 'Vincent M', 'Wang HG', 'Zacher P', 'Rush E', 'Pitt GS', 'Au PYB', 'Shashi V']","['*Autistic Disorder/genetics', '*Calcium Channels, L-Type/genetics', 'Humans', '*Long QT Syndrome', 'Phenotype', '*Syndactyly']",https://pubmed.ncbi.nlm.nih.gov/34163037/
1180,CACNA1C,26048451,CACNA1C risk variant is associated with increased amygdala volume.,"['Lancaster TM', 'Foley S', 'Tansey KE', 'Linden DE', 'Caseras X']","['Alleles', 'Amygdala/*pathology', 'Calcium Channels, L-Type/*genetics/physiology', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Male', 'Organ Size/genetics/physiology', 'Psychotic Disorders/genetics', 'Risk Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26048451/
1181,CACNA1C,25290268,CACNA1C risk variant affects reward responsiveness in healthy individuals.,"['Lancaster TM', 'Heerey EA', 'Mantripragada K', 'Linden DE']","['Adult', 'Brain/*physiology', 'Brain Mapping/methods', 'Calcium Channels, L-Type/*genetics', 'Female', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Polymorphism, Single Nucleotide/*genetics', 'Reference Values', '*Reward', 'Risk', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25290268/
1182,CACNA1C,26756527,The impact of CACNA1C allelic variation on regional gray matter volume in Chinese population.,"['Huang L', 'Mo Y', 'Sun X', 'Yu H', 'Li H', 'Wu L', 'Li M']","['Adult', '*Alleles', 'Asian People/*genetics', 'Calcium Channels, L-Type/*genetics', 'Female', 'Gray Matter/*anatomy & histology', 'Humans', 'Male', 'Organ Size/genetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/26756527/
1183,CACNA1C,22957138,Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals.,"['Hori H', 'Yamamoto N', 'Fujii T', 'Teraishi T', 'Sasayama D', 'Matsuo J', 'Kawamoto Y', 'Kinoshita Y', 'Ota M', 'Hattori K', 'Tatsumi M', 'Arima K', 'Kunugi H']","['Adult', 'Analysis of Variance', 'Calcium Channels, L-Type/*genetics', 'Case-Control Studies', '*Cognition', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genotype', 'Humans', 'Male', 'Polymorphism, Single Nucleotide', 'Schizophrenia/*genetics', '*Schizophrenic Psychology', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/22957138/
1184,CACNA1C,37306960,Pleiotropic Association of CACNA1C Variants With Neuropsychiatric Disorders.,"['Wang Z', 'Lin X', 'Luo X', 'Xiao J', 'Zhang Y', 'Xu J', 'Wang S', 'Zhao F', 'Wang H', 'Zheng H', 'Zhang W', 'Lin C', 'Tan Z', 'Cao L', 'Wang Z', 'Tan Y', 'Chen W', 'Cao Y', 'Guo X', 'Pittenger C', 'Luo X']","['Humans', '*Calcium Channels, L-Type/genetics', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', '*Parkinson Disease/genetics', 'Polymorphism, Single Nucleotide/genetics', 'RNA, Messenger', '*Schizophrenia/genetics', '*Bipolar Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/37306960/
1185,CACNA1C,34210324,CACNA1C is a prognostic predictor for patients with ovarian cancer.,"['Chang X', 'Dong Y']","['Antigens, Neoplasm', 'Calcium Channels, L-Type/*genetics/immunology/metabolism', 'Female', 'Humans', 'Microsatellite Instability', 'Mutation', 'Ovarian Neoplasms/*genetics/immunology/metabolism', 'Prognosis', 'Proportional Hazards Models', 'Protein Interaction Maps']",https://pubmed.ncbi.nlm.nih.gov/34210324/
1186,CACNA1C,16610939,CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension.,"['Bremer T', 'Man A', 'Kask K', 'Diamond C']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Amlodipine/therapeutic use', 'Antihypertensive Agents/*therapeutic use', 'Calcium Channel Blockers/*therapeutic use', 'Calcium Channels, L-Type/drug effects/*genetics', 'Felodipine/therapeutic use', 'Female', 'Genotype', 'Haplotypes', 'Humans', 'Hypertension/*drug therapy/*genetics', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Retrospective Studies']",https://pubmed.ncbi.nlm.nih.gov/16610939/
1187,CACNA1C,20636642,Evidence for cis-acting regulation of ANK3 and CACNA1C gene expression.,"['Quinn EM', 'Hill M', 'Anney R', 'Gill M', 'Corvin AP', 'Morris DW']","['Allelic Imbalance/*genetics', 'Ankyrins/*genetics', 'Bipolar Disorder/*genetics', 'Calcium Channels, L-Type/*genetics', 'Gene Expression Regulation', 'Genetic Predisposition to Disease', 'Humans', 'Polymorphism, Single Nucleotide', 'Regulatory Elements, Transcriptional/*genetics']",https://pubmed.ncbi.nlm.nih.gov/20636642/
1188,CACNA1C,22705413,CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease.,"['Bhat S', 'Dao DT', 'Terrillion CE', 'Arad M', 'Smith RJ', 'Soldatov NM', 'Gould TD']","['Calcium Channels, L-Type/*genetics', 'Genetic Variation/*genetics', 'Humans', 'Mental Disorders/*genetics/*physiopathology']",https://pubmed.ncbi.nlm.nih.gov/22705413/
1189,CACNA1C,33938268,"An independent, replicable, functional and significant risk variant block at intron 3 of CACNA1C for schizophrenia.","['Wang Z', 'Chen W', 'Cao Y', 'Dou Y', 'Fu Y', 'Zhang Y', 'Luo X', 'Kang L', 'Liu N', 'Shi YS', 'Li CR', 'Xu Y', 'Guo X', 'Luo X']","['Humans', 'Calcium Channels, L-Type/genetics', 'Genetic Predisposition to Disease/genetics', 'Genome-Wide Association Study', 'Introns/genetics', 'Polymorphism, Single Nucleotide/genetics', 'RNA, Messenger', '*Schizophrenia/genetics']",https://pubmed.ncbi.nlm.nih.gov/33938268/
1190,CACNA1C,26541689,CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder.,"['Jakobsson J', 'Palsson E', 'Sellgren C', 'Rydberg F', 'Ekman A', 'Zetterberg H', 'Blennow K', 'Landen M']","['Adult', 'Alleles', 'Biomarkers/cerebrospinal fluid', 'Bipolar Disorder/*genetics', 'Calcium Channels, L-Type/*genetics', 'Case-Control Studies', 'Female', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Humans', 'Male', 'Middle Aged', 'Phosphorylation', '*Polymorphism, Single Nucleotide', 'tau Proteins/*cerebrospinal fluid']",https://pubmed.ncbi.nlm.nih.gov/26541689/
1191,CACNA1C,18711365,Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.,"['Ferreira MA', ""O'Donovan MC"", 'Meng YA', 'Jones IR', 'Ruderfer DM', 'Jones L', 'Fan J', 'Kirov G', 'Perlis RH', 'Green EK', 'Smoller JW', 'Grozeva D', 'Stone J', 'Nikolov I', 'Chambert K', 'Hamshere ML', 'Nimgaonkar VL', 'Moskvina V', 'Thase ME', 'Caesar S', 'Sachs GS', 'Franklin J', 'Gordon-Smith K', 'Ardlie KG', 'Gabriel SB', 'Fraser C', 'Blumenstiel B', 'Defelice M', 'Breen G', 'Gill M', 'Morris DW', 'Elkin A', 'Muir WJ', 'McGhee KA', 'Williamson R', 'MacIntyre DJ', 'MacLean AW', 'St CD', 'Robinson M', 'Van Beck M', 'Pereira AC', 'Kandaswamy R', 'McQuillin A', 'Collier DA', 'Bass NJ', 'Young AH', 'Lawrence J', 'Ferrier IN', 'Anjorin A', 'Farmer A', 'Curtis D', 'Scolnick EM', 'McGuffin P', 'Daly MJ', 'Corvin AP', 'Holmans PA', 'Blackwood DH', 'Gurling HM', 'Owen MJ', 'Purcell SM', 'Sklar P', 'Craddock N']","['Ankyrins/*genetics', 'Bipolar Disorder/*genetics', 'Calcium Channels, L-Type/*genetics', 'Chromosomes, Human, Pair 10', 'Chromosomes, Human, Pair 12', 'Chromosomes, Human, Pair 15', 'Genetic Predisposition to Disease', '*Genome-Wide Association Study', 'Humans', 'Logistic Models', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/18711365/
1192,CACNA1C,38657895,Effects of CACNA1C and ANK3 on cognitive function in patients with bipolar disorder.,"['Yang Y', 'Zhu Z', 'Hui L', 'Sun P']","['Adult', 'Female', 'Humans', 'Male', 'Middle Aged', '*Ankyrins/genetics', 'Attention/physiology', '*Bipolar Disorder/genetics/psychology', '*Calcium Channels, L-Type/genetics', 'Cognition', 'Cognitive Dysfunction/genetics', 'Memory, Short-Term', 'Neuropsychological Tests', '*Polymorphism, Single Nucleotide', 'East Asian People/genetics']",https://pubmed.ncbi.nlm.nih.gov/38657895/
1193,CACNA1D,36592224,CACNA1D-Related Channelopathies: From Hypertension to Autism.,['Ortner NJ'],"['Humans', '*Autistic Disorder/genetics', '*Channelopathies/genetics', '*Hypertension/genetics', 'Calcium Channels, L-Type/genetics']",https://pubmed.ncbi.nlm.nih.gov/36592224/
1194,CACNA1D,35590368,tRF-Val-CAC-016 modulates the transduction of CACNA1d-mediated MAPK signaling pathways to suppress the proliferation of gastric carcinoma.,"['Xu W', 'Zheng J', 'Wang X', 'Zhou B', 'Chen H', 'Li G', 'Yan F']","['Calcium Channels, L-Type/metabolism', '*Carcinoma', 'Cell Proliferation/genetics', 'Humans', 'MAP Kinase Signaling System', 'RNA, Transfer/genetics/metabolism', '*Stomach Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/35590368/
1195,CACNA1D,38511854,Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant.,"['Ezell KM', 'Tinker RJ', 'Furuta Y', 'Gulsevin A', 'Bastarache L', 'Hamid R', 'Cogan JD', 'Rives L', 'Neumann S', 'Corner B', 'Kozuria M', 'Phillips JA 3rd']","['Humans', '*Calcium Channels, L-Type/genetics', 'Female', 'Child, Preschool', '*Mosaicism', '*Rare Diseases/genetics/diagnosis', 'Undiagnosed Diseases/genetics/diagnosis', 'Phenotype', 'Mutation/genetics', 'Seizures/genetics/diagnosis']",https://pubmed.ncbi.nlm.nih.gov/38511854/
1196,CACNA1D,35453044,Generation of the human induced pluripotent stem cell line (IBKMOLi002-A) from PBMCs of a patient carrying the heterozygous L271H mutation of the voltage-gated calcium channel subunit Ca(v)1.3-encoding CACNA1D gene.,"['Tisch M', 'Carmen De Mingo Alemany M', 'Suarez-Cubero M', 'Fauth C', 'Defrancesco M', 'Zschocke J', 'Gunther K', 'Edenhofer F']","['Blood Cells', 'Calcium Channels/metabolism', 'Calcium Channels, L-Type/genetics/metabolism', 'Humans', '*Hypoglycemia/metabolism', '*Induced Pluripotent Stem Cells/metabolism', 'Mutation/genetics']",https://pubmed.ncbi.nlm.nih.gov/35453044/
1197,CACNA1D,36949059,CACNA1D overexpression and voltage-gated calcium channels in prostate cancer during androgen deprivation.,"['McKerr N', 'Mohd-Sarip A', 'Dorrian H', 'Breen C', 'A James J', 'McQuaid S', 'Mills IG', 'McCloskey KD']","['Male', 'Humans', '*Prostatic Neoplasms/drug therapy/genetics/metabolism', 'Androgens', 'Androgen Antagonists/pharmacology/therapeutic use', 'Nifedipine/pharmacology', 'Mibefradil/pharmacology', 'Cell Line, Tumor', 'Receptors, Androgen/genetics/metabolism', 'Calcium Channels, L-Type/genetics']",https://pubmed.ncbi.nlm.nih.gov/36949059/
1198,CACNA1D,26606680,Clinical and Steroidogenic Characteristics of Aldosterone-Producing Adenomas With ATPase or CACNA1D Gene Mutations.,"['Kitamoto T', 'Suematsu S', 'Yamazaki Y', 'Nakamura Y', 'Sasano H', 'Matsuzawa Y', 'Saito J', 'Omura M', 'Nishikawa T']","['Adenoma/*genetics/*metabolism/pathology', 'Adenosine Triphosphatases/*genetics', 'Adrenal Gland Neoplasms/*genetics/*metabolism/pathology', 'Adrenocorticotropic Hormone/pharmacology', 'Adult', 'Aldosterone/*biosynthesis', 'Bucladesine/pharmacology', 'Calcium Channels, L-Type/*genetics', 'Cells, Cultured', 'Female', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/biosynthesis/genetics', 'Humans', 'Hydrocortisone/blood', 'Hyperaldosteronism/*genetics', 'Male', 'Middle Aged', 'Mutation/genetics', 'Plasma Membrane Calcium-Transporting ATPases/biosynthesis/genetics', 'Receptor, Melanocortin, Type 2/genetics', 'Renin/blood', 'Retrospective Studies', 'Steroids/*biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/26606680/
1199,CACNA1D,36208199,Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies.,"['Torok F', 'Tezcan K', 'Filippini L', 'Fernandez-Quintero ML', 'Zanetti L', 'Liedl KR', 'Drexel RS', 'Striessnig J', 'Ortner NJ']","['Humans', '*Calcium', 'Germ-Line Mutation', 'Isradipine', 'Molecular Docking Simulation', '*Channelopathies', 'Phenotype', 'Germ Cells', 'Calcium Channels, L-Type']",https://pubmed.ncbi.nlm.nih.gov/36208199/
1200,CACNA1D,39551029,"Generation of an iPSC cell line (VANYHHi001-A) from a patient with cardiac arrythmias carrying CACNA1D, SCN5A, and DSP variants.","['Sleiman Y', 'Reisqs JB', 'Bianca Tan R', 'Cecchin F', 'Chahine M', 'Boutjdir M']","['Adolescent', 'Humans', 'Male', '*Arrhythmias, Cardiac/genetics', '*Calcium Channels, L-Type/genetics/metabolism', 'Cell Differentiation', '*Cell Line', '*Induced Pluripotent Stem Cells/metabolism', '*NAV1.5 Voltage-Gated Sodium Channel/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39551029/
1201,CACNA1D,38553610,Pathogenicity of de novo CACNA1D Ca(2+) channel variants predicted from sequence co-variation.,"['Tang X', 'Ortner NJ', 'Nikonishyna YV', 'Fernandez-Quintero ML', 'Kokot J', 'Striessnig J', 'Liedl KR']","['*Calcium Channels, L-Type/genetics/metabolism', 'Humans', '*Mutation, Missense', 'Evolution, Molecular']",https://pubmed.ncbi.nlm.nih.gov/38553610/
1202,CACNA1D,23913004,Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.,"['Azizan EA', 'Poulsen H', 'Tuluc P', 'Zhou J', 'Clausen MV', 'Lieb A', 'Maniero C', 'Garg S', 'Bochukova EG', 'Zhao W', 'Shaikh LH', 'Brighton CA', 'Teo AE', 'Davenport AP', 'Dekkers T', 'Tops B', 'Kusters B', 'Ceral J', 'Yeo GS', 'Neogi SG', 'McFarlane I', 'Rosenfeld N', 'Marass F', 'Hadfield J', 'Margas W', 'Chaggar K', 'Solar M', 'Deinum J', 'Dolphin AC', 'Farooqi IS', 'Striessnig J', 'Nissen P', 'Brown MJ']","['Adrenal Cortex Diseases/complications/diagnosis/*genetics', 'Amino Acid Substitution', 'Calcium Channels, L-Type/chemistry/*genetics/metabolism', 'Cluster Analysis', 'Female', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/genetics/metabolism', 'Gene Expression Profiling', 'Humans', 'Hypertension/diagnosis/etiology/*genetics', 'Male', '*Mutation', 'Protein Conformation', 'Sodium-Potassium-Exchanging ATPase/chemistry/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/23913004/
1203,CACNA1D,28584016,Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel CACNA1D Mutation.,"['Tan GC', 'Negro G', 'Pinggera A', 'Tizen Laim NMS', 'Mohamed Rose I', 'Ceral J', 'Ryska A', 'Chin LK', 'Kamaruddin NA', 'Mohd Mokhtar N', 'A Jamal AR', 'Sukor N', 'Solar M', 'Striessnig J', 'Brown MJ', 'Azizan EA']","['*Adenoma/genetics/pathology', '*Adrenal Gland Neoplasms/genetics/pathology', 'Adrenal Glands/*pathology', 'Adult', 'Aldosterone/*metabolism', 'Calcium Channels, L-Type/*genetics', 'Female', 'G Protein-Coupled Inwardly-Rectifying Potassium Channels/*genetics', 'Genetic Predisposition to Disease', 'Humans', '*Hyperaldosteronism/genetics/pathology', 'Male', 'Middle Aged', 'Sodium-Potassium-Exchanging ATPase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28584016/
1204,CACNA1D,39273144,"Association Study of CACNA1D, KCNJ11, KCNQ1, and CACNA1E Single-Nucleotide Polymorphisms with Type 2 Diabetes Mellitus.","['Diaz-Garcia JD', 'Leyva-Leyva M', 'Sanchez-Aguillon F', 'de Leon-Bautista MP', 'Fuentes-Venegas A', 'Torres-Viloria A', 'Tenorio-Aguirre EK', 'Morales-Lazaro SL', 'Olivo-Diaz A', 'Gonzalez-Ramirez R']","['Adult', 'Aged', 'Aged, 80 and over', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Female', '*Potassium Channels, Inwardly Rectifying/genetics', '*KCNQ1 Potassium Channel/genetics', '*Calcium Channels, R-Type/genetics', '*Cation Transport Proteins/genetics', '*Calcium Channels, L-Type/genetics', '*Diabetes Mellitus, Type 2/genetics', 'Haplotypes', 'Genetic Predisposition to Disease']",https://pubmed.ncbi.nlm.nih.gov/39273144/
1205,CACNA1D,28472301,New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy.,"['Pinggera A', 'Mackenroth L', 'Rump A', 'Schallner J', 'Beleggia F', 'Wollnik B', 'Striessnig J']","['Autism Spectrum Disorder/*genetics', 'Calcium Channels, L-Type/*genetics/metabolism', 'Child', 'Epilepsy/genetics/metabolism', 'Gain of Function Mutation/genetics', 'Humans', 'Ion Channel Gating/physiology', 'Male', 'Mutation', 'Mutation, Missense', 'Patch-Clamp Techniques', 'Seizures/genetics']",https://pubmed.ncbi.nlm.nih.gov/28472301/
1206,CACNA1S,35039355,Novel CACNA1S mutation in hypokalaemic periodic paralysis.,"['Luis T', 'Linhares MI', 'Silva SR', 'Rodrigues F']","['Adolescent', 'Calcium Channels, L-Type', 'Female', 'Genetic Testing', 'Humans', '*Hypokalemia', '*Hypokalemic Periodic Paralysis/diagnosis/genetics', 'Mutation', 'Potassium/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/35039355/
1207,CACNA1S,28011884,Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.,"['Beam TA', 'Loudermilk EF', 'Kisor DF']","['Calcium Channels/*genetics', 'Calcium Channels, L-Type', 'Genetic Predisposition to Disease', 'Humans', 'Malignant Hyperthermia/*genetics/*physiopathology', 'Mutation/*genetics', 'Pharmacogenetics', 'Ryanodine Receptor Calcium Release Channel/genetics']",https://pubmed.ncbi.nlm.nih.gov/28011884/
1208,CACNA1S,26433613,The R900S mutation in CACNA1S associated with hypokalemic periodic paralysis.,"['Ke Q', 'He F', 'Lu L', 'Yu P', 'Jiang Y', 'Weng C', 'Huang H', 'Yi X', 'Qi M']","['Acetazolamide/therapeutic use', 'Adult', 'Asian People', 'Calcium Channels/*genetics', 'Calcium Channels, L-Type', 'Female', 'Humans', 'Hypokalemic Periodic Paralysis/drug therapy/*genetics/physiopathology', 'Male', 'Middle Aged', '*Mutation', 'Pedigree', 'Phenotype', 'Potassium/therapeutic use', 'Sequence Analysis, DNA', 'Treatment Outcome', 'Triamterene/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/26433613/
1209,CACNA1S,12066739,No evidence of mutations in the CACNA1S gene in the UK malignant hyperthermia population.,"['Brooks C', 'Robinson RL', 'Halsall PJ', 'Hopkins PM']","['Calcium Channels, L-Type/*genetics', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Malignant Hyperthermia/*genetics', '*Mutation', 'Pedigree']",https://pubmed.ncbi.nlm.nih.gov/12066739/
1210,CACNA1S,21845430,A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance.,"['Li FF', 'Li QQ', 'Tan ZX', 'Zhang SY', 'Liu J', 'Zhao EY', 'Yu GC', 'Zhou J', 'Zhang LM', 'Liu SL']","['Adolescent', 'Amino Acid Sequence', 'Amino Acid Substitution', 'Asian People/genetics', 'Calcium Channels/chemistry/*genetics/physiology', 'Calcium Channels, L-Type', 'Chromosomes, Human, Pair 1/genetics', 'Exons/genetics', 'Female', 'Genes, Dominant', 'Genotype', 'Haplotypes', 'Humans', 'Hypokalemic Periodic Paralysis/*genetics', 'Male', 'Middle Aged', 'Models, Molecular', 'Molecular Sequence Data', '*Mutation, Missense', 'Pedigree', '*Penetrance', '*Point Mutation', 'Protein Conformation', 'Sequence Alignment', 'Sequence Analysis, DNA', 'Sequence Homology, Amino Acid', '*Sex Characteristics', 'Species Specificity', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21845430/
1211,CACNA1S,37679049,CACNA1S Variant Associated With a Myalgic Myopathy Phenotype.,"['Periviita V', 'Palmio J', 'Jokela M', 'Hartikainen P', 'Vihola A', 'Rauramaa T', 'Udd B']","['Humans', '*Myalgia/genetics', 'Quality of Life', '*Muscular Diseases/genetics/diagnosis', 'Muscle Weakness/genetics', 'Phenotype', 'Calcium Channels, L-Type/genetics']",https://pubmed.ncbi.nlm.nih.gov/37679049/
1212,CACNA1S,38788083,"Early-Onset Autosomal Dominant Myopathy with Vacuolated Fibers and Tubular Aggregates but No Periodic Paralysis, in a Patient with the c.1583G>A (p.R528H) mutation in the CACNA1S Gene.","['Bisciglia M', 'Kadhim H', 'Lecomte S', 'Vandernoot I', 'Desmyter L', 'Remiche G']","['Humans', 'Male', 'Aged', '*Calcium Channels, L-Type/genetics', '*Mutation', 'Muscular Diseases/genetics', 'Vacuoles/pathology/genetics', 'Muscle, Skeletal/pathology', 'Age of Onset', 'Hypokalemic Periodic Paralysis/genetics']",https://pubmed.ncbi.nlm.nih.gov/38788083/
1213,CACNA1S,37510268,Congenital Myopathy as a Phenotypic Expression of CACNA1S Gene Mutation: Case Report and Systematic Review of the Literature.,"['Marinella G', 'Orsini A', 'Scacciati M', 'Costa E', 'Santangelo A', 'Astrea G', 'Frosini S', 'Pasquariello R', 'Rubegni A', 'Sgherri G', 'Corsi M', 'Bonuccelli A', 'Battini R']","['Female', 'Humans', 'Calcium Channels, L-Type/genetics', '*Muscular Diseases/genetics', 'Mutation', 'Muscle, Skeletal/pathology', 'Phenotype', '*Myotonia Congenita/genetics']",https://pubmed.ncbi.nlm.nih.gov/37510268/
1214,CACNA1S,37784084,A novel CACNA1S gene variant in a child with hypokalemic periodic paralysis: a case report and literature review.,"['Zhou W', 'Zhao P', 'Gao J', 'Zhang Y']","['Humans', 'Male', 'Child', '*Hypokalemic Periodic Paralysis/diagnosis/genetics/complications', 'Mutation', 'Phenotype', 'Muscle Weakness', 'Family', 'Calcium Channels, L-Type/genetics']",https://pubmed.ncbi.nlm.nih.gov/37784084/
1215,CACNA1S,18835861,Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene.,"['Chabrier S', 'Monnier N', 'Lunardi J']","['Calcium Channels/*genetics', 'Calcium Channels, L-Type', 'Child, Preschool', 'Chromosome Mapping', 'DNA Mutational Analysis', 'Humans', 'Hypokalemic Periodic Paralysis/*genetics', 'Male', '*Mutation']",https://pubmed.ncbi.nlm.nih.gov/18835861/
1216,CACNA1S,31851124,PharmGKB summary: very important pharmacogene information for CACNA1S.,"['Sangkuhl K', 'Dirksen RT', 'Alvarellos ML', 'Altman RB', 'Klein TE']","['Calcium Channels, L-Type/chemistry/*genetics', 'Genetic Predisposition to Disease', 'Humans', 'Hypokalemic Periodic Paralysis/*genetics', 'Malignant Hyperthermia/*genetics', 'Models, Molecular', '*Mutation', 'Pharmacogenomic Variants', 'Protein Conformation']",https://pubmed.ncbi.nlm.nih.gov/31851124/
1217,CACNA1S,25658027,Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness.,"['Fiszer D', 'Shaw MA', 'Fisher NA', 'Carr IM', 'Gupta PK', 'Watkins EJ', 'Roiz de Sa D', 'Kim JH', 'Hopkins PM']","['Calcium Channels/*genetics', 'Calcium Channels, L-Type', 'DNA/genetics', 'DNA Primers', 'Exons', 'Heat Stress Disorders/*genetics', 'Humans', 'Malignant Hyperthermia/*genetics', 'Polymerase Chain Reaction/methods', 'Ryanodine Receptor Calcium Release Channel/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25658027/
1218,CACNA1S,26252573,Mutation analysis of CACNA1S and SCN4A in patients with hypokalemic periodic paralysis.,"['Wang XY', 'Ren BW', 'Yong ZH', 'Xu HY', 'Fu QX', 'Yao HB']","['Adolescent', 'Adult', 'Amino Acid Substitution', 'Asian People/genetics', 'Base Sequence', 'Calcium Channels/*genetics', 'Calcium Channels, L-Type', 'DNA Mutational Analysis', 'Exons', 'Female', 'Humans', 'Hypokalemic Periodic Paralysis/*genetics', 'Male', 'Middle Aged', 'Molecular Sequence Data', 'Mutation', 'NAV1.4 Voltage-Gated Sodium Channel/*genetics', 'Pedigree', 'Sequence Alignment', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26252573/
1219,CACNA1S,12636044,Identification of new polymorphisms in the CACNA1S gene.,"['Carsana A', 'Fortunato G', 'De Sarno C', 'Brancadoro V', 'Salvatore F']","['Amino Acid Substitution/genetics', 'Calcium Channels, L-Type/*genetics', 'DNA Primers', 'Exons', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Heterozygote', 'Humans', 'Introns', 'Malignant Hyperthermia/*genetics', 'Molecular Sequence Data', 'Polymorphism, Genetic/*genetics', 'Restriction Mapping']",https://pubmed.ncbi.nlm.nih.gov/12636044/
1220,SLC6A3,26593110,Meta-analysis of the association of the SLC6A3 3'-UTR VNTR with cognition.,"['Ettinger U', 'Merten N', 'Kambeitz J']","['*Cognition', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Humans', '*Minisatellite Repeats', '*Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/26593110/
1221,SLC6A3,29171685,SLC6A3 polymorphism and response to methylphenidate in children with ADHD: A systematic review and meta-analysis.,"['Soleimani R', 'Salehi Z', 'Soltanipour S', 'Hasandokht T', 'Jalali MM']","['Adolescent', 'Attention Deficit Disorder with Hyperactivity/genetics/physiopathology', 'Biomarkers, Pharmacological', 'Child', 'Dopamine Plasma Membrane Transport Proteins/*drug effects/*genetics', 'Female', 'Humans', 'Male', 'Methylphenidate/pharmacology/*therapeutic use', 'Polymorphism, Genetic/genetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/29171685/
1222,SLC6A3,16710758,Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo.,"['Drgon T', 'Lin Z', 'Wang GJ', 'Fowler J', 'Pablo J', 'Mash DC', 'Volkow N', 'Uhl GR']","[""5' Flanking Region"", 'Adult', 'Attention Deficit Disorder with Hyperactivity/metabolism', 'Basal Ganglia/metabolism', 'Base Sequence', 'Dopamine Plasma Membrane Transport Proteins/*genetics/*metabolism', 'Female', 'Gene Expression', 'Gene Frequency', '*Genetic Variation', '*Haplotypes', 'Humans', 'Male', 'Molecular Sequence Data', 'Sequence Analysis, DNA', 'Sequence Homology, Nucleic Acid']",https://pubmed.ncbi.nlm.nih.gov/16710758/
1223,SLC6A3,28666839,Dopamine transporter (DAT1/SLC6A3) polymorphism and the association between being born small for gestational age and symptoms of ADHD.,"['Waldie KE', 'Cornforth CM', 'Webb RE', 'Thompson JMD', 'Murphy R', 'Moreau D', 'Slykerman R', 'Morgan AR', 'Ferguson LR', 'Mitchell EA']","['Age Factors', 'Analysis of Variance', 'Attention Deficit Disorder with Hyperactivity/*genetics/physiopathology', 'Child', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Female', '*Gene-Environment Interaction', 'Genotype', '*Gestational Age', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/*genetics', 'Social Class', 'Surveys and Questionnaires']",https://pubmed.ncbi.nlm.nih.gov/28666839/
1224,SLC6A3,34650206,The dopamine transporter gene SLC6A3: multidisease risks.,"['Reith MEA', 'Kortagere S', 'Wiers CE', 'Sun H', 'Kurian MA', 'Galli A', 'Volkow ND', 'Lin Z']","['*Attention Deficit Disorder with Hyperactivity/genetics', '*Dopamine Plasma Membrane Transport Proteins/genetics/metabolism', 'Haplotypes', 'Humans', 'Mutation', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/34650206/
1225,SLC6A3,19450132,Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review.,"['van der Zwaluw CS', 'Engels RC', 'Buitelaar J', 'Verkes RJ', 'Franke B', 'Scholte RH']","['Alcohol Withdrawal Delirium/*genetics', 'Alcoholism/epidemiology/*genetics/metabolism', 'Case-Control Studies', 'DNA, Complementary/genetics', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Environment', 'Family', 'Female', 'Genetic Variation', 'Humans', 'Male', 'Minisatellite Repeats/genetics', 'Racial Groups/genetics', 'Risk Factors', 'Sex Characteristics', 'Tandem Repeat Sequences']",https://pubmed.ncbi.nlm.nih.gov/19450132/
1226,SLC6A3,35940320,Interaction between manganese and SLC6A3 genetic polymorphisms in relation to dyslexia.,"['Zhu K', 'Liu Q', 'Xie X', 'Jiang Q', 'Feng Y', 'Xiao P', 'Wu X', 'Zhu B', 'Song R']","['Case-Control Studies', 'Child', 'Dopamine Plasma Membrane Transport Proteins/genetics', '*Dyslexia/genetics', 'Genetic Predisposition to Disease', 'Humans', '*Manganese/adverse effects', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/35940320/
1227,SLC6A3,25617181,A genetic-demographic approach reveals a gender-specific association of SLC6A3/DAT1 40 bp-VNTR with life-expectancy.,"['Hadi F', 'Dato S', 'Carpi FM', 'Prontera P', 'Crucianelli F', 'Renda F', 'Passarino G', 'Napolioni V']","['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Base Pairing/*genetics/physiology', 'Demography', 'Dopamine/metabolism', 'Dopamine Plasma Membrane Transport Proteins/*genetics/physiology', 'Female', 'Genotype', 'Humans', 'Italy', 'Longevity/*genetics/physiology', 'Male', 'Middle Aged', 'Minisatellite Repeats/*genetics/physiology', 'Models, Genetic', 'Population Groups/*genetics', '*Sex Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25617181/
1228,SLC6A3,27882466,Frequency of 3' VNTR Polymorphism in the Dopamine Transporter Gene SLC6A3 in Humans Predisposed to Antisocial Behavior.,"['Cherepkova EV', 'Aftanas LI', 'Maksimov N', 'Menshanov PN']","[""3' Untranslated Regions"", 'Adult', 'Alleles', 'Antisocial Personality Disorder/diagnosis/*genetics/psychology', 'Case-Control Studies', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Fraud/psychology', 'Gene Expression', '*Gene Frequency', '*Genetic Predisposition to Disease', 'Homicide/psychology', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Prisoners/*psychology', 'Russia', 'Tandem Repeat Sequences', 'Theft/psychology', 'White People']",https://pubmed.ncbi.nlm.nih.gov/27882466/
1229,SLC6A3,31185047,Presence of recombination hotspots throughout SLC6A3.,"['Zhao J', 'Zhou Y', 'Xiong N', 'Qing H', 'Wang T', 'Lin Z']","['Black or African American', 'Cohort Studies', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Female', 'Genetic Markers', '*Genome, Human', 'Humans', 'Male', '*Recombination, Genetic', 'Substance-Related Disorders/*genetics', 'White People']",https://pubmed.ncbi.nlm.nih.gov/31185047/
1230,SLC6A3,37628576,"LRP5, SLC6A3, and SOX10 Expression in Conventional Ameloblastoma.","['Correa-Arzate L', 'Portilla-Robertson J', 'Ramirez-Jarquin JO', 'Jacinto-Aleman LF', 'Mejia-Velazquez CP', 'Villanueva-Sanchez FG', 'Rodriguez-Vazquez M']","['Humans', '*Ameloblastoma/genetics', 'Vorinostat', 'Cell Proliferation/genetics', 'Computational Biology', 'SOXE Transcription Factors/genetics', 'Low Density Lipoprotein Receptor-Related Protein-5', 'Dopamine Plasma Membrane Transport Proteins']",https://pubmed.ncbi.nlm.nih.gov/37628576/
1231,SLC6A3,34199792,SLC6A3 (DAT1) as a Novel Candidate Biomarker Gene for Suicidal Behavior.,"['Rafikova E', 'Shadrina M', 'Slominsky P', 'Guekht A', 'Ryskov A', 'Shibalev D', 'Vasilyev V']","['Adult', 'Catechol O-Methyltransferase/genetics', 'Depression/*genetics', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Suicide, Attempted/*statistics & numerical data']",https://pubmed.ncbi.nlm.nih.gov/34199792/
1232,SLC6A3,33887543,SLC6A3 as a potential circulating biomarker for gastric cancer detection and progression monitoring.,"['Liu S', 'Cui M', 'Zang J', 'Wang J', 'Shi X', 'Qian F', 'Xu S', 'Jing R']","['Adult', 'Aged', 'Biomarkers, Tumor/*metabolism', 'Disease Progression', 'Dopamine Plasma Membrane Transport Proteins/*metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Prognosis', 'Stomach Neoplasms/*pathology']",https://pubmed.ncbi.nlm.nih.gov/33887543/
1233,SLC6A3,36754567,A novel hypervariable variable number tandem repeat in the dopamine transporter gene (SLC6A3).,"['Apsley AT', 'Domico ER', 'Verbiest MA', 'Brogan CA', 'Buck ER', 'Burich AJ', 'Cardone KM', 'Stone WJ', 'Anisimova M', 'Vandenbergh DJ']","['Alleles', '*Dopamine Plasma Membrane Transport Proteins/genetics', 'Haplotypes', 'Introns', '*Minisatellite Repeats/genetics', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/36754567/
1234,SLC6A3,15381926,Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers.,"['Erblich J', 'Lerman C', 'Self DW', 'Diaz GA', 'Bovbjerg DH']","['Adult', 'Black or African American/*genetics/psychology', 'Association Learning/physiology', 'Behavior, Addictive/*genetics/psychology', 'Cues', 'Dopamine Plasma Membrane Transport Proteins', 'Female', 'Humans', 'Male', 'Membrane Glycoproteins/*genetics', 'Membrane Transport Proteins/*genetics', 'Middle Aged', 'Minisatellite Repeats/genetics', 'Nerve Tissue Proteins/*genetics', 'New York City/epidemiology', 'Polymorphism, Restriction Fragment Length', 'Receptors, Dopamine D2/*genetics', 'Smoking/ethnology/*genetics/psychology']",https://pubmed.ncbi.nlm.nih.gov/15381926/
1235,SLC6A3,26245713,"Association of COMT and SLC6A3 polymorphisms with impulsivity, response inhibition and brain function.","['Kasparbauer AM', 'Merten N', 'Aichert DS', 'Wostmann N', 'Meindl T', 'Rujescu D', 'Ettinger U']","['Adolescent', 'Adult', 'Brain/physiology', 'Cartilage Oligomeric Matrix Protein/*genetics', 'Dopamine Plasma Membrane Transport Proteins/*genetics', 'Female', 'Frontal Lobe/physiology', 'Genotype', 'Humans', '*Impulsive Behavior', '*Inhibition, Psychological', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Neostriatum/physiology', 'Oxygen/blood', 'Polymorphism, Genetic/genetics', 'Psychometrics', 'Psychomotor Performance/physiology', 'Saccades/physiology', 'Stroop Test', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26245713/
1236,SLC6A3,35098587,SLC6A3 gene polymorphisms are associated with striatal dopamine transporter changes after glucose loading.,"['Pak K', 'Seo S', 'Kim K', 'Lee MJ', 'Kim IJ']","['Corpus Striatum/diagnostic imaging/metabolism', '*Dopamine Plasma Membrane Transport Proteins/genetics/metabolism', '*Glucose', 'Humans', 'Male', 'Minisatellite Repeats/genetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/35098587/
1237,DHFR,33663366,2-Substituted-mercapto-quinazolin-4(3H)-ones as DHFR Inhibitors.,"['El-Subbagh HI', 'Sabry MA']","['Folic Acid Antagonists/*pharmacology', 'Methotrexate/pharmacology', 'Quinazolines/*pharmacology', 'Tetrahydrofolate Dehydrogenase/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33663366/
1238,DHFR,36055220,The hidden (degron) truth behind the degradation of DHFR disease-associated variants.,['Koren I'],['*Tetrahydrofolate Dehydrogenase/chemistry/genetics/metabolism'],https://pubmed.ncbi.nlm.nih.gov/36055220/
1239,DHFR,23581023,New mechanisms for an old drug; DHFR- and non-DHFR-mediated effects of methotrexate in cancer cells.,"['Neradil J', 'Pavlasova G', 'Veselska R']","['Antimetabolites, Antineoplastic/*pharmacology', 'Cell Death/drug effects', 'Cell Differentiation/drug effects', 'Folic Acid/metabolism', 'Folic Acid Antagonists/pharmacology', 'Histone Deacetylase Inhibitors/pharmacology', 'Humans', 'Methotrexate/*pharmacology', 'Methylation/drug effects', 'Nucleotides/biosynthesis', 'Tetrahydrofolate Dehydrogenase/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/23581023/
1240,DHFR,26881719,Repositioning of DHFR Inhibitors.,"['Lele AC', 'Mishra DA', 'Kamil TK', 'Bhakta S', 'Degani MS']","['Anti-Infective Agents/chemistry/*pharmacology', 'Antineoplastic Agents/pharmacology', 'Drug Repositioning/*methods', 'Folic Acid Antagonists/*chemistry/*pharmacology', 'Humans', 'Methotrexate/chemistry/pharmacology', 'Pteridines/chemistry/pharmacology', 'Tetrahydrofolate Dehydrogenase/chemistry/metabolism', 'Trimethoprim/chemistry/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/26881719/
1241,DHFR,32391884,Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia.,"['Tulstrup M', 'Moriyama T', 'Jiang C', 'Grosjean M', 'Nersting J', 'Abrahamsson J', 'Grell K', 'Hjalgrim LL', 'Jonsson OG', 'Kanerva J', 'Lund B', 'Nielsen SN', 'Nielsen RL', 'Overgaard U', 'Quist-Paulsen P', 'Pruunsild K', 'Vaitkeviciene G', 'Wolthers BO', 'Zhang H', 'Gupta R', 'Yang JJ', 'Schmiegelow K']","['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Female', 'Genome-Wide Association Study', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Methotrexate/administration & dosage/*analogs & derivatives/metabolism', 'Middle Aged', 'Neoplasm Recurrence, Local/drug therapy/genetics/metabolism/*pathology', 'Peptide Synthases/*genetics', 'Polyglutamic Acid/administration & dosage/*analogs & derivatives/metabolism', '*Polymorphism, Single Nucleotide', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/genetics/metabolism/*pathology', 'Prognosis', 'Tetrahydrofolate Dehydrogenase/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32391884/
1242,DHFR,34138546,Deciphering Antifungal Drug Resistance in Pneumocystis jirovecii DHFR with Molecular Dynamics and Machine Learning.,"['Leidner F', 'Kurt Yilmaz N', 'Schiffer CA']","['*Drug Resistance, Fungal', 'Machine Learning', 'Molecular Dynamics Simulation', '*Pneumocystis carinii/drug effects/metabolism', 'Tetrahydrofolate Dehydrogenase/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34138546/
1243,DHFR,35984987,DHFR Mutants Modulate Their Synchronized Dynamics with the Substrate by Shifting Hydrogen Bond Occupancies.,"['Cetin E', 'Atilgan AR', 'Atilgan C']","['*Escherichia coli/enzymology', 'Hydrogen Bonding', 'Kinetics', 'Mutation', 'Point Mutation', '*Tetrahydrofolate Dehydrogenase/chemistry', '*Escherichia coli Proteins/chemistry']",https://pubmed.ncbi.nlm.nih.gov/35984987/
1244,DHFR,30638963,Cryo-Cooling Effect on DHFR Crystal Studied by Replica-Exchange Molecular Dynamics Simulations.,"['Nagai T', 'Tama F', 'Miyashita O']","['*Cold Temperature', 'Escherichia coli/enzymology', 'Hydrogen Bonding', 'Hydrophobic and Hydrophilic Interactions', '*Molecular Dynamics Simulation', 'Protein Conformation', 'Tetrahydrofolate Dehydrogenase/*chemistry', 'Water/chemistry']",https://pubmed.ncbi.nlm.nih.gov/30638963/
1245,DHFR,25778468,"Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.","['Jabeen S', 'Holmboe L', 'Alnaes GI', 'Andersen AM', 'Hall KS', 'Kristensen VN']","['Alleles', 'Disease-Free Survival', 'Dose-Response Relationship, Drug', 'Female', 'Humans', 'Kaplan-Meier Estimate', 'Male', 'Methotrexate/administration & dosage/adverse effects', 'Methylenetetrahydrofolate Reductase (NADPH2)/*genetics', 'Osteosarcoma/drug therapy/*genetics/pathology', 'Polymorphism, Single Nucleotide', 'Replication Protein C/*genetics', 'Tetrahydrofolate Dehydrogenase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25778468/
1246,DHFR,29352991,"Molecular monitoring of dihydrofolatereductase (dhfr) and dihydropteroatesynthetase (dhps) associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates of Palawan, Philippines.","['Bareng AP', 'Espino FE', 'Chaijaroenkul W', 'Na-Bangchang K']","['Antimalarials/*pharmacology', 'Dihydropteroate Synthase/*genetics', 'Drug Combinations', 'Drug Resistance/*genetics', 'Haplotypes', 'Humans', 'Malaria, Vivax/drug therapy', 'Molecular Epidemiology', 'Mutation', 'Philippines', 'Plasmodium vivax/*drug effects/genetics/isolation & purification', 'Polymerase Chain Reaction', 'Polymorphism, Single Nucleotide', 'Pyrimethamine/*pharmacology', 'Sulfadoxine/*pharmacology', 'Tetrahydrofolate Dehydrogenase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29352991/
1247,DHFR,33530764,Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening.,"['Hoarau M', 'Vanichtanankul J', 'Srimongkolpithak N', 'Vitsupakorn D', 'Yuthavong Y', 'Kamchonwongpaisan S']","['Antimalarials/chemical synthesis/chemistry/*pharmacology', 'Crystallography, X-Ray', 'Dose-Response Relationship, Drug', '*Drug Discovery', 'Drug Evaluation, Preclinical', 'Enzyme Inhibitors/chemical synthesis/chemistry/*pharmacology', 'Models, Molecular', 'Molecular Docking Simulation', 'Molecular Structure', 'Plasmodium falciparum/*drug effects/enzymology', 'Proguanil/chemical synthesis/chemistry/pharmacology', 'Protozoan Proteins/*antagonists & inhibitors/isolation & purification/metabolism', 'Pyrimethamine/chemical synthesis/chemistry/pharmacology', 'Structure-Activity Relationship', 'Tetrahydrofolate Dehydrogenase/isolation & purification/metabolism', 'Triazines/chemical synthesis/chemistry/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/33530764/
1248,DHFR,37875111,Methotrexate-based PROTACs as DHFR-specific chemical probes.,"['Rana S', 'Dranchak P', 'Dahlin JL', 'Lamy L', 'Li W', 'Oliphant E', 'Shrimp JH', 'Rajacharya GH', 'Tharakan R', 'Holland DO', 'Whitten AS', 'Wilson KM', 'Singh PK', 'Durum SK', 'Tao D', 'Rai G', 'Inglese J']","['Humans', '*Antineoplastic Agents/pharmacology/therapeutic use', 'Carbon', '*Folic Acid Antagonists/chemistry/metabolism/pharmacology/therapeutic use', 'Methotrexate/pharmacology/metabolism/therapeutic use', '*Neoplasms/drug therapy', 'Proteolysis Targeting Chimera', 'Tetrahydrofolate Dehydrogenase/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37875111/
1249,DHFR,29886325,"Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).","['Francesconi V', 'Giovannini L', 'Santucci M', 'Cichero E', 'Costi MP', 'Naesens L', 'Giordanetto F', 'Tonelli M']","['Antiviral Agents/chemical synthesis/chemistry/*pharmacology', 'Aza Compounds/chemical synthesis/chemistry/*pharmacology', 'Dose-Response Relationship, Drug', 'Folic Acid Antagonists/chemical synthesis/chemistry/*pharmacology', 'Models, Molecular', 'Molecular Structure', 'Orthomyxoviridae/*drug effects/enzymology', 'Spiro Compounds/chemical synthesis/chemistry/*pharmacology', 'Structure-Activity Relationship', 'Tetrahydrofolate Dehydrogenase/*metabolism', 'Triazines/chemical synthesis/chemistry/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/29886325/
1250,TNK2,23686771,Mutations in TNK2 in severe autosomal recessive infantile onset epilepsy.,"['Hitomi Y', 'Heinzen EL', 'Donatello S', 'Dahl HH', 'Damiano JA', 'McMahon JM', 'Berkovic SF', 'Scheffer IE', 'Legros B', 'Rai M', 'Weckhuysen S', 'Suls A', 'De Jonghe P', 'Pandolfo M', 'Goldstein DB', 'Van Bogaert P', 'Depondt C']","['Child, Preschool', 'Epilepsy/*genetics', 'Female', 'Genotype', 'Humans', 'Infant', 'Male', 'Mutation', 'Mutation, Missense', 'Pedigree', 'Protein-Tyrosine Kinases/*genetics', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/23686771/
1251,TNK2,35057760,Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes.,"['Kong D', 'Li G', 'Yang Z', 'Cheng S', 'Zhang W', 'Feng L', 'Zhang K']","['Biomarkers, Tumor/genetics/immunology', 'Colon/immunology/metabolism', 'Colonic Neoplasms/*genetics/immunology/*mortality', 'Databases, Genetic', 'Gene Expression/genetics', 'Humans', 'Inflammation', 'Predictive Value of Tests', 'Prognosis', 'Protein-Tyrosine Kinases/*metabolism', 'Signal Transduction/genetics', 'Tumor Microenvironment/immunology']",https://pubmed.ncbi.nlm.nih.gov/35057760/
1252,TNK2,34735773,Small Molecules Targeting Activated Cdc42-Associated Kinase 1 (ACK1/TNK2) for the Treatment of Cancers.,"['Wang A', 'Pei J', 'Shuai W', 'Lin C', 'Feng L', 'Wang Y', 'Lin F', 'Ouyang L', 'Wang G']","['Antineoplastic Agents/*pharmacology', 'Humans', '*Molecular Targeted Therapy', 'Neoplasms/*drug therapy', 'Protein Kinase Inhibitors/*pharmacology', 'Protein-Tyrosine Kinases/*antagonists & inhibitors/metabolism', 'Signal Transduction', 'Small Molecule Libraries/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/34735773/
1253,TNK2,25347744,ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.,"['Mahajan K', 'Mahajan NP']","['Breast Neoplasms/metabolism/pathology', 'Female', 'Humans', 'Male', 'Prostatic Neoplasms/metabolism/pathology', 'Protein Binding', 'Protein-Tyrosine Kinases/*metabolism', 'Receptors, Androgen/*metabolism', 'Receptors, Estrogen/*metabolism', '*Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/25347744/
1254,TNK2,37133719,Host factor TNK2 is required for influenza virus infection.,"['Zhou A', 'Zhang W', 'Wang B']","['Humans', 'A549 Cells', '*Influenza A virus/genetics', '*Influenza, Human/genetics', '*Protein-Tyrosine Kinases']",https://pubmed.ncbi.nlm.nih.gov/37133719/
1255,TNK2,33484472,TNK2 promoted esophageal cancer progression via activating egfr-akt signaling.,"['Zhang A', 'Zhang R', 'Yang Z', 'Tian R']","['Biomarkers, Tumor/metabolism', 'ErbB Receptors/metabolism', 'Esophageal Neoplasms/metabolism/*mortality/*pathology', 'Humans', 'Kaplan-Meier Estimate', 'Linear Models', 'Protein-Tyrosine Kinases/*metabolism', 'Proto-Oncogene Proteins c-akt/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/33484472/
1256,TNK2,25699576,Development of novel ACK1/TNK2 inhibitors using a fragment-based approach.,"['Lawrence HR', 'Mahajan K', 'Luo Y', 'Zhang D', 'Tindall N', 'Huseyin M', 'Gevariya H', 'Kazi S', 'Ozcan S', 'Mahajan NP', 'Lawrence NJ']","['Antineoplastic Agents/*chemistry/*pharmacology', 'Cell Line, Tumor', '*Drug Design', 'Humans', 'Molecular Docking Simulation', 'Neoplasms/drug therapy/enzymology', 'Protein Kinase Inhibitors/*chemistry/*pharmacology', 'Protein-Tyrosine Kinases/*antagonists & inhibitors/chemistry/metabolism', 'Small Molecule Libraries/chemistry/pharmacology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/25699576/
1257,TNK2,34428048,Proximity-Dependent Biotinylation to Elucidate the Interactome of TNK2 Nonreceptor Tyrosine Kinase.,"['Tahir R', 'Madugundu AK', 'Udainiya S', 'Cutler JA', 'Renuse S', 'Wang L', 'Pearson NA', 'Mitchell CJ', 'Mahajan N', 'Pandey A', 'Wu X']","['Biotinylation', 'Protein Binding', '*Protein-Tyrosine Kinases/genetics', '*Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/34428048/
1258,TNK2,35941836,ELK1-Induced upregulation of long non-coding TNK2-AS1 promotes the progression of acute myeloid leukemia by EZH2-mediated epigenetic silencing of CELF2.,"['Guo D', 'Zhang A', 'Suo M', 'Wang P', 'Liang Y']","['Humans', 'Up-Regulation', 'Cell Line, Tumor', 'Phosphatidylinositol 3-Kinases/metabolism', 'Cell Proliferation/genetics', '*Leukemia, Myeloid, Acute/pathology', 'Epigenesis, Genetic', '*RNA, Long Noncoding/genetics', 'Gene Expression Regulation, Neoplastic', '*MicroRNAs/genetics', 'CELF Proteins/genetics/metabolism', 'Nerve Tissue Proteins/genetics', 'Enhancer of Zeste Homolog 2 Protein/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35941836/
1259,TNK2,39639371,TNK2 Inhibitor (R)-9bMS Causes Polyploidization Through Mitotic Failure by Targeting Aurora B.,"['Murata M', 'Kuwajima H', 'Tanaka J', 'Hasegawa N', 'Yuki R', 'Saito Y', 'Nakayama Y']","['*Aurora Kinase B/antagonists & inhibitors/metabolism', 'Humans', '*Mitosis/drug effects', '*Polyploidy', 'Protein Kinase Inhibitors/pharmacology', 'Cell Proliferation/drug effects', 'Phosphorylation/drug effects']",https://pubmed.ncbi.nlm.nih.gov/39639371/
1260,TNK2,30454892,The positive feedback between lncRNA TNK2-AS1 and STAT3 enhances angiogenesis in non-small cell lung cancer.,"['Wang Y', 'Han D', 'Pan L', 'Sun J']","['Base Sequence', 'Carcinoma, Non-Small-Cell Lung/*blood supply/*genetics/pathology', 'Cell Line, Tumor', 'Disease Progression', '*Feedback, Physiological', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Lung Neoplasms/*blood supply/*genetics/pathology', 'Neovascularization, Pathologic/*genetics/pathology', 'RNA, Long Noncoding/genetics/*metabolism', 'STAT3 Transcription Factor/*metabolism', 'Signal Transduction', 'Transcription, Genetic', 'Up-Regulation/genetics', 'Vascular Endothelial Growth Factor A/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30454892/
1261,ERBB3,29338072,Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.,"['Ross JS', 'Fakih M', 'Ali SM', 'Elvin JA', 'Schrock AB', 'Suh J', 'Vergilio JA', 'Ramkissoon S', 'Severson E', 'Daniel S', 'Fabrizio D', 'Frampton G', 'Sun J', 'Miller VA', 'Stephens PJ', 'Gay LM']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Antineoplastic Combined Chemotherapy Protocols/*therapeutic use', 'Biomarkers, Tumor/genetics', 'Child', 'Colorectal Neoplasms/drug therapy/*genetics/pathology', 'Female', 'Follow-Up Studies', '*Gene Amplification', 'Gene Expression Regulation, Neoplastic', 'Genomics', 'Humans', 'Male', 'Microsatellite Instability', 'Middle Aged', '*Molecular Targeted Therapy', '*Mutation', 'Prognosis', 'Receptor, ErbB-2/*genetics', 'Receptor, ErbB-3/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29338072/
1262,ERBB3,23792093,IGF-1R and ErbB3/HER3 contribute to enhanced proliferation and carcinogenesis in trastuzumab-resistant ovarian cancer model.,"['Jia Y', 'Zhang Y', 'Qiao C', 'Liu G', 'Zhao Q', 'Zhou T', 'Chen G', 'Li Y', 'Feng J', 'Li Y', 'Zhang Q', 'Peng H']","['Antibodies, Monoclonal, Humanized/*therapeutic use', 'Antineoplastic Agents/*therapeutic use', 'Cell Line, Tumor', '*Cell Proliferation', '*Cell Transformation, Neoplastic', 'Drug Resistance, Neoplasm', 'Female', 'Humans', 'Ovarian Neoplasms/drug therapy/*metabolism/pathology', 'Receptor, ErbB-2/*metabolism', 'Receptor, IGF Type 1/*metabolism', 'Trastuzumab', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/23792093/
1263,ERBB3,36266942,Discoidin domain receptor 1 regulates ErbB2/ErbB3 signaling in mammary epithelial cells.,"['Toscani AM', 'Aguilera P', 'Coluccio Leskow F']","['*Discoidin Domain Receptor 1/metabolism', '*Receptor Protein-Tyrosine Kinases/metabolism', 'Signal Transduction', 'Discoidin Domain Receptors/metabolism', 'Epithelial Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36266942/
1264,ERBB3,23611113,Interaction of Necl-4/CADM4 with ErbB3 and integrin alpha6 beta4 and inhibition of ErbB2/ErbB3 signaling and hemidesmosome disassembly.,"['Sugiyama H', 'Mizutani K', 'Kurita S', 'Okimoto N', 'Shimono Y', 'Takai Y']","['Caco-2 Cells', 'Cell Adhesion Molecules/chemistry/*metabolism', 'Cells, Cultured', 'HEK293 Cells', 'Hemidesmosomes/*metabolism', 'Humans', 'Immunoglobulins/chemistry/*metabolism', 'Integrin alpha6beta4/*metabolism', 'Receptor, ErbB-2/*antagonists & inhibitors/chemistry/metabolism', 'Receptor, ErbB-3/*antagonists & inhibitors/chemistry/*metabolism', '*Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/23611113/
1265,ERBB3,23090500,"Simulation of homology models for the extracellular domains (ECD) of ErbB3, ErbB4 and the ErbB2-ErbB3 complex in their active conformations.","['Franco-Gonzalez JF', 'Ramos J', 'Cruz VL', 'Martinez-Salazar J']","['ErbB Receptors/*chemistry', 'Humans', 'Ligands', '*Molecular Dynamics Simulation', 'Neuregulin-1/*chemistry', 'Protein Binding', 'Protein Interaction Domains and Motifs', 'Protein Multimerization', 'Protein Structure, Secondary', 'Receptor, ErbB-2/*chemistry', 'Receptor, ErbB-3/*chemistry', 'Receptor, ErbB-4', 'Structural Homology, Protein', 'Water/chemistry']",https://pubmed.ncbi.nlm.nih.gov/23090500/
1266,ERBB3,1361525,The erbB-3 gene in human pancreatic cancer.,"['Lemoine NR', 'Lobresco M', 'Leung H', 'Barton C', 'Hughes CM', 'Prigent SA', 'Gullick WJ', 'Kloppel G']","['Amino Acid Sequence', 'Blotting, Southern', 'Cell Line', 'Chronic Disease', 'ErbB Receptors/genetics', 'Gene Amplification', 'Gene Expression/*genetics', 'Gene Rearrangement', 'Humans', 'Immunohistochemistry', 'Molecular Sequence Data', 'Oncogene Proteins v-erbB', 'Pancreas/chemistry', 'Pancreatic Neoplasms/*genetics/metabolism', 'Pancreatitis/genetics/metabolism', 'Proto-Oncogene Proteins/analysis/*genetics', 'Receptor, ErbB-3', 'Retroviridae Proteins, Oncogenic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/1361525/
1267,ERBB3,9815939,Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression.,"['Friess H', 'Yamanaka Y', 'Kobrin MS', 'Do DA', 'Buchler MW', 'Korc M']","['Adenocarcinoma/*metabolism/pathology', 'Adult', 'Aged', 'Blotting, Northern', 'Blotting, Southern', 'ErbB Receptors/*metabolism', 'Female', '*Genes, erbB', 'Humans', 'Male', 'Middle Aged', 'Neoplasm Proteins/*metabolism', 'Pancreas/metabolism', 'Pancreatic Neoplasms/*metabolism/pathology', 'Proto-Oncogene Proteins/*metabolism', 'RNA, Messenger/metabolism', 'Receptor, ErbB-3', 'Survival Analysis', 'Tumor Cells, Cultured/metabolism']",https://pubmed.ncbi.nlm.nih.gov/9815939/
1268,ERBB3,24449784,Role of erbB3 receptors in cancer therapeutic resistance.,"['Lee Y', 'Ma J', 'Lyu H', 'Huang J', 'Kim A', 'Liu B']","['Drug Resistance, Neoplasm/*drug effects/physiology', 'Humans', 'Models, Biological', 'Molecular Targeted Therapy/methods', 'Neoplasms/*drug therapy/metabolism/physiopathology', 'Phosphorylation', 'Receptor, ErbB-2/metabolism', 'Receptor, ErbB-3/*antagonists & inhibitors/metabolism', 'Signal Transduction/*drug effects/physiology']",https://pubmed.ncbi.nlm.nih.gov/24449784/
1269,LYN,27728800,A New Role for Lyn in the CLL Microenvironment.,"['Dong S', 'Byrd JC']","['Humans', '*Leukemia, Lymphocytic, Chronic, B-Cell', 'Macrophages', 'Myeloid Cells', '*src-Family Kinases']",https://pubmed.ncbi.nlm.nih.gov/27728800/
1270,LYN,36899005,LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1.,"['Vom Stein AF', 'Rebollido-Rios R', 'Lukas A', 'Koch M', 'von Lom A', 'Reinartz S', 'Bachurski D', 'Rose F', 'Bozek K', 'Abdallah AT', 'Kohlhas V', 'Saggau J', 'Zolzer R', 'Zhao Y', 'Bruns C', 'Brockelmann PJ', 'Lohneis P', 'Buttner R', 'Haupl B', 'Oellerich T', 'Nguyen PH', 'Hallek M']","['Humans', 'Fibroblasts/metabolism', 'Gene Expression Regulation, Leukemic', 'Leukemia/genetics', '*Leukemia, Lymphocytic, Chronic, B-Cell/genetics', 'Signal Transduction', '*src-Family Kinases/metabolism', '*Proto-Oncogene Proteins c-jun/metabolism', '*Thrombospondins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36899005/
1271,LYN,36932076,Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome.,"['de Jesus AA', 'Chen G', 'Yang D', 'Brdicka T', 'Ruth NM', 'Bennin D', 'Cebecauerova D', 'Malcova H', 'Freeman H', 'Martin N', 'Svojgr K', 'Passo MH', 'Bhuyan F', 'Alehashemi S', 'Rastegar AT', 'Uss K', 'Kardava L', 'Marrero B', 'Duric I', 'Omoyinmi E', 'Peldova P', 'Lee CR', 'Kleiner DE', 'Hadigan CM', 'Hewitt SM', 'Pittaluga S', 'Carmona-Rivera C', 'Calvo KR', 'Shah N', 'Balascakova M', 'Fink DL', 'Kotalova R', 'Parackova Z', 'Peterkova L', 'Kuzilkova D', 'Campr V', 'Sramkova L', 'Biancotto A', 'Brooks SR', 'Manes C', 'Meffre E', 'Harper RL', 'Kuehn H', 'Kaplan MJ', 'Brogan P', 'Rosenzweig SD', 'Merchant M', 'Deng Z', 'Huttenlocher A', 'Moir SL', 'Kuhns DB', 'Boehm M', 'Skvarova Kramarzova K', 'Goldbach-Mansky R']","['Humans', 'Dasatinib', '*Endothelial Cells/metabolism', 'Inflammation/metabolism', 'Neutrophils/metabolism', 'Phosphorylation', '*src-Family Kinases/genetics/metabolism', '*Vasculitis/genetics']",https://pubmed.ncbi.nlm.nih.gov/36932076/
1272,LYN,11929545,c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs.,"['Stein M', 'Bagnoli F', 'Halenbeck R', 'Rappuoli R', 'Fantl WJ', 'Covacci A']","['Amino Acid Motifs', 'Amino Acid Sequence', '*Antigens, Bacterial', 'Bacterial Proteins/genetics/*metabolism', 'Binding Sites', 'CSK Tyrosine-Protein Kinase', 'Helicobacter pylori/genetics/*metabolism', 'Molecular Sequence Data', 'Phosphorylation', 'Protein-Tyrosine Kinases/*metabolism', 'Pyrazoles/pharmacology', 'Pyrimidines/pharmacology', 'Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods', 'Tyrosine/genetics/*metabolism', 'src-Family Kinases/antagonists & inhibitors/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/11929545/
1273,LYN,35710616,Fumarate suppresses B-cell activation and function through direct inactivation of LYN.,"['Cheng J', 'Liu Y', 'Yan J', 'Zhao L', 'Zhou Y', 'Shen X', 'Chen Y', 'Chen Y', 'Meng X', 'Zhang X', 'Jiang P']","['Fumarate Hydratase/metabolism', '*Fumarates/pharmacology', 'Protein-Tyrosine Kinases/metabolism', '*Receptors, Antigen, B-Cell/metabolism', 'Signal Transduction', 'src-Family Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35710616/
1274,EPHA2,33686241,Oncogenic functions and therapeutic targeting of EphA2 in cancer.,"['Wilson K', 'Shiuan E', 'Brantley-Sieders DM']","['Humans', 'Neoplasms/*genetics', 'Oncogenes/*genetics', 'Receptor, EphA2/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33686241/
1275,EPHA2,37736700,Targeting EPHA2 with Kinase Inhibitors in Colorectal Cancer.,"['Troster A', 'Jores N', 'Mineev KS', 'Sreeramulu S', 'DiPrima M', 'Tosato G', 'Schwalbe H']","['Humans', '*Receptor, EphA2/metabolism', 'Receptors, Vascular Endothelial Growth Factor', '*Colorectal Neoplasms/drug therapy/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37736700/
1276,EPHA2,37972196,Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly.,"['Shi X', 'Lingerak R', 'Herting CJ', 'Ge Y', 'Kim S', 'Toth P', 'Wang W', 'Brown BP', 'Meiler J', 'Sossey-Alaoui K', 'Buck M', 'Himanen J', 'Hambardzumyan D', 'Nikolov DB', 'Smith AW', 'Wang B']","['Humans', 'Ligands', 'Neoplasm Invasiveness', 'Phosphorylation', '*Receptor, EphA2/chemistry/metabolism', 'Signal Transduction', 'Spectrometry, Fluorescence', '*Protein Multimerization', '*Tumor Suppressor Proteins/chemistry/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37972196/
1277,EPHA2,37924938,Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.,"['Primeaux M', 'Liu X', 'Gowrikumar S', 'Fatima I', 'Fisher KW', 'Bastola D', 'Vecchio AJ', 'Singh AB', 'Dhawan P']","['Humans', 'Cell Line, Tumor', 'Claudin-1/genetics/metabolism', '*Colorectal Neoplasms/drug therapy/genetics/pathology', 'Drug Resistance, Neoplasm', 'Gene Expression Regulation, Neoplastic', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/37924938/
1278,EPHA2,35105853,EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.,"['Gai QJ', 'Fu Z', 'He J', 'Mao M', 'Yao XX', 'Qin Y', 'Lan X', 'Zhang L', 'Miao JY', 'Wang YX', 'Zhu J', 'Yang FC', 'Lu HM', 'Yan ZX', 'Chen FL', 'Shi Y', 'Ping YF', 'Cui YH', 'Zhang X', 'Liu X', 'Yao XH', 'Lv SQ', 'Bian XW', 'Wang Y']","['Biomarkers, Tumor/genetics/*metabolism', 'Cell Line, Tumor', 'Glioblastoma/diagnosis/genetics/*metabolism', 'Humans', 'Neoplasm Proteins/genetics/*metabolism', 'Platelet-Derived Growth Factor/genetics/*metabolism', 'Prognosis', 'Receptor, EphA2/genetics/*metabolism', 'Receptor, Platelet-Derived Growth Factor alpha/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/35105853/
1279,EPHA2,29997324,Theoretical Model of EphA2-Ephrin A1 Inhibition.,"['Jedwabny W', 'Lodola A', 'Dyguda-Kazimierowicz E']","['Binding Sites', 'Ephrin-A1/chemistry/*metabolism', '*Models, Biological', 'Receptor, EphA2/chemistry/*metabolism', 'Static Electricity', 'Thermodynamics']",https://pubmed.ncbi.nlm.nih.gov/29997324/
1280,EPHA2,35227773,Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma.,"['Husain A', 'Chiu YT', 'Sze KM', 'Ho DW', 'Tsui YM', 'Suarez EMS', 'Zhang VX', 'Chan LK', 'Lee E', 'Lee JM', 'Cheung TT', 'Wong CC', 'Chung CY', 'Ng IO']","['*Carcinoma, Hepatocellular/pathology', 'Cell Line, Tumor', '*Ephrin-A3/genetics/metabolism', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Hypoxia', '*Liver Neoplasms/pathology', '*Receptor, EphA2/genetics/metabolism', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/35227773/
1281,EPHA2,26724997,Structures of the EphA2 Receptor at the Membrane: Role of Lipid Interactions.,"['Chavent M', 'Seiradake E', 'Jones EY', 'Sansom MS']","['Binding Sites', 'Humans', 'Lipid Bilayers/chemistry/*metabolism', 'Models, Molecular', 'Molecular Dynamics Simulation', 'Mutation', 'Protein Binding', 'Protein Structure, Tertiary', 'Receptor, EphA2/*chemistry/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/26724997/
1282,EPHA2,38531846,USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway.,"['Li A', 'Wang S', 'Nie J', 'Xiao S', 'Xie X', 'Zhang Y', 'Tong W', 'Yao G', 'Liu N', 'Dan F', 'Shu Z', 'Liu J', 'Liu Z', 'Yang F']","['Humans', 'Proto-Oncogene Proteins c-akt/metabolism', 'Phosphatidylinositol 3-Kinases/metabolism', 'Cell Line, Tumor', 'Signal Transduction', 'Cell Proliferation', '*Osteosarcoma/pathology', '*Bone Neoplasms/pathology', 'Cell Movement', 'Ubiquitin-Specific Proteases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38531846/
1283,FYN,36754870,Role of Fyn in hematological malignancies.,"['Li S', 'Liu C', 'Tang Y']","['Humans', '*Hematologic Neoplasms/genetics', '*Neoplasms', 'Phosphotransferases', 'Protein-Tyrosine Kinases/metabolism', 'Proto-Oncogene Proteins/genetics', 'Proto-Oncogene Proteins c-fyn/genetics', 'src-Family Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36754870/
1284,FYN,37093456,Advances in the expression and function of Fyn in different human tumors.,"['Liu C', 'Li S', 'Tang Y']","['Humans', '*Melanoma', 'Phosphorylation', '*Protein-Tyrosine Kinases', 'Proto-Oncogene Proteins c-fyn/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37093456/
1285,FYN,26305432,Fyn is an important molecule in cancer pathogenesis and drug resistance.,"['Elias D', 'Ditzel HJ']","['Antineoplastic Agents/therapeutic use', 'Drug Resistance, Neoplasm/*genetics', 'Humans', 'Neoplasms/drug therapy/*genetics/*pathology', 'Proto-Oncogene Proteins c-fyn/*genetics', 'Signal Transduction/drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/26305432/
1286,FYN,36740671,FYN: emerging biological roles and potential therapeutic targets in cancer.,"['Peng S', 'Fu Y']","['Humans', 'Cell Movement', '*Neoplasms/genetics/therapy', '*Proto-Oncogene Proteins c-fyn/genetics/metabolism', '*Signal Transduction', 'src-Family Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36740671/
1287,FYN,28092037,Structural Characterization of Monomeric/Dimeric State of p59(fyn) SH2 Domain.,"['Huculeci R', 'Kieken F', 'Garcia-Pino A', 'Buts L', 'van Nuland N', 'Lenaerts T']","['Chromatography, Gel', 'Circular Dichroism', 'Cloning, Molecular', 'Gene Expression', 'Nuclear Magnetic Resonance, Biomolecular', 'Plasmids/genetics', 'Protein Binding', 'Protein Multimerization', 'Proto-Oncogene Proteins c-fyn/*chemistry/genetics/isolation & purification/metabolism', 'Recombinant Fusion Proteins', 'Structure-Activity Relationship', '*src Homology Domains']",https://pubmed.ncbi.nlm.nih.gov/28092037/
1288,FYN,34939537,Role of Fyn Kinase Inhibitors in Switching Neuroinflammatory Pathways.,"['Marotta G', 'Basagni F', 'Rosini M', 'Minarini A']","['*Alzheimer Disease/metabolism', 'Cell Differentiation', 'Humans', '*Neurodegenerative Diseases/drug therapy', 'Phosphorylation', 'Proto-Oncogene Proteins c-fyn/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/34939537/
1289,FYN,36157893,Fyn Signaling in Ischemia-Reperfusion Injury: Potential and Therapeutic Implications.,"['Du F', 'Tang T', 'Li Q', 'Liu J']","['*Brain Ischemia/metabolism', 'Calcium', 'Humans', '*Ischemic Stroke', 'Peroxynitrous Acid', 'Protein-Tyrosine Kinases', '*Reperfusion Injury/metabolism', 'Superoxides', 'src-Family Kinases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36157893/
1290,FYN,25225878,Probing the interaction between U24 and the SH3 domain of Fyn tyrosine kinase.,"['Sang Y', 'Tait AR', 'Scott WR', 'Creagh AL', 'Kumar P', 'Haynes CA', 'Straus SK']","['Amino Acid Sequence', 'Circular Dichroism', 'Gene Deletion', 'Gene Expression Regulation, Viral', 'Herpesvirus 6, Human/genetics/*metabolism', 'Herpesvirus 7, Human/genetics/*metabolism', 'Mutation', 'Nuclear Magnetic Resonance, Biomolecular', 'Protein Conformation', 'Protein Structure, Tertiary', 'Proto-Oncogene Proteins c-fyn/chemistry/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25225878/
1291,FYN,19728795,Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?,"['Vatish M', 'Yamada E', 'Pessin JE', 'Bastie CC']","['Adenylate Kinase/chemistry/*metabolism', 'Humans', 'Insulin/metabolism', '*Lipid Metabolism', 'Oxidation-Reduction', 'Protein Conformation', 'Proto-Oncogene Proteins c-fyn/*metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/19728795/
1292,HTR3A,35457612,"Serotonin Receptor HTR3A Gene Polymorphisms rs1985242 and rs1062613, E-Cigarette Use and Personality.","['Suchanecka A', 'Chmielowiec J', 'Chmielowiec K', 'Trybek G', 'Jaron A', 'Czarny W', 'Krol P', 'Masiak J', 'Grzywacz A']","['*Electronic Nicotine Delivery Systems', 'Personality/genetics', 'Personality Inventory', 'Polymorphism, Genetic', 'Receptors, Serotonin/genetics', '*Vaping']",https://pubmed.ncbi.nlm.nih.gov/35457612/
1293,HTR3A,27144979,The association of HTR3A mRNA expression and craving in Han Chinese alcohol-dependent patients: a preliminary study.,"['Xu YH', 'Wang LL', 'Shi L', 'Lei JP', 'Miao Q', 'Liu TQ', 'Hao W', 'Lu L', 'Zhang RL']","['Acetylation', 'Adult', 'Alcoholism/*genetics', 'Asian People/*genetics/*psychology', 'Case-Control Studies', '*Craving', 'Gene Expression/genetics', 'Humans', 'Male', 'Middle Aged', 'Promoter Regions, Genetic', 'Receptors, Serotonin, 5-HT3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27144979/
1294,HTR3A,34022433,linc01305 promotes metastasis and proliferation of esophageal squamous cell carcinoma through interacting with IGF2BP2 and IGF2BP3 to stabilize HTR3A mRNA.,"['Huang GW', 'Chen QQ', 'Ma CC', 'Xie LH', 'Gu J']","['Apoptosis', 'Biomarkers, Tumor/genetics/metabolism', 'Cell Movement', 'Cell Proliferation', 'Epithelial-Mesenchymal Transition', 'Esophageal Neoplasms/genetics/metabolism/*pathology', 'Esophageal Squamous Cell Carcinoma/genetics/metabolism/*secondary', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Prognosis', 'RNA, Long Noncoding/*genetics', 'RNA-Binding Proteins/genetics/*metabolism', 'Receptors, Serotonin, 5-HT3/*chemistry/genetics/metabolism', 'Survival Rate', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/34022433/
1295,HTR3A,32736413,HTR3A is correlated with unfavorable histology and promotes proliferation through ERK phosphorylation in lung adenocarcinoma.,"['Tone M', 'Tahara S', 'Nojima S', 'Motooka D', 'Okuzaki D', 'Morii E']","['Adenocarcinoma of Lung/*drug therapy/*genetics/pathology', 'Aged', 'Cell Proliferation/drug effects', 'ErbB Receptors/genetics', 'Female', 'Gene Expression Regulation, Neoplastic/genetics', 'Gene Knockdown Techniques', 'Humans', 'Ki-67 Antigen/genetics', 'Male', 'Middle Aged', 'Mitogen-Activated Protein Kinase 3/genetics', 'Phosphorylation/drug effects', 'Prognosis', 'Receptors, Serotonin, 5-HT3/*genetics', 'Serotonin 5-HT3 Receptor Antagonists/pharmacology', 'Tropisetron/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/32736413/
1296,HTR3A,27706728,"Associations of serotonin receptor gene HTR3A, HTR3B, and HTR3A haplotypes with bipolar disorder in Chinese patients.","['Jian J', 'Li C', 'Xu J', 'Qiao D', 'Mi G', 'Chen X', 'Tang M']","['Alleles', 'Bipolar Disorder/*genetics/pathology', 'China', 'Female', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Receptors, Serotonin, 5-HT3/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27706728/
1297,HTR3A,16000636,A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala.,"['Iidaka T', 'Ozaki N', 'Matsumoto A', 'Nogawa J', 'Kinoshita Y', 'Suzuki T', 'Iwata N', 'Yamamoto Y', 'Okada T', 'Sadato N']","['Adult', 'Alleles', '*Amino Acid Substitution', 'Amygdala/*physiology', 'Face', 'Female', 'Genotype', 'Habituation, Psychophysiologic/*genetics/physiology', 'Humans', 'Japan', 'Limbic System/physiology', 'Magnetic Resonance Imaging', 'Male', 'Oxygen/blood', 'Pattern Recognition, Visual/*physiology', 'Personality', '*Polymorphism, Single Nucleotide', 'Prefrontal Cortex/*physiology', 'Reaction Time/genetics/physiology', 'Receptors, Serotonin, 5-HT3/genetics/*physiology', 'Serotonin/physiology', 'Temperament']",https://pubmed.ncbi.nlm.nih.gov/16000636/
1298,HTR3A,14557147,A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women.,"['Melke J', 'Westberg L', 'Nilsson S', 'Landen M', 'Soderstrom H', 'Baghaei F', 'Rosmond R', 'Holm G', 'Bjorntorp P', 'Nilsson LG', 'Adolfsson R', 'Eriksson E']","['Adult', 'Cohort Studies', 'Female', 'Genotype', 'Humans', 'Middle Aged', 'Personality/classification/*genetics', 'Personality Assessment', 'Personality Inventory', 'Polymorphism, Genetic/*genetics', 'Receptors, Serotonin, 5-HT3/*genetics', 'Serine Endopeptidases/genetics', 'Sweden']",https://pubmed.ncbi.nlm.nih.gov/14557147/
1299,HTR3A,15293096,Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients.,"['Frank B', 'Niesler B', 'Bondy B', 'Spath M', 'Pongratz DE', 'Ackenheil M', 'Fischer C', 'Rappold G']","['Chromatography, High Pressure Liquid', 'DNA/genetics', 'DNA Mutational Analysis', 'Female', 'Fibromyalgia/*genetics/metabolism/pathology', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Humans', 'Male', 'Polymorphism, Single-Stranded Conformational', 'Receptors, Serotonin/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/15293096/
1300,HTR3A,16487942,Distinguishable haplotype blocks in the HTR3A and HTR3B region in the Japanese reveal evidence of association of HTR3B with female major depression.,"['Yamada K', 'Hattori E', 'Iwayama Y', 'Ohnishi T', 'Ohba H', 'Toyota T', 'Takao H', 'Minabe Y', 'Nakatani N', 'Higuchi T', 'Detera-Wadleigh SD', 'Yoshikawa T']","['Adult', 'Databases, Genetic', 'Depressive Disorder, Major/*epidemiology/*genetics', 'Exons/genetics', 'Female', 'Gene Frequency', 'Genetic Testing', 'Genotype', 'Haplotypes', 'Humans', 'Introns/genetics', 'Japan/epidemiology', 'Male', 'Middle Aged', 'Mood Disorders/epidemiology/genetics', 'Mutation/genetics', 'Polymorphism, Genetic/genetics', 'Polymorphism, Single Nucleotide/genetics', 'Psychiatric Status Rating Scales', 'Receptors, Serotonin, 5-HT3/*genetics', 'Schizophrenia/epidemiology/genetics']",https://pubmed.ncbi.nlm.nih.gov/16487942/
1301,HTR3A,18359159,"Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population.","['Ji X', 'Takahashi N', 'Saito S', 'Ishihara R', 'Maeno N', 'Inada T', 'Ozaki N']","['Adult', 'Aged', 'Antipsychotic Agents/therapeutic use', 'DNA Mutational Analysis', 'Drug Resistance/genetics', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Japan/ethnology', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Mutation', 'Pharmacogenetics', 'Receptor, Serotonin, 5-HT2A/*genetics', 'Receptors, Serotonin/*genetics', 'Receptors, Serotonin, 5-HT3', 'Receptors, Serotonin, 5-HT4/*genetics', 'Schizophrenia/drug therapy/epidemiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/18359159/
1302,HTR3A,28002447,Influence of Polymorphisms in the HTR3A and HTR3B Genes on Experimental Pain and the Effect of the 5-HT3 Antagonist Granisetron.,"['Louca Jounger S', 'Christidis N', 'Hedenberg-Magnusson B', 'List T', 'Svensson P', 'Schalling M', 'Ernberg M']","['Adult', 'Alleles', 'Double-Blind Method', 'Female', 'Genotype', 'Granisetron/*therapeutic use', 'Healthy Volunteers', 'Humans', 'Male', 'Myalgia/chemically induced/*drug therapy/*genetics/prevention & control', 'Pain Threshold/physiology', 'Placebo Effect', 'Polymorphism, Single Nucleotide', 'Receptors, Serotonin, 5-HT3/*genetics', 'Serotonin 5-HT3 Receptor Antagonists/*therapeutic use', 'Sex Factors', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28002447/
1303,HTR3A,22700043,Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia.,"['Rajkumar AP', 'Poonkuzhali B', 'Kuruvilla A', 'Srivastava A', 'Jacob M', 'Jacob KS']","['Adult', 'Antipsychotic Agents/blood/pharmacokinetics/*therapeutic use', 'Case-Control Studies', 'Chi-Square Distribution', 'Clozapine/blood/pharmacokinetics/*therapeutic use', 'Cross-Sectional Studies', 'Drug Resistance/genetics', 'Female', 'Gene Frequency', 'Genotype', 'Humans', 'Logistic Models', 'Male', 'Middle Aged', 'Multivariate Analysis', 'Odds Ratio', 'Pharmacogenetics', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Psychiatric Status Rating Scales', 'Receptors, Serotonin, 5-HT3/*drug effects/*genetics', 'Schizophrenia/diagnosis/*drug therapy/*genetics', 'Schizophrenic Psychology', 'Serotonin Antagonists/blood/pharmacokinetics/*therapeutic use', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/22700043/
1304,HTR3A,16314763,Serotonin receptor genes HTR3A and HTR3B are not involved in Gilles de la Tourette syndrome.,"['Niesler B', 'Frank B', 'Hebebrand J', 'Rappold G']","['Base Sequence', '*Genetic Variation', 'Humans', '*Mutation', '*Polymorphism, Single-Stranded Conformational', 'Receptors, Serotonin/*genetics', 'Receptors, Serotonin, 5-HT3', 'Tourette Syndrome/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16314763/
1305,HTR3A,31868947,5'UTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls-Preliminary evidence.,"['Ledermann K', 'Hasler G', 'Jenewein J', 'Sprott H', 'Schnyder U', 'Martin-Soelch C']","[""5' Untranslated Regions"", 'Adult', 'Aged', 'Dopamine/metabolism', 'Female', 'Fibromyalgia/diagnostic imaging/*genetics', 'Humans', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Positron-Emission Tomography', 'Putamen/diagnostic imaging/*metabolism', 'Receptors, Dopamine D2/metabolism', 'Receptors, Serotonin, 5-HT3/*genetics', 'Reward']",https://pubmed.ncbi.nlm.nih.gov/31868947/
1306,UGT1A1,36443464,Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.,"['Hulshof EC', 'Deenen MJ', 'Nijenhuis M', 'Soree B', 'de Boer-Veger NJ', 'Buunk AM', 'Houwink EJF', 'Risselada A', 'Rongen GAPJM', 'van Schaik RHN', 'Touw DJ', 'van der Weide J', 'van Westrhenen R', 'Deneer VHM', 'Guchelaar HJ', 'Swen JJ']","['Humans', 'Irinotecan/therapeutic use', '*Camptothecin/adverse effects', '*Pharmacogenetics', 'Genotype', 'Polymorphism, Genetic', 'Drug Interactions']",https://pubmed.ncbi.nlm.nih.gov/36443464/
1307,UGT1A1,28494109,Oncology Drug Dosing in Gilbert Syndrome Associated with UGT1A1: A Summary of the Literature.,"['Ha VH', 'Jupp J', 'Tsang RY']","['Antineoplastic Combined Chemotherapy Protocols/administration & dosage/*therapeutic use', 'Dose-Response Relationship, Drug', 'Genetic Predisposition to Disease', 'Gilbert Disease/*drug therapy/genetics', 'Glucuronosyltransferase/*genetics', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/28494109/
1308,UGT1A1,37535593,Photoinduced electron transfer detection method for identifying UGT1A1*28 microsatellites.,"['Tsuchida S', 'Himi N', 'Miura Y', 'Kodama S', 'Shindo T', 'Nakagawa K', 'Aoki T']","['*Electrons', '*DNA/genetics', 'Nucleic Acid Hybridization/methods', 'DNA, Complementary', 'DNA, Single-Stranded/genetics', 'Microsatellite Repeats/genetics']",https://pubmed.ncbi.nlm.nih.gov/37535593/
1309,UGT1A1,37470120,UGT1A1 genotype-guided dosing of irinotecan: time to prioritize patient safety.,"['Peeters SL', 'Deenen MJ', 'Thijs AM', 'Hulshof EC', 'Mathijssen RH', 'Gelderblom H', 'Guchelaar HJ', 'Swen JJ']","['Humans', 'Irinotecan/adverse effects', '*Camptothecin/adverse effects', 'Patient Safety', 'Genotype', '*Neoplasms/drug therapy', 'Glucuronosyltransferase/genetics']",https://pubmed.ncbi.nlm.nih.gov/37470120/
1310,UGT1A1,36343684,Inhibition of UGT1A1*1 and UGT1A1*6 catalyzed glucuronidation of SN-38 by silybins.,"['Li W', 'Chen YN', 'Chen YY', 'Wang Z', 'Wang Z', 'Jiang LL', 'Shi HC', 'Liu Y']","['Irinotecan/metabolism', 'Silybin/metabolism/pharmacology', '*Glucuronosyltransferase/metabolism', '*Silybum marianum', 'Microsomes, Liver/metabolism', 'Catalysis', 'Camptothecin']",https://pubmed.ncbi.nlm.nih.gov/36343684/
1311,UGT1A1,28990653,Mechanism of in-vitro inhibition of UGT1A1 by paritaprevir.,"['Alam N', 'Angeli MG', 'Greenblatt DJ']","['Adolescent', 'Adult', 'Aged', 'Antiviral Agents/pharmacokinetics/*pharmacology', 'Child', 'Child, Preschool', 'Cyclopropanes', 'Drug Interactions', 'Enzyme Inhibitors/pharmacology', 'Ethinyl Estradiol/metabolism', 'Glucuronosyltransferase/*antagonists & inhibitors', 'Humans', 'Lactams, Macrocyclic', 'Macrocyclic Compounds/pharmacokinetics/*pharmacology', 'Male', 'Microsomes, Liver/*drug effects/enzymology', 'Middle Aged', 'Probenecid/pharmacology', 'Proline/analogs & derivatives', 'Sulfonamides', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28990653/
1312,UGT1A1,28074472,Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype.,"['Roncato R', 'Cecchin E', 'Montico M', 'De Mattia E', 'Giodini L', 'Buonadonna A', 'Solfrini V', 'Innocenti F', 'Toffoli G']","['Antineoplastic Combined Chemotherapy Protocols/administration & dosage/*adverse effects', 'Camptothecin/administration & dosage/adverse effects/*analogs & derivatives', '*Colorectal Neoplasms/drug therapy/pathology', 'Cost-Benefit Analysis', '*Drug-Related Side Effects and Adverse Reactions/economics/genetics/therapy', 'Female', 'Fluorouracil/administration & dosage/adverse effects', 'Glucuronosyltransferase/*genetics', 'Humans', '*Irinotecan/administration & dosage/adverse effects/pharmacokinetics', 'Italy', 'Leucovorin/administration & dosage/adverse effects', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Patient Care Management/economics/methods', '*Pharmacogenomic Testing/economics/methods', 'Pharmacogenomic Variants/genetics', 'Retrospective Studies', 'Topoisomerase I Inhibitors/administration & dosage/adverse effects/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/28074472/
1313,UGT1A1,35501760,Associations between UGT1A1 and SLCO1B1 polymorphisms and susceptibility to neonatal hyperbilirubinemia in Thai population.,"['Atasilp C', 'Kanjanapipak J', 'Vichayaprasertkul J', 'Jinda P', 'Tiyasirichokchai R', 'Srisawasdi P', 'Prempunpong C', 'Chamnanphon M', 'Puangpetch A', 'Vanwong N', 'Klongthalay S', 'Jantararoungtong T', 'Sukasem C']","['Bilirubin', 'Glucuronosyltransferase', 'Humans', '*Hyperbilirubinemia, Neonatal/genetics', 'Infant, Newborn', '*Jaundice, Neonatal/complications/genetics', 'Liver-Specific Organic Anion Transporter 1/genetics', 'Polymorphism, Genetic', 'Thailand']",https://pubmed.ncbi.nlm.nih.gov/35501760/
1314,UGT1A1,39903581,Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patient.,"['Alarcon-Payer C', 'Sanchez Suarez MDM', 'Roldan AM', 'Morales AJ']","['Humans', '*Glucuronosyltransferase/genetics', 'Female', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics', '*Hyperbilirubinemia/chemically induced/genetics', '*Pyrimidines/adverse effects', 'Adult', 'Polymorphism, Genetic', '*Antineoplastic Agents/adverse effects/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/39903581/
1315,UGT1A1,29932297,UGT1A1*6 and UGT1A1*28 polymorphisms are correlated with irinotecan-induced toxicity: A meta-analysis.,"['Yang Y', 'Zhou M', 'Hu M', 'Cui Y', 'Zhong Q', 'Liang L', 'Huang F']","['Antineoplastic Agents/*adverse effects', 'Diarrhea/chemically induced/genetics', 'Female', 'Genetic Predisposition to Disease/genetics', 'Genotype', 'Glucuronosyltransferase/*genetics', 'Humans', 'Irinotecan/*adverse effects', 'Male', 'Middle Aged', 'Neoplasms/drug therapy', 'Neutropenia/chemically induced/genetics', 'Polymorphism, Single Nucleotide/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29932297/
1316,UGT1A1,26417955,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.,"['Gammal RS', 'Court MH', 'Haidar CE', 'Iwuchukwu OF', 'Gaur AH', 'Alvarellos M', 'Guillemette C', 'Lennox JL', 'Whirl-Carrillo M', 'Brummel SS', 'Ratain MJ', 'Klein TE', 'Schackman BR', 'Caudle KE', 'Haas DW']","['Atazanavir Sulfate/*adverse effects', 'Genetic Predisposition to Disease', 'Genotype', 'Glucuronosyltransferase/*antagonists & inhibitors/genetics/metabolism', 'HIV Protease Inhibitors/*adverse effects', 'Humans', 'Hyperbilirubinemia/*chemically induced/enzymology/genetics', 'Jaundice/*chemically induced/enzymology/genetics', 'Liver/*drug effects/enzymology', 'Pharmacogenetics/*standards', 'Phenotype', 'Risk Assessment', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/26417955/
1317,UGT1A1,29504153,"Relevance of CYP3A4*20, UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity.","['Riera P', 'Salazar J', 'Virgili AC', 'Tobena M', 'Sebio A', 'Gallano P', 'Barnadas A', 'Paez D']","['Aged', 'Asthenia/*chemically induced/diagnosis/genetics', 'Colorectal Neoplasms/*drug therapy/pathology', 'Cytochrome P-450 CYP3A/*genetics/metabolism', 'Diarrhea/*chemically induced/diagnosis/genetics', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Glucuronosyltransferase/*genetics/metabolism', 'Heterozygote', 'Humans', 'Irinotecan/*adverse effects', 'Male', 'Neutropenia/*chemically induced/diagnosis/genetics', '*Pharmacogenomic Variants', 'Phenotype', 'Risk Factors', 'Severity of Illness Index', 'Topoisomerase I Inhibitors/*adverse effects']",https://pubmed.ncbi.nlm.nih.gov/29504153/
1318,UGT1A1,20709051,The effect of UGT1A1 promoter polymorphism on bilirubin response to hydroxyurea therapy in hemoglobinopathies.,"['Italia KY', 'Jijina FF', 'Jain D', 'Merchant R', 'Nadkarni AH', 'Mukherjee M', 'Ghosh K', 'Colah RB']","['Adolescent', 'Adult', 'Bilirubin/*blood', 'Child', 'Gene Deletion', 'Glucuronosyltransferase/*genetics', 'Hemoglobinopathies/blood/*drug therapy/*genetics', 'Humans', 'Hydroxyurea/*therapeutic use', '*Polymorphism, Genetic', '*Promoter Regions, Genetic', 'Repetitive Sequences, Nucleic Acid/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/20709051/
1319,UGT1A1,34807779,The relationship between UGT1A1 gene & various diseases and prevention strategies.,"['Liu D', 'Yu Q', 'Ning Q', 'Liu Z', 'Song J']","['Bilirubin/metabolism', '*Crigler-Najjar Syndrome/genetics', '*Gilbert Disease/genetics', 'Glucuronosyltransferase/*genetics/metabolism', 'Humans', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/34807779/
1320,UGT1A1,36520959,UGT1A1 variants in Chinese Uighur and Han newborns and its correlation with neonatal hyperbilirubinemia.,"['Yang H', 'Li H', 'Xia Q', 'Dai W', 'Li X', 'Liu Y', 'Nie J', 'Yang F', 'Sun Y', 'Feng L', 'Yang L']","['Infant', 'Infant, Newborn', 'Humans', 'East Asian People', '*Hyperbilirubinemia, Neonatal/diagnosis', 'Glucuronosyltransferase/genetics', '*Jaundice, Neonatal', 'Asian People/genetics', 'Bilirubin']",https://pubmed.ncbi.nlm.nih.gov/36520959/
1321,UGT1A1,14647407,A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia.,"['Danoff TM', 'Campbell DA', 'McCarthy LC', 'Lewis KF', 'Repasch MH', 'Saunders AM', 'Spurr NK', 'Purvis IJ', 'Roses AD', 'Xu CF']","['Dinucleotide Repeats/genetics', 'Double-Blind Method', '*Genetic Predisposition to Disease', 'Genetic Variation', 'Gilbert Disease/*enzymology/*genetics', 'Glucuronosyltransferase/*genetics', 'Humans', 'Hyperbilirubinemia/chemically induced/*genetics', 'Isoenzymes/genetics', 'Polymorphism, Genetic', 'Prospective Studies', 'ortho-Aminobenzoates/*adverse effects']",https://pubmed.ncbi.nlm.nih.gov/14647407/
1322,CYP2C9,32189324,Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.,"['Theken KN', 'Lee CR', 'Gong L', 'Caudle KE', 'Formea CM', 'Gaedigk A', 'Klein TE', 'Agundez JAG', 'Grosser T']","['Anti-Inflammatory Agents, Non-Steroidal/adverse effects/*pharmacokinetics', 'Clinical Decision-Making', 'Consensus', 'Cytochrome P-450 CYP2C9/*genetics/metabolism', 'Drug Interactions', 'Drug-Related Side Effects and Adverse Reactions/enzymology/*genetics', 'Genotype', 'Humans', 'Pharmacogenetics/*standards', 'Pharmacogenomic Testing/*standards', '*Pharmacogenomic Variants', 'Phenotype', 'Predictive Value of Tests', 'Risk Assessment', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/32189324/
1323,CYP2C9,18690857,The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance.,"['Rosemary J', 'Adithan C']","['Alleles', 'Aryl Hydrocarbon Hydroxylases/*genetics', 'Cytochrome P-450 CYP2C19', 'Cytochrome P-450 CYP2C9', 'Ethnicity', 'Genotype', 'Humans', 'Pharmaceutical Preparations/administration & dosage/metabolism', '*Pharmacogenetics', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/18690857/
1324,CYP2C9,32510242,An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.,"['Chang WC', 'Hung SI', 'Carleton BC', 'Chung WH']","['Anticonvulsants/*administration & dosage/adverse effects/pharmacokinetics', 'Cytochrome P-450 CYP2C9/genetics', 'Epilepsy/*drug therapy', 'HLA-B Antigens/genetics', 'Humans', 'Pharmacogenetics', 'Phenytoin/*administration & dosage/adverse effects/pharmacokinetics', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/32510242/
1325,CYP2C9,38470454,Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients.,"['Zhang S', 'Zhao M', 'Zhong S', 'Niu J', 'Zhou L', 'Zhu B', 'Su H', 'Cao W', 'Xing Q', 'Yan H', 'Han X', 'Fu Q', 'Li Q', 'Chen L', 'Yang F', 'Zhang N', 'Wu H', 'He L', 'Qin S']","['Humans', '*Cytochrome P-450 CYP2C9/genetics', '*Vitamin K Epoxide Reductases/genetics', '*Warfarin/adverse effects/administration & dosage', 'Female', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', '*Anticoagulants/adverse effects/administration & dosage', 'Aged', '*Asian People/genetics', 'Hemorrhage/chemically induced/genetics', 'China', 'Adult', 'Genotype', 'Genetic Association Studies', 'East Asian People']",https://pubmed.ncbi.nlm.nih.gov/38470454/
1326,CYP2C9,31520636,A Rare Combination of CYP2C9*3/*3 and VKORC1 1639AA in a Patient Who Had Myxoma and Thromboembolism.,"['Son KH', 'Lee SI', 'Choi CH', 'Park KY', 'Park CH']","['Anticoagulants/*adverse effects', 'Cytochrome P-450 CYP2C9/*genetics', 'Female', 'Heart Neoplasms/*genetics', 'Humans', '*Mutation', 'Myxoma/complications/*genetics', 'Thromboembolism/complications/*genetics', 'Vitamin K Epoxide Reductases/*genetics', 'Warfarin/*adverse effects', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/31520636/
1327,CYP2C9,31673144,"CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysis.","['Takeuchi M', 'Kobayashi T', 'Biss T', 'Kamali F', 'Vear SI', 'Ho RH', 'Bajolle F', 'Loriot MA', 'Shaw K', 'Carleton BC', 'Hamberg AK', 'Wadelius M', 'Hirono K', 'Taguchi M', 'Wakamiya T', 'Yanagimachi M', 'Hirai K', 'Itoh K', 'Brandao LR', 'Ito S']","['Anticoagulants/*administration & dosage', 'Child', 'Cross-Sectional Studies/methods', 'Cytochrome P-450 CYP2C9/*genetics', 'Cytochrome P450 Family 4/*genetics', 'Humans', 'Maintenance Chemotherapy/methods', 'Observational Studies as Topic/methods', 'Polymorphism, Single Nucleotide/*genetics', 'Vitamin K Epoxide Reductases/*genetics', 'Warfarin/*administration & dosage']",https://pubmed.ncbi.nlm.nih.gov/31673144/
1328,CYP2C9,26595139,Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.,"['Cespedes-Garro C', 'Fricke-Galindo I', 'Naranjo ME', 'Rodrigues-Soares F', 'Farinas H', 'de Andres F', 'Lopez-Lopez M', 'Penas-Lledo EM', 'LLerena A']","['Cytochrome P-450 CYP2C9/*genetics', '*Gene Frequency', 'Genotype', 'Humans', 'Phenotype', 'Racial Groups/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26595139/
1329,CYP2C9,34748821,CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.,"['Schleiff MA', 'Crosby S', 'Blue M', 'Schleiff BM', 'Boysen G', 'Miller GP']","['Anti-Inflammatory Agents, Non-Steroidal/*metabolism/toxicity', 'Cytochrome P-450 CYP2C9/*metabolism', 'Cytochrome P-450 CYP3A/*metabolism', 'Diphenylamine/*metabolism/toxicity', 'Humans', 'Inactivation, Metabolic/drug effects/physiology', 'Microsomes, Liver/*drug effects/*metabolism', 'Substrate Specificity/drug effects/physiology']",https://pubmed.ncbi.nlm.nih.gov/34748821/
1330,CYP2C9,27393744,Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing.,"['Obeng AO', 'Kaszemacher T', 'Abul-Husn NS', 'Gottesman O', 'Vega A', 'Waite E', 'Myers K', 'Cho J', 'Bottinger EP', 'Ellis SB', 'Scott SA']","['*Algorithms', 'Anticoagulants/administration & dosage', 'Cytochrome P-450 CYP2C9/*genetics', 'Dose-Response Relationship, Drug', 'Drug Dosage Calculations', '*Electronic Health Records', 'Ethnicity', '*Genetic Testing', 'Humans', 'Pharmacogenetics/methods', 'Polymorphism, Genetic', 'Vitamin K Epoxide Reductases/*genetics', 'Warfarin/*administration & dosage']",https://pubmed.ncbi.nlm.nih.gov/27393744/
1331,CYP2C9,36546741,Frequency Distribution of CYP2C9 and VKORC1 Mutations among Bulgarian Patients and their Importance for Anticoagulant Therapy.,"['Velizarova M', 'Abedinov P', 'Svinarov D', 'Nikolov V', 'Hristova J']","['Humans', 'Male', 'Middle Aged', 'Aged', 'Female', 'Cytochrome P-450 CYP2C9/genetics', '*Warfarin/pharmacokinetics', 'Bulgaria', '*Aryl Hydrocarbon Hydroxylases/genetics', 'Vitamin K Epoxide Reductases/genetics', 'Anticoagulants/pharmacology/therapeutic use', 'Gene Frequency', 'Genotype', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/36546741/
1332,CYP2C9,34952963,Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects.,"['Kim NT', 'Cho CK', 'Kang P', 'Park HJ', 'Lee YJ', 'Bae JW', 'Jang CG', 'Lee SY']","['Administration, Oral', 'Adult', 'Alleles', 'Asian People', 'Blood Glucose/metabolism', 'Cytochrome P-450 CYP2C9/*genetics', 'Diabetes Mellitus, Type 2/*drug therapy/genetics', 'Female', '*Genetic Predisposition to Disease', 'Glipizide/blood/pharmacokinetics/*pharmacology', 'Healthy Volunteers', 'Humans', 'Hypoglycemic Agents/blood/pharmacokinetics/*pharmacology', 'Male', 'Polymorphism, Genetic/drug effects', 'Republic of Korea', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34952963/
1333,CYP2C9,37318060,"Associations between SLCO1B1, APOE and CYP2C9 and lipid-lowering efficacy and pharmacokinetics of fluvastatin: a meta-analysis.","['Zhang ZH', 'Yue Sun LC', 'Gu HY', 'Jiang C', 'Yi ZM']","['Humans', 'Fluvastatin', 'Cytochrome P-450 CYP2C9/genetics', 'Genotype', '*Cholesterol', 'Apolipoproteins E', '*Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use/pharmacokinetics', 'Liver-Specific Organic Anion Transporter 1/genetics']",https://pubmed.ncbi.nlm.nih.gov/37318060/
1334,CYP2C9,37097441,Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects.,"['Kang P', 'Cho CK', 'Jang CG', 'Lee SY', 'Lee YJ', 'Choi CI', 'Bae JW']","['Humans', '*Gliclazide/pharmacokinetics', 'Healthy Volunteers', 'Cytochrome P-450 CYP2C9/genetics', 'Hypoglycemic Agents/pharmacokinetics', '*Aryl Hydrocarbon Hydroxylases/genetics/metabolism', 'Cytochrome P-450 CYP2C19/genetics', 'Genotype', 'Insulin', 'Polymorphism, Genetic/genetics']",https://pubmed.ncbi.nlm.nih.gov/37097441/
1335,CYP2C9,29105855,"Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.","['Stage TB', 'Graff M', 'Wong S', 'Rasmussen LL', 'Nielsen F', 'Pottegard A', 'Brosen K', 'Kroetz DL', 'Khojasteh SC', 'Damkier P']","['Adult', 'Anti-Bacterial Agents/pharmacology', 'Area Under Curve', 'Chromatography, Liquid', 'Cross-Over Studies', 'Cytochrome P-450 CYP2C19/biosynthesis/*drug effects', 'Cytochrome P-450 CYP2C9/biosynthesis/*drug effects', 'Cytochrome P-450 CYP3A/biosynthesis/*drug effects', 'Cytochrome P-450 Enzyme System/biosynthesis/drug effects', 'Dicloxacillin/*pharmacology', 'Drug Interactions', 'Enzyme Induction/drug effects', 'Female', 'Hepatocytes/drug effects/enzymology', 'Humans', 'Male', 'Mass Spectrometry', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29105855/
1336,CYP2C9,36960518,Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant.,"['Mehta MP', 'Gajjar ND', 'Patel RJ', 'Joshi LP', 'Shah GB']","['Humans', 'Clopidogrel/therapeutic use', 'Cytochrome P-450 CYP2C9/genetics', '*Aryl Hydrocarbon Hydroxylases/genetics/metabolism', 'Cytochrome P-450 CYP2C19/genetics', 'Prevalence', 'Genotype', 'Platelet Aggregation Inhibitors/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/36960518/
1337,CYP2C9,29181698,"Pharmacokinetics of CYP2C9, CYP2C19, and CYP2D6 substrates in healthy Chinese and European subjects.","['Lu S', 'Nand RA', 'Yang JS', 'Chen G', 'Gross AS']","['Algorithms', 'Area Under Curve', 'Asian People', 'China', 'Cohort Studies', 'Cytochrome P-450 CYP2C19/genetics/*metabolism', 'Cytochrome P-450 CYP2C9/genetics/*metabolism', 'Cytochrome P-450 CYP2D6/genetics/*metabolism', 'Databases, Genetic', 'Databases, Pharmaceutical', 'Female', 'Humans', 'Internet', 'Male', 'Pharmaceutical Preparations/blood', 'Pharmacogenetics/methods', '*Pharmacokinetics', '*Polymorphism, Genetic', 'Substrate Specificity', 'White People']",https://pubmed.ncbi.nlm.nih.gov/29181698/
1338,PDE5A,38135092,Ent-labdane-type diterpene glycosides obtained from Rubus chingii Hu and their inhibitory effects on PDE5A activity.,"['Yu JD', 'Wang JY', 'Liu JY', 'Xu YC', 'Zhang X', 'Du J', 'Wu XH', 'Chen L', 'Wu YC', 'Li YM']","['*Rubus/chemistry', 'Molecular Structure', 'Glycosides/pharmacology/chemistry', 'Cyclic Nucleotide Phosphodiesterases, Type 5', '*Diterpenes/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/38135092/
1339,PDE5A,20563733,Phosphodiesterase-5 gene (PDE5A) polymorphisms are associated with progression of childhood IgA nephropathy.,"['Hahn WH', 'Suh JS', 'Cho BS']","['Adolescent', 'Adult', 'Case-Control Studies', 'Cell Proliferation', 'Child', 'Cyclic Nucleotide Phosphodiesterases, Type 5/*genetics', 'Disease Progression', 'Female', 'Gene Frequency', 'Genes, Dominant', 'Genetic Predisposition to Disease', 'Glomerulonephritis, IGA/enzymology/*genetics/pathology', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Logistic Models', 'Male', 'Mesangial Cells/pathology', 'Middle Aged', 'Nephrotic Syndrome/enzymology/genetics', 'Odds Ratio', 'Phenotype', 'Podocytes/pathology', '*Polymorphism, Single Nucleotide', 'Proteinuria/enzymology/genetics', 'Republic of Korea', 'Risk Assessment', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/20563733/
1340,PDE5A,25247292,Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A.,"['Caroe Nordgaard J', 'Kruse LS', 'Gammeltoft S', 'Kruuse CR']","['Amino Acid Substitution', 'Calcitonin Gene-Related Peptide/pharmacology', 'Catalytic Domain', 'Cell Line', 'Cilostazol', 'Cyclic GMP/*metabolism', 'Cyclic Nucleotide Phosphodiesterases, Type 5/chemistry/*genetics/*metabolism', 'Humans', 'In Vitro Techniques', 'Models, Molecular', 'Nitroglycerin/pharmacology', 'Phosphodiesterase Inhibitors/pharmacology', 'Piperazines/pharmacology', 'Purines/pharmacology', 'Serine/*metabolism', 'Sildenafil Citrate', 'Sulfonamides/pharmacology', 'Sumatriptan/pharmacology', 'Tetrazoles/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/25247292/
1341,PDE5A,30747070,"Novel Pyrazolo[4, 3-c]Quinolin-3-One Derivatives as PDE5A Inhibitors.","['Shaik A', 'Agarwal HK', 'Bhakuni R', 'Kirubakaran S']","['Antineoplastic Agents/chemical synthesis/chemistry/*pharmacology', 'Cell Proliferation/drug effects', 'Cell Survival/drug effects', 'Crystallography, X-Ray', 'Cyclic Nucleotide Phosphodiesterases, Type 5/*metabolism', 'Drug Screening Assays, Antitumor', 'HCT116 Cells', 'Humans', 'Models, Molecular', 'Molecular Structure', 'Phosphodiesterase 5 Inhibitors/chemical synthesis/*chemistry/*pharmacology', 'Pyrazoles/chemical synthesis/chemistry/*pharmacology', 'Quinolones/chemical synthesis/chemistry/pharmacology', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/30747070/
1342,PDE5A,36730555,LncRNA ARAP1-AS1 targets miR-516b-5p/PDE5A axis to facilitate the progression of thyroid cancer.,"['Du Q', 'Huang L', 'Guo W']","['Humans', 'Carrier Proteins/genetics', 'Cell Line, Tumor', 'Cell Movement/genetics', 'Cell Proliferation/genetics', 'Gene Expression Regulation, Neoplastic', 'GTPase-Activating Proteins/metabolism', '*MicroRNAs/metabolism', '*RNA, Long Noncoding/genetics/metabolism', '*Thyroid Neoplasms/genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/36730555/
1343,PDE5A,27235284,PDE5A Polymorphisms Influence on Sildenafil Treatment Success.,"['Marchal-Escalona C', 'Herrera-Imbroda B', 'Clemente-Postigo M', 'Alcaide-Torres J', 'Quinonero A', 'Marchal M', 'Queipo-Ortuno MI', 'Aragon IM', 'Martin-Morales A', 'Lara MF', 'Cardona F']","['Aged', 'Cardiovascular Diseases/chemically induced', 'Cyclic Nucleotide Phosphodiesterases, Type 5/*drug effects/*genetics', 'Erectile Dysfunction/*drug therapy/*genetics', 'Humans', 'Male', 'Middle Aged', 'Penile Erection/drug effects', 'Phosphodiesterase 5 Inhibitors/*therapeutic use', 'Piperazines/therapeutic use', 'Polymorphism, Genetic', 'Prospective Studies', 'Risk Factors', 'Sildenafil Citrate/*therapeutic use', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/27235284/
1344,PDE5A,37017666,IncRNA XIST Stimulates Papillary Thyroid Cancer Development through the miR-330-3p/PDE5A Axis.,"['Cai T', 'He Y', 'Peng B']","['Humans', 'Cell Movement', 'Cell Proliferation', '*MicroRNAs/genetics', '*RNA, Long Noncoding/genetics', 'Thyroid Cancer, Papillary/genetics', '*Thyroid Neoplasms/genetics', 'Cyclic Nucleotide Phosphodiesterases, Type 5/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37017666/
1345,PDE5A,36217175,"Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCdelta for tumorigenesis.","['Renaud E', 'Riegel K', 'Romero R', 'Suryamohan K', 'Distler U', 'Tenzer S', 'Schad A', 'Musholt TJ', 'Rajalingam K']","['Adult', 'Carcinogenesis', '*Carcinoma, Papillary/genetics/pathology', 'Humans', 'Mutation', 'Proteomics', 'Proto-Oncogene Proteins B-raf/genetics', 'Thyroid Cancer, Papillary/genetics/pathology', '*Thyroid Neoplasms/genetics/pathology', 'Transcription Factors/genetics', 'Tripartite Motif Proteins/genetics', 'Ubiquitin-Protein Ligases/genetics', 'Ubiquitins/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/36217175/
1346,GSR,35468576,"A preliminary study on the treatment of human blood soiled stubs, in presence of GSR particles.","['Rotter G', 'Pazzi M', 'Mattutino G']","['Humans', 'Microscopy, Electron, Scanning', '*Soil', 'Specimen Handling', '*Wounds, Gunshot']",https://pubmed.ncbi.nlm.nih.gov/35468576/
1347,GSR,14469217,Effects of operant reinforcement on the GSR.,"['MANDLER G', 'PREVEN DW', 'KUHLMAN CK']","['*Conditioning, Operant', '*Galvanic Skin Response', 'Humans', '*Learning', '*Reflex', '*Reinforcement, Psychology']",https://pubmed.ncbi.nlm.nih.gov/14469217/
1348,GSR,34619559,Finding GSR evidence on used towels.,"['Rosengarten H', 'Israelsohn O', 'Sirota N', 'Mero O']","['Antimony', 'Barium', '*Firearms', 'Hand', 'Humans', 'Male', '*Wounds, Gunshot']",https://pubmed.ncbi.nlm.nih.gov/34619559/
1349,GSR,17477205,Cognitive manipulation of GSR extinction: analogues for conditioning therapies.,"['Koenig KP', 'Henriksen K']","['Association Learning', '*Aversive Therapy', 'Awareness', '*Cognition', '*Conditioning, Classical', '*Desensitization, Psychologic', 'Electroshock', '*Extinction, Psychological', 'Feedback, Psychological', '*Galvanic Skin Response', 'Humans', 'Knowledge of Results, Psychological']",https://pubmed.ncbi.nlm.nih.gov/17477205/
1350,GSR,2287683,Effect of auditory subliminal stimulation on GSR.,"['Kotze HF', 'Moller AT']","['Adult', '*Arousal', 'Attention', 'Female', 'Galvanic Skin Response', 'Humans', 'Male', '*Speech Perception', '*Subliminal Stimulation']",https://pubmed.ncbi.nlm.nih.gov/2287683/
1351,GSR,7167271,On-line analysis of the GSR.,['Fried R'],"['Adult', '*Computers, Analog', 'Female', 'Galvanic Skin Response/*physiology', 'Habituation, Psychophysiologic/*physiology', 'Humans', 'Middle Aged', '*Online Systems']",https://pubmed.ncbi.nlm.nih.gov/7167271/
1352,GSR,588885,Effects of phase-of-respiration on GSR detection.,['Diekhoff GM'],"['Awareness', 'Feedback', '*Galvanic Skin Response', 'Humans', 'Photic Stimulation', '*Respiration']",https://pubmed.ncbi.nlm.nih.gov/588885/
1353,GSR,35361806,"Identification, analysis of deleterious SNPs of the human GSR gene and their effects on the structure and functions of associated proteins and other diseases.","['Vyas B', 'Bhowmik R', 'Akhter M', 'Ahmad FJ']","['Glutathione', 'Glutathione Disulfide', '*Glutathione Reductase/genetics', 'Humans', 'Mutation', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/35361806/
1354,GSR,27522206,"Green and sustainable remediation (GSR) evaluation: framework, standards, and tool. A case study in Taiwan.","['Huang WY', 'Hung W', 'Vu CT', 'Chen WT', 'Lai JW', 'Lin C']","['Ecosystem', 'Environmental Restoration and Remediation/*methods', 'Green Chemistry Technology/*methods', 'Hydrocarbons/*analysis', 'Models, Theoretical', 'Petroleum/*analysis', 'Taiwan']",https://pubmed.ncbi.nlm.nih.gov/27522206/
1355,GSR,3982867,GSR as reflection of decision-making under conditions of delay.,"['Rotenberg VS', 'Vedenyapin AB']","['Adolescent', 'Adult', 'Decision Making/*physiology', 'Female', '*Galvanic Skin Response', 'Humans', 'Male', 'Reaction Time']",https://pubmed.ncbi.nlm.nih.gov/3982867/
1356,GSR,11714158,Is there a real danger of concealing gunshot residue (GSR) particles by skin debris using the tape-lift method for sampling GSR from hands?,['Zeichner A'],"['*Firearms', 'Forensic Medicine/*methods', '*Hand', 'Humans', 'Israel', 'Microscopy, Electron, Scanning', 'Skin/*chemistry', 'Steel']",https://pubmed.ncbi.nlm.nih.gov/11714158/
1357,GSR,35041606,Inter-Brain Synchrony Levels According to Task Execution Modes and Difficulty Levels: An fNIRS/GSR Study.,"['Park J', 'Shin J', 'Jeong J']","['Adult', 'Brain/physiology', '*Brain Mapping/methods', 'Cooperative Behavior', '*Galvanic Skin Response', 'Humans', 'Interpersonal Relations', 'Spectroscopy, Near-Infrared/methods', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/35041606/
1358,GSR,37687860,Monitoring Inattention in Construction Workers Caused by Physical Fatigue Using Electrocardiograph (ECG) and Galvanic Skin Response (GSR) Sensors.,"['Ouyang Y', 'Liu M', 'Cheng C', 'Yang Y', 'He S', 'Zheng L']","['Humans', '*Construction Industry', 'Galvanic Skin Response', 'Electrocardiography', 'Algorithms', 'Fatigue/diagnosis']",https://pubmed.ncbi.nlm.nih.gov/37687860/
1359,GSR,21493046,"Impairments in ""top-down"" processing in bipolar disorder: a simultaneous fMRI-GSR study.","['Lagopoulos J', 'Malhi G']","['Adult', 'Bipolar Disorder/*pathology/*physiopathology', 'Brain/*blood supply/*pathology', 'Brain Mapping', 'Female', 'Galvanic Skin Response/*physiology', 'Humans', 'Image Processing, Computer-Assisted/methods', 'Magnetic Resonance Imaging/*methods', 'Male', 'Middle Aged', 'Oxygen/blood', 'Psychiatric Status Rating Scales', 'Reaction Time/physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21493046/
1360,GSR,8754577,Epidermal cells on stubs used for detection of GSR with SEM-EDX: analysis of DNA polymorphisms.,"['Torre C', 'Gino S']","['DNA/*analysis', 'Epidermis/*ultrastructure', 'Forensic Anthropology/*methods', 'Hair/ultrastructure', 'Humans', 'Microscopy, Electron, Scanning', '*Polymorphism, Genetic', 'Specimen Handling/*methods', 'Wounds, Gunshot/*pathology']",https://pubmed.ncbi.nlm.nih.gov/8754577/
1361,GSR,34542048,Decoding the coupling between the brain and skin reactions in auditory stimulation by information-based analysis of EEG and GSR signals.,"['Pakniyat N', 'Namazi H']","['Acoustic Stimulation', '*Brain/physiology', '*Electroencephalography/methods', 'Entropy', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/34542048/
1362,CYP2C8,27548563,Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters.,"['Tornio A', 'Neuvonen PJ', 'Niemi M', 'Backman JT']","['Cytochrome P-450 CYP2C8/drug effects', 'Cytochrome P-450 CYP2C8 Inhibitors/metabolism/*pharmacology', 'Drug Interactions', 'Gemfibrozil/analogs & derivatives/metabolism/*pharmacology', 'Glucuronates/metabolism/pharmacology', 'Humans', 'Hypolipidemic Agents/metabolism/pharmacology', 'Membrane Transport Proteins/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/27548563/
1363,CYP2C8,36065758,CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride.,"['Campodonico DM', 'Zubiaur P', 'Soria-Chacartegui P', 'Casajus A', 'Villapalos-Garcia G', 'Navares-Gomez M', 'Gomez-Fernandez A', 'Parra-Garces R', 'Mejia-Abril G', 'Roman M', 'Martin-Vilchez S', 'Ochoa D', 'Abad-Santos F']","['*Benzamides', 'Cytochrome P-450 CYP2C8/genetics', '*Cytochrome P-450 CYP3A', 'Cytochrome P-450 Enzyme System', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/36065758/
1364,CYP2C8,16646575,Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.,"['Garcia-Martin E', 'Martinez C', 'Ladero JM', 'Agundez JA']","['Aryl Hydrocarbon Hydroxylases/*genetics', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP2C9', 'Ethnicity/*genetics', '*Genetic Variation', '*Health', 'Humans', 'Polymorphism, Genetic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16646575/
1365,CYP2C8,36139056,"Inhibition of CYP2C8 by Acyl Glucuronides of Gemfibrozil and Clopidogrel: Pharmacological Significance, Progress and Challenges.",['Shah MB'],"['Cholesterol', 'Clopidogrel/pharmacology', 'Cytochrome P-450 CYP2C8/metabolism', '*Gemfibrozil/metabolism/pharmacology', '*Glucuronides/metabolism', 'Heme', 'Platelet Aggregation Inhibitors', 'Triglycerides']",https://pubmed.ncbi.nlm.nih.gov/36139056/
1366,CYP2C8,30636597,Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis.,"['Zhou S', 'Xiang Q', 'Mu G', 'Ma L', 'Chen S', 'Xie Q', 'Zhang Z', 'Cui Y']","['Carbamates/metabolism/*pharmacokinetics', 'Cytochrome P-450 CYP2C8/*genetics/metabolism', 'Hypoglycemic Agents/metabolism/*pharmacokinetics', 'Liver-Specific Organic Anion Transporter 1/*genetics/metabolism', 'Piperidines/metabolism/*pharmacokinetics', '*Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/30636597/
1367,CYP2C8,36178950,CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.,"['Dalle Fratte C', 'Gagno S', 'Roncato R', 'Polesel J', 'Zanchetta M', 'Buzzo M', 'Posocco B', 'De Mattia E', 'Borsatti R', 'Puglisi F', 'Foltran L', 'Guardascione M', 'Buonadonna A', 'Cecchin E', 'Toffoli G']","['Humans', '*Cytochrome P-450 CYP2D6/genetics', 'Imatinib Mesylate/adverse effects/pharmacokinetics', 'Cytochrome P-450 CYP2C8/genetics', 'Pharmacogenetics', 'Cytochrome P-450 CYP2C9/genetics', 'Prospective Studies', 'Chromatography, Liquid', '*Gastrointestinal Stromal Tumors/drug therapy/genetics', 'Tandem Mass Spectrometry', 'Cytochromes/genetics', 'Genotype', 'Cytochrome P-450 CYP2C19/genetics']",https://pubmed.ncbi.nlm.nih.gov/36178950/
1368,CYP2C8,27087514,"Interactions Among CYP2C8, EPHX2, and CYP4A11 Variants and CYP Plasma Metabolite Levels in Ischemic Stroke.","['Yi X', 'Wu L', 'Liao D', 'Wang C', 'Zhang B']","['Aged', 'Biomarkers/*analysis', 'Brain Ischemia/blood/*genetics/pathology', 'Cytochrome P-450 CYP2C8/*genetics', 'Cytochrome P-450 CYP4A/*genetics', 'Epoxide Hydrolases/*genetics', 'Female', 'Follow-Up Studies', 'Genetic Variation/*genetics', 'Genotype', 'Humans', 'Hydroxyeicosatetraenoic Acids/blood', 'Male', 'Prognosis', 'Stroke/blood/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/27087514/
1369,CYP2C8,35134542,"CYP2C8, CYP2C9, and CYP2C19 Characterization Using Next-Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project.","['Gaedigk A', 'Boone EC', 'Scherer SE', 'Lee SB', 'Numanagic I', 'Sahinalp C', 'Smith JD', 'McGee S', 'Radhakrishnan A', 'Qin X', 'Wang WY', 'Farrow EG', 'Gonzaludo N', 'Halpern AL', 'Nickerson DA', 'Miller NA', 'Pratt VM', 'Kalman LV']","['Alleles', '*Cytochrome P-450 CYP2C19/genetics', '*Cytochrome P-450 CYP2C8/genetics', '*Cytochrome P-450 CYP2C9/genetics', '*Genetic Testing', 'Genotype', 'Haplotypes/genetics', '*High-Throughput Nucleotide Sequencing', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/35134542/
1370,CYP2C8,31849280,CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy.,"['Genvigir FDV', 'Campos-Salazar AB', 'Felipe CR', 'Tedesco-Silva H Jr', 'Medina-Pestana JO', 'Doi SQ', 'Cerda A', 'Hirata MH', 'Herrero MJ', 'Alino SF', 'Hirata RDC']","['Adult', 'Brazil/epidemiology', 'Cytochrome P-450 CYP2C8/*genetics', 'Cytochrome P-450 CYP3A/*genetics', 'Female', 'Genotype', 'Humans', 'Immunosuppression Therapy/methods', 'Immunosuppressive Agents/administration & dosage/*adverse effects/immunology', 'Kidney/drug effects/pathology', 'Kidney Transplantation/*adverse effects', 'Male', 'Middle Aged', 'Multidrug Resistance-Associated Protein 2', 'Polymorphism, Single Nucleotide/genetics', 'Tacrolimus/administration & dosage/*adverse effects/immunology', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/31849280/
1371,CYP2C8,27271184,CYP2C8 and SLCO1B1 Variants and Therapeutic Response to Thiazolidinediones in Patients With Type 2 Diabetes.,"['Dawed AY', 'Donnelly L', 'Tavendale R', 'Carr F', 'Leese G', 'Palmer CN', 'Pearson ER', 'Zhou K']","['Aged', 'Blood Glucose/metabolism', 'Cytochrome P-450 CYP2C8/*genetics', 'Diabetes Mellitus, Type 2/*drug therapy/metabolism', 'Female', 'Genotype', 'Humans', 'Hypoglycemic Agents/*therapeutic use', 'Linear Models', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Male', 'Middle Aged', 'Pharmacogenetics', 'Pioglitazone', 'Polymorphism, Single Nucleotide', 'Rosiglitazone', 'Scotland', 'Thiazolidinediones/*therapeutic use', 'Treatment Outcome', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/27271184/
1372,CYP2C8,35922716,"Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia.","['Zuo W', 'Liu B', 'Chen M', 'Zhang B', 'Han B']","['ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics', '*Anemia, Aplastic/chemically induced/drug therapy/genetics', 'Benzoates', 'Camptothecin', 'Cytochrome P-450 CYP2C8/genetics', 'Genotype', 'Glucuronosyltransferase/genetics', 'Humans', 'Hydrazines/adverse effects', 'Neoplasm Proteins/genetics', 'Polymorphism, Genetic', 'Pyrazoles']",https://pubmed.ncbi.nlm.nih.gov/35922716/
1373,CYP2C8,26122864,Effect of gender and CYP2C9 and CYP2C8 polymorphisms on the pharmacokinetics of ibuprofen enantiomers.,"['Ochoa D', 'Prieto-Perez R', 'Roman M', 'Talegon M', 'Rivas A', 'Galicia I', 'Abad-Santos F', 'Cabaleiro T']","['Adult', 'Anti-Inflammatory Agents, Non-Steroidal/adverse effects/chemistry/*pharmacokinetics', 'Area Under Curve', 'Aryl Hydrocarbon Hydroxylases/*genetics', 'Cytochrome P-450 CYP2C8/*genetics', 'Cytochrome P-450 CYP2C9/*genetics', 'Female', 'Gene Frequency', 'Genotype', 'Half-Life', 'Humans', 'Ibuprofen/adverse effects/chemistry/*pharmacokinetics', 'Male', 'Polymorphism, Genetic/genetics', 'Stereoisomerism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26122864/
1374,CYP2C8,33556367,Differential inhibition of human CYP2C8 and molecular docking interactions elicited by sorafenib and its major N-oxide metabolite.,"['Nair PC', 'Gillani TB', 'Rawling T', 'Murray M']","['Adult', 'Biotransformation/drug effects', 'Catalytic Domain', 'Cytochrome P-450 CYP2C8/*chemistry/*metabolism', 'Cytochrome P-450 CYP2C8 Inhibitors/*pharmacology', 'Humans', 'Losartan/pharmacology', 'Male', '*Metabolome', 'Microsomes, Liver/drug effects/enzymology', 'Middle Aged', '*Molecular Docking Simulation', 'Oxidation-Reduction', 'Oxides/*pharmacology', 'Sorafenib/*metabolism/*pharmacology', 'Substrate Specificity/drug effects']",https://pubmed.ncbi.nlm.nih.gov/33556367/
1375,CYP2C8,32364081,"Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells.","['Diab T', 'Alkafaas SS', 'Shalaby TI', 'Hessien M']","['Antineoplastic Agents, Phytogenic/chemistry/*pharmacology', 'Apoptosis/drug effects', 'Cell Proliferation/drug effects', 'Cell Survival/drug effects', 'Cytochrome P-450 CYP2C8/*metabolism', 'Cytochrome P-450 CYP3A/*metabolism', 'Dose-Response Relationship, Drug', 'Drug Screening Assays, Antitumor', 'Humans', 'Molecular Structure', 'Nanoparticles/*chemistry', 'Paclitaxel/chemistry/*pharmacology', 'Polylactic Acid-Polyglycolic Acid Copolymer/chemistry', 'RNA, Messenger/drug effects/metabolism', 'Repressor Proteins/*antagonists & inhibitors/metabolism', 'Structure-Activity Relationship', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/32364081/
1376,CYP2C8,31287236,"Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers.","['Tugnait M', 'Gupta N', 'Hanley MJ', 'Sonnichsen D', 'Kerstein D', 'Dorer DJ', 'Venkatakrishnan K', 'Narasimhan N']","['Administration, Oral', 'Adult', 'Aged', 'Anaplastic Lymphoma Kinase/*antagonists & inhibitors/metabolism', 'Area Under Curve', 'Carcinoma, Non-Small-Cell Lung/*drug therapy', 'Cross-Over Studies', 'Cytochrome P-450 CYP2B6 Inducers/administration & dosage/pharmacokinetics', 'Cytochrome P-450 CYP2C8/metabolism', 'Cytochrome P-450 CYP2C8 Inhibitors/administration & dosage/pharmacokinetics', 'Cytochrome P-450 CYP3A Inducers/*pharmacology', 'Cytochrome P-450 CYP3A Inhibitors/*pharmacology', 'Drug Interactions', 'Drug Therapy, Combination', 'Female', 'Gemfibrozil/administration & dosage/pharmacokinetics', 'Healthy Volunteers', 'Humans', 'Itraconazole/administration & dosage/pharmacokinetics', 'Lung Neoplasms/pathology', 'Male', 'Middle Aged', 'Organophosphorus Compounds/administration & dosage/*pharmacokinetics', 'Protein Kinase Inhibitors/administration & dosage/*pharmacokinetics', 'Pyrimidines/administration & dosage/*pharmacokinetics', 'Rifampin/administration & dosage/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/31287236/
1377,CYP2C8,34789487,"Predictive In Vitro-In Vivo Extrapolation for Time Dependent Inhibition of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 Using Pooled Human Hepatocytes, Human Liver Microsomes, and a Simple Mechanistic Static Model.","['Ramsden D', 'Perloff ES', 'Whitcher-Johnstone A', 'Ho T', 'Patel R', 'Kozminski KD', 'Fullenwider CL', 'Zhang JG']","['Cytochrome P-450 CYP1A2/metabolism', 'Cytochrome P-450 CYP2C19/metabolism', 'Cytochrome P-450 CYP2C8', 'Cytochrome P-450 CYP2C9', '*Cytochrome P-450 CYP2D6/metabolism', 'Hepatocytes/metabolism', 'Humans', '*Microsomes, Liver/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34789487/
1378,CYP2C8,28316087,"Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.","['Genvigir FDV', 'Nishikawa AM', 'Felipe CR', 'Tedesco-Silva H Jr', 'Oliveira N', 'Salazar ABC', 'Medina-Pestana JO', 'Doi SQ', 'Hirata MH', 'Hirata RDC']","['Adult', 'Brazil/epidemiology', 'Cytochrome P-450 CYP2C8/*genetics', 'Cytochrome P-450 CYP2J2', 'Cytochrome P-450 Enzyme System/*genetics', 'Female', 'Graft Rejection/epidemiology/*genetics/prevention & control', 'Humans', 'Immunosuppressive Agents/blood/therapeutic use', '*Kidney Transplantation/adverse effects', 'Male', 'Multidrug Resistance-Associated Protein 2', 'Multidrug Resistance-Associated Proteins/*genetics', 'Mycophenolic Acid/blood/*therapeutic use', 'Polymorphism, Single Nucleotide', 'Prospective Studies', 'Tacrolimus/blood/*therapeutic use', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/28316087/
1379,COMT,35472623,Catechol-O-methyltransferase (COMT) Val158Met Polymorphism and Prepulse Inhibition of the Change-related Cerebral Response.,"['Motomura E', 'Tanii H', 'Kawano Y', 'Inui K', 'Okada M']","['Acoustic Stimulation/methods', '*Catechol O-Methyltransferase/genetics', 'Dopamine/metabolism', 'Evoked Potentials, Auditory/genetics', 'Humans', '*Prepulse Inhibition/genetics']",https://pubmed.ncbi.nlm.nih.gov/35472623/
1380,COMT,25666727,"Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.","['Papenberg G', 'Salami A', 'Persson J', 'Lindenberger U', 'Backman L']","['Aging/*genetics', 'Apolipoproteins E/*genetics', '*Brain/blood supply/physiology', 'Brain-Derived Neurotrophic Factor/*genetics', 'Catechol O-Methyltransferase/*genetics', 'Female', 'Functional Laterality', '*Genetic Variation', 'Humans', 'Intracellular Signaling Peptides and Proteins/*genetics', 'Magnetic Resonance Imaging', 'Male', 'Phosphoproteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25666727/
1381,COMT,28368213,Association between COMT Val158Met polymorphism and competition results of competitive swimmers.,"['Abe D', 'Doi H', 'Asai T', 'Kimura M', 'Wada T', 'Takahashi Y', 'Matsumoto T', 'Shinohara K']","['Catechol O-Methyltransferase/*genetics', 'Competitive Behavior/*physiology', 'Genotype', 'Humans', 'Male', '*Polymorphism, Single Nucleotide', 'Swimming/*physiology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28368213/
1382,COMT,33298758,"Leadership Style, Headache, and Neck Pain: The Moderating Role of the Catechol-O-Methyltransferase (COMT) Genotype.","['Christensen JO', 'Nielsen MB', 'Sannes AC', 'Gjerstad J']","['*Catechol O-Methyltransferase/genetics', 'Genotype', 'Headache/genetics', 'Humans', 'Leadership', '*Neck Pain/genetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/33298758/
1383,COMT,27646972,Association between COMT Val158Met polymorphism and preeclampsia in the Chinese Han population.,"['Zhao X', 'Liu J', 'Zhao C', 'Ye P', 'Ji J', 'Wang J', 'Song W', 'Xu J', 'Liu S']","['Adult', 'Alleles', 'Asian People/genetics', 'Catechol O-Methyltransferase/*genetics', 'China', 'Female', 'Gene Frequency', 'Genetic Association Studies', '*Genetic Predisposition to Disease', '*Genotype', 'Humans', '*Polymorphism, Single Nucleotide', 'Pre-Eclampsia/*genetics', 'Pregnancy']",https://pubmed.ncbi.nlm.nih.gov/27646972/
1384,COMT,11147510,COMT inhibitors and liver toxicity.,['Watkins P'],"['Benzophenones/*adverse effects/*therapeutic use', '*Catechol O-Methyltransferase Inhibitors', 'Catechols/*adverse effects/*therapeutic use', 'Humans', 'Liver/*drug effects', 'Nitriles', 'Nitrophenols', 'Parkinson Disease/*drug therapy', 'Tolcapone']",https://pubmed.ncbi.nlm.nih.gov/11147510/
1385,COMT,33716157,Brain predictive coding processes are associated to COMT gene Val158Met polymorphism.,"['Bonetti L', 'Bruzzone SEP', 'Sedghi NA', 'Haumann NT', 'Paunio T', 'Kantojarvi K', 'Kliuchko M', 'Vuust P', 'Brattico E']","['Adult', 'Brain/*diagnostic imaging/*physiology', 'Catechol O-Methyltransferase/*genetics', 'Female', 'Forecasting', 'Humans', 'Magnetic Resonance Imaging/methods', 'Magnetoencephalography/methods', 'Male', 'Methionine/*genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Valine/*genetics']",https://pubmed.ncbi.nlm.nih.gov/33716157/
1386,COMT,17700596,Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy.,"['Anttila S', 'Huuhka K', 'Huuhka M', 'Illi A', 'Rontu R', 'Leinonen E', 'Lehtimaki T']","['Adult', 'Aged', 'Catechol O-Methyltransferase/*genetics', 'Depressive Disorder, Major/enzymology/genetics/*therapy', '*Electroconvulsive Therapy', 'Female', '*Gene Expression Regulation, Enzymologic', 'Gene Frequency', 'Homozygote', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Psychiatric Status Rating Scales', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/17700596/
1387,COMT,35590332,"Connecting DCX, COMT and FMR1 in social behavior and cognitive impairment.","['Delprato A', 'Xiao E', 'Manoj D']","['Catechol O-Methyltransferase/metabolism', '*Cognitive Dysfunction', 'Fragile X Mental Retardation Protein/genetics/metabolism', 'Hippocampus/metabolism', 'Humans', '*Intellectual Disability/genetics/metabolism', 'Neurogenesis/genetics', 'Social Behavior']",https://pubmed.ncbi.nlm.nih.gov/35590332/
1388,COMT,30075828,Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia.,"['Ivanova SA', 'Alifirova VM', 'Pozhidaev IV', 'Freidin MB', 'Zhukova IA', 'Osmanova DZ', 'Zhukova NG', 'Mironova YA', 'Tiguntsev VV', 'Fedorenko OY', 'Bokhan NA', 'Wilffert B', 'Loonen AJM']","['Adult', 'Aged', 'Aged, 80 and over', 'Antiparkinson Agents/*adverse effects/therapeutic use', 'Catechol O-Methyltransferase/*genetics', 'Dyskinesia, Drug-Induced/enzymology/*genetics/prevention & control', 'Female', 'Humans', 'Levodopa/*adverse effects/therapeutic use', 'Male', 'Middle Aged', 'Parkinson Disease/*drug therapy/enzymology/genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Regression Analysis']",https://pubmed.ncbi.nlm.nih.gov/30075828/
1389,COMT,28456872,"Catechol-O-Methyltransferase (COMT): An Update on Its Role in Cancer, Neurological and Cardiovascular Diseases.","['Bastos P', 'Gomes T', 'Ribeiro L']","['Cardiovascular Diseases/*enzymology', 'Catechol O-Methyltransferase/*metabolism', 'Humans', 'Neoplasms/*enzymology', 'Nervous System Diseases/*enzymology']",https://pubmed.ncbi.nlm.nih.gov/28456872/
1390,COMT,21156209,"COMT Val158Met polymorphism, verbalizing of emotion and activation of affective brain systems.","['Swart M', 'Bruggeman R', 'Laroi F', 'Alizadeh BZ', 'Kema I', 'Kortekaas R', 'Wiersma D', 'Aleman A']","['Brain/*physiology', 'Catechol O-Methyltransferase/*genetics', 'Emotions/*physiology', 'Female', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Polymorphism, Single Nucleotide/genetics', 'Verbal Behavior', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/21156209/
1391,COMT,17963454,Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review.,"['Zoccolella S', 'Iliceto G', 'deMari M', 'Livrea P', 'Lamberti P']","['*Catechol O-Methyltransferase Inhibitors', 'Enzyme Inhibitors/*pharmacology', 'Humans', 'Hyperhomocysteinemia/*chemically induced', 'Levodopa/*adverse effects', 'Vitamin B Complex/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/17963454/
1392,COMT,11925305,A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition.,"['Malhotra AK', 'Kestler LJ', 'Mazzanti C', 'Bates JA', 'Goldberg T', 'Goldman D']","['Adult', 'Alleles', 'Codon', 'Cognition/*physiology', 'Female', '*Genotype', 'Humans', 'Male', 'Methionine/genetics', 'Middle Aged', 'Neuropsychological Tests', 'Polymorphism, Genetic/*genetics', 'Prefrontal Cortex/*physiology', 'Reference Values', 'Valine/genetics']",https://pubmed.ncbi.nlm.nih.gov/11925305/
1393,COMT,23774999,COMT Val158Met polymorphism and executive functions in obsessive-compulsive disorder.,"['Tukel R', 'Gurvit H', 'Ozturk N', 'Ozata B', 'Ertekin BA', 'Ertekin E', 'Baran B', 'Kalem SA', 'Buyukgok D', 'Direskeneli GS']","['Adult', 'Analysis of Variance', 'Catechol O-Methyltransferase/*genetics', 'Cognition Disorders/*etiology', 'Executive Function/*physiology', 'Female', 'Gene Frequency', 'Genotype', 'Humans', 'Male', 'Methionine/genetics', 'Neuropsychological Tests', 'Obsessive-Compulsive Disorder/*complications/*genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Psychiatric Status Rating Scales', 'Valine/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23774999/
1394,COMT,22417933,Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder.,"['Narasimhan S', 'Aquino TD', 'Multani PK', 'Rickels K', 'Lohoff FW']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Antidepressive Agents, Second-Generation/*therapeutic use', 'Anxiety/*drug therapy/*genetics', 'Catechol O-Methyltransferase/*genetics', 'Cyclohexanols/*therapeutic use', 'Female', 'Gene Frequency', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Mutation/*genetics', '*Pharmacogenetics', 'Venlafaxine Hydrochloride', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22417933/
1395,COMT,21695287,COMT genetic variants and pain.,"['Belfer I', 'Segall S']","['Catechol O-Methyltransferase/*genetics', '*Genetic Variation', 'Humans', 'Neuralgia/enzymology/etiology', 'Pain/enzymology/*etiology']",https://pubmed.ncbi.nlm.nih.gov/21695287/
1396,COMT,17640440,COMT Val158Met moderation of stress-induced psychosis.,"['Stefanis NC', 'Henquet C', 'Avramopoulos D', 'Smyrnis N', 'Evdokimidis I', 'Myin-Germeys I', 'Stefanis CN', 'Van Os J']","['Adult', 'Catechol O-Methyltransferase/*genetics/metabolism', 'Genetic Predisposition to Disease/*genetics/psychology', 'Genotype', 'Greece', 'Humans', 'Life Change Events', 'Male', 'Military Personnel/psychology', 'Occupational Exposure', '*Polymorphism, Genetic', 'Psychotic Disorders/*enzymology/genetics/physiopathology', 'Stress, Psychological/*enzymology/genetics/physiopathology']",https://pubmed.ncbi.nlm.nih.gov/17640440/
1397,CYP1A2,37844569,"Caffeine, CYP1A2 Genotype, and Exercise Performance: A Systematic Review and Meta-analysis.","['Barreto G', 'Esteves GP', 'Marticorena F', 'Oliveira TN', 'Grgic J', 'Saunders B']","['Humans', '*Caffeine/pharmacology', 'Cytochrome P-450 CYP1A2/genetics', 'Genotype', 'Exercise', '*Performance-Enhancing Substances']",https://pubmed.ncbi.nlm.nih.gov/37844569/
1398,CYP1A2,26916064,"Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations.","['Kesharwani SS', 'Nandekar PP', 'Pragyan P', 'Rathod V', 'Sangamwar AT']","['Antineoplastic Agents/chemistry/*pharmacology', 'Catalytic Domain/drug effects', 'Cytochrome P-450 CYP1A1/*chemistry/metabolism', 'Cytochrome P-450 CYP1A2/*chemistry/metabolism', 'Cytochrome P-450 CYP1B1/*chemistry/metabolism', 'Databases, Chemical', 'Drug Design', 'Humans', 'Ligands', 'Models, Molecular', 'Molecular Docking Simulation', 'Molecular Dynamics Simulation', 'Protein Structure, Secondary', 'Substrate Specificity']",https://pubmed.ncbi.nlm.nih.gov/26916064/
1399,CYP1A2,26247834,Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.,"['Manda VK', 'Avula B', 'Chittiboyina AG', 'Khan IA', 'Walker LA', 'Khan SI']","['Aegle/*chemistry', 'Amides/pharmacology', 'Coumarins/pharmacology', 'Cytochrome P-450 CYP1A2/*metabolism', 'Cytochrome P-450 CYP1A2 Inhibitors/pharmacology', 'Cytochrome P-450 CYP3A/*metabolism', 'Cytochrome P-450 CYP3A Inhibitors/pharmacology', 'Fruit/chemistry', 'Furans/pharmacology', 'Furocoumarins/pharmacology', 'Humans', 'Microsomes, Liver/drug effects/metabolism', 'Plant Extracts/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/26247834/
1400,CYP1A2,36011409,"Relationship between Nutrition, Lifestyle, and Neurodegenerative Disease: Lessons from ADH1B, CYP1A2 and MTHFR.","['Barati S', 'Fabrizio C', 'Strafella C', 'Cascella R', 'Caputo V', 'Megalizzi D', 'Peconi C', 'Mela J', 'Colantoni L', 'Caltagirone C', 'Termine A', 'Giardina E']","['Alcohol Dehydrogenase', '*Alzheimer Disease/genetics', 'Cytochrome P-450 CYP1A2/genetics', 'Epigenesis, Genetic', 'Humans', 'Life Style', 'Methylenetetrahydrofolate Reductase (NADPH2)/genetics', '*Neurodegenerative Diseases/genetics', 'Nutritional Status', '*Parkinson Disease/genetics']",https://pubmed.ncbi.nlm.nih.gov/36011409/
1401,CYP1A2,33260381,Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro.,"['Yim SK', 'Kim K', 'Chun S', 'Oh T', 'Jung W', 'Jung K', 'Yun CH']","['Binding Sites', 'Catalytic Domain', 'Cytochrome P-450 CYP1A2/*metabolism', 'Cytochrome P-450 CYP1A2 Inhibitors/isolation & purification/*pharmacology', 'Cytochrome P-450 CYP3A/*metabolism', 'Cytochrome P-450 CYP3A Inhibitors/isolation & purification/*pharmacology', 'Dose-Response Relationship, Drug', 'Humans', 'Kinetics', '*Molecular Docking Simulation', 'Molecular Structure', 'Protein Binding', 'Seaweed/*metabolism', 'Structure-Activity Relationship', 'Undaria/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33260381/
1402,CYP1A2,25115775,Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.,"['He XF', 'Wei J', 'Liu ZZ', 'Xie JJ', 'Wang W', 'Du YP', 'Chen Y', 'Si HQ', 'Liu Q', 'Wu LX', 'Wei W']","['Amino Acid Substitution', 'Colorectal Neoplasms/*genetics', 'Cytochrome P-450 CYP1A2/*genetics', 'Cytochrome P-450 CYP1B1/*genetics', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Odds Ratio', '*Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Publication Bias', 'Risk']",https://pubmed.ncbi.nlm.nih.gov/25115775/
1403,CYP1A2,32295624,"CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance.","['Grgic J', 'Pickering C', 'Bishop DJ', 'Schoenfeld BJ', 'Mikulic P', 'Pedisic Z']","['Adult', '*Athletic Performance', 'Caffeine/*administration & dosage', 'Cross-Over Studies', 'Cytochrome P-450 CYP1A2/*genetics', 'Double-Blind Method', 'Genotype', 'Humans', 'Male', 'Performance-Enhancing Substances/*administration & dosage', '*Resistance Training', 'Sports Nutritional Physiological Phenomena', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32295624/
1404,CYP1A2,37511239,"Hydration and Structural Adaptations of the Human CYP1A1, CYP1A2, and CYP1B1 Active Sites by Molecular Dynamics Simulations.","['Dutkiewicz Z', 'Mikstacka R']","['Humans', '*Cytochrome P-450 CYP1A1/metabolism', '*Cytochrome P-450 CYP1A2/metabolism', 'Molecular Dynamics Simulation', 'Catalytic Domain', 'Ligands', 'Cytochrome P-450 CYP1B1/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37511239/
1405,CYP1A2,23492909,Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers.,"['Dobrinas M', 'Cornuz J', 'Eap CB']","['Adult', 'Caffeine/administration & dosage', 'Constitutive Androstane Receptor', 'Cytochrome P-450 CYP1A2/*genetics', 'Female', 'Genotype', 'Humans', 'Male', '*Pharmacogenetics', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Pregnane X Receptor', 'Receptors, Aryl Hydrocarbon/genetics', 'Receptors, Cytoplasmic and Nuclear/genetics', 'Receptors, Steroid/genetics', 'Smoking/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/23492909/
1406,CYP1A2,36017806,Evaluation of the Herb-Drug Interaction Potential of Commonly Used Botanicals on the US Market with Regard to PXR- and AhR-Mediated Influences on CYP3A4 and CYP1A2.,"['Haron MH', 'Dale O', 'Martin K', 'Avula B', 'Chittiboyina AG', 'Khan IA', 'Gurley BJ', 'Khan SI']","['Humans', '*Cytochrome P-450 CYP1A2/metabolism', 'Cytochrome P-450 CYP3A/metabolism', '*Receptors, Steroid/metabolism', 'Herb-Drug Interactions', 'Receptors, Aryl Hydrocarbon/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36017806/
1407,CYP1A2,29509641,"Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes.","['Guest N', 'Corey P', 'Vescovi J', 'El-Sohemy A']","['Adult', 'Caffeine/administration & dosage/*metabolism', 'Cytochrome P-450 CYP1A2/*genetics', 'Double-Blind Method', 'Exercise Test/methods', '*Genotype', 'Heart Rate', 'Humans', 'Male', 'Perception/physiology', 'Physical Endurance/*physiology', 'Physical Exertion', '*Polymorphism, Single Nucleotide', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29509641/
1408,CYP1A2,37269349,The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients.,"['Demirbugen Oz M', 'Ozdemir F', 'Tok KC', 'Dural E', 'Kir Y', 'Ulusoy M', 'Gumustas M', 'Baskak B', 'Suzen HS']","['Humans', '*Clozapine/adverse effects', '*Schizophrenia/drug therapy/genetics', 'Cytochrome P-450 CYP1A2/genetics/metabolism', 'Caffeine/adverse effects', '*Antipsychotic Agents/adverse effects', 'Life Style', 'Genetic Variation']",https://pubmed.ncbi.nlm.nih.gov/37269349/
1409,CYP1A2,34564706,"CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study.","['Gkouskou KG', 'Georgiopoulos G', 'Vlastos I', 'Lazou E', 'Chaniotis D', 'Papaioannou TG', 'Mantzoros CS', 'Sanoudou D', 'Eliopoulos AG']","['Adolescent', 'Appetite/*drug effects/physiology', 'Body Mass Index', 'Coffee/drug effects/*metabolism', 'Cohort Studies', 'Cross-Over Studies', 'Cytochrome P-450 CYP1A2/genetics/metabolism/*pharmacology', 'Eating/*drug effects/physiology', 'Feeding Behavior/physiology', 'Female', 'Healthy Volunteers/statistics & numerical data', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34564706/
1410,CYP1A2,34359083,"Bulbine natalensis (currently Bulbine latifolia) and select bulbine knipholones modulate the activity of AhR, CYP1A2, CYP2B6, and P-gp.","['Husain I', 'Dale OR', 'Manda V', 'Ali Z', 'Gurley BJ', 'Chittiboyina AG', 'Khan IA', 'Khan SI']","['Anthraquinones', '*Cytochrome P-450 CYP1A2/metabolism', 'Cytochrome P-450 CYP2B6', 'Cytochrome P-450 Enzyme System/genetics', 'Humans', 'Isoenzymes', 'Plant Extracts/pharmacology', 'RNA, Messenger', 'Receptors, Aryl Hydrocarbon', 'Water', '*Asphodelaceae']",https://pubmed.ncbi.nlm.nih.gov/34359083/
1411,CYP2B6,37032427,"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.","['Bousman CA', 'Stevenson JM', 'Ramsey LB', 'Sangkuhl K', 'Hicks JK', 'Strawn JR', 'Singh AB', 'Ruano G', 'Mueller DJ', 'Tsermpini EE', 'Brown JT', 'Bell GC', 'Leeder JS', 'Gaedigk A', 'Scott SA', 'Klein TE', 'Caudle KE', 'Bishop JR']","['Humans', '*Selective Serotonin Reuptake Inhibitors', 'Cytochrome P-450 CYP2D6/genetics/metabolism', 'Cytochrome P-450 CYP2B6/genetics', 'Pharmacogenetics', '*Depressive Disorder, Major/drug therapy/genetics', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Serotonin', 'Antidepressive Agents/therapeutic use', 'Citalopram/therapeutic use', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/37032427/
1412,CYP2B6,35194103,CYP2B6 allelic variants and non-genetic factors influence CYP2B6 enzyme function.,"['Mango K', 'Kiss AF', 'Fekete F', 'Erdos R', 'Monostory K']","['*Alleles', 'Cytochrome P-450 CYP2B6/*genetics/*physiology', 'Gene Expression', 'Genotype', 'Humans', 'Liver/enzymology', 'Phenotype', '*Polymorphism, Genetic', 'RNA, Messenger/genetics/metabolism', 'White People']",https://pubmed.ncbi.nlm.nih.gov/35194103/
1413,CYP2B6,36162369,Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam.,"['Zubiaur P', 'Figueiredo-Tor L', 'Villapalos-Garcia G', 'Soria-Chacartegui P', 'Navares-Gomez M', 'Novalbos J', 'Matas M', 'Calleja S', 'Mejia-Abril G', 'Roman M', 'Ochoa D', 'Abad-Santos F']","['*Cytochrome P-450 CYP2B6/genetics', '*Cytochrome P-450 CYP2C19/genetics', '*Diazepam/adverse effects/pharmacokinetics', 'Phenotype', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/36162369/
1414,CYP2B6,37264909,Association Between CYP2B6 Polymorphisms and Efficacy of Clopidogrel in Minor Stroke or Transient Ischemic Attack.,"['Qiu X', 'Zhang Y', 'Gu H', 'Jiang Y', 'Pan Y', 'Jiang Y', 'Meng X', 'Wang Y', 'Zhao X', 'Li H', 'Wang X', 'Wang Y', 'Li Z']","['*Clopidogrel/administration & dosage', 'Humans', 'Middle Aged', '*Aspirin/administration & dosage', '*Cytochrome P-450 CYP2B6/genetics', '*Platelet Aggregation Inhibitors/administration & dosage', 'Male', 'Female', '*Stroke/drug therapy/prevention & control', 'Recurrence']",https://pubmed.ncbi.nlm.nih.gov/37264909/
1415,CYP2B6,34949964,"Frequencies of CYP2B6( *)4,( *)5, and ( *)6 Alleles within an Iranian Population (Mazandaran).","['Hashemi-Soteh MB', 'Hosseini E', 'Fazelnia S', 'Ghasemian-Sorbeni F', 'Madahian S', 'Shiran MR']","['Alleles', '*Cytochrome P-450 CYP2B6/genetics', 'Gene Frequency', 'Genetics, Population', 'Genotype', 'Humans', 'Iran']",https://pubmed.ncbi.nlm.nih.gov/34949964/
1416,CYP2B6,32960272,CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.,"['Griesel R', 'Maartens G', 'Chirehwa M', 'Sokhela S', 'Akpomiemie G', 'Moorhouse M', 'Venter F', 'Sinxadi P']","['Female', 'Humans', 'Male', 'Alkynes/adverse effects', '*Anti-HIV Agents/adverse effects', 'Benzoxazines/adverse effects', 'Cyclopropanes/adverse effects', 'Cytochrome P-450 CYP2B6/genetics', 'Genotype', 'Heterocyclic Compounds, 3-Ring/adverse effects', '*HIV Infections/drug therapy/genetics', 'Oxazines/adverse effects', 'Piperazines/adverse effects', 'Pyridones/adverse effects', '*Weight Gain/genetics']",https://pubmed.ncbi.nlm.nih.gov/32960272/
1417,CYP2B6,34752647,Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta-analysis.,"['Eum S', 'Sayre F', 'Lee AM', 'Stingl JC', 'Bishop JR']","['Bupropion/*analogs & derivatives/therapeutic use', '*Cytochrome P-450 CYP2B6/genetics', 'Genotype', 'Humans', 'Polymorphism, Genetic/genetics']",https://pubmed.ncbi.nlm.nih.gov/34752647/
1418,CYP2B6,16857630,Genotyping of CYP2B6 and therapeutic drug monitoring in an HIV-infected patient with high efavirenz plasma concentrations and severe CNS side-effects.,"['Mathiesen S', 'Justesen US', 'Von Luttichau HR', 'Hansen AB']","['Adult', 'Alkynes', 'Anti-HIV Agents/adverse effects/*blood/pharmacokinetics/therapeutic use', 'Aryl Hydrocarbon Hydroxylases/*genetics/metabolism', 'Benzoxazines', 'Central Nervous System Diseases/blood/*chemically induced/enzymology/genetics', 'Cyclopropanes', 'Cytochrome P-450 CYP2B6', 'Drug Monitoring', 'Genotype', '*HIV', 'HIV Infections/*blood/drug therapy/*enzymology/genetics', 'Humans', 'Lopinavir', 'Male', 'Oxazines/adverse effects/*blood/pharmacokinetics/therapeutic use', 'Oxidoreductases, N-Demethylating/*genetics/metabolism', 'Pyrimidinones/adverse effects/blood/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/16857630/
1419,CYP2B6,35852913,Influence of CYP2B6 and CYP3A4 polymorphisms on the virologic and immunologic responses of patients treated with efavirenz-containing regimen.,"['Kassogue Y', 'Diakite B', 'Maiga M', 'Kassogue O', 'Konate I', 'Tamboura K', 'Diarra F', 'Diarra Z', 'Sawadogo MK', 'Goita Y', 'Sissoko SB', 'Sissoko AS', 'Guirou N', 'Dehbi H', 'Nadifi S', 'Bah S', 'Traore CB', 'Kamate B', 'Dao S', 'Dolo G']","['Alkynes', '*Anti-HIV Agents/pharmacology', '*Benzoxazines/pharmacology', '*Cyclopropanes/pharmacology', 'Cytochrome P-450 CYP2B6/genetics', 'Cytochrome P-450 CYP2B6 Inhibitors/pharmacology', 'Cytochrome P-450 CYP3A/genetics', 'Genotype', '*HIV Infections/drug therapy/enzymology/genetics', 'Humans', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/35852913/
1420,CYP2B6,21150552,Paradoxically elevated efavirenz concentrations in HIV/tuberculosis-coinfected patients with CYP2B6 516TT genotype on rifampin-containing antituberculous therapy.,"['Kwara A', 'Lartey M', 'Sagoe KW', 'Court MH']","['Anti-HIV Agents/*pharmacology', 'Antibiotics, Antitubercular/*pharmacology', 'HIV Infections/*drug therapy/genetics', 'HIV-1/*drug effects/genetics', 'Humans', 'Polymorphism, Single Nucleotide', 'Rifampin/*pharmacology', 'Tuberculosis/*drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/21150552/
1421,CYP2B6,31218720,The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.,"['Helsby NA', 'Yong M', 'van Kan M', 'de Zoysa JR', 'Burns KE']","['Antineoplastic Agents, Alkylating/*pharmacokinetics/therapeutic use', 'Cyclophosphamide/*pharmacokinetics/therapeutic use', 'Cytochrome P-450 CYP2B6/*genetics/metabolism', 'Cytochrome P-450 CYP2C19/*genetics/metabolism', 'Germ-Line Mutation', 'Haplotypes', 'Humans', 'Immunosuppressive Agents/*pharmacokinetics/therapeutic use', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/31218720/
1422,CYP2B6,36817260,Allelic and Genotype Frequencies of CYP2B6( *)2 (64C > T) and CYP2B6( *)3 (777C > A) in Three Dominant Ethnicities of the Iranian Population.,"['Khavandegar A', 'Tavakoli-Far B', 'Ansari S', 'Veis-Karami P', 'Ghasemi F', 'Sheibaninia S', 'Jazayeri R', 'Houshmand M']","['Male', 'Female', 'Humans', 'Iran/epidemiology', 'Cytochrome P-450 CYP2B6/genetics', '*Polymorphism, Single Nucleotide', 'Gene Frequency', 'Genotype', '*Cytochrome P-450 Enzyme System/genetics', 'Alleles']",https://pubmed.ncbi.nlm.nih.gov/36817260/
1423,CYP2B6,30907440,Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.,"['Victorri-Vigneau C', 'Verstuyft C', 'Bouquie R', 'Laforgue EJ', 'Hardouin JB', 'Leboucher J', 'Le Geay B', 'Dano C', 'Challet-Bouju G', 'Grall-Bronnec M']","['Adult', 'Cross-Sectional Studies', 'Cytochrome P-450 CYP2B6/*genetics', 'Cytochrome P-450 CYP2D6/*genetics', 'Dose-Response Relationship, Drug', 'Female', 'Genotype', 'Humans', 'Male', 'Methadone/*administration & dosage/pharmacokinetics/pharmacology', 'Opiate Substitution Treatment/methods', 'Opioid-Related Disorders/*drug therapy', 'Stereoisomerism']",https://pubmed.ncbi.nlm.nih.gov/30907440/
1424,CYP2B6,35404482,Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck.,"['Liu H', 'Li G', 'Sturgis EM', 'Shete S', 'Dahlstrom KR', 'Du M', 'Amos CI', 'Christiani DC', 'Lazarus P', 'Wei Q']","['17-Hydroxysteroid Dehydrogenases', '*Carcinoma, Squamous Cell/pathology', 'Case-Control Studies', 'Cytochrome P-450 CYP2B6/genetics', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genotype', '*Head and Neck Neoplasms/genetics', 'Humans', '*Oropharyngeal Neoplasms/genetics', 'Polymorphism, Single Nucleotide', 'RNA, Messenger', 'Risk Factors', 'Squamous Cell Carcinoma of Head and Neck/genetics']",https://pubmed.ncbi.nlm.nih.gov/35404482/
1425,CYP2B6,35690682,Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity.,"['Petros Z', 'Habtewold A', 'Makonnen E', 'Aklillu E']","['Alkynes', '*Anti-HIV Agents/adverse effects', 'Benzoxazines/adverse effects', 'Constitutive Androstane Receptor', 'Cyclopropanes/therapeutic use', 'Cytochrome P-450 CYP2B6/genetics', 'Genotype', '*HIV Infections/drug therapy/genetics', 'Humans', 'Pregnane X Receptor/genetics', 'Tandem Mass Spectrometry']",https://pubmed.ncbi.nlm.nih.gov/35690682/
1426,CYP2B6,35538637,Methadone pharmacogenetics in vitro and in vivo: Metabolism by CYP2B6 polymorphic variants and genetic variability in paediatric disposition.,"['Wang PF', 'Sharma A', 'Montana M', 'Neiner A', 'Juriga L', 'Reddy KN', 'Tallchief D', 'Blood J', 'Kharasch ED']","['Cytochrome P-450 CYP2B6/genetics/metabolism', 'Cytochrome P-450 Enzyme System/metabolism', 'Cytochromes b', '*Methadone', '*Pharmacogenetics']",https://pubmed.ncbi.nlm.nih.gov/35538637/
1427,CYP2B6,34397877,Association between CYP2B6 c.516G >T variant and acute leukaemia: A protocol for systematic review and meta-analysis.,"['Xiong X', 'Yu D', 'Gao Q', 'Zhang Y', 'Yin Q', 'Chen X', 'Xiao H', 'Tong R']","['Alleles', 'Cytochrome P-450 CYP2B6/*genetics/metabolism', 'DNA, Neoplasm/*genetics', '*Genetic Predisposition to Disease', 'Humans', 'Leukemia, Myeloid, Acute/*genetics/metabolism', '*Polymorphism, Single Nucleotide', 'Meta-Analysis as Topic', 'Systematic Review as Topic']",https://pubmed.ncbi.nlm.nih.gov/34397877/
1428,CYP2B6,25391641,"Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.","['Colic A', 'Alessandrini M', 'Pepper MS']","['Alkynes', 'Anti-HIV Agents/pharmacokinetics/*therapeutic use', 'Benzoxazines/pharmacokinetics/*therapeutic use', 'Black People/*genetics', 'Cyclopropanes', 'Cytochrome P-450 CYP2A6/*genetics/metabolism', 'Cytochrome P-450 CYP2B6/*genetics/metabolism', 'Glucuronosyltransferase/*genetics/metabolism', 'HIV Infections/*drug therapy/enzymology', 'Humans', 'Metabolic Detoxication, Phase I', 'Metabolic Detoxication, Phase II', 'Nevirapine/pharmacokinetics/*therapeutic use', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/25391641/
1429,CYP2B6,29468507,Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics.,"['Kanaya A', 'Sato T', 'Fuse N', 'Yamaguchi H', 'Mano N', 'Yamauchi M']","['Adult', 'Aged', 'Anesthetics, Intravenous/blood/*pharmacokinetics', 'Area Under Curve', '*Body Mass Index', 'Cytochrome P-450 CYP2B6/*genetics', 'Female', '*Genotype', 'Glucuronosyltransferase/*genetics', 'Hemoglobins/analysis', 'Humans', 'Hypnotics and Sedatives/blood/*pharmacokinetics', 'Injections, Intravenous', 'Linear Models', 'Male', 'Middle Aged', 'Multivariate Analysis', 'Polymorphism, Single Nucleotide', 'Propofol/blood/*pharmacokinetics', 'UDP-Glucuronosyltransferase 1A9']",https://pubmed.ncbi.nlm.nih.gov/29468507/
1430,CYP2C19,37032427,"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.","['Bousman CA', 'Stevenson JM', 'Ramsey LB', 'Sangkuhl K', 'Hicks JK', 'Strawn JR', 'Singh AB', 'Ruano G', 'Mueller DJ', 'Tsermpini EE', 'Brown JT', 'Bell GC', 'Leeder JS', 'Gaedigk A', 'Scott SA', 'Klein TE', 'Caudle KE', 'Bishop JR']","['Humans', '*Selective Serotonin Reuptake Inhibitors', 'Cytochrome P-450 CYP2D6/genetics/metabolism', 'Cytochrome P-450 CYP2B6/genetics', 'Pharmacogenetics', '*Depressive Disorder, Major/drug therapy/genetics', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Serotonin Plasma Membrane Transport Proteins/genetics', 'Serotonin', 'Antidepressive Agents/therapeutic use', 'Citalopram/therapeutic use', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/37032427/
1431,CYP2C19,25974703,Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.,"['Hicks JK', 'Bishop JR', 'Sangkuhl K', 'Muller DJ', 'Ji Y', 'Leckband SG', 'Leeder JS', 'Graham RL', 'Chiulli DL', 'LLerena A', 'Skaar TC', 'Scott SA', 'Stingl JC', 'Klein TE', 'Caudle KE', 'Gaedigk A']","['Biotransformation', 'Cytochrome P-450 CYP2C19/*genetics/metabolism', 'Cytochrome P-450 CYP2D6/*genetics/metabolism', '*Drug Dosage Calculations', 'Genotype', 'Humans', 'Patient Safety', 'Pharmacogenetics/*standards', 'Phenotype', '*Polymorphism, Genetic', 'Risk Assessment', 'Risk Factors', 'Selective Serotonin Reuptake Inhibitors/*administration & dosage/adverse effects/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/25974703/
1432,CYP2C19,35226525,"In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke.",['Joundi RA'],"['Alleles', 'Clopidogrel/therapeutic use', 'Cytochrome P-450 CYP2C19/genetics', 'Humans', '*Ischemic Attack, Transient/drug therapy/genetics', 'Platelet Aggregation Inhibitors/therapeutic use', '*Stroke/drug therapy/genetics', 'Ticagrelor/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/35226525/
1433,CYP2C19,30022682,Effect of CYP2C19 and CYP2D6 genotype on tamoxifen treatment outcome indicates endogenous and exogenous interplay.,"['Sim S', 'Lovrot J', 'Lindh JD', 'Bergh J', 'Xie H']","['Adult', 'Aged', 'Aged, 80 and over', 'Antineoplastic Agents, Hormonal/*therapeutic use', 'Breast Neoplasms/*drug therapy/*genetics', 'Chemotherapy, Adjuvant/methods', 'Cytochrome P-450 CYP2C19/*genetics', 'Cytochrome P-450 CYP2D6/*genetics', 'Disease-Free Survival', 'Female', 'Genotype', 'Humans', 'Middle Aged', 'Neoplasm Recurrence, Local/genetics', 'Premenopause/genetics', 'Tamoxifen/*therapeutic use', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/30022682/
1434,CYP2C19,18690857,The pharmacogenetics of CYP2C9 and CYP2C19: ethnic variation and clinical significance.,"['Rosemary J', 'Adithan C']","['Alleles', 'Aryl Hydrocarbon Hydroxylases/*genetics', 'Cytochrome P-450 CYP2C19', 'Cytochrome P-450 CYP2C9', 'Ethnicity', 'Genotype', 'Humans', 'Pharmaceutical Preparations/administration & dosage/metabolism', '*Pharmacogenetics', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/18690857/
1435,CYP2C19,36162369,Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam.,"['Zubiaur P', 'Figueiredo-Tor L', 'Villapalos-Garcia G', 'Soria-Chacartegui P', 'Navares-Gomez M', 'Novalbos J', 'Matas M', 'Calleja S', 'Mejia-Abril G', 'Roman M', 'Ochoa D', 'Abad-Santos F']","['*Cytochrome P-450 CYP2B6/genetics', '*Cytochrome P-450 CYP2C19/genetics', '*Diazepam/adverse effects/pharmacokinetics', 'Phenotype', 'Humans']",https://pubmed.ncbi.nlm.nih.gov/36162369/
1436,CYP2C19,35034351,Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update.,"['Lee CR', 'Luzum JA', 'Sangkuhl K', 'Gammal RS', 'Sabatine MS', 'Stein CM', 'Kisor DF', 'Limdi NA', 'Lee YM', 'Scott SA', 'Hulot JS', 'Roden DM', 'Gaedigk A', 'Caudle KE', 'Klein TE', 'Johnson JA', 'Shuldiner AR']","['Clopidogrel/adverse effects', 'Cytochrome P-450 CYP2C19/genetics/metabolism', '*Platelet Aggregation Inhibitors/adverse effects/metabolism', 'Pharmacogenetics', 'Ticlopidine/adverse effects', '*Prodrugs', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/35034351/
1437,CYP2C19,39010708,Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole.,"['Klomp SD', 'Veringa A', 'Alffenaar JC', 'de Boer MGJ', 'Span LFR', 'Guchelaar HJ', 'Swen JJ']","['*Voriconazole/administration & dosage/pharmacokinetics/blood', 'Humans', '*Cytochrome P-450 CYP2C19/genetics/metabolism', 'Male', 'Female', '*Inflammation/drug therapy/genetics', 'Middle Aged', '*Antifungal Agents/administration & dosage/pharmacokinetics/blood/adverse effects/pharmacology', 'Adult', '*C-Reactive Protein/analysis/metabolism', '*Genotype', 'Aged', 'Prospective Studies', 'Aspergillosis/drug therapy/genetics', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/39010708/
1438,CYP2C19,38631139,Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review.,"['de Brabander E', 'Kleine Schaars K', 'van Amelsvoort T', 'van Westrhenen R']","['Humans', '*Antipsychotic Agents/adverse effects/pharmacokinetics', '*Aripiprazole/adverse effects/pharmacokinetics', '*Cytochrome P-450 CYP2C19/genetics/metabolism', '*Cytochrome P-450 CYP2D6/genetics/metabolism', '*Risperidone/adverse effects/pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/38631139/
1439,CYP2C19,37072025,Relationship between clock gene expression and CYP2C19 and CYP3A4 with benzodiazepines.,"['Tani N', 'Ikeda T', 'Ishikawa T']","['Humans', '*Benzodiazepines/toxicity', 'Cytochrome P-450 CYP3A/genetics', 'ARNTL Transcription Factors/genetics/metabolism', 'Cytochrome P-450 CYP2C19/genetics', 'Diazepam/pharmacology', '*Liver Neoplasms', 'Gene Expression']",https://pubmed.ncbi.nlm.nih.gov/37072025/
1440,CYP2C19,30554109,Does obtaining CYP2D6 and CYP2C19 pharmacogenetic testing predict antidepressant response or adverse drug reactions?,"['Solomon HV', 'Cates KW', 'Li KJ']","['Antidepressive Agents/adverse effects/*therapeutic use', 'Cytochrome P-450 CYP2C19/*genetics', 'Cytochrome P-450 CYP2D6/*genetics', 'Depressive Disorder/*drug therapy/genetics', 'Drug-Related Side Effects and Adverse Reactions/*genetics', '*Genotype', 'Humans', '*Pharmacogenomic Testing', 'Prospective Studies', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/30554109/
1441,CYP2C19,26404412,"Identification and in silico prediction of metabolites of the model compound, tebufenozide by human CYP3A4 and CYP2C19.","['Shirotani N', 'Togawa M', 'Ikushiro S', 'Sakaki T', 'Harada T', 'Miyagawa H', 'Matsui M', 'Nagahori H', 'Mikata K', 'Nishioka K', 'Hirai N', 'Akamatsu M']","['*Computer Simulation', 'Cytochrome P-450 CYP2C19/*metabolism', 'Cytochrome P-450 CYP3A/*metabolism', 'Humans', 'Hydrazines/*analysis/*metabolism', 'Molecular Docking Simulation', 'Software']",https://pubmed.ncbi.nlm.nih.gov/26404412/
1442,CYP2C19,38897411,Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity.,"['Shoji K', 'Hikino K', 'Saito J', 'Matsui T', 'Utano T', 'Takebayashi A', 'Tomizawa D', 'Kato M', 'Matsumoto K', 'Ishikawa T', 'Kawai T', 'Nakamura H', 'Miyairi I', 'Terao C', 'Mushiroda T']","['Humans', '*Cytochrome P-450 CYP2C19/genetics', '*Voriconazole/pharmacokinetics/therapeutic use', 'Child', 'Child, Preschool', 'Female', 'Male', '*Antifungal Agents/pharmacokinetics', '*Neoplasms/immunology/drug therapy', '*Genotype', 'Infant', 'Adolescent', 'Polymorphism, Genetic', 'Phenotype', 'Pharmacogenetics']",https://pubmed.ncbi.nlm.nih.gov/38897411/
1443,CYP2C19,38721014,CYP2C19 polymorphism and coronary in-stent restenosis: A systematic review and meta-analysis.,"['Pintaningrum Y', 'Vitriyaturrida', 'Dewi IP', 'Putra HBP', 'Mappangara I', 'Amir M', 'Yusuf I', 'Bukhari A']","['Humans', '*Coronary Restenosis/genetics', '*Cytochrome P-450 CYP2C19/genetics', '*Stents/adverse effects', 'Polymorphism, Genetic', 'Percutaneous Coronary Intervention/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/38721014/
1444,CYP2C19,37728834,Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone.,"['Byeon JY', 'Cho CK', 'Kang P', 'Kim SH', 'Jang CG', 'Lee SY', 'Lee YJ']","['Humans', 'Cytochrome P-450 CYP2D6/genetics/metabolism', '*Tolperisone/pharmacokinetics', 'Chromatography, Liquid', '*Cigarette Smoking', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Area Under Curve', 'Tandem Mass Spectrometry', 'Polymorphism, Genetic', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/37728834/
1445,CYP2C19,31218720,The importance of both CYP2C19 and CYP2B6 germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.,"['Helsby NA', 'Yong M', 'van Kan M', 'de Zoysa JR', 'Burns KE']","['Antineoplastic Agents, Alkylating/*pharmacokinetics/therapeutic use', 'Cyclophosphamide/*pharmacokinetics/therapeutic use', 'Cytochrome P-450 CYP2B6/*genetics/metabolism', 'Cytochrome P-450 CYP2C19/*genetics/metabolism', 'Germ-Line Mutation', 'Haplotypes', 'Humans', 'Immunosuppressive Agents/*pharmacokinetics/therapeutic use', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/31218720/
1446,CYP2C19,29350207,Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients.,"['Zhuo ZL', 'Xian HP', 'Long Y', 'Liu C', 'Sun YY', 'Ma YT', 'Gao H', 'Zhao JZ', 'Zhao XT']","['ATP Binding Cassette Transporter, Subfamily B/genetics', 'Aged', 'Asian People', 'Cardiovascular Diseases/*drug therapy/genetics', 'Case-Control Studies', 'China', 'Clopidogrel/*therapeutic use', 'Cytochrome P-450 CYP2C19/*genetics', 'Drug Resistance/genetics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Platelet Aggregation Inhibitors/*therapeutic use', 'Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/29350207/
1447,CYP2C19,37796764,"Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.","['Islam F', 'Magarbeh L', 'Elsheikh SSM', 'Kloiber S', 'Espinola CW', 'Bhat V', 'Frey BN', 'Milev R', 'Soares CN', 'Parikh SV', 'Placenza F', 'Hassel S', 'Taylor VH', 'Leri F', 'Blier P', 'Uher R', 'Farzan F', 'Lam RW', 'Turecki G', 'Foster JA', 'Rotzinger S', 'Kennedy SH', 'Muller DJ']","['Adult', 'Male', 'Female', 'Humans', '*Cytochrome P-450 CYP2D6/genetics/metabolism', 'Aripiprazole/adverse effects', 'Escitalopram', 'Citalopram/adverse effects', '*Depressive Disorder, Major/drug therapy/genetics', 'Cytochrome P-450 CYP2C19/genetics/metabolism', 'Depression', 'Canada', 'Biomarkers', 'ATP Binding Cassette Transporter, Subfamily B']",https://pubmed.ncbi.nlm.nih.gov/37796764/
1448,TUBB4B,38749881,Rare variants and handedness: spotlight on TUBB4B.,['Ocklenburg S'],"['*Tubulin/genetics', 'Humans', '*Functional Laterality/genetics', 'Genetic Variation', 'Microtubules/genetics']",https://pubmed.ncbi.nlm.nih.gov/38749881/
1449,TUBB4B,36787097,TUBB4B is a novel therapeutic target in non-alcoholic fatty liver disease-associated hepatocellular carcinoma.,"['Yang Z', 'Gao S', 'Wong CC', 'Liu W', 'Chen H', 'Shang H', 'Wu ZY', 'Xu L', 'Zhang X', 'Wong N', 'Kuang M', 'Yu J']","['Humans', '*Carcinoma, Hepatocellular/drug therapy/genetics/metabolism', '*Liver Neoplasms/drug therapy/genetics/metabolism', '*Non-alcoholic Fatty Liver Disease/drug therapy/genetics/metabolism', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/36787097/
1450,TUBB4B,35240325,TUBB4B gene mutation in Leber phenotype of congenital amaurosis syndrome associated with early-onset deafness.,"['Maasz A', 'Hadzsiev K', 'Ripszam R', 'Zsigmond A', 'Maka E', 'Knezy K', 'Lesch B', 'Nemeth A', 'Bene J', 'Galik B', 'Gyenesei A', 'Melegh B']","['Blindness', '*Deafness/genetics', 'Female', 'Humans', '*Leber Congenital Amaurosis/genetics', 'Mutation', 'Pedigree', 'Phenotype', '*Tubulin/genetics']",https://pubmed.ncbi.nlm.nih.gov/35240325/
1451,TUBB4B,31375012,TUBB4B Downregulation Is Critical for Increasing Migration of Metastatic Colon Cancer Cells.,"['Sobierajska K', 'Ciszewski WM', 'Wawro ME', 'Wieczorek-Szukala K', 'Boncela J', 'Papiewska-Pajak I', 'Niewiarowska J', 'Kowalska MA']","['Adenocarcinoma/*metabolism/pathology', 'Cell Adhesion', '*Cell Movement', 'Colonic Neoplasms/*metabolism/pathology', '*Epithelial-Mesenchymal Transition', 'HT29 Cells', 'Humans', 'Microtubules/metabolism', 'Tubulin/*physiology', 'Vimentin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/31375012/
1452,TUBB4B,38719929,Comprehensive analysis of two hotspot codons in the TUBB4B gene and associated phenotypes.,"['Bodenbender JP', 'Marino V', 'Philipp J', 'Tropitzsch A', 'Kernstock C', 'Stingl K', 'Kempf M', 'Haack TB', 'Zuleger T', 'Mazzola P', 'Kohl S', 'Weisschuh N', ""Dell'Orco D"", 'Kuhlewein L']","['Humans', 'Female', '*Tubulin/genetics/chemistry', 'Male', 'Adult', '*Phenotype', '*Hearing Loss, Sensorineural/genetics', '*Codon/genetics', 'Middle Aged', 'Mutation, Missense', 'Child', 'Pedigree', 'Adolescent', 'Amino Acid Substitution', 'Young Adult', 'Retinitis Pigmentosa/genetics']",https://pubmed.ncbi.nlm.nih.gov/38719929/
1453,TUBB4B,29198720,Mutations in TUBB4B Cause a Distinctive Sensorineural Disease.,"['Luscan R', 'Mechaussier S', 'Paul A', 'Tian G', 'Gerard X', 'Defoort-Dellhemmes S', 'Loundon N', 'Audo I', 'Bonnin S', 'LeGargasson JF', 'Dumont J', 'Goudin N', 'Garfa-Traore M', 'Bras M', 'Pouliet A', 'Bessieres B', 'Boddaert N', 'Sahel JA', 'Lyonnet S', 'Kaplan J', 'Cowan NJ', 'Rozet JM', 'Marlin S', 'Perrault I']","['Adult', 'Binding Sites/genetics', 'Cells, Cultured', 'Child', 'DNA Mutational Analysis', 'Female', 'Humans', 'Leber Congenital Amaurosis/*genetics', 'Male', 'Microtubules/*genetics/metabolism', 'Middle Aged', 'Mutation, Missense/genetics', 'Photoreceptor Cells/metabolism', 'Tubulin/*genetics/metabolism', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/29198720/
1454,TUBB4B,39876836,A Novel Variant in TUBB4B Causes Progressive Cone-Rod Dystrophy and Early Onset Sensorineural Hearing Loss.,"['Scarpato M', 'Testa F', 'Nesti A', 'Zeuli R', 'Boccia R', 'Auletta G', 'Banfi S', 'Simonelli F', 'Karali M']","['Humans', '*Tubulin/genetics/chemistry', '*Hearing Loss, Sensorineural/genetics/pathology', 'Male', 'Female', '*Pedigree', '*Mutation, Missense', '*Cone-Rod Dystrophies/genetics/pathology', 'Adult', 'Child']",https://pubmed.ncbi.nlm.nih.gov/39876836/
1455,HPRT1,27379977,Mutation in the Human HPRT1 Gene and the Lesch-Nyhan Syndrome.,"['Nguyen KV', 'Nyhan WL']","['Adult', 'Base Sequence', 'DNA Mutational Analysis', 'Genetic Association Studies', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics', 'Lesch-Nyhan Syndrome/diagnosis/*genetics', 'Male', 'Molecular Diagnostic Techniques', 'Mutation, Missense', 'Point Mutation', 'Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/27379977/
1456,HPRT1,25965333,Lesch-Nyhan Syndrome in a Family with a Deletion Followed by an Insertion within the HPRT1 Gene.,"['Nguyen KV', 'Nyhan WL']","['Cells, Cultured', 'Family', 'Female', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics', '*INDEL Mutation', 'Lesch-Nyhan Syndrome/*genetics', 'Male']",https://pubmed.ncbi.nlm.nih.gov/25965333/
1457,HPRT1,29185864,Novel mutation in the human HPRT1 gene and the Lesch-Nyhan disease.,"['Nguyen KV', 'Naviaux RK', 'Nyhan WL']","['Base Sequence', 'Child, Preschool', 'Exons/genetics', 'Female', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics/metabolism', 'Lesch-Nyhan Syndrome/*enzymology/*genetics', 'Male', '*Mutation, Missense', 'Pedigree']",https://pubmed.ncbi.nlm.nih.gov/29185864/
1458,HPRT1,28045594,Human HPRT1 gene and the Lesch-Nyhan disease: Substitution of alanine for glycine and inversely in the HGprt enzyme protein.,"['Nguyen KV', 'Naviaux RK', 'Nyhan WL']","['Adult', 'Alanine', '*Amino Acid Substitution', 'Child, Preschool', 'Exons', 'Female', 'Glycine', 'Heterozygote', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/deficiency/*genetics', 'Infant', 'Lesch-Nyhan Syndrome/*genetics', 'Male', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/28045594/
1459,HPRT1,27754763,Novel mutation in HPRT1 causing a splicing error with multiple variations.,"['Baba S', 'Saito T', 'Yamada Y', 'Takeshita E', 'Nomura N', 'Yamada K', 'Wakamatsu N', 'Sasaki M']","['Erythrocytes/enzymology', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics/metabolism', 'Infant', 'Lesch-Nyhan Syndrome/etiology/*genetics', 'Male', '*Mutation', '*RNA Splicing']",https://pubmed.ncbi.nlm.nih.gov/27754763/
1460,HPRT1,28524722,Lesch-Nyhan disease in two families from Chiloe Island with mutations in the HPRT1 gene.,"['Nguyen KV', 'Silva S', 'Troncoso M', 'Naviaux RK', 'Nyhan WL']","['Adolescent', 'Adult', 'Base Sequence', 'Chile', 'Exons/genetics', 'Female', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics', '*Islands', 'Lesch-Nyhan Syndrome/*enzymology/*genetics', 'Male', '*Mutation', '*Pedigree', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28524722/
1461,HPRT1,25547367,Prenatal diagnosis based on HPRT1 gene mutation in a Lesch-Nyhan family.,"['Liu N', 'Zhuo ZH', 'Wang HL', 'Kong XD', 'Shi HR', 'Wu QH', 'Jiang M']","['Asian People', 'DNA Mutational Analysis', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics', 'Infant', 'Lesch-Nyhan Syndrome/*genetics', 'Male', 'Prenatal Diagnosis']",https://pubmed.ncbi.nlm.nih.gov/25547367/
1462,HPRT1,37331109,CRISPR/Cas9-mediated generation of human embryonic stem cell sub-lines with HPRT1 gene knockout to model Lesch Nyhan disease.,"['Boissart C', 'Chatrousse L', 'Poullion T', 'El-Kassar L', 'Giraud-Triboult K', 'Benchoua A']","['Humans', 'Male', '*Lesch-Nyhan Syndrome/genetics/metabolism', 'Hypoxanthine Phosphoribosyltransferase/genetics/metabolism', 'CRISPR-Cas Systems/genetics', 'Gene Knockout Techniques', '*Human Embryonic Stem Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37331109/
1463,HPRT1,20544509,"Molecular analysis of two enzyme genes, HPRT1 and PRPS1, causing X-linked inborn errors of purine metabolism.","['Yamada Y', 'Yamada K', 'Nomura N', 'Yamano A', 'Kimura R', 'Tomida S', 'Naiki M', 'Wakamatsu N']","['DNA Mutational Analysis', '*Genetic Diseases, X-Linked/enzymology', '*Genetic Predisposition to Disease', 'Humans', 'Hyperuricemia/etiology/genetics', '*Hypoxanthine Phosphoribosyltransferase/genetics/metabolism', 'Lesch-Nyhan Syndrome/etiology/genetics', 'Purines/*metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', '*Ribose-Phosphate Pyrophosphokinase/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/20544509/
1464,HPRT1,22132985,Molecular characterization of a deletion in the HPRT1 gene in a patient with Lesch-Nyhan syndrome.,"['Taniguchi A', 'Yamada Y', 'Hakoda M', 'Sekita C', 'Kawamoto M', 'Kaneko H', 'Yamanaka H']","['Adolescent', 'Base Sequence', 'Chromosome Breakpoints', '*Gene Deletion', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics', 'Lesch-Nyhan Syndrome/*enzymology/*genetics', 'Male', 'Molecular Sequence Data']",https://pubmed.ncbi.nlm.nih.gov/22132985/
1465,HPRT1,38154384,Generation of an iPSC line (SDQLCHi030-A) derived from PBMCs of a patient with Lesch-Nyhan syndrome caused by HPRT1 mutation.,"['Li Y', 'Zhang H', 'Guan J', 'Wang B', 'Zhang H', 'Liu Y', 'Gai Z']","['Child', 'Humans', '*Lesch-Nyhan Syndrome/genetics', '*Induced Pluripotent Stem Cells', 'Leukocytes, Mononuclear', 'Hypoxanthine Phosphoribosyltransferase/genetics', 'Mutation/genetics', 'Cell Differentiation', 'Peptide Initiation Factors/genetics']",https://pubmed.ncbi.nlm.nih.gov/38154384/
1466,HPRT1,22183764,Lesch-Nyhan syndrome in an Indian family with novel mutation in the HPRT1 gene.,"['Sharma S', 'Jimenez RT', 'Aneja S', 'Garcia MG', 'Sethi GR']","['Adolescent', 'Base Sequence', '*Frameshift Mutation', 'Genetic Markers', 'Genetic Testing', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics', 'India', 'Infant', 'Lesch-Nyhan Syndrome/diagnosis/*genetics', 'Male', '*Sequence Deletion']",https://pubmed.ncbi.nlm.nih.gov/22183764/
1467,HPRT1,32128695,HPRT-related hyperuricemia with a novel p.V35M mutation in HPRT1 presenting familial juvenile gout.,"['Mishima E', 'Mori T', 'Nakajima Y', 'Toyohara T', 'Kikuchi K', 'Oikawa Y', 'Matsuhashi T', 'Maeda Y', 'Suzuki T', 'Kudo M', 'Ito S', 'Sohara E', 'Uchida S', 'Abe T']","['Febuxostat/administration & dosage/therapeutic use', 'Gout/complications/diagnosis/drug therapy/*genetics', 'Gout Suppressants/administration & dosage/therapeutic use', 'Humans', 'Hyperuricemia/blood/diagnosis/drug therapy/etiology/*genetics', 'Hypoxanthine Phosphoribosyltransferase/*deficiency/*genetics', 'Kidney Calculi/diagnosis/etiology/pathology', 'Kidney Diseases/diagnosis/drug therapy/*genetics', 'Male', 'Mutation, Missense/genetics', 'Treatment Outcome', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32128695/
1468,HPRT1,15571223,Mutations in the hypoxanthine guanine phosphoribosyltransferase gene (HPRT1) in Asian HPRT deficient families.,"['Yamada Y', 'Yamada K', 'Sonta S', 'Wakamatsu N', 'Ogasawara N']","['Exons', 'Family Health', 'Female', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*deficiency/*genetics', 'India', 'Japan', 'Korea', 'Lesch-Nyhan Syndrome/genetics', 'Male', '*Mutation', 'Phenotype', 'Polymerase Chain Reaction', 'RNA, Messenger/metabolism', 'Sequence Analysis, DNA', 'Syndrome']",https://pubmed.ncbi.nlm.nih.gov/15571223/
1469,HPRT1,24940672,Hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiencies: HPRT1 mutations in new Japanese families and PRPP concentration.,"['Yamada Y', 'Nomura N', 'Yamada K', 'Kimura R', 'Fukushi D', 'Wakamatsu N', 'Matsuda Y', 'Yamauchi T', 'Ueda T', 'Hasegawa H', 'Nakamura M', 'Ichida K', 'Kaneko K', 'Fujimori S']","['Asian People/*genetics', 'Erythrocytes/enzymology', 'Female', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/deficiency/*genetics', 'Lesch-Nyhan Syndrome/*blood/enzymology/*genetics', 'Male', '*Mutation', '*Pedigree', 'Ribose-Phosphate Pyrophosphokinase/*blood']",https://pubmed.ncbi.nlm.nih.gov/24940672/
1470,HPRT1,38159260,Prognostic significance and immunological role of HPRT1 in human cancers.,"['Lu Y', 'Chen R', 'Zhang H', 'Sun X', 'Li X', 'Yang M', 'Zhang X']","['Humans', 'Prognosis', '*Adenocarcinoma', '*Colonic Neoplasms', '*Thyroid Neoplasms', 'Hypoxanthine Phosphoribosyltransferase', '*Lung Neoplasms']",https://pubmed.ncbi.nlm.nih.gov/38159260/
1471,HPRT1,34231338,Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma.,"['Ahmadi M', 'Eftekhari Kenzerki M', 'Akrami SM', 'Pashangzadeh S', 'Hajiesmaeili F', 'Rahnavard S', 'Habibipour L', 'Saffarzadeh N', 'Mousavi P']","['*Biomarkers, Tumor', 'Computational Biology', 'DNA Mutational Analysis', 'Databases, Genetic', 'Drug Resistance, Neoplasm', '*Gene Expression', 'Gene Expression Profiling', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Hypoxanthine Phosphoribosyltransferase/*genetics', 'Mutation', 'RNA, Messenger', 'ROC Curve', 'Squamous Cell Carcinoma of Head and Neck/diagnosis/*genetics/*mortality']",https://pubmed.ncbi.nlm.nih.gov/34231338/
1472,PPARD,32198386,The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis.,"['Ding X', 'Han X', 'Yuan H', 'Zhang Y', 'Gao Y']","['Adult', 'Asian People/genetics', 'Astrocytoma/*genetics/mortality/therapy', 'Biomarkers, Tumor/genetics', 'Brain Neoplasms/*genetics/mortality/therapy', 'Case-Control Studies', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease/genetics', 'Glioma/*genetics/mortality/therapy', 'Humans', 'Male', 'PPAR delta/*genetics', 'PPAR gamma/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Prognosis']",https://pubmed.ncbi.nlm.nih.gov/32198386/
1473,PPARD,19666693,Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance?,"['Eynon N', 'Meckel Y', 'Alves AJ', 'Yamin C', 'Sagiv M', 'Goldhammer E', 'Sagiv M']","['Adult', 'Alleles', 'Athletic Performance/physiology', 'DNA/biosynthesis/genetics', 'Female', 'Gene Frequency', 'Genotype', 'Heat-Shock Proteins/*genetics/*physiology', 'Humans', 'Male', 'PPAR delta/*genetics/*physiology', 'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha', 'Phenotype', 'Physical Endurance/*genetics/*physiology', 'Polymorphism, Genetic/physiology', 'Reverse Transcriptase Polymerase Chain Reaction', 'Transcription Factors/*genetics/*physiology']",https://pubmed.ncbi.nlm.nih.gov/19666693/
1474,PPARD,31148953,Polymorphism of the PPARD Gene and Dynamic Balance Performance in Han Chinese Children.,"['Cao Y', 'Zhang Q', 'Chen J', 'Li Z', 'Zhou Z', 'Shen J', 'Wang D', 'Pan D', 'Wang Z', 'Ke D', 'Wang X', 'Lu D', 'Zhao Y', 'Cheng S', 'Shi Y']","['Alleles', 'Asian People/genetics', 'Child', 'China', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Linkage', 'Genetic Predisposition to Disease', '*Genotype', 'Humans', 'Linkage Disequilibrium', 'Male', 'Odds Ratio', 'PPAR delta/*genetics', '*Polymorphism, Single Nucleotide', 'Postural Balance/*genetics', 'Quantitative Trait Loci']",https://pubmed.ncbi.nlm.nih.gov/31148953/
1475,PPARD,16979821,PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease.,"['Holzapfel J', 'Heun R', 'Lutjohann D', 'Jessen F', 'Maier W', 'Kolsch H']","['Aged', 'Aged, 80 and over', '*Alzheimer Disease/genetics/metabolism', 'Cholesterol/*metabolism', 'Female', '*Genetic Predisposition to Disease', '*Haplotypes', 'Humans', 'Middle Aged', 'PPAR delta/*genetics/metabolism', 'Polymorphism, Genetic', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/16979821/
1476,PPARD,21834910,Peroxisome proliferator-activated receptor delta (PPARD) genetic variation and type 2 diabetes in middle-aged Chinese women.,"['Villegas R', 'Williams S', 'Gao Y', 'Cai Q', 'Li H', 'Elasy T', 'Cai H', 'Edwards T', 'Xiang YB', 'Zheng W', 'Long J', 'Ou Shu X']","['Adult', 'Aged', 'Asian People/genetics', '*Body Mass Index', 'Diabetes Mellitus, Type 2/*genetics', 'Female', 'Genome-Wide Association Study', 'Humans', 'Middle Aged', '*Motor Activity', 'PPAR delta/*genetics', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/21834910/
1477,PPARD,18438697,"Genetic study between SIRT1, PPARD, PGC-1alpha genes and Alzheimer's disease.","['Helisalmi S', 'Vepsalainen S', 'Hiltunen M', 'Koivisto AM', 'Salminen A', 'Laakso M', 'Soininen H']","['Aged', 'Alzheimer Disease/epidemiology/*genetics', 'Apolipoproteins E/genetics', 'Case-Control Studies', 'DNA Mutational Analysis', 'Female', 'Finland/epidemiology', 'Gene Frequency', 'Genetic Markers', 'Genetic Predisposition to Disease/genetics', 'Genetic Testing', 'Genotype', 'Heat-Shock Proteins/*genetics', 'Humans', 'Male', 'Middle Aged', 'PPAR delta/*genetics', 'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha', 'Polymorphism, Genetic/genetics', 'Polymorphism, Single Nucleotide/genetics', 'Risk Assessment', 'Sex Factors', 'Sirtuin 1', 'Sirtuins/*genetics', 'Transcription Factors/*genetics']",https://pubmed.ncbi.nlm.nih.gov/18438697/
1478,PPARD,35205333,Unraveling Gut Microbiota Signatures Associated with PPARD and PARGC1A Genetic Polymorphisms in a Healthy Population.,"['Bailen M', 'Tabone M', 'Bressa C', 'Lominchar MGM', 'Larrosa M', 'Gonzalez-Soltero R']","['*Diabetes Mellitus, Type 2/genetics', '*Gastrointestinal Microbiome/genetics', 'Heat-Shock Proteins/genetics', 'Humans', '*PPAR delta/genetics', 'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/genetics', 'Polymorphism, Single Nucleotide/genetics', 'Sugars', 'Transcription Factors/genetics']",https://pubmed.ncbi.nlm.nih.gov/35205333/
1479,PPARD,24391853,Variants of the PPARD gene and their clinicopathological significance in colorectal cancer.,"['Ticha I', 'Gnosa S', 'Lindblom A', 'Liu T', 'Sun XF']","['Aged', 'Biomarkers, Tumor/*genetics', 'Case-Control Studies', 'Colorectal Neoplasms/*genetics/*pathology', 'DNA Mutational Analysis', 'DNA Primers/chemistry/genetics', 'Exons/genetics', 'Family', 'Female', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Mutation/*genetics', 'Neoplasm Staging', 'PPAR delta/*genetics', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/24391853/
1480,PPARD,17327385,Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.,"['Stefan N', 'Thamer C', 'Staiger H', 'Machicao F', 'Machann J', 'Schick F', 'Venter C', 'Niess A', 'Laakso M', 'Fritsche A', 'Haring HU']","['Adiposity/physiology', 'Adult', 'Aerobiosis/genetics/physiology', 'Anaerobic Threshold/physiology', 'Body Composition/physiology', 'Cells, Cultured', 'Diet', 'Female', 'Genotype', 'Glucose Tolerance Test', 'Haplotypes', 'Heat-Shock Proteins/*genetics', 'Humans', 'Insulin Resistance/*physiology', '*Life Style', 'Male', 'Middle Aged', 'Mitochondria, Muscle/*physiology', 'Muscle Fibers, Skeletal/metabolism', 'Muscle, Skeletal/cytology/metabolism', 'PPAR delta/*genetics', 'Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha', 'Physical Fitness/*physiology', 'Polymorphism, Single Nucleotide/genetics', 'Transcription Factors/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17327385/
1481,PPARD,32566688,Single Nucleotide Polymorphisms in PPARD Associated with Systemic Lupus Erythematosus in Chinese Populations.,"['Qi YY', 'Zhai YL', 'Liu XR', 'Zhang XX', 'Zhao YF', 'Ning XH', 'Zhao ZZ']","['Alleles', 'Asian People/genetics', 'Case-Control Studies', 'China/epidemiology', 'Computational Biology/methods', 'Female', 'Gene Expression', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Lupus Erythematosus, Systemic/epidemiology/*genetics', 'Male', 'Molecular Sequence Annotation', 'Odds Ratio', 'PPAR delta/*genetics', '*Polymorphism, Single Nucleotide', 'Quantitative Trait Loci']",https://pubmed.ncbi.nlm.nih.gov/32566688/
1482,PPARD,36051387,Effects of PPARD gene variants on the therapeutic responses to exenatide in chinese patients with type 2 diabetes mellitus.,"['Song J', 'Li N', 'Hu R', 'Yu Y', 'Xu K', 'Ling H', 'Lu Q', 'Yang T', 'Wang T', 'Yin X']","['China/epidemiology', '*Diabetes Mellitus, Type 2/drug therapy/genetics', 'Exenatide/therapeutic use', 'Humans', '*Insulin Resistance/genetics', '*PPAR delta/genetics/therapeutic use', 'Prospective Studies']",https://pubmed.ncbi.nlm.nih.gov/36051387/
1483,NR3C1,37807060,Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy.,"['Yan M', 'Wang J', 'Wang H', 'Zhou J', 'Qi H', 'Naji Y', 'Zhao L', 'Tang Y', 'Dai Y']","['Humans', '*Carcinoma, Renal Cell/pathology', '*Kidney Neoplasms/pathology', 'Mitophagy/genetics', 'Cell Line, Tumor', 'Endoplasmic Reticulum Stress', 'Cell Proliferation/genetics', 'Protein Kinases/metabolism', 'Gene Expression Regulation, Neoplastic', 'Receptors, Glucocorticoid/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37807060/
1484,NR3C1,30006372,Bilateral adrenal hyperplasia and NR3C1 mutations causing glucocorticoid resistance: Is there an association?,"['Nicolaides NC', 'Chrousos GP']","['*Glucocorticoids', 'Humans', 'Hyperplasia', 'Mutation', 'Prevalence', 'Receptors, Glucocorticoid/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30006372/
1485,NR3C1,37845495,Decreased mononuclear cell NR3C1 SKA2 and FKPB5 expression levels among adult survivors of suicide bombing terror attacks in childhood are associated with the development of PTSD.,"['Goltser-Dubner T', 'Shalev A', 'Benarroch F', 'Canetti L', 'Yogev M', 'Kalla C', 'Masarwa R', 'Martin J', 'Pevzner D', 'Oz O', 'Saloner C', 'Amer R', 'Lavon M', 'Lotan A', 'Galili-Weisstub E', 'Segman R']","['Humans', 'Young Adult', 'Chromosomal Proteins, Non-Histone', 'Glucocorticoids', 'Receptors, Glucocorticoid/genetics/metabolism', '*Stress Disorders, Post-Traumatic/genetics/metabolism', '*Suicide', 'Child']",https://pubmed.ncbi.nlm.nih.gov/37845495/
1486,NR3C1,20731635,Glucocorticoid receptor (NR3C1) gene polymorphisms and onset of alcohol abuse in adolescents.,"['Desrivieres S', 'Lourdusamy A', 'Muller C', 'Ducci F', 'Wong CP', 'Kaakinen M', 'Pouta A', 'Hartikainen AL', 'Isohanni M', 'Charoen P', 'Peltonen L', 'Freimer N', 'Elliott P', 'Jarvelin MR', 'Schumann G']","['Adolescent', 'Age of Onset', 'Alcohol Drinking/genetics', 'Alcoholic Intoxication/genetics', 'Alcoholism/*genetics', '*Alleles', 'Cohort Studies', 'Female', 'Finland', 'Genetic Predisposition to Disease/*genetics', 'Genetic Testing', 'Humans', 'Male', 'Phenotype', 'Polymorphism, Genetic/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Prospective Studies', 'Receptors, Glucocorticoid/*genetics', 'Sex Factors']",https://pubmed.ncbi.nlm.nih.gov/20731635/
1487,NR3C1,34519616,Perinatal stress and methylation of the NR3C1 gene in newborns: systematic review.,"['Chalfun G', 'Reis MM', 'de Oliveira MBG', 'de Araujo Brasil A', 'Dos Santos Salu M', 'da Cunha AJLA', 'Prata-Barbosa A', 'de Magalhaes-Barbosa MC']","['*DNA Methylation', 'Exons', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Pregnancy', 'Protein Processing, Post-Translational', '*Receptors, Glucocorticoid/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34519616/
1488,NR3C1,36377555,"Evaluation of DNA methylation in BDNF, SLC6A4, NR3C1 and FKBP5 before and after treatment with selective serotonin-reuptake inhibitor in major depressive disorder.","['Mohammadi S', 'Beh-Pajooh A', 'Ahmadimanesh M', 'Amini M', 'Ghazi-Khansari M', 'Moallem SA', 'Hosseini R', 'Nourian YH', 'Ghahremani MH']","['Humans', 'Brain-Derived Neurotrophic Factor/genetics/metabolism', '*Depressive Disorder, Major/drug therapy/genetics', '*DNA Methylation', 'Promoter Regions, Genetic', 'Receptors, Glucocorticoid/genetics', 'Serotonin/metabolism', 'Serotonin Plasma Membrane Transport Proteins/genetics/metabolism', '*Selective Serotonin Reuptake Inhibitors/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/36377555/
1489,NR3C1,18663733,"Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality and extends a haplotype with putative clinical relevance.","['Kumsta R', 'Moser D', 'Streit F', 'Koper JW', 'Meyer J', 'Wust S']","['Adrenocorticotropic Hormone/analysis/genetics', 'Alleles', 'Cell Line, Tumor', 'Depressive Disorder, Major/*genetics', 'Haplotypes/*genetics', 'Humans', 'Hydrocortisone/analysis/genetics', 'Linkage Disequilibrium/genetics', 'Polymorphism, Single Nucleotide/genetics', 'Promoter Regions, Genetic', 'Receptors, Glucocorticoid/*genetics', 'Stress, Psychological/genetics', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/18663733/
1490,NR3C1,29058930,NR3C1 methylation as a moderator of the effects of maternal support and stress on insecure attachment development.,"['Bosmans G', 'Young JF', 'Hankin BL']","['Adolescent', 'Anxiety/genetics/metabolism', 'Child', 'Child Behavior Disorders/genetics/metabolism', '*DNA Methylation', 'Depression/genetics/metabolism', 'Epigenesis, Genetic', 'Female', 'Humans', 'Longitudinal Studies', 'Male', 'Maternal Behavior/*psychology', 'Mother-Child Relations/*psychology', '*Object Attachment', 'Psychology, Child', 'Receptors, Glucocorticoid/*genetics/metabolism', 'Regression Analysis', 'Stress, Psychological/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/29058930/
1491,NR3C1,32983174,Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.,"['Park JH', 'Lee HK']","['Adult', 'Aged', 'Betacoronavirus/*immunology', 'Bronchoalveolar Lavage Fluid/immunology', 'COVID-19', 'Coronavirus Infections/*immunology/virology', 'Epithelial Cells/pathology', 'Extracellular Traps/immunology', 'Female', 'Gene Expression Profiling/methods', 'Humans', 'Inflammation/immunology', 'Interleukin-8/*genetics/metabolism', 'Male', 'Middle Aged', 'Myeloid Cells/immunology', 'Neutrophil Infiltration/immunology', 'Neutrophils/*immunology', 'Pandemics', 'Pneumonia, Viral/*immunology/virology', 'RNA-Seq', 'Receptors, Glucocorticoid/*genetics/metabolism', 'SARS-CoV-2', '*Severity of Illness Index', 'Single-Cell Analysis/methods', '*Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/32983174/
1492,NR3C1,27620456,"Childhood abuse, promoter methylation of leukocyte NR3C1 and the potential modifying effect of emotional support.","['Shields AE', 'Wise LA', 'Ruiz-Narvaez EA', 'Seddighzadeh B', 'Byun HM', 'Cozier YC', 'Rosenberg L', 'Palmer JR', 'Baccarelli AA']","['Adolescent', 'Adult', 'Aged', 'Child', '*Child Abuse', 'Child, Preschool', '*DNA Methylation', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Leukocytes/metabolism', 'Middle Aged', 'Promoter Regions, Genetic', 'Receptors, Glucocorticoid/*genetics', '*Social Support', 'Stress, Psychological/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27620456/
1493,NR3C1,30176278,"Glucocorticoid receptor gene (NR3C1) DNA methylation in association with trauma, psychopathology, transcript expression, or genotypic variation: A systematic review.","['Watkeys OJ', 'Kremerskothen K', 'Quide Y', 'Fullerton JM', 'Green MJ']","['*DNA Methylation', 'Epigenesis, Genetic', 'Gene Expression', 'Genetic Variation', 'Humans', 'Mental Disorders/genetics/metabolism', 'Receptors, Glucocorticoid/*genetics/*metabolism', 'Stress, Psychological/*genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/30176278/
1494,NR3C1,37650932,Prediction and prognostic potential of NR3C1 gene expression level in DLBCL patients.,"['Yan C', 'He X', 'Qi R', 'Cao L', 'Zheng S', 'Huang C', 'Yang P', 'Wang J', 'Zhu M', 'Li S', 'Dong G', 'Jing H', 'Zhang W', 'Liu X']","['Humans', 'Prognosis', '*Lymphoma, Large B-Cell, Diffuse/genetics', '*Lymphoma, Non-Hodgkin', 'L-Lactate Dehydrogenase', 'Gene Expression', 'Receptors, Glucocorticoid']",https://pubmed.ncbi.nlm.nih.gov/37650932/
1495,NR3C1,21789663,"Maternal depression and child and adolescent depression symptoms: an exploratory test for moderation by CRHR1, FKBP5 and NR3C1 gene variants.","['Lewis G', 'Collishaw S', 'Harold G', 'Rice F', 'Thapar A']","['Adolescent', 'Adult', 'Child', 'Depression/*genetics', 'Female', '*Genetic Variation', 'Genotype', 'Humans', 'Male', 'Models, Genetic', 'Models, Theoretical', 'Mothers', 'Polymorphism, Single Nucleotide', 'Receptors, Corticotropin-Releasing Hormone/*genetics', 'Receptors, Glucocorticoid/*genetics', 'Risk', 'Tacrolimus Binding Proteins/*genetics', 'CRF Receptor, Type 1']",https://pubmed.ncbi.nlm.nih.gov/21789663/
1496,NR3C1,38584335,A novel mutation in the NR3C1 gene associated with reversible glucocorticoid resistance.,"['Laulhe M', 'Kuhn E', 'Bouligand J', 'Amazit L', 'Perrot J', 'Lebigot E', 'Kamenicky P', 'Lombes M', 'Fagart J', 'Viengchareun S', 'Martinerie L']","['Humans', 'Adrenocorticotropic Hormone/genetics', '*Glucocorticoids/pharmacology/therapeutic use/metabolism', 'Hydrocortisone', 'Ligands', '*Metabolism, Inborn Errors', 'Mutation', '*Receptors, Glucocorticoid/genetics/metabolism/deficiency', 'Syndrome']",https://pubmed.ncbi.nlm.nih.gov/38584335/
1497,CHRNA4,21500914,The nicotinic acetylcholine receptor gene CHRNA4 is associated with negative emotionality.,"['Markett S', 'Montag C', 'Reuter M']","['Adult', 'Alleles', 'Anxiety/genetics', 'Female', 'Genetic Association Studies', 'Genetic Markers/genetics', 'Homozygote', 'Humans', 'Male', '*Negativism', 'Personality/genetics', 'Personality Inventory', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Nicotinic/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Smoking/genetics/psychology']",https://pubmed.ncbi.nlm.nih.gov/21500914/
1498,CHRNA4,10450598,SER252PHE and 776INS3 mutations in the CHRNA4 gene are rare in the Italian ADNFLE population.,"['Tenchini ML', 'Duga S', 'Bonati MT', 'Asselta R', 'Oldani A', 'Zucconi M', 'Malcovati M', 'Dalpra L', 'Ferini-Strambi L']","['Adolescent', 'Adult', 'Alleles', 'Chromosome Aberrations/*genetics', 'Chromosome Disorders', 'Chromosome Mapping', 'DNA Mutational Analysis', 'Epilepsy, Frontal Lobe/diagnosis/*genetics', 'Ethnicity/*genetics', 'Female', 'Genes, Dominant/*genetics', 'Genetic Linkage/genetics', 'Genetic Predisposition to Disease/*genetics', 'Humans', 'Male', 'Mutagenesis, Insertional/*genetics', 'Mutation, Missense/*genetics', 'Pedigree', 'Polymerase Chain Reaction', 'Receptors, Nicotinic/*genetics', 'Sleep Wake Disorders/diagnosis/*genetics']",https://pubmed.ncbi.nlm.nih.gov/10450598/
1499,CHRNA4,8833159,Exon-intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4).,"['Steinlein O', 'Weiland S', 'Stoodt J', 'Propping P']","['Amino Acid Sequence', 'Base Sequence', 'Cloning, Molecular', 'Cosmids', 'DNA, Complementary', '*Exons', 'Humans', '*Introns', 'Molecular Sequence Data', 'Open Reading Frames', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/8833159/
1500,CHRNA4,22373960,A cognitive phenotype for a polymorphism in the nicotinic receptor gene CHRNA4.,"['Greenwood PM', 'Parasuraman R', 'Espeseth T']","['Attention/physiology', 'Brain/physiology', 'Cognition/*physiology', 'Genetic Variation', 'Genotype', 'Humans', 'Phenotype', 'Psychomotor Performance/physiology', 'Receptors, Nicotinic/*genetics/*physiology', 'Visual Perception/physiology']",https://pubmed.ncbi.nlm.nih.gov/22373960/
1501,CHRNA4,32031532,Two mutations in the nicotinic acetylcholine receptor subunit A4 (CHRNA4) in a family with autosomal dominant sleep-related hypermotor epilepsy.,"['Langenbruch L', 'Biskup S', 'Young P', 'Drager B', 'Moddel G']","['Adult', 'Aged', '*Epilepsies, Partial/complications/genetics/physiopathology', 'Female', 'Humans', 'Middle Aged', 'Pedigree', 'Receptors, Nicotinic/*genetics', '*Sleep Arousal Disorders/etiology/genetics/physiopathology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32031532/
1502,CHRNA4,39193833,"Clinical, molecular, physiologic, and therapeutic feature of patients with CHRNA4 and CHRNB2 deficiency: A systematic review.","['Jalaiei A', 'Asadi MR', 'Daneshmandpour Y', 'Rezazadeh M', 'Ghafouri-Fard S']","['Humans', '*Receptors, Nicotinic/genetics', 'Mutation/genetics', 'Neurodegenerative Diseases/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39193833/
1503,CHRNA4,9175743,An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy.,"['Steinlein OK', 'Magnusson A', 'Stoodt J', 'Bertrand S', 'Weiland S', 'Berkovic SF', 'Nakken KO', 'Propping P', 'Bertrand D']","['Amino Acid Sequence', 'Base Sequence', 'Calcium', 'Cell Membrane Permeability', 'DNA, Complementary', 'Epilepsy, Frontal Lobe/*genetics', 'Family', 'Female', '*Genes, Dominant', 'Humans', 'Leucine', 'Male', 'Molecular Sequence Data', 'Mutagenesis, Insertional', 'Pedigree', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/9175743/
1504,CHRNA4,7607646,Detection of a CfoI polymorphism within exon 5 of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4).,['Steinlein O'],"['Base Sequence', 'Exons/*genetics', 'Humans', 'Molecular Sequence Data', 'Polymerase Chain Reaction', '*Polymorphism, Genetic', 'Polymorphism, Single-Stranded Conformational', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/7607646/
1505,CHRNA4,9216991,A nonsense mutation in the alpha4 subunit of the nicotinic acetylcholine receptor (CHRNA4) cosegregates with 20q-linked benign neonatal familial convulsions (EBNI).,"['Beck C', 'Moulard B', 'Steinlein O', 'Guipponi M', 'Vallee L', 'Montpied P', 'Baldy-Moulnier M', 'Malafosse A']","['DNA Probes', 'DNA, Single-Stranded/analysis', 'Genetic Linkage/*genetics', 'Humans', 'Mutation/*genetics', 'Pedigree', 'Polymerase Chain Reaction', 'Receptors, Nicotinic/*genetics', 'Seizures/*genetics']",https://pubmed.ncbi.nlm.nih.gov/9216991/
1506,CHRNA4,32536355,Variants in CHRNB2 and CHRNA4 Identified in Patients with Insular Epilepsy.,"['Cadieux-Dion M', 'Meneghini S', 'Villa C', 'Toffa DH', 'Wickstrom R', 'Bouthillier A', 'Sandvik U', 'Gustavsson B', 'Mohamed I', 'Cossette P', 'Combi R', 'Becchetti A', 'Nguyen DK']","['Cerebral Cortex', '*Epilepsy, Frontal Lobe/genetics', 'Humans', 'Mutation, Missense', '*Receptors, Nicotinic/genetics']",https://pubmed.ncbi.nlm.nih.gov/32536355/
1507,CHRNA4,28582665,"The influence of CHRNA4, COMT, and maternal sensitivity on orienting and executive attention in 6-month-old infants.","['Quan J', 'Ong ML', 'Bureau JF', 'Sim LW', 'Sanmugam S', 'Abdul Malik AB', 'Wong E', 'Wong J', 'Chong YS', 'Saw SM', 'Kwek K', 'Qiu A', 'Holbrook JD', 'Rifkin-Graboi A']","['Adult', 'Attention/*physiology', 'Catechol O-Methyltransferase/*genetics', 'Child Development/*physiology', 'Executive Function/*physiology', 'Female', '*Gene-Environment Interaction', 'Humans', 'Infant', 'Male', 'Maternal Behavior/*physiology', 'Orientation, Spatial/*physiology', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28582665/
1508,CHRNA4,10549797,Mutation screening of the CHRNA4 and CHRNB2 nicotinic cholinergic receptor genes in Alzheimer's disease.,"['Steinlein OK', 'Stoodt J', 'de Vos RA', 'Steur EN', 'Wevers A', 'Schutz U', 'Schroder H']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/*genetics/metabolism', 'Cells, Cultured', 'DNA/analysis/genetics', 'Female', 'Fibroblasts', 'Genetic Testing', 'Humans', 'Male', 'Mutation/physiology', 'Polymorphism, Genetic/genetics', 'Receptors, Nicotinic/*biosynthesis/genetics', 'Reverse Transcriptase Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/10549797/
1509,CHRNA4,15026168,Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease.,"['Cook LJ', 'Ho LW', 'Taylor AE', 'Brayne C', 'Evans JG', 'Xuereb J', 'Cairns NJ', 'Pritchard A', 'Lemmon H', 'Mann D', 'St Clair D', 'Turic D', 'Hollingworth P', 'Moore PJ', 'Jehu L', 'Archer N', 'Walter S', 'Foy C', 'Edmondson A', 'Powell J', 'Lovestone S', 'Owen MJ', 'Williams J', 'Lendon C', 'Rubinsztein DC']","['Aged', 'Alleles', 'Alzheimer Disease/*genetics', 'Chi-Square Distribution', 'Confidence Intervals', 'Female', 'Genotype', 'Humans', 'Male', 'Odds Ratio', 'Polymorphism, Genetic/*genetics', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15026168/
1510,CHRNA4,27611310,CHRNA4 and ANKK1 Polymorphisms Influence Smoking-Induced Nicotinic Acetylcholine Receptor Upregulation.,"['Esterlis I', 'Hillmer AT', 'Bois F', 'Pittman B', 'McGovern E', ""O'Malley SS"", 'Picciotto MR', 'Yang BZ', 'Gelernter J', 'Cosgrove KP']","['Adult', 'Case-Control Studies', 'Corpus Striatum/*diagnostic imaging/metabolism', 'Female', 'Humans', 'Iodine Radioisotopes', 'Male', 'Polymorphism, Single Nucleotide', 'Protein Serine-Threonine Kinases/*genetics/metabolism', 'Receptors, Nicotinic/genetics/metabolism/*physiology', 'Smoking/*physiopathology', 'Smoking Cessation/methods', 'Smoking Prevention', 'Tobacco Use Disorder/genetics', 'Tomography, Emission-Computed, Single-Photon', 'Up-Regulation', 'White People']",https://pubmed.ncbi.nlm.nih.gov/27611310/
1511,CHRNA4,26125703,Association of CHRNA4 gene rs1044396 and rs1044397 polymorphisms with Parkinson's disease symptoms and smoking.,"['Zhang LM', 'Zhang XP', 'Chen YQ', 'Ye W']","['Age of Onset', 'Aged', 'Aged, 80 and over', 'Base Sequence', 'Behavior Rating Scale', 'Case-Control Studies', 'Female', 'Gene Expression', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Molecular Sequence Data', 'Parkinson Disease/complications/*genetics/pathology', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Sex Factors', 'Smoking/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/26125703/
1512,CHRNA4,35093606,Autosomal dominant sleep-related hypermotor epilepsy caused by a previously unreported CHRNA4 variant.,"['Nielsen TO', 'Herlin MK', 'Linnet KM', 'Beniczky S', 'Sommerlund M', 'Granild-Jensen JB', 'Gregersen PA']","['*Arthrogryposis', '*Epilepsy/drug therapy/genetics', 'Humans', 'Male', '*Receptors, Nicotinic/genetics', 'Seizures', 'Sleep']",https://pubmed.ncbi.nlm.nih.gov/35093606/
1513,CHRNA4,29630124,Study of candidate gene cHRNA4 for familial epilepsy syndrome.,"['Wang N', 'Huang HL', 'Zhou H']","['Adolescent', 'Adult', 'Aged', 'Electroencephalography', 'Epilepsies, Partial/*genetics/physiopathology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Mutation', 'Pedigree', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29630124/
1514,CHRNA2,34952750,CHRNA2: a new paradigm in beige thermoregulation and metabolism.,"['Ma Y', 'Liu S', 'Jun H', 'Wu J']","['Adipocytes/metabolism', '*Adipocytes, Beige/metabolism', 'Adipose Tissue/metabolism', 'Energy Metabolism', 'Humans', '*Receptors, Nicotinic/metabolism', 'Thermogenesis', 'Uncoupling Protein 1/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34952750/
1515,CHRNA2,31209380,Genome-wide association study implicates CHRNA2 in cannabis use disorder.,"['Demontis D', 'Rajagopal VM', 'Thorgeirsson TE', 'Als TD', 'Grove J', 'Leppala K', 'Gudbjartsson DF', 'Pallesen J', 'Hjorthoj C', 'Reginsson GW', 'Tyrfingsson T', 'Runarsdottir V', 'Qvist P', 'Christensen JH', 'Bybjerg-Grauholm J', 'Baekvad-Hansen M', 'Huckins LM', 'Stahl EA', 'Timmermann A', 'Agerbo E', 'Hougaard DM', 'Werge T', 'Mors O', 'Mortensen PB', 'Nordentoft M', 'Daly MJ', 'Stefansson H', 'Stefansson K', 'Nyegaard M', 'Borglum AD']","['Age of Onset', 'Alleles', 'Attention Deficit Disorder with Hyperactivity/genetics', 'Brain/metabolism', 'Case-Control Studies', 'Chromosomes, Human, Pair 8/genetics', 'Cognition/physiology', 'Cohort Studies', 'Confounding Factors, Epidemiologic', 'Denmark', 'Educational Status', 'Female', 'Gene Expression Profiling', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', 'Iceland', 'Male', 'Marijuana Abuse/*genetics', 'Multifactorial Inheritance', 'Nerve Tissue Proteins/biosynthesis/genetics/*physiology', 'Polymorphism, Single Nucleotide', 'Quantitative Trait Loci', 'Receptors, Nicotinic/biosynthesis/genetics/*physiology', 'Schizophrenia/genetics', 'Smoking/genetics', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/31209380/
1516,CHRNA2,18226955,CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients.,"['Combi R', 'Ferini-Strambi L', 'Tenchini ML']","['Adult', 'Child', 'Cohort Studies', 'Epilepsy, Frontal Lobe/*genetics', 'Exons/genetics', 'Genetic Predisposition to Disease', 'Humans', 'Italy', 'Mutation', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/18226955/
1517,CHRNA2,24253422,Significant associations of CHRNA2 and CHRNA6 with nicotine dependence in European American and African American populations.,"['Wang S', 'D van der Vaart A', 'Xu Q', 'Seneviratne C', 'Pomerleau OF', 'Pomerleau CS', 'Payne TJ', 'Ma JZ', 'Li MD']","['Black People/*genetics', 'Case-Control Studies', 'Chromosomes, Human, Pair 8', 'Haplotypes', 'Humans', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics', 'White People/*genetics', 'Black or African American']",https://pubmed.ncbi.nlm.nih.gov/24253422/
1518,CHRNA2,18588430,Association of CHRNA2 polymorphisms with overweight/obesity and clinical characteristics in a Korean population.,['Kim J'],"['Adult', 'Female', 'Humans', 'Korea/epidemiology', 'Male', 'Obesity/epidemiology/*genetics', 'Overweight/epidemiology/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/18588430/
1519,CHRNA2,25847220,Mutation of CHRNA2 in a family with benign familial infantile seizures: Potential role of nicotinic acetylcholine receptor in various phenotypes of epilepsy.,"['Trivisano M', 'Terracciano A', 'Milano T', 'Cappelletti S', 'Pietrafusa N', 'Bertini ES', 'Vigevano F', 'Specchio N']","['Adult', 'Arginine/genetics', 'Child, Preschool', 'DNA Mutational Analysis', 'Electroencephalography', 'Epilepsy, Benign Neonatal/*genetics/physiopathology', 'Female', 'Humans', 'Male', 'Mutation/*genetics', '*Pedigree', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25847220/
1520,CHRNA2,39596607,Two Novel Variants in the CHRNA2 and SCN2A Genes in Italian Patients with Febrile Seizures.,"['Procopio R', 'Gagliardi M', 'Talarico M', 'Fortunato F', 'Sammarra I', 'Procopio AC', 'Roncada P', 'Malanga D', 'Annesi G', 'Gambardella A']","['Humans', '*Seizures, Febrile/genetics', '*NAV1.2 Voltage-Gated Sodium Channel/genetics', '*Receptors, Nicotinic/genetics', 'Male', 'Female', 'Italy', 'Child, Preschool', 'Infant', 'Genetic Predisposition to Disease', 'Child', 'Pedigree', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/39596607/
1521,CHRNA2,25770198,Nocturnal frontal lobe epilepsy with paroxysmal arousals due to CHRNA2 loss of function.,"['Conti V', 'Aracri P', 'Chiti L', 'Brusco S', 'Mari F', 'Marini C', 'Albanese M', 'Marchi A', 'Liguori C', 'Placidi F', 'Romigi A', 'Becchetti A', 'Guerrini R']","['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Cohort Studies', 'Epilepsy, Frontal Lobe/complications/genetics/physiopathology', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Parasomnias/etiology/*genetics/physiopathology', 'Pedigree', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25770198/
1522,CHRNA2,17602836,A major role of the nicotinic acetylcholine receptor gene CHRNA2 in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is unlikely.,"['Gu W', 'Bertrand D', 'Steinlein OK']","['Chromosome Disorders/*genetics', 'Epilepsy, Frontal Lobe/*genetics/physiopathology/psychology', 'Fear/physiology', 'Humans', 'Mutation/physiology', 'Phenotype', 'Receptors, Nicotinic/*genetics/physiology', 'Reverse Transcriptase Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/17602836/
1523,CHRNA2,11436130,"Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1).","['Blaveri E', 'Kalsi G', 'Lawrence J', 'Quested D', 'Moorey H', 'Lamb G', 'Kohen D', 'Shiwach R', 'Chowdhury U', 'Curtis D', 'McQuillin A', 'Gramoustianou ES', 'Gurling HM']","[""3' Untranslated Regions"", 'Alleles', 'Arylamine N-Acetyltransferase/*genetics', 'Case-Control Studies', '*Chromosomes, Human, Pair 8', 'Genotype', 'Humans', 'Mutation', 'Polymerase Chain Reaction', 'Polymorphism, Restriction Fragment Length', 'Protein Precursors/*genetics', 'Quantitative Trait, Heritable', 'Receptors, Nicotinic/*genetics', 'Receptors, Opioid/*genetics', 'Repetitive Sequences, Nucleic Acid', 'Schizophrenia/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11436130/
1524,CHRNA2,15996750,No association between common variations in the neuronal nicotinic acetylcholine receptor alpha2 subunit gene (CHRNA2) and bipolar I disorder.,"['Lohoff FW', 'Ferraro TN', 'McNabb L', 'Schwebel C', 'Dahl JP', 'Doyle GA', 'Buono RJ', 'Berrettini WH']","['Bipolar Disorder/diagnosis/epidemiology/*genetics', 'Case-Control Studies', 'Chromosomes, Human, Pair 8/genetics', 'Diagnostic and Statistical Manual of Mental Disorders', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genetic Variation/*genetics', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Polymorphism, Genetic/genetics', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/epidemiology']",https://pubmed.ncbi.nlm.nih.gov/15996750/
1525,AR,29655414,Augmented reality (AR) and virtual reality (VR) applied in dentistry.,"['Huang TK', 'Yang CH', 'Hsieh YH', 'Wang JC', 'Hung CC']","['Academic Performance/statistics & numerical data', 'Computer Simulation', 'Dentistry/*methods', 'Education, Dental/*methods', 'Humans', 'Students, Dental', '*Teaching', '*Virtual Reality']",https://pubmed.ncbi.nlm.nih.gov/29655414/
1526,AR,36588499,YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth.,"['Li X', 'Zhuo S', 'Cho YS', 'Liu Y', 'Yang Y', 'Zhu J', 'Jiang J']","['Male', 'Humans', '*Transcription Factors/genetics/metabolism', 'Adaptor Proteins, Signal Transducing/genetics/metabolism', 'YAP-Signaling Proteins', 'Signal Transduction', '*Prostatic Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/36588499/
1527,AR,25184630,AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.,"['Antonarakis ES', 'Lu C', 'Wang H', 'Luber B', 'Nakazawa M', 'Roeser JC', 'Chen Y', 'Mohammad TA', 'Chen Y', 'Fedor HL', 'Lotan TL', 'Zheng Q', 'De Marzo AM', 'Isaacs JT', 'Isaacs WB', 'Nadal R', 'Paller CJ', 'Denmeade SR', 'Carducci MA', 'Eisenberger MA', 'Luo J']","['Androstenes', 'Androstenols/*therapeutic use', 'Benzamides', 'Drug Resistance, Neoplasm/*genetics', 'Humans', 'Male', 'Morphinans/analysis', 'Nitriles', 'Phenylthiohydantoin/*analogs & derivatives/therapeutic use', 'Prostatic Neoplasms/drug therapy/*genetics', 'RNA, Neoplasm/*analysis', 'Receptors, Androgen/analysis/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Survival Analysis']",https://pubmed.ncbi.nlm.nih.gov/25184630/
1528,AR,35973029,The beta(2)AR gets SNOed.,['Foley JF'],['*Signal Transduction'],https://pubmed.ncbi.nlm.nih.gov/35973029/
1529,AR,36704869,Augmented Resuscitation- simulacrum of AR.,['Jacobs C'],"['*Augmented Reality', '*Virtual Reality']",https://pubmed.ncbi.nlm.nih.gov/36704869/
1530,AR,37038004,Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer.,"['Bakht MK', 'Yamada Y', 'Ku SY', 'Venkadakrishnan VB', 'Korsen JA', 'Kalidindi TM', 'Mizuno K', 'Ahn SH', 'Seo JH', 'Garcia MM', 'Khani F', 'Elemento O', 'Long HW', 'Chaglassian A', 'Pillarsetty N', 'Lewis JS', 'Freedman M', 'Belanger AP', 'Nguyen QD', 'Beltran H']","['Male', 'Humans', '*Prostatic Neoplasms, Castration-Resistant/genetics/metabolism', 'Prostate/metabolism', 'Prostate-Specific Antigen/genetics/metabolism', 'Positron-Emission Tomography/methods', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/37038004/
1531,AR,19602746,Quantification of AS and AR.,"['Mehta Y', 'Singh R']","['Algorithms', 'Aortic Valve/*diagnostic imaging/*surgery', 'Aortic Valve Insufficiency/diagnostic imaging/*surgery', 'Aortic Valve Stenosis/*diagnostic imaging/surgery', 'Echocardiography', 'Echocardiography, Doppler', '*Echocardiography, Transesophageal', 'Endocardial Cushion Defects/diagnostic imaging/surgery', 'Heart Valve Prosthesis Implantation', 'Hemodynamics/physiology', 'Humans', 'Pulmonary Artery/surgery', 'Pulmonary Veins/abnormalities/diagnostic imaging']",https://pubmed.ncbi.nlm.nih.gov/19602746/
1532,AR,32779650,Synthesis of Ar@C(60) using molecular surgery.,"['Bloodworth S', 'Hoffman G', 'Walkey MC', 'Bacanu GR', 'Herniman JM', 'Levitt MH', 'Whitby RJ']","['Argon/*chemistry', 'Chemistry Techniques, Synthetic', 'Fullerenes/*chemistry', 'Photochemical Processes', 'Pressure']",https://pubmed.ncbi.nlm.nih.gov/32779650/
1533,AR,31313801,Total synthesis of (+)-ar-macrocarpene.,"['Khatua A', 'Niyogi S', 'Bisai V']","['Molecular Structure', 'Sesquiterpenes/*chemical synthesis/chemistry', 'Stereoisomerism']",https://pubmed.ncbi.nlm.nih.gov/31313801/
1534,AR,26687559,"Leucocontextins A-R, lanostane-type triterpenoids from Ganoderma leucocontextum.","['Zhao ZZ', 'Chen HP', 'Li ZH', 'Dong ZJ', 'Bai X', 'Zhou ZY', 'Feng T', 'Liu JK']","['Fruiting Bodies, Fungal/chemistry', 'Ganoderma/*chemistry', 'Humans', 'K562 Cells', 'MCF-7 Cells', 'Molecular Structure', 'Triterpenes/*chemistry/isolation & purification']",https://pubmed.ncbi.nlm.nih.gov/26687559/
1535,AR,39495177,"Unearthing a Prostate Cancer cfDNA Signature that ""Stems"" from AR Alterations.","['Nawfal R', 'El Hajj Chehade R', 'Berchuck JE']","['Humans', 'Male', '*Prostatic Neoplasms/genetics/pathology/blood/diagnosis', '*Receptors, Androgen/genetics', '*Biomarkers, Tumor/genetics', 'Cell-Free Nucleic Acids/genetics/blood', 'Prognosis', 'Liquid Biopsy/methods', 'Mutation', 'Circulating Tumor DNA/genetics/blood']",https://pubmed.ncbi.nlm.nih.gov/39495177/
1536,AR,36060957,Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.,"['Jaiswal B', 'Agarwal A', 'Gupta A']","['Acetylation', 'Androgens', 'Histone Acetyltransferases/genetics/metabolism', 'Humans', '*Lysine Acetyltransferases/metabolism', 'Male', '*Prostatic Neoplasms/metabolism/pathology', '*Receptors, Androgen/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36060957/
1537,CHRNB3,24675634,Variants near CHRNB3-CHRNA6 are associated with DSM-5 cocaine use disorder: evidence for pleiotropy.,"['Sadler B', 'Haller G', 'Agrawal A', 'Culverhouse R', 'Bucholz K', 'Brooks A', 'Tischfield J', 'Johnson EO', 'Edenberg H', 'Schuckit M', 'Saccone N', 'Bierut L', 'Goate A']","['Alleles', 'Bipolar Disorder/genetics', 'Cocaine-Related Disorders/*diagnosis/*genetics', 'Gene Frequency', '*Genetic Association Studies', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Odds Ratio', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/24675634/
1538,CHRNB3,22524403,CHRNB3 is more strongly associated with Fagerstrom test for cigarette dependence-based nicotine dependence than cigarettes per day: phenotype definition changes genome-wide association studies results.,"['Rice JP', 'Hartz SM', 'Agrawal A', 'Almasy L', 'Bennett S', 'Breslau N', 'Bucholz KK', 'Doheny KF', 'Edenberg HJ', 'Goate AM', 'Hesselbrock V', 'Howells WB', 'Johnson EO', 'Kramer J', 'Krueger RF', 'Kuperman S', 'Laurie C', 'Manolio TA', 'Neuman RJ', 'Nurnberger JI', 'Porjesz B', 'Pugh E', 'Ramos EM', 'Saccone N', 'Saccone S', 'Schuckit M', 'Bierut LJ']","['Adult', 'Aged', 'Case-Control Studies', 'Chromosomes, Human, Pair 8/*genetics', 'Female', 'Genetic Loci/*genetics', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Phenotype', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Nicotinic/*genetics', 'Tobacco Products', 'Tobacco Use Disorder/diagnosis/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22524403/
1539,CHRNB3,27085880,Evidence for Association Between Low Frequency Variants in CHRNA6/CHRNB3 and Antisocial Drug Dependence.,"['Kamens HM', 'Corley RP', 'Richmond PA', 'Darlington TM', 'Dowell R', 'Hopfer CJ', 'Stallings MC', 'Hewitt JK', 'Brown SA', 'Ehringer MA']","['Adolescent', 'Antisocial Personality Disorder', 'Female', 'Gene Frequency/*genetics', '*Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans', 'Male', 'Quality Control', 'Receptors, Nicotinic/*genetics', 'Software', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27085880/
1540,CHRNB3,24057674,Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependence.,"['Haller G', 'Kapoor M', 'Budde J', 'Xuei X', 'Edenberg H', 'Nurnberger J', 'Kramer J', 'Brooks A', 'Tischfield J', 'Almasy L', 'Agrawal A', 'Bucholz K', 'Rice J', 'Saccone N', 'Bierut L', 'Goate A']","['Black or African American/genetics', 'Case-Control Studies', 'Cocaine-Related Disorders/*genetics', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Humans', 'Nerve Tissue Proteins/genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/24057674/
1541,CHRNB3,19500157,SNPs in CHRNA6 and CHRNB3 are associated with alcohol consumption in a nationally representative sample.,"['Hoft NR', 'Corley RP', 'McQueen MB', 'Huizinga D', 'Menard S', 'Ehringer MA']","['Adult', 'Alcohol Drinking/*genetics/metabolism/psychology', 'Alcohol-Induced Disorders, Nervous System/genetics/metabolism/psychology', 'Brain Chemistry/drug effects/genetics', 'Cohort Studies', 'Female', 'Genetic Predisposition to Disease/*genetics/psychology', 'Humans', 'Male', 'Phenotype', 'Polymorphism, Single Nucleotide/drug effects/*genetics', 'Receptors, Nicotinic/*genetics', 'United States']",https://pubmed.ncbi.nlm.nih.gov/19500157/
1542,CHRNB3,24731518,CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking.,"['Bar-Shira A', 'Gana-Weisz M', 'Gan-Or Z', 'Giladi E', 'Giladi N', 'Orr-Urtreger A']","['Aged', 'Corpus Striatum/metabolism', 'Female', 'Gene Frequency/*genetics', '*Genetic Association Studies', 'Genotype', 'Heterozygote', 'Humans', 'Male', 'Middle Aged', 'Nicotine/therapeutic use', 'Octamer Transcription Factor-1', 'Parkinson Disease/drug therapy/*genetics', 'Promoter Regions, Genetic/*genetics', 'Receptors, Nicotinic/deficiency/*genetics', 'Smoking/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24731518/
1543,CHRNB3,28851948,Significant association of the CHRNB3-CHRNA6 gene cluster with nicotine dependence in the Chinese Han population.,"['Wen L', 'Han H', 'Liu Q', 'Su K', 'Yang Z', 'Cui W', 'Yuan W', 'Ma Y', 'Fan R', 'Chen J', 'Jiang K', 'Jiang X', 'Payne TJ', 'Wang J', 'Li MD']","['Adult', 'Asian People', 'Humans', 'Male', 'Middle Aged', '*Multigene Family', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28851948/
1544,CHRNB3,24792900,Combined effect between CHRNB3-CHRNA6 region gene variant (rs6474412) and smoking in psoriasis vulgaris severity.,"['Zhu KJ', 'Quan C', 'Zhang C', 'Liu Z', 'Liu H', 'Li M', 'Li SJ', 'Zhu CY', 'Shi G', 'Li KS', 'Fan YM']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Alcohol Drinking/adverse effects', 'Asian People/genetics', 'Body Mass Index', 'Case-Control Studies', 'China', 'Disease Progression', 'Environmental Exposure', 'Female', 'Gene-Environment Interaction', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Hospitalization', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Psoriasis/etiology/*genetics', 'Receptors, Nicotinic/*genetics', 'Risk Factors', '*Severity of Illness Index', 'Smoking/adverse effects/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24792900/
1545,CHRNB3,25823894,A genetic variant in CHRNB3-CHRNA6 increases risk of esophageal squamous cell carcinoma in Chinese populations.,"['Song Y', 'Wang Y', 'Xu L', 'Ma J', 'Chen E', 'Zang R', 'Jia W', 'Tao X', 'Hu L']","['Biomarkers, Tumor/*genetics', 'Carcinoma, Squamous Cell/epidemiology/*genetics/pathology', 'Case-Control Studies', 'China/epidemiology', 'Esophageal Neoplasms/epidemiology/*genetics/pathology', 'Female', 'Follow-Up Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Polymorphism, Single Nucleotide/*genetics', 'Prognosis', 'ROC Curve', 'Receptors, Nicotinic/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/25823894/
1546,CHRNB3,24401102,Multiple distinct CHRNB3-CHRNA6 variants are genetic risk factors for nicotine dependence in African Americans and European Americans.,"['Culverhouse RC', 'Johnson EO', 'Breslau N', 'Hatsukami DK', 'Sadler B', 'Brooks AI', 'Hesselbrock VM', 'Schuckit MA', 'Tischfield JA', 'Goate AM', 'Saccone NL', 'Bierut LJ']","['Adolescent', 'Adult', 'Black or African American/*genetics', 'Aged', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics', 'White People/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24401102/
1547,CHRNB3,18704094,Genetic association of the CHRNA6 and CHRNB3 genes with tobacco dependence in a nationally representative sample.,"['Hoft NR', 'Corley RP', 'McQueen MB', 'Schlaepfer IR', 'Huizinga D', 'Ehringer MA']","['Adolescent', 'Adult', 'Child', 'Data Collection', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Longitudinal Studies', 'Male', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Racial Groups/genetics', 'Receptors, Nicotinic/*genetics', 'Siblings', 'Smoking Cessation', 'Tobacco Use Disorder/*genetics', 'United States']",https://pubmed.ncbi.nlm.nih.gov/18704094/
1548,CHRNB3,20418888,Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.,"['Thorgeirsson TE', 'Gudbjartsson DF', 'Surakka I', 'Vink JM', 'Amin N', 'Geller F', 'Sulem P', 'Rafnar T', 'Esko T', 'Walter S', 'Gieger C', 'Rawal R', 'Mangino M', 'Prokopenko I', 'Magi R', 'Keskitalo K', 'Gudjonsdottir IH', 'Gretarsdottir S', 'Stefansson H', 'Thompson JR', 'Aulchenko YS', 'Nelis M', 'Aben KK', 'den Heijer M', 'Dirksen A', 'Ashraf H', 'Soranzo N', 'Valdes AM', 'Steves C', 'Uitterlinden AG', 'Hofman A', 'Tonjes A', 'Kovacs P', 'Hottenga JJ', 'Willemsen G', 'Vogelzangs N', 'Doring A', 'Dahmen N', 'Nitz B', 'Pergadia ML', 'Saez B', 'De Diego V', 'Lezcano V', 'Garcia-Prats MD', 'Ripatti S', 'Perola M', 'Kettunen J', 'Hartikainen AL', 'Pouta A', 'Laitinen J', 'Isohanni M', 'Huei-Yi S', 'Allen M', 'Krestyaninova M', 'Hall AS', 'Jones GT', 'van Rij AM', 'Mueller T', 'Dieplinger B', 'Haltmayer M', 'Jonsson S', 'Matthiasson SE', 'Oskarsson H', 'Tyrfingsson T', 'Kiemeney LA', 'Mayordomo JI', 'Lindholt JS', 'Pedersen JH', 'Franklin WA', 'Wolf H', 'Montgomery GW', 'Heath AC', 'Martin NG', 'Madden PA', 'Giegling I', 'Rujescu D', 'Jarvelin MR', 'Salomaa V', 'Stumvoll M', 'Spector TD', 'Wichmann HE', 'Metspalu A', 'Samani NJ', 'Penninx BW', 'Oostra BA', 'Boomsma DI', 'Tiemeier H', 'van Duijn CM', 'Kaprio J', 'Gulcher JR', 'McCarthy MI', 'Peltonen L', 'Thorsteinsdottir U', 'Stefansson K']","['Alleles', 'Aryl Hydrocarbon Hydroxylases/*genetics', 'Cohort Studies', 'Cytochrome P-450 CYP2A6', 'Female', '*Genetic Variation', 'Genome-Wide Association Study', 'Genomics', 'Humans', 'Lung Neoplasms/genetics', 'Male', 'Odds Ratio', 'Phenotype', 'Receptors, Nicotinic/*genetics', 'Smoking/*genetics', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/20418888/
1549,CHRNB3,18055561,The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco.,"['Zeiger JS', 'Haberstick BC', 'Schlaepfer I', 'Collins AC', 'Corley RP', 'Crowley TJ', 'Hewitt JK', 'Hopfer CJ', 'Lessem J', 'McQueen MB', 'Rhee SH', 'Ehringer MA']","['Adolescent', 'Adult', 'Black or African American/statistics & numerical data', 'Alcoholism/genetics', 'Alleles', 'Data Interpretation, Statistical', 'Female', 'Gene Frequency', 'Genetic Markers', 'Genetic Variation', 'Haplotypes', 'Hispanic or Latino/statistics & numerical data', 'Humans', 'Linear Models', 'Male', 'Nerve Tissue Proteins/*genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Siblings', 'Smoking/genetics', 'Tobacco Use Disorder/*genetics', 'White People/statistics & numerical data']",https://pubmed.ncbi.nlm.nih.gov/18055561/
1550,CHRNB3,27050379,Genetic variants of CHRNA5-A3 and CHRNB3-A6 predict survival of patients with advanced non-small cell lung cancer.,"['Wang Y', 'Peng X', 'Zhu L', 'Hu L', 'Song Y']","['Adult', 'Aged', 'Aged, 80 and over', 'Asian People/genetics', 'Carcinoma, Non-Small-Cell Lung/*genetics/mortality', 'Disease-Free Survival', 'Female', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Kaplan-Meier Estimate', 'Lung Neoplasms/*genetics/mortality', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', 'Polymorphism, Single Nucleotide', 'Proportional Hazards Models', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27050379/
1551,CHRNB4,25172267,Unmethylation of the CHRNB4 gene is an unfavorable prognostic factor in non-small cell lung cancer.,"['Yoo SS', 'Lee SM', 'Do SK', 'Lee WK', 'Kim DS', 'Park JY']","['Adult', 'Aged', 'Carcinoma, Non-Small-Cell Lung/*genetics/*mortality/pathology', 'Cell Line, Tumor', 'CpG Islands', '*DNA Methylation', 'Female', 'Humans', 'Lung Neoplasms/*genetics/*mortality/pathology', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Nerve Tissue Proteins/*genetics', 'Patient Outcome Assessment', 'Polymorphism, Single Nucleotide', 'Prognosis', 'Receptors, Nicotinic/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/25172267/
1552,CHRNB4,38862938,"Investigating CHRNA5, CHRNA3, and CHRNB4 variants in the genetic landscape of substance use disorder in Jordan.","['Al-Eitan L', 'Shatnawi M', 'Alghamdi M']","['Humans', 'Male', 'Young Adult', 'Adult', '*Substance-Related Disorders/genetics', '*Receptors, Nicotinic/genetics', '*Nerve Tissue Proteins/genetics', 'Polymorphism, Genetic', 'Alleles', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/38862938/
1553,CHRNB4,27758088,"The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.","['Barrie ES', 'Hartmann K', 'Lee SH', 'Frater JT', 'Seweryn M', 'Wang D', 'Sadee W']","['Computational Biology/methods', 'Databases, Genetic', 'Enhancer Elements, Genetic', 'Gene Expression', '*Gene Expression Regulation', 'Genetic Association Studies/methods', 'Genetic Linkage', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genomics/methods', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Multigene Family', 'Nerve Tissue Proteins/*genetics', 'Organ Specificity/genetics', 'Polymorphism, Single Nucleotide', 'Quantitative Trait Loci', 'Receptors, Nicotinic/*genetics', 'Regulatory Sequences, Nucleic Acid', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/27758088/
1554,CHRNB4,23691088,Alternative CHRNB4 3'-UTRs mediate the allelic effects of SNP rs1948 on gene expression.,"['Gallego X', 'Cox RJ', 'Laughlin JR', 'Stitzel JA', 'Ehringer MA']","[""3' Untranslated Regions/*genetics"", '*Alleles', 'Base Sequence', 'Cell Line, Tumor', 'Gene Expression Regulation/*genetics', 'Humans', 'Luciferases/genetics', 'MicroRNAs/genetics', 'Nerve Tissue Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23691088/
1555,CHRNB4,30882151,Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.,"['Culverhouse RC', 'Chen LS', 'Saccone NL', 'Ma Y', 'Piper ME', 'Baker TB', 'Bierut LJ']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Bupropion/adverse effects', 'Chromosomes, Human, Pair 15/*genetics', 'Female', 'Gastrointestinal Diseases/chemically induced/*genetics', 'Genetic Variation/genetics', 'Humans', 'Male', 'Middle Aged', 'Multigene Family/genetics', 'Nerve Tissue Proteins/*genetics', 'Predictive Value of Tests', 'Receptors, Nicotinic/*genetics', 'Smoking Cessation/methods', 'Smoking Cessation Agents/*adverse effects', 'Tobacco Use/*genetics/therapy', 'Varenicline/adverse effects', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30882151/
1556,CHRNB4,19859904,Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.,"['Li MD', 'Xu Q', 'Lou XY', 'Payne TJ', 'Niu T', 'Ma JZ']","['Black or African American/ethnology/*genetics', 'Gene Frequency/genetics', '*Genetic Predisposition to Disease', 'Haplotypes/genetics', 'Humans', 'Linkage Disequilibrium/genetics', 'Models, Genetic', 'Multigene Family/genetics', 'Nerve Tissue Proteins/genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*ethnology/*genetics', 'White People/ethnology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/19859904/
1557,CHRNB4,22042774,Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence.,"['Haller G', 'Druley T', 'Vallania FL', 'Mitra RD', 'Li P', 'Akk G', 'Steinbach JH', 'Breslau N', 'Johnson E', 'Hatsukami D', 'Stitzel J', 'Bierut LJ', 'Goate AM']","['Adult', 'Black or African American/genetics', 'Female', 'HEK293 Cells', 'Humans', 'Male', 'Nerve Tissue Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Risk', 'Tobacco Use Disorder/ethnology/*genetics', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/22042774/
1558,CHRNB4,21228559,"An exploratory study on the CHRNA3-CHRNA5-CHRNB4 cluster, smoking, and Parkinson's disease.","['Gao J', 'Xu H', 'Weinberg C', 'Huang X', 'Park Y', 'Hollenbeck A', 'Blair A', 'Schatzkin A', 'Burch L', 'Chen H']","['Case-Control Studies', 'Cohort Studies', 'Follow-Up Studies', 'Genetic Variation/genetics', 'Humans', 'Multigene Family/*genetics', 'Nerve Tissue Proteins/*genetics', 'Parkinson Disease/etiology/*genetics/prevention & control', 'Polymorphism, Single Nucleotide/*genetics', 'Prospective Studies', 'Receptors, Nicotinic/*genetics', 'Smoking/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21228559/
1559,CHRNB4,26942719,Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.,"['Zhang Y', 'Jiang M', 'Li Q', 'Liang W', 'He Q', 'Chen W', 'He J']","['Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Asian People/genetics', 'Case-Control Studies', 'China', 'Chromosomes, Human, Pair 15/*genetics', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Humans', 'Lung Neoplasms/ethnology/*genetics', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26942719/
1560,CHRNB4,21747048,Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.,"['Wassenaar CA', 'Dong Q', 'Wei Q', 'Amos CI', 'Spitz MR', 'Tyndale RF']","['Adult', 'Aged', 'Aryl Hydrocarbon Hydroxylases/*genetics', 'Confounding Factors, Epidemiologic', 'Cytochrome P-450 CYP2A6', 'Female', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Genotype', 'Humans', 'Lung Neoplasms/*etiology/genetics', 'Male', 'Middle Aged', 'Multigene Family', 'Nerve Tissue Proteins/*genetics', 'Nitrosamines/metabolism', 'Receptors, Nicotinic/*genetics', 'Risk Assessment', 'Risk Factors', 'Smoking/*adverse effects/*genetics', 'Surveys and Questionnaires', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21747048/
1561,CHRNB4,29666375,"Association and cis-mQTL analysis of variants in CHRNA3-A5, CHRNA7, CHRNB2, and CHRNB4 in relation to nicotine dependence in a Chinese Han population.","['Liu Q', 'Han H', 'Wang M', 'Yao Y', 'Wen L', 'Jiang K', 'Ma Y', 'Fan R', 'Chen J', 'Su K', 'Yang Z', 'Cui W', 'Yuan W', 'Jiang X', 'Li J', 'Payne TJ', 'Wang J', 'Li MD']","['Adult', 'Asian People/*genetics', 'China', 'DNA Methylation', 'Genetic Association Studies', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Nerve Tissue Proteins/genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics', 'alpha7 Nicotinic Acetylcholine Receptor/genetics']",https://pubmed.ncbi.nlm.nih.gov/29666375/
1562,CHRNB4,20631687,Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility.,"['Zhang H', 'Kranzler HR', 'Poling J', 'Gelernter J']","['Adult', 'Black or African American/genetics', 'Cognition/*physiology', 'Genetic Variation/genetics', 'Humans', 'Male', 'Middle Aged', 'Multigene Family/*genetics', 'Nerve Tissue Proteins/*genetics', 'Neuropsychological Tests', 'Receptors, Nicotinic/*genetics', 'Smoking/*genetics/psychology', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/20631687/
1563,CHRNB4,22945651,Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.,"['Scherf DB', 'Sarkisyan N', 'Jacobsson H', 'Claus R', 'Bermejo JL', 'Peil B', 'Gu L', 'Muley T', 'Meister M', 'Dienemann H', 'Plass C', 'Risch A']","['Azacitidine/analogs & derivatives/pharmacology', 'Carcinoma, Non-Small-Cell Lung/genetics/*pathology', 'Cell Line, Tumor', 'Cell Proliferation/drug effects', 'DNA Methylation/drug effects/*genetics', 'Decitabine', 'Epigenesis, Genetic/drug effects/*genetics', 'Gene Expression Regulation, Neoplastic/drug effects', 'Gene Knockdown Techniques', 'Genetic Predisposition to Disease/genetics', '*Genotype', 'Humans', 'Lung Neoplasms/genetics/*pathology', 'Nerve Tissue Proteins/deficiency/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Promoter Regions, Genetic/drug effects/*genetics', 'Receptors, Nicotinic/deficiency/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22945651/
1564,CHRNB4,11450844,Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4.,"['Lev-Lehman E', 'Bercovich D', 'Xu W', 'Stockton DW', 'Beaudet AL']","['Autonomic Nervous System Diseases/*genetics/physiopathology', 'Chromosome Mapping', 'DNA Mutational Analysis', 'Exons/genetics', 'Female', 'Genetic Variation', 'Genomic Library', 'Humans', 'Introns/genetics', 'Male', 'Mutation', 'Polymorphism, Genetic/*genetics', 'Protein Subunits', 'Receptors, Nicotinic/deficiency/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11450844/
1565,CHRNB4,22648373,Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.,"['Chen LS', 'Baker TB', 'Piper ME', 'Breslau N', 'Cannon DS', 'Doheny KF', 'Gogarten SM', 'Johnson EO', 'Saccone NL', 'Wang JC', 'Weiss RB', 'Goate AM', 'Bierut LJ']","['Age Factors', 'Clinical Trials as Topic/statistics & numerical data', 'Female', 'Haplotypes', 'Humans', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking Cessation/*methods', 'Tobacco Use Disorder/drug therapy/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22648373/
1566,CHRNB4,22042234,Externalizing behaviors are associated with SNPs in the CHRNA5/CHRNA3/CHRNB4 gene cluster.,"['Stephens SH', 'Hoft NR', 'Schlaepfer IR', 'Young SE', 'Corley RC', 'McQueen MB', 'Hopfer C', 'Crowley T', 'Stallings M', 'Hewitt J', 'Ehringer MA']","['Adolescent', 'Child Behavior Disorders/*genetics/psychology', 'Family', 'Female', 'Humans', 'Linkage Disequilibrium/genetics', 'Longitudinal Studies', 'Male', 'Multigene Family/*genetics', 'Nerve Tissue Proteins/*genetics', 'Phenotype', 'Polymerase Chain Reaction', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Nicotinic/*genetics', 'Smoking/genetics/psychology', 'Substance-Related Disorders/*genetics/psychology']",https://pubmed.ncbi.nlm.nih.gov/22042234/
1567,CHRNB2,17900292,Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene.,"['Diaz-Otero F', 'Quesada M', 'Morales-Corraliza J', 'Martinez-Parra C', 'Gomez-Garre P', 'Serratosa JM']","['Adult', 'Age of Onset', 'DNA Mutational Analysis', 'Electroencephalography/statistics & numerical data', 'Epilepsy, Frontal Lobe/diagnosis/epidemiology/*genetics', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease/genetics', 'Humans', 'Male', 'Mutation/*genetics', 'Mutation, Missense/genetics', 'Pedigree', 'Phenotype', 'Receptors, Nicotinic/*genetics', 'Sequence Analysis', 'Sleep/genetics/physiology', 'Sleep Wake Disorders/diagnosis/epidemiology/genetics', 'Spain/epidemiology', 'Videotape Recording', 'Wakefulness/physiology', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/17900292/
1568,CHRNB2,10549797,Mutation screening of the CHRNA4 and CHRNB2 nicotinic cholinergic receptor genes in Alzheimer's disease.,"['Steinlein OK', 'Stoodt J', 'de Vos RA', 'Steur EN', 'Wevers A', 'Schutz U', 'Schroder H']","['Aged', 'Aged, 80 and over', 'Alzheimer Disease/*genetics/metabolism', 'Cells, Cultured', 'DNA/analysis/genetics', 'Female', 'Fibroblasts', 'Genetic Testing', 'Humans', 'Male', 'Mutation/physiology', 'Polymorphism, Genetic/genetics', 'Receptors, Nicotinic/*biosynthesis/genetics', 'Reverse Transcriptase Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/10549797/
1569,CHRNB2,39193833,"Clinical, molecular, physiologic, and therapeutic feature of patients with CHRNA4 and CHRNB2 deficiency: A systematic review.","['Jalaiei A', 'Asadi MR', 'Daneshmandpour Y', 'Rezazadeh M', 'Ghafouri-Fard S']","['Humans', '*Receptors, Nicotinic/genetics', 'Mutation/genetics', 'Neurodegenerative Diseases/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39193833/
1570,CHRNB2,15964197,The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits.,"['Bertrand D', 'Elmslie F', 'Hughes E', 'Trounce J', 'Sander T', 'Bertrand S', 'Steinlein OK']","['Acetylcholine/metabolism', 'Adolescent', 'Adult', 'Cognition Disorders/genetics/metabolism/physiopathology', 'DNA Mutational Analysis', 'Epilepsy/complications/*genetics/metabolism', 'Female', 'Frontal Lobe/*metabolism/physiopathology', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Male', 'Memory Disorders/*genetics/metabolism/physiopathology', 'Mutation/*genetics', 'Pedigree', 'Phenotype', 'Receptors, Nicotinic/*genetics', 'Synaptic Transmission/genetics']",https://pubmed.ncbi.nlm.nih.gov/15964197/
1571,CHRNB2,15026168,Candidate gene association studies of the alpha 4 (CHRNA4) and beta 2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease.,"['Cook LJ', 'Ho LW', 'Taylor AE', 'Brayne C', 'Evans JG', 'Xuereb J', 'Cairns NJ', 'Pritchard A', 'Lemmon H', 'Mann D', 'St Clair D', 'Turic D', 'Hollingworth P', 'Moore PJ', 'Jehu L', 'Archer N', 'Walter S', 'Foy C', 'Edmondson A', 'Powell J', 'Lovestone S', 'Owen MJ', 'Williams J', 'Lendon C', 'Rubinsztein DC']","['Aged', 'Alleles', 'Alzheimer Disease/*genetics', 'Chi-Square Distribution', 'Confidence Intervals', 'Female', 'Genotype', 'Humans', 'Male', 'Odds Ratio', 'Polymorphism, Genetic/*genetics', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15026168/
1572,CHRNB2,26475232,Generalized epilepsy in a family with basal ganglia calcifications and mutations in SLC20A2 and CHRNB2.,"['Fjaer R', 'Brodtkorb E', 'Oye AM', 'Sheng Y', 'Vigeland MD', 'Kvistad KA', 'Backe PH', 'Selmer KK']","['Adult', 'Amino Acid Sequence', 'Basal Ganglia/*pathology', '*Calcinosis', 'Epilepsy, Generalized/diagnosis/*genetics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Molecular Sequence Data', '*Mutation, Missense', 'Pedigree', 'Receptors, Nicotinic/*genetics', 'Sodium-Phosphate Cotransporter Proteins, Type III/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26475232/
1573,CHRNB2,32536355,Variants in CHRNB2 and CHRNA4 Identified in Patients with Insular Epilepsy.,"['Cadieux-Dion M', 'Meneghini S', 'Villa C', 'Toffa DH', 'Wickstrom R', 'Bouthillier A', 'Sandvik U', 'Gustavsson B', 'Mohamed I', 'Cossette P', 'Combi R', 'Becchetti A', 'Nguyen DK']","['Cerebral Cortex', '*Epilepsy, Frontal Lobe/genetics', 'Humans', 'Mutation, Missense', '*Receptors, Nicotinic/genetics']",https://pubmed.ncbi.nlm.nih.gov/32536355/
1574,CHRNB2,25640319,The possible role of maternal bonding style and CHRNB2 gene polymorphisms in nicotine dependence and related depressive phenotype.,"['Csala I', 'Egervari L', 'Dome P', 'Faludi G', 'Dome B', 'Lazary J']","['Adult', 'Aged', 'Analysis of Variance', '*Depression/etiology/genetics/psychology', 'Female', 'Gene-Environment Interaction', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Linear Models', 'Male', 'Middle Aged', 'Mother-Child Relations/*psychology', '*Object Attachment', 'Phenotype', 'Polymorphism, Genetic/*genetics', 'Promoter Regions, Genetic/genetics', 'Receptors, Nicotinic/*genetics', '*Tobacco Use Disorder/etiology/genetics/psychology']",https://pubmed.ncbi.nlm.nih.gov/25640319/
1575,CHRNB2,23037950,Possible association of nicotinic acetylcholine receptor gene (CHRNA4 and CHRNB2) polymorphisms with nicotine dependence in Japanese males: an exploratory study.,"['Chen HI', 'Shinkai T', 'Utsunomiya K', 'Yamada K', 'Sakata S', 'Fukunaka Y', 'Hwang R', 'De Luca V', 'Ohmori O', 'Kennedy JL', 'Chuang HY', 'Nakamura J']","['Adult', 'Alleles', 'Asian People/*genetics/psychology', 'Epistasis, Genetic/genetics', 'Genetic Predisposition to Disease/*genetics', 'Humans', 'Male', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23037950/
1576,CHRNB2,18534558,"Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence.","['Li MD', 'Lou XY', 'Chen G', 'Ma JZ', 'Elston RC']","['Adult', 'Black People/genetics', 'Brain-Derived Neurotrophic Factor/*genetics', 'Case-Control Studies', 'Epistasis, Genetic/*genetics', 'Female', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Receptor, trkB/*genetics', 'Receptors, Nicotinic/*genetics', 'Retrospective Studies', 'Tobacco Use Disorder/*genetics', 'White People/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/18534558/
1577,CHRNB2,11952766,Mutational analysis of nicotinic acetylcholine receptor beta2 subunit gene (CHRNB2) in a representative cohort of Italian probands affected by autosomal dominant nocturnal frontal lobe epilepsy.,"['Duga S', 'Asselta R', 'Bonati MT', 'Malcovati M', 'Dalpra L', 'Oldani A', 'Zucconi M', 'Ferini-Strambi L', 'Tenchini ML']","['Base Sequence/genetics', 'Cohort Studies', '*DNA Mutational Analysis', 'Epilepsy, Frontal Lobe/*genetics', '*Genes, Dominant', 'Genetic Variation', 'Humans', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11952766/
1578,CHRNB2,20854418,CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences.,"['Hoft NR', 'Stitzel JA', 'Hutchison KE', 'Ehringer MA']","['Adolescent', 'Adult', 'Cells, Cultured', 'DNA/genetics', 'Ethnicity', 'Female', 'Gene Expression/*physiology', 'Genotype', 'Humans', 'Luciferases/genetics', 'Male', 'Middle Aged', 'Nicotine/*pharmacology', 'Phenotype', 'Plasmids/genetics', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic/*genetics', 'Receptors, Nicotinic/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Sex Characteristics', 'Smoking/epidemiology/*genetics/psychology', 'Socioeconomic Factors', 'Transfection', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/20854418/
1579,CHRNB2,19755656,Nicotinic acetylcholine receptor beta2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch.,"['Perkins KA', 'Lerman C', 'Mercincavage M', 'Fonte CA', 'Briski JL']","['Administration, Cutaneous', 'Adolescent', 'Adult', 'Aged', 'Female', 'Humans', 'Male', 'Middle Aged', 'Nicotine/*administration & dosage/genetics', 'Receptors, Nicotinic/*genetics', 'Smoking/*genetics/*therapy', 'Smoking Cessation/*methods', 'Treatment Outcome', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/19755656/
1580,CHRNB2,22897520,Hippocampal sclerosis worsens autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) phenotype related to CHRNB2 mutation.,"['Labate A', 'Mumoli L', 'Fratto A', 'Quattrone A', 'Gambardella A']","['Child', 'Epilepsy, Frontal Lobe/genetics/*pathology/*physiopathology', 'Female', 'Hippocampus/*pathology/physiopathology', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', '*Mutation', 'Pedigree', 'Phenotype', 'Receptors, Nicotinic/*genetics', 'Sclerosis/*complications/pathology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/22897520/
1581,CHRNB2,9921897,The structures of the human neuronal nicotinic acetylcholine receptor beta2- and alpha3-subunit genes (CHRNB2 and CHRNA3).,"['Rempel N', 'Heyers S', 'Engels H', 'Sleegers E', 'Steinlein OK']","['Amino Acid Sequence', 'Base Sequence', 'Chromosomes, Human, Pair 1', 'DNA Mutational Analysis', 'Epilepsy, Frontal Lobe/*genetics', 'Exons', 'Humans', 'In Situ Hybridization, Fluorescence', 'Introns', 'Male', 'Molecular Sequence Data', 'Neurons', 'Polymerase Chain Reaction', 'Polymorphism, Genetic', 'Receptors, Nicotinic/*genetics', 'Sequence Analysis, DNA', 'Trinucleotide Repeats']",https://pubmed.ncbi.nlm.nih.gov/9921897/
1582,CHRNB2,37706497,Two novel variants of the STXBP1 and CHRNB2 genes identified in a Chinese boy with refractory seizures and developmental delay.,"['Wang S', 'Cui D', 'Ling X', 'Hou Y', 'Sun J']","['Humans', 'Male', '*Arthrogryposis', '*Brain Diseases', 'East Asian People', 'Munc18 Proteins/genetics', 'Seizures/genetics']",https://pubmed.ncbi.nlm.nih.gov/37706497/
1583,CHRFAM7A,31048268,Effect of donepezil on the expression and responsiveness to LPS of CHRNA7 and CHRFAM7A in macrophages: A possible link to the cholinergic anti-inflammatory pathway.,"['Maroli A', 'Di Lascio S', 'Drufuca L', 'Cardani S', 'Setten E', 'Locati M', 'Fornasari D', 'Benfante R']","['Anti-Inflammatory Agents/*pharmacology', 'Base Sequence', 'Cholinergic Agonists/*pharmacology', 'Cholinesterase Inhibitors/*pharmacology', 'Donepezil/*pharmacology', 'Down-Regulation/drug effects', 'Drug Synergism', 'Gene Expression Regulation/*drug effects', 'Humans', 'Immunologic Factors/*pharmacology', 'Lipopolysaccharides/*pharmacology', 'Macrophages/*drug effects/metabolism', 'Monocytes/drug effects/metabolism', 'Neuroimmunomodulation/*drug effects', 'Protein Isoforms/genetics', 'Regulatory Sequences, Nucleic Acid', 'THP-1 Cells', 'Transcription, Genetic/drug effects', 'alpha7 Nicotinic Acetylcholine Receptor/*biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/31048268/
1584,CHRFAM7A,37164281,Unanswered questions in the regulation and function of the duplicated alpha7 nicotinic receptor gene CHRFAM7A.,"['Leonard S', 'Benfante R']","['Humans', 'DNA Copy Number Variations', 'alpha7 Nicotinic Acetylcholine Receptor/genetics/metabolism', '*Mental Disorders', 'Cognition', 'Mutation', '*Receptors, Nicotinic/genetics']",https://pubmed.ncbi.nlm.nih.gov/37164281/
1585,CHRFAM7A,33405023,CHRFAM7A Overexpression Attenuates Cerebral Ischemia-Reperfusion Injury via Inhibiting Microglia Pyroptosis Mediated by the NLRP3/Caspase-1 pathway.,"['Cao X', 'Wang Y', 'Gao L']","['Brain/*enzymology/pathology', 'Brain Ischemia/*enzymology/genetics/pathology', 'Case-Control Studies', 'Caspase 1/genetics/*metabolism', 'Cell Line', 'Cell Proliferation', 'Cytokines/genetics/metabolism', 'Female', 'Humans', 'Male', 'Microglia/*enzymology/pathology', 'NLR Family, Pyrin Domain-Containing 3 Protein/genetics/*metabolism', 'Phenotype', '*Pyroptosis', 'Reperfusion Injury/*enzymology/genetics/pathology', 'Signal Transduction', 'Up-Regulation', 'alpha7 Nicotinic Acetylcholine Receptor/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/33405023/
1586,CHRFAM7A,38569318,CHRFAM7A diversifies human immune adaption through Ca(2+) signalling and actin cytoskeleton reorganization.,"['Szigeti K', 'Ihnatovych I', 'Notari E', 'Dorn RP', 'Maly I', 'He M', 'Birkaya B', 'Prasad S', 'Byrne RS', 'Indurthi DC', 'Nimmer E', 'Heo Y', 'Retfalvi K', 'Chaves L', 'Sule N', 'Hofmann WA', 'Auerbach A', 'Wilding G', 'Bae Y', 'Reynolds J']","['Humans', '*Actin Cytoskeleton/metabolism', '*alpha7 Nicotinic Acetylcholine Receptor/metabolism/genetics', 'Calcium/metabolism', '*Calcium Signaling', 'Immunity, Innate', '*Induced Pluripotent Stem Cells/metabolism/cytology', 'Monocytes/metabolism', 'Phagocytosis', 'rac1 GTP-Binding Protein/metabolism/genetics']",https://pubmed.ncbi.nlm.nih.gov/38569318/
1587,CHRFAM7A,20926142,Expression of the alpha7 nAChR subunit duplicate form (CHRFAM7A) is down-regulated in the monocytic cell line THP-1 on treatment with LPS.,"['Benfante R', 'Antonini RA', 'De Pizzol M', 'Gotti C', 'Clementi F', 'Locati M', 'Fornasari D']","['Cell Line', 'Down-Regulation', 'Enzyme-Linked Immunosorbent Assay', 'Gene Expression Regulation/*immunology', 'Genes, Duplicate', 'Humans', 'Immunoblotting', 'Inflammation/chemically induced/*genetics', 'Lipopolysaccharides/adverse effects/immunology', 'Monocytes/*immunology/metabolism', 'Protein Isoforms/biosynthesis/genetics', 'Receptors, Nicotinic/*biosynthesis/genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Transcription, Genetic', 'alpha7 Nicotinic Acetylcholine Receptor']",https://pubmed.ncbi.nlm.nih.gov/20926142/
1588,CHRFAM7A,35408823,"The Human-Restricted Isoform of the alpha7 nAChR, CHRFAM7A: A Double-Edged Sword in Neurological and Inflammatory Disorders.","['Di Lascio S', 'Fornasari D', 'Benfante R']","['Binding Sites', '*Genes, Duplicate', 'Humans', '*Inflammation/genetics/metabolism', '*Neurodegenerative Diseases/genetics/metabolism', 'Neurons/metabolism', 'Protein Isoforms/metabolism', '*alpha7 Nicotinic Acetylcholine Receptor/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35408823/
1589,CHRFAM7A,30089821,Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment.,"['Cameli C', 'Bacchelli E', 'De Paola M', 'Giucastro G', 'Cifiello S', 'Collo G', 'Cainazzo MM', 'Pini LA', 'Maestrini E', 'Zoli M']","['Adolescent', 'Adult', 'Aged', '*DNA Copy Number Variations', 'Drug Resistance/genetics', 'Female', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Smoking Cessation Agents/*therapeutic use', 'Tobacco Use Disorder/drug therapy/*genetics', 'Varenicline/*therapeutic use', 'alpha7 Nicotinic Acetylcholine Receptor/*genetics']",https://pubmed.ncbi.nlm.nih.gov/30089821/
1590,CHRFAM7A,29305655,CHRFAM7A gene expression in schizophrenia: clinical correlates and the effect of antipsychotic treatment.,"['Kalmady SV', 'Agrawal R', 'Venugopal D', 'Shivakumar V', 'Amaresha AC', 'Agarwal SM', 'Subbanna M', 'Rajasekaran A', 'Narayanaswamy JC', 'Debnath M', 'Venkatasubramanian G']","['Adult', 'Antipsychotic Agents/*therapeutic use', 'Female', 'Gene Expression/*drug effects', 'Humans', 'Male', 'Schizophrenia/*drug therapy/*genetics', 'alpha7 Nicotinic Acetylcholine Receptor/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29305655/
1591,CHRFAM7A,26206074,CHRNA7 and CHRFAM7A mRNAs: co-localized and their expression levels altered in the postmortem dorsolateral prefrontal cortex in major psychiatric disorders.,"['Kunii Y', 'Zhang W', 'Xu Q', 'Hyde TM', 'McFadden W', 'Shin JH', 'Deep-Soboslay A', 'Ye T', 'Li C', 'Kleinman JE', 'Wang KH', 'Lipska BK']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Bipolar Disorder/*genetics/metabolism', 'Case-Control Studies', 'Depressive Disorder, Major/*genetics/metabolism', 'Female', 'Fetus/*metabolism', 'Gene Expression', 'Humans', 'In Situ Hybridization, Fluorescence', 'Male', 'Middle Aged', 'Prefrontal Cortex/*metabolism', 'RNA, Messenger/*metabolism', 'Real-Time Polymerase Chain Reaction', 'Reverse Transcriptase Polymerase Chain Reaction', 'Schizophrenia/*genetics/metabolism', 'Young Adult', 'alpha7 Nicotinic Acetylcholine Receptor/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26206074/
1592,CHRFAM7A,25473097,"CHRFAM7A, a human-specific and partially duplicated alpha7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury.","['Costantini TW', 'Dang X', 'Coimbra R', 'Eliceiri BP', 'Baird A']","['Drug Design', 'Gene Duplication/*immunology', 'Gene Expression Regulation/immunology', 'Humans', 'Infections/drug therapy/genetics/*immunology/pathology', 'Inflammation/genetics/immunology/pathology', 'Ion Channel Gating/*immunology', 'Leukocytes/*immunology/pathology', 'RNA, Messenger/genetics/immunology', 'alpha7 Nicotinic Acetylcholine Receptor/genetics/*immunology']",https://pubmed.ncbi.nlm.nih.gov/25473097/
1593,CHRFAM7A,19149910,CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance.,"['Petrovsky N', 'Schmechtig A', 'Flomen RH', 'Kumari V', 'Collier D', 'Makoff A', 'Wagner M', 'Ettinger U']","['Adult', 'Analysis of Variance', 'Electrooculography/methods', 'Female', 'Genotype', 'Humans', 'Male', 'Personality/genetics', 'Polymorphism, Genetic/*genetics', 'Problem Solving/*physiology', 'Receptors, Nicotinic/*genetics', 'Saccades/*genetics', 'Sequence Deletion/*genetics', 'Surveys and Questionnaires', 'Young Adult', 'alpha7 Nicotinic Acetylcholine Receptor']",https://pubmed.ncbi.nlm.nih.gov/19149910/
1594,CHRNA5,32049419,CHRNA5 rs16969968 polymorphism is associated with lung cancer risk: A meta-analysis.,"['Zhou W', 'Zhu W', 'Tong X', 'Ming S', 'Ding Y', 'Li Y', 'Li Y']","['Alleles', 'Asian People/genetics', 'Case-Control Studies', 'Genetic Predisposition to Disease/*genetics', 'Genome-Wide Association Study/methods', 'Genotype', 'Humans', 'Lung Neoplasms/*genetics', 'Nerve Tissue Proteins/*genetics', 'Odds Ratio', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking/epidemiology/trends', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/32049419/
1595,CHRNA5,33578531,The relationship between CHRNA5/A3/B4 gene cluster polymorphisms and lung cancer risk: An updated meta-analysis and systematic review.,"['Yi X', 'Li W', 'Wang Y', 'Chen X', 'Ye F', 'Sun G', 'Chen J']","['Genetic Predisposition to Disease/*genetics', 'Humans', 'Lung Neoplasms/etiology/*genetics', 'Multigene Family/genetics', 'Nerve Tissue Proteins/*genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Receptors, Nicotinic/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/33578531/
1596,CHRNA5,29609626,CHRNA5 and CHRNA3 polymorphism and lung cancer susceptibility in Palestinian population.,"['Ayesh BM', 'Al-Masri R', 'Abed AA']","['Aged', 'Aged, 80 and over', 'Alleles', 'Arabs/genetics', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Lung Neoplasms/*genetics', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Smoking']",https://pubmed.ncbi.nlm.nih.gov/29609626/
1597,CHRNA5,36078193,Association of Polymorphism CHRNA5 and CHRNA3 Gene in People Addicted to Nicotine.,"['Chmielowiec K', 'Chmielowiec J', 'Stronska-Pluta A', 'Trybek G', 'Smiarowska M', 'Suchanecka A', 'Wozniak G', 'Jaron A', 'Grzywacz A']","['Genetic Predisposition to Disease', 'Humans', 'Nerve Tissue Proteins/genetics', 'Nicotine', 'Polymorphism, Single Nucleotide', '*Receptors, Nicotinic/genetics', '*Tobacco Use Disorder/epidemiology/genetics']",https://pubmed.ncbi.nlm.nih.gov/36078193/
1598,CHRNA5,25873736,CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.,"['Chen LS', 'Hung RJ', 'Baker T', 'Horton A', 'Culverhouse R', 'Saccone N', 'Cheng I', 'Deng B', 'Han Y', 'Hansen HM', 'Horsman J', 'Kim C', 'Lutz S', 'Rosenberger A', 'Aben KK', 'Andrew AS', 'Breslau N', 'Chang SC', 'Dieffenbach AK', 'Dienemann H', 'Frederiksen B', 'Han J', 'Hatsukami DK', 'Johnson EO', 'Pande M', 'Wrensch MR', 'McLaughlin J', 'Skaug V', 'van der Heijden HF', 'Wampfler J', 'Wenzlaff A', 'Woll P', 'Zienolddiny S', 'Bickeboller H', 'Brenner H', 'Duell EJ', 'Haugen A', 'Heinrich J', 'Hokanson JE', 'Hunter DJ', 'Kiemeney LA', 'Lazarus P', 'Le Marchand L', 'Liu G', 'Mayordomo J', 'Risch A', 'Schwartz AG', 'Teare D', 'Wu X', 'Wiencke JK', 'Yang P', 'Zhang ZF', 'Spitz MR', 'Kraft P', 'Amos CI', 'Bierut LJ']","['Genetic Variation', 'Humans', 'Lung Neoplasms/*diagnosis/*etiology/genetics', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', 'Phenotype', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking/adverse effects/*genetics', '*Smoking Cessation/statistics & numerical data', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/25873736/
1599,CHRNA5,36794842,CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women.,"['Jones SK', 'Alberg AJ', 'Wallace K', 'Froeliger B', 'Carpenter MJ', 'Wolf BJ']","['Humans', 'Female', 'Adult', '*Smoking Cessation/methods', 'Longitudinal Studies', 'Cross-Sectional Studies', '*Receptors, Nicotinic/genetics', 'Nerve Tissue Proteins/genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D2/genetics']",https://pubmed.ncbi.nlm.nih.gov/36794842/
1600,CHRNA5,22071378,Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis.,"['Ware JJ', 'van den Bree MB', 'Munafo MR']","['Female', 'Genetic Predisposition to Disease', 'Humans', 'Linkage Disequilibrium', 'Lung Neoplasms/genetics', 'Male', '*Multigene Family/genetics', 'Nerve Tissue Proteins/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Receptors, Nicotinic/*genetics', 'Smoking/*genetics', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/22071378/
1601,CHRNA5,26434895,"CHRNA5 rs16969968 Polymorphism Association with Risk of Lung Cancer--Evidence from 17,962 Lung Cancer Cases and 77,216 Control Subjects.","['Xu ZW', 'Wang GN', 'Dong ZZ', 'Li TH', 'Cao C', 'Jin YH']","['Asian People/*genetics', 'Case-Control Studies', 'Humans', 'Lung Neoplasms/*genetics', 'Nerve Tissue Proteins/*genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking', 'White People/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26434895/
1602,CHRNA5,27355804,SNPs in NRXN1 and CHRNA5 are associated to smoking and regulation of GABAergic and glutamatergic pathways.,"['Perez-Rubio G', 'Perez-Rodriguez ME', 'Fernandez-Lopez JC', 'Ramirez-Venegas A', 'Garcia-Colunga J', 'Avila-Moreno F', 'Camarena A', 'Sansores RH', 'Falfan-Valencia R']","['Adult', 'Aged', 'Calcium-Binding Proteins', 'Cell Adhesion Molecules, Neuronal/*genetics', 'Cross-Sectional Studies', 'Female', 'Genetic Association Studies/methods', 'Humans', 'Male', 'Mexico/epidemiology', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', 'Neural Cell Adhesion Molecules', 'Polymorphism, Single Nucleotide/*genetics', 'Principal Component Analysis/methods', 'Receptors, GABA/*physiology', 'Receptors, Glutamate/*physiology', 'Receptors, Nicotinic/*genetics', 'Smoking/epidemiology/*genetics/therapy', 'Smoking Cessation/methods']",https://pubmed.ncbi.nlm.nih.gov/27355804/
1603,CHRNA5,33469842,CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.,"['Shehwana H', 'Keskus AG', 'Ozdemir SE', 'Acikgoz AA', 'Biyik-Sit R', 'Cagnan I', 'Gunes D', 'Jahja E', 'Cingir-Koker S', 'Olmezer G', 'Sucularli C', 'Konu O']","['Breast Neoplasms/genetics/*metabolism/pathology', 'Cell Line, Tumor', 'Estrogen Receptor alpha/metabolism', 'Estrogens/*metabolism/pharmacology', 'Female', 'Gene Expression Regulation, Neoplastic/drug effects', 'Gene Regulatory Networks', 'Humans', 'Nerve Tissue Proteins/genetics/*metabolism', 'Prognosis', 'RNA, Small Interfering/metabolism', 'Receptors, Estrogen/metabolism', 'Receptors, Nicotinic/genetics/*metabolism', '*Signal Transduction/drug effects', 'Transcription Factors/metabolism', 'Up-Regulation/drug effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/33469842/
1604,CHRNA3,27029810,Variants near CHRNA3/5 and APOE have age- and sex-related effects on human lifespan.,"['Joshi PK', 'Fischer K', 'Schraut KE', 'Campbell H', 'Esko T', 'Wilson JF']","['Adult', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Apolipoproteins E/*genetics/physiology', 'Cohort Studies', 'Female', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Longevity/*genetics', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics/physiology', 'Proportional Hazards Models', 'Receptors, Nicotinic/*genetics/physiology', 'Sex Factors', 'United Kingdom']",https://pubmed.ncbi.nlm.nih.gov/27029810/
1605,CHRNA3,9921897,The structures of the human neuronal nicotinic acetylcholine receptor beta2- and alpha3-subunit genes (CHRNB2 and CHRNA3).,"['Rempel N', 'Heyers S', 'Engels H', 'Sleegers E', 'Steinlein OK']","['Amino Acid Sequence', 'Base Sequence', 'Chromosomes, Human, Pair 1', 'DNA Mutational Analysis', 'Epilepsy, Frontal Lobe/*genetics', 'Exons', 'Humans', 'In Situ Hybridization, Fluorescence', 'Introns', 'Male', 'Molecular Sequence Data', 'Neurons', 'Polymerase Chain Reaction', 'Polymorphism, Genetic', 'Receptors, Nicotinic/*genetics', 'Sequence Analysis, DNA', 'Trinucleotide Repeats']",https://pubmed.ncbi.nlm.nih.gov/9921897/
1606,CHRNA3,10923651,Refined mapping of CHRNA3/A5/B4 gene cluster and its implications in ADNFLE.,"['Bonati MT', 'Asselta R', 'Duga S', 'Ferini-Strambi L', 'Oldani A', 'Zucconi M', 'Malcovati M', 'Dalpra L', 'Tenchini ML']","['Chromosome Mapping', '*Chromosomes, Human, Pair 15', 'Circadian Rhythm', 'Consanguinity', 'Epilepsy, Frontal Lobe/*genetics/physiopathology', 'Female', 'Genetic Markers', 'Humans', 'Male', 'Microsatellite Repeats', '*Multigene Family', 'Pedigree', '*Polymorphism, Genetic', 'Protein Subunits', 'Receptors, Nicotinic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/10923651/
1607,CHRNA3,23255854,A functional polymorphism in the CHRNA3 gene and risk of chronic obstructive pulmonary disease in a Korean population.,"['Lee JY', 'Yoo SS', 'Kang HG', 'Jin G', 'Bae EY', 'Choi YY', 'Choi JE', 'Jeon HS', 'Lee J', 'Lee SY', 'Cha SI', 'Kim CH', 'Park JY']","['Adult', 'Aged', 'Alleles', 'Asian People/*genetics', 'Case-Control Studies', 'Female', 'Forced Expiratory Volume', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Odds Ratio', '*Polymorphism, Single Nucleotide', 'Pulmonary Disease, Chronic Obstructive/*genetics/physiopathology', 'Receptors, Nicotinic/*genetics', 'Republic of Korea', 'Risk Factors', 'Smoking']",https://pubmed.ncbi.nlm.nih.gov/23255854/
1608,CHRNA3,36078193,Association of Polymorphism CHRNA5 and CHRNA3 Gene in People Addicted to Nicotine.,"['Chmielowiec K', 'Chmielowiec J', 'Stronska-Pluta A', 'Trybek G', 'Smiarowska M', 'Suchanecka A', 'Wozniak G', 'Jaron A', 'Grzywacz A']","['Genetic Predisposition to Disease', 'Humans', 'Nerve Tissue Proteins/genetics', 'Nicotine', 'Polymorphism, Single Nucleotide', '*Receptors, Nicotinic/genetics', '*Tobacco Use Disorder/epidemiology/genetics']",https://pubmed.ncbi.nlm.nih.gov/36078193/
1609,CHRNA3,29609626,CHRNA5 and CHRNA3 polymorphism and lung cancer susceptibility in Palestinian population.,"['Ayesh BM', 'Al-Masri R', 'Abed AA']","['Aged', 'Aged, 80 and over', 'Alleles', 'Arabs/genetics', 'Female', 'Gene Frequency', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Lung Neoplasms/*genetics', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Smoking']",https://pubmed.ncbi.nlm.nih.gov/29609626/
1610,CHRNA3,21858091,In vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expression.,"['Doyle GA', 'Wang MJ', 'Chou AD', 'Oleynick JU', 'Arnold SE', 'Buono RJ', 'Ferraro TN', 'Berrettini WH']","[""5' Untranslated Regions/genetics"", 'Autopsy', 'Binding Sites/genetics', 'Brain/metabolism', 'Cell Line, Tumor', 'Electrophoretic Mobility Shift Assay', 'Gene Expression Regulation', 'Gene Frequency', 'Genetic Predisposition to Disease/genetics', 'Genotype', 'Haplotypes/*genetics', 'HeLa Cells', 'Humans', 'Luciferases/genetics/metabolism', 'Mutation', 'Nerve Tissue Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic/genetics', 'Protein Binding', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Sp1 Transcription Factor/metabolism', 'Tobacco Use Disorder/genetics', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/21858091/
1611,CHRNA3,31599127,Polymorphisms of CHRNA3 and CHRNA5: Head and neck cancer and cigarette consumption intensity in a Brazilian population.,"['Silva MR', 'Gattas GJF', 'De Antonio J', 'Firigato I', 'Curioni OA', 'Goncalves FT']","['Brazil/epidemiology', 'Case-Control Studies', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Head and Neck Neoplasms/chemically induced/*genetics', 'Heterozygote', 'Humans', 'Male', 'Nerve Tissue Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Smoking/adverse effects/*epidemiology', 'Surveys and Questionnaires']",https://pubmed.ncbi.nlm.nih.gov/31599127/
1612,CHRNA3,26751916,CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers.,"['Kupiainen H', 'Kuokkanen M', 'Kontto J', 'Virtamo J', 'Salomaa V', 'Lindqvist A', 'Kilpelainen M', 'Laitinen T']","['Aged', 'Female', 'Finland', 'Genetic Predisposition to Disease', 'Humans', 'Logistic Models', 'Lung Neoplasms/*genetics/mortality', 'Male', 'Middle Aged', 'Mortality', 'Neoplasms/genetics/mortality', 'Nerve Tissue Proteins/*genetics', 'Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Prognosis', 'Proportional Hazards Models', 'Pulmonary Disease, Chronic Obstructive/*genetics/mortality', 'Receptors, Nicotinic/*genetics', 'Smoking/*genetics/mortality']",https://pubmed.ncbi.nlm.nih.gov/26751916/
1613,CHRNA3,25874685,CHRNA3 rs6495308 genotype as an effect modifier of the association between daily cigarette consumption and hypertension in Chinese male smokers.,"['Wu XY', 'Zhou SY', 'Niu ZZ', 'Liu T', 'Xie CB', 'Chen WQ']","['Adult', 'Aged', 'Aged, 80 and over', 'China', 'Cross-Sectional Studies', 'Effect Modifier, Epidemiologic', 'Female', 'Genetic Markers', '*Genotype', 'Homozygote', 'Humans', 'Hypertension/*etiology/genetics', 'Male', 'Middle Aged', 'Mutation', '*Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking/*adverse effects/genetics']",https://pubmed.ncbi.nlm.nih.gov/25874685/
1614,CHRNA3,40072291,Investigating the role of eight SNPs in CHRNA3 for COPD susceptibility in the Chinese elderly population.,"['Zheng Y', 'Zhao J', 'Liu M', 'Liu Y', 'Ding Y', 'Xie T']","['Humans', '*Pulmonary Disease, Chronic Obstructive/genetics', '*Polymorphism, Single Nucleotide', '*Receptors, Nicotinic/genetics', 'Male', 'Aged', 'Female', '*Genetic Predisposition to Disease', 'China/epidemiology', '*Asian People/genetics', 'Case-Control Studies', '*Haplotypes', 'Linkage Disequilibrium', 'Middle Aged', 'Risk Factors', 'Genotype', 'Aged, 80 and over', 'East Asian People']",https://pubmed.ncbi.nlm.nih.gov/40072291/
1615,CHRNA3,22914670,Association of IREB2 and CHRNA3/5 polymorphisms with COPD and COPD-related phenotypes in a Chinese Han population.,"['Zhou H', 'Yang J', 'Li D', 'Xiao J', 'Wang B', 'Wang L', 'Ma C', 'Xu S', 'Ou X', 'Feng Y']","['Aged', 'Asian People/genetics', 'Body Mass Index', 'Case-Control Studies', 'China', 'Female', 'Forced Expiratory Volume/genetics', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Haplotypes', 'Humans', 'Iron Regulatory Protein 2/*genetics', 'Linkage Disequilibrium', 'Lung/physiology/physiopathology', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Pulmonary Disease, Chronic Obstructive/*genetics', 'Receptors, Nicotinic/*genetics', 'Smoking/genetics']",https://pubmed.ncbi.nlm.nih.gov/22914670/
1616,CHRNA3,33947782,Familial Autonomic Ganglionopathy Caused by Rare CHRNA3 Genetic Variants.,"['Shibao CA', 'Joos K', 'Phillips JA 3rd', 'Cogan J', 'Newman JH', 'Hamid R', 'Meiler J', 'Capra J', 'Sheehan J', 'Vetrini F', 'Yang Y', 'Black B', 'Diedrich A', 'Roberston D', 'Biaggioni I']","['Adolescent', 'Adult', 'Autonomic Nervous System Diseases/*genetics', 'Constipation/genetics', 'Female', 'Genes, Recessive', 'Humans', 'Hypotension, Orthostatic/genetics', 'Male', 'Miosis/genetics', '*Mutation', 'Pedigree', 'Receptors, Nicotinic/*genetics', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/33947782/
1617,CHRNA3,22461431,"CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland.","['Hardin M', 'Zielinski J', 'Wan ES', 'Hersh CP', 'Castaldi PJ', 'Schwinder E', 'Hawrylkiewicz I', 'Sliwinski P', 'Cho MH', 'Silverman EK']","['Adenylyl Cyclases/*genetics', 'Cohort Studies', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study/methods', 'Humans', 'Iron Regulatory Protein 2/*genetics', 'Male', 'Middle Aged', 'Nerve Tissue Proteins/*genetics', 'Phenotype', 'Poland', 'Polymorphism, Single Nucleotide', 'Pulmonary Disease, Chronic Obstructive/*genetics', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/22461431/
1618,CHRNA3,24588897,CHRNA5 and CHRNA3 variants and level of neuroticism in young adult Mexican American men and women.,"['Criado JR', 'Gizer IR', 'Edenberg HJ', 'Ehlers CL']","['Anxiety Disorders/epidemiology/*genetics', 'Female', 'Humans', 'Linkage Disequilibrium', 'Male', 'Mexican Americans/*genetics/statistics & numerical data', 'Nerve Tissue Proteins/*genetics', 'Neuroticism', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24588897/
1619,CHRNA3,27758088,"The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.","['Barrie ES', 'Hartmann K', 'Lee SH', 'Frater JT', 'Seweryn M', 'Wang D', 'Sadee W']","['Computational Biology/methods', 'Databases, Genetic', 'Enhancer Elements, Genetic', 'Gene Expression', '*Gene Expression Regulation', 'Genetic Association Studies/methods', 'Genetic Linkage', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genomics/methods', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Multigene Family', 'Nerve Tissue Proteins/*genetics', 'Organ Specificity/genetics', 'Polymorphism, Single Nucleotide', 'Quantitative Trait Loci', 'Receptors, Nicotinic/*genetics', 'Regulatory Sequences, Nucleic Acid', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/27758088/
1620,CHRNA3,24535486,"CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.","['Kaur-Knudsen D', 'Bojesen SE', 'Nordestgaard BG']","['Adult', 'Aged', 'Cytochrome P-450 CYP3A/*genetics', 'Denmark', 'Forced Expiratory Volume', 'Genetic Variation', 'Genome-Wide Association Study', 'Humans', 'Lung/*physiology', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Pulmonary Disease, Chronic Obstructive/*genetics', 'Receptors, Nicotinic/*genetics', 'Smoking/*adverse effects']",https://pubmed.ncbi.nlm.nih.gov/24535486/
1621,CHRNA3,38862938,"Investigating CHRNA5, CHRNA3, and CHRNB4 variants in the genetic landscape of substance use disorder in Jordan.","['Al-Eitan L', 'Shatnawi M', 'Alghamdi M']","['Humans', 'Male', 'Young Adult', 'Adult', '*Substance-Related Disorders/genetics', '*Receptors, Nicotinic/genetics', '*Nerve Tissue Proteins/genetics', 'Polymorphism, Genetic', 'Alleles', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/38862938/
1622,CHRNA10,15531379,Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes.,"['Peng H', 'Ferris RL', 'Matthews T', 'Hiel H', 'Lopez-Albaitero A', 'Lustig LR']","['Acetylcholine/pharmacology', 'B-Lymphocyte Subsets/drug effects/*metabolism', 'Cell Separation', 'Flow Cytometry', 'Humans', 'Jurkat Cells', 'RNA, Messenger/metabolism', 'Receptors, Nicotinic/analysis/genetics/*metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', 'T-Lymphocyte Subsets/drug effects/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/15531379/
1623,CHRNA9,25142973,CHRNA9 polymorphisms and smoking exposure synergize to increase the risk of breast cancer in Taiwan.,"['Hsieh YC', 'Lee CH', 'Tu SH', 'Wu CH', 'Hung CS', 'Hsieh MC', 'Chuang CW', 'Ho YS', 'Chiou HY']","['Adult', 'Aged', 'Breast Neoplasms/epidemiology/*genetics/pathology', 'Female', '*Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking/adverse effects/*genetics', 'Taiwan']",https://pubmed.ncbi.nlm.nih.gov/25142973/
1624,CHRNA9,24676996,Neuronal acetylcholine receptor subunit alpha-9 (CHRNA9) polymorphisms are associated with NSCLC risk in a Chinese population.,"['Wang Y', 'Zhang Y', 'Gu C', 'Bao W', 'Bao Y']","['Adenocarcinoma/epidemiology/genetics/pathology', 'Asian People/*genetics', 'Carcinoma, Non-Small-Cell Lung/epidemiology/*genetics/pathology', 'Carcinoma, Squamous Cell/epidemiology/genetics/pathology', 'Case-Control Studies', 'China/epidemiology', 'Female', 'Follow-Up Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Lung Neoplasms/epidemiology/*genetics/pathology', 'Male', 'Neoplasm Staging', 'Polymorphism, Single Nucleotide/*genetics', 'Prognosis', 'Receptors, Nicotinic/*genetics', 'Risk Factors', 'Smoking/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/24676996/
1625,CHRNA9,15531379,Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes.,"['Peng H', 'Ferris RL', 'Matthews T', 'Hiel H', 'Lopez-Albaitero A', 'Lustig LR']","['Acetylcholine/pharmacology', 'B-Lymphocyte Subsets/drug effects/*metabolism', 'Cell Separation', 'Flow Cytometry', 'Humans', 'Jurkat Cells', 'RNA, Messenger/metabolism', 'Receptors, Nicotinic/analysis/genetics/*metabolism', 'Reverse Transcriptase Polymerase Chain Reaction', 'T-Lymphocyte Subsets/drug effects/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/15531379/
1626,CHRNA9,12697997,Chromosome location and characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) gene.,"['Lustig LR', 'Peng H']","['Amino Acid Sequence', 'Base Sequence', 'Chromosome Mapping', 'Chromosomes, Human, Pair 4', 'Gene Components', 'Humans', 'Molecular Sequence Data', 'Promoter Regions, Genetic', 'Protein Subunits', 'RNA Splice Sites', 'Receptors, Nicotinic/*genetics', 'Response Elements']",https://pubmed.ncbi.nlm.nih.gov/12697997/
1627,CHRNA6,28851948,Significant association of the CHRNB3-CHRNA6 gene cluster with nicotine dependence in the Chinese Han population.,"['Wen L', 'Han H', 'Liu Q', 'Su K', 'Yang Z', 'Cui W', 'Yuan W', 'Ma Y', 'Fan R', 'Chen J', 'Jiang K', 'Jiang X', 'Payne TJ', 'Wang J', 'Li MD']","['Adult', 'Asian People', 'Humans', 'Male', 'Middle Aged', '*Multigene Family', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28851948/
1628,CHRNA6,38447752,CHRNA6 RNA In Situ Hybridization Is a Useful Tool for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma.,"['Dulken BW', 'Kingsley L', 'Zdravkovic S', 'Cespedes O', 'Qian X', 'Suster DI', 'Charville GW']","['Adult', 'Aged', 'Aged, 80 and over', 'Female', 'Humans', 'Male', 'Middle Aged', '*Biomarkers, Tumor/genetics/analysis', '*Chondrosarcoma/genetics/pathology/diagnosis/metabolism', 'Immunohistochemistry', '*In Situ Hybridization/methods', '*Neoplasms, Connective and Soft Tissue/genetics/pathology/diagnosis', 'Neoplasms, Connective Tissue/genetics/pathology/diagnosis', 'Receptors, Nicotinic/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38447752/
1629,CHRNA6,24675634,Variants near CHRNB3-CHRNA6 are associated with DSM-5 cocaine use disorder: evidence for pleiotropy.,"['Sadler B', 'Haller G', 'Agrawal A', 'Culverhouse R', 'Bucholz K', 'Brooks A', 'Tischfield J', 'Johnson EO', 'Edenberg H', 'Schuckit M', 'Saccone N', 'Bierut L', 'Goate A']","['Alleles', 'Bipolar Disorder/genetics', 'Cocaine-Related Disorders/*diagnosis/*genetics', 'Gene Frequency', '*Genetic Association Studies', '*Genetic Predisposition to Disease', '*Genetic Variation', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Odds Ratio', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/24675634/
1630,CHRNA6,37680128,Involvement of CHRNA6 in the Immune Response in Lung Squamous Cell Carcinoma and its Potential as a Drug Target for the Disease.,"['Zhang F', 'Zhang M', 'Yuan X', 'Tao Y', 'Wang J']","['Humans', '*Carcinoma, Non-Small-Cell Lung', '*Carcinoma, Squamous Cell/drug therapy/immunology', 'Cholinergic Agents', 'Immunity', 'Lung', '*Lung Neoplasms/drug therapy/immunology', 'Prognosis', '*Receptors, Nicotinic/immunology/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37680128/
1631,CHRNA6,25823894,A genetic variant in CHRNB3-CHRNA6 increases risk of esophageal squamous cell carcinoma in Chinese populations.,"['Song Y', 'Wang Y', 'Xu L', 'Ma J', 'Chen E', 'Zang R', 'Jia W', 'Tao X', 'Hu L']","['Biomarkers, Tumor/*genetics', 'Carcinoma, Squamous Cell/epidemiology/*genetics/pathology', 'Case-Control Studies', 'China/epidemiology', 'Esophageal Neoplasms/epidemiology/*genetics/pathology', 'Female', 'Follow-Up Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Polymorphism, Single Nucleotide/*genetics', 'Prognosis', 'ROC Curve', 'Receptors, Nicotinic/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/25823894/
1632,CHRNA6,24253422,Significant associations of CHRNA2 and CHRNA6 with nicotine dependence in European American and African American populations.,"['Wang S', 'D van der Vaart A', 'Xu Q', 'Seneviratne C', 'Pomerleau OF', 'Pomerleau CS', 'Payne TJ', 'Ma JZ', 'Li MD']","['Black People/*genetics', 'Case-Control Studies', 'Chromosomes, Human, Pair 8', 'Haplotypes', 'Humans', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics', 'White People/*genetics', 'Black or African American']",https://pubmed.ncbi.nlm.nih.gov/24253422/
1633,CHRNA6,19500157,SNPs in CHRNA6 and CHRNB3 are associated with alcohol consumption in a nationally representative sample.,"['Hoft NR', 'Corley RP', 'McQueen MB', 'Huizinga D', 'Menard S', 'Ehringer MA']","['Adult', 'Alcohol Drinking/*genetics/metabolism/psychology', 'Alcohol-Induced Disorders, Nervous System/genetics/metabolism/psychology', 'Brain Chemistry/drug effects/genetics', 'Cohort Studies', 'Female', 'Genetic Predisposition to Disease/*genetics/psychology', 'Humans', 'Male', 'Phenotype', 'Polymorphism, Single Nucleotide/drug effects/*genetics', 'Receptors, Nicotinic/*genetics', 'United States']",https://pubmed.ncbi.nlm.nih.gov/19500157/
1634,CHRNA6,24792900,Combined effect between CHRNB3-CHRNA6 region gene variant (rs6474412) and smoking in psoriasis vulgaris severity.,"['Zhu KJ', 'Quan C', 'Zhang C', 'Liu Z', 'Liu H', 'Li M', 'Li SJ', 'Zhu CY', 'Shi G', 'Li KS', 'Fan YM']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Alcohol Drinking/adverse effects', 'Asian People/genetics', 'Body Mass Index', 'Case-Control Studies', 'China', 'Disease Progression', 'Environmental Exposure', 'Female', 'Gene-Environment Interaction', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Hospitalization', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Psoriasis/etiology/*genetics', 'Receptors, Nicotinic/*genetics', 'Risk Factors', '*Severity of Illness Index', 'Smoking/adverse effects/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24792900/
1635,CHRNA6,18704094,Genetic association of the CHRNA6 and CHRNB3 genes with tobacco dependence in a nationally representative sample.,"['Hoft NR', 'Corley RP', 'McQueen MB', 'Schlaepfer IR', 'Huizinga D', 'Ehringer MA']","['Adolescent', 'Adult', 'Child', 'Data Collection', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Longitudinal Studies', 'Male', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Racial Groups/genetics', 'Receptors, Nicotinic/*genetics', 'Siblings', 'Smoking Cessation', 'Tobacco Use Disorder/*genetics', 'United States']",https://pubmed.ncbi.nlm.nih.gov/18704094/
1636,CHRNA6,32120303,Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism.,"['Martinelli S', 'Cordeddu V', 'Galosi S', 'Lanzo A', 'Palma E', 'Pannone L', 'Ciolfi A', 'Di Nottia M', 'Rizza T', 'Bocchinfuso G', 'Traversa A', 'Caputo V', 'Farrotti A', 'Carducci C', 'Bernardini L', 'Cogo S', 'Paglione M', 'Venditti M', 'Bentivoglio A', 'Ng J', 'Kurian MA', 'Civiero L', 'Greggio E', 'Stella L', 'Trettel F', 'Sciaccaluga M', 'Roseti C', 'Carrozzo R', 'Fucile S', 'Limatola C', 'Di Schiavi E', 'Tartaglia M', 'Leuzzi V']","['Age of Onset', 'Child', 'Humans', 'Male', 'Mutation', 'Parkinsonian Disorders/*genetics', 'Receptors, Nicotinic/*genetics', 'Severity of Illness Index', 'Tryptophan-tRNA Ligase/*genetics', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/32120303/
1637,CHRNA6,27085880,Evidence for Association Between Low Frequency Variants in CHRNA6/CHRNB3 and Antisocial Drug Dependence.,"['Kamens HM', 'Corley RP', 'Richmond PA', 'Darlington TM', 'Dowell R', 'Hopfer CJ', 'Stallings MC', 'Hewitt JK', 'Brown SA', 'Ehringer MA']","['Adolescent', 'Antisocial Personality Disorder', 'Female', 'Gene Frequency/*genetics', '*Genetic Association Studies', '*Genetic Predisposition to Disease', 'Humans', 'Male', 'Quality Control', 'Receptors, Nicotinic/*genetics', 'Software', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27085880/
1638,CHRNA6,20418888,Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior.,"['Thorgeirsson TE', 'Gudbjartsson DF', 'Surakka I', 'Vink JM', 'Amin N', 'Geller F', 'Sulem P', 'Rafnar T', 'Esko T', 'Walter S', 'Gieger C', 'Rawal R', 'Mangino M', 'Prokopenko I', 'Magi R', 'Keskitalo K', 'Gudjonsdottir IH', 'Gretarsdottir S', 'Stefansson H', 'Thompson JR', 'Aulchenko YS', 'Nelis M', 'Aben KK', 'den Heijer M', 'Dirksen A', 'Ashraf H', 'Soranzo N', 'Valdes AM', 'Steves C', 'Uitterlinden AG', 'Hofman A', 'Tonjes A', 'Kovacs P', 'Hottenga JJ', 'Willemsen G', 'Vogelzangs N', 'Doring A', 'Dahmen N', 'Nitz B', 'Pergadia ML', 'Saez B', 'De Diego V', 'Lezcano V', 'Garcia-Prats MD', 'Ripatti S', 'Perola M', 'Kettunen J', 'Hartikainen AL', 'Pouta A', 'Laitinen J', 'Isohanni M', 'Huei-Yi S', 'Allen M', 'Krestyaninova M', 'Hall AS', 'Jones GT', 'van Rij AM', 'Mueller T', 'Dieplinger B', 'Haltmayer M', 'Jonsson S', 'Matthiasson SE', 'Oskarsson H', 'Tyrfingsson T', 'Kiemeney LA', 'Mayordomo JI', 'Lindholt JS', 'Pedersen JH', 'Franklin WA', 'Wolf H', 'Montgomery GW', 'Heath AC', 'Martin NG', 'Madden PA', 'Giegling I', 'Rujescu D', 'Jarvelin MR', 'Salomaa V', 'Stumvoll M', 'Spector TD', 'Wichmann HE', 'Metspalu A', 'Samani NJ', 'Penninx BW', 'Oostra BA', 'Boomsma DI', 'Tiemeier H', 'van Duijn CM', 'Kaprio J', 'Gulcher JR', 'McCarthy MI', 'Peltonen L', 'Thorsteinsdottir U', 'Stefansson K']","['Alleles', 'Aryl Hydrocarbon Hydroxylases/*genetics', 'Cohort Studies', 'Cytochrome P-450 CYP2A6', 'Female', '*Genetic Variation', 'Genome-Wide Association Study', 'Genomics', 'Humans', 'Lung Neoplasms/genetics', 'Male', 'Odds Ratio', 'Phenotype', 'Receptors, Nicotinic/*genetics', 'Smoking/*genetics', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/20418888/
1639,CHRNA6,18055561,The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco.,"['Zeiger JS', 'Haberstick BC', 'Schlaepfer I', 'Collins AC', 'Corley RP', 'Crowley TJ', 'Hewitt JK', 'Hopfer CJ', 'Lessem J', 'McQueen MB', 'Rhee SH', 'Ehringer MA']","['Adolescent', 'Adult', 'Black or African American/statistics & numerical data', 'Alcoholism/genetics', 'Alleles', 'Data Interpretation, Statistical', 'Female', 'Gene Frequency', 'Genetic Markers', 'Genetic Variation', 'Haplotypes', 'Hispanic or Latino/statistics & numerical data', 'Humans', 'Linear Models', 'Male', 'Nerve Tissue Proteins/*genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Siblings', 'Smoking/genetics', 'Tobacco Use Disorder/*genetics', 'White People/statistics & numerical data']",https://pubmed.ncbi.nlm.nih.gov/18055561/
1640,CHRNA6,24401102,Multiple distinct CHRNB3-CHRNA6 variants are genetic risk factors for nicotine dependence in African Americans and European Americans.,"['Culverhouse RC', 'Johnson EO', 'Breslau N', 'Hatsukami DK', 'Sadler B', 'Brooks AI', 'Hesselbrock VM', 'Schuckit MA', 'Tischfield JA', 'Goate AM', 'Saccone NL', 'Bierut LJ']","['Adolescent', 'Adult', 'Black or African American/*genetics', 'Aged', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptors, Nicotinic/*genetics', 'Tobacco Use Disorder/*genetics', 'White People/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/24401102/
1641,NR1I2,26267044,Polymorphisms in SLCO1B3 and NR1I2 as genetic determinants of hematotoxicity of carboplatin and paclitaxel combination.,"['Mbatchi LC', 'Schmitt A', 'Thomas F', 'Cazaubon Y', 'Robert J', 'Lumbroso S', 'Brouillet JP', 'Pourquier P', 'Chatelut E', 'Boyer JC', 'Evrard A']","['Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Antineoplastic Agents/administration & dosage', 'Antineoplastic Agents, Phytogenic/administration & dosage', 'Carboplatin/administration & dosage', 'Cohort Studies', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Male', 'Middle Aged', 'Organic Anion Transporters, Sodium-Independent/*genetics', 'Paclitaxel/administration & dosage', 'Polymorphism, Single Nucleotide', 'Pregnane X Receptor', 'Receptors, Steroid/*genetics', 'Solute Carrier Organic Anion Transporter Family Member 1B3', 'Thrombocytopenia/*chemically induced/epidemiology/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26267044/
1642,NR1I2,27894906,Relationship between NR1I2 polymorphisms and inflammatory bowel disease risk: A systematic review and meta-analysis.,"['Sun MY', 'Lin JN']","['Colitis, Ulcerative/genetics', 'Crohn Disease/genetics', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Inflammatory Bowel Diseases/*genetics', 'Linkage Disequilibrium/genetics', 'Polymorphism, Genetic/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Pregnane X Receptor', 'Receptors, Steroid/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27894906/
1643,NR1I2,29199543,Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.,"['Mbatchi LC', 'Brouillet JP', 'Evrard A']","['Constitutive Androstane Receptor', 'Humans', 'Polymorphism, Genetic/*genetics', 'Pregnane X Receptor', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Steroid/*genetics', 'Xenobiotics/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/29199543/
1644,NR1I2,39754510,"The impact of CYP3A5, NR1I2, and POR polymorphisms on tacrolimus dose-adjusted concentration and clinical outcomes in adult allogeneic haematopoietic stem cell transplantation.","['Gao Y', 'Ma J']","['Humans', '*Hematopoietic Stem Cell Transplantation', '*Tacrolimus/pharmacokinetics', '*Cytochrome P-450 CYP3A/genetics/metabolism', 'Adult', 'Male', 'Female', '*Graft vs Host Disease/genetics', 'Pregnane X Receptor/genetics/metabolism', 'Transplantation, Homologous', 'Middle Aged', 'Immunosuppressive Agents/pharmacokinetics', 'Retrospective Studies', 'Polymorphism, Genetic', 'Genotype', 'Polymorphism, Single Nucleotide', 'Cytochrome P-450 Enzyme System']",https://pubmed.ncbi.nlm.nih.gov/39754510/
1645,NR1I2,30487649,Influences of an NR1I2 polymorphism on heterogeneous antiplatelet reactivity responses to clopidogrel and clinical outcomes in acute ischemic stroke patients.,"['Chen YB', 'Zhou ZY', 'Li GM', 'Xiao CX', 'Yu WB', 'Zhong SL', 'Cai YF', 'Jin J', 'Huang M']","['Acute Disease', 'Aged', 'Aged, 80 and over', 'Aspirin/therapeutic use', 'Brain Infarction/diagnosis/*drug therapy/*genetics', 'Clopidogrel/*therapeutic use', 'Cohort Studies', 'Cytochrome P-450 CYP2C19/genetics', 'Female', 'Humans', 'Male', 'Middle Aged', 'Platelet Aggregation/genetics', 'Platelet Aggregation Inhibitors/*therapeutic use', '*Polymorphism, Single Nucleotide', 'Pregnane X Receptor/*genetics', 'Prognosis', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/30487649/
1646,NR1I2,32387752,Association between NR1I2 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population: A case-control study.,"['Yang M', 'Pan H', 'Chen H', 'Liu W', 'Lu L', 'He X', 'Yi H', 'Tang S']","['Adult', 'Aged', 'Antitubercular Agents/*adverse effects/therapeutic use', 'Asian People/genetics', 'Case-Control Studies', 'Chemical and Drug Induced Liver Injury/etiology/*genetics/pathology', 'Female', 'Genetic Predisposition to Disease', 'Haplotypes', 'Humans', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Pregnane X Receptor/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32387752/
1647,NR1I2,28676933,"Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer.","['Mbatchi LC', 'Gassiot M', 'Pourquier P', 'Goberna A', 'Mahammedi H', 'Mourey L', 'Joly F', 'Lumbroso S', 'Evrard A', 'Houede N']","['Aged', 'Antineoplastic Agents/pharmacokinetics/*therapeutic use', 'Cytochrome P-450 CYP3A/*genetics/metabolism', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Sirolimus/*analogs & derivatives/pharmacokinetics/therapeutic use', 'Urinary Bladder Neoplasms/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28676933/
1648,NR1I2,23079705,"PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population.","['Lima LO', 'Almeida S', 'Hutz MH', 'Fiegenbaum M']","['Adult', 'Amplified Fragment Length Polymorphism Analysis', 'Brazil', 'Constitutive Androstane Receptor', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Hypertriglyceridemia/genetics', 'Linkage Disequilibrium', 'Lipoproteins/*blood', 'Male', 'Middle Aged', 'PPAR alpha/*genetics', 'Polymorphism, Restriction Fragment Length', 'Pregnane X Receptor', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Steroid/*genetics', 'Retinoid X Receptor alpha/*genetics', 'Risk', 'Sequence Analysis, DNA', 'Sex Characteristics', 'Triglycerides/*blood']",https://pubmed.ncbi.nlm.nih.gov/23079705/
1649,NR1I2,29219065,"Transactivation Assays that Identify Indirect and Direct Activators of Human Pregnane X Receptor (PXR, NR1I2) and Constitutive Androstane Receptor (CAR, NR1I3).","['Pinne M', 'Ponce E', 'Raucy JL']","['*Biological Assay', 'Constitutive Androstane Receptor', 'Drug Discovery/methods', 'Hep G2 Cells', 'Humans', 'Ligands', 'Phenobarbital/pharmacology', 'Pregnane X Receptor', 'Promoter Regions, Genetic', 'Receptors, Cytoplasmic and Nuclear/*agonists/genetics', 'Receptors, Steroid/*agonists/genetics', 'Staurosporine/analogs & derivatives/pharmacology', 'Transcriptional Activation/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/29219065/
1650,NR1I2,27116457,Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients.,"['Mbatchi LC', 'Robert J', 'Ychou M', 'Boyer JC', 'Del Rio M', 'Gassiot M', 'Thomas F', 'Tubiana N', 'Evrard A']","['Adult', 'Aged', 'Aged, 80 and over', 'Antineoplastic Agents, Phytogenic/administration & dosage/*metabolism/*pharmacokinetics/toxicity', 'Camptothecin/administration & dosage/*analogs & derivatives/metabolism/pharmacokinetics/toxicity', 'Cohort Studies', 'Colorectal Neoplasms/*drug therapy', 'Constitutive Androstane Receptor', 'Drug Interactions', 'Female', 'France/epidemiology', 'Genetic Markers', 'Humans', 'Irinotecan', 'Male', 'Middle Aged', 'Neoplasm Metastasis/drug therapy', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide/*genetics', 'Predictive Value of Tests', 'Pregnane X Receptor', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Steroid/genetics', '*Xenobiotics']",https://pubmed.ncbi.nlm.nih.gov/27116457/
1651,NR1I2,28777242,Analysis of common polymorphisms within NR1I2 and NR1I3 genes and tacrolimus dose-adjusted concentration in stable kidney transplant recipients.,"['Kurzawski M', 'Malinowski D', 'Dziewanowski K', 'Drozdzik M']","['Adolescent', 'Adult', 'Aged', 'Constitutive Androstane Receptor', 'Female', 'Humans', 'Immunosuppressive Agents/*administration & dosage', '*Kidney Transplantation', 'Male', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Pregnane X Receptor', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Steroid/*genetics', 'Tacrolimus/*administration & dosage', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/28777242/
1652,NR1I2,17925385,Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression.,"['Lamba J', 'Lamba V', 'Strom S', 'Venkataramanan R', 'Schuetz E']","['Cytochrome P-450 CYP3A', 'Cytochrome P-450 Enzyme System/*biosynthesis/metabolism', 'Female', 'Hepatocytes/drug effects/enzymology', 'Humans', 'Introns/*genetics', 'Liver/drug effects/*enzymology', 'Male', '*Polymorphism, Single Nucleotide', 'Pregnane X Receptor', '*Promoter Regions, Genetic', 'Receptors, Steroid/*genetics', 'Rifampin/pharmacology', 'Sex Characteristics']",https://pubmed.ncbi.nlm.nih.gov/17925385/
1653,NR1I2,24232815,"Influence of PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms on the lipid-lowering efficacy and safety of statin therapy.","['Lima LO', 'Bruxel EM', 'Hutz MH', 'Van der Sand CR', 'Van der Sand LC', 'Ferreira ME', 'Pires RC', 'Fiegenbaum M', 'Almeida S']","['Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Anticholesteremic Agents/adverse effects/*therapeutic use', 'Atorvastatin', 'Constitutive Androstane Receptor', 'Dyslipidemias/*drug therapy/genetics', 'Female', 'Genotype', 'Heptanoic Acids/adverse effects/therapeutic use', 'Humans', 'Lipids/blood', 'Male', 'Middle Aged', 'PPAR alpha/*genetics', 'Polymerase Chain Reaction', '*Polymorphism, Genetic', 'Pregnane X Receptor', 'Pyrroles/adverse effects/therapeutic use', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Steroid/*genetics', 'Retinoid X Receptor alpha/*genetics', 'Risk Factors', 'Simvastatin/adverse effects/therapeutic use', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/24232815/
1654,NR1I2,17507630,Phytoestrogen exposure is associated with circulating sex hormone levels in postmenopausal women and interact with ESR1 and NR1I2 gene variants.,"['Low YL', 'Dunning AM', 'Dowsett M', 'Folkerd E', 'Doody D', 'Taylor J', 'Bhaniani A', 'Luben R', 'Khaw KT', 'Wareham NJ', 'Bingham SA']","['Aged', 'Biomarkers, Tumor/blood', 'Cross-Sectional Studies', 'Diet', 'Female', 'Genotype', 'Gonadal Steroid Hormones/*blood', 'Humans', 'Middle Aged', 'Phytoestrogens/*administration & dosage/metabolism/urine', '*Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Postmenopause/blood/metabolism', 'Pregnane X Receptor', 'Prospective Studies', 'Receptors, Estrogen/*genetics', 'Receptors, Steroid/*genetics', 'Sex Hormone-Binding Globulin/*analysis/metabolism', 'Glycine max']",https://pubmed.ncbi.nlm.nih.gov/17507630/
1655,NR1I2,20861742,Nuclear receptor-mediated induction of CYP450 by antiretrovirals: functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans.,"['Svard J', 'Spiers JP', 'Mulcahy F', 'Hennessy M']","['Adult', 'Africa South of the Sahara', 'Androstanes', 'Anti-HIV Agents/*pharmacology/therapeutic use', 'Aryl Hydrocarbon Hydroxylases/biosynthesis/*genetics', 'Black People/genetics', 'Cell Line', 'Cytochrome P-450 CYP2B6', 'Cytochrome P-450 CYP3A/biosynthesis/*genetics', 'Drug Interactions', 'Female', 'Genotype', 'HIV Infections/drug therapy/*genetics', 'HIV Protease Inhibitors/pharmacology/therapeutic use', 'Hep G2 Cells', 'Humans', 'Male', 'Middle Aged', 'Oxidoreductases, N-Demethylating/biosynthesis/*genetics', '*Polymorphism, Single Nucleotide', 'Pregnane X Receptor', 'Promoter Regions, Genetic', 'Receptors, Steroid/*genetics', 'Reverse Transcriptase Inhibitors/pharmacology/therapeutic use', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/20861742/
1656,HCAR3,34419055,Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.,"['Yang X', 'Wei W', 'Tan S', 'Guo L', 'Qiao S', 'Yao B', 'Wang Z']","['Biomarkers, Tumor/genetics', '*Colorectal Neoplasms/genetics', 'Databases, Genetic', 'Gene Expression Regulation, Neoplastic', 'Humans', '*Insulin', 'Prognosis', '*Proteins', 'Receptors, G-Protein-Coupled', '*Receptors, Nicotinic']",https://pubmed.ncbi.nlm.nih.gov/34419055/
1657,HCAR3,34948292,Alterations in Kynurenine and NAD(+) Salvage Pathways during the Successful Treatment of Inflammatory Bowel Disease Suggest HCAR3 and NNMT as Potential Drug Targets.,"['Wnorowski A', 'Wnorowska S', 'Kurzepa J', 'Parada-Turska J']","['Colitis/drug therapy/metabolism', 'Humans', 'Inflammatory Bowel Diseases/drug therapy/*metabolism', 'Infliximab/pharmacology', 'Kynurenine/*metabolism', 'Metabolic Networks and Pathways/drug effects/physiology', 'Nicotinamide N-Methyltransferase/*metabolism', 'Quinolinic Acid/pharmacology', 'Receptors, G-Protein-Coupled/*metabolism', 'Receptors, Nicotinic/*metabolism', 'Tryptophan/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34948292/
1658,HCAR3,39427321,Structural basis for ligand recognition of the human hydroxycarboxylic acid receptor HCAR3.,"['Ye F', 'Pan X', 'Zhang Z', 'Xiang X', 'Li X', 'Zhang B', 'Ning P', 'Liu A', 'Wang Q', 'Gong K', 'Li J', 'Zhu L', 'Qian C', 'Chen G', 'Du Y']","['Humans', 'Ligands', '*Receptors, G-Protein-Coupled/metabolism/chemistry', '*Cryoelectron Microscopy', 'Niacin/metabolism/chemistry/analogs & derivatives', 'HEK293 Cells', 'Protein Binding', 'Receptors, Nicotinic']",https://pubmed.ncbi.nlm.nih.gov/39427321/
1659,HCAR3,38103827,"GPCR Screening Reveals that the Metabolite Receptor HCAR3 Regulates Epithelial Proliferation, Migration, and Cellular Respiration.","['Pedro MP', 'Lund K', 'Kang SWS', 'Chen T', 'Stuelten CH', 'Porat-Shliom N', 'Iglesias-Bartolome R']","['Humans', '*Cell Movement', '*Keratinocytes/metabolism/cytology', '*Receptors, G-Protein-Coupled/metabolism/genetics', '*Cell Proliferation', '*Cell Respiration/physiology', 'Signal Transduction', 'Cell Differentiation', 'Cells, Cultured', 'Receptors, Leukotriene B4/metabolism/genetics', 'Epithelial Cells/metabolism', 'Receptors, Nicotinic']",https://pubmed.ncbi.nlm.nih.gov/38103827/
1660,HCAR3,37984442,Altered HCAR3 expression may underlying the blunted niacin responses of the psychiatric disorders and the risk of schizophrenia.,"['Jiang J', 'Wang D', 'Gao Y', 'Sun L', 'Li S', 'Hu X', 'Li Z', 'Zhang J', 'Ji F', 'Tian Y', 'Guan L', 'Li Z', 'He L', 'Wan C']","['Humans', '*Niacin/pharmacology/therapeutic use', '*Schizophrenia/drug therapy', 'Endophenotypes', 'Polymorphism, Single Nucleotide', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', '*Receptors, Nicotinic/genetics/therapeutic use', 'Receptors, G-Protein-Coupled/genetics/metabolism/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/37984442/
1661,HCAR2,31617441,Activation of HCAR2 by niacin: benefits beyond lipid lowering.,['Tuteja S'],"['Cholesterol, HDL/genetics', 'Coronary Disease/*drug therapy/genetics/pathology', 'Genotype', 'Humans', 'Hypolipidemic Agents/adverse effects/*therapeutic use', 'Lipids/antagonists & inhibitors/genetics', 'Niacin/adverse effects/*pharmacology', 'Polymorphism, Single Nucleotide', 'Receptors, G-Protein-Coupled/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31617441/
1662,HCAR2,37993467,Orthosteric and allosteric modulation of human HCAR2 signaling complex.,"['Mao C', 'Gao M', 'Zang SK', 'Zhu Y', 'Shen DD', 'Chen LN', 'Yang L', 'Wang Z', 'Zhang H', 'Wang WW', 'Shen Q', 'Lu Y', 'Ma X', 'Zhang Y']","['Humans', '*Receptors, G-Protein-Coupled/metabolism', '*Niacin/pharmacology', 'Ligands', 'Signal Transduction', 'Allosteric Regulation', 'Allosteric Site']",https://pubmed.ncbi.nlm.nih.gov/37993467/
1663,HCAR2,37743365,Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2.,"['Cheng L', 'Sun S', 'Wang H', 'Zhao C', 'Tian X', 'Liu Y', 'Fu P', 'Shao Z', 'Chai R', 'Yan W']","['Cryoelectron Microscopy', 'Ligands', '*Biological Assay', '*Cyclohexanecarboxylic Acids']",https://pubmed.ncbi.nlm.nih.gov/37743365/
1664,HCAR2,37578011,Ebola Virus Infection Induces HCAR2 Expression Leading to Cell Death.,"['Kuroda M', 'Halfmann PJ', 'Kawaoka Y']","['Humans', 'Cell Death', '*Ebolavirus/physiology', '*Hemorrhagic Fever, Ebola', 'RNA, Messenger/metabolism', 'Viral Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37578011/
1665,HCAR2,38918366,Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.,"['Shenol A', 'Tenente R', 'Luckmann M', 'Frimurer TM', 'Schwartz TW']","['Humans', 'Ligands', '*Receptors, G-Protein-Coupled/metabolism/chemistry/agonists', '*Protein Binding', '*GTP-Binding Proteins/metabolism', 'Binding Sites', 'Niacin/metabolism/chemistry', 'Allosteric Regulation', '3-Hydroxybutyric Acid/chemistry/metabolism', 'Molecular Dynamics Simulation']",https://pubmed.ncbi.nlm.nih.gov/38918366/
1666,GBA2,38302739,Mitochondrial dysfunction in NPC1-deficiency is not rescued by drugs targeting the glucosylceramidase GBA2 and the cholesterol-binding proteins TSPO and StARD1.,"['Wheeler S', 'Bhardwaj M', 'Kenyon V', 'Ferraz MJ', 'Aerts JMFG', 'Sillence DJ']","['Humans', 'Glucosylceramidase/genetics/metabolism', 'Intracellular Signaling Peptides and Proteins/genetics/metabolism', '*Niemann-Pick Disease, Type C/drug therapy/genetics/metabolism', 'Cholesterol/metabolism', '*Mitochondrial Diseases', 'Niemann-Pick C1 Protein/metabolism', 'Receptors, GABA/metabolism', '*Phosphoproteins', 'Steroidogenic Acute Regulatory Protein']",https://pubmed.ncbi.nlm.nih.gov/38302739/
1667,GBA2,29524657,Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia.,"['Coarelli G', 'Romano S', 'Travaglini L', 'Ferraldeschi M', 'Nicita F', 'Spadaro M', 'Fornasiero A', 'Frontali M', 'Salvetti M', 'Bertini E', 'Ristori G']","['Cerebellar Ataxia/surgery', 'Corpus Callosum/surgery', 'Glucosylceramidase', 'Humans', 'Magnetic Resonance Imaging/methods', 'Male', 'Middle Aged', 'Mutation/*genetics', 'Pedigree', 'Peripheral Nervous System Diseases/complications/*genetics', 'Spastic Paraplegia, Hereditary/diagnosis/*genetics', 'beta-Glucosidase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/29524657/
1668,GBA2,38334933,Hereditary spastic paraparesis type 46 (SPG46): new GBA2 variants in a large Italian case series and review of the literature.,"['Cioffi E', 'Coppola G', 'Musumeci O', 'Gallone S', 'Silvestri G', 'Rossi S', 'Piemonte F', ""D'Amico J"", 'Tessa A', 'Santorelli FM', 'Casali C']","['Adult', 'Female', 'Humans', 'Male', 'Middle Aged', '*Glucosylceramidase/genetics', 'Italy', 'Mutation/genetics', 'Pedigree', 'Phenotype', 'Spastic Paraplegia, Hereditary/genetics/diagnosis']",https://pubmed.ncbi.nlm.nih.gov/38334933/
1669,GBA2,28052128,GBA2 Mutations Cause a Marinesco-Sjogren-Like Syndrome: Genetic and Biochemical Studies.,"['Haugarvoll K', 'Johansson S', 'Rodriguez CE', 'Boman H', 'Haukanes BI', 'Bruland O', 'Roque F', 'Jonassen I', 'Blomqvist M', 'Telstad W', 'Mansson JE', 'Knappskog PM', 'Bindoff LA']","['Aged', 'Child', 'Child, Preschool', 'Female', 'Glucosylceramidase', 'Homozygote', 'Humans', 'Male', 'Middle Aged', 'Mutation/*genetics', 'Pedigree', 'Spinocerebellar Degenerations/*genetics', 'beta-Glucosidase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28052128/
1670,GBA2,25141135,GBA2-encoded beta-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa.,"['Loberto N', 'Tebon M', 'Lampronti I', 'Marchetti N', 'Aureli M', 'Bassi R', 'Giri MG', 'Bezzerri V', 'Lovato V', 'Cantu C', 'Munari S', 'Cheng SH', 'Cavazzini A', 'Gambari R', 'Sonnino S', 'Cabrini G', 'Dechecchi MC']","['1-Deoxynojirimycin/analogs & derivatives/pharmacology', 'Bronchi/drug effects/enzymology/microbiology', 'Cystic Fibrosis/*enzymology', 'Epithelial Cells/drug effects/enzymology/microbiology', 'Glucosylceramidase', 'Glycoside Hydrolase Inhibitors/pharmacology', 'Humans', 'Inflammation/*enzymology/microbiology', 'Pseudomonas Infections/*enzymology/microbiology', '*Pseudomonas aeruginosa', 'beta-Glucosidase/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/25141135/
1671,GBA2,28975712,Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2.,"['Gu X', 'Gupta V', 'Yang Y', 'Zhu JY', 'Carlson EJ', 'Kingsley C', 'Tash JS', 'Schonbrunn E', 'Hawkinson J', 'Georg GI']","['1-Deoxynojirimycin/analogs & derivatives/chemistry/*pharmacology', 'Amino Alcohols/chemistry/*pharmacology', 'Cyclopentanes/chemistry/*pharmacology', 'Dose-Response Relationship, Drug', '*Drug Discovery', 'Enzyme Inhibitors/chemical synthesis/chemistry/*pharmacology', 'Humans', 'Molecular Conformation', 'Structure-Activity Relationship', 'beta-Glucosidase/*antagonists & inhibitors/metabolism']",https://pubmed.ncbi.nlm.nih.gov/28975712/
1672,GBA2,34251556,Spastic paraplegia type 46: novel and recurrent GBA2 gene variants in a compound heterozygous Italian patient with spastic ataxia phenotype.,"['Gatti M', 'Magri S', 'Di Bella D', 'Sarto E', 'Taroni F', 'Mariotti C', 'Nanetti L']","['Child, Preschool', 'Glucosylceramidase/genetics', 'Humans', 'Intellectual Disability', 'Italy', '*Muscle Spasticity', 'Mutation/genetics', 'Optic Atrophy', 'Paraplegia/genetics', 'Pedigree', 'Phenotype', '*Spastic Paraplegia, Hereditary/genetics', 'Spinocerebellar Ataxias']",https://pubmed.ncbi.nlm.nih.gov/34251556/
1673,GBA2,23332917,Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity.,"['Hammer MB', 'Eleuch-Fayache G', 'Schottlaender LV', 'Nehdi H', 'Gibbs JR', 'Arepalli SK', 'Chong SB', 'Hernandez DG', 'Sailer A', 'Liu G', 'Mistry PK', 'Cai H', 'Shrader G', 'Sassi C', 'Bouhlal Y', 'Houlden H', 'Hentati F', 'Amouri R', 'Singleton AB']","['Adolescent', 'Adult', 'Amino Acid Sequence', 'Base Sequence', 'Cerebellar Ataxia/*complications/*genetics', 'Child', 'Child, Preschool', 'DNA Mutational Analysis', 'Family', 'Female', 'Genes, Recessive/*genetics', 'Glucosylceramidase', 'Humans', 'Male', 'Molecular Sequence Data', 'Muscle Spasticity/*complications/*genetics', 'Mutation/*genetics', 'Pedigree', 'Tunisia', 'beta-Glucosidase/chemistry/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23332917/
1674,GBA2,32492073,Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation.,"['Sultana S', 'Stewart J', 'van der Spoel AC']","['Alleles', 'Cell Line, Tumor', 'Cell Membrane/metabolism/ultrastructure', 'Glucosylceramidase/genetics/*metabolism', 'Humans', 'Membrane Potential, Mitochondrial', 'Microscopy, Electron', 'Mitochondria/enzymology/*pathology/ultrastructure', 'Mutation', 'Spastic Paraplegia, Hereditary/genetics', 'Spinocerebellar Degenerations/genetics']",https://pubmed.ncbi.nlm.nih.gov/32492073/
1675,GBA2,30308956,Biochemical Characterization of the GBA2 c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia.,"['Malekkou A', 'Samarani M', 'Drousiotou A', 'Votsi C', 'Sonnino S', 'Pantzaris M', 'Chiricozzi E', 'Zamba-Papanicolaou E', 'Aureli M', 'Loberto N', 'Christodoulou K']","['Alleles', 'Biomarkers', 'Cell Line', 'Enzyme Activation', 'Glucosylceramidase/metabolism', 'Glucosylceramides/metabolism', 'Humans', 'Intellectual Disability/*genetics/*metabolism', 'Lymphocytes/*metabolism', 'Muscle Spasticity/*genetics/*metabolism', '*Mutation, Missense', 'Optic Atrophy/*genetics/*metabolism', 'Spinocerebellar Ataxias/*genetics/*metabolism', 'beta-Glucosidase/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30308956/
1676,BCHE,36096160,BChE inhibitors from marine organisms - A review.,"['Lins Alves LK', 'Cechinel Filho V', 'de Souza RLR', 'Furtado-Alle L']","['Acetylcholine', 'Acetylcholinesterase', '*Alzheimer Disease/drug therapy', 'Aquatic Organisms', '*Butyrylcholinesterase', 'Cholinesterase Inhibitors/pharmacology/therapeutic use', 'Complex Mixtures/therapeutic use', 'Humans', 'Molecular Docking Simulation']",https://pubmed.ncbi.nlm.nih.gov/36096160/
1677,BCHE,29363710,Anti-Alzheimers activity and molecular mechanism of albumin-derived peptides against AChE and BChE.,"['Yu Z', 'Wu S', 'Zhao W', 'Ding L', 'Fan Y', 'Shiuan D', 'Liu J', 'Chen F']","['Acetylcholinesterase/chemistry/*metabolism', 'Albumins/*chemistry', 'Alzheimer Disease/drug therapy/*enzymology', 'Butyrylcholinesterase/chemistry/*metabolism', 'Cholinesterase Inhibitors/*chemistry', 'Humans', 'Hydrolysis', 'Molecular Docking Simulation', 'Peptides/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/29363710/
1678,BCHE,8622553,Cocaine and butyrylcholinesterase (BChE): determination of enzymatic parameters.,"['Mattes C', 'Bradley R', 'Slaughter E', 'Browne S']","['Benzoates/metabolism', 'Benzoic Acid', 'Binding Sites', 'Butyrylcholinesterase/*blood/chemistry/isolation & purification', 'Cocaine/analogs & derivatives/*metabolism', 'Humans', 'Kinetics', 'Macromolecular Substances']",https://pubmed.ncbi.nlm.nih.gov/8622553/
1679,BCHE,35915658,BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.,"['Liu J', 'Tian T', 'Liu X', 'Cui Z']","['Biomarkers, Tumor/genetics', 'Butyrophilins', 'Butyrylcholinesterase/genetics/*metabolism', '*Endometrial Neoplasms/genetics', 'Female', 'Humans', 'Immunotherapy/methods', 'Prognosis', 'Tumor Microenvironment/genetics']",https://pubmed.ncbi.nlm.nih.gov/35915658/
1680,BCHE,36126749,Novel activity of human BChE: Lipid hydrolysis.,"['Gok M', 'Cicek C', 'Sari S', 'Bodur E']","['Humans', '*Butyrylcholinesterase', '*Acetylcholinesterase/metabolism', 'Hydrolysis', 'Molecular Docking Simulation', 'Lipase', 'Lipids', 'Cholinesterase Inhibitors/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/36126749/
1681,BCHE,38357546,Progressions of the correlation between lipid metabolism and immune infiltration characteristics in gastric cancer and identification of BCHE as a potential biomarker.,"['Wang S', 'Huang X', 'Zhao S', 'Lv J', 'Li Y', 'Wang S', 'Guo J', 'Wang Y', 'Wang R', 'Zhang M', 'Qiu W']","['Humans', 'Algorithms', 'Biological Assay', 'Biomarkers', 'Disease Progression', 'Lipid Metabolism', '*Stomach Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/38357546/
1682,BCHE,32208851,"Goodyschle A, a new butenolide with significant BchE inhibitory activity from Goodyera schlechtendaliana.","['Dai LY', 'Yin QM', 'Qiu JK', 'Zhang ZY', 'Li G', 'Huang MN', 'Liu L']","['4-Butyrolactone/analogs & derivatives', '*Acetylcholinesterase/metabolism', '*Butyrylcholinesterase/metabolism', 'Cholinesterase Inhibitors/pharmacology', 'Humans', 'Structure-Activity Relationship']",https://pubmed.ncbi.nlm.nih.gov/32208851/
1683,BCHE,8860008,Butyrylcholinesterase variants (BCHE and CHE2 Loci) associated with erythrocyte acetylcholinesterase inhibition in farmers exposed to pesticides.,"['Fontoura-da-Silva SE', 'Chautard-Freire-Maia EA']","['Acetylcholinesterase/blood', 'Adolescent', 'Adult', 'Aged', ""Agricultural Workers' Diseases/chemically induced/enzymology/*genetics"", 'Butyrylcholinesterase/*genetics', 'Cholinesterase Inhibitors/*pharmacology', 'Cholinesterases/genetics', 'Chromosome Mapping', 'Erythrocytes/*enzymology', 'Female', '*Genetic Variation', 'Humans', 'Male', 'Middle Aged', 'Pesticides/*pharmacology', 'Risk Assessment']",https://pubmed.ncbi.nlm.nih.gov/8860008/
1684,BCHE,15781196,Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample.,"['Souza RL', 'Mikami LR', 'Maegawa RO', 'Chautard-Freire-Maia EA']","['Blood Donors', 'Brazil', 'Butyrylcholinesterase/*genetics', 'Exons', 'Gene Frequency', '*Genetic Variation', 'Humans', '*Mutation', 'Mutation, Missense']",https://pubmed.ncbi.nlm.nih.gov/15781196/
1685,BCHE,34502357,Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE.,"['Magar P', 'Parravicini O', 'Stepankova S', 'Svrckova K', 'Garro AD', 'Jendrzejewska I', 'Pauk K', 'Hosek J', 'Jampilek J', 'Enriz RD', 'Imramovsky A']","['Acetylcholinesterase/metabolism', 'Binding Sites', 'Butyrylcholinesterase/metabolism', 'Carbamates/chemical synthesis/*chemistry', 'Catalytic Domain', 'Cholinesterase Inhibitors/*chemistry', 'Humans', 'Molecular Docking Simulation', 'Molecular Dynamics Simulation', 'Structure-Activity Relationship', 'Sulfonamides/chemical synthesis/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/34502357/
1686,BCHE,7489367,Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers.,"['Loewenstein-Lichtenstein Y', 'Schwarz M', 'Glick D', 'Norgaard-Pedersen B', 'Zakut H', 'Soreq H']","['Acetylcholinesterase/metabolism', 'Binding Sites', 'Butyrylcholinesterase/*metabolism', 'Butyrylthiocholine/metabolism', 'Carbamates/pharmacology', 'Cholinesterase Inhibitors/*pharmacology', '*Homozygote', 'Humans', 'Male', 'Pyridostigmine Bromide/*pharmacology', 'Tacrine/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/7489367/
1687,BCHE,33024248,Characterization of four BCHE mutations associated with prolonged effect of suxamethonium.,"['Brazzolotto X', 'Courcelle S', 'Sauvanet C', 'Guillon V', 'Igert A', 'Kononchik J', 'Nachon F', 'Ceppa F', 'Delacour H']","['Adult', 'Aged, 80 and over', 'Butyrylcholinesterase/*genetics', 'Female', 'Humans', 'Kinetics', 'Middle Aged', 'Mivacurium/adverse effects', 'Mutation/*genetics', 'Phenotype', 'Succinylcholine/*adverse effects']",https://pubmed.ncbi.nlm.nih.gov/33024248/
1688,BCHE,26497592,The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis.,"['Pleva L', 'Kovarova P', 'Faldynova L', 'Plevova P', 'Hilscherova S', 'Zapletalova J', 'Kusnierova P', 'Kukla P']","['Aged', 'Alleles', 'Butyrylcholinesterase/*genetics', 'Coronary Restenosis/*genetics/*surgery', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', '*Percutaneous Coronary Intervention/instrumentation', 'Polymorphism, Single Nucleotide', 'Risk Factors', '*Stents']",https://pubmed.ncbi.nlm.nih.gov/26497592/
1689,BCHE,36592809,"Dysregulation of butyrylcholinesterase, BCHE gene SNP rs1803274, and pro-inflammatory cytokines in occupational workers.","['Khan SA', 'Leonel Javeres MN', 'Abbas Shah ST', 'Bibi N', 'Muneer Z', 'Hussain S', 'Nepovimova E', 'Kuca K', 'Nurulain SM']","['Humans', '*Butyrylcholinesterase/genetics', '*Cytokines/genetics', 'Gasoline', 'Interleukin-6', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/36592809/
1690,BCHE,37708555,"Study on the Expression Significance of Mb, BChE and cTnI in Myocardial Infarction and Their Relationship with Prognosis.","['Lu J', 'Song J', 'Liu F', 'Chen B', 'Dong Y', 'Yang Y']","['Humans', 'Troponin I', 'Myoglobin', 'Prospective Studies', '*Percutaneous Coronary Intervention', '*Myocardial Infarction/diagnosis', 'Prognosis', 'Biomarkers', 'Cholinesterases']",https://pubmed.ncbi.nlm.nih.gov/37708555/
1691,MMP2,14533872,Membrane-associated MMP-2 in human cervical cancer.,"['Mitra A', 'Chakrabarti J', 'Chattopadhyay N', 'Chatterjee A']","['Cell Membrane', '*Cell Transformation, Neoplastic', 'Female', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Matrix Metalloproteinase 2/*pharmacology', 'Neoplasm Invasiveness', 'Tissue Inhibitor of Metalloproteinase-2/*pharmacology', 'Uterine Cervical Neoplasms/*enzymology/*physiopathology']",https://pubmed.ncbi.nlm.nih.gov/14533872/
1692,MMP2,37531192,Imaging application of an MMP2-sensitive tumor-targeted prussian blue fluorescent nanoprobe.,"['Zhou X', 'Zhang C', 'Zhou Q', 'Liang J', 'Zhang X', 'Shi Y', 'Zhu J', 'Zhong L']","['Humans', '*Matrix Metalloproteinase 2', '*Neoplasms/diagnostic imaging', 'Ferrocyanides', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/37531192/
1693,MMP2,34432647,GDF-8 stimulates trophoblast cell invasion by inducing ALK5-SMAD2/3-mediated MMP2 expression.,"['Fang L', 'Wang Z', 'Wu Z', 'Yan Y', 'Gao Y', 'Li Y', 'Cheng JC', 'Sun YP']","['Cell Movement', 'Female', 'Humans', '*Matrix Metalloproteinase 2/genetics/metabolism', '*Myostatin/metabolism', 'Placenta/metabolism', 'Pregnancy', '*Receptor, Transforming Growth Factor-beta Type I', '*Smad2 Protein/metabolism', '*Smad3 Protein', 'Transforming Growth Factor beta/metabolism', '*Trophoblasts/metabolism']",https://pubmed.ncbi.nlm.nih.gov/34432647/
1694,MMP2,32646603,Association of MMP2-1306C/T Polymorphism with Ischemic Retinal Vein Occlusion.,"['Christodoulou A', 'Bagli E', 'Gazouli M', 'Moschos MM', 'Kitsos G']","['Aged', 'Female', 'Genetic Predisposition to Disease/*genetics', 'Humans', 'Male', 'Matrix Metalloproteinase 2/*genetics', 'Polymorphism, Genetic/*genetics', 'Retinal Vein Occlusion/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32646603/
1695,MMP2,28487020,Invasion of trophoblast cell lines is inhibited by miR-93 via MMP-2.,"['Pan Q', 'Niu H', 'Cheng L', 'Li X', 'Zhang Q', 'Ning Y']","['Cell Line', 'Cell Movement', 'Female', 'Humans', 'Matrix Metalloproteinase 2/*metabolism', 'MicroRNAs/*metabolism', 'Pre-Eclampsia/*enzymology/etiology', 'Pregnancy', 'Trophoblasts/*physiology']",https://pubmed.ncbi.nlm.nih.gov/28487020/
1696,MMP2,37459959,MMP-2 and its implications on cardiac function and structure: Interplay with inflammation in hypertension.,"['Ribeiro Vitorino T', 'Ferraz do Prado A', 'Bruno de Assis Cau S', 'Rizzi E']","['Humans', 'Matrix Metalloproteinase 2', '*Heart Failure', '*Hypertension', 'Inflammation', 'Cytokines']",https://pubmed.ncbi.nlm.nih.gov/37459959/
1697,MMP2,27996045,PI16 is a shear stress and inflammation-regulated inhibitor of MMP2.,"['Hazell GG', 'Peachey AM', 'Teasdale JE', 'Sala-Newby GB', 'Angelini GD', 'Newby AC', 'White SJ']","['Alternative Splicing', 'Carrier Proteins/*genetics', 'Cell Movement', 'Coronary Vessels/*metabolism/pathology', 'Endothelial Cells/*metabolism', 'Endothelium, Vascular/metabolism/pathology', '*Gene Expression Regulation', 'Glycoproteins/*genetics', 'Humans', 'Immunohistochemistry', '*Inflammation', 'Matrix Metalloproteinase 2/*metabolism', 'Peptide Library', 'Peptides/chemistry', 'Phenotype', 'Stress, Mechanical', 'Tumor Necrosis Factor-alpha/metabolism']",https://pubmed.ncbi.nlm.nih.gov/27996045/
1698,MMP2,25753382,Immunohistochemical analysis on MMP-2 and MMP-9 for wound age determination.,"['Ishida Y', 'Kuninaka Y', 'Nosaka M', 'Kimura A', 'Kawaguchi T', 'Hama M', 'Sakamoto S', 'Shinozaki K', 'Eisenmenger W', 'Kondo T']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Cell Count', 'Child', 'Forensic Pathology', 'Humans', 'Immunohistochemistry', 'Macrophages/*metabolism', 'Matrix Metalloproteinase 2/*metabolism', 'Matrix Metalloproteinase 9/*metabolism', 'Middle Aged', 'Skin/*injuries/*pathology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/25753382/
1699,MMP2,34634916,Ligand-based design of anticancer MMP2 inhibitors: a review.,"['Sanyal S', 'Amin SA', 'Adhikari N', 'Jha T']","['Antineoplastic Agents/chemical synthesis/chemistry/*pharmacology', 'Cell Proliferation/drug effects', '*Drug Design', 'Drug Screening Assays, Antitumor', 'Humans', 'Ligands', 'Matrix Metalloproteinase 2/*metabolism', 'Matrix Metalloproteinase Inhibitors/chemical synthesis/chemistry/*pharmacology', 'Molecular Structure']",https://pubmed.ncbi.nlm.nih.gov/34634916/
1700,GGPS1,38129970,Expanding the phenotypic and genotypic spectrum of GGPS1 related congenital muscular dystrophy.,"['Altassan R', 'AlQudairy H', 'AlJebreen S', 'AlMuhaizea M', 'Al-Hindi H', 'Pena-Guerra KA', 'Ghebeh H', 'Almzroua A', 'Albakheet A', 'AlDosary M', 'Colak D', 'Arold ST', 'Kaya N']","['Female', 'Humans', '*Muscular Dystrophies/diagnosis/genetics', 'Homozygote', '*Hearing Loss', '*Primary Ovarian Insufficiency', '*Deafness', '*Dimethylallyltranstransferase/genetics', 'Geranyltranstransferase/genetics', 'Farnesyltranstransferase/genetics']",https://pubmed.ncbi.nlm.nih.gov/38129970/
1701,GGPS1,35869884,GGPS1-associated muscular dystrophy with and without hearing loss.,"['Kaiyrzhanov R', 'Perry L', 'Rocca C', 'Zaki MS', 'Hosny H', 'Araujo Martins Moreno C', 'Phadke R', 'Zaharieva I', 'Camelo Gontijo C', 'Beetz C', 'Pini V', 'Movahedinia M', 'Zanoteli E', 'DiTroia S', 'Vuillaumier-Barrot S', 'Isapof A', 'Mehrjardi MYV', 'Ghasemi N', 'Sarkozy A', 'Muntoni F', 'Whalen S', 'Vona B', 'Houlden H', 'Maroofian R']","['*Deafness', '*Dimethylallyltranstransferase/genetics', 'Farnesyltranstransferase/genetics', 'Female', 'Geranyltranstransferase/genetics', '*Hearing Loss/genetics', 'Humans', '*Muscular Dystrophies/genetics', 'Mutation, Missense', '*Primary Ovarian Insufficiency']",https://pubmed.ncbi.nlm.nih.gov/35869884/
1702,GGPS1,32399598,"Genomic sequencing highlights the diverse molecular causes of Perrault syndrome: a peroxisomal disorder (PEX6), metabolic disorders (CLPP, GGPS1), and mtDNA maintenance/translation disorders (LARS2, TFAM).","['Tucker EJ', 'Rius R', 'Jaillard S', 'Bell K', 'Lamont PJ', 'Travessa A', 'Dupont J', 'Sampaio L', 'Dulon J', 'Vuillaumier-Barrot S', 'Whalen S', 'Isapof A', 'Stojkovic T', 'Quijano-Roy S', 'Robevska G', 'van den Bergen J', 'Hanna C', 'Simpson A', 'Ayers K', 'Thorburn DR', 'Christodoulou J', 'Touraine P', 'Sinclair AH']","['ATPases Associated with Diverse Cellular Activities/*genetics', 'Adolescent', 'Adult', 'Amino Acyl-tRNA Synthetases/*genetics', 'Base Sequence', 'Child', 'DNA, Mitochondrial/genetics', 'DNA-Binding Proteins/*genetics', 'Dimethylallyltranstransferase/*genetics', 'Endopeptidase Clp/*genetics', 'Farnesyltranstransferase/*genetics', 'Female', 'Gene Expression', '*Genetic Predisposition to Disease', 'Geranyltranstransferase/*genetics', 'Gonadal Dysgenesis, 46,XX/diagnosis/*genetics/pathology', 'Hearing Loss, Sensorineural/diagnosis/*genetics/pathology', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Male', 'Mitochondrial Proteins/*genetics', 'Ovary/metabolism/pathology', 'Pedigree', 'Peroxisomes/metabolism/pathology', 'Transcription Factors/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32399598/
1703,TYMS,23930679,Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics.,"['Lima A', 'Azevedo R', 'Sousa H', 'Seabra V', 'Medeiros R']","['Antimetabolites, Antineoplastic/therapeutic use', 'Fluorouracil/therapeutic use', 'Humans', 'Methotrexate/therapeutic use', '*Molecular Epidemiology', '*Pharmacogenetics', 'Polymorphism, Genetic', 'Thymidylate Synthase/antagonists & inhibitors/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23930679/
1704,TYMS,29380036,TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis.,"['Bae SC', 'Lee YH']","['*Antirheumatic Agents/adverse effects/pharmacology', '*Arthritis, Rheumatoid/drug therapy/genetics', 'Humans', '*Methotrexate/adverse effects/pharmacology', 'Polymorphism, Genetic', '*Thymidylate Synthase/genetics']",https://pubmed.ncbi.nlm.nih.gov/29380036/
1705,TYMS,34651293,Significance of microRNA-330-5p/TYMS Expression Axis in the Pathogenesis of Colorectal Tumorigenesis.,"['Karimi L', 'Jaberi M', 'Asadi M', 'Zarredar H', 'Zafari V', 'Bornehdeli S', 'Niknam S', 'Kermani TA']","['Humans', 'Thymidylate Synthase/genetics/metabolism', '*Colorectal Neoplasms/pathology', '*MicroRNAs/genetics/metabolism', 'Carcinogenesis/genetics', 'Cell Proliferation/genetics', 'Cell Transformation, Neoplastic', 'Gene Expression Regulation, Neoplastic', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/34651293/
1706,TYMS,36137946,DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients.,"['Khalij Y', 'Belaid I', 'Chouchane S', 'Amor D', 'Omezzine A', 'Ben Rejeb N', 'Ben Ahmed S', 'Bouslama A']","['Humans', '*Dihydrouracil Dehydrogenase (NADP)/genetics', 'Thymidylate Synthase/genetics', 'Antimetabolites, Antineoplastic/adverse effects', 'Prospective Studies', ""5' Untranslated Regions"", 'Polymorphism, Genetic', 'Fluorouracil/adverse effects', '*Colorectal Neoplasms/drug therapy/genetics']",https://pubmed.ncbi.nlm.nih.gov/36137946/
1707,TYMS,32024416,"MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis.","['Sundbaum JK', 'Baecklund E', 'Eriksson N', 'Hallberg P', 'Kohnke H', 'Wadelius M']","['Antirheumatic Agents/*adverse effects/therapeutic use', 'Arthritis, Rheumatoid/*drug therapy/genetics', 'Female', 'Genotype', 'Humans', 'Liver/*drug effects/metabolism', 'Liver Function Tests', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Logistic Models', 'Male', 'Methotrexate/*adverse effects/therapeutic use', 'Methylenetetrahydrofolate Reductase (NADPH2)/*genetics', 'Middle Aged', '*Polymorphism, Single Nucleotide', 'Thymidylate Synthase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/32024416/
1708,TYMS,35880438,"Investigation of DPYD, MTHFR and TYMS polymorphisms on 5-fluorouracil related toxicities in colorectal cancer.","['Cevik M', 'Namal E', 'Sener ND', 'Koksal UI', 'Cagatay P', 'Deliorman G', 'Ciftci C', 'Karaalp A', 'Susleyici B']","['*Colorectal Neoplasms/drug therapy/genetics', '*Dihydrouracil Dehydrogenase (NADP)/genetics', 'Fluorouracil/adverse effects', 'Genotype', 'Humans', 'Methylenetetrahydrofolate Reductase (NADPH2)/genetics', 'Polymorphism, Genetic/genetics', 'Thymidylate Synthase/genetics']",https://pubmed.ncbi.nlm.nih.gov/35880438/
1709,TYMS,31861032,TYMS presents a novel biomarker for diagnosis and prognosis in patients with pancreatic cancer.,"['Fu Z', 'Jiao Y', 'Li Y', 'Ji B', 'Jia B', 'Liu B']","['Biomarkers, Tumor/metabolism', 'Case-Control Studies', 'China/epidemiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Pancreatic Neoplasms/diagnosis/*metabolism/mortality', 'Prognosis', 'Thymidylate Synthase/*metabolism', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/31861032/
1710,TYMS,21254360,"NAT1, NOS3, and TYMS genotypes and the risk of conotruncal cardiac defects.","['Lupo PJ', 'Mitchell LE', 'Goldmuntz E']","['Adult', 'Arylamine N-Acetyltransferase/genetics', 'Female', 'Folic Acid/*metabolism', '*Genetic Predisposition to Disease', 'Genotype', 'Heart Defects, Congenital/genetics', 'Humans', 'Isoenzymes/genetics', 'Male', 'Nitric Oxide Synthase Type III/*genetics', '*Polymorphism, Single Nucleotide', 'Risk Factors', 'Thymidylate Synthase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21254360/
1711,TYMS,29735940,New Insight into the Octamer of TYMS Stabilized by Intermolecular Cys43-Disulfide.,"['Xie D', 'Wang L', 'Xiao Q', 'Wu X', 'Zhang L', 'Yang Q', 'Wang L']","['Cysteine/*chemistry', 'Disulfides/chemistry', 'Enzyme Stability', 'Humans', 'Kinetics', 'Models, Molecular', 'Protein Conformation', 'Protein Multimerization', 'Thymidylate Synthase/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/29735940/
1712,TYMS,31838077,Evaluating the role of ENOSF1 and TYMS variants as predictors in fluoropyrimidine-related toxicities: An IPD meta-analysis.,"['Hamzic S', 'Kummer D', 'Froehlich TK', 'Joerger M', 'Aebi S', 'Palles C', 'Thomlinson I', 'Meulendijks D', 'Schellens JHM', 'Garcia-Gonzalez X', 'Lopez-Fernandez LA', 'Amstutz U', 'Largiader CR']","['Antimetabolites, Antineoplastic/*adverse effects', 'Capecitabine/*adverse effects', 'Fluorouracil/*adverse effects', 'Hand-Foot Syndrome/*genetics', 'Humans', 'Hydro-Lyases/*genetics', 'Neoplasms/*drug therapy/genetics', 'Thymidylate Synthase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31838077/
1713,TYMS,20371218,"TYMS, MTHFR, p53 and MDR1 gene polymorphisms in breast cancer patients treated with adjuvant therapy.","['Henriquez-Hernandez LA', 'Perez LF', 'Hernandez AG', 'de Leon AC', 'Diaz-Chico B', 'Rosales AM']","['ATP Binding Cassette Transporter, Subfamily B', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/*genetics', 'Adult', 'Aged', 'Antineoplastic Combined Chemotherapy Protocols/*therapeutic use', 'Breast Neoplasms/drug therapy/*genetics/pathology', 'Carcinoma, Ductal, Breast/drug therapy/genetics/pathology', 'Carcinoma, Lobular/drug therapy/genetics/pathology', 'Chemotherapy, Adjuvant', 'Female', 'Genotype', 'Humans', 'Methylenetetrahydrofolate Reductase (NADPH2)/*genetics', 'Middle Aged', 'Polymorphism, Genetic/*genetics', 'Prognosis', 'Thymidylate Synthase/*genetics', 'Tumor Suppressor Protein p53/*genetics']",https://pubmed.ncbi.nlm.nih.gov/20371218/
1714,TYMS,32542457,"Predictive Potential of PD-L1, TYMS, and DCC Expressions in Treatment Outcome of Colorectal Carcinoma.","['Onwe EE', 'Ghani FA', 'Abdullah M', 'Osman M', 'Zin RRM', 'Vivian AN', 'Mohtarrudin N']","['B7-H1 Antigen/biosynthesis/*metabolism', 'Biomarkers, Tumor/*analysis', 'Colorectal Neoplasms/*drug therapy/*metabolism', 'DCC Receptor/biosynthesis/*metabolism', 'Female', 'Humans', 'Immunohistochemistry', 'Male', 'Thymidylate Synthase/biosynthesis/*metabolism', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/32542457/
1715,TYMS,34100299,Gender-dependent association of TYMS-TSER polymorphism with 5-fluorouracil or capecitabine-based chemotherapy toxicity.,"['Ioannou C', 'Ragia G', 'Balgkouranidou I', 'Xenidis N', 'Amarantidis K', 'Koukaki T', 'Biziota E', 'Kakolyris S', 'Manolopoulos VG']","['Adult', 'Aged', 'Aged, 80 and over', 'Antimetabolites, Antineoplastic/*administration & dosage/adverse effects', 'Antineoplastic Combined Chemotherapy Protocols/administration & dosage', 'Capecitabine/*administration & dosage/adverse effects', 'Female', 'Fluorouracil/*administration & dosage/adverse effects', 'Humans', 'Male', 'Middle Aged', 'Neoplasms/drug therapy/genetics', 'Polymorphism, Genetic/*genetics', '*Sex Characteristics', 'Thymidylate Synthase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/34100299/
1716,TYMS,22110208,Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer.,"['Cho YB', 'Chung HJ', 'Lee WY', 'Choi SH', 'Kim HC', 'Yun SH', 'Chun HK']","['Adenocarcinoma/drug therapy/*genetics/secondary', 'Adenocarcinoma, Mucinous/drug therapy/*genetics/secondary', 'Aged', 'Antineoplastic Combined Chemotherapy Protocols/*therapeutic use', 'Carcinoma, Signet Ring Cell/drug therapy/*genetics/secondary', 'Colorectal Neoplasms/drug therapy/*genetics/pathology', 'DNA-Binding Proteins/*genetics', 'Drug Resistance, Neoplasm/*genetics', 'Endonucleases/*genetics', 'Female', 'Fluorouracil/administration & dosage', 'Humans', 'Male', 'Middle Aged', 'Neoplasm Recurrence, Local/drug therapy/genetics/pathology', 'Organoplatinum Compounds/administration & dosage', 'Oxaliplatin', 'Prognosis', 'RNA, Messenger/genetics', 'Real-Time Polymerase Chain Reaction', 'Thymidylate Synthase/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22110208/
1717,TYMS,28932083,"Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer.","['Ntavatzikos A', 'Spathis A', 'Patapis P', 'Machairas N', 'Peros G', 'Konstantoudakis S', 'Leventakou D', 'Panayiotides IG', 'Karakitsos P', 'Koumarianou A']","[""3' Untranslated Regions/genetics"", 'Adult', 'Aged', 'Aged, 80 and over', 'Antineoplastic Combined Chemotherapy Protocols/pharmacology/*therapeutic use', 'Biomarkers, Tumor/genetics', 'Colorectal Neoplasms/drug therapy/*genetics/mortality/pathology', 'Disease Progression', 'Disease-Free Survival', 'Drug Resistance, Neoplasm/*genetics', 'Female', 'Follow-Up Studies', 'Genetic Testing/methods', 'Humans', 'Male', 'Middle Aged', 'Mutation', 'Polymorphism, Single Nucleotide', 'Prognosis', 'Proto-Oncogene Proteins B-raf/*genetics', 'Proto-Oncogene Proteins p21(ras)/*genetics', 'Real-Time Polymerase Chain Reaction', 'Retrospective Studies', 'Survival Analysis', 'Thymidylate Synthase/*genetics/metabolism', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/28932083/
1718,SLC22A1,28230985,Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).,"['Chen EC', 'Khuri N', 'Liang X', 'Stecula A', 'Chien HC', 'Yee SW', 'Huang Y', 'Sali A', 'Giacomini KM']","['Drug Discovery', 'HEK293 Cells', 'Humans', 'Ligands', 'Molecular Docking Simulation', 'Organic Cation Transporter 1/*antagonists & inhibitors/chemistry/*metabolism', 'Small Molecule Libraries/*chemistry/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/28230985/
1719,SLC22A1,29427770,Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis.,"['Cargnin S', 'Ravegnini G', 'Soverini S', 'Angelini S', 'Terrazzino S']","['Antineoplastic Agents/pharmacology/*therapeutic use', 'Asian People/genetics', 'Cytochrome P-450 CYP3A/*genetics', 'Genotype', 'Humans', 'Imatinib Mesylate/pharmacology/*therapeutic use', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy/genetics', 'Organic Cation Transporter 1/*genetics', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/29427770/
1720,SLC22A1,39068198,OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids.,"['Mickols E', 'Meyer A', 'Handin N', 'Stuwe M', 'Eriksson J', 'Rudfeldt J', 'Blom K', 'Fryknas M', 'Sellin ME', 'Lauschke VM', 'Karlgren M', 'Artursson P']","['Humans', 'Cells, Cultured', '*Hepatocytes/metabolism', 'Kinetics', 'Octamer Transcription Factor-1/metabolism/genetics', '*Organic Cation Transporter 1/metabolism/genetics', 'Proteomics/methods', 'Signal Transduction', '*Spheroids, Cellular/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39068198/
1721,SLC22A1,15499200,Seven novel single nucleotide polymorphisms in the human SLC22A1 gene encoding organic cation transporter 1 (OCT1).,"['Itoda M', 'Saito Y', 'Maekawa K', 'Hichiya H', 'Komamura K', 'Kamakura S', 'Kitakaze M', 'Tomoike H', 'Ueno K', 'Ozawa S', 'Sawada J']","['Genetic Variation/genetics', 'Humans', 'Organic Cation Transporter 1/*genetics', 'Polymorphism, Single Nucleotide/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15499200/
1722,SLC22A1,11388889,"Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1).","['Hayer M', 'Bonisch H', 'Bruss M']","['1-Methyl-4-phenylpyridinium/metabolism', 'Alternative Splicing', 'Amino Acid Sequence', 'Base Sequence', 'Carrier Proteins/*genetics/*metabolism', 'Cell Line', 'Cloning, Molecular', 'DNA Primers/genetics', 'DNA, Complementary/genetics', 'Exons', 'Gene Expression', 'Humans', 'Introns', 'Ion Transport', 'Membrane Proteins/*genetics/*metabolism', 'Molecular Sequence Data', 'Organic Cation Transporter 1', 'Protein Isoforms/genetics/metabolism', 'Sequence Homology, Amino Acid', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/11388889/
1723,SLC22A1,40004467,Genetic Variants of SLC22A1 rs628031 and rs622342 and Glycemic Control in T2DM Patients from Northern Mexico.,"['Moreno-Gonzalez JG', 'Reza-Lopez SA', 'Gonzalez-Rodriguez E', 'Siqueiros-Cendon TS', 'Escareno Contreras A', 'Rascon-Cruz Q', 'Leal-Berumen I']","['Humans', '*Diabetes Mellitus, Type 2/genetics/drug therapy/blood', 'Female', 'Male', 'Mexico', 'Middle Aged', '*Metformin/therapeutic use', '*Polymorphism, Single Nucleotide', 'Cross-Sectional Studies', 'Glycemic Control', 'Organic Cation Transporter 1/genetics', 'Glycated Hemoglobin/metabolism/genetics', 'Aged', 'Blood Glucose', 'Adult', 'Genotype', 'Hypoglycemic Agents/therapeutic use', 'Octamer Transcription Factor-1']",https://pubmed.ncbi.nlm.nih.gov/40004467/
1724,SLC22A1,9605850,The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26.,"['Koehler MR', 'Wissinger B', 'Gorboulev V', 'Koepsell H', 'Schmid M']","['Carrier Proteins/*genetics', 'Chaperonin Containing TCP-1', 'Chaperonins', 'Chromosome Mapping', '*Chromosomes, Human, Pair 6', 'Heat-Shock Proteins/*genetics', 'Humans', 'Molecular Chaperones/*genetics', '*Organic Cation Transport Proteins', 'Organic Cation Transporter 2', 'Polymerase Chain Reaction']",https://pubmed.ncbi.nlm.nih.gov/9605850/
1725,SLC22A1,39668580,Effect of SLC22A1 polymorphism on the pharmacokinetics of proguanil in Korean: A semi-physiologic population pharmacokinetic approach.,"['Khwarg J', 'Yang E', 'Park CS', 'Ji SC', 'Yu KS', 'Lee S']","['Adult', 'Female', 'Humans', 'Male', 'Middle Aged', 'Young Adult', 'Antimalarials/pharmacokinetics/administration & dosage', '*Cytochrome P-450 CYP2C19/genetics/metabolism', 'Genotype', '*Octamer Transcription Factor-1/genetics/metabolism', '*Polymorphism, Single Nucleotide', '*Proguanil/pharmacokinetics/administration & dosage', 'Prospective Studies', 'Republic of Korea', 'East Asian People/genetics']",https://pubmed.ncbi.nlm.nih.gov/39668580/
1726,SLC22A1,35905099,The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.,"['Ningrum VDA', 'Sadewa AH', 'Ikawati Z', 'Yuliwulandari R', 'Ikhsan MR', 'Fajriyah R']","['Blood Glucose', 'Catecholamine Plasma Membrane Transport Proteins/*metabolism', 'Cohort Studies', '*Diabetes Mellitus, Type 2/drug therapy/genetics', 'Genotype', 'Humans', 'Hypoglycemic Agents/pharmacology/therapeutic use', '*Metformin/pharmacology', 'Organic Cation Transport Proteins/genetics', 'Prospective Studies']",https://pubmed.ncbi.nlm.nih.gov/35905099/
1727,SLC22A1,37550919,Influence of Solute Carrier Family 22 Member 1 (SLC22A1) Gene Polymorphism on Metformin Pharmacokinetics and HbA1c Levels: A Systematic Review.,"['Pradana AD', 'Kristin E', 'Nugrahaningsih DAA', 'Nugroho AK', 'Pinzon RT']","['*Metformin/pharmacokinetics/therapeutic use', 'Humans', '*Glycated Hemoglobin/analysis/metabolism', '*Hypoglycemic Agents/pharmacokinetics/therapeutic use', 'Diabetes Mellitus, Type 2/drug therapy/genetics/blood', 'Polymorphism, Single Nucleotide', 'Polymorphism, Genetic', '*Octamer Transcription Factor-1']",https://pubmed.ncbi.nlm.nih.gov/37550919/
1728,SLC22A1,35456416,The Role of SLC22A1 and Genomic Ancestry on Toxicity during Treatment in Children with Acute Lymphoblastic Leukemia of the Amazon Region.,"['Fernandes SSM', 'Leitao LPC', 'Cohen-Paes AN', 'Gellen LPA', 'Pastana LF', 'de Carvalho DC', 'Modesto AAC', 'da Costa ACA', 'Wanderley AV', 'Lima CHV', 'Pereira EEB', 'Fernandes MR', 'Burbano RMR', 'de Assumpcao PP', 'Santos SEBD', 'Santos NPCD']","['Adolescent', 'Black People', 'Child', 'Humans', '*Organic Cation Transporter 1/genetics', 'Polymorphism, Genetic', '*Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/genetics', 'Pyrophosphatases/genetics']",https://pubmed.ncbi.nlm.nih.gov/35456416/
1729,SLC22A1,34927264,Genetic variants in SLC22A1 are related to serum lipid levels in Mexican women.,"['Cahua-Pablo JA', 'Gomez-Zamudio JH', 'Resendiz-Abarca CA', 'Tello-Flores VA', 'Eulogio-Metodio Y', 'Ramirez-Vargas MA', 'Cruz M', 'Del Carmen Alarcon-Romero L', 'Matia-Garcia I', 'Marino-Ortega LA', 'Zubillaga-Guerrero MI', 'Flores-Alfaro E']","['*Atherosclerosis', 'Catecholamine Plasma Membrane Transport Proteins/*genetics', 'Cholesterol, HDL', 'Cholesterol, LDL', '*Dyslipidemias/genetics', 'Female', 'Gene Frequency', 'Genotype', 'Haplotypes', 'Humans', 'Mexico', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/34927264/
1730,SLC22A1,30274012,Relationship Between SLC22A1 and SLC22A4 Gene Polymorphisms and Risk of Type 2 Diabetes in Chinese Han Population.,"['Long G', 'Zhang G', 'Zhang F', 'Ye D', 'Yang D', 'Yang Y']","['Adult', 'Aged', 'Aged, 80 and over', 'Asian People/genetics', 'Case-Control Studies', 'China/epidemiology', 'Diabetes Mellitus, Type 2/diagnosis/ethnology/*genetics', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Male', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics', 'Organic Cation Transporter 1/*genetics', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Risk Assessment', 'Risk Factors', 'Symporters', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/30274012/
1731,SLC22A1,31974043,rs622342A>C in SLC22A1 is associated with metformin pharmacokinetics and glycemic response.,"['Naja K', 'El Shamieh S', 'Fakhoury R']","['Adult', 'Aged', 'Creatinine/blood', 'Diabetes Mellitus, Type 2/diagnosis/*drug therapy/metabolism', 'Female', 'Glucose Tolerance Test', 'Humans', 'Hypoglycemic Agents/administration & dosage/blood/*pharmacokinetics', 'Lactic Acid/blood', 'Male', 'Metformin/administration & dosage/blood/*pharmacokinetics', 'Middle Aged', 'Organic Cation Transporter 1/genetics/*metabolism', 'Polymorphism, Genetic/genetics']",https://pubmed.ncbi.nlm.nih.gov/31974043/
1732,SLC22A1,34128532,"Association of SLC22A1,SLCO1B3 Drug Transporter Polymorphisms and Smoking with Disease Risk and Cytogenetic Response to Imatinib in Patients with Chronic Myeloid Leukemia.","['Mohammadi F', 'Rostami G', 'Assad D', 'Shafiei M', 'Hamid M', 'Jalaeikhoo H']","['Antineoplastic Agents/therapeutic use', 'Catecholamine Plasma Membrane Transport Proteins/*genetics', 'Cytogenetic Analysis', 'Humans', 'Imatinib Mesylate/therapeutic use', '*Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy/genetics', 'Pharmaceutical Preparations', 'Polymorphism, Single Nucleotide/genetics', 'Smoking', 'Solute Carrier Organic Anion Transporter Family Member 1B3/*genetics/therapeutic use', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/34128532/
1733,SLC22A1,29567937,Imatinib Affects the Expression of SLC22A1 in a Non-Linear Concentration-Dependent Manner Within 24 Hours.,"['Sreenivasan Tantuan S', 'Viljoen CD']","['Humans', 'Imatinib Mesylate/*pharmacology', 'K562 Cells', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism', 'Organic Cation Transporter 1/*metabolism', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/29567937/
1734,SLC22A9,26239079,"Variability in hepatic expression of organic anion transporter 7/SLC22A9, a novel pravastatin uptake transporter: impact of genetic and regulatory factors.","['Emami Riedmaier A', 'Burk O', 'van Eijck BA', 'Schaeffeler E', 'Klein K', 'Fehr S', 'Biskup S', 'Muller S', 'Winter S', 'Zanger UM', 'Schwab M', 'Nies AT']","['Biological Transport', 'Gene Expression Regulation', 'HEK293 Cells', 'Hepatocyte Nuclear Factor 4/genetics/metabolism', 'Heterozygote', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/*metabolism', 'Kinetics', 'Liver/*metabolism', 'Mutation, Missense', 'Organic Anion Transporters, Sodium-Independent/*genetics/metabolism', 'Pharmacogenomic Variants/*genetics', 'Phenotype', 'Pravastatin/*metabolism', 'Transfection', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/26239079/
1735,SLC22A9,33013684,The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans.,"['Nies AT', 'Weiss S', 'Schaeffeler E', 'Hannemann A', 'Volker U', 'Wallaschofski H', 'Schwab M']","['Adult', 'Aged', 'Aged, 80 and over', 'Biomarkers/*blood', 'Bone Density', 'Bone Remodeling', 'Case-Control Studies', 'Cross-Sectional Studies', 'Europe/epidemiology', 'Female', 'Fractures, Bone/blood/*genetics', 'Gene Expression Profiling', '*Genetic Predisposition to Disease', 'Humans', 'Male', 'Middle Aged', 'Organic Anion Transporters, Sodium-Independent/blood/*genetics', 'Osteoporosis/blood/*epidemiology/genetics/pathology', '*Polymorphism, Single Nucleotide', 'Prognosis', 'White People/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33013684/
1736,SLC22A11,37894870,SLC22A11 Inserts the Uremic Toxins Indoxyl Sulfate and P-Cresol Sulfate into the Plasma Membrane.,"['Tust M', 'Muller JP', 'Fischer D', 'Grundemann D']","['Humans', 'Uremic Toxins', 'Indican/metabolism', 'Chromatography, Liquid', 'HEK293 Cells', 'Tandem Mass Spectrometry', '*Renal Insufficiency, Chronic/metabolism', 'Cresols/metabolism', '*Toxins, Biological/metabolism', 'Cell Membrane/metabolism', 'Organic Anion Transporters, Sodium-Independent']",https://pubmed.ncbi.nlm.nih.gov/37894870/
1737,SLC22A11,38222853,"Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout.","['Vavra J', 'Pavelcova K', 'Masinova J', 'Hasikova L', 'Bubenikova E', 'Urbanova A', 'Mancikova A', 'Stiburkova B']","['Humans', '*Gout/genetics', '*Hyperuricemia/genetics', '*Organic Anion Transporters/genetics', '*Organic Anion Transporters, Sodium-Independent/genetics', 'Uric Acid/metabolism', '*Sodium-Phosphate Cotransporter Proteins, Type I/genetics']",https://pubmed.ncbi.nlm.nih.gov/38222853/
1738,SLC22A11,32363570,Multifaceted genome-wide study identifies novel regulatory loci in SLC22A11 and ZNF45 for body mass index in Indians.,"['Giri AK', 'Prasad G', 'Bandesh K', 'Parekatt V', 'Mahajan A', 'Banerjee P', 'Kauser Y', 'Chakraborty S', 'Rajashekar D', 'Sharma A', 'Mathur SK', 'Basu A', 'McCarthy MI', 'Tandon N', 'Bharadwaj D']","['Adolescent', 'Adult', 'Asian People/genetics', 'Body Mass Index', 'DNA Methylation', 'Female', 'Gene-Environment Interaction', 'Genetic Predisposition to Disease', '*Genome-Wide Association Study', 'Humans', 'Indians, North American/genetics', 'Kruppel-Like Transcription Factors/*genetics', 'Male', 'Obesity/*genetics/pathology', 'Organic Anion Transporters, Sodium-Independent/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Quantitative Trait Loci/genetics', 'Regulatory Sequences, Nucleic Acid/genetics', 'Repressor Proteins/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/32363570/
1739,SLC22A11,24025986,A common variant of organic anion transporter 4 (OAT4/SLC22A11) gene is associated with renal underexcretion type gout.,"['Sakiyama M', 'Matsuo H', 'Shimizu S', 'Nakashima H', 'Nakayama A', 'Chiba T', 'Naito M', 'Takada T', 'Suzuki H', 'Hamajima N', 'Ichida K', 'Shimizu T', 'Shinomiya N']","['Asian People/genetics', 'Case-Control Studies', 'Chi-Square Distribution', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Gout/ethnology/*genetics/*metabolism', 'Humans', 'Japan', 'Kidney/*metabolism', 'Male', 'Odds Ratio', 'Organic Anion Transporters, Sodium-Independent/*genetics/*metabolism', 'Phenotype', '*Polymorphism, Single Nucleotide', 'Renal Elimination/*genetics', 'Risk Factors', 'Uric Acid/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/24025986/
1740,SLC22A11,24360580,Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects.,"['Flynn TJ', 'Phipps-Green A', 'Hollis-Moffatt JE', 'Merriman ME', 'Topless R', 'Montgomery G', 'Chapman B', 'Stamp LK', 'Dalbeth N', 'Merriman TR']","['Adult', 'Case-Control Studies', 'Female', 'Genetic Loci', 'Genetic Predisposition to Disease/*genetics', 'Genome-Wide Association Study', 'Gout/*genetics', 'Haplotypes', 'Humans', 'Male', 'Middle Aged', 'New Zealand', 'Oligonucleotide Array Sequence Analysis', 'Organic Anion Transporters/*genetics', 'Organic Anion Transporters, Sodium-Independent/*genetics', 'Organic Cation Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/24360580/
1741,SLC22A11,28027879,A novel mode of operation of SLC22A11: Membrane insertion of estrone sulfate versus translocation of uric acid and glutamate.,"['Skwara P', 'Schomig E', 'Grundemann D']","['Biological Transport', 'Cell Membrane/metabolism', 'Estrone/*analogs & derivatives/metabolism', 'Glutamic Acid/*metabolism', 'HEK293 Cells', 'Humans', 'Organic Anion Transporters, Sodium-Independent/*metabolism', 'Uric Acid/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/28027879/
1742,SLC22A11,22877817,"Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11).","['Wang L', 'Sweet DH']","['*Food-Drug Interactions', 'Humans', 'Hydroxybenzoates/*pharmacology', 'Inhibitory Concentration 50', 'Organic Anion Transporters/classification/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/22877817/
1743,SLC22A7,26428001,Modulation of ALDH5A1 and SLC22A7 by microRNA hsa-miR-29a-3p in human liver cells.,"['Yu D', 'Tolleson WH', 'Knox B', 'Jin Y', 'Guo L', 'Guo Y', 'Kadlubar SA', 'Ning B']","['HEK293 Cells', 'Hep G2 Cells', 'Hepatocytes/drug effects/*metabolism', 'Humans', 'MicroRNAs/genetics/*metabolism/pharmacology', 'Organic Anion Transporters, Sodium-Independent/*antagonists & inhibitors/*physiology', 'Succinate-Semialdehyde Dehydrogenase/*antagonists & inhibitors/*physiology']",https://pubmed.ncbi.nlm.nih.gov/26428001/
1744,SLC22A7,26230641,Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children.,"['Visscher H', 'Rassekh SR', 'Sandor GS', 'Caron HN', 'van Dalen EC', 'Kremer LC', 'van der Pal HJ', 'Rogers PC', 'Rieder MJ', 'Carleton BC', 'Hayden MR', 'Ross CJ']","['Anthracyclines/*adverse effects', 'Cardiotoxicity/*genetics', 'Case-Control Studies', 'Child', 'Child, Preschool', 'Female', 'Follow-Up Studies', 'Genotype', 'Heart Diseases/*chemically induced/*genetics', 'Humans', 'Male', 'Organic Anion Transporters, Sodium-Independent/*genetics', 'Organic Cation Transport Proteins/*genetics', 'Oxidative Stress/genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Risk']",https://pubmed.ncbi.nlm.nih.gov/26230641/
1745,SLC22A7,18216183,Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP.,"['Cropp CD', 'Komori T', 'Shima JE', 'Urban TJ', 'Yee SW', 'More SS', 'Giacomini KM']","['Alternative Splicing/genetics', 'Amino Acids', 'Biological Transport', 'Cell Line', 'Cyclic GMP/*metabolism', 'Deoxyguanosine/metabolism', 'Extracellular Space/metabolism', 'Gene Expression Profiling', 'Humans', 'Intracellular Space/metabolism', 'Nucleosides/metabolism', 'Organic Anion Transporters, Sodium-Independent/chemistry/genetics/*metabolism', 'RNA, Messenger/genetics/metabolism', 'Substrate Specificity', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/18216183/
1746,SLC22A7,20190416,Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human.,"['Sato M', 'Mamada H', 'Anzai N', 'Shirasaka Y', 'Nakanishi T', 'Tamai I']","['Biological Transport', 'Carbon Isotopes', 'Carboxylic Acids/pharmacology', 'Cell Line', 'Humans', 'Hydrogen-Ion Concentration', 'Hyperuricemia/*metabolism', 'Kidney/*metabolism', 'Organic Anion Transporters, Sodium-Independent/*metabolism', 'Uric Acid/blood/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/20190416/
1747,SLC22A7,29244191,The role of OAT2 (SLC22A7) in the cyclic nucleotide biokinetics of human erythrocytes.,"['Sager G', 'Smaglyukova N', 'Fuskevaag OM']","['Biological Transport/physiology', 'Cyclic AMP/*metabolism', 'Cyclic GMP/*metabolism', 'Erythrocytes/*metabolism', 'Humans', 'Nucleotides/*metabolism', 'Organic Anion Transporters, Sodium-Independent/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/29244191/
1748,SLC22A7,32001236,Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7).,"['Mathialagan S', 'Bi YA', 'Costales C', 'Kalgutkar AS', 'Rodrigues AD', 'Varma MVS']","['Biological Transport/drug effects/physiology', 'Cells, Cultured', 'Dose-Response Relationship, Drug', 'HEK293 Cells', 'Hepatocytes/drug effects/*metabolism', 'Humans', 'Liver/cytology/drug effects/*metabolism', 'Niacin/*metabolism', 'Organic Anion Transporters, Sodium-Independent/*metabolism', 'Rifamycins/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/32001236/
1749,RARB,24492483,Synergistic chromatin repression of the tumor suppressor gene RARB in human prostate cancers.,"['Moison C', 'Assemat F', 'Daunay A', 'Tost J', 'Guieysse-Peugeot AL', 'Arimondo PB']","['Aged', 'Chromatin/*metabolism', 'CpG Islands', 'DNA Methylation', '*Genes, Tumor Suppressor', 'Histones/metabolism', 'Humans', 'Male', 'Middle Aged', 'Promoter Regions, Genetic', 'Prostatic Neoplasms/*metabolism/pathology', 'Receptors, Retinoic Acid/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/24492483/
1750,RARB,36214504,Epigenetic regulation of RARB overcomes the radio-resistance of colorectal carcinoma cells via cancer stem cells.,"['Shu Y', 'Lan J', 'Hu Z', 'Liu W', 'Song R']","['Humans', 'Cell Line, Tumor', '*Colorectal Neoplasms/genetics/radiotherapy', '*Epigenesis, Genetic', 'Gene Expression Regulation, Neoplastic', 'HCT116 Cells', 'Neoplastic Stem Cells/pathology', '*Receptors, Retinoic Acid/genetics']",https://pubmed.ncbi.nlm.nih.gov/36214504/
1751,RARB,39179979,"RARB associated with MSI, affects progression and prognosis of gastric cancer.","['Cai X', 'Lin W', 'Wu F', 'Song G', 'Qian Z', 'Wang Y']","['Female', 'Humans', 'Male', 'Middle Aged', 'Cell Line, Tumor', 'Cell Movement/genetics', '*Cell Proliferation/genetics', '*Disease Progression', 'Down-Regulation', '*Epithelial-Mesenchymal Transition/genetics', 'Gene Knockdown Techniques', '*Microsatellite Instability', 'Neoplasm Invasiveness/genetics', 'Prognosis', '*Stomach Neoplasms/genetics/pathology/mortality', '*Receptors, Retinoic Acid/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39179979/
1752,RARB,37331258,Exploring the interactions of antihistamine with retinoic acid receptor beta (RARB) by molecular dynamics simulations and genome-wide meta-analysis.,"['Kim MJ', 'Kulkarni V', 'Goode MA', 'Sivesind TE']","['Humans', '*Molecular Dynamics Simulation', 'Receptors, Histamine H1/genetics', '*HIV Infections', 'Receptors, Retinoic Acid/genetics/metabolism', 'Histamine Antagonists/pharmacology/therapeutic use', 'Histamine H1 Antagonists/pharmacology/therapeutic use', 'Alitretinoin', 'Tretinoin/metabolism/pharmacology']",https://pubmed.ncbi.nlm.nih.gov/37331258/
1753,RARB,37548362,Promoter hypermethylation of RARB and GSTP1 genes in plasma cell-free DNA as breast cancer biomarkers in Peruvian women.,"['Danos P', 'Giannoni-Luza S', 'Murillo Carrasco AG', 'Acosta O', 'Guevara-Fujita ML', 'Cotrina Concha JM', 'Guerra Miller H', 'Pinto Oblitas J', 'Aguilar Cartagena A', 'Araujo JM', 'Fujita R', 'Buleje Sono JL']","['Female', 'Humans', 'Middle Aged', 'Biomarkers, Tumor/genetics', 'Breast/pathology', '*Breast Neoplasms/genetics/pathology', 'Case-Control Studies', 'DNA Methylation', 'Glutathione S-Transferase pi/genetics', 'Peru']",https://pubmed.ncbi.nlm.nih.gov/37548362/
1754,RARB,26823825,"DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.","['Sun Y', 'Li S', 'Shen K', 'Ye S', 'Cao D', 'Yang J']","['Adult', 'Aged', 'Area Under Curve', 'Biomarkers, Tumor/analysis/*genetics', 'DNA Methylation', 'DNA Modification Methylases/analysis/*genetics', 'DNA Repair Enzymes/analysis/*genetics', 'Death-Associated Protein Kinases/analysis/*genetics', 'Female', 'Humans', 'Middle Aged', 'Neoplasm Grading', '*Promoter Regions, Genetic', 'ROC Curve', 'Receptors, Retinoic Acid/analysis/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction/methods', 'Sensitivity and Specificity', 'Tumor Suppressor Proteins/analysis/*genetics', 'Uterine Cervical Neoplasms/genetics/*pathology', 'Uterine Cervical Dysplasia/genetics/*pathology']",https://pubmed.ncbi.nlm.nih.gov/26823825/
1755,RARB,39450403,A De Novo Noncoding RARB Variant Associated with Complex Microphthalmia Alters a Putative Regulatory Element.,"['Replogle MR', 'Thompson S', 'Reis LM', 'Semina EV']","['Humans', '*Microphthalmos/genetics', '*Receptors, Retinoic Acid/genetics/metabolism', 'Alternative Splicing', 'Regulatory Sequences, Nucleic Acid/genetics', 'Male', 'Gene Expression Regulation', 'Mutation', 'Female']",https://pubmed.ncbi.nlm.nih.gov/39450403/
1756,RARB,25805039,"Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.","['Pirouzpanah S', 'Taleban FA', 'Mehdipour P', 'Atri M']","['Adult', 'BRCA1 Protein/*genetics', 'Breast/metabolism/pathology', 'Breast Neoplasms/*genetics/metabolism/pathology', '*DNA Methylation', 'Diet', 'Female', 'Folic Acid/*metabolism', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Middle Aged', 'Promoter Regions, Genetic', 'Receptors, Retinoic Acid/*genetics', 'Tumor Suppressor Proteins/*genetics', 'Vitamin B 12/metabolism']",https://pubmed.ncbi.nlm.nih.gov/25805039/
1757,RARB,37283355,Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion.,"['Kirkham JK', 'Liu YC', 'Foy SG', 'Ma J', 'Gheorghe G', 'Furtado LV', 'Popescu MI', 'Klco JM', 'Karol SE', 'Blackburn PR']","['Male', 'Humans', 'Adolescent', '*Leukemia, Promyelocytic, Acute/drug therapy/genetics/metabolism', 'Translocation, Genetic', 'Tretinoin/therapeutic use', '*Leukemia, Myeloid, Acute/genetics', 'Retinoic Acid Receptor alpha/genetics', 'Genomics', 'Oncogene Proteins, Fusion/genetics', 'Fibronectins/genetics']",https://pubmed.ncbi.nlm.nih.gov/37283355/
1758,RARB,27120018,Gain-of-Function Mutations in RARB Cause Intellectual Disability with Progressive Motor Impairment.,"['Srour M', 'Caron V', 'Pearson T', 'Nielsen SB', 'Levesque S', 'Delrue MA', 'Becker TA', 'Hamdan FF', 'Kibar Z', 'Sattler SG', 'Schneider MC', 'Bitoun P', 'Chassaing N', 'Rosenfeld JA', 'Xia F', 'Desai S', 'Roeder E', 'Kimonis V', 'Schneider A', 'Littlejohn RO', 'Douzgou S', 'Tremblay A', 'Michaud JL']","['Adolescent', 'Child', 'Child, Preschool', 'Dystonic Disorders', 'Female', '*Gain of Function Mutation', 'Humans', 'Infant, Newborn', 'Intellectual Disability/*genetics', 'Male', 'Models, Molecular', 'Movement Disorders/*genetics', 'Mutation, Missense', 'Protein Conformation', 'Receptors, Retinoic Acid/chemistry/*genetics', 'Transcriptional Activation']",https://pubmed.ncbi.nlm.nih.gov/27120018/
1759,RARB,24414001,RARB and STMN2 polymorphisms are not associated with sporadic Creutzfeldt-Jakob disease (CJD) in the Korean population.,"['Jeong BH', 'Kim HJ', 'Lee KH', 'Carp RI', 'Kim YS']","['Aged', 'Alleles', 'Asian People/*genetics', 'Creutzfeldt-Jakob Syndrome/*genetics', 'Female', 'Gene Frequency', '*Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Haplotypes', 'Humans', 'Male', 'Membrane Proteins/*genetics', 'Middle Aged', '*Polymorphism, Genetic', 'Receptors, Retinoic Acid/*genetics', 'Republic of Korea', 'Sex Factors', 'Stathmin']",https://pubmed.ncbi.nlm.nih.gov/24414001/
1760,RARB,1665705,Implication of RARB in epidermoid (Squamous) lung cancer.,"['Houle B', 'Leduc F', 'Bradley WE']","['Carcinoma, Non-Small-Cell Lung/genetics', 'Carcinoma, Small Cell/*genetics', 'Carcinoma, Squamous Cell/*genetics', 'Carrier Proteins/*genetics', 'Cell Line', '*Chromosome Deletion', '*Chromosomes, Human, Pair 3', 'DNA, Neoplasm/genetics/isolation & purification', 'Heterozygote', 'Humans', 'Lung Neoplasms/*genetics', 'Receptors, Retinoic Acid']",https://pubmed.ncbi.nlm.nih.gov/1665705/
1761,RARB,18036402,"DNA methylation patterns of the CDH1, RARB, and SFN genes in choroid plexus tumors.","['Losi-Guembarovski R', 'Kuasne H', 'Guembarovski AL', 'Rainho CA', 'Colus IM']","['14-3-3 Proteins', 'Aged', 'Antigens, CD', 'Biomarkers, Tumor/*genetics', 'Cadherins/*genetics', 'Carcinoma/genetics', 'Child', 'Child, Preschool', 'Choroid Plexus/metabolism', 'Choroid Plexus Neoplasms/*genetics', '*DNA Methylation', 'Exonucleases/*genetics', 'Exoribonucleases', 'Female', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Neoplasm Proteins/*genetics', 'Papilloma/genetics', 'Receptors, Retinoic Acid/*genetics', 'Retrospective Studies']",https://pubmed.ncbi.nlm.nih.gov/18036402/
1762,RARB,34086186,MiR-141-3p and miR-200a-3p are involved in Th17 cell differentiation by negatively regulating RARB expression.,"['Bahmani L', 'Baghi M', 'Peymani M', 'Javeri A', 'Ghaedi K']","['Autoimmune Diseases/genetics/immunology', 'Cell Differentiation/*genetics', 'Cells, Cultured', 'Gene Expression/*genetics', 'Gene Expression Regulation, Developmental/*genetics', 'Humans', 'MicroRNAs/*genetics/*physiology', 'Receptors, Retinoic Acid/*genetics/*metabolism', 'Th17 Cells/*physiology']",https://pubmed.ncbi.nlm.nih.gov/34086186/
1763,RARB,27342319,miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway.,"['Shen CT', 'Qiu ZL', 'Song HJ', 'Wei WJ', 'Luo QY']","[""3' Untranslated Regions"", 'Adult', 'Carcinoma, Papillary/*genetics/pathology', 'Cell Line, Tumor', 'Cell Proliferation', 'Cell Survival', 'Female', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Iodine/metabolism', 'Lung Neoplasms/genetics/*secondary', 'MAP Kinase Signaling System', 'Male', 'MicroRNAs/*genetics/metabolism', 'Middle Aged', 'Receptors, Retinoic Acid/*genetics', 'Receptors, Thyrotropin/metabolism', 'Symporters/*metabolism', 'Thyroid Cancer, Papillary', 'Thyroid Neoplasms/*genetics/pathology', 'Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/27342319/
1764,RARB,10198169,"Linkage of the nuclear hormone receptor genes NR1D2, THRB, and RARB: evidence for an ancient, large-scale duplication.","['Koh YS', 'Moore DD']","['Chromosomes, Human, Pair 3/*genetics', 'Contig Mapping', 'DNA-Binding Proteins/genetics', 'Gene Duplication', 'Genetic Linkage', 'Humans', 'In Situ Hybridization, Fluorescence', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Retinoic Acid/genetics', 'Receptors, Thyroid Hormone/genetics']",https://pubmed.ncbi.nlm.nih.gov/10198169/
1765,RARB,37321544,De novo retinoic acid receptor beta (RARB) variant associated with microphthalmia and dystonia.,"['Trieschmann G', 'Wilhelm C', 'Berweck S', 'Zech M']","['Female', 'Humans', '*Dystonia', '*Dystonic Disorders', '*Eye Abnormalities', '*Microphthalmos/genetics', '*Movement Disorders', 'Receptors, Retinoic Acid/genetics']",https://pubmed.ncbi.nlm.nih.gov/37321544/
1766,RARB,16157195,"Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes.","['Chan EC', 'Lam SY', 'Fu KH', 'Kwong YL']","['Asian People', 'Carcinoma, Non-Small-Cell Lung/*genetics', 'DNA Methylation', 'DNA-Binding Proteins/*genetics', 'Female', '*Genes, p16', 'Genotype', 'Glutathione S-Transferase pi', 'Glutathione Transferase/*genetics', 'Granulocyte Colony-Stimulating Factor', 'Hematopoietic Cell Growth Factors/*genetics', 'Humans', 'Interleukin-3', 'Isoenzymes/*genetics', 'Lung Neoplasms/*genetics', 'Male', 'Middle Aged', '*Polymorphism, Genetic', 'Promoter Regions, Genetic', 'Receptors, Retinoic Acid/*genetics', 'Recombinant Fusion Proteins/*genetics', 'Recombinant Proteins', 'X-ray Repair Cross Complementing Protein 1']",https://pubmed.ncbi.nlm.nih.gov/16157195/
1767,RARA,33428799,Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA.,"['Wang Z', 'Wen L', 'Zhang L', 'Xu X', 'Chen X', 'Yao L', 'Wang M', 'Shen Z', 'Mo G', 'Wang Y', 'Zhao D', 'Cai W', 'Shen J', 'Chi X', 'Xu Y', 'Zeng Z', 'Pan J', 'Ruan C', 'Wu D', 'Jia Z', 'Chen S']","['Chromosomes, Human, Pair 15/*genetics', 'Chromosomes, Human, Pair 17/*genetics', 'Gene Expression Regulation, Leukemic', 'Humans', 'In Situ Hybridization, Fluorescence', 'Intracellular Signaling Peptides and Proteins/*genetics/metabolism', 'Leukemia, Promyelocytic, Acute/*genetics/metabolism/pathology', 'Male', 'Middle Aged', 'Oncogene Proteins, Fusion/*genetics/metabolism', 'Retinoic Acid Receptor alpha/*genetics/metabolism', '*Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/33428799/
1768,RARA,37655965,Structural Basis of PML-RARA Oncoprotein Targeting by Arsenic Unravels a Cysteine Rheostat Controlling PML Body Assembly and Function.,"['Bercier P', 'Wang QQ', 'Zang N', 'Zhang J', 'Yang C', 'Maimaitiyiming Y', 'Abou-Ghali M', 'Berthier C', 'Wu C', 'Niwa-Kawakita M', 'Dirami T', 'Geoffroy MC', 'Ferhi O', 'Quentin S', 'Benhenda S', 'Ogra Y', 'Gueroui Z', 'Zhou C', 'Naranmandura H', 'de The H', 'Lallemand-Breitenbach V']","['Humans', '*Arsenic/pharmacology', 'Promyelocytic Leukemia Nuclear Bodies', 'Cysteine', '*Arsenicals/pharmacology', 'Oxides/pharmacology', 'Arsenic Trioxide/pharmacology', '*Leukemia, Promyelocytic, Acute/drug therapy/genetics/metabolism', 'Oncogene Proteins', 'Oncogene Proteins, Fusion/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37655965/
1769,RARA,35427362,The Escherichia coli serS gene promoter region overlaps with the rarA gene.,"['Jain K', 'Stanage TH', 'Wood EA', 'Cox MM']","['*Amino Acyl-tRNA Synthetases/genetics', 'Escherichia coli/metabolism', 'Promoter Regions, Genetic', '*Serine-tRNA Ligase/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35427362/
1770,RARA,38294534,"Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia.","['Chen Y', 'Pan M', 'Chen L', 'Peng M', 'Liu Z', 'Fang Y', 'Du Y', 'Yang Y', 'Xu P']","['Humans', '*Leukemia, Promyelocytic, Acute/diagnosis/genetics/drug therapy', 'In Situ Hybridization, Fluorescence', 'Tretinoin/therapeutic use', 'Retinoic Acid Receptor alpha/genetics', 'Carrier Proteins/genetics', 'Translocation, Genetic', 'Oncogene Proteins, Fusion/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/38294534/
1771,RARA,21156244,FISH-negative cryptic PML-RARA rearrangement detected by long-distance polymerase chain reaction and sequencing analyses: a case study and review of the literature.,"['Kim MJ', 'Cho SY', 'Kim MH', 'Lee JJ', 'Kang SY', 'Cho EH', 'Huh J', 'Yoon HJ', 'Park TS', 'Lee WI', 'Marschalek R', 'Meyer C']","['Adolescent', 'Adult', 'Chromosomes/ultrastructure', '*Cytogenetics', 'Female', '*Gene Rearrangement', 'Genome, Human', 'Humans', 'In Situ Hybridization, Fluorescence', 'Karyotyping', 'Male', 'Middle Aged', 'Oncogene Proteins, Fusion/*genetics', 'Polymerase Chain Reaction/*methods', 'Reverse Transcriptase Polymerase Chain Reaction/methods', 'Sequence Analysis, DNA/*methods']",https://pubmed.ncbi.nlm.nih.gov/21156244/
1772,RARA,25197424,"Tetraploidy acute promyelocytic leuemia with double t(15;17)/PML-RARA, a case report with review of literature.","['Dalia SM', 'Horna P', 'Zhang L']","['Antineoplastic Combined Chemotherapy Protocols/therapeutic use', 'Flow Cytometry', 'Humans', 'Idarubicin/administration & dosage', 'In Situ Hybridization, Fluorescence', 'Leukemia, Promyelocytic, Acute/drug therapy/*genetics/pathology', 'Male', 'Middle Aged', 'Oncogene Proteins, Fusion/*genetics', 'Tetraploidy', 'Translocation, Genetic', 'Tretinoin/administration & dosage']",https://pubmed.ncbi.nlm.nih.gov/25197424/
1773,RARA,31662438,"MED12, TERT and RARA in fibroepithelial tumours of the breast.","['Chang HY', 'Koh VCY', 'Md Nasir ND', 'Ng CCY', 'Guan P', 'Thike AA', 'Teh BT', 'Tan PH']","['Biomarkers, Tumor/*genetics', 'Breast Neoplasms/*genetics/pathology', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Mediator Complex/*genetics', '*Mutation', 'Mutation Rate', 'Neoplasms, Fibroepithelial/*genetics/pathology', 'Phenotype', 'Retinoic Acid Receptor alpha/*genetics', 'Risk Factors', 'Telomerase/*genetics', 'Transcriptome']",https://pubmed.ncbi.nlm.nih.gov/31662438/
1774,RARA,2220349,"Primary melanoma of the cervix uteri, an avis rara? A review of the literature.","['Vleugels MP', 'Brolmann HA', 'van Beek M']","['Female', 'Humans', '*Melanoma/pathology', 'Middle Aged', '*Uterine Neoplasms/pathology']",https://pubmed.ncbi.nlm.nih.gov/2220349/
1775,RARA,39046762,Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APL.,"['Zhou X', 'Chen X', 'Chen J', 'Wen L', 'Zhang Z', 'Qin YZ', 'Cao P', 'Xing H', 'Mi Y', 'Wang W', 'Zhang G', 'Li J', 'Wu H', 'Zhang Z', 'Zhang J', 'Su Z', 'Wang F', 'Zhang Y', 'Ma X', 'Fang J', 'Wu P', 'Wang T', 'Fan G', 'Zhao Y', 'Jin D', 'Zhang X', 'Ma X', 'Wu Q', 'Zhang Z', 'Wang L', 'Ma F', 'Xiao X', 'Wu C', 'Sun K', 'Tang R', 'Zhang Y', 'Wu S', 'Gao R', 'Zhang L', 'Zheng H', 'Zhao Y', 'Zhu HH', 'Lu D', 'Lu P', 'Chen S', 'Liu H']","['Humans', '*Leukemia, Promyelocytic, Acute/genetics/metabolism/pathology', '*Retinoic Acid Receptor alpha/genetics/metabolism', '*Oncogene Proteins, Fusion/genetics/metabolism', '*Retinoic Acid Receptor gamma', 'Receptors, Retinoic Acid/genetics/metabolism', 'Male', 'Tretinoin/metabolism', 'Female']",https://pubmed.ncbi.nlm.nih.gov/39046762/
1776,RARA,36130886,A Pathogenic NRAS c.38G>A (p.G13D) Mutation in RARA Translocation-negative Acute Promyelocytic-like Leukemia with Concomitant Myelodysplastic Syndrome.,"['Goto H', 'Yakushijin K', 'Adachi Y', 'Matsumoto H', 'Yamamoto K', 'Matsumoto S', 'Yamashita T', 'Higashime A', 'Kawaguchi K', 'Kurata K', 'Matsuoka H', 'Minami H']","['Aged', 'Humans', 'Male', 'Granulocyte Precursor Cells/pathology', 'GTP Phosphohydrolases/genetics', '*Leukemia, Promyelocytic, Acute/complications/diagnosis/genetics', 'Membrane Proteins/genetics', 'Mutation/genetics', '*Myelodysplastic Syndromes/complications/genetics', 'Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/36130886/
1777,RARA,34230915,PML/RARA destabilization by hyperthermia: a new model for oncogenic fusion protein degradation?,"['Wu HC', 'Rerolle D', 'de The H']","['Arsenic Trioxide', '*Arsenicals/pharmacology', 'Humans', '*Hyperthermia, Induced', '*Leukemia, Promyelocytic, Acute/metabolism', 'Oxides/pharmacology', 'Proteolysis']",https://pubmed.ncbi.nlm.nih.gov/34230915/
1778,RARA,28183680,Diagnosis of variant RARA translocation using standard dual-color dual-fusion PML/RARA FISH probes: An illustrative report.,"['Singh MK', 'Parihar M', 'Arora N', 'Mishra DK', 'Bhave SJ', 'Chandy M']","['Adult', 'Humans', '*In Situ Hybridization, Fluorescence', '*Leukemia, Promyelocytic, Acute/diagnosis/genetics/pathology', 'Male', 'Oncogene Proteins, Fusion/*genetics', '*Reverse Transcriptase Polymerase Chain Reaction', '*Translocation, Genetic']",https://pubmed.ncbi.nlm.nih.gov/28183680/
1779,GSK3B,25535399,Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes.,"['Park SB', 'Kwok JB', 'Loy CT', 'Friedlander ML', 'Lin CS', 'Krishnan AV', 'Lewis CR', 'Kiernan MC']","['Adult', 'Aged', 'Antineoplastic Agents, Phytogenic/*adverse effects/therapeutic use', 'Female', 'Genotype', 'Glycogen Synthase Kinase 3/genetics', 'Glycogen Synthase Kinase 3 beta', 'Humans', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Neoplasms/*complications/diagnosis/drug therapy/genetics', 'Paclitaxel/*adverse effects/therapeutic use', 'Peripheral Nervous System Diseases/diagnosis/*etiology', 'Polymorphism, Genetic', 'tau Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/25535399/
1780,GSK3B,35821283,Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma.,"['Zhu MC', 'Zhang YH', 'Xiong P', 'Fan XW', 'Li GL', 'Zhu M']","['Humans', 'RNA, Circular/genetics', 'beta Catenin/genetics', 'Glycogen Synthase Kinase 3 beta/genetics/metabolism', '*MicroRNAs/genetics/metabolism', 'Gene Expression Regulation, Neoplastic', 'Cell Proliferation/genetics', 'Cell Line, Tumor', '*Adenocarcinoma of Lung/genetics/metabolism/pathology', '*Lung Neoplasms/pathology']",https://pubmed.ncbi.nlm.nih.gov/35821283/
1781,GSK3B,18588978,Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures.,"['Rankin CA', 'Sun Q', 'Gamblin TC']","['Alzheimer Disease/*metabolism/physiopathology', 'Brain/metabolism/pathology/ultrastructure', 'Catalytic Domain/physiology', 'Cell-Free System/chemistry/metabolism', 'Epitopes/chemistry/metabolism', 'Glycogen Synthase Kinase 3/chemistry/*metabolism', 'Glycogen Synthase Kinase 3 beta', 'Humans', 'Models, Biological', 'Neurofibrillary Tangles/chemistry/*metabolism/pathology', 'Neurons/*metabolism/pathology/ultrastructure', 'Phosphorylation', 'Polymers/chemistry/metabolism', 'Protein Binding', 'tau Proteins/chemistry/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/18588978/
1782,GSK3B,23525328,"Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype.","['Izzo G', 'Forlenza OV', 'Santos Bd', 'Bertolucci PH', 'Ojopi EB', 'Gattaz WF', 'Kerr DS']","['Adaptor Proteins, Signal Transducing/*genetics', 'Age of Onset', 'Aged', 'Alzheimer Disease/*genetics', 'Apolipoprotein E4/*genetics', 'Cytoskeletal Proteins/*genetics', 'Female', 'Humans', 'LDL-Receptor Related Proteins/*genetics', 'Male', 'Membrane Transport Proteins/*genetics', 'Nuclear Proteins/*genetics', 'Polymorphism, Single Nucleotide/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/23525328/
1783,GSK3B,35005835,MicroRNA-214-3p facilitates M2 macrophage polarization by targeting GSK3B.,"['Peng LY', 'Li BB', 'Deng KB', 'Wang WG']","['Down-Regulation', 'Glycogen Synthase Kinase 3 beta/genetics/metabolism', 'Humans', 'Macrophage Activation/genetics', 'Macrophages/metabolism', '*MicroRNAs/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35005835/
1784,GSK3B,38814517,beta-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression.,"['Wang R', 'Tang D', 'Ou L', 'Jiang J', 'Wu YN', 'Tian X']","['Humans', '*Sitosterols/pharmacology', '*Glycogen Synthase Kinase 3 beta/metabolism/genetics', '*Carcinoma, Hepatocellular/pathology/genetics/drug therapy/metabolism', '*Liver Neoplasms/pathology/genetics/drug therapy/metabolism', '*Cell Proliferation/drug effects/genetics', '*Apoptosis/drug effects/genetics', 'Cell Line, Tumor', '*Epithelial-Mesenchymal Transition/drug effects/genetics', 'Cell Movement/drug effects/genetics', 'Gene Expression/genetics/drug effects', 'Phenotype', 'Neoplasm Invasiveness/genetics', 'Cell Survival/drug effects/genetics', 'Network Pharmacology', 'Gene Expression Regulation, Neoplastic/drug effects']",https://pubmed.ncbi.nlm.nih.gov/38814517/
1785,GSK3B,31665698,A comprehensive analysis of GSK3B variation for schizophrenia in Han Chinese individuals.,"['Chen Y', 'Hua S', 'Wang W', 'Fan W', 'Tang W', 'Zhang Y', 'Zhang C']","['Asian People/*genetics', 'China', 'Cognitive Dysfunction/etiology/*genetics', 'Glycogen Synthase Kinase 3 beta/*genetics', 'Hippocampus/*metabolism', 'Humans', 'Schizophrenia/complications/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31665698/
1786,GSK3B,15981102,"Infrequent mutation of APC, AXIN1, and GSK3B in human pituitary adenomas with abnormal accumulation of CTNNB1.","['Sun C', 'Yamato T', 'Kondo E', 'Furukawa T', 'Ikeda H', 'Horii A']","['Adenoma/*genetics/metabolism', 'Adenomatous Polyposis Coli Protein/*genetics', 'Adult', 'Aged', 'Axin Protein', 'Cytoskeletal Proteins/*metabolism', 'DNA Mutational Analysis', 'Female', 'Gene Expression Regulation, Neoplastic', 'Glycogen Synthase Kinase 3/*genetics', 'Glycogen Synthase Kinase 3 beta', 'Humans', 'Intercellular Signaling Peptides and Proteins/metabolism', 'Male', 'Middle Aged', 'Pituitary Neoplasms/*genetics/metabolism', 'Repressor Proteins/*genetics', 'Signal Transduction/genetics', 'Trans-Activators/*metabolism', 'Wnt Proteins', 'beta Catenin']",https://pubmed.ncbi.nlm.nih.gov/15981102/
1787,GSK3B,34162557,Downregulation of GSK3B by miR-132-3p Enhances Etoposide-Induced Breast Cancer Cell Apoptosis.,"['Xu C', 'Du Z', 'Ren S', 'Pian Y']","['Antineoplastic Agents, Phytogenic/pharmacology', 'Apoptosis', 'Biomarkers, Tumor/genetics/*metabolism', 'Breast Neoplasms/drug therapy/genetics/metabolism/*pathology', 'Cell Proliferation', 'Etoposide/*pharmacology', 'Female', 'Gene Expression Regulation, Neoplastic/*drug effects', 'Glycogen Synthase Kinase 3 beta/genetics/*metabolism', 'Humans', 'MicroRNAs/*genetics', 'Neoplasms/genetics/metabolism/*pathology', 'Prognosis', 'Survival Rate', 'Tumor Cells, Cultured']",https://pubmed.ncbi.nlm.nih.gov/34162557/
1788,GSK3B,23951236,GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals.,"['Dobson-Stone C', 'Polly P', 'Korgaonkar MS', 'Williams LM', 'Gordon E', 'Schofield PR', 'Mather K', 'Armstrong NJ', 'Wen W', 'Sachdev PS', 'Kwok JB']","['Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Brain/*anatomy & histology/*metabolism', 'Cohort Studies', 'Female', '*Genetic Association Studies', 'Genotype', 'Glycogen Synthase Kinase 3/*genetics', 'Glycogen Synthase Kinase 3 beta', 'Humans', 'Male', 'Middle Aged', 'Organ Size', '*Polymorphism, Genetic', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Transcription, Genetic', 'Young Adult', 'tau Proteins/*genetics']",https://pubmed.ncbi.nlm.nih.gov/23951236/
1789,REN,24864403,Antibiotics or no antibiotics: reflections on Ren and Malmstrom.,"['Berenstein D', 'Freymiller EG', 'Leizerovitz M']","['*Antibiotic Prophylaxis', 'Dry Socket/prevention & control', 'Humans', 'Molar, Third/*surgery', 'Postoperative Complications/*prevention & control', 'Surgical Wound Infection/prevention & control', '*Tooth Extraction/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/24864403/
1790,REN,38411777,"Genetic Appraisal of RAAS-Associated SNPs: REN (rs16853055), AGT (rs3789678) and ACE (rs4305) in Preeclamptic Women Living with HIV Infection.","['Govindsamy A', 'Singh S', 'Naicker T']","['Humans', 'Pregnancy', 'Female', '*Pre-Eclampsia/genetics', '*HIV Infections/genetics/complications', '*Polymorphism, Single Nucleotide/genetics', '*Angiotensinogen/genetics', '*Renin-Angiotensin System/genetics', '*Renin/genetics', '*Peptidyl-Dipeptidase A/genetics', 'Genetic Predisposition to Disease', 'Pregnancy Complications, Infectious/genetics/virology']",https://pubmed.ncbi.nlm.nih.gov/38411777/
1791,REN,26133929,"Complete genome sequence of Lactobacillus salivarius Ren, a probiotic strain with anti-tumor activity.","['Sun E', 'Ren F', 'Liu S', 'Ge S', 'Zhang M', 'Guo H', 'Jiang L', 'Zhang H', 'Zhao L']","['Aged, 80 and over', 'Antineoplastic Agents/pharmacology', 'Bacterial Proteins/genetics/pharmacology', 'Base Composition', 'China', 'Feces/microbiology', 'Genome Size', '*Genome, Bacterial', 'Humans', 'Lactobacillus/*genetics', 'Molecular Sequence Data', 'Probiotics', 'Sequence Analysis, DNA/*methods']",https://pubmed.ncbi.nlm.nih.gov/26133929/
1792,REN,2563155,HinfI RFLP at the human renin (REN) gene locus.,['Masharani U'],"['Chromosome Mapping', '*Chromosomes, Human, Pair 1', 'Deoxyribonucleases, Type II Site-Specific', '*Genes', 'Humans', '*Polymorphism, Genetic', '*Polymorphism, Restriction Fragment Length', 'Renin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/2563155/
1793,REN,31913517,Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine.,"['Rapoport AM', 'Lin T', 'Tepper SJ']","['Acute Disease', '*Analgesia/instrumentation/methods', '*Electric Stimulation Therapy/instrumentation/methods', 'Humans', '*Median Nerve', 'Migraine Disorders/*therapy', '*Musculocutaneous Nerve', 'Wearable Electronic Devices']",https://pubmed.ncbi.nlm.nih.gov/31913517/
1794,REN,32045853,Zao Ren An Shen for insomnia: a systematic review with meta-analysis.,"['Birling Y', 'Jia M', 'Li G', 'Sarris J', 'Bensoussan A', 'Zhu X']","['Databases, Factual', 'Drugs, Chinese Herbal/*therapeutic use', 'Humans', '*Randomized Controlled Trials as Topic', 'Sleep Initiation and Maintenance Disorders/*drug therapy', 'Surveys and Questionnaires']",https://pubmed.ncbi.nlm.nih.gov/32045853/
1795,REN,14586105,"A thermostable laccase from Streptomyces lavendulae REN-7: purification, characterization, nucleotide sequence, and expression.","['Suzuki T', 'Endo K', 'Ito M', 'Tsujibo H', 'Miyamoto K', 'Inamori Y']","['Base Sequence', 'Catechol Oxidase', 'Enzyme Stability', 'Escherichia coli/genetics', 'Hydrazones/metabolism', 'Laccase/chemistry/*genetics/*isolation & purification', 'Molecular Sequence Data', 'Streptomyces/*enzymology', 'Substrate Specificity', 'Temperature']",https://pubmed.ncbi.nlm.nih.gov/14586105/
1796,REN,1723718,"A traditional Chinese herbal medicine, ren-shen-yang-rong-tang (Japanese name: ninjin-yoei-to) augments the production of granulocyte-macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro.","['Okamura S', 'Shimoda K', 'Yu LX', 'Omori F', 'Niho Y']","['Dose-Response Relationship, Drug', 'Drugs, Chinese Herbal/*pharmacology', 'Enzyme-Linked Immunosorbent Assay', 'Granulocyte Colony-Stimulating Factor', 'Granulocyte-Macrophage Colony-Stimulating Factor/*biosynthesis', 'Humans', 'In Vitro Techniques', 'Leukocytes, Mononuclear/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/1723718/
1797,REN,29624573,Emotion computing using Word Mover's Distance features based on Ren_CECps.,"['Ren F', 'Liu N']","['Algorithms', '*Artificial Intelligence', '*Computer Simulation', '*Emotions', 'Humans', '*Models, Theoretical']",https://pubmed.ncbi.nlm.nih.gov/29624573/
1798,DHODH,39761766,Ferroptosis and PANoptosis under hypoxia pivoting on the crosstalk between DHODH and GPX4 in corneal epithelium.,"['Wu MF', 'Peng X', 'Zhang MC', 'Guo H', 'Xie HT']","['*Ferroptosis/genetics', '*Phospholipid Hydroperoxide Glutathione Peroxidase/metabolism/genetics', 'Humans', '*Oxidoreductases Acting on CH-CH Group Donors/metabolism/genetics', '*Lipid Peroxidation/genetics', '*Epithelium, Corneal/metabolism/pathology', '*Reactive Oxygen Species/metabolism', '*Dihydroorotate Dehydrogenase/metabolism', 'Cell Hypoxia', 'Membrane Potential, Mitochondrial', 'Cell Line', 'Mitochondria/metabolism/genetics/pathology', 'Cell Survival', 'Gene Expression Regulation', 'Gene Knockdown Techniques', 'Quinoxalines', 'Spiro Compounds']",https://pubmed.ncbi.nlm.nih.gov/39761766/
1799,DHODH,37665563,"Discovery of dual-target natural antimalarial agents against DHODH and PMT of Plasmodium falciparum: pharmacophore modelling, molecular docking, quantum mechanics, and molecular dynamics simulations.","['Elamin EM', 'Eshage SE', 'Mohmmode SM', 'Mukhtar RM', 'Mahjoub M', 'Sadelin E', 'Shoaib TH', 'Edris A', 'Elshamly EM', 'Makki AA', 'Ashour A', 'Sherif AE', 'Osman W', 'Ibrahim SRM', 'Mohamed GA', 'Alzain AA']","['Humans', 'Dihydroorotate Dehydrogenase', '*Antimalarials/pharmacology/chemistry', 'Molecular Docking Simulation', 'Plasmodium falciparum', 'Molecular Dynamics Simulation', '*Oxidoreductases Acting on CH-CH Group Donors/chemistry/metabolism', 'Pharmacophore', 'Quantitative Structure-Activity Relationship', '*Malaria/drug therapy']",https://pubmed.ncbi.nlm.nih.gov/37665563/
1800,DHODH,37821729,"Parasitic Protozoans: Exploring the Potential of N,N'-Bis[2-(5-bromo-7-azabenzimidazol-1-yl)-2-oxoethyl]ethylene-1,3-Diamine and Its Cyclohexyl-1,2-diamine Analogue as TryR and Pf-DHODH Inhibitors.","['Oluwafemi KA', 'Oyeneyin OE', 'Babatunde DD', 'Agbaffa EB', 'Aigbogun JA', 'Odeja OO', 'Emmanuel AV']","['Dihydroorotate Dehydrogenase', '*Enzyme Inhibitors/pharmacology', 'Ethylenes', '*Plasmodium falciparum/drug effects', '*Trypanosoma/drug effects']",https://pubmed.ncbi.nlm.nih.gov/37821729/
1801,DHODH,34747629,"Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomide.","['Makarem YS', 'Hareedy MS', 'Hassanien M', 'Ahmed EA', 'Hetta HF', 'Mohamed AA']","['ATP Binding Cassette Transporter, Subfamily G, Member 2/*genetics', 'Adult', 'Aged', 'Antirheumatic Agents/adverse effects/pharmacology', 'Arthritis, Rheumatoid/diet therapy/genetics', 'Cytochrome P-450 CYP2C19/*genetics', 'Dihydroorotate Dehydrogenase/*genetics', 'Female', 'Gene Frequency/genetics', 'Genotype', 'Humans', 'Leflunomide/*adverse effects/*pharmacology', 'Male', 'Middle Aged', 'Neoplasm Proteins/*genetics', 'Pharmacogenetics/methods', 'Polymorphism, Single Nucleotide/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/34747629/
1802,DHODH,32339392,Precision Medicine With Leflunomide: Consideration of the DHODH Haplotype and Plasma Teriflunomide Concentration and Modification of Outcomes in Patients With Rheumatoid Arthritis.,"['Wiese MD', 'Hopkins AM', 'King C', 'Wechalekar MD', 'Lee A', 'Spargo L', 'Metcalf R', 'McWilliams L', 'Hill C', 'Cleland LG', 'Proudman SM']","['Adult', 'Arthritis, Rheumatoid/diagnosis/*drug therapy/genetics', 'Crotonates/blood/*pharmacokinetics', 'Dihydroorotate Dehydrogenase', 'Drug Monitoring', 'Enzyme Inhibitors/administration & dosage/blood/*pharmacokinetics', 'Female', 'Haplotypes', 'Humans', 'Hydroxybutyrates/blood/*pharmacokinetics', 'Immunosuppressive Agents/administration & dosage/blood/*pharmacokinetics', 'Leflunomide/administration & dosage/blood/*pharmacokinetics', 'Male', 'Middle Aged', 'Nitriles/blood/*pharmacokinetics', 'Oxidoreductases Acting on CH-CH Group Donors/*antagonists & inhibitors/*genetics/metabolism', 'Pharmacogenetics', '*Pharmacogenomic Variants', '*Polymorphism, Single Nucleotide', 'Precision Medicine', 'Recovery of Function', 'Remission Induction', 'Toluidines/blood/*pharmacokinetics', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/32339392/
1803,DHODH,35790845,Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis.,"['Tomic B', 'Smoljo T', 'Lalic H', 'Dembitz V', 'Batinic J', 'Batinic D', 'Bedalov A', 'Visnjic D']","['Cell Differentiation', 'Checkpoint Kinase 1/metabolism', '*Cytarabine/pharmacology/therapeutic use', 'Dihydroorotate Dehydrogenase', 'Enzyme Inhibitors/pharmacology', 'Humans', '*Leukemia, Myeloid, Acute/genetics', 'Pyrimidines/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/35790845/
1804,OPRM1,35779341,The interplay between parental care and OPRM1 in reward responsiveness.,"['Wang Q', 'Yang Y', 'Yu R', 'Zhao W', 'Wang M', 'Wang Y', 'Guo W', 'He L', 'Gong P']","['Anxiety/genetics', 'Fear', 'Humans', 'Motivation', 'Receptors, Opioid, mu/genetics', '*Reinforcement, Psychology', '*Reward']",https://pubmed.ncbi.nlm.nih.gov/35779341/
1805,OPRM1,33387367,"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.","['Crews KR', 'Monte AA', 'Huddart R', 'Caudle KE', 'Kharasch ED', 'Gaedigk A', 'Dunnenberger HM', 'Leeder JS', 'Callaghan JT', 'Samer CF', 'Klein TE', 'Haidar CE', 'Van Driest SL', 'Ruano G', 'Sangkuhl K', 'Cavallari LH', 'Muller DJ', 'Prows CA', 'Nagy M', 'Somogyi AA', 'Skaar TC']","['Analgesics, Opioid/*therapeutic use', 'Catechol O-Methyltransferase/*genetics', 'Cytochrome P-450 CYP2D6/*genetics', 'Genotype', 'Humans', 'Pain/*drug therapy', 'Pharmacogenomic Testing', 'Pharmacogenomic Variants', 'Receptors, Opioid, mu/*genetics']",https://pubmed.ncbi.nlm.nih.gov/33387367/
1806,OPRM1,24201053,Pharmacogenetics of OPRM1.,"['Crist RC', 'Berrettini WH']","['Alcoholism/drug therapy/genetics', 'Analgesia', 'Humans', 'Opioid-Related Disorders/genetics', 'Pain/drug therapy/genetics', '*Pharmacogenetics', 'Receptors, Opioid, mu/*genetics', 'Tobacco Use Disorder/genetics']",https://pubmed.ncbi.nlm.nih.gov/24201053/
1807,OPRM1,38341456,The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life.,"['Haupt LM', 'Haywood A', 'Sutherland HG', 'Yu C', 'Albury CL', 'Pharasi A', 'Zunk M', 'George R', 'Griffiths LR', 'Good P', 'Hardy J']","['Adult', 'Humans', 'Analgesics, Opioid/therapeutic use', '*Cancer Pain/drug therapy/genetics', 'Genotype', 'Methadone/therapeutic use', '*Neoplasms/complications/drug therapy/genetics', 'Pain Management', 'Polymorphism, Single Nucleotide', 'Prospective Studies', 'Receptors, Opioid, mu/genetics']",https://pubmed.ncbi.nlm.nih.gov/38341456/
1808,OPRM1,22909206,"Influence of the OPRM1 A118G polymorphism on alcohol-induced euphoria, risk for alcoholism and the clinical efficacy of naltrexone.","['Setiawan E', 'Pihl RO', 'Benkelfat C', 'Leyton M']","['Alcoholism/*drug therapy/*genetics', 'Alcohols/metabolism/toxicity', 'Euphoria', 'Genotype', 'Humans', 'Naltrexone/*administration & dosage', 'Narcotic Antagonists/administration & dosage', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Receptors, Opioid, mu/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22909206/
1809,OPRM1,24236490,micro-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain.,"['Walter C', 'Doehring A', 'Oertel BG', 'Lotsch J']","['Genetic Variation/*genetics', 'Humans', 'Pain/*genetics', 'Receptors, Opioid, mu/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24236490/
1810,OPRM1,21158011,CYP2B6 and OPRM1 gene variations predict methadone-related deaths.,"['Bunten H', 'Liang WJ', 'Pounder D', 'Seneviratne C', 'Osselton MD']","['*Alleles', 'Aryl Hydrocarbon Hydroxylases/*genetics', 'Benzodiazepines/pharmacokinetics/toxicity', 'Cause of Death', 'Cytochrome P-450 CYP2B6', 'Drug Synergism', 'Gene Frequency/genetics', 'Genetic Carrier Screening', 'Genetic Predisposition to Disease/genetics', 'Genetic Testing', 'Genetic Variation/*genetics', '*Genotype', 'Heroin Dependence/blood/*mortality/*rehabilitation', 'Humans', 'Methadone/pharmacokinetics/*toxicity', 'Morphine/pharmacokinetics', 'Narcotics/pharmacokinetics/*toxicity', 'Opiate Substitution Treatment/*adverse effects/*mortality', 'Oxidoreductases, N-Demethylating/*genetics', 'Receptors, Opioid, mu/*genetics', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/21158011/
1811,OPRM1,15608594,A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans.,"['Ray LA', 'Hutchison KE']","['Adult', 'Affect/*drug effects/physiology', 'Alcohol Drinking/*genetics', 'Alleles', 'Breath Tests/methods', 'Chi-Square Distribution', 'Ethanol/*administration & dosage', 'Female', 'Humans', 'Infusions, Intravenous', 'Male', 'Polymorphism, Genetic/*genetics', 'Receptors, Opioid, mu/*genetics']",https://pubmed.ncbi.nlm.nih.gov/15608594/
1812,OPRM1,15007373,The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial.,"['Lerman C', 'Wileyto EP', 'Patterson F', 'Rukstalis M', 'Audrain-McGovern J', 'Restine S', 'Shields PG', 'Kaufmann V', 'Redden D', 'Benowitz N', 'Berrettini WH']","['Administration, Cutaneous', 'Administration, Intranasal', 'Adult', 'Asparagine/genetics', 'Aspartic Acid/genetics', 'Female', 'Follow-Up Studies', 'Genetic Variation/drug effects/*genetics', 'Humans', 'Male', 'Middle Aged', 'Nicotine/*administration & dosage', 'Predictive Value of Tests', 'Receptors, Opioid, mu/*genetics', 'Smoking/*drug therapy/*genetics', 'Time Factors']",https://pubmed.ncbi.nlm.nih.gov/15007373/
1813,OPRM1,27958381,A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence.,"['Crist RC', 'Doyle GA', 'Nelson EC', 'Degenhardt L', 'Martin NG', 'Montgomery GW', 'Saxon AJ', 'Ling W', 'Berrettini WH']","[""3' Untranslated Regions/*genetics"", 'Adult', 'Alleles', 'Analgesics, Opioid/*therapeutic use', 'Australia', 'Buprenorphine/therapeutic use', 'Buprenorphine, Naloxone Drug Combination/therapeutic use', 'Female', 'Genotype', 'Humans', 'Male', 'Methadone/*therapeutic use', 'Narcotic Antagonists/therapeutic use', 'Opiate Substitution Treatment/methods', 'Opioid-Related Disorders/*drug therapy/*genetics', 'Polymorphism, Genetic/*genetics', 'Receptors, Opioid, mu/*genetics', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/27958381/
1814,OPRM1,23658070,Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder.,"['Cooper AJ', 'Rickels K', 'Lohoff FW']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Anxiety Disorders/*drug therapy/genetics', 'Cyclohexanols/administration & dosage/*therapeutic use', 'Delayed-Action Preparations', 'Double-Blind Method', 'Female', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Pharmacogenetics', 'Polymorphism, Single Nucleotide', 'Receptors, Opioid, mu/*genetics', 'Secondary Prevention', 'Selective Serotonin Reuptake Inhibitors/administration & dosage/*therapeutic use', 'Venlafaxine Hydrochloride', 'White People/genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23658070/
1815,OPRM1,25293315,Renilla luciferase reporter assay to study 3'UTR-driven posttranscriptional regulations of OPRM1.,"['Vincelli G', 'Bedini A']","[""3' Untranslated Regions/*genetics"", 'Genes, Reporter', 'Luciferases/genetics/metabolism', 'Neuroglia/metabolism', 'Protein Processing, Post-Translational/*genetics', 'RNA, Messenger/biosynthesis/genetics', 'Receptors, Opioid, mu/biosynthesis/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25293315/
1816,OPRM1,35761357,Associations of the A118G OPRM1 polymorphism with sociotropy and interpersonal sensitivity.,"['Suzuki A', 'Shirata T', 'Noto K', 'Matsumoto Y', 'Muraosa H', 'Abe M', 'Goto K', 'Otani K']","['Genotype', 'Humans', 'Object Attachment', '*Personality/genetics', '*Polymorphism, Genetic/genetics', 'Polymorphism, Single Nucleotide', 'Receptors, Opioid, mu/*genetics', 'Social Behavior']",https://pubmed.ncbi.nlm.nih.gov/35761357/
1817,SCN8A,34431999,Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications.,"['Johannesen KM', 'Liu Y', 'Koko M', 'Gjerulfsen CE', 'Sonnenberg L', 'Schubert J', 'Fenger CD', 'Eltokhi A', 'Rannap M', 'Koch NA', 'Lauxmann S', 'Kruger J', 'Kegele J', 'Canafoglia L', 'Franceschetti S', 'Mayer T', 'Rebstock J', 'Zacher P', 'Ruf S', 'Alber M', 'Sterbova K', 'Lassuthova P', 'Vlckova M', 'Lemke JR', 'Platzer K', 'Krey I', 'Heine C', 'Wieczorek D', 'Kroell-Seger J', 'Lund C', 'Klein KM', 'Au PYB', 'Rho JM', 'Ho AW', 'Masnada S', 'Veggiotti P', 'Giordano L', 'Accorsi P', 'Hoei-Hansen CE', 'Striano P', 'Zara F', 'Verhelst H', 'Verhoeven JS', 'Braakman HMH', 'van der Zwaag B', 'Harder AVE', 'Brilstra E', 'Pendziwiat M', 'Lebon S', 'Vaccarezza M', 'Le NM', 'Christensen J', 'Gronborg S', 'Scherer SW', 'Howe J', 'Fazeli W', 'Howell KB', 'Leventer R', 'Stutterd C', 'Walsh S', 'Gerard M', 'Gerard B', 'Matricardi S', 'Bonardi CM', 'Sartori S', 'Berger A', 'Hoffman-Zacharska D', 'Mastrangelo M', 'Darra F', 'Vollo A', 'Motazacker MM', 'Lakeman P', 'Nizon M', 'Betzler C', 'Altuzarra C', 'Caume R', 'Roubertie A', 'Gelisse P', 'Marini C', 'Guerrini R', 'Bilan F', 'Tibussek D', 'Koch-Hogrebe M', 'Perry MS', 'Ichikawa S', 'Dadali E', 'Sharkov A', 'Mishina I', 'Abramov M', 'Kanivets I', 'Korostelev S', 'Kutsev S', 'Wain KE', 'Eisenhauer N', 'Wagner M', 'Savatt JM', 'Muller-Schluter K', 'Bassan H', 'Borovikov A', 'Nassogne MC', 'Destree A', 'Schoonjans AS', 'Meuwissen M', 'Buzatu M', 'Jansen A', 'Scalais E', 'Srivastava S', 'Tan WH', 'Olson HE', 'Loddenkemper T', 'Poduri A', 'Helbig KL', 'Helbig I', 'Fitzgerald MP', 'Goldberg EM', 'Roser T', 'Borggraefe I', 'Brunger T', 'May P', 'Lal D', 'Lederer D', 'Rubboli G', 'Heyne HO', 'Lesca G', 'Hedrich UBS', 'Benda J', 'Gardella E', 'Lerche H', 'Moller RS']","['*Epilepsy, Generalized/drug therapy/genetics', '*Epileptic Syndromes/drug therapy/genetics', 'Genetic Association Studies', 'Humans', 'Infant', '*Intellectual Disability/genetics', 'Mutation', '*NAV1.6 Voltage-Gated Sodium Channel/genetics', 'Prognosis', 'Seizures/drug therapy/genetics', 'Sodium Channel Blockers/therapeutic use']",https://pubmed.ncbi.nlm.nih.gov/34431999/
1818,SCN8A,36357057,Neuraxial block anesthetic technique in a patient with SCN8A encephalopathy: case report.,"['Machado EGE', 'Bill IDRC', 'Ara Jo MMPDN', 'Neves JFNPD', 'Mau S GL', 'Marcos MFB', 'Ara Jo FP']","['Humans', 'Male', 'Child, Preschool', 'NAV1.6 Voltage-Gated Sodium Channel/genetics', '*Dexmedetomidine', '*Epilepsy', 'Mutation', '*Anesthetics']",https://pubmed.ncbi.nlm.nih.gov/36357057/
1819,SCN8A,40033685,SCN8A Epileptic Encephalopathy Mutation Displays a Loss-of-Function Phenotype and Distinct Insensitivity to Valproate.,"['Zhu Y', 'Wang G', 'Wang K', 'Sun M', 'Zhao L', 'Zeng Y', 'Yan C', 'Ji Y', 'Hou Y', 'Li Z', 'Tao J']","['*NAV1.6 Voltage-Gated Sodium Channel/genetics', 'Humans', '*Valproic Acid/pharmacology', '*Anticonvulsants/pharmacology', 'HEK293 Cells', 'Mutation, Missense', 'Phenotype', 'Epilepsy/genetics/drug therapy', 'Female', 'Male', 'Loss of Function Mutation', 'Child', 'Child, Preschool']",https://pubmed.ncbi.nlm.nih.gov/40033685/
1820,SCN8A,27900360,SCN8A mutation in a child presenting with seizures and developmental delays.,"['Malcolmson J', 'Kleyner R', 'Tegay D', 'Adams W', 'Ward K', 'Coppinger J', 'Nelson L', 'Meisler MH', 'Wang K', 'Robison R', 'Lyon GJ']","['Child, Preschool', 'Developmental Disabilities/complications/genetics', 'Epilepsy/complications', 'Female', 'Humans', 'Mutation, Missense/genetics', 'NAV1.6 Voltage-Gated Sodium Channel/*genetics/metabolism', 'Seizures/complications/genetics', 'Sequence Analysis, DNA', 'Exome Sequencing/methods']",https://pubmed.ncbi.nlm.nih.gov/27900360/
1821,SCN8A,38233770,Expanding the genotype-phenotype spectrum in SCN8A-related disorders.,"['Hebbar M', 'Al-Taweel N', 'Gill I', 'Boelman C', 'Dean RA', 'Goodchild SJ', 'Mezeyova J', 'Shuart NG', 'Johnson JP Jr', 'Lee J', 'Michoulas A', 'Huh LL', 'Armstrong L', 'Connolly MB', 'Demos MK']","['Humans', '*Epilepsy/genetics', 'Genotype', '*Cognitive Dysfunction', '*Epilepsy, Generalized', 'Phenotype', 'Mutation/genetics', 'NAV1.6 Voltage-Gated Sodium Channel/genetics']",https://pubmed.ncbi.nlm.nih.gov/38233770/
1822,SCN8A,33428824,Gain-of-function mutation Met136Val in SCN8A may not be a common cause of trigeminal neuralgia.,"['Sekula RF', 'Deeley K', 'Denwood H', 'Vieira AR']","['Female', '*Gain of Function Mutation', 'Humans', 'Male', 'Middle Aged', 'NAV1.6 Voltage-Gated Sodium Channel/*genetics', 'Trigeminal Neuralgia/*genetics/pathology']",https://pubmed.ncbi.nlm.nih.gov/33428824/
1823,SCN8A,27659738,SCN8A Epileptic Encephalopathy: Detection of Fetal Seizures Guides Multidisciplinary Approach to Diagnosis and Treatment.,"['McNally MA', 'Johnson J', 'Huisman TA', 'Poretti A', 'Baranano KW', 'Baschat AA', 'Stafstrom CE']","['Brain/diagnostic imaging/drug effects/embryology/physiopathology', 'Epilepsy/*diagnosis/genetics/physiopathology/*therapy', 'Female', 'Fetal Diseases/*diagnosis/genetics/physiopathology/*therapy', 'Humans', 'Infant, Newborn', 'NAV1.6 Voltage-Gated Sodium Channel/*genetics', 'Seizures/diagnosis/genetics/physiopathology/therapy', 'Ultrasonography, Prenatal']",https://pubmed.ncbi.nlm.nih.gov/27659738/
1824,SCN8A,38802994,"Global modified Delphi consensus on diagnosis, phenotypes, and treatment of SCN8A-related epilepsy and/or neurodevelopmental disorders.","['Conecker G', 'Xia MY', 'Hecker J', 'Achkar C', 'Cukiert C', 'Devries S', 'Donner E', 'Fitzgerald MP', 'Gardella E', 'Hammer M', 'Hegde A', 'Hu C', 'Kato M', 'Luo T', 'Schreiber JM', 'Wang Y', 'Kooistra T', 'Oudin M', 'Waldrop K', 'Youngquist JT', 'Zhang D', 'Wirrell E', 'Perry MS']","['Humans', 'Anticonvulsants/therapeutic use', '*Consensus', 'Delphi Technique', '*Epilepsy/diagnosis/therapy/genetics', '*NAV1.6 Voltage-Gated Sodium Channel/genetics', '*Neurodevelopmental Disorders/diagnosis/genetics/therapy', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/38802994/
1825,SCN8A,31672125,A de novo SCN8A heterozygous mutation in a child with epileptic encephalopathy: a case report.,"['Lin KM', 'Su G', 'Wang F', 'Zhang X', 'Wang Y', 'Ren J', 'Wang X', 'Yao Y', 'Zhou Y']","['Child, Preschool', 'Drug Resistant Epilepsy/diagnostic imaging/genetics', 'Female', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Magnetic Resonance Imaging', 'Mutation, Missense/*genetics', 'NAV1.6 Voltage-Gated Sodium Channel/*genetics', 'Positron-Emission Tomography', 'Spasms, Infantile/diagnostic imaging/*genetics', 'Exome Sequencing/methods']",https://pubmed.ncbi.nlm.nih.gov/31672125/
1826,SCN8A,34353676,"SCN8A Epilepsy, Developmental Encephalopathy, and Related Disorders.","['Talwar D', 'Hammer MF']","['Child', 'Congresses as Topic', 'Epilepsy/drug therapy/*genetics/*physiopathology', 'Gain of Function Mutation', 'Humans', 'Loss of Function Mutation', 'NAV1.6 Voltage-Gated Sodium Channel/*genetics']",https://pubmed.ncbi.nlm.nih.gov/34353676/
1827,CXCR4,20484021,CXCL12 (SDF-1)/CXCR4 pathway in cancer.,"['Teicher BA', 'Fricker SP']","['Chemokine CXCL12/*metabolism', 'Drug Delivery Systems', 'Humans', 'Neoplasms/drug therapy/genetics/*metabolism', 'Receptors, CXCR4/*antagonists & inhibitors', 'Signal Transduction/genetics']",https://pubmed.ncbi.nlm.nih.gov/20484021/
1828,CXCR4,36442720,CXCL12/CXCR4: An amazing challenge and opportunity in the fight against fibrosis.,"['Wu X', 'Qian L', 'Zhao H', 'Lei W', 'Liu Y', 'Xu X', 'Li J', 'Yang Z', 'Wang D', 'Zhang Y', 'Zhang Y', 'Tang R', 'Yang Y', 'Tian Y']","['Humans', 'Ligands', '*Chemokine CXCL12', '*Receptors, CXCR4', 'Fibrosis', 'Lung', 'Signal Transduction']",https://pubmed.ncbi.nlm.nih.gov/36442720/
1829,CXCR4,35674738,CXCR4-targeted theranostics in oncology.,"['Buck AK', 'Serfling SE', 'Lindner T', 'Hanscheid H', 'Schirbel A', 'Hahner S', 'Fassnacht M', 'Einsele H', 'Werner RA']","['Adult', '*Coordination Complexes', '*Hematologic Neoplasms', 'Humans', '*Lymphoma', '*Multiple Myeloma', 'Peptides, Cyclic', 'Precision Medicine', 'Receptors, CXCR4', 'Tomography, X-Ray Computed']",https://pubmed.ncbi.nlm.nih.gov/35674738/
1830,CXCR4,28875842,Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.,"['Zhou W', 'Guo S', 'Liu M', 'Burow ME', 'Wang G']","['Antineoplastic Agents/chemistry/*pharmacology', 'Chemokine CXCL12/*antagonists & inhibitors/metabolism', 'Humans', '*Immunotherapy', 'Neoplasms/immunology/metabolism/*therapy', 'Receptors, CXCR4/*antagonists & inhibitors/metabolism', 'Signal Transduction/drug effects']",https://pubmed.ncbi.nlm.nih.gov/28875842/
1831,CXCR4,23211868,Halting metastasis through CXCR4 inhibition.,"['Ramsey DM', 'McAlpine SR']","['Antibodies, Monoclonal/immunology', 'Antineoplastic Agents/*therapeutic use', 'Benzylamines', 'Binding Sites', 'Chemokine CXCL12/antagonists & inhibitors/metabolism', 'Clinical Trials as Topic', 'Cyclams', 'Heterocyclic Compounds/chemistry/*therapeutic use', 'Humans', 'Neoplasm Metastasis/*drug therapy/*pathology', 'Neoplasms/*drug therapy/*pathology', 'Peptides/metabolism', 'Receptors, CXCR4/*antagonists & inhibitors/metabolism', 'Single-Domain Antibodies/immunology']",https://pubmed.ncbi.nlm.nih.gov/23211868/
1832,CXCR4,40042244,CXCR4-A Potential Novel Theranostic Target in Adrenocortical Carcinoma.,"['Nazar A', 'Kalshetty A', 'Basu S']","['Humans', '*Receptors, CXCR4/metabolism', '*Adrenocortical Carcinoma/diagnostic imaging/metabolism/therapy/pathology', 'Positron Emission Tomography Computed Tomography', 'Female', '*Adrenal Cortex Neoplasms/diagnostic imaging/metabolism/therapy/pathology', 'Middle Aged', '*Molecular Targeted Therapy', '*Theranostic Nanomedicine', 'Male', 'Peptides, Cyclic', 'Coordination Complexes']",https://pubmed.ncbi.nlm.nih.gov/40042244/
1833,CXCR4,26299663,CXCR4 and Glioblastoma.,['Richardson PJ'],"['Cell Differentiation', 'Glioblastoma/*drug therapy/genetics/pathology', 'Humans', 'Neoplastic Stem Cells/pathology', 'Receptors, CXCR4/*antagonists & inhibitors/genetics']",https://pubmed.ncbi.nlm.nih.gov/26299663/
1834,CXCR4,18523970,New insights on the role of CXCR4 in cancer metastasis.,['Zlotnik A'],"['Cell Movement', 'Chemokine CXCL12/*metabolism', 'Humans', 'Lymphatic Metastasis', 'Neoplasms/*pathology', 'Receptors, CCR7/metabolism', 'Receptors, CXCR4/*physiology', '*Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/18523970/
1835,CXCR4,26247892,Controlled delivery of SDF-1alpha and IGF-1: CXCR4(+) cell recruitment and functional skeletal muscle recovery.,"['Rybalko VY', 'Pham CB', 'Hsieh PL', 'Hammers DW', 'Merscham-Banda M', 'Suggs LJ', 'Farrar RP']","['Cell Differentiation/*drug effects', 'Cell Movement/*drug effects', 'Chemokine CXCL12/*chemistry/pharmacokinetics/pharmacology', 'Drug Delivery Systems', 'Fibrin/*chemistry/pharmacology', 'Humans', 'Insulin-Like Growth Factor I/*administration & dosage/chemistry', 'Muscle, Skeletal/*drug effects', 'Receptors, CXCR4/*chemistry/metabolism', 'Recovery of Function/*drug effects', 'Regeneration/*drug effects', 'Signal Transduction/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/26247892/
1836,CXCR4,23538388,Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.,"[""O'Boyle G"", 'Swidenbank I', 'Marshall H', 'Barker CE', 'Armstrong J', 'White SA', 'Fricker SP', 'Plummer R', 'Wright M', 'Lovat PE']","['Aminoquinolines/*pharmacology', 'Benzimidazoles/*pharmacology', 'Butylamines', 'Cell Line, Tumor', 'Cell Migration Inhibition/*drug effects', 'Chemokine CXCL12/*antagonists & inhibitors', 'Flow Cytometry', 'Heterocyclic Compounds, 1-Ring', 'Humans', 'Liver Neoplasms/secondary', 'Melanoma/*drug therapy/*pathology', 'Receptors, CXCR4/*antagonists & inhibitors']",https://pubmed.ncbi.nlm.nih.gov/23538388/
1837,CXCR4,20594270,CXCR4 and cancer.,"['Furusato B', 'Mohamed A', 'Uhlen M', 'Rhim JS']","['Biomarkers, Tumor/genetics/metabolism', 'Humans', 'Neoplasms/genetics/*metabolism', 'Neoplastic Stem Cells/*metabolism', 'Receptors, CXCR4/genetics/*metabolism', 'Signal Transduction/*physiology']",https://pubmed.ncbi.nlm.nih.gov/20594270/
1838,PLG,32662180,Functions of the plasminogen receptor Plg-R(KT).,"['Miles LA', 'Vago JP', 'Sousa LP', 'Parmer RJ']","['Cell Membrane', 'Female', '*Fibrinolysin', 'Humans', 'Inflammation', '*Plasminogen']",https://pubmed.ncbi.nlm.nih.gov/32662180/
1839,PLG,27830864,Novel l-prolyl-l-leucylglycinamide (PLG) tripeptidomimetics based on a 2-azanorbornane scaffold as positive allosteric modulators of the D(2)R.,"['Sampaio-Dias IE', 'Sousa CA', 'Garcia-Mera X', 'Ferreira da Costa J', 'Caamano O', 'Rodriguez-Borges JE']","['Allosteric Regulation/drug effects', '*Drug Design', 'MSH Release-Inhibiting Hormone/*chemistry', 'Norbornanes/*chemistry', 'Peptidomimetics/*chemistry/*pharmacology', 'Receptors, Dopamine D2/chemistry/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/27830864/
1840,PLG,16980275,About mean diameter and size distributions of poly(lactide-co-glycolide) (PLG) microspheres.,"['Berchane NS', 'Jebrail FF', 'Carson KH', 'Rice-Ficht AC', 'Andrews MJ']","['Biocompatible Materials', 'Delayed-Action Preparations', 'Drug Compounding/methods', 'Emulsions', '*Lactic Acid', 'Mathematics', 'Microscopy, Electron, Scanning', '*Microspheres', 'Models, Chemical', 'Particle Size', '*Polyglycolic Acid', 'Polylactic Acid-Polyglycolic Acid Copolymer', '*Polymers']",https://pubmed.ncbi.nlm.nih.gov/16980275/
1841,PLG,35454092,Plg-R(KT) Expression in Human Breast Cancer Tissues.,"['Miles LA', 'Krajewski S', 'Baik N', 'Parmer RJ', 'Mueller BM']","['*Breast Neoplasms/genetics', 'Cell Membrane/metabolism', 'Female', 'Humans', 'Plasminogen/metabolism', '*Receptors, Cell Surface/genetics', 'Serine Proteases', 'Tumor Microenvironment']",https://pubmed.ncbi.nlm.nih.gov/35454092/
1842,PLG,10825551,Incorporation of protein in PLG-microspheres with retention of bioactivity.,"['Sturesson C', 'Carlfors J']","['Drug Carriers', 'Freeze Drying', '*Lactic Acid', 'Microspheres', 'Particle Size', '*Polyglycolic Acid', 'Polylactic Acid-Polyglycolic Acid Copolymer', '*Polymers', 'Proteins/*chemistry', 'Surface Properties', 'Urease/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/10825551/
1843,PLG,37093347,Plasma exosomal protein PLG and SERPINA1 in colorectal cancer diagnosis and coagulation abnormalities.,"['Li L', 'Song X', 'Chen G', 'Zhang Z', 'Zheng B', 'Zhang Q', 'Wang S', 'Xie L']","['Humans', '*Colorectal Neoplasms/pathology', 'Proteomics', 'Biomarkers, Tumor/metabolism', 'Prognosis', 'Neoplasm Staging', '*Exosomes/metabolism', 'alpha 1-Antitrypsin/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37093347/
1844,PLG,15081161,A simplified model to predict the thermal response of PLG and its influence on BLEVE.,"['Gong YW', 'Lin WS', 'Gu AZ', 'Lu XS']","['Explosions', '*Fires', 'Forecasting', '*Gases', 'Hazardous Substances', '*Models, Theoretical', 'Temperature', 'Volatilization']",https://pubmed.ncbi.nlm.nih.gov/15081161/
1845,PLG,7027624,Genetic polymorphism of plasminogen: a new basic variant (PLG B) and population study in Japanese.,"['Nishimukai H', 'Kera Y', 'Sakata K', 'Yamasawa K']","['Adult', 'Alleles', 'Child', 'Electrophoresis, Agar Gel', 'Female', 'Gene Frequency', 'Humans', 'Immunosorbent Techniques', 'Isoelectric Focusing', 'Japan', 'Male', 'Plasminogen/*genetics', '*Polymorphism, Genetic']",https://pubmed.ncbi.nlm.nih.gov/7027624/
1846,PLG,35887087,PLG-007 and Its Active Component Galactomannan-alpha Competitively Inhibit Enzymes That Hydrolyze Glucose Polymers.,"['Miller MC', 'Dregni AJ', 'Platt D', 'Mayo KH']","['*Amylopectin/chemistry', 'Galactose/analogs & derivatives', 'Glucose', 'Hydrolysis', 'Lactase', 'Mannans', 'Starch/metabolism', 'alpha-Amylases/metabolism', '*alpha-Glucosidases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35887087/
1847,RXRA,26575331,Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.,"['Yin J', 'Liu H', 'Yi X', 'Wu W', 'Amos CI', 'Fang S', 'Lee JE', 'Han J', 'Wei Q']","['*Databases, Genetic', 'Disease-Free Survival', 'Female', 'Follow-Up Studies', 'Genome-Wide Association Study', 'Humans', 'Male', '*Melanoma/genetics/mortality', 'Neoplasm Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Retinoid X Receptor alpha/*genetics', '*Skin Neoplasms/genetics/mortality', 'Survival Rate', 'Vitamin D-Binding Protein/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26575331/
1848,RXRA,30413149,"ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients.","['Grzegorzewska AE', 'Niepolski L', 'Swiderska MK', 'Mostowska A', 'Stolarek I', 'Warchol W', 'Figlerowicz M', 'Jagodzinski PP']","['Adipogenesis/genetics', 'Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Blood Proteins/*genetics/immunology', 'Cholesterol, HDL/blood', 'Cholesterol, LDL/blood', 'Comorbidity', 'Cross-Sectional Studies', 'Dyslipidemias/*genetics/immunology/mortality/therapy', 'Epistasis, Genetic', 'Female', 'Genotype', 'Humans', 'Intercellular Signaling Peptides and Proteins', 'Interleukin-12 Subunit p40/genetics/immunology', 'Interleukin-18/genetics/immunology', 'Kaplan-Meier Estimate', 'Liver X Receptors/*genetics/immunology', 'Male', 'Middle Aged', 'Myocardial Infarction/*genetics/immunology/mortality/therapy', 'Peptides/*genetics/immunology', '*Polymorphism, Single Nucleotide', '*Renal Dialysis', 'Renal Insufficiency, Chronic/*genetics/immunology/mortality/therapy', 'Retinoid X Receptor alpha/*genetics/immunology', 'T-Lymphocytes, Helper-Inducer/immunology/pathology', 'Triglycerides/blood']",https://pubmed.ncbi.nlm.nih.gov/30413149/
1849,RXRA,11450851,Single nucleotide polymorphisms of RXRA encoding retinoid X receptor alpha.,"['Hegele RA', 'Cao H']","[""3' Untranslated Regions/genetics"", 'DNA Mutational Analysis', 'Gene Frequency/genetics', 'Genotype', 'Humans', 'Introns/genetics', 'Molecular Sequence Data', 'Polymorphism, Single Nucleotide/*genetics', 'Racial Groups/genetics', 'Receptors, Retinoic Acid/*genetics', 'Retinoid X Receptors', 'Transcription Factors/*genetics']",https://pubmed.ncbi.nlm.nih.gov/11450851/
1850,RXRA,37698375,Zinc finger protein ZBTB17 controls cellular senescence via interacting with nuclear receptor RXRA and its downstream calcium signaling.,"['Wang C', 'Gao Y', 'Luan C', 'Sun W', 'Ge S', 'Li Y', 'Xu L', 'Du Q', 'Liu W', 'Lu G', 'Gong W', 'Ma X']","['*Calcium Signaling', '*Receptors, Cytoplasmic and Nuclear', 'Cellular Senescence', 'Calcium Channels', 'Zinc Fingers']",https://pubmed.ncbi.nlm.nih.gov/37698375/
1851,RXRA,23079705,"PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population.","['Lima LO', 'Almeida S', 'Hutz MH', 'Fiegenbaum M']","['Adult', 'Amplified Fragment Length Polymorphism Analysis', 'Brazil', 'Constitutive Androstane Receptor', 'Female', 'Gene Frequency', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Humans', 'Hypertriglyceridemia/genetics', 'Linkage Disequilibrium', 'Lipoproteins/*blood', 'Male', 'Middle Aged', 'PPAR alpha/*genetics', 'Polymorphism, Restriction Fragment Length', 'Pregnane X Receptor', 'Receptors, Cytoplasmic and Nuclear/*genetics', 'Receptors, Steroid/*genetics', 'Retinoid X Receptor alpha/*genetics', 'Risk', 'Sequence Analysis, DNA', 'Sex Characteristics', 'Triglycerides/*blood']",https://pubmed.ncbi.nlm.nih.gov/23079705/
1852,RXRA,38123121,"Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)(2)D(3) in A431 squamous cell carcinoma.","['Olszewska AM', 'Nowak JI', 'Myszczynski K', 'Slominski A', 'Zmijewski MA']","['Humans', '*Calcitriol/pharmacology/metabolism', 'Receptors, Calcitriol/genetics/metabolism', 'Vitamin D/pharmacology', 'Genomics', '*Carcinoma, Squamous Cell/drug therapy/genetics', 'Vitamin D3 24-Hydroxylase']",https://pubmed.ncbi.nlm.nih.gov/38123121/
1853,RXRA,30216632,The nuclear receptor RXRA controls cellular senescence by regulating calcium signaling.,"['Ma X', 'Warnier M', 'Raynard C', 'Ferrand M', 'Kirsh O', 'Defossez PA', 'Martin N', 'Bernard D']","['Calcium/metabolism', 'Calcium Channels/metabolism', '*Calcium Signaling/drug effects', 'Cell Line', '*Cellular Senescence/drug effects', 'Chelating Agents/pharmacology', 'DNA Damage', 'Endoplasmic Reticulum/drug effects/metabolism', 'Humans', 'Inositol 1,4,5-Trisphosphate Receptors/metabolism', 'Mitochondria/drug effects/metabolism', 'RNA, Small Interfering/metabolism', 'Reactive Oxygen Species/metabolism', 'Repressor Proteins/metabolism', 'Retinoid X Receptor alpha/*metabolism', 'Transcription, Genetic/drug effects', 'Tumor Suppressor Protein p53/metabolism']",https://pubmed.ncbi.nlm.nih.gov/30216632/
1854,RXRA,34239022,EGR1 and RXRA transcription factors link TGF-beta pathway and CCL2 expression in triple negative breast cancer cells.,"['Gorbacheva AM', 'Uvarova AN', 'Ustiugova AS', 'Bhattacharyya A', 'Korneev KV', 'Kuprash DV', 'Mitkin NA']","['Base Sequence', 'Binding Sites', 'Cell Line, Tumor', 'Chemokine CCL2/genetics/*metabolism', 'Early Growth Response Protein 1/*metabolism', 'Female', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Models, Biological', 'Point Mutation/genetics', 'Promoter Regions, Genetic/genetics', 'Protein Binding', 'Retinoid X Receptor alpha/*metabolism', '*Signal Transduction', 'Transforming Growth Factor beta/*metabolism', 'Triple Negative Breast Neoplasms/genetics/*metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/34239022/
1855,RXRA,31710612,Tributyltin chloride (TBT) induces RXRA down-regulation and lipid accumulation in human liver cells.,"['Stossi F', 'Dandekar RD', 'Johnson H', 'Lavere P', 'Foulds CE', 'Mancini MG', 'Mancini MA']","['Cell Line', 'Deoxyglucose/pharmacology', 'Dose-Response Relationship, Drug', 'Down-Regulation/*drug effects', 'Hep G2 Cells', 'Hepatocytes/*drug effects/metabolism', 'Humans', 'In Situ Hybridization, Fluorescence', 'Lipid Metabolism/*drug effects', 'Retinoid X Receptor alpha/genetics/*metabolism', 'Trialkyltin Compounds/*pharmacology']",https://pubmed.ncbi.nlm.nih.gov/31710612/
1856,RXRG,31558802,Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.,"['Joseph C', 'Al-Izzi S', 'Alsaleem M', 'Kurozumi S', 'Toss MS', 'Arshad M', 'Goh FQ', 'Alshankyty IM', 'Aleskandarany MA', 'Ali S', 'Ellis IO', 'Mongan NP', 'Green AR', 'Rakha EA']","['Biomarkers, Tumor/metabolism', 'Breast Neoplasms/genetics/*metabolism/pathology', 'Cohort Studies', 'Female', 'Gene Expression', 'Humans', 'Immunohistochemistry', 'Neoplasm Invasiveness', 'Prognosis', 'RNA, Messenger/genetics/metabolism', 'Receptors, Estrogen/*metabolism', 'Retinoid X Receptor gamma/biosynthesis/genetics/*metabolism', 'Tissue Array Analysis']",https://pubmed.ncbi.nlm.nih.gov/31558802/
1857,RXRG,31808386,Association between Single-nucleotide Polymorphisms of RXRG and Genetic Susceptibility to Type 2 Diabetes in South China.,"['Yu H', 'Wang S', 'Hu W', 'Xu L', 'Ding Y', 'Kong D', 'Pan H']","['Aged', 'Alleles', 'Asian People', 'Case-Control Studies', 'Diabetes Mellitus, Type 2/genetics', 'Female', 'Gene Frequency/genetics', 'Genetic Association Studies', 'Genetic Predisposition to Disease/genetics', 'Genotype', 'Haplotypes/genetics', 'Humans', 'Linkage Disequilibrium/genetics', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Retinoid X Receptor gamma/*genetics', 'Software']",https://pubmed.ncbi.nlm.nih.gov/31808386/
1858,RXRG,27245436,Whole-exome identifies RXRG and TH germline variants in familial isolated prolactinoma.,"['Melo FM', 'Couto PP', 'Bale AE', 'Bastos-Rodrigues L', 'Passos FM', 'Lisboa RG', 'Ng JM', 'Curran T', 'Dias EP', 'Friedman E', 'De Marco L']","['Adenoma/*genetics', 'Adult', 'Computer Simulation', 'DNA Mutational Analysis', 'Exome', 'Female', 'Genetic Predisposition to Disease', '*Germ-Line Mutation', 'Growth Hormone-Secreting Pituitary Adenoma/*genetics', 'Humans', 'Intracellular Signaling Peptides and Proteins/chemistry/genetics', 'Male', 'Pedigree', 'Prolactinoma/*genetics', 'Proto-Oncogene Proteins/chemistry/genetics', 'Receptors, Prolactin/chemistry/genetics', 'Retinoid X Receptor gamma/chemistry/*genetics', 'Tyrosine 3-Monooxygenase/chemistry/*genetics']",https://pubmed.ncbi.nlm.nih.gov/27245436/
1859,SLC47A1,22882994,Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.,"['Tkac I', 'Klimcakova L', 'Javorsky M', 'Fabianova M', 'Schroner Z', 'Hermanova H', 'Babjakova E', 'Tkacova R']","['Alleles', 'Diabetes Mellitus, Type 2/*drug therapy/*genetics', 'Dose-Response Relationship, Drug', 'Double-Blind Method', 'Female', 'Genotype', 'Humans', 'Hypoglycemic Agents/*pharmacology', 'Male', 'Metformin/*pharmacology', 'Middle Aged', 'Organic Cation Transport Proteins', '*Polymorphism, Single Nucleotide', 'Treatment Outcome']",https://pubmed.ncbi.nlm.nih.gov/22882994/
1860,SLC47A1,35639991,Association of the SLC47A1 Gene Variant With Responses to Metformin Monotherapy in Drug-naive Patients With Type 2 Diabetes.,"['Kim H', 'Bae S', 'Yoon HY', 'Yee J', 'Gwak HS']","['Blood Glucose', '*Diabetes Mellitus, Type 2/drug therapy/genetics', 'Glycated Hemoglobin/analysis', 'Humans', 'Hypoglycemic Agents/adverse effects', '*Metformin', 'Organic Cation Transport Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/35639991/
1861,SLC47A1,35905099,The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.,"['Ningrum VDA', 'Sadewa AH', 'Ikawati Z', 'Yuliwulandari R', 'Ikhsan MR', 'Fajriyah R']","['Blood Glucose', 'Catecholamine Plasma Membrane Transport Proteins/*metabolism', 'Cohort Studies', '*Diabetes Mellitus, Type 2/drug therapy/genetics', 'Genotype', 'Humans', 'Hypoglycemic Agents/pharmacology/therapeutic use', '*Metformin/pharmacology', 'Organic Cation Transport Proteins/genetics', 'Prospective Studies']",https://pubmed.ncbi.nlm.nih.gov/35905099/
1862,SLC47A1,34505146,Genomic editing of metformin efficacy-associated genetic variants in SLC47A1 does not alter SLC47A1 expression.,"['Kalamajski S', 'Huang M', 'Dalla-Riva J', 'Keller M', 'Dawed AY', 'Hansson O', 'Pearson ER', 'Mulder H', 'Franks PW']","['Genomics', 'Genotype', 'Glycated Hemoglobin/genetics', 'Hypoglycemic Agents/therapeutic use', '*Metformin/pharmacology', 'Organic Cation Transport Proteins/genetics', 'Polymorphism, Single Nucleotide/genetics']",https://pubmed.ncbi.nlm.nih.gov/34505146/
1863,SLC47A1,30433870,Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients.,"['Raj GM', 'Mathaiyan J', 'Wyawahare M', 'Priyadarshini R']","['Blood Glucose/analysis', 'Diabetes Mellitus, Type 2/blood/*drug therapy/genetics', 'Dose-Response Relationship, Drug', 'Female', 'Genotype', 'Glycated Hemoglobin/analysis', 'Humans', 'Hypoglycemic Agents/administration & dosage/adverse effects/*therapeutic use', 'Male', 'Metformin/administration & dosage/adverse effects/*therapeutic use', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Prospective Studies']",https://pubmed.ncbi.nlm.nih.gov/30433870/
1864,SLC47A1,27226103,Lack of genomic diversity in the SLC47A1 gene within the indigenous Xhosa population.,"['Jacobs C', 'Pearce B', 'Hoosain N', 'Benjeddou M']","['Adult', 'Female', 'Gene Frequency/genetics', 'Genomics', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Population Groups/*genetics', 'South Africa', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27226103/
1865,SLC47A1,29070695,Relationship between DNA Methylation in the 5' CpG Island of the SLC47A1 (Multidrug and Toxin Extrusion Protein MATE1) Gene and Interindividual Variability in MATE1 Expression in the Human Liver.,"['Tanaka T', 'Hirota T', 'Ieiri I']","['Adolescent', 'Adult', 'Aged', 'CpG Islands/*physiology', 'DNA Methylation/*physiology', 'Female', 'Gene Expression', 'Genetic Variation/*physiology', 'HEK293 Cells', 'Hep G2 Cells', 'Humans', 'Liver/*metabolism', 'Male', 'Middle Aged', 'Organic Cation Transport Proteins/*biosynthesis/*genetics', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/29070695/
1866,SLC47A1,26004431,SLC47A1 gene rs2289669 G>A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients.,"['He R', 'Zhang D', 'Lu W', 'Zheng T', 'Wan L', 'Liu F', 'Jia W']","['Administration, Oral', 'Aged', 'Asian People/genetics', 'Diabetes Mellitus, Type 2/*drug therapy/ethnology/*metabolism', 'Female', 'Genotype', 'Humans', 'Hypoglycemic Agents/*pharmacokinetics/therapeutic use', 'Male', 'Metformin/*pharmacokinetics/therapeutic use', 'Middle Aged', 'Organic Cation Transport Proteins/genetics/*metabolism', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/26004431/
1867,SLC47A1,23241029,"Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.","['Wittwer MB', 'Zur AA', 'Khuri N', 'Kido Y', 'Kosaka A', 'Zhang X', 'Morrissey KM', 'Sali A', 'Huang Y', 'Giacomini KM']","['*Computer Simulation', 'Fluorescent Dyes', 'Organic Cation Transport Proteins/*antagonists & inhibitors', '*Prescription Drugs']",https://pubmed.ncbi.nlm.nih.gov/23241029/
1868,SLC47A1,20053795,"Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.","['Meyer zu Schwabedissen HE', 'Verstuyft C', 'Kroemer HK', 'Becquemont L', 'Kim RB']","['Alleles', 'Cloning, Molecular', 'Genetic Variation', 'Genotype', 'HeLa Cells', 'Humans', 'Organic Cation Transport Proteins/antagonists & inhibitors/*genetics/*metabolism', 'Organic Cation Transporter 2', '*Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/20053795/
1869,SLC47A1,36786075,The association study between changes in HbA1C with rs2250486 and rs67238751 genetic variants for SLC47A1 in newly diagnosed Iranian patients with type 2 diabetes mellitus: 6 months follow-up study.,"['Semnani A', 'Kazerouni F', 'Kalbasi S', 'Shahrokhi SZ', 'Rahimipour A']","['Humans', '*Diabetes Mellitus, Type 2/drug therapy/genetics', 'Follow-Up Studies', 'Glycated Hemoglobin', 'Hypoglycemic Agents', 'Iran', '*Metformin']",https://pubmed.ncbi.nlm.nih.gov/36786075/
1870,SLC47A1,22569819,Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events.,"['Iwata K', 'Aizawa K', 'Kamitsu S', 'Jingami S', 'Fukunaga E', 'Yoshida M', 'Yoshimura M', 'Hamada A', 'Saito H']","['Adult', 'Aged', 'Aged, 80 and over', 'Alleles', 'Antineoplastic Agents/*adverse effects/blood/therapeutic use', 'Carcinoma/drug therapy', 'Cisplatin/*adverse effects/blood/therapeutic use', 'Dose-Response Relationship, Drug', 'Female', 'Genetic Predisposition to Disease/genetics', 'Genotype', 'Glomerular Filtration Rate/physiology', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics', 'Organic Cation Transporter 2', 'Polymorphism, Single Nucleotide/*genetics', 'Renal Insufficiency/*chemically induced/epidemiology/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22569819/
1871,SLC47A1,28321905,Differential increments of basal glucagon-like-1 peptide concentration among SLC47A1 rs2289669 genotypes were associated with inter-individual variability in glycaemic response to metformin in Chinese people with newly diagnosed Type 2 diabetes.,"['Liang H', 'Xu W', 'Zhou L', 'Yang W', 'Weng J']","['Adult', 'China', 'Cohort Studies', 'Diabetes Mellitus, Type 2/blood/drug therapy/*genetics/metabolism', 'Drug Resistance/genetics', 'Female', 'Follow-Up Studies', 'Genetic Association Studies', 'Glucagon-Like Peptide 1/*blood', 'Glycated Hemoglobin/analysis', 'Humans', 'Hyperglycemia/*prevention & control', 'Hypoglycemia/prevention & control', 'Hypoglycemic Agents/*therapeutic use', 'Introns', 'Linear Models', 'Male', 'Metformin/*therapeutic use', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics/metabolism', '*Polymorphism, Single Nucleotide', 'Prospective Studies']",https://pubmed.ncbi.nlm.nih.gov/28321905/
1872,ABCB5,35907754,Deciphering the roles of ABCB5 in normal and cancer cells.,"['Duvivier L', 'Gillet JP']","['ATP Binding Cassette Transporter, Subfamily B/genetics/metabolism', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism', 'Adenosine Triphosphate', 'Humans', '*Melanoma/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35907754/
1873,ABCB5,26043974,MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5.,"['Yang G', 'Jiang O', 'Ling D', 'Jiang X', 'Yuan P', 'Zeng G', 'Zhu J', 'Tian J', 'Weng Y', 'Wu D']","[""3' Untranslated Regions"", 'ATP Binding Cassette Transporter, Subfamily B', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/antagonists & inhibitors/*genetics/metabolism', 'Antibiotics, Antineoplastic/pharmacology', 'Base Sequence', 'Colonic Neoplasms/metabolism/physiopathology', 'Down-Regulation/*drug effects', 'Doxorubicin/*toxicity', 'Drug Resistance, Neoplasm/drug effects', 'Genes, Reporter', 'HT29 Cells', 'Humans', 'MicroRNAs/antagonists & inhibitors/genetics/*pharmacology', 'Oligonucleotides, Antisense/metabolism', 'RNA Interference', 'RNA, Small Interfering/metabolism', 'Real-Time Polymerase Chain Reaction', 'Sequence Alignment']",https://pubmed.ncbi.nlm.nih.gov/26043974/
1874,ABCB5,36373310,"Expression and clinical significance of TYRP1, ABCB5, and MMP17 in sinonasal mucosal melanoma.","['Tu J', 'Wang J', 'Tang B', 'Zhang Z', 'Han M', 'Li M', 'Yu J', 'Shen L', 'Zhang M', 'Ye J']","['Humans', '*Matrix Metalloproteinase 17', 'Retrospective Studies', '*Melanoma/genetics', 'Exome Sequencing', 'RNA, Messenger', 'ATP Binding Cassette Transporter, Subfamily B/genetics', 'Membrane Glycoproteins', 'Oxidoreductases']",https://pubmed.ncbi.nlm.nih.gov/36373310/
1875,ABCB5,39273646,Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population.,"['Meshko B', 'Volatier TLA', 'Mann J', 'Kluth MA', 'Ganss C', 'Frank MH', 'Frank NY', 'Ksander BR', 'Cursiefen C', 'Notara M']","['Humans', '*Mesenchymal Stem Cells/metabolism/cytology', '*Vascular Endothelial Growth Factor A/metabolism', '*ATP Binding Cassette Transporter, Subfamily B/metabolism/genetics', 'Cell Differentiation', 'Vascular Endothelial Growth Factor C/metabolism', 'Cell Proliferation', 'Limbus Corneae/metabolism/cytology', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism', 'Jurkat Cells', 'Cells, Cultured', 'Stromal Cells/metabolism', 'Coculture Techniques', 'Endothelial Cells/metabolism']",https://pubmed.ncbi.nlm.nih.gov/39273646/
1876,ABCB5,36613507,Skin-Derived ABCB5(+) Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine.,"['Niebergall-Roth E', 'Frank NY', 'Ganss C', 'Frank MH', 'Kluth MA']","['United States', 'Humans', '*Mesenchymal Stem Cells/metabolism', '*Epidermolysis Bullosa Dystrophica/metabolism', 'Germany', 'ATP Binding Cassette Transporter, Subfamily B/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36613507/
1877,ABCB5,31595650,ABCB5 is activated by MITF and beta-catenin and is associated with melanoma differentiation.,"['Louphrasitthiphol P', 'Chauhan J', 'Goding CR']","['ATP Binding Cassette Transporter, Subfamily B/genetics/*metabolism', 'Base Sequence', '*Cell Differentiation', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Melanoma/genetics/*metabolism/*pathology', 'Microphthalmia-Associated Transcription Factor/*metabolism', 'Phenotype', 'Skin Neoplasms/genetics/*metabolism/*pathology', 'beta Catenin/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31595650/
1878,ABCB5,34571550,Islet Co-Expression of CD133 and ABCB5 in Human Retinoblastoma Specimens.,"['Zschoche M', 'Skosyrski S', 'Babst N', 'Ranjbar M', 'Rommel F', 'Kurz M', 'Tura A', 'Joachim SC', 'Kociok N', 'Kakkassery V']","['Humans', '*Retinoblastoma/genetics/drug therapy/metabolism', 'Etoposide/therapeutic use', '*Retinal Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/34571550/
1879,ABCB5,26843453,Elevated expression of ABCB5 in ocular surface squamous neoplasia.,"['Jongkhajornpong P', 'Nakamura T', 'Sotozono C', 'Nagata M', 'Inatomi T', 'Kinoshita S']","['ATP Binding Cassette Transporter, Subfamily B', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/*metabolism', 'Carcinoma, Squamous Cell/*metabolism', 'Eye Neoplasms/*metabolism', 'Female', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Limbus Corneae/metabolism', 'Male', 'Neoplastic Stem Cells/metabolism', '*Up-Regulation']",https://pubmed.ncbi.nlm.nih.gov/26843453/
1880,ABCB5,27663144,"Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.","['Gambichler T', 'Petig AL', 'Stockfleth E', 'Stucker M']","['ATP Binding Cassette Transporter, Subfamily B', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/*metabolism', 'Adapalene/*metabolism', 'Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Case-Control Studies', 'Female', 'Humans', 'Male', 'Melanoma/*metabolism/mortality/pathology', 'Middle Aged', 'Neoplasm Staging', 'Nevus, Pigmented/*metabolism/mortality/pathology', 'SOXE Transcription Factors/*metabolism', 'Skin Neoplasms/*metabolism/mortality/pathology', 'Survival Rate', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/27663144/
1881,ABCB5,29929490,Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.,"['Xiao J', 'Egger ME', 'McMasters KM', 'Hao H']","['ATP Binding Cassette Transporter, Subfamily B', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/*biosynthesis', 'Antineoplastic Agents/pharmacology', 'Cell Line, Tumor', 'Drug Resistance, Neoplasm/*physiology', 'Humans', 'Melanoma/*pathology', 'Proto-Oncogene Proteins B-raf/antagonists & inhibitors', 'Skin Neoplasms/*pathology', 'Vemurafenib/pharmacology', 'Melanoma, Cutaneous Malignant']",https://pubmed.ncbi.nlm.nih.gov/29929490/
1882,ABCB5,26975227,"Pharmacogenetics of ABCB5, ABCC5 and RLIP76 and doxorubicin pharmacokinetics in Asian breast cancer patients.","['Lal S', 'Sutiman N', 'Ooi LL', 'Wong ZW', 'Wong NS', 'Ang PCS', 'Chowbay B']","['ATP Binding Cassette Transporter, Subfamily B', 'ATP Binding Cassette Transporter, Subfamily B, Member 1/*genetics', 'ATP-Binding Cassette Transporters/*genetics', 'Adult', 'Aged', 'Alleles', 'Antibiotics, Antineoplastic/pharmacokinetics/therapeutic use', 'Asian People/*genetics', 'Breast Neoplasms/*drug therapy/*genetics', 'Doxorubicin/*pharmacokinetics/therapeutic use', 'Exons/genetics', 'Female', 'GTPase-Activating Proteins/*genetics', 'Gene Frequency/genetics', 'Genetic Association Studies', 'Genotype', 'Haplotypes/genetics', 'Humans', 'Middle Aged', 'Multidrug Resistance-Associated Proteins/*genetics', 'Pharmacogenetics/methods', 'Polymorphism, Genetic/genetics']",https://pubmed.ncbi.nlm.nih.gov/26975227/
1883,KCNA3,22045429,Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population.,"['Ota M', 'Ito T', 'Umemura T', 'Katsuyama Y', 'Yoshizawa K', 'Hamano H', 'Kawa S']","['Adult', 'Aged', 'Autoimmune Diseases/*genetics', 'Base Sequence', 'Case-Control Studies', 'Female', '*Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Haplotypes', 'Humans', 'Japan', 'Kv1.3 Potassium Channel/*genetics', 'Linkage Disequilibrium', 'Male', 'Microsatellite Repeats', 'Middle Aged', 'Pancreatitis/*genetics/*immunology', 'Polymorphism, Single Nucleotide', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/22045429/
1884,KCNA3,32056271,A common genetic variant rs2821557 in KCNA3 is linked to the severity of multiple sclerosis.,"['Lioudyno V', 'Abdurasulova I', 'Negoreeva I', 'Stoliarov I', 'Kudriavtsev I', 'Serebryakova M', 'Klimenko V', 'Lioudyno M']","['Adult', 'Disease Progression', 'Female', 'Genetic Predisposition to Disease/*genetics', 'Genotype', 'Humans', 'Kv1.3 Potassium Channel', 'Male', 'Middle Aged', 'Multiple Sclerosis/*genetics', 'Polymorphism, Single Nucleotide', 'Receptors, CXCR3/metabolism']",https://pubmed.ncbi.nlm.nih.gov/32056271/
1885,KCNA3,38890756,"Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study.","['Bian Y', 'Gao Y', 'Lin H', 'Sun C', 'Wang W', 'Sun S', 'Li X', 'Feng Z', 'Ren J', 'Chen H', 'Lu C', 'Xu J', 'Zhou J', 'Wan K', 'Xin L', 'Li Z', 'Wang L']","['Adult', 'Aged', 'Female', 'Humans', 'Male', 'Middle Aged', 'Biomarkers, Tumor/genetics/blood', 'Cell-Free Nucleic Acids/blood', '*DNA Methylation', 'Double-Blind Method', '*Esophageal Neoplasms/diagnosis/genetics/blood', 'Prospective Studies']",https://pubmed.ncbi.nlm.nih.gov/38890756/
1886,KCNA3,37650127,Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinoma.,"['Bian Y', 'Gao Y', 'Lu C', 'Tian B', 'Xin L', 'Lin H', 'Zhang Y', 'Zhang X', 'Zhou S', 'Wan K', 'Zhou J', 'Li Z', 'Chen H', 'Wang L']","['Humans', '*Esophageal Squamous Cell Carcinoma/genetics/diagnosis', '*DNA Methylation/genetics', '*Esophageal Neoplasms/genetics/diagnosis', '*Biomarkers, Tumor/genetics', 'Female', 'Male', 'Middle Aged', 'Aged', 'CpG Islands/genetics']",https://pubmed.ncbi.nlm.nih.gov/37650127/
1887,CACNA1F,36191840,Assessing the Pathogenicity of In-Frame CACNA1F Indel Variants Using Structural Modeling.,"['Sallah SR', 'Sergouniotis PI', 'Hardcastle C', 'Ramsden S', 'Lotery AJ', 'Lench N', 'Lovell SC', 'Black GCM']","['Humans', 'Virulence', 'Calcium Channels, L-Type/genetics', '*Night Blindness/genetics/metabolism', '*Eye Diseases, Hereditary/genetics/metabolism', 'Mutation']",https://pubmed.ncbi.nlm.nih.gov/36191840/
1888,CACNA1F,12719097,A novel CACNA1F mutation in a french family with the incomplete type of X-linked congenital stationary night blindness.,"['Jacobi FK', 'Hamel CP', 'Arnaud B', 'Blin N', 'Broghammer M', 'Jacobi PC', 'Apfelstedt-Sylla E', 'Pusch CM']","['Calcium Channels/*genetics/metabolism', '*Calcium Channels, L-Type', 'Chromosomes, Human, X/genetics', 'Electroretinography', '*Frameshift Mutation', 'France', 'Gene Deletion', 'Genetic Diseases, X-Linked/*genetics', 'Genetic Linkage', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Night Blindness/congenital/*genetics/physiopathology', 'Pedigree', 'Photoreceptor Cells, Vertebrate/physiology', 'Visual Acuity']",https://pubmed.ncbi.nlm.nih.gov/12719097/
1889,CACNA1F,10900517,Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F.,"['Boycott KM', 'Pearce WG', 'Bech-Hansen NT']","['Adolescent', 'Adult', 'Calcium Channels/*genetics', '*Calcium Channels, L-Type', 'Child', 'Child, Preschool', 'DNA Mutational Analysis', 'Dark Adaptation/physiology', 'Electroretinography', 'Eye Abnormalities/*genetics/physiopathology', 'Genetic Linkage/*genetics', 'Humans', 'Infant', 'Male', 'Middle Aged', 'Myopia/genetics/physiopathology', 'Night Blindness/*genetics/physiopathology', 'Nystagmus, Pathologic/genetics/physiopathology', 'Pedigree', '*Point Mutation', 'Polymerase Chain Reaction', 'Visual Acuity', '*X Chromosome']",https://pubmed.ncbi.nlm.nih.gov/10900517/
1890,CACNA1F,26436388,Establishment and rapid detection of a heterozygous missense mutation in the CACNA1F gene by ARMS technique with double-base mismatched primers.,"['Yang WC', 'Zhu L', 'Zhou BX', 'Tania S', 'Zhou Q', 'Khan MA', 'Fu XL', 'Cheng JL', 'Lv HB', 'Fu JJ']","['Base Pair Mismatch/*genetics', 'Base Sequence', 'Calcium Channels, L-Type/*genetics', 'DNA Primers/*metabolism', 'Heterozygote', 'Humans', 'Molecular Sequence Data', 'Mutation, Missense/*genetics', 'Point Mutation/genetics', 'Polymerase Chain Reaction/*methods', 'Reproducibility of Results', 'Sequence Analysis, DNA']",https://pubmed.ncbi.nlm.nih.gov/26436388/
1891,CACNA1F,36165086,Identification of a novel CACNA1F mutation in a Chinese family with CORDX3.,"['Du M', 'Li Y', 'Zheng P', 'Zhong L', 'Zhao W', 'Zhang Y', 'Gu H', 'Li X', 'Liu Z']","['Female', 'Humans', 'Calcium Channels, L-Type/genetics', 'China', '*Genetic Diseases, X-Linked/pathology', 'Mutation', '*Retinal Diseases', '*Retinitis Pigmentosa/genetics', 'Male']",https://pubmed.ncbi.nlm.nih.gov/36165086/
1892,CACNA1F,36469668,Optic nerve involvement in CACNA1F-related disease: observations from a multicentric case series.,"['Marziali E', 'Van Den Broeck F', 'Bargiacchi S', 'Fortunato P', 'Caputo R', 'Sodi A', 'De Zaeytijd J', 'Murro V', 'Mucciolo DP', 'Giorgio D', 'Passerini I', 'Palazzo V', 'Peluso F', 'de Baere E', 'Zeitz C', 'Leroy BP', 'Secci J', 'Bacci GM']","['Genetic Diseases, X-Linked', '*Night Blindness/diagnosis/genetics', 'Calcium Channels, L-Type/genetics', '*Retinal Diseases/genetics', 'Optic Nerve', 'Tomography, Optical Coherence', 'Humans', '*Myopia/diagnosis/genetics', 'Eye Diseases, Hereditary']",https://pubmed.ncbi.nlm.nih.gov/36469668/
1893,CACNA1F,36833327,Concomitant Calcium Channelopathies Involving CACNA1A and CACNA1F: A Case Report and Review of the Literature.,"['Schaare D', 'Sarasua SM', 'Lusk L', 'Parthasarathy S', 'Wang L', 'Helbig I', 'Boccuto L']","['Male', 'Humans', 'Calcium', '*Channelopathies/genetics', '*Migraine with Aura/complications/genetics', 'Central Nervous System', 'Calcium Channels', 'Calcium Channels, L-Type']",https://pubmed.ncbi.nlm.nih.gov/36833327/
1894,CACNA1F,33668843,Optic Atrophy and Inner Retinal Thinning in CACNA1F-related Congenital Stationary Night Blindness.,"['Leahy KE', 'Wright T', 'Grudzinska Pechhacker MK', 'Audo I', 'Tumber A', 'Tavares E', 'MacDonald H', 'Locke J', 'VandenHoven C', 'Zeitz C', 'Heon E', 'Buncic JR', 'Vincent A']","['Adolescent', 'Adult', 'Aged', 'Child', 'Electroretinography', 'Eye Diseases, Hereditary/*diagnostic imaging/genetics/pathology', 'Female', 'Genetic Diseases, X-Linked/*diagnostic imaging/genetics/pathology', 'Humans', 'Male', 'Middle Aged', 'Myopia/*diagnostic imaging/genetics/pathology', 'Night Blindness/*diagnostic imaging/genetics/pathology', 'Optic Atrophy/diagnostic imaging/*pathology', 'Refraction, Ocular', 'Retina/diagnostic imaging/*pathology', 'Retrospective Studies', 'Tomography, Optical Coherence/*methods', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33668843/
1895,CACNA1F,39858572,Novel Splice-Altering Variants in the CHM and CACNA1F Genes Causative of X-Linked Choroideremia and Cone Dystrophy.,"['Ridgeway AR', 'Shortall C', 'Finnegan LK', 'Long R', 'Matthews E', 'Dockery A', 'Kopcic E', 'Whelan L', 'Kirk C', 'Silvestri G', 'Turner J', 'Keegan DJ', 'Millington-Ward S', 'Chadderton N', 'Duignan E', 'Kenna PF', 'Farrar GJ']","['Humans', '*Choroideremia/genetics/pathology', 'HEK293 Cells', 'Male', '*Cone Dystrophy/genetics/pathology', '*Pedigree', 'Calcium Channels, L-Type/genetics', 'RNA Splicing/genetics', 'Female', 'Mutation', 'High-Throughput Nucleotide Sequencing', 'Genetic Diseases, X-Linked/genetics/pathology', 'Adult', 'Adaptor Proteins, Signal Transducing']",https://pubmed.ncbi.nlm.nih.gov/39858572/
1896,CACNA1F,39652271,Novel CACNA1F pathogenic variant in pediatric incomplete X-linked CSNB: integrating portable ERG and genetic analysis.,"['Wen L', 'Liu Y', 'Yang Z', 'Mei S', 'Xin Y', 'Li S']","['Humans', '*Night Blindness/genetics/physiopathology/diagnosis', 'Male', '*Electroretinography', '*Genetic Diseases, X-Linked/genetics/physiopathology/diagnosis', 'Child, Preschool', '*Myopia/genetics/physiopathology/diagnosis', '*Eye Diseases, Hereditary/genetics/physiopathology/diagnosis', '*Calcium Channels, L-Type/genetics', 'Genetic Testing', 'Visual Acuity/physiology', 'Exome Sequencing', 'Codon, Nonsense', 'DNA Mutational Analysis', 'Pedigree', 'DNA/genetics']",https://pubmed.ncbi.nlm.nih.gov/39652271/
1897,CACNA1F,38474172,Aland Island Eye Disease with Retinoschisis in the Clinical Spectrum of CACNA1F-Associated Retinopathy-A Case Report.,"['Wygledowska-Promienska D', 'Swierczynska M', 'Spiewak D', 'Pojda-Wilczek D', 'Tronina A', 'Dorecka M', 'Smedowski A']","['Male', 'Humans', 'Child, Preschool', 'Infant', 'Middle Aged', '*Retinoschisis', 'Calcium Channels, L-Type/metabolism', '*Genetic Diseases, X-Linked/genetics', '*Retinal Diseases', 'Retina/metabolism', 'Mutation', '*Night Blindness', '*Myopia', '*Albinism, Ocular', '*Retinitis Pigmentosa', '*Eye Diseases, Hereditary']",https://pubmed.ncbi.nlm.nih.gov/38474172/
1898,CACNA1F,31651202,An Ashkenazi Jewish founder mutation in CACNA1F causes retinal phenotype in both hemizygous males and heterozygous female carriers.,"['Kimchi A', 'Meiner V', 'Silverstein S', 'Macarov M', 'Mor-Shaked H', 'Blumenfeld A', 'Audo I', 'Zeitz C', 'Mechoulam H', 'Banin E', 'Sharon D', 'Yahalom C']","['Adult', 'Aged', 'Arthritis/*genetics', 'Calcium Channels, L-Type/*genetics', 'Deafness/*genetics', 'Eye Diseases, Hereditary/*etiology/pathology', 'Female', 'Follow-Up Studies', 'Founder Effect', 'Genetic Diseases, X-Linked/*etiology/pathology', 'Genetic Testing', '*Hemizygote', '*Heterozygote', 'Humans', 'Jews/*genetics', 'Male', 'Middle Aged', '*Mutation, Missense', 'Myopia/*etiology/pathology', 'Night Blindness/*etiology/pathology', 'Pedigree', 'Phenotype', 'Polychondritis, Relapsing/*genetics', 'Prognosis', 'Retinal Diseases/*etiology/pathology', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/31651202/
1899,CACNA1F,35947237,A clinical and electrophysiological case study of a child with a novel frame shift mutation in the CACNA1F and missense variation of RIMS1 genes.,"['Weston P', 'Taranath D', 'Liebelt J', 'Smith N']","['Calcium Channels, L-Type/genetics', 'Child', 'Electroretinography', 'Evoked Potentials, Visual', 'Eye Diseases, Hereditary', 'Frameshift Mutation', '*Genetic Diseases, X-Linked/genetics', 'Humans', 'Infant', 'Male', 'Mutation', 'Myopia', '*Night Blindness/diagnosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/35947237/
1900,CACNA1G,39287920,CACNA1G Causes Dominantly Inherited Myoclonus-Ataxia with Intellectual Disability: A Case Report.,"['De Riggi M', 'De Giorgi A', 'Pollini L', 'Angelini L', 'Paparella G', 'Cannavacciuolo A', 'Birreci D', 'Costa D', 'Tessa A', 'Natale G', 'Fiorelli M', 'Galatolo D', 'Santorelli FM', 'Galosi S', 'Bologna M']","['Humans', 'Male', 'Middle Aged', '*Intellectual Disability/genetics', '*Calcium Channels, T-Type/genetics', 'Spinocerebellar Ataxias/genetics/complications/congenital']",https://pubmed.ncbi.nlm.nih.gov/39287920/
1901,CACNA1G,39419023,Human assembloids reveal the consequences of CACNA1G gene variants in the thalamocortical pathway.,"['Kim JI', 'Miura Y', 'Li MY', 'Revah O', 'Selvaraj S', 'Birey F', 'Meng X', 'Thete MV', 'Pavlov SD', 'Andersen J', 'Pasca AM', 'Porteus MH', 'Huguenard JR', 'Pasca SP']","['Humans', '*Thalamus/metabolism', '*Calcium Channels, T-Type/genetics', '*Cerebral Cortex', 'Neural Pathways', 'Neurons/metabolism', 'Male', 'Female', 'Genetic Variation/genetics']",https://pubmed.ncbi.nlm.nih.gov/39419023/
1902,CACNA1G,39674904,The characterization of new de novo CACNA1G variants affecting the intracellular gate of Cav3.1 channel broadens the spectrum of neurodevelopmental phenotypes in SCA42ND.,"['Qebibo L', 'Davakan A', 'Nesson-Dauphin M', 'Boulali N', 'Siquier-Pernet K', 'Afenjar A', 'Amiel J', 'Bartholdi D', 'Barth M', 'Blondiaux E', 'Cristian I', 'Frazier Z', 'Goldenberg A', 'Good JM', 'Salussolia CL', 'Sahin M', 'McCullagh H', 'McDonald K', 'McRae A', 'Morrison J', 'Pinner J', 'Shinawi M', 'Toutain A', 'Vyhnalkova E', 'Wheeler PG', 'Wilnai Y', 'Hausman-Kedem M', 'Coolen M', 'Cantagrel V', 'Burglen L', 'Lory P']","['Humans', '*Calcium Channels, T-Type/genetics/metabolism', 'Female', 'Male', 'Child', '*Phenotype', '*Mutation, Missense/genetics', '*Neurodevelopmental Disorders/genetics/pathology', 'Child, Preschool', 'Genetic Association Studies', 'Adolescent', 'Heterozygote', 'Infant']",https://pubmed.ncbi.nlm.nih.gov/39674904/
1903,CACNA1G,31957825,Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.,"['Wei LJ', 'Bai DM', 'Wang ZY', 'Liu BC']","['Calcium Channels, T-Type/genetics/*metabolism', 'Cell Proliferation', 'Cells, Cultured', 'Colorectal Neoplasms/genetics/*metabolism/pathology', '*Down-Regulation', 'Humans', 'RNA, Long Noncoding/genetics/*metabolism', 'Tumor Suppressor Protein p53/genetics/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/31957825/
1904,CACNA1G,16671074,"Profiling the array of Ca(v)3.1 variants from the human T-type calcium channel gene CACNA1G: alternative structures, developmental expression, and biophysical variations.","['Emerick MC', 'Stein R', 'Kunze R', 'McNulty MM', 'Regan MR', 'Hanck DA', 'Agnew WS']","['Alternative Splicing', 'Biophysics/methods', 'Brain/embryology/metabolism', 'Calcium Channels, T-Type/chemistry/*physiology', 'DNA, Complementary/metabolism', '*Gene Expression Regulation, Developmental', 'Genetic Variation', 'Humans', 'Kinetics', 'Open Reading Frames', 'Patch-Clamp Techniques', 'Protein Conformation', 'Protein Structure, Tertiary']",https://pubmed.ncbi.nlm.nih.gov/16671074/
1905,CACNA1G,17397049,Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online.,"['Singh B', 'Monteil A', 'Bidaud I', 'Sugimoto Y', 'Suzuki T', 'Hamano S', 'Oguni H', 'Osawa M', 'Alonso ME', 'Delgado-Escueta AV', 'Inoue Y', 'Yasui-Furukori N', 'Kaneko S', 'Lory P', 'Yamakawa K']","['Calcium Channels, T-Type', 'Epilepsy/*genetics', 'Humans', '*Mutation']",https://pubmed.ncbi.nlm.nih.gov/17397049/
1906,CACNA1G,31836334,Infantile-Onset Syndromic Cerebellar Ataxia and CACNA1G Mutations.,"['Barresi S', 'Dentici ML', 'Manzoni F', 'Bellacchio E', 'Agolini E', 'Pizzi S', 'Ciolfi A', 'Tarnopolsky M', 'Brady L', 'Garone G', 'Novelli A', 'Mei D', 'Guerrini R', 'Capuano A', 'Pantaleoni C', 'Tartaglia M']","['Age of Onset', 'Atrophy', 'Calcium Channels, T-Type/*genetics', 'Cerebellar Ataxia/congenital/genetics/pathology/physiopathology', 'Cerebellar Diseases/complications/*genetics/*pathology/*physiopathology', 'Child', 'Child, Preschool', 'Craniofacial Abnormalities/genetics/pathology', 'Female', 'Humans', 'Infant', 'Magnetic Resonance Imaging', 'Male', 'Mutation, Missense', 'Neurodevelopmental Disorders/etiology/*genetics/*physiopathology', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/31836334/
1907,CACNA1G,32736238,De novo CACNA1G variants in developmental delay and early-onset epileptic encephalopathies.,"['Kunii M', 'Doi H', 'Hashiguchi S', 'Matsuishi T', 'Sakai Y', 'Iai M', 'Okubo M', 'Nakamura H', 'Takahashi K', 'Katsumoto A', 'Tada M', 'Takeuchi H', 'Ishikawa T', 'Miyake N', 'Saitsu H', 'Matsumoto N', 'Tanaka F']","['*Calcium Channels, T-Type/genetics', '*Cerebellar Ataxia', 'HEK293 Cells', 'Humans', 'Infant, Newborn', 'Mutation/genetics', 'Phenotype', '*Spasms, Infantile/genetics', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/32736238/
1908,CACNA1G,19455149,High-density SNP association study of the 17q21 chromosomal region linked to autism identifies CACNA1G as a novel candidate gene.,"['Strom SP', 'Stone JL', 'Ten Bosch JR', 'Merriman B', 'Cantor RM', 'Geschwind DH', 'Nelson SF']","['Autistic Disorder/epidemiology/*genetics', 'Calcium Channels, T-Type/*genetics', 'Child', '*Chromosomes, Human, Pair 17', 'Female', 'Follow-Up Studies', 'Gene Dosage', 'Genetic Markers', 'Genetic Predisposition to Disease/epidemiology', 'Haplotypes', 'Humans', 'Linkage Disequilibrium', 'Lod Score', 'Male', '*Polymorphism, Single Nucleotide', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/19455149/
1909,CACNA1G,30200108,A case of a novel CACNA1G mutation from a Chinese family with SCA42: A case report and literature review.,"['Li X', 'Zhou C', 'Cui L', 'Zhu L', 'Du H', 'Liu J', 'Wang C', 'Fang S']","['Calcium Channels, T-Type/*genetics', 'Family', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Middle Aged', '*Mutation', 'Spinocerebellar Ataxias/diagnostic imaging/*genetics/therapy']",https://pubmed.ncbi.nlm.nih.gov/30200108/
1910,CACNA1G,36508879,Paroxysmal Tonic Upgaze in a Patient With Congenital Ataxia due to a De Novo Missense Variant of CACNA1G.,"['Riquet A', 'Cleuziou P', 'Floret V', 'Quesque F', 'Defoort S', 'Smol T']","['Infant', 'Humans', 'Child', 'Ataxia', '*Cerebellar Ataxia', '*Spinocerebellar Ataxias/complications/genetics', 'Mutation/genetics', '*Cerebellar Diseases', '*Calcium Channels, T-Type/genetics']",https://pubmed.ncbi.nlm.nih.gov/36508879/
1911,CACNA1G,32495824,Long non-coding RNA CACNA1G-AS1 promotes proliferation and invasion and inhibits apoptosis by regulating expression of miR-205 in human keloid fibroblasts.,"['Zhao X', 'Jie X', 'Gao YK', 'Nie B', 'Jiang H']","['*Apoptosis', 'Case-Control Studies', '*Cell Movement', '*Cell Proliferation', 'Cells, Cultured', 'Fibroblasts/*metabolism/pathology', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Keloid/genetics/*metabolism/pathology', 'MicroRNAs/genetics/*metabolism', 'RNA, Long Noncoding/genetics/*metabolism', 'Signal Transduction', 'Skin/*metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/32495824/
1912,CACNA1G,26715324,"A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia.","['Morino H', 'Matsuda Y', 'Muguruma K', 'Miyamoto R', 'Ohsawa R', 'Ohtake T', 'Otobe R', 'Watanabe M', 'Maruyama H', 'Hashimoto K', 'Kawakami H']","['Adolescent', 'Adult', 'Age of Onset', 'Aged', 'Asian People/genetics', 'Calcium Channels, T-Type/*genetics/physiology', 'Exome', 'Female', 'Fibroblasts/pathology', 'Genes, Dominant', 'Genetic Linkage', 'Genotype', 'HEK293 Cells', 'HeLa Cells', 'Humans', 'Induced Pluripotent Stem Cells/cytology', 'Japan', 'Male', 'Membrane Potentials', 'Middle Aged', 'Neurogenesis', 'Patch-Clamp Techniques', 'Pedigree', 'Purkinje Cells/cytology', 'Recombinant Fusion Proteins/metabolism', 'Spinocerebellar Ataxias/*genetics/physiopathology', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/26715324/
1913,CACNA1G,32878331,Novel Missense CACNA1G Mutations Associated with Infantile-Onset Developmental and Epileptic Encephalopathy.,"['Berecki G', 'Helbig KL', 'Ware TL', 'Grinton B', 'Skraban CM', 'Marsh ED', 'Berkovic SF', 'Petrou S']","['Calcium Channels, T-Type/*genetics', 'Developmental Disabilities/*genetics/*pathology', 'Female', 'Humans', 'Male', '*Mutation, Missense', 'Phenotype', 'Spasms, Infantile/*genetics/*pathology']",https://pubmed.ncbi.nlm.nih.gov/32878331/
1914,CACNA1G,29509247,"Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.","['Yu PF', 'Kang AR', 'Jing LJ', 'Wang YM']","['A549 Cells', 'Aged', 'Calcium Channels, T-Type/*biosynthesis/genetics', 'Carcinoma, Non-Small-Cell Lung/genetics/*metabolism', 'Cell Movement/physiology', 'Epithelial-Mesenchymal Transition/*physiology', 'Female', 'Heterogeneous-Nuclear Ribonucleoprotein Group A-B/*biosynthesis/genetics', 'Humans', 'Lung Neoplasms/genetics/*metabolism/pathology', 'Lymphatic Metastasis/genetics/pathology', 'Male', 'Middle Aged', 'Neoplasm Invasiveness/genetics/pathology', 'RNA, Long Noncoding/*biosynthesis/genetics']",https://pubmed.ncbi.nlm.nih.gov/29509247/
1915,PDE11A,20351491,"Familial micronodular adrenocortical disease, Cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A).","['Carney JA', 'Gaillard RC', 'Bertherat J', 'Stratakis CA']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Adrenal Cortex/metabolism/pathology', 'Adrenal Cortex Diseases/*genetics/pathology/surgery', 'Adrenal Glands/pathology', 'Adrenalectomy', 'Adult', 'Child', 'Cushing Syndrome/*genetics/pathology/surgery', 'Family Health', 'Female', 'Genetic Predisposition to Disease', 'Humans', 'Organ Size', 'Phosphoric Diester Hydrolases/*genetics/metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/20351491/
1916,PDE11A,35929507,Functional characteristics and research trends of PDE11A in human diseases (Review).,"['Kong G', 'Lee H', 'Vo TT', 'Juang U', 'Kwon SH', 'Park J', 'Park J', 'Kim SH']","[""*3',5'-Cyclic-GMP Phosphodiesterases/genetics"", 'Cyclic AMP-Dependent Protein Kinases/genetics', 'Cyclic GMP', 'Humans', 'Male', 'Mutation', '*Phosphoric Diester Hydrolases/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35929507/
1917,PDE11A,33661511,PDE11A gene polymorphism in testicular cancer: sperm parameters and hormonal profile.,"['Faja F', 'Finocchi F', 'Carlini T', 'Rizzo F', 'Pallotti F', 'Spaziani M', 'Balercia G', 'Lenzi A', 'Paoli D', 'Lombardo F']","[""3',5'-Cyclic-GMP Phosphodiesterases/*genetics"", 'Case-Control Studies', 'Follow-Up Studies', '*Genetic Predisposition to Disease', 'Hormones/analysis/*metabolism', 'Humans', 'Male', 'Middle Aged', 'Neoplasms, Germ Cell and Embryonal/genetics/metabolism/*pathology', '*Polymorphism, Single Nucleotide', 'Prognosis', 'Semen Analysis', 'Spermatozoa/metabolism/*pathology', 'Testicular Neoplasms/genetics/metabolism/*pathology']",https://pubmed.ncbi.nlm.nih.gov/33661511/
1918,PDE11A,33835157,Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer's disease.,"['Qin W', 'Zhou A', 'Zuo X', 'Jia L', 'Li F', 'Wang Q', 'Li Y', 'Wei Y', 'Jin H', 'Cruchaga C', 'Benitez BA', 'Jia J']","[""3',5'-Cyclic-GMP Phosphodiesterases/genetics"", '*Alzheimer Disease/genetics', 'Exome/genetics', 'Humans', 'Phosphoric Diester Hydrolases/genetics/metabolism', 'Exome Sequencing']",https://pubmed.ncbi.nlm.nih.gov/33835157/
1919,PDE11A,26459559,Rare inactivating PDE11A variants associated with testicular germ cell tumors.,"['Pathak A', 'Stewart DR', 'Faucz FR', 'Xekouki P', 'Bass S', 'Vogt A', 'Zhang X', 'Boland J', 'Yeager M', 'Loud JT', 'Nathanson KL', 'McGlynn KA', 'Stratakis CA', 'Greene MH', 'Mirabello L']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Amino Acid Substitution', 'Case-Control Studies', 'Cyclic AMP/metabolism', 'DNA, Neoplasm/genetics', 'Genetic Predisposition to Disease', 'Genotype', 'HEK293 Cells', 'Humans', 'Introns/genetics', 'Male', 'Mutagenesis, Site-Directed', 'Mutation, Missense', 'Neoplasm Proteins/*genetics/physiology', 'Neoplasms, Germ Cell and Embryonal/enzymology/*genetics', 'Phosphoric Diester Hydrolases/*genetics/physiology', 'Point Mutation', 'Protein Isoforms/genetics', 'RNA Splice Sites/genetics', 'Risk', 'Testicular Neoplasms/enzymology/*genetics', 'Transfection', 'United States', 'White People/genetics']",https://pubmed.ncbi.nlm.nih.gov/26459559/
1920,PDE11A,15995148,Expression of PDE11A in normal and malignant human tissues.,"[""D'Andrea MR"", 'Qiu Y', 'Haynes-Johnson D', 'Bhattacharjee S', 'Kraft P', 'Lundeen S']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Endothelial Cells/enzymology', 'Epithelial Cells/enzymology', 'Humans', 'Immunohistochemistry', 'Myocytes, Smooth Muscle/enzymology', 'Neoplasms/*enzymology', 'Organ Specificity', 'Phosphoric Diester Hydrolases/*biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/15995148/
1921,PDE11A,20881257,Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer.,"['Faucz FR', 'Horvath A', 'Rothenbuhler A', 'Almeida MQ', 'Libe R', 'Raffin-Sanson ML', 'Bertherat J', 'Carraro DM', 'Soares FA', 'Molina Gde C', 'Campos AH', 'Alexandre RB', 'Bendhack ML', 'Nesterova M', 'Stratakis CA']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Brazil', '*Genetic Predisposition to Disease', '*Genetic Variation', 'HEK293 Cells', 'Humans', 'Immunohistochemistry', 'Male', 'Mutation', 'Phosphoric Diester Hydrolases/*genetics/metabolism', 'Prostatic Neoplasms/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/20881257/
1922,PDE11A,18559625,Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.,"['Libe R', 'Fratticci A', 'Coste J', 'Tissier F', 'Horvath A', 'Ragazzon B', 'Rene-Corail F', 'Groussin L', 'Bertagna X', 'Raffin-Sanson ML', 'Stratakis CA', 'Bertherat J']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Adrenal Cortex Neoplasms/*genetics/metabolism', 'Adrenocortical Adenoma/*genetics/metabolism', 'Adult', 'Base Sequence', 'Case-Control Studies', 'DNA Mutational Analysis', 'Female', '*Genetic Predisposition to Disease', 'Humans', 'Male', 'Middle Aged', 'Mutation, Missense', 'Phosphoric Diester Hydrolases/*genetics/metabolism', 'Polymorphism, Single Nucleotide', 'Precancerous Conditions/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/18559625/
1923,PDE11A,21047926,Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.,"['Libe R', 'Horvath A', 'Vezzosi D', 'Fratticci A', 'Coste J', 'Perlemoine K', 'Ragazzon B', 'Guillaud-Bataille M', 'Groussin L', 'Clauser E', 'Raffin-Sanson ML', 'Siegel J', 'Moran J', 'Drori-Herishanu L', 'Faucz FR', 'Lodish M', 'Nesterova M', 'Bertagna X', 'Bertherat J', 'Stratakis CA']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Adolescent', 'Adrenal Gland Neoplasms/*genetics', 'Adult', 'Carney Complex/*genetics', 'Child', 'Child, Preschool', 'Cyclic AMP-Dependent Protein Kinase RIalpha Subunit/*genetics', 'Female', 'Genetic Variation', 'HEK293 Cells', 'Humans', 'Male', 'Middle Aged', 'Mutation', 'Phenotype', 'Phosphoric Diester Hydrolases/*genetics', 'RNA, Small Interfering', 'Sertoli Cell Tumor/*genetics', 'Sex Factors', 'Testicular Neoplasms/*genetics']",https://pubmed.ncbi.nlm.nih.gov/21047926/
1924,PDE11A,10725373,Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A.,"['Fawcett L', 'Baxendale R', 'Stacey P', 'McGrouther C', 'Harrow I', 'Soderling S', 'Hetman J', 'Beavo JA', 'Phillips SC']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Amino Acid Sequence', 'Base Sequence', 'Cloning, Molecular', 'DNA, Complementary', 'Enzyme Inhibitors', 'Expressed Sequence Tags', 'Humans', 'Kinetics', 'Molecular Sequence Data', '*Multigene Family', 'Open Reading Frames', 'Phosphodiesterase Inhibitors', 'Phosphoric Diester Hydrolases/*genetics/metabolism', 'RNA, Messenger/genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/10725373/
1925,PDE11A,11121118,Genomic organization of the human phosphodiesterase PDE11A gene. Evolutionary relatedness with other PDEs containing GAF domains.,"['Yuasa K', 'Kanoh Y', 'Okumura K', 'Omori K']","[""3',5'-Cyclic-GMP Phosphodiesterases/genetics"", 'Amino Acid Sequence', 'Base Sequence', 'Chromosome Mapping', 'Chromosomes, Human, Pair 2', 'Cyclic Nucleotide Phosphodiesterases, Type 5', 'Cyclic Nucleotide Phosphodiesterases, Type 6', 'DNA/analysis', '*Evolution, Molecular', 'Exons', 'Genome, Human', 'Humans', 'Introns', 'Molecular Sequence Data', 'Phosphoric Diester Hydrolases/*genetics', 'Promoter Regions, Genetic', 'Protein Structure, Tertiary', 'RNA, Messenger/metabolism', 'Sequence Homology, Amino Acid', 'Tissue Distribution']",https://pubmed.ncbi.nlm.nih.gov/11121118/
1926,PDE11A,22996146,Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors.,"['Vezzosi D', 'Libe R', 'Baudry C', 'Rizk-Rabin M', 'Horvath A', 'Levy I', 'Rene-Corail F', 'Ragazzon B', 'Stratakis CA', 'Vandecasteele G', 'Bertherat J']","[""3',5'-Cyclic-GMP Phosphodiesterases"", 'Adrenal Gland Neoplasms/*genetics', 'Adult', 'Cushing Syndrome/*genetics', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Genotype', 'HEK293 Cells', 'Humans', 'Phosphoric Diester Hydrolases/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22996146/
1927,CYSLTR1,37580467,Inhibition of CysLTR1 reduces the levels of aggregated proteins in retinal pigment epithelial cells.,"['Koller A', 'Brunner SM', 'Preishuber-Pflugl J', 'Mayr D', 'Ladek AM', 'Runge C', 'Reitsamer HA', 'Trost A']","['*Autophagosomes/metabolism', '*Autophagy', '*Epithelial Cells/metabolism', 'Lysosomes/metabolism', 'Reactive Oxygen Species/metabolism', 'Retina/cytology']",https://pubmed.ncbi.nlm.nih.gov/37580467/
1928,CYSLTR1,39389443,CYSLTR1 antagonism displays potent anti-tumor effects in uveal melanoma.,"['Garcia de Alba Graue P', 'Abdouh M', 'Goyeneche A', 'Burnier JV', 'Burnier MN']","['Humans', '*Uveal Neoplasms/metabolism/drug therapy/pathology/genetics', '*Receptors, Leukotriene/metabolism/genetics', '*Melanoma/metabolism/pathology/drug therapy/genetics', '*Apoptosis/drug effects', '*Cell Proliferation/drug effects', 'Male', 'Female', 'Middle Aged', 'Cell Line, Tumor', 'Tumor Cells, Cultured', 'Aged', 'Gene Expression Regulation, Neoplastic', 'Cell Survival/drug effects', 'Blotting, Western', 'Uveal Melanoma']",https://pubmed.ncbi.nlm.nih.gov/39389443/
1929,CYSLTR1,16771777,Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitis.,"['Zhang J', 'Migita O', 'Koga M', 'Shibasaki M', 'Arinami T', 'Noguchi E']","['Adolescent', 'Alternative Splicing', 'Amino Acid Sequence/genetics', 'Asthma/*genetics', 'Base Sequence/genetics', 'Child', 'Gene Expression Regulation/genetics', 'Genome Components/*genetics', 'Humans', 'Japan', 'Membrane Proteins/chemistry/*genetics', 'Molecular Sequence Data', 'Polymorphism, Genetic/genetics', 'Receptors, Leukotriene/chemistry/*genetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Rhinitis/*genetics', 'Transcription, Genetic/*genetics']",https://pubmed.ncbi.nlm.nih.gov/16771777/
1930,CYSLTR1,33837837,The relevance of CYSLTR1 gene polymorphism to the severity of allergic rhinitis and clinical responsiveness of montelukast in children.,"['Zhao M', 'Li H', 'Li H']","['Acetates/therapeutic use', 'Anti-Asthmatic Agents/*therapeutic use', 'Child', 'Cyclopropanes', 'Gene Frequency', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Polymorphism, Single Nucleotide', '*Quinolines/therapeutic use', 'Receptors, Leukotriene/*genetics', '*Rhinitis, Allergic/drug therapy/genetics', 'Sulfides']",https://pubmed.ncbi.nlm.nih.gov/33837837/
1931,CYSLTR1,29331588,Antagonism of cysteinyl leukotriene receptor 1 (cysLTR1) by montelukast suppresses cell senescence of chondrocytes.,"['Song W', 'Zhang Y', 'Wang J', 'Ma T', 'Hao L', 'Wang K']","['Acetates/*pharmacology', 'Adult', 'Cellular Senescence/*drug effects', 'Chondrocytes/*metabolism/pathology', 'Cyclin-Dependent Kinase Inhibitor p21/metabolism', 'Cyclopropanes', 'Female', 'Humans', 'Male', 'Plasminogen Activator Inhibitor 1/metabolism', 'Quinolines/*pharmacology', 'Receptors, Leukotriene/*metabolism', 'Sulfides', 'Tumor Necrosis Factor-alpha/biosynthesis', 'Tumor Suppressor Protein p53/metabolism', 'Up-Regulation/drug effects']",https://pubmed.ncbi.nlm.nih.gov/29331588/
1932,CYSLTR1,27221082,Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between allergic and nonallergic snoring children.,"['Paulucci BP', 'Pereira J', 'Picciarelli P', 'Levy D', 'Di Francesco RC']","['Adenoids/*metabolism/pathology', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Hyperplasia/genetics/metabolism', 'Hypersensitivity/genetics/metabolism/pathology', 'Lymphocytes/*metabolism', 'Male', 'Palatine Tonsil/*metabolism/pathology', 'RNA, Messenger/metabolism', 'Receptors, Leukotriene/*genetics', 'Snoring/genetics/metabolism/pathology']",https://pubmed.ncbi.nlm.nih.gov/27221082/
1933,CYSLTR1,17924829,CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients.,"['Kim SH', 'Ye YM', 'Hur GY', 'Lee SK', 'Sampson AP', 'Lee HY', 'Park HS']","['Anti-Inflammatory Agents, Non-Steroidal/adverse effects', 'Aspirin/*adverse effects', 'Asthma/drug therapy', 'Child', 'Drug Hypersensitivity/*genetics', 'Forced Expiratory Volume', 'Humans', 'Korea', 'Leukotriene Antagonists/*therapeutic use', 'Membrane Proteins/*genetics', '*Polymorphism, Genetic', '*Promoter Regions, Genetic', 'Receptors, Leukotriene/*genetics']",https://pubmed.ncbi.nlm.nih.gov/17924829/
1934,CYSLTR1,17641958,Differential contribution of the CysLTR1 gene in patients with aspirin hypersensitivity.,"['Kim SH', 'Yang EM', 'Park HJ', 'Ye YM', 'Lee HY', 'Park HS']","['Adult', 'Aspirin/*adverse effects', 'Asthma/genetics/immunology', 'Case-Control Studies', 'Diagnosis, Differential', 'Drug Hypersensitivity/diagnosis/enzymology/*genetics/immunology', 'Female', 'Genetic Markers', 'Glutathione Transferase/genetics', 'Humans', 'Hypersensitivity, Immediate/diagnosis/genetics/immunology', 'Male', 'Membrane Proteins/*genetics', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Receptors, Leukotriene/*genetics', 'U937 Cells', 'Urticaria/genetics/immunology']",https://pubmed.ncbi.nlm.nih.gov/17641958/
1935,CYSLTR1,17406065,Functional polymorphism and differential regulation of CYSLTR1 transcription in human airway smooth muscle and monocytes.,"['Duroudier NP', 'Sayers I', 'Castagna CC', 'Fenech AG', 'Halapi E', 'Swan C', 'Hall IP']","['Alleles', 'Alternative Splicing', '*Gene Expression Regulation', 'Haplotypes', 'Humans', 'Leukocytes, Mononuclear/metabolism', 'Leukotrienes/metabolism', 'Membrane Proteins/*metabolism', 'Models, Genetic', 'Monocytes/*metabolism', 'Muscle, Smooth/*metabolism', '*Polymorphism, Genetic', 'Promoter Regions, Genetic', 'Receptors, Leukotriene/*metabolism', 'Risk', 'Trachea/*metabolism', 'Transcription, Genetic']",https://pubmed.ncbi.nlm.nih.gov/17406065/
1936,CYSLTR1,19080797,Analysis of 927T > C CYSLTR1 and -444A > C LTC4S polymorphisms in children with asthma.,"['Arriba-Mendez S', 'Sanz C', 'Isidoro-Garcia M', 'Pascual M', 'Avila C', 'Davila I', 'Lorente F']","['Adolescent', 'Alleles', 'Asthma/*genetics', 'Child', 'Female', 'Gene Frequency', 'Genotype', 'Glutathione Transferase/*genetics', 'Humans', 'Male', 'Monte Carlo Method', 'Polymorphism, Genetic', 'Receptors, Leukotriene/*genetics', 'Skin Tests']",https://pubmed.ncbi.nlm.nih.gov/19080797/
1937,CYSLTR1,16846449,927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis.,"['Arriba-Mendez S', 'Sanz C', 'Isidoro-Garcia M', 'Davild I', 'Laffond E', 'Horeno E', 'Avila C', 'Lorente F']","['Adolescent', 'Adult', 'Alleles', 'Asthma/*genetics/immunology', 'Child', 'Dermatitis, Atopic/*genetics/immunology', 'Eosinophils/immunology', 'Female', 'Humans', 'Immunoglobulin E/immunology', 'Male', 'Membrane Proteins/*genetics/immunology', 'Middle Aged', 'Polymorphism, Single Nucleotide', 'Receptors, Leukotriene/*genetics/immunology', 'Th2 Cells/immunology']",https://pubmed.ncbi.nlm.nih.gov/16846449/
1938,CYSLTR1,28034578,Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes.,"['Matsumoto H', 'Kanemitsu Y', 'Nagasaki T', 'Tohda Y', 'Horiguchi T', 'Kita H', 'Kuwabara K', 'Tomii K', 'Otsuka K', 'Fujimura M', 'Ohkura N', 'Tomita K', 'Yokoyama A', 'Ohnishi H', 'Nakano Y', 'Oguma T', 'Hozawa S', 'Izuhara Y', 'Ito I', 'Oguma T', 'Inoue H', 'Tajiri T', 'Iwata T', 'Ono J', 'Ohta S', 'Hirota T', 'Kawaguchi T', 'Tamari M', 'Yokoyama T', 'Tabara Y', 'Matsuda F', 'Izuhara K', 'Niimi A', 'Mishima M']","['Aged', 'Alleles', 'Asthma/*diagnosis/*etiology/metabolism', 'Biomarkers', 'Case-Control Studies', 'Disease Susceptibility', 'Enterotoxins/*immunology', 'Female', 'Gene Frequency', 'Genetic Association Studies', '*Genetic Variation', 'Genotype', 'Humans', 'Immunization', 'Immunoglobulin E/blood/immunology', 'Leukocyte Count', 'Male', 'Middle Aged', '*Phenotype', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic', 'Receptors, Leukotriene/*genetics/metabolism', 'Respiratory Function Tests', 'Risk Factors', 'Staphylococcus aureus/*immunology']",https://pubmed.ncbi.nlm.nih.gov/28034578/
1939,CACNA2D1,38536483,CACNA2D1 regulates the progression and influences the microenvironment of colon cancer.,"['Inoue H', 'Shiozaki A', 'Kosuga T', 'Shimizu H', 'Kudou M', 'Arita T', 'Konishi H', 'Komatsu S', 'Kuriu Y', 'Kubota T', 'Fujiwara H', 'Morinaga Y', 'Konishi E', 'Otsuji E']","['Aged', 'Female', 'Humans', 'Male', 'Middle Aged', '*Apoptosis', '*Calcium Channels/genetics/metabolism', 'Cell Line, Tumor', 'Cell Movement', 'Cell Proliferation', 'Coculture Techniques', '*Colonic Neoplasms/genetics/pathology', '*Disease Progression', 'Epithelial-Mesenchymal Transition/genetics', 'Fibroblasts/metabolism/pathology', 'Gene Expression Regulation, Neoplastic', 'Gene Knockdown Techniques', 'HCT116 Cells', 'Prognosis', '*Tumor Microenvironment/genetics']",https://pubmed.ncbi.nlm.nih.gov/38536483/
1940,CACNA2D1,24438356,The perfect storm? Histiocytoid cardiomyopathy and compound CACNA2D1 and RANGRF mutation in a baby.,"['Cataldo S', 'Annoni GA', 'Marziliano N']","['Alleles', 'Calcium Channels/*genetics/metabolism', 'Cardiomyopathies/*congenital/diagnosis/genetics/metabolism', 'DNA/*genetics', 'DNA Mutational Analysis', 'Electron Transport Complex III/*deficiency/genetics/metabolism', 'Electrophysiologic Techniques, Cardiac', 'Female', 'Humans', 'Infant, Newborn', '*Mutation', 'ran GTP-Binding Protein/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/24438356/
1941,CACNA2D1,39354346,Novel heterozygous mutation of CACNA2D1 gene in a Chinese family with arrhythmia.,"['Wang Q', 'Deng Y', 'Fan LL', 'Dong Y', 'Zhang AQ', 'Liu YX']","['Adult', 'Female', 'Humans', 'Male', 'Middle Aged', 'Action Potentials', '*Arrhythmias, Cardiac/genetics/diagnosis/physiopathology', '*Calcium Channels/genetics', 'China', 'DNA Mutational Analysis', 'East Asian People', 'Exome Sequencing', 'Genetic Predisposition to Disease', 'Heart Rate/genetics', 'Heredity', 'Heterozygote', '*Mutation, Missense', 'Pedigree', 'Phenotype']",https://pubmed.ncbi.nlm.nih.gov/39354346/
1942,CACNA2D1,31725046,MicroRNA-107 inhibits proliferation and invasion of laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in vitro.,"['Huang C', 'Wang Z', 'Zhang K', 'Dong Y', 'Zhang A', 'Lu C', 'Liu L']","['Calcium Channels/*genetics', 'Cell Line, Tumor', 'Cell Movement', 'Cell Proliferation', 'Humans', 'Laryngeal Neoplasms/*pathology', 'Male', 'MicroRNAs/*physiology', 'Neoplasm Invasiveness', 'Squamous Cell Carcinoma of Head and Neck/*pathology']",https://pubmed.ncbi.nlm.nih.gov/31725046/
1943,CACNA2D1,25373460,miR‑107 promotes the erythroid differentiation of leukemia cells via the downregulation of Cacna2d1.,"['Ruan J', 'Liu X', 'Xiong X', 'Zhang C', 'Li J', 'Zheng H', 'Huang C', 'Shi Q', 'Weng Y']","[""3' Untranslated Regions"", 'Antigens, CD/metabolism', 'Base Sequence', 'Calcium Channels/genetics/*metabolism', 'Cell Differentiation', 'Cell Line, Tumor', 'Cell Proliferation', 'Down-Regulation', 'Erythroid Cells/cytology', 'Fusion Proteins, bcr-abl/metabolism', 'Humans', 'K562 Cells', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism/pathology', 'MicroRNAs/antagonists & inhibitors/genetics/*metabolism', 'Oligonucleotides/metabolism', 'Receptors, Transferrin/metabolism', 'Sequence Alignment', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/25373460/
1944,CACNA2D1,24937803,"Mapping breakpoints of a familial chromosome insertion (18,7) (q22.1; q36.2q21.11) to DPP6 and CACNA2D1 genes in an azoospermic male.","['Li L', 'Chen H', 'Yin C', 'Yang C', 'Wang B', 'Zheng S', 'Zhang J', 'Fan W']","['Adult', 'Azoospermia/*genetics', 'Calcium Channels/*genetics', 'Chromosome Aberrations', '*Chromosome Fragile Sites', '*Chromosomes, Human, Pair 18', '*Chromosomes, Human, Pair 7', 'Chromosomes, Human, Y', 'Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/*genetics', 'Female', 'Humans', 'In Situ Hybridization, Fluorescence', 'Karyotyping', 'Male', 'Nerve Tissue Proteins/*genetics', 'Pedigree', 'Potassium Channels/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24937803/
1945,CACNA2D1,25074461,Genomic aberrations of the CACNA2D1 gene in three patients with epilepsy and intellectual disability.,"['Vergult S', 'Dheedene A', 'Meurs A', 'Faes F', 'Isidor B', 'Janssens S', 'Gautier A', 'Le Caignec C', 'Menten B']","['Adolescent', 'Calcium Channels/*genetics', '*Chromosome Aberrations', 'Comparative Genomic Hybridization', 'Epilepsy/*diagnosis/*genetics', 'Female', '*Genetic Association Studies', 'Humans', 'In Situ Hybridization, Fluorescence', 'Infant', 'Intellectual Disability/*diagnosis/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25074461/
1946,CACNA2D2,37047559,MicroRNA-423-5p Mediates Cocaine-Induced Smooth Muscle Cell Contraction by Targeting Cacna2d2.,"['Dykxhoorn DM', 'Wang H', 'Da Fonseca Ferreira A', 'Wei J', 'Dong C']","['Humans', '*Cocaine/adverse effects/metabolism', 'Calcium/metabolism', '*MicroRNAs/metabolism', '*Atherosclerosis/metabolism', '*Cocaine-Related Disorders/metabolism', 'Myocytes, Smooth Muscle/metabolism', 'Cell Proliferation', 'Calcium Channels/metabolism']",https://pubmed.ncbi.nlm.nih.gov/37047559/
1947,CACNA2D2,31402629,Biallelic CACNA2D2 variants in epileptic encephalopathy and cerebellar atrophy.,"['Punetha J', 'Karaca E', 'Gezdirici A', 'Lamont RE', 'Pehlivan D', 'Marafi D', 'Appendino JP', 'Hunter JV', 'Akdemir ZC', 'Fatih JM', 'Jhangiani SN', 'Gibbs RA', 'Innes AM', 'Posey JE', 'Lupski JR']","['Adult', 'Atrophy', 'Calcium Channels/*genetics', 'Cerebellar Ataxia/genetics', 'Cerebellar Diseases/*genetics', 'Epilepsy/*genetics', 'Female', 'Humans', 'Male', 'Mutation, Missense', 'Pedigree', 'Seizures', 'Siblings', 'Spasms, Infantile/*genetics']",https://pubmed.ncbi.nlm.nih.gov/31402629/
1948,CACNA2D2,24358150,A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy.,"['Pippucci T', 'Parmeggiani A', 'Palombo F', 'Maresca A', 'Angius A', 'Crisponi L', 'Cucca F', 'Liguori R', 'Valentino ML', 'Seri M', 'Carelli V']","['Calcium Channels/*genetics', 'Child', 'Child, Preschool', 'Humans', 'Infant', 'Male', '*Mutation', 'Phenotype', 'Spasms, Infantile/*genetics']",https://pubmed.ncbi.nlm.nih.gov/24358150/
1949,CACNA2D2,28850479,"Genetic susceptibility to postherniotomy pain. The influence of polymorphisms in the Mu opioid receptor, TNF-alpha, GRIK3, GCH1, BDNF and CACNA2D2 genes.","['Kalliomaki ML', 'Sandblom G', 'Hallberg M', 'Gronbladh A', 'Gunnarsson U', 'Gordh T', 'Ginya H', 'Nyberg F']","['Brain-Derived Neurotrophic Factor', 'Calcium Channels/genetics', 'Cohort Studies', '*Genetic Predisposition to Disease', 'Hernia', 'Herniorrhaphy', 'Humans', 'Pain, Postoperative/*genetics', 'Receptors, Kainic Acid/genetics', 'Receptors, Opioid, mu', 'Tumor Necrosis Factor-alpha/*genetics', 'GluK3 Kainate Receptor']",https://pubmed.ncbi.nlm.nih.gov/28850479/
1950,SLC22A8,23649425,Reduced renal clearance of cefotaxime in asians with a low-frequency polymorphism of OAT3 (SLC22A8).,"['Yee SW', 'Nguyen AN', 'Brown C', 'Savic RM', 'Zhang Y', 'Castro RA', 'Cropp CD', 'Choi JH', 'Singh D', 'Tahara H', 'Stocker SL', 'Huang Y', 'Brett CM', 'Giacomini KM']","['Adolescent', 'Adult', 'Anti-Bacterial Agents/*blood/*metabolism', 'Asian People/genetics', 'Cefotaxime/*blood/*metabolism', 'Female', 'Gene Frequency', 'HEK293 Cells', 'Humans', 'Kidney/*metabolism', 'Male', 'Organic Anion Transporters, Sodium-Independent/*genetics/metabolism', 'Polymorphism, Genetic', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/23649425/
1951,SLC22A8,16247710,Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis.,"['Sakurai Y', 'Motohashi H', 'Ogasawara K', 'Terada T', 'Masuda S', 'Katsura T', 'Mori N', 'Matsuura M', 'Doi T', 'Fukatsu A', 'Inui K']","['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Alanine Transaminase/blood', 'Anions/metabolism', 'Aspartate Aminotransferases/blood', 'Cefazolin/pharmacokinetics', 'DNA, Complementary/biosynthesis/genetics', 'Female', 'Genotype', 'Glomerulonephritis, Membranoproliferative/*metabolism', 'Humans', 'Kidney/*metabolism', 'L-Lactate Dehydrogenase/blood', 'Male', 'Middle Aged', 'Organic Anion Transporters, Sodium-Independent/*metabolism', 'Pharmaceutical Preparations/*metabolism', 'RNA, Messenger/biosynthesis']",https://pubmed.ncbi.nlm.nih.gov/16247710/
1952,SLC22A8,36123895,SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics.,"['Xu K', 'Wu Y', 'Chi H', 'Li Y', 'She Y', 'Yin X', 'Liu X', 'He B', 'Li X', 'Du H']","['Biomarkers, Tumor/metabolism', '*Carcinoma, Renal Cell/pathology', 'Computational Biology', 'Humans', '*Kidney Neoplasms/pathology', 'Prognosis', 'Tumor Microenvironment/genetics']",https://pubmed.ncbi.nlm.nih.gov/36123895/
1953,SLC22A8,12811365,Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics.,"['Nishizato Y', 'Ieiri I', 'Suzuki H', 'Kimura M', 'Kawabata K', 'Hirota T', 'Takane H', 'Irie S', 'Kusuhara H', 'Urasaki Y', 'Urae A', 'Higuchi S', 'Otsubo K', 'Sugiyama Y']","['Adult', 'Alleles', 'Area Under Curve', 'Asian People', 'Biotransformation', 'Black People', 'DNA/analysis/biosynthesis/genetics', 'Gene Frequency', 'Haplotypes', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors/*pharmacokinetics', 'Japan', 'Liver-Specific Organic Anion Transporter 1/*genetics', 'Organic Anion Transporters, Sodium-Independent/*genetics', 'Polymorphism, Genetic/genetics', 'Pravastatin/*pharmacokinetics', 'Reverse Transcriptase Polymerase Chain Reaction', 'Terminology as Topic', 'White People']",https://pubmed.ncbi.nlm.nih.gov/12811365/
1954,SLC22A8,35406626,Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort.,"['Vavra J', 'Mancikova A', 'Pavelcova K', 'Hasikova L', 'Bohata J', 'Stiburkova B']","['Biological Transport', '*Gout/genetics/metabolism', 'HEK293 Cells', 'Humans', '*Hyperuricemia/genetics', '*Organic Anion Transport Protein 1/genetics', '*Organic Anion Transporters, Sodium-Independent/genetics', 'Uric Acid/metabolism']",https://pubmed.ncbi.nlm.nih.gov/35406626/
1955,SLC22A8,16291576,The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics.,"['Erdman AR', 'Mangravite LM', 'Urban TJ', 'Lagpacan LL', 'Castro RA', 'de la Cruz M', 'Chan W', 'Huang CC', 'Johns SJ', 'Kawamoto M', 'Stryke D', 'Taylor TR', 'Carlson EJ', 'Ferrin TE', 'Brett CM', 'Burchard EG', 'Giacomini KM']","['Alleles', 'DNA Mutational Analysis', 'Ethnicity', '*Genetic Variation', 'Genetics, Population', 'Humans', 'Organic Anion Transporters, Sodium-Independent/*genetics/*physiology', 'Pharmaceutical Preparations/metabolism', 'Pharmacokinetics']",https://pubmed.ncbi.nlm.nih.gov/16291576/
1956,SLC22A8,17502342,Human organic anion transporters 1 (hOAT1/SLC22A6) and 3 (hOAT3/SLC22A8) transport edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one) and its sulfate conjugate.,"['Mizuno N', 'Takahashi T', 'Iwase Y', 'Kusuhara H', 'Niwa T', 'Sugiyama Y']","['Antipyrine/*analogs & derivatives/metabolism/pharmacokinetics/pharmacology', 'Biological Transport', 'Cell Line', 'Cell Proliferation/drug effects', 'Edaravone', 'Free Radical Scavengers/metabolism/pharmacokinetics/pharmacology', 'Glucuronides/metabolism', 'Humans', 'Kidney/cytology/metabolism', 'Kidney Tubules, Proximal/metabolism', 'Kinetics', 'Organic Anion Transport Protein 1/genetics/*metabolism', 'Organic Anion Transporters, Sodium-Independent/genetics/*metabolism', 'Sulfuric Acid Esters/*metabolism', 'Transfection']",https://pubmed.ncbi.nlm.nih.gov/17502342/
1957,SLC22A8,22877817,"Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11).","['Wang L', 'Sweet DH']","['*Food-Drug Interactions', 'Humans', 'Hydroxybenzoates/*pharmacology', 'Inhibitory Concentration 50', 'Organic Anion Transporters/classification/*drug effects']",https://pubmed.ncbi.nlm.nih.gov/22877817/
1958,GSTP1,38016474,SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation.,"['Zhang W', 'Dai J', 'Hou G', 'Liu H', 'Zheng S', 'Wang X', 'Lin Q', 'Zhang Y', 'Lu M', 'Gong Y', 'Xiang Z', 'Yu Y', 'Hu Y']","['United States', '*Ferroptosis/genetics', 'Ubiquitination', 'Down-Regulation', 'Glutathione', 'Peroxidases', '*Neoplasms/genetics']",https://pubmed.ncbi.nlm.nih.gov/38016474/
1959,GSTP1,32535103,Targeting G6PD reverses paclitaxel resistance in ovarian cancer by suppressing GSTP1.,"['Feng Q', 'Li X', 'Sun W', 'Sun M', 'Li Z', 'Sheng H', 'Xie F', 'Zhang S', 'Shan C']","['Antineoplastic Agents, Phytogenic/administration & dosage/metabolism', 'Cell Line, Tumor', 'Cell Proliferation/drug effects/physiology', 'Dose-Response Relationship, Drug', 'Drug Delivery Systems/*methods', 'Drug Resistance, Neoplasm/*drug effects/physiology', 'Female', 'Glucosephosphate Dehydrogenase/antagonists & inhibitors/*metabolism', 'Glutathione S-Transferase pi/antagonists & inhibitors/*biosynthesis', 'Humans', 'Ovarian Neoplasms/drug therapy/*metabolism', 'Paclitaxel/administration & dosage/*metabolism']",https://pubmed.ncbi.nlm.nih.gov/32535103/
1960,GSTP1,27113843,A tyrosine-reactive irreversible inhibitor for glutathione S-transferase Pi (GSTP1).,"['Crawford LA', 'Weerapana E']","['Enzyme Inhibitors/*chemistry/pharmacology', 'Glutathione S-Transferase pi/antagonists & inhibitors/*chemistry', 'Humans', 'Models, Molecular', 'Molecular Conformation', 'Molecular Structure', 'Protein Binding', 'Structure-Activity Relationship', 'Tyrosine/*chemistry']",https://pubmed.ncbi.nlm.nih.gov/27113843/
1961,GSTP1,36709476,Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase Inhibitors.,"['Wang SQ', 'Chen JJ', 'Jiang Y', 'Lei ZN', 'Ruan YC', 'Pan Y', 'Yam JWP', 'Wong MP', 'Xiao ZJ']","['Humans', 'Glutathione S-Transferase pi/genetics/metabolism', 'Tyrosine Kinase Inhibitors', 'NF-E2-Related Factor 2', '*Lung Neoplasms/drug therapy/metabolism', '*Adenocarcinoma of Lung/drug therapy', 'Receptor Protein-Tyrosine Kinases']",https://pubmed.ncbi.nlm.nih.gov/36709476/
1962,GSTP1,10909855,Extended structural variation of a pentanucleotide repeat in the GSTP1 gene: characterisation in a normal population and in thyroid and gastric tumours.,"['Alves C', 'Silva F', 'Gusmao L', 'Seruca R', 'Soares P', 'Reis RM', 'Amorim A']","['Alleles', 'DNA Mutational Analysis', 'DNA Primers/chemistry', 'Gene Frequency', 'Genetic Markers', 'Genotype', 'Glutathione S-Transferase pi', 'Glutathione Transferase/*genetics', 'Humans', 'Isoenzymes/*genetics', 'Loss of Heterozygosity', '*Minisatellite Repeats', '*Mutation', 'Oligonucleotides/*chemistry', 'Polymerase Chain Reaction', 'Sequence Analysis, DNA', 'Stomach Neoplasms/*enzymology', 'Thyroid Neoplasms/*enzymology']",https://pubmed.ncbi.nlm.nih.gov/10909855/
1963,GSTP1,29305565,GSTP1 methylation in cancer: a liquid biopsy biomarker?,"['Gurioli G', 'Martignano F', 'Salvi S', 'Costantini M', 'Gunelli R', 'Casadio V']","['Biomarkers, Tumor/*genetics', 'Glutathione S-Transferase pi/*genetics', 'Humans', 'Liquid Biopsy', 'Male', 'Methylation', 'Prostatic Neoplasms/*diagnosis/genetics']",https://pubmed.ncbi.nlm.nih.gov/29305565/
1964,GSTP1,22183307,"Common polymorphisms in CYP1A1, GSTM1, GSTT1, GSTP1 and XPD genes and endogenous DNA damage.","['Wlodarczyk M', 'Nowicka G']","['Adult', 'Cytochrome P-450 CYP1A1/*genetics', 'DNA Damage/*genetics', 'Female', 'Gene Frequency/genetics', 'Glutathione S-Transferase pi/*genetics', 'Glutathione Transferase/*genetics', 'Heterozygote', 'Humans', 'Male', 'Middle Aged', 'Polymerase Chain Reaction', '*Polymorphism, Genetic', 'Polymorphism, Restriction Fragment Length', 'Xeroderma Pigmentosum Group D Protein/*genetics']",https://pubmed.ncbi.nlm.nih.gov/22183307/
1965,GSTP1,31875251,The association between GSTP1 polymorphism and pre-eclampsia risk: a system review and meta-analysis.,"['Yi K', 'Xu J', 'Peng B']","['Female', 'Genetic Predisposition to Disease', 'Glutathione S-Transferase pi/*adverse effects', 'Humans', 'Oxidative Stress/*physiology', 'Polymorphism, Single Nucleotide', 'Pre-Eclampsia/*genetics/physiopathology', 'Pregnancy', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/31875251/
1966,GSTP1,35893933,"The Associations between Metalloestrogens, GSTP1, and SLC11A2 Polymorphism and the Risk of Endometrial Cancer.","['Michalczyk K', 'Kapczuk P', 'Witczak G', 'Bosiacki M', 'Kurzawski M', 'Chlubek D', 'Cymbaluk-Ploska A']","['Cadmium', 'Case-Control Studies', '*Cation Transport Proteins/genetics', '*Endometrial Neoplasms/genetics', 'Female', 'Genetic Predisposition to Disease', 'Genotype', '*Glutathione S-Transferase pi/genetics', 'Humans', 'Polymorphism, Single Nucleotide', 'Retrospective Studies', 'Risk Factors', '*Trace Elements']",https://pubmed.ncbi.nlm.nih.gov/35893933/
1967,GSTP1,26545608,CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.,"['Akhtar S', 'Mahjabeen I', 'Akram Z', 'Kayani MA']","['Adult', 'Breast Neoplasms/*genetics', 'Case-Control Studies', 'Cytochrome P-450 CYP1A1/*genetics', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'Glutathione S-Transferase pi/*genetics', 'Humans', 'Middle Aged', 'Mutation', 'Pakistan', 'Polymorphism, Genetic', 'Polymorphism, Single-Stranded Conformational']",https://pubmed.ncbi.nlm.nih.gov/26545608/
1968,GSTP1,34238333,GSTP1 as a novel target in radiation induced lung injury.,"['Lei X', 'Du L', 'Yu W', 'Wang Y', 'Ma N', 'Qu B']","['Adult', 'Genetic Predisposition to Disease', 'Genotype', 'Glutathione S-Transferase pi/genetics', 'Glutathione Transferase', 'Humans', 'Lung', '*Lung Injury/genetics']",https://pubmed.ncbi.nlm.nih.gov/34238333/
1969,GSTP1,29970711,Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis.,"['Li Y', 'Cai Y', 'Chen H', 'Mao L']","['Carcinoma, Hepatocellular/diagnosis/*genetics', 'Case-Control Studies', 'CpG Islands', '*DNA Methylation', 'Epigenesis, Genetic', 'Female', 'Gene Expression Regulation, Neoplastic', '*Genetic Association Studies', '*Genetic Predisposition to Disease', 'Glutathione S-Transferase pi/*genetics', 'Humans', 'Liver Neoplasms/diagnosis/*genetics', 'Male', 'Odds Ratio', 'Promoter Regions, Genetic', 'Publication Bias']",https://pubmed.ncbi.nlm.nih.gov/29970711/
1970,GSTP1,23299794,XRCC1 and GSTP1 polymorphisms and prognosis of oxaliplatin-based chemotherapy in colorectal cancer: a meta-analysis.,"['Ye F', 'Liu Z', 'Tan A', 'Liao M', 'Mo Z', 'Yang X']","['Antineoplastic Agents/pharmacokinetics/*therapeutic use', 'Colorectal Neoplasms/*drug therapy/metabolism', 'Confidence Intervals', 'DNA Repair', 'DNA-Binding Proteins/*genetics', 'Disease-Free Survival', 'Genetic Markers', 'Genotype', 'Glutathione S-Transferase pi/*genetics', 'Organoplatinum Compounds/pharmacokinetics/*therapeutic use', 'Oxaliplatin', 'Polymorphism, Genetic/genetics', 'Prognosis', 'Proportional Hazards Models', 'Risk Assessment', 'X-ray Repair Cross Complementing Protein 1']",https://pubmed.ncbi.nlm.nih.gov/23299794/
1971,TUBA4A,26675813,Assessing the role of TUBA4A gene in frontotemporal degeneration.,"['Dols-Icardo O', 'Iborra O', 'Valdivia J', 'Pastor P', 'Ruiz A', 'Lopez de Munain A', 'Sanchez-Valle R', 'Alvarez V', 'Sanchez-Juan P', 'Lleo A', 'Fortea J', 'Blesa R', 'Cardona F', 'Baquero M', 'Alonso MD', 'Ortega-Cubero S', 'Pastor MA', 'Razquin C', 'Boada M', 'Hernandez I', 'Gorostidi A', 'Moreno F', 'Zulaika M', 'Llado A', 'Coto E', 'Combarros O', 'Perez-Tur J', 'Clarimon J']","['Adult', 'Aged', 'Aged, 80 and over', 'Amyotrophic Lateral Sclerosis/genetics', 'Cohort Studies', 'Female', 'Frontotemporal Dementia/*genetics', '*Genetic Association Studies', 'Heterozygote', 'Humans', 'Male', 'Middle Aged', '*Mutation', 'Tubulin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26675813/
1972,TUBA4A,37418012,A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A.,"['Torella A', 'Ricca I', 'Piluso G', 'Galatolo D', 'De Michele G', 'Zanobio M', 'Trovato R', 'De Michele G', 'Zeuli R', 'Pane C', 'Cocozza S', 'Sacca F', 'Santorelli FM', 'Nigro V', 'Filla A']","['Humans', '*Intellectual Disability/genetics', 'Muscle Spasticity/genetics/pathology', 'Mutation/genetics', '*Optic Atrophy/genetics', 'Phenotype', '*Spastic Paraplegia, Hereditary/genetics', '*Spinocerebellar Ataxias/genetics/pathology', '*Tubulin/genetics']",https://pubmed.ncbi.nlm.nih.gov/37418012/
1973,TUBA4A,38884572,De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticity.,"['Benkirane M', 'Bonhomme M', 'Morsy H', 'Safgren SL', 'Marelli C', 'Chaussenot A', 'Smedley D', 'Cipriani V', 'de Sainte-Agathe JM', 'Ding C', 'Larrieu L', 'Vestito L', 'Margot H', 'Lesca G', 'Ramond F', 'Castrioto A', 'Baux D', 'Verheijen J', 'Sansa E', 'Giunti P', 'Haetty A', 'Bergougnoux A', 'Pointaux M', 'Ardouin O', 'Van Goethem C', 'Vincent MC', 'Hadjivassiliou M', 'Cossee M', 'Rouaud T', 'Bartsch O', 'Freeman WD', 'Wierenga KJ', 'Klee EW', 'Vandrovcova J', 'Houlden H', 'Debant A', 'Koenig M']","['Humans', '*Tubulin/genetics', 'Male', 'Female', 'Middle Aged', '*Muscle Spasticity/genetics', '*Mutation, Missense/genetics', 'Adult', 'Aged', 'Cerebellar Ataxia/genetics', 'Spinocerebellar Ataxias/genetics', 'Pedigree', 'Cohort Studies', 'France', 'Intellectual Disability', 'Optic Atrophy']",https://pubmed.ncbi.nlm.nih.gov/38884572/
1974,TUBA4A,25374348,Excess of rare damaging TUBA4A variants suggests cytoskeletal defects in ALS.,"['Rademakers R', 'van Blitterswijk M']","['Amyotrophic Lateral Sclerosis/*genetics', 'Exome/*genetics', '*Genetic Predisposition to Disease', 'Humans', 'Mutation/*genetics', 'Tubulin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/25374348/
1975,TUBA4A,33760283,An autopsy case of pure nigropathy with TUBA4A nonsense mutation.,"['Okada K', 'Hata Y', 'Ichimata S', 'Yoshida K', 'Oku Y', 'Asahi T', 'Nishida N']","['Amyotrophic Lateral Sclerosis/diagnosis/genetics', 'Autopsy/methods', 'Brain/*pathology', 'Codon, Nonsense/genetics', 'Frontotemporal Dementia/diagnosis/genetics', 'Humans', 'Mutation/*genetics', 'Parkinson Disease/diagnosis/*genetics/pathology', 'Tubulin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/33760283/
1976,TUBA4A,36747013,In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration.,"['Ganne A', 'Balasubramaniam M', 'Ayyadevara H', 'Kiaei L', 'Shmookler Reis RJ', 'Varughese KI', 'Kiaei M']","['Humans', '*Amyotrophic Lateral Sclerosis/metabolism', 'Tubulin/genetics', 'Superoxide Dismutase-1/genetics', 'Molecular Docking Simulation', 'C9orf72 Protein/genetics', 'Mutation', 'Microtubules/metabolism', 'Guanosine Triphosphate', 'Profilins/genetics']",https://pubmed.ncbi.nlm.nih.gov/36747013/
1977,TUBA4A,38413182,Novel TUBA4A variant causes congenital myopathy with focal myofibrillar disorganisation.,"['Wan Y', 'Zhou C', 'Chang X', 'Wu L', 'Zheng Y', 'Yu J', 'Bai L', 'Luan M', 'Yu M', 'Wang Q', 'Zhang W', 'Yuan Y', 'Deng J', 'Wang Z']","['Adult', 'Female', 'Humans', 'Male', 'Exome Sequencing', 'Muscle, Skeletal/pathology/diagnostic imaging/metabolism', 'Mutation', 'Myofibrils/pathology/genetics', '*Myopathies, Structural, Congenital/genetics/pathology', 'Myotonia Congenita/genetics/pathology', 'Pedigree', '*Tubulin/genetics']",https://pubmed.ncbi.nlm.nih.gov/38413182/
1978,TUBA4A,26465396,TUBA4A may not be a significant genetic factor in Chinese ALS patients.,"['Li J', 'He J', 'Tang L', 'Chen L', 'Xu L', 'Ma Y', 'Zhang N', 'Fan D']","['Age Distribution', 'Amyotrophic Lateral Sclerosis/*epidemiology/*genetics', 'China/epidemiology', 'Comorbidity', 'Female', 'Genetic Association Studies', 'Genetic Markers/genetics', 'Genetic Predisposition to Disease/*epidemiology/*genetics', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Single Nucleotide/*genetics', 'Prevalence', 'Reproducibility of Results', 'Risk Assessment/methods', 'Sensitivity and Specificity', 'Sex Distribution', 'Tubulin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/26465396/
1979,TUBA4A,35327632,Frontotemporal Lobar Degeneration Case with an N-Terminal TUBA4A Mutation Exhibits Reduced TUBA4A Levels in the Brain and TDP-43 Pathology.,"['Van Schoor E', 'Vandenbulcke M', 'Bercier V', 'Vandenberghe R', 'van der Zee J', 'Van Broeckhoven C', 'Otto M', 'Hanseeuw B', 'Van Damme P', 'Van Den Bosch L', 'Thal DR']","['Brain/metabolism', 'DNA-Binding Proteins/genetics/metabolism', '*Frontotemporal Dementia', '*Frontotemporal Lobar Degeneration/genetics/metabolism/pathology', 'Humans', 'Mutation', 'RNA, Messenger/genetics']",https://pubmed.ncbi.nlm.nih.gov/35327632/
1980,TUBA4A,25374358,Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.,"['Smith BN', 'Ticozzi N', 'Fallini C', 'Gkazi AS', 'Topp S', 'Kenna KP', 'Scotter EL', 'Kost J', 'Keagle P', 'Miller JW', 'Calini D', 'Vance C', 'Danielson EW', 'Troakes C', 'Tiloca C', 'Al-Sarraj S', 'Lewis EA', 'King A', 'Colombrita C', 'Pensato V', 'Castellotti B', 'de Belleroche J', 'Baas F', 'ten Asbroek AL', 'Sapp PC', 'McKenna-Yasek D', 'McLaughlin RL', 'Polak M', 'Asress S', 'Esteban-Perez J', 'Munoz-Blanco JL', 'Simpson M', 'van Rheenen W', 'Diekstra FP', 'Lauria G', 'Duga S', 'Corti S', 'Cereda C', 'Corrado L', 'Soraru G', 'Morrison KE', 'Williams KL', 'Nicholson GA', 'Blair IP', 'Dion PA', 'Leblond CS', 'Rouleau GA', 'Hardiman O', 'Veldink JH', 'van den Berg LH', 'Al-Chalabi A', 'Pall H', 'Shaw PJ', 'Turner MR', 'Talbot K', 'Taroni F', 'Garcia-Redondo A', 'Wu Z', 'Glass JD', 'Gellera C', 'Ratti A', 'Brown RH Jr', 'Silani V', 'Shaw CE', 'Landers JE']","['Amyotrophic Lateral Sclerosis/*genetics', 'Brain/metabolism/pathology', 'Exome/*genetics', '*Genetic Predisposition to Disease', 'Humans', 'Mutation/*genetics', 'Neurons/metabolism', 'Sequence Analysis, DNA', 'Tubulin/*genetics/metabolism']",https://pubmed.ncbi.nlm.nih.gov/25374358/
1981,TUBA4A,28069311,Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients.,"['Perrone F', 'Nguyen HP', 'Van Mossevelde S', 'Moisse M', 'Sieben A', 'Santens P', 'De Bleecker J', 'Vandenbulcke M', 'Engelborghs S', 'Baets J', 'Cras P', 'Vandenberghe R', 'De Jonghe P', 'De Deyn PP', 'Martin JJ', 'Van Damme P', 'Van Broeckhoven C', 'van der Zee J']","['Aged', 'Aged, 80 and over', 'Amyotrophic Lateral Sclerosis/*genetics', 'Belgium', 'Cohort Studies', 'Female', 'Frontotemporal Dementia/*genetics', '*Genetic Association Studies', 'Humans', 'Male', 'Middle Aged', 'Mitochondrial Proteins/*genetics', '*Mutation', 'Tubulin/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28069311/
1982,GABBR2,37668872,HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes.,"['Al-Khfaji KMS', 'Zamani NK', 'Arefian E']","['*Herpesvirus 1, Human/genetics', ""3' Untranslated Regions"", 'Gene Expression Regulation, Viral', '*MicroRNAs/genetics/metabolism', 'Luciferases/genetics']",https://pubmed.ncbi.nlm.nih.gov/37668872/
1983,GABBR2,35414446,Paroxysmal limb dystonias associated with GABBR2 pathogenic variant: A case-based literature review.,"[""D'Onofrio G"", 'Riva A', 'Di Rosa G', ""Cali' E"", 'Efthymiou S', 'Gitto E', 'Madia F', 'Accogli A', 'Zara F', 'Houlden H', 'Salpietro V', 'Striano P', 'Soler D']","['Child', '*Dystonia', '*Epilepsy/drug therapy/genetics', 'Extremities', 'Female', 'Humans', 'Muscle Hypotonia', 'Receptors, GABA-B', '*Rett Syndrome/genetics']",https://pubmed.ncbi.nlm.nih.gov/35414446/
1984,GABBR2,37762034,GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer.,"['Elahi Najafi MA', 'Yasui M', 'Teramoto Y', 'Tatenuma T', 'Jiang G', 'Miyamoto H']","['Humans', '*Cisplatin/pharmacology/therapeutic use', 'Receptors, Androgen/genetics/metabolism', 'Dihydrotestosterone/pharmacology', '*Urinary Bladder Neoplasms/drug therapy/genetics/metabolism', 'Cell Proliferation', 'Cell Line, Tumor']",https://pubmed.ncbi.nlm.nih.gov/37762034/
1985,GABBR2,28856709,GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy.,"['Yoo Y', 'Jung J', 'Lee YN', 'Lee Y', 'Cho H', 'Na E', 'Hong J', 'Kim E', 'Lee JS', 'Lee JS', 'Hong C', 'Park SY', 'Wie J', 'Miller K', 'Shur N', 'Clow C', 'Ebel RS', 'DeBrosse SD', 'Henderson LB', 'Willaert R', 'Castaldi C', 'Tikhonova I', 'Bilguvar K', 'Mane S', 'Kim KJ', 'Hwang YS', 'Lee SG', 'So I', 'Lim BC', 'Choi HJ', 'Seong JY', 'Shin YB', 'Jung H', 'Chae JH', 'Choi M']","['Exome', 'Genotype', 'HEK293 Cells', 'Humans', 'Methyl-CpG-Binding Protein 2/genetics', '*Mutation', 'Phenotype', 'Receptors, GABA-B/*genetics', 'Rett Syndrome/*genetics', 'Signal Transduction/genetics', 'Spasms, Infantile/*genetics']",https://pubmed.ncbi.nlm.nih.gov/28856709/
1986,GABBR2,27033668,A GABBR2 gene variant modifies pathophysiology in Huntington's disease.,"['Philpott AL', 'Fitzgerald PB', 'Bailey NW', 'Churchyard A', 'Georgiou-Karistianis N', 'Cummins TD']","['Adult', 'Age of Onset', 'Cerebral Cortex/physiopathology', 'Cross-Sectional Studies', 'Female', 'Genetic Association Studies', 'Humans', 'Huntington Disease/*genetics/physiopathology', 'Male', 'Middle Aged', 'Neuronal Plasticity', 'Polymorphism, Single Nucleotide', 'Receptors, Dopamine D2/genetics', 'Receptors, GABA-A/genetics', 'Receptors, GABA-B/*genetics', 'Spinal Cord/physiopathology', 'Transcranial Magnetic Stimulation']",https://pubmed.ncbi.nlm.nih.gov/27033668/
1987,GABBR2,19763258,Association and interaction analyses of GABBR1 and GABBR2 with nicotine dependence in European- and African-American populations.,"['Li MD', 'Mangold JE', 'Seneviratne C', 'Chen GB', 'Ma JZ', 'Lou XY', 'Payne TJ']","['Adult', 'Black or African American', 'Black People', 'Epistasis, Genetic', 'Female', 'Genetic Predisposition to Disease', 'Genetic Variation', 'Haplotypes', 'Humans', 'Male', 'Middle Aged', 'Polymorphism, Genetic', 'Receptors, GABA-B/*genetics/*physiology', 'Risk', 'Smoking', 'Tobacco Use Disorder/*genetics', 'United States', 'White People']",https://pubmed.ncbi.nlm.nih.gov/19763258/
1988,GABBR2,28490462,Genome-wide DNA Methylation Analysis Reveals GABBR2 as a Novel Epigenetic Target for EGFR 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment.,"['Niu X', 'Liu F', 'Zhou Y', 'Zhou Z', 'Zhou D', 'Wang T', 'Li Z', 'Ye X', 'Yu Y', 'Weng X', 'Zhang H', 'Ye J', 'Liao M', 'Liu Y', 'Chen Z', 'Lu S']","['Adenocarcinoma/drug therapy/*genetics/pathology', 'Adenocarcinoma of Lung', 'Apoptosis/genetics', 'Cell Line, Tumor', 'Cell Proliferation', 'DNA Methylation/drug effects/*genetics', 'Drug Resistance, Neoplasm/genetics', 'Epigenesis, Genetic/genetics', 'ErbB Receptors/*genetics', 'Erlotinib Hydrochloride/administration & dosage', 'Gene Expression Regulation, Neoplastic/drug effects', 'Genome, Human/drug effects/genetics', 'Humans', 'Lung Neoplasms/drug therapy/*genetics/pathology', 'Male', 'Middle Aged', 'Mutation', 'Protein Kinase Inhibitors/administration & dosage', 'Receptors, GABA-B/*genetics', 'Repressor Proteins/genetics', 'Sequence Deletion', 'Signal Transduction/drug effects', 'Treatment Outcome', 'Tumor Suppressor Proteins/genetics']",https://pubmed.ncbi.nlm.nih.gov/28490462/
1989,SLC22A3,28743982,Oesophageal cancer: RNA editing of SLC22A3 mRNAs: causative relevance to familial ESCC?,['Nishikura K'],"['*Carcinoma, Squamous Cell', '*Esophageal Neoplasms', 'Humans', 'RNA Editing', 'RNA, Messenger']",https://pubmed.ncbi.nlm.nih.gov/28743982/
1990,SLC22A3,36461046,SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia.,"['Gu Y', 'Xu ZJ', 'Zhou JD', 'Wen XM', 'Jin Y', 'Yuan Q', 'Xia PH', 'Feng Y', 'Yang L', 'Lin J', 'Qian J']","['Humans', '*DNA Methylation', 'Prognosis', 'Gene Silencing', '*Leukemia, Myeloid, Acute/genetics', 'Protein Processing, Post-Translational']",https://pubmed.ncbi.nlm.nih.gov/36461046/
1991,SLC22A3,37948393,Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients.,"['Al-Eitan LN', 'Almasri AY', 'Alnaamneh AH', 'Mihyar A']","['Drug Resistance', 'Warfarin/pharmacology', 'Anticoagulants', 'Lipoprotein(a)/genetics', 'Polymorphism, Single Nucleotide', 'MEF2 Transcription Factors/genetics', 'Humans', '*Cardiovascular Diseases', 'Jordan', 'Genetic Predisposition to Disease', 'Metabolism, Inborn Errors', 'Genotype']",https://pubmed.ncbi.nlm.nih.gov/37948393/
1992,SLC22A3,34969749,A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy.,"['Li J', 'Persaud AK', 'Johnson JA', 'Sborov DW', 'Phelps MA', 'Hofmeister CC', 'Poi MJ']","['Adult', 'Aged', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Melphalan/adverse effects/therapeutic use', 'Middle Aged', 'Multiple Myeloma/complications/genetics/pathology/*therapy', 'Organic Cation Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide/genetics', 'Stem Cell Transplantation/adverse effects', 'Stomatitis/epidemiology/*genetics/pathology', 'Transplantation, Autologous/adverse effects']",https://pubmed.ncbi.nlm.nih.gov/34969749/
1993,SLC22A3,36254631,Repression of SLC22A3 by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer.,"['Seo E', 'Jee B', 'Chung JH', 'Song W', 'Sung HH', 'Jeon HG', 'Jeong BC', 'Seo SI', 'Jeon SS', 'Lee HM', 'Kang M']","['Humans', 'Male', '*Androgen Receptor Antagonists/pharmacology/therapeutic use', '*Antineoplastic Agents, Hormonal/pharmacology/therapeutic use', '*Drug Resistance, Neoplasm/genetics', 'Nitriles/pharmacology/therapeutic use', '*Organic Cation Transport Proteins/metabolism', 'Phenylthiohydantoin/pharmacology/therapeutic use', '*Prostatic Neoplasms, Castration-Resistant/drug therapy/genetics/metabolism/secondary', 'Receptors, Androgen/genetics/metabolism', 'Transcriptional Coactivator with PDZ-Binding Motif Proteins/metabolism', '*YAP-Signaling Proteins/metabolism']",https://pubmed.ncbi.nlm.nih.gov/36254631/
1994,SLC22A3,31874997,Protein expression of ABCC2 and SLC22A3 associates with prognosis of pancreatic adenocarcinoma.,"['Cervenkova L', 'Vycital O', 'Bruha J', 'Rosendorf J', 'Palek R', 'Liska V', 'Daum O', 'Mohelnikova-Duchonova B', 'Soucek P']","['*Adenocarcinoma/metabolism/mortality/pathology', 'Aged', 'Disease-Free Survival', 'Female', '*Gene Expression Regulation, Neoplastic', 'Humans', 'Male', 'Middle Aged', 'Multidrug Resistance-Associated Protein 2', 'Multidrug Resistance-Associated Proteins/*biosynthesis', 'Neoplasm Proteins/*biosynthesis', 'Organic Cation Transport Proteins/*biosynthesis', '*Pancreatic Neoplasms/metabolism/mortality/pathology', 'Survival Rate']",https://pubmed.ncbi.nlm.nih.gov/31874997/
1995,SLC22A3,30772277,SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia.,"['Paquette M', 'Bernard S', 'Baass A']","['Adult', 'Cardiovascular Diseases/*genetics', 'Cohort Studies', 'Female', 'Genome-Wide Association Study', 'Humans', 'Hyperlipoproteinemia Type II/*genetics', 'Lipoprotein(a)/blood/*metabolism', 'Male', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/30772277/
1996,SLC22A3,37924453,Genetic preservation of SLC22A3 in the Admixed and Xhosa populations living in the Western Cape.,"['Pearce B', 'Jacobs C', 'Benjeddou M']","['Humans', 'Cations', 'Gene Frequency/genetics', '*Metformin', '*Polymorphism, Single Nucleotide/genetics', 'South Africa']",https://pubmed.ncbi.nlm.nih.gov/37924453/
1997,SLC22A3,27893421,PHACTR1 and SLC22A3 gene polymorphisms are associated with reduced coronary artery disease risk in the male Chinese Han population.,"['Zhao Q', 'Wei H', 'Liu D', 'Shi B', 'Li L', 'Yan M', 'Zhang X', 'Wang F', 'Ouyang Y']","['Aged', 'Alleles', 'Asian People/*genetics', 'Case-Control Studies', 'China/epidemiology', 'Coronary Artery Disease/*epidemiology/*genetics', 'Gene Frequency', 'Genetic Association Studies', '*Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Male', 'Microfilament Proteins/*genetics', 'Middle Aged', 'Odds Ratio', 'Organic Cation Transport Proteins/*genetics', '*Polymorphism, Single Nucleotide', 'Sex Factors']",https://pubmed.ncbi.nlm.nih.gov/27893421/
1998,SLC22A3,27417586,Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease.,"['Wang L', 'Chen J', 'Zeng Y', 'Wei J', 'Jing J', 'Li G', 'Su L', 'Tang X', 'Wu T', 'Zhou L']","[""3' Untranslated Regions"", 'Aged', 'Apolipoprotein A-II/*genetics/metabolism', 'Asian People/genetics', 'Binding Sites', 'Case-Control Studies', 'China/epidemiology', 'Coronary Angiography', 'Coronary Artery Disease/blood/diagnostic imaging/ethnology/*genetics', 'Female', 'Gene Expression Regulation', 'Genetic Association Studies', '*Genetic Loci', 'Genetic Markers', 'Genetic Predisposition to Disease', 'HEK293 Cells', 'HeLa Cells', 'Humans', 'Lipoprotein(a)/blood/*genetics', 'Male', 'MicroRNAs/genetics/metabolism', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics/metabolism', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Risk Factors', 'Severity of Illness Index']",https://pubmed.ncbi.nlm.nih.gov/27417586/
1999,SLC22A3,33168399,Effect of Genetic Polymorphisms of Human SLC22A3 in the 5'-flanking Region on OCT3 Expression and Sebum Levels in Human Skin.,"['Takechi T', 'Hirota T', 'Fujii K', 'Nakahara T', 'Sakai T', 'Maeda N', 'Furue M', 'Ieiri I']","[""5' Flanking Region/genetics"", 'Adult', 'Female', 'Gene Expression Regulation', 'Gene Knockdown Techniques', 'HaCaT Cells', 'Humans', 'Immunohistochemistry', 'Middle Aged', 'Octamer Transcription Factor-3/*metabolism', 'Organic Cation Transport Proteins/*genetics/metabolism', 'Polymorphism, Single Nucleotide', 'Promoter Regions, Genetic/genetics', 'Sebum/*metabolism', 'Skin/*metabolism', 'Skin Physiological Phenomena/*genetics', 'Transcriptional Activation', 'Tumor Suppressor Protein p53/metabolism', 'Young Adult']",https://pubmed.ncbi.nlm.nih.gov/33168399/
2000,SLC22A3,30561001,Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer.,"['Ren A', 'Sun S', 'Li S', 'Chen T', 'Shu Y', 'Du M', 'Zhu L']","['Asian People/genetics', 'Cell Death/genetics', 'Cell Proliferation/genetics', 'Chromosomes, Human, Pair 6', 'Colorectal Neoplasms/blood/*genetics/pathology', 'Ethnicity/genetics', 'Female', 'Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Genotype', 'Humans', 'Male', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics', 'Polymorphism, Single Nucleotide']",https://pubmed.ncbi.nlm.nih.gov/30561001/
2001,SLC22A3,28272475,"SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.","['Mohelnikova-Duchonova B', 'Strouhal O', 'Hughes DJ', 'Holcatova I', 'Oliverius M', 'Kala Z', 'Campa D', 'Rizzato C', 'Canzian F', 'Pezzilli R', 'Talar-Wojnarowska R', 'Malecka-Panas E', 'Sperti C', 'Federico Zambon C', 'Pedrazzoli S', 'Fogar P', 'Milanetto AC', 'Capurso G', 'Delle Fave G', 'Valente R', 'Gazouli M', 'Malleo G', 'Teresa Lawlor R', 'Strobel O', 'Hackert T', 'Giese N', 'Vodicka P', 'Vodickova L', 'Landi S', 'Tavano F', 'Gioffreda D', 'Piepoli A', 'Pazienza V', 'Mambrini A', 'Pedata M', 'Cantore M', 'Bambi F', 'Ermini S', 'Funel N', 'Lemstrova R', 'Soucek P']","['Adult', 'Aged', 'Carcinoma, Pancreatic Ductal/*genetics/pathology', 'Enhancer Elements, Genetic/genetics', 'Female', 'Genetic Predisposition to Disease/*genetics', 'Humans', 'Kaplan-Meier Estimate', 'Male', 'Middle Aged', 'Organic Cation Transport Proteins/*genetics', 'Pancreatic Neoplasms/*genetics/pathology', '*Polymorphism, Single Nucleotide', 'Prognosis', 'Risk Factors']",https://pubmed.ncbi.nlm.nih.gov/28272475/
